age,sex,hospdead,dzgroup,edu,income,charges,race,ca,prg2m,prg6m,dnr,dnrday,meanbp,wblc,hrt,resp,temp,pafi,alb,bili,crea,sod,ph,glucose,bun,urine,adlp,adls,sfdm2,adlsc
62.84998,male,0.0,Lung Cancer,11.0,$11-$25k,9715.0,other,metastatic,0.5,0.25,no dnr,5.0,97.0,6.0,69.0,22.0,36.0,388.0,1.7998047,0.19998169,1.19995117,141.0,7.459961,135.0,23.0,1968.0,7.0,7.0,<2 mo. follow-up,7.0
60.33899,female,1.0,Cirrhosis,12.0,$11-$25k,34496.0,white,no,0.0,0.0,no dnr,9.0,43.0,17.0976562,112.0,34.0,34.59375,98.0,2.8999023,0.89990234,5.5,132.0,7.25,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
52.74698,female,0.0,Cirrhosis,12.0,under $11k,41094.0,white,no,0.75,0.5,no dnr,17.0,70.0,8.5,88.0,28.0,37.39844,231.65625,2.8999023,2.19970703,2.0,134.0,7.459961,135.0,23.0,1968.0,1.0,0.0,<2 mo. follow-up,0.0
42.38498,female,0.0,Lung Cancer,11.0,under $11k,3075.0,white,metastatic,0.899999619,0.5,no dnr,3.0,75.0,9.09960938,88.0,32.0,35.0,224.0,2.8999023,0.89990234,0.79992676,139.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
79.88495,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,50127.0,white,no,0.899999619,0.8999996,no dnr,16.0,59.0,13.5,112.0,20.0,37.89844,173.3125,2.8999023,0.89990234,0.79992676,143.0,7.509766,135.0,23.0,1968.0,0.0,2.0,no(M2 and SIP pres),2.0
93.01599,male,1.0,Coma,14.0,under $11k,6884.0,white,no,0.0,0.0,no dnr,4.0,110.0,10.3984375,101.0,44.0,38.39844,266.625,2.8999023,0.89990234,0.69995117,140.0,7.65918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
62.37097,male,0.0,CHF,14.0,$25-$50k,30460.0,white,no,0.699999809,0.6999998,no dnr,9.0,78.0,11.6992188,120.0,28.0,37.39844,309.5,4.7998047,0.39996338,1.59985352,132.0,7.479492,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
86.83899,male,0.0,CHF,12.0,under $11k,30460.0,white,no,0.799999714,0.3999999,no dnr,7.0,72.0,13.5996094,100.0,26.0,37.59375,404.75,2.8999023,0.89990234,2.0,139.0,7.509766,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
85.65594,male,0.0,Lung Cancer,12.0,under $11k,25024.0,black,metastatic,0.049999982,0.0001249999,dnr after sadm,2.0,97.0,9.69921875,56.0,20.0,36.59375,357.125,2.8999023,0.39996338,1.0,143.0,7.449219,135.0,23.0,1968.0,0.0,7.0,<2 mo. follow-up,7.0
42.25897,female,0.0,Colon Cancer,11.0,$25-$50k,9914.0,hispanic,metastatic,0.699999809,0.5,no dnr,8.0,84.0,11.2988281,94.0,20.0,38.19531,224.0,4.6992188,0.19998169,0.79992676,139.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
47.94498,male,0.0,CHF,12.0,under $11k,15558.0,white,no,0.699999809,0.5,no dnr,7.0,70.0,10.8984375,105.0,24.0,36.5,224.0,4.1992188,0.5,1.0,134.0,7.419922,135.0,23.0,1968.0,2.0,1.0,no(M2 and SIP pres),1.0
59.20099,male,1.0,Lung Cancer,14.0,under $11k,29388.0,white,metastatic,0.699999809,0.5,dnr after sadm,12.0,77.0,10.7988281,90.0,22.0,36.39844,224.0,2.8999023,0.89990234,1.09985352,136.0,7.419922,135.0,23.0,1968.0,1.0,1.0,<2 mo. follow-up,1.0
29.002,female,0.0,Cirrhosis,16.0,$11-$25k,4353.0,white,no,0.699999809,0.5,no dnr,4.0,56.0,5.5,56.0,20.0,37.19531,224.0,2.8999023,6.09960938,0.69995117,130.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
68.14197,male,0.0,CHF,12.0,$11-$25k,19783.0,white,no,0.899999619,0.6999998,no dnr,8.0,68.0,9.3984375,80.0,22.0,36.0,224.0,2.8999023,0.59997559,2.59960938,139.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
43.53998,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,706577.0,white,no,0.899999619,0.8999996,no dnr,115.0,67.0,24.5976562,172.0,20.0,38.79688,113.32812,2.8999023,0.89990234,0.59997559,134.0,7.399414,135.0,23.0,1968.0,0.0,1.0,SIP>=30,2.7641602
58.823,female,0.0,Lung Cancer,12.0,>$50k,10758.0,white,metastatic,0.899999619,0.6999998,no dnr,7.0,97.0,15.8984375,92.0,20.0,37.19531,224.0,4.2998047,0.19998169,0.79992676,134.0,7.419922,135.0,23.0,1968.0,2.0,0.0,<2 mo. follow-up,0.0
45.418,male,0.0,Lung Cancer,12.0,under $11k,8400.0,white,metastatic,0.699999809,0.5,no dnr,7.0,97.0,10.7988281,100.0,24.0,37.29688,585.125,2.8999023,0.29998779,1.09985352,137.0,7.489258,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.3515625
63.66299,female,1.0,ARF/MOSF w/Sepsis,22.0,$25-$50k,283303.0,white,no,0.099999964,0.0009999992,dnr after sadm,12.0,69.0,30.0976562,108.0,22.0,36.69531,155.53125,2.8999023,14.0,2.89990234,130.0,7.449219,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
31.84399,male,1.0,Cirrhosis,16.0,under $11k,27985.0,white,no,0.699999809,0.5,dnr after sadm,12.0,83.0,5.0,100.0,24.0,37.39844,224.0,1.6999512,12.7988281,0.29998779,122.0,7.419922,135.0,23.0,1968.0,7.0,7.0,<2 mo. follow-up,7.0
55.13797,male,0.0,CHF,8.0,$11-$25k,18191.0,hispanic,no,0.5,0.5,no dnr,10.0,78.0,10.5996094,72.0,20.0,36.0,224.0,2.8999023,0.89990234,1.5,134.0,7.419922,135.0,23.0,1968.0,3.0,1.0,no(M2 and SIP pres),2.5110989
68.25494,male,0.0,Lung Cancer,13.0,>$50k,10755.0,white,metastatic,0.899999619,0.6999998,no dnr,7.0,91.0,5.0,92.0,20.0,36.5,224.0,4.2998047,0.29998779,1.19995117,138.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
48.70398,male,0.0,Lung Cancer,16.0,under $11k,55384.0,other,metastatic,0.5,0.125,dnr after sadm,11.0,66.0,12.5,125.0,30.0,37.0,170.0,2.8999023,0.89990234,1.0,133.0,7.519531,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.2636719
49.61298,female,0.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,542266.0,white,no,0.599999905,0.5,no dnr,50.0,67.0,11.0,120.0,48.0,38.89844,200.0,2.0,4.09960938,0.59997559,130.0,7.399414,135.0,23.0,1968.0,0.0,5.0,adl>=4 (>=5 if sur),5.0
50.724,female,0.0,Lung Cancer,12.0,$25-$50k,4913.0,asian,metastatic,1.0,1.0,no dnr,3.0,71.0,9.79882812,88.0,24.0,37.39844,224.0,2.8999023,0.89990234,0.89990234,141.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.065918
29.36099,female,0.0,Colon Cancer,17.0,$25-$50k,7792.0,white,metastatic,0.5,0.09999996,no dnr,4.0,96.0,10.5996094,112.0,20.0,37.0,224.0,3.699707,1.39990234,0.59997559,137.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.8149414
53.84,male,0.0,COPD,12.0,under $11k,9871.0,white,no,0.899999619,0.5999999,dnr after sadm,4.0,134.0,7.79980469,106.0,22.0,37.89844,304.125,3.7998047,0.5,0.79992676,141.0,7.379883,135.0,23.0,1968.0,5.0,4.0,no(M2 and SIP pres),4.0
82.41498,female,1.0,Lung Cancer,12.0,under $11k,7212.0,white,metastatic,0.699999809,0.5,dnr before sadm,-1.0,75.0,6.79980469,114.0,20.0,37.19531,224.0,3.0996094,0.89990234,1.79980469,131.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.7041016
27.32399,male,1.0,MOSF w/Malig,19.0,under $11k,160060.0,asian,yes,0.049999982,0.0001249999,dnr after sadm,5.0,77.0,0.09999084,144.0,36.0,38.89844,45.0,2.3999023,5.0,1.39990234,147.0,7.30957,135.0,23.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
30.10799,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,57611.0,asian,no,0.699999809,0.5,no dnr,10.0,92.0,8.79882812,112.0,27.0,37.59375,225.0,2.8999023,0.89990234,0.39996338,134.0,7.459961,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.8461914
50.37097,male,0.0,Cirrhosis,16.0,$11-$25k,465380.0,white,no,0.699999809,0.5,no dnr,105.0,98.0,8.3984375,82.0,20.0,37.39844,197.5,3.0,6.79980469,0.69995117,138.0,7.319336,135.0,23.0,1968.0,3.0,1.0,SIP>=30,1.0
74.48297,male,0.0,CHF,16.0,>$50k,18134.0,white,no,0.949999809,0.5999999,no dnr,15.0,111.0,6.89941406,60.0,32.0,36.79688,224.0,3.7998047,0.59997559,1.59985352,142.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
55.73199,male,0.0,Cirrhosis,8.0,under $11k,52092.0,hispanic,no,0.899999619,0.8999996,no dnr,13.0,121.0,19.6992188,118.0,18.0,37.39844,404.75,2.199707,0.89990234,0.79992676,117.0,7.379883,135.0,23.0,1968.0,7.0,6.0,SIP>=30,6.0
77.21295,female,0.0,COPD,0.0,under $11k,9078.0,hispanic,no,0.75,0.75,dnr after sadm,2.0,113.0,8.29882812,93.0,25.0,36.19531,250.0,2.8999023,0.89990234,2.09960938,145.0,7.269531,135.0,23.0,1968.0,0.0,7.0,<2 mo. follow-up,7.0
61.02399,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,109627.0,white,no,0.599999905,0.5999999,dnr after sadm,17.0,80.0,15.3984375,128.0,30.0,38.5,217.5,2.2998047,0.39996338,2.39990234,143.0,7.329102,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.8251953
56.48999,female,0.0,CHF,12.0,under $11k,38548.0,hispanic,no,0.699999809,0.5,no dnr,5.0,38.0,10.5996094,92.0,20.0,36.0,224.0,2.8999023,0.89990234,6.0,133.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.0981445
57.53299,female,0.0,Cirrhosis,14.0,under $11k,156556.0,hispanic,no,0.699999809,0.5,no dnr,28.0,77.0,12.1992188,92.0,18.0,37.59375,552.375,2.5,23.5976562,0.89990234,132.0,7.439453,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),3.1318359
68.98596,female,0.0,COPD,10.0,under $11k,5763.0,white,no,0.989999771,0.9499998,no dnr,4.0,76.0,10.5996094,78.0,26.0,36.59375,280.9375,4.0,0.89990234,0.79992676,142.0,7.359375,135.0,23.0,1968.0,1.0,0.0,SIP>=30,0.0
41.97897,male,0.0,CHF,14.0,$11-$25k,5552.0,white,no,0.699999809,0.5,no dnr,6.0,120.0,8.3984375,86.0,22.0,37.5,295.1875,2.8999023,0.89990234,1.79980469,129.0,7.5,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
19.79199,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,167971.0,black,no,0.899999619,0.75,no dnr,33.0,83.0,9.59960938,52.0,6.0,39.0,310.0,2.8999023,0.89990234,1.19995117,131.0,7.439453,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
57.50897,female,0.0,CHF,14.0,under $11k,6403.0,black,no,1.0,1.0,no dnr,4.0,83.0,14.2988281,106.0,24.0,36.79688,280.9375,2.8999023,0.89990234,2.29980469,138.0,7.449219,135.0,23.0,1968.0,5.0,6.0,SIP>=30,6.0
73.40698,male,0.0,Colon Cancer,12.0,under $11k,22934.0,white,metastatic,0.899999619,0.3999999,no dnr,9.0,71.0,16.5,76.0,10.0,37.0,224.0,4.0,0.59997559,0.79992676,141.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.4677734
68.31799,male,0.0,Colon Cancer,21.0,>$50k,9205.0,white,metastatic,0.699999809,0.5,no dnr,6.0,89.0,10.5996094,92.0,18.0,39.0,224.0,2.8999023,0.5,1.0,136.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
75.79498,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,271250.0,white,no,0.699999809,0.5,dnr after sadm,21.0,59.0,30.5976562,90.0,22.0,37.5,70.90625,1.8999023,5.39941406,2.69970703,128.0,7.329102,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.6855469
45.71899,male,0.0,CHF,12.0,under $11k,115112.0,white,no,0.899999619,0.5,no dnr,20.0,57.0,12.2988281,96.0,22.0,36.0,185.0,3.8999023,0.89990234,1.39990234,135.0,7.599609,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
75.48798,male,0.0,CHF,16.0,under $11k,120920.0,hispanic,no,0.5,0.5,dnr after sadm,16.0,62.0,21.796875,102.0,24.0,36.59375,415.0,2.8999023,0.89990234,4.0,124.0,7.429688,135.0,23.0,1968.0,2.0,0.0,<2 mo. follow-up,0.0
74.995,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,348931.0,white,no,0.699999809,0.5,dnr after sadm,23.0,50.0,51.1953125,120.0,18.0,36.19531,237.5,2.8999023,1.0,4.79980469,135.0,7.439453,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.4423828
56.19397,male,1.0,ARF/MOSF w/Sepsis,6.0,under $11k,230733.0,other,no,0.699999809,0.5,dnr after sadm,20.0,68.0,26.6992188,130.0,28.0,38.5,121.65625,1.6999512,3.89990234,2.09960938,131.0,7.449219,135.0,23.0,1968.0,0.0,3.0,<2 mo. follow-up,3.0
44.849,female,0.0,MOSF w/Malig,10.0,$11-$25k,25176.0,hispanic,yes,0.599999905,0.3999999,no dnr,12.0,91.0,4.69921875,70.0,32.0,37.09375,447.5625,2.2998047,7.0,0.79992676,136.0,7.359375,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
51.09698,female,0.0,CHF,11.0,under $11k,30877.0,black,no,0.949999809,0.9499998,no dnr,19.0,100.0,5.69921875,120.0,32.0,37.59375,203.6875,4.1992188,0.19998169,4.0,140.0,7.459961,135.0,23.0,1968.0,2.0,1.0,<2 mo. follow-up,1.8389997
36.30899,male,0.0,CHF,16.0,under $11k,23476.0,white,no,0.599999905,0.5,no dnr,11.0,64.0,6.79980469,115.0,20.0,36.29688,224.0,4.3994141,4.5,1.29980469,121.0,7.419922,135.0,23.0,1968.0,1.0,0.0,<2 mo. follow-up,0.0
76.25696,male,0.0,CHF,12.0,under $11k,14926.0,white,no,0.899999619,0.75,no dnr,9.0,74.0,9.29882812,96.0,30.0,36.39844,266.625,2.8999023,1.09985352,1.19995117,141.0,7.399414,135.0,23.0,1968.0,1.0,2.0,<2 mo. follow-up,2.0
51.30499,male,0.0,CHF,12.0,under $11k,52187.0,black,no,0.799999714,0.75,no dnr,25.0,71.0,10.5996094,104.0,18.0,36.5,224.0,2.8999023,0.89990234,2.39990234,128.0,7.419922,135.0,23.0,1968.0,1.0,0.0,no(M2 and SIP pres),0.0
74.54297,female,0.0,COPD,12.0,under $11k,9631.0,white,no,0.699999809,0.5,no dnr,7.0,83.0,14.1992188,92.0,22.0,36.39844,164.0,3.2998047,0.29998779,0.79992676,137.0,7.449219,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
54.30798,male,0.0,Lung Cancer,17.0,$25-$50k,29939.0,white,metastatic,1.0,1.0,no dnr,12.0,95.0,11.5996094,108.0,22.0,38.0,183.0,2.8999023,0.89990234,0.79992676,136.0,7.399414,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
77.57697,female,0.0,CHF,12.0,under $11k,3124.0,other,no,0.699999809,0.5,no dnr,3.0,90.0,12.3984375,84.0,32.0,36.59375,276.1875,2.8999023,0.89990234,0.79992676,139.0,7.469727,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.3085938
84.95795,male,0.0,CHF,14.0,>$50k,30942.0,white,no,0.949999809,0.8499999,no dnr,17.0,92.0,13.6992188,80.0,32.0,37.19531,313.3125,3.7998047,0.29998779,1.29980469,137.0,7.429688,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
41.52197,male,1.0,MOSF w/Malig,18.0,>$50k,320843.0,white,yes,0.099999964,0.0009999992,no dnr,21.0,66.0,0.19998169,130.0,18.0,37.5,315.0,1.8999023,3.79980469,7.29980469,134.0,7.359375,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
39.685,female,0.0,ARF/MOSF w/Sepsis,22.0,$25-$50k,220639.0,white,no,0.599999905,0.5999999,no dnr,35.0,62.0,36.6953125,125.0,24.0,39.19531,208.5625,1.5998535,0.39996338,7.69921875,139.0,7.399414,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
72.55896,female,1.0,COPD,12.0,under $11k,4894.0,white,metastatic,0.699999809,0.5,dnr after sadm,1.0,123.0,13.2988281,98.0,32.0,37.19531,144.875,2.8999023,0.89990234,0.5,136.0,7.339844,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.9550781
60.10098,male,0.0,Cirrhosis,12.0,under $11k,63466.0,white,no,0.699999809,0.5,no dnr,15.0,110.0,6.29980469,125.0,10.0,38.09375,208.0,2.7998047,3.39990234,1.0,142.0,7.439453,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.3813477
70.81195,male,0.0,CHF,12.0,under $11k,6254.0,black,no,0.899999619,0.7999997,no dnr,8.0,88.0,6.89941406,80.0,22.0,37.0,224.0,2.8999023,0.89990234,1.79980469,142.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5957031
30.76199,male,0.0,CHF,10.0,under $11k,8437.0,hispanic,no,0.799999714,0.6999998,no dnr,6.0,70.0,6.59960938,122.0,16.0,36.5,528.5,2.8999023,0.89990234,2.09960938,133.0,7.459961,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
64.23798,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,321716.0,white,no,0.899999619,0.8999996,no dnr,61.0,68.0,9.5,122.0,12.0,38.69531,114.0,2.8999023,0.89990234,1.29980469,136.0,7.319336,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
51.70999,male,0.0,CHF,12.0,under $11k,31222.0,asian,no,0.799999714,0.1999999,no dnr,12.0,50.0,6.69921875,75.0,20.0,36.79688,224.0,3.699707,0.89990234,0.89990234,138.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
64.64294,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,180786.0,white,no,0.699999809,0.5,no dnr,17.0,68.0,13.2988281,92.0,38.0,38.79688,113.67188,3.3999023,1.09985352,2.29980469,133.0,7.479492,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
69.41498,male,0.0,Lung Cancer,16.0,$25-$50k,8706.0,white,metastatic,0.699999809,0.5,dnr after sadm,2.0,109.0,5.29980469,68.0,20.0,36.89844,224.0,2.699707,0.89990234,0.69995117,133.0,7.419922,135.0,23.0,1968.0,0.0,2.0,adl>=4 (>=5 if sur),2.0
57.19098,male,0.0,CHF,12.0,$11-$25k,28476.0,white,no,0.299999952,0.09999996,no dnr,9.0,59.0,16.0,85.0,26.0,36.79688,204.75,2.8999023,0.5,0.79992676,126.0,7.449219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
37.73297,male,0.0,CHF,12.0,$25-$50k,26278.0,white,no,0.199999928,0.04999998,no dnr,9.0,67.0,7.5,130.0,16.0,36.5,347.5625,3.0,0.59997559,0.89990234,132.0,7.469727,135.0,23.0,1968.0,5.0,7.0,<2 mo. follow-up,7.0
44.05499,female,0.0,Colon Cancer,16.0,>$50k,18563.0,white,metastatic,1.0,0.6999998,no dnr,7.0,85.0,8.5,72.0,20.0,37.39844,224.0,2.8999023,0.89990234,1.19995117,140.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
72.15594,male,0.0,ARF/MOSF w/Sepsis,12.0,>$50k,187014.0,white,no,0.799999714,0.7999997,no dnr,35.0,75.0,17.296875,120.0,24.0,38.29688,257.5,2.5996094,4.89941406,0.69995117,135.0,7.5,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),2.7045898
45.56598,male,1.0,MOSF w/Malig,18.0,$25-$50k,181701.0,white,yes,0.699999809,0.5,dnr after sadm,3.0,33.0,0.29998779,140.0,33.0,38.5,129.0,2.2998047,31.3984375,4.79980469,142.0,7.359375,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
41.95999,male,0.0,Lung Cancer,16.0,>$50k,4173.0,white,metastatic,0.949999809,0.7999997,no dnr,4.0,97.0,10.7988281,88.0,20.0,36.39844,380.9375,3.7998047,0.5,1.09985352,133.0,7.479492,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.1796875
59.31,male,0.0,ARF/MOSF w/Sepsis,15.0,>$50k,538692.0,white,no,0.5,0.3999999,no dnr,72.0,60.0,19.3984375,160.0,38.0,37.29688,113.32812,3.0996094,13.0996094,1.29980469,142.0,7.509766,135.0,23.0,1968.0,0.0,2.0,adl>=4 (>=5 if sur),2.0
45.61499,female,1.0,Cirrhosis,16.0,>$50k,302353.0,white,no,0.299999952,0.25,dnr after sadm,41.0,57.0,13.5996094,112.0,28.0,38.59375,134.4375,1.6999512,1.5,0.89990234,139.0,7.179688,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.5454102
65.98499,female,0.0,Colon Cancer,12.0,under $11k,18980.0,hispanic,metastatic,0.699999809,0.5,no dnr,10.0,127.0,17.796875,96.0,26.0,38.89844,372.0,4.0996094,0.29998779,0.79992676,140.0,7.399414,135.0,23.0,1968.0,1.0,1.0,no(M2 and SIP pres),1.1668997
95.79199,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,74764.0,white,no,0.699999809,0.5,dnr after sadm,16.0,88.0,11.5996094,65.0,8.0,37.19531,360.0,2.5996094,0.89990234,1.69995117,147.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,5.9414062
76.59094,male,0.0,Colon Cancer,17.0,$11-$25k,7137.0,white,metastatic,0.699999809,0.5,dnr after sadm,1.0,83.0,12.7988281,76.0,18.0,38.29688,390.4375,4.0996094,0.79992676,0.79992676,146.0,7.439453,135.0,23.0,1968.0,1.0,2.0,<2 mo. follow-up,2.0
68.10095,male,0.0,CHF,12.0,$11-$25k,9586.0,white,no,0.899999619,0.6999998,no dnr,4.0,72.0,5.89941406,80.0,18.0,36.79688,224.0,2.8999023,0.89990234,2.19970703,137.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.9719238
78.85297,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,39420.0,white,no,0.699999809,0.5,dnr after sadm,4.0,60.0,36.1953125,112.0,11.0,36.59375,214.28125,2.8999023,1.09985352,1.09985352,137.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,4.9472656
37.87,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,397017.0,white,no,0.099999964,0.0009999992,no dnr,120.0,83.0,23.5,122.0,26.0,37.59375,257.5,2.8999023,3.09960938,5.19921875,134.0,7.379883,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5400391
74.90997,female,0.0,COPD,16.0,under $11k,8166.0,white,no,0.799999714,0.6999998,no dnr,6.0,106.0,11.3984375,84.0,22.0,37.0,424.0,2.8999023,0.89990234,0.79992676,142.0,7.399414,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
31.702,female,0.0,Cirrhosis,14.0,under $11k,231119.0,black,no,0.199999928,0.09999996,no dnr,49.0,77.0,7.69921875,80.0,20.0,37.19531,490.4375,2.199707,2.69970703,1.39990234,127.0,7.489258,135.0,23.0,1968.0,6.0,1.0,SIP>=30,1.0
54.93997,female,0.0,CHF,14.0,$11-$25k,27561.0,white,no,0.699999809,0.5,no dnr,10.0,55.0,6.19921875,104.0,24.0,36.79688,504.0,3.5996094,1.09985352,0.79992676,136.0,7.459961,135.0,23.0,1968.0,1.0,0.0,<2 mo. follow-up,0.0
43.30197,male,1.0,Cirrhosis,14.0,under $11k,283145.0,hispanic,no,0.699999809,0.5,no dnr,39.0,83.0,10.0,80.0,20.0,37.0,224.0,2.0996094,13.0,1.0,130.0,7.419922,135.0,23.0,1968.0,3.0,2.0,<2 mo. follow-up,2.0
54.92999,female,0.0,Lung Cancer,12.0,$25-$50k,15392.0,asian,metastatic,0.699999809,0.5,no dnr,8.0,143.0,10.6992188,84.0,40.0,36.19531,224.0,3.2998047,0.89990234,0.79992676,135.0,7.419922,135.0,23.0,1968.0,1.0,0.0,<2 mo. follow-up,0.0
70.21497,male,0.0,Colon Cancer,12.0,$11-$25k,8442.0,white,metastatic,0.899999619,0.5,no dnr,7.0,117.0,10.1992188,22.0,18.0,38.0,224.0,3.0996094,0.69995117,1.29980469,137.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
67.09399,female,0.0,Cirrhosis,3.0,under $11k,71992.0,black,no,0.699999809,0.5,dnr after sadm,5.0,104.0,21.796875,82.0,20.0,37.0,224.0,2.0,6.59960938,0.59997559,135.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
65.05096,male,0.0,Cirrhosis,14.0,$25-$50k,14944.0,white,no,0.699999809,0.5,no dnr,10.0,77.0,12.0996094,72.0,22.0,36.39844,224.0,2.5,21.6992188,1.19995117,130.0,7.419922,135.0,23.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
69.34698,male,1.0,MOSF w/Malig,18.0,under $11k,433684.0,asian,metastatic,0.699999809,0.5,no dnr,42.0,112.0,10.3984375,125.0,14.0,36.5,274.25,3.7998047,5.69921875,1.09985352,140.0,7.449219,135.0,23.0,1968.0,0.0,4.0,<2 mo. follow-up,4.0
64.98798,female,0.0,Lung Cancer,12.0,under $11k,8137.0,white,metastatic,0.699999809,0.5,no dnr,4.0,110.0,18.796875,80.0,20.0,36.39844,224.0,2.8999023,0.89990234,0.69995117,134.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.1987305
80.62097,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,104163.0,white,no,0.699999809,0.5,dnr after sadm,2.0,61.0,23.0,140.0,32.0,39.19531,75.54688,2.2998047,1.5,1.89990234,135.0,7.129883,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.3618164
72.172,male,1.0,Lung Cancer,12.0,under $11k,62158.0,white,metastatic,0.5,0.25,no dnr,12.0,63.0,5.09960938,140.0,36.0,36.5,176.65625,2.699707,0.89990234,1.09985352,135.0,7.55957,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
53.06198,male,0.0,COPD,12.0,under $11k,6734.0,white,yes,0.699999809,0.5,dnr after sadm,1.0,77.0,10.8984375,72.0,24.0,36.39844,280.9375,3.8999023,0.89990234,0.79992676,126.0,7.479492,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.6191406
52.50699,female,1.0,CHF,12.0,$11-$25k,20735.0,white,no,0.599999905,0.1999999,dnr after sadm,6.0,67.0,8.5,88.0,20.0,36.59375,224.0,3.0996094,0.69995117,1.39990234,129.0,7.419922,135.0,23.0,1968.0,6.0,7.0,<2 mo. follow-up,7.0
74.97095,male,0.0,Colon Cancer,12.0,under $11k,43009.0,white,metastatic,0.899999619,0.8499999,no dnr,19.0,91.0,6.79980469,88.0,20.0,36.79688,224.0,4.5996094,2.5,1.09985352,142.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.9162598
53.34998,male,0.0,ARF/MOSF w/Sepsis,17.0,>$50k,483991.0,asian,no,0.5,0.1999999,no dnr,52.0,73.0,19.5,158.0,36.0,39.29688,187.5,3.5996094,11.0996094,2.69970703,154.0,7.369141,135.0,23.0,1968.0,0.0,6.0,<2 mo. follow-up,6.0
89.58795,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,19238.0,white,metastatic,0.699999809,0.5,no dnr,4.0,33.0,13.6992188,0.0,0.0,38.5,122.0,2.2998047,0.5,1.0,130.0,7.289062,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,5.5683594
56.62399,male,0.0,Colon Cancer,12.0,>$50k,27408.0,white,metastatic,0.699999809,0.5,no dnr,11.0,116.0,8.19921875,102.0,18.0,38.39844,224.0,4.2998047,0.29998779,1.19995117,136.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
75.04199,male,0.0,Colon Cancer,16.0,under $11k,8723.0,hispanic,metastatic,0.699999809,0.5,no dnr,6.0,123.0,16.296875,112.0,28.0,36.0,352.375,2.8999023,1.69995117,7.59960938,134.0,7.479492,135.0,23.0,1968.0,0.0,1.0,SIP>=30,2.2495117
75.76196,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,74162.0,white,no,0.799999714,0.7999997,no dnr,21.0,68.0,16.5976562,79.0,20.0,37.19531,132.71875,2.8999023,0.89990234,1.09985352,132.0,7.489258,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
32.99899,female,1.0,Cirrhosis,19.0,$25-$50k,88720.0,other,no,0.0,0.0,dnr after sadm,10.0,62.0,11.5996094,130.0,8.0,36.59375,296.625,2.0,31.0,4.19921875,127.0,7.389648,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
72.39697,female,0.0,CHF,10.0,under $11k,11588.0,black,no,0.699999809,0.5,no dnr,4.0,115.0,6.59960938,104.0,20.0,37.29688,460.0,2.8999023,0.89990234,2.29980469,138.0,7.549805,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
66.5,male,0.0,CHF,10.0,under $11k,29870.0,white,no,0.25,0.75,no dnr,12.0,85.0,10.8984375,88.0,16.0,36.39844,224.0,2.8999023,0.89990234,2.29980469,133.0,7.419922,135.0,23.0,1968.0,2.0,0.0,no(M2 and SIP pres),0.0
72.78296,male,0.0,CHF,13.0,under $11k,45798.0,white,no,0.799999714,0.75,no dnr,24.0,65.0,13.5,105.0,26.0,39.0,132.5,2.8999023,0.5,1.69995117,139.0,7.519531,135.0,23.0,1968.0,2.0,1.0,no(M2 and SIP pres),1.8389997
61.56897,female,0.0,CHF,8.0,under $11k,22040.0,white,no,1.0,0.8999996,no dnr,11.0,90.0,6.5,80.0,20.0,36.0,224.0,4.6992188,1.09985352,1.69995117,134.0,7.419922,135.0,23.0,1968.0,1.0,1.0,no(M2 and SIP pres),1.0
52.43298,female,0.0,Colon Cancer,16.0,$11-$25k,12161.0,black,metastatic,0.699999809,0.5,dnr after sadm,3.0,89.0,7.89941406,46.0,20.0,36.79688,224.0,2.8999023,0.39996338,0.89990234,140.0,7.419922,135.0,23.0,1968.0,2.0,2.0,<2 mo. follow-up,2.0
66.93195,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,88469.0,black,yes,0.949999809,0.8499999,no dnr,17.0,141.0,22.296875,148.0,28.0,37.5,256.625,2.199707,0.79992676,1.09985352,142.0,7.459961,135.0,23.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
84.76697,female,0.0,COPD,16.0,under $11k,19608.0,white,no,0.5,0.3999999,no dnr,8.0,70.0,11.5,75.0,50.0,36.5,200.0,2.8999023,0.89990234,0.79992676,138.0,7.429688,135.0,23.0,1968.0,1.0,7.0,adl>=4 (>=5 if sur),7.0
80.172,male,0.0,CHF,8.0,$11-$25k,6148.0,white,no,0.949999809,0.7999997,no dnr,6.0,83.0,15.8984375,85.0,20.0,36.0,462.5,2.8999023,0.29998779,1.29980469,136.0,7.349609,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
79.96997,male,0.0,CHF,14.0,$11-$25k,17554.0,other,no,0.699999809,0.5,no dnr,11.0,69.0,11.1992188,62.0,20.0,36.5,352.375,2.8999023,0.89990234,1.5,140.0,7.469727,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
66.45599,male,0.0,CHF,16.0,under $11k,25668.0,white,no,0.699999809,0.5,no dnr,12.0,85.0,4.79980469,70.0,20.0,36.39844,224.0,3.699707,1.19995117,0.89990234,129.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
58.116,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,33960.0,white,no,0.199999928,0.1999999,dnr after sadm,4.0,66.0,18.8984375,130.0,30.0,37.69531,81.32812,2.2998047,10.5,0.79992676,143.0,7.459961,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.7563477
67.49097,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,172597.0,white,no,0.899999619,0.8999996,no dnr,24.0,100.0,18.296875,102.0,20.0,37.39844,156.0,4.7998047,1.39990234,5.79980469,141.0,7.469727,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.7509766
52.09,male,0.0,Cirrhosis,8.0,$11-$25k,13414.0,white,no,0.899999619,0.7999997,no dnr,11.0,89.0,6.39941406,92.0,20.0,37.39844,442.8125,2.199707,10.8984375,1.19995117,133.0,7.429688,135.0,23.0,1968.0,5.0,1.0,<2 mo. follow-up,1.0
66.59296,male,0.0,CHF,8.0,$11-$25k,5872.0,black,no,0.949999809,0.7999997,no dnr,5.0,76.0,6.5,84.0,24.0,36.39844,533.25,3.699707,3.39990234,1.59985352,139.0,7.479492,135.0,23.0,1968.0,1.0,0.0,<2 mo. follow-up,0.0
56.13998,male,0.0,Cirrhosis,12.0,under $11k,6083.0,white,no,0.699999809,0.5,no dnr,5.0,109.0,5.39941406,80.0,20.0,36.59375,224.0,3.0,1.09985352,1.89990234,139.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.0625
63.76199,male,0.0,Colon Cancer,12.0,under $11k,7737.0,white,metastatic,0.099999964,0.0009999992,dnr after sadm,1.0,104.0,7.79980469,78.0,22.0,36.59375,224.0,2.8999023,0.89990234,1.19995117,137.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.7080078
39.73199,male,0.0,CHF,12.0,under $11k,16616.0,black,no,0.5,0.5,no dnr,8.0,69.0,10.5996094,112.0,22.0,37.19531,224.0,2.8999023,0.89990234,1.39990234,137.0,7.419922,135.0,23.0,1968.0,6.0,4.0,no(M2 and SIP pres),4.0
60.40198,male,0.0,CHF,16.0,>$50k,9381.0,white,no,0.699999809,0.75,no dnr,3.0,80.0,9.09960938,106.0,18.0,37.0,224.0,4.2998047,0.89990234,1.09985352,137.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
57.771,male,0.0,Colon Cancer,12.0,under $11k,25187.0,other,metastatic,1.0,1.0,no dnr,9.0,111.0,9.29882812,88.0,20.0,38.0,224.0,4.2998047,0.89990234,1.5,138.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.0932617
48.07397,male,0.0,CHF,12.0,under $11k,5570.0,other,no,0.899999619,0.6999998,no dnr,4.0,69.0,8.19921875,88.0,28.0,36.39844,255.0,2.8999023,0.89990234,1.69995117,135.0,7.5,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.3574219
76.68396,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,229314.0,black,yes,0.699999809,0.5,dnr after sadm,44.0,84.0,24.796875,145.0,16.0,38.69531,150.0,2.8999023,0.29998779,0.79992676,138.0,7.509766,135.0,23.0,1968.0,0.0,3.0,<2 mo. follow-up,3.0
78.35699,male,0.0,CHF,12.0,under $11k,4629.0,black,no,0.699999809,0.5,no dnr,4.0,60.0,8.59960938,115.0,20.0,36.0,404.75,2.8999023,0.89990234,1.5,137.0,7.469727,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
85.29999,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,20365.0,white,no,0.099999964,0.0009999992,dnr after sadm,1.0,62.0,12.0996094,64.0,36.0,36.89844,142.84375,2.5996094,0.59997559,1.29980469,146.0,7.299805,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.9472656
62.47498,male,0.0,CHF,11.0,$11-$25k,68367.0,white,no,0.5,0.09999996,no dnr,22.0,55.0,11.2988281,105.0,24.0,36.69531,224.0,3.2998047,2.39990234,1.5,125.0,7.419922,135.0,23.0,1968.0,1.0,0.0,no(M2 and SIP pres),0.0
76.41296,female,0.0,CHF,6.0,under $11k,4386.0,black,no,0.75,0.5,no dnr,4.0,113.0,3.19970703,80.0,20.0,36.29688,224.0,3.0996094,0.79992676,2.19970703,144.0,7.419922,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),2.3959961
45.11398,male,1.0,Lung Cancer,12.0,under $11k,13100.0,black,metastatic,0.699999809,0.5,dnr after sadm,1.0,109.0,10.7988281,98.0,18.0,36.39844,224.0,3.199707,0.89990234,0.59997559,130.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.7583008
68.12598,female,0.0,Cirrhosis,12.0,under $11k,6992.0,black,no,0.699999809,0.5,no dnr,5.0,80.0,6.39941406,80.0,16.0,37.19531,485.6875,2.5,3.39990234,0.69995117,133.0,7.459961,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.2592773
82.17694,female,0.0,Lung Cancer,15.0,$25-$50k,15942.0,white,metastatic,0.699999809,0.5,no dnr,10.0,90.0,17.296875,80.0,24.0,37.69531,224.0,4.3994141,1.0,0.89990234,140.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
41.87,male,0.0,Cirrhosis,12.0,>$50k,68108.0,white,no,0.5,0.5999999,no dnr,15.0,95.0,18.296875,64.0,16.0,36.5,235.0,2.8999023,2.29980469,1.09985352,140.0,7.449219,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
76.20795,female,0.0,Cirrhosis,11.0,under $11k,3644.0,black,no,0.199999928,0.007999994,no dnr,3.0,103.0,4.79980469,90.0,20.0,37.69531,224.0,2.8999023,0.89990234,1.5,124.0,7.419922,135.0,23.0,1968.0,0.0,6.0,<2 mo. follow-up,6.0
60.04398,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,506141.0,white,no,0.5,0.25,no dnr,11.0,67.0,1.09985352,82.0,26.0,37.39844,228.875,4.0,1.39990234,2.09960938,131.0,7.399414,135.0,23.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
77.13898,male,1.0,ARF/MOSF w/Sepsis,20.0,$11-$25k,159553.0,white,no,0.699999809,0.5,dnr after sadm,8.0,67.0,14.5996094,94.0,24.0,36.19531,156.90625,2.8999023,1.79980469,2.5,137.0,7.5,135.0,23.0,1968.0,0.0,4.0,<2 mo. follow-up,4.0
72.96399,female,0.0,ARF/MOSF w/Sepsis,13.0,$11-$25k,42243.0,white,no,0.899999619,0.7999997,no dnr,8.0,56.0,3.89990234,69.0,20.0,38.5,110.0,2.5996094,0.89990234,0.59997559,135.0,7.349609,135.0,23.0,1968.0,4.0,3.0,adl>=4 (>=5 if sur),3.0
59.40598,male,0.0,CHF,12.0,>$50k,19852.0,white,no,0.849999905,0.75,no dnr,9.0,57.0,7.59960938,114.0,28.0,36.5,224.0,4.0,1.09985352,2.79980469,135.0,7.419922,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
72.83795,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,740010.0,white,no,0.699999809,0.5,dnr after sadm,67.0,67.0,11.5996094,95.0,18.0,38.79688,140.0,2.699707,0.89990234,3.5,134.0,7.469727,135.0,23.0,1968.0,0.0,1.0,Coma or Intub,2.8237305
50.23099,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,44480.0,white,no,0.949999809,0.8999996,no dnr,13.0,94.0,11.8984375,97.0,38.0,39.19531,204.0625,2.8999023,0.89990234,1.09985352,140.0,7.429688,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.4614258
71.56195,female,0.0,Colon Cancer,12.0,$25-$50k,15051.0,white,metastatic,0.949999809,0.5,no dnr,8.0,137.0,15.3984375,80.0,20.0,38.5,224.0,4.3994141,0.89990234,0.69995117,141.0,7.419922,135.0,23.0,1968.0,1.0,1.0,<2 mo. follow-up,1.1668997
71.90399,male,0.0,Colon Cancer,10.0,under $11k,24612.0,hispanic,metastatic,0.949999809,0.8573747,no dnr,9.0,106.0,13.8984375,88.0,20.0,36.0,224.0,3.8999023,0.59997559,1.29980469,136.0,7.419922,135.0,23.0,1968.0,1.0,0.0,no(M2 and SIP pres),0.0
44.62997,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,40418.0,white,no,0.699999809,0.5,no dnr,6.0,78.0,28.296875,122.0,16.0,38.69531,204.4375,4.1992188,0.89990234,1.0,140.0,7.5,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.3632812
51.98398,female,0.0,Colon Cancer,17.0,>$50k,29303.0,white,metastatic,0.949999809,0.8573747,no dnr,12.0,95.0,13.8984375,64.0,18.0,37.5,300.0,4.5996094,1.09985352,0.59997559,137.0,7.469727,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
53.82599,male,0.0,CHF,12.0,$25-$50k,24587.0,hispanic,no,0.849999905,0.6141248,no dnr,16.0,63.0,8.0,96.0,18.0,35.89844,224.0,2.8999023,0.89990234,1.59985352,129.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.6064453
50.431,male,1.0,MOSF w/Malig,12.0,under $11k,70463.0,white,yes,0.699999809,0.5,dnr after sadm,6.0,54.0,12.6992188,136.0,32.0,36.89844,175.0,2.8999023,7.79980469,2.69970703,132.0,7.189453,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.1044922
31.69099,male,0.0,ARF/MOSF w/Sepsis,14.0,$11-$25k,274531.0,hispanic,no,0.75,0.6999998,no dnr,28.0,140.0,13.3984375,50.0,28.0,38.89844,167.5,3.8999023,27.5,0.89990234,137.0,7.5,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
65.30896,female,0.0,COPD,12.0,under $11k,84901.0,white,no,0.899999619,0.7999997,no dnr,25.0,99.0,14.5996094,150.0,16.0,37.39844,348.5625,2.8999023,0.89990234,0.69995117,136.0,7.469727,135.0,23.0,1968.0,0.0,1.0,SIP>=30,3.0009766
81.54095,male,0.0,CHF,12.0,$25-$50k,20850.0,white,yes,0.25,0.09999996,no dnr,15.0,84.0,65.0,61.0,20.0,37.19531,359.25,2.2998047,0.89990234,1.79980469,139.0,7.449219,135.0,23.0,1968.0,0.0,6.0,<2 mo. follow-up,6.0
66.39795,male,0.0,CHF,16.0,under $11k,17247.0,white,no,0.699999809,0.6999998,no dnr,6.0,59.0,6.09960938,54.0,18.0,36.59375,376.1875,4.1992188,0.89990234,1.5,134.0,7.469727,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
50.20099,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,218924.0,white,no,0.099999964,0.0009999992,dnr after sadm,16.0,60.0,3.89990234,145.0,27.0,37.69531,122.5,2.8999023,0.5,3.39990234,134.0,7.229492,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5366211
88.29797,male,0.0,CHF,8.0,under $11k,63639.0,white,no,0.699999809,0.5,no dnr,29.0,72.0,11.1992188,80.0,26.0,37.19531,180.0,2.8999023,0.89990234,2.0,131.0,7.479492,135.0,23.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
58.41498,female,0.0,Colon Cancer,14.0,$25-$50k,58940.0,white,metastatic,0.899999619,0.75,no dnr,23.0,91.0,5.09960938,88.0,24.0,37.0,224.0,2.8999023,1.0,1.0,138.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5058594
56.34998,female,0.0,Lung Cancer,12.0,under $11k,26731.0,white,metastatic,0.699999809,0.5,dnr after sadm,7.0,67.0,7.59960938,140.0,36.0,39.0,216.65625,2.8999023,0.89990234,0.79992676,135.0,7.459961,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.6875
71.69897,female,0.0,Colon Cancer,19.0,under $11k,5319.0,white,metastatic,0.699999809,0.5,no dnr,5.0,68.0,5.29980469,60.0,20.0,37.0,224.0,3.2998047,0.59997559,0.89990234,143.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
32.13998,male,1.0,MOSF w/Malig,12.0,under $11k,256835.0,other,yes,0.099999964,0.0009999992,no dnr,27.0,24.0,20.1992188,145.0,30.0,38.69531,222.5,2.8999023,1.0,2.19970703,125.0,7.349609,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.2148438
48.10999,female,0.0,Cirrhosis,2.0,$11-$25k,56562.0,hispanic,no,0.799999714,0.3999999,no dnr,26.0,77.0,4.79980469,92.0,30.0,36.19531,224.0,2.8999023,17.796875,1.0,131.0,7.419922,135.0,23.0,1968.0,3.0,0.0,<2 mo. follow-up,0.0
76.383,male,0.0,Colon Cancer,12.0,under $11k,24788.0,other,metastatic,0.949999809,0.75,no dnr,11.0,82.0,5.5,62.0,18.0,37.0,390.4375,4.2998047,0.5,1.0,134.0,7.389648,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.262207
57.81,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,125797.0,white,no,0.399999857,0.3,dnr after sadm,8.0,113.0,20.5976562,82.0,16.0,37.0,267.5,2.8999023,4.39941406,2.69970703,144.0,7.429688,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
66.76794,female,0.0,Colon Cancer,12.0,under $11k,15358.0,white,metastatic,0.699999809,0.5,no dnr,11.0,79.0,3.29980469,87.0,19.0,36.5,224.0,2.8999023,0.5,1.29980469,139.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
46.45898,male,0.0,Colon Cancer,16.0,>$50k,21906.0,white,metastatic,0.949999809,0.75,no dnr,7.0,89.0,9.69921875,80.0,20.0,37.5,224.0,4.2998047,0.19998169,1.09985352,135.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
64.34796,female,0.0,Colon Cancer,12.0,$11-$25k,77328.0,white,metastatic,0.899999619,0.75,no dnr,20.0,120.0,11.0996094,112.0,28.0,38.79688,224.0,2.699707,0.69995117,0.79992676,138.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
75.23596,female,0.0,Colon Cancer,12.0,$11-$25k,26189.0,asian,metastatic,0.949999809,0.75,no dnr,12.0,103.0,10.2988281,90.0,20.0,37.0,628.0,4.3994141,0.5,1.29980469,137.0,7.289062,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
74.60394,male,0.0,ARF/MOSF w/Sepsis,10.0,under $11k,58853.0,white,no,0.699999809,0.5999999,no dnr,14.0,157.0,14.6992188,40.0,16.0,36.0,220.0,2.8999023,0.59997559,1.79980469,136.0,7.359375,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,4.6474609
36.45999,female,0.0,Coma,12.0,under $11k,201322.0,white,no,0.699999809,0.5,no dnr,33.0,110.0,16.0,123.0,34.0,39.0,104.0,5.6992188,0.89990234,0.69995117,139.0,7.5,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.3637695
63.77298,male,1.0,ARF/MOSF w/Sepsis,16.0,>$50k,89043.0,white,no,0.5,0.15,dnr after sadm,17.0,71.0,11.5996094,96.0,32.0,38.0,128.5625,3.5996094,0.5,0.79992676,127.0,7.479492,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,4.4150391
65.70599,male,0.0,Colon Cancer,18.0,$25-$50k,8729.0,hispanic,metastatic,0.699999809,0.5,no dnr,7.0,84.0,10.5,81.0,20.0,37.89844,224.0,2.8999023,5.0,1.19995117,138.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
20.83199,male,1.0,MOSF w/Malig,12.0,under $11k,392950.0,white,yes,0.699999809,0.5,dnr after sadm,1.0,0.0,5.79980469,0.0,0.0,37.79688,130.0,4.0,10.5,3.59960938,132.0,7.279297,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.1416016
52.668,female,1.0,Coma,12.0,under $11k,104602.0,white,no,0.699999809,0.5,no dnr,9.0,88.0,14.8984375,72.0,12.0,36.19531,277.5,2.8999023,0.89990234,0.5,138.0,7.579102,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5009766
75.36798,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,125256.0,white,no,0.049999982,0.0001249999,no dnr,13.0,63.0,12.8984375,60.0,4.0,37.79688,166.0,2.8999023,1.09985352,8.59960938,132.0,7.469727,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.9306641
53.86697,male,0.0,CHF,18.0,under $11k,20923.0,white,no,0.699999809,0.5,no dnr,4.0,63.0,6.5,68.0,26.0,36.0,400.0,3.8999023,0.09999084,1.29980469,139.0,7.459961,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
44.35898,male,0.0,CHF,12.0,$11-$25k,12042.0,white,no,0.699999809,0.5,no dnr,5.0,69.0,9.5,136.0,20.0,36.39844,261.875,2.8999023,0.5,1.59985352,137.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.4326172
53.62097,female,0.0,Cirrhosis,12.0,under $11k,279530.0,white,no,0.649999619,0.3999999,no dnr,34.0,76.0,6.5,88.0,18.0,37.19531,224.0,2.199707,1.5,1.09985352,128.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.4321289
84.90295,female,0.0,Colon Cancer,15.0,$11-$25k,9291.0,white,metastatic,0.799999714,0.5,no dnr,7.0,86.0,4.79980469,80.0,20.0,36.29688,224.0,3.0996094,0.69995117,1.69995117,141.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
70.83899,male,0.0,CHF,12.0,under $11k,10955.0,white,no,0.699999809,0.5,dnr after sadm,2.0,68.0,10.0,61.0,39.0,37.09375,383.625,2.8999023,0.89990234,3.29980469,133.0,7.579102,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,4.1845703
70.06195,male,0.0,CHF,12.0,under $11k,15687.0,hispanic,no,0.849999905,0.6999998,no dnr,11.0,111.0,7.39941406,80.0,16.0,35.89844,304.75,3.199707,1.39990234,2.69970703,134.0,7.479492,135.0,23.0,1968.0,0.0,1.0,SIP>=30,1.0
37.71899,male,1.0,ARF/MOSF w/Sepsis,13.0,under $11k,268805.0,white,no,0.099999964,0.0009999992,no dnr,9.0,61.0,0.09999084,140.0,45.0,39.09375,238.0,2.8999023,0.79992676,2.79980469,148.0,7.429688,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
65.45697,female,1.0,Lung Cancer,13.0,$11-$25k,41397.0,black,metastatic,0.449999809,0.1999999,dnr after sadm,17.0,90.0,18.8984375,68.0,18.0,36.19531,285.6875,3.7998047,0.69995117,1.0,134.0,7.459961,135.0,23.0,1968.0,0.0,5.0,<2 mo. follow-up,5.0
29.88399,female,0.0,ARF/MOSF w/Sepsis,16.0,>$50k,223581.0,white,yes,0.799999714,0.7999997,dnr after sadm,33.0,81.0,10.5996094,118.0,20.0,38.0,95.0,2.5996094,6.0,0.59997559,135.0,7.389648,135.0,23.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
87.521,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,469824.0,white,no,0.699999809,0.5,no dnr,90.0,127.0,15.5,120.0,34.0,37.79688,75.0,2.0996094,0.09999084,1.19995117,134.0,7.469727,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.3193359
18.146,male,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,641888.0,hispanic,no,0.799999714,0.7999997,no dnr,85.0,44.0,2.0,142.0,27.0,37.19531,314.25,1.8999023,0.29998779,10.6992188,134.0,7.349609,135.0,23.0,1968.0,0.0,0.0,Coma or Intub,0.0
42.92398,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,277421.0,white,no,0.699999809,0.5,dnr after sadm,9.0,63.0,32.59375,132.0,50.0,39.5,77.32812,2.0996094,0.89990234,1.5,135.0,7.209961,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.0610352
37.396,female,1.0,Cirrhosis,13.0,$11-$25k,166927.0,black,yes,0.699999809,0.5,dnr after sadm,16.0,73.0,5.89941406,120.0,24.0,37.09375,233.3125,2.8999023,0.89990234,3.19970703,132.0,7.40918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.8491211
63.46899,male,0.0,Colon Cancer,12.0,under $11k,29732.0,white,metastatic,0.949999809,0.7999997,no dnr,12.0,124.0,5.39941406,118.0,20.0,37.39844,313.3125,4.6992188,0.79992676,0.79992676,133.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.1762695
53.57999,female,0.0,COPD,12.0,under $11k,5132.0,white,no,0.699999809,0.5,no dnr,5.0,93.0,12.3984375,92.0,12.0,36.59375,256.0,2.8999023,0.29998779,1.09985352,136.0,7.519531,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.3583984
70.07495,male,0.0,CHF,11.0,$11-$25k,33290.0,black,no,0.699999809,0.5,no dnr,20.0,80.0,10.5996094,90.0,18.0,36.79688,224.0,4.0996094,0.89990234,2.0,132.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
47.633,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,138674.0,asian,no,0.049999982,0.0001249999,dnr after sadm,2.0,25.0,4.5,125.0,10.0,36.0,167.34375,2.8999023,32.3984375,3.59960938,142.0,7.5,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.6940918
51.54797,male,0.0,ARF/MOSF w/Sepsis,10.0,under $11k,170244.0,white,yes,0.25,0.015625,no dnr,37.0,65.0,17.5976562,126.0,29.0,37.89844,165.0,2.8999023,0.89990234,0.59997559,132.0,7.469727,135.0,23.0,1968.0,0.0,2.0,no(M2 and SIP pres),2.0
90.83899,female,0.0,CHF,12.0,under $11k,14065.0,white,no,0.5,0.25,dnr after sadm,1.0,100.0,10.8984375,82.0,22.0,36.19531,210.0,2.8999023,0.89990234,1.0,145.0,7.519531,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.8759766
35.625,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,23421.0,black,no,0.699999809,0.5,no dnr,3.0,25.0,19.796875,150.0,28.0,37.19531,309.5,2.8999023,0.89990234,2.5,135.0,7.15918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.0986328
63.85999,female,1.0,Coma,12.0,under $11k,47424.0,white,no,0.699999809,0.5,no dnr,9.0,139.0,8.29882812,122.0,10.0,38.69531,350.0,2.8999023,0.89990234,0.69995117,149.0,7.529297,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5307617
67.04199,male,0.0,ARF/MOSF w/Sepsis,10.0,$11-$25k,100735.0,white,no,0.979999542,0.9499998,no dnr,31.0,129.0,9.3984375,125.0,36.0,38.0,272.5,3.199707,0.89990234,1.0,138.0,7.489258,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
61.16098,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,970982.0,white,no,0.5,0.5,no dnr,106.0,66.0,14.6992188,105.0,20.0,36.5,274.0,3.199707,6.09960938,2.59960938,134.0,7.40918,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),2.8037109
77.13098,male,0.0,Lung Cancer,12.0,under $11k,29403.0,white,metastatic,0.699999809,0.5,no dnr,5.0,62.0,5.59960938,82.0,12.0,36.39844,276.1875,2.8999023,0.89990234,1.19995117,135.0,7.429688,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.9814453
19.14,male,0.0,CHF,12.0,$25-$50k,216359.0,white,no,0.699999809,0.5,no dnr,56.0,61.0,8.5,108.0,26.0,36.5,224.0,4.2998047,1.09985352,0.89990234,125.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
64.18097,male,0.0,Colon Cancer,14.0,$11-$25k,26311.0,white,metastatic,0.899999619,0.75,no dnr,11.0,100.0,9.29882812,120.0,18.0,37.5,224.0,4.2998047,1.09985352,0.79992676,133.0,7.419922,135.0,23.0,1968.0,1.0,0.0,no(M2 and SIP pres),0.0
53.30298,female,0.0,Colon Cancer,12.0,under $11k,17823.0,white,metastatic,0.949999809,0.8999996,no dnr,9.0,89.0,10.1992188,120.0,20.0,39.69531,224.0,2.8999023,0.39996338,0.69995117,138.0,7.419922,135.0,23.0,1968.0,2.0,1.0,no(M2 and SIP pres),1.8389997
55.28799,female,0.0,CHF,13.0,under $11k,19419.0,white,yes,0.799999714,0.1999999,no dnr,9.0,59.0,5.79980469,145.0,20.0,37.0,456.625,2.8999023,0.79992676,0.89990234,133.0,7.369141,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),3.1230469
53.14697,male,0.0,CHF,14.0,under $11k,16552.0,asian,no,0.799999714,0.3999999,no dnr,6.0,75.0,6.69921875,72.0,18.0,36.09375,224.0,4.6992188,2.79980469,1.09985352,136.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
32.44098,male,0.0,ARF/MOSF w/Sepsis,11.0,under $11k,1273347.0,white,no,0.299999952,0.3,no dnr,281.0,51.0,16.6992188,96.0,30.0,37.39844,108.5625,2.3999023,1.0,0.69995117,143.0,7.509766,135.0,23.0,1968.0,0.0,7.0,Coma or Intub,7.0
58.95999,female,0.0,ARF/MOSF w/Sepsis,13.0,$25-$50k,207902.0,white,no,0.799999714,0.75,no dnr,26.0,115.0,6.19921875,132.0,20.0,39.79688,326.625,2.8999023,0.89990234,0.59997559,136.0,7.5,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
27.411,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,122322.0,white,no,0.5,0.7999997,no dnr,27.0,78.0,27.5976562,130.0,8.0,38.5,228.0,2.5996094,1.59985352,0.69995117,137.0,7.529297,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
77.09497,male,0.0,CHF,16.0,>$50k,23862.0,white,no,0.299999952,0.09999996,no dnr,9.0,93.0,11.5996094,86.0,22.0,36.59375,224.0,2.8999023,0.89990234,3.39990234,137.0,7.419922,135.0,23.0,1968.0,3.0,0.0,<2 mo. follow-up,0.0
63.69299,female,0.0,CHF,11.0,$11-$25k,46112.0,white,no,0.699999809,0.5,dnr after sadm,3.0,52.0,10.6992188,122.0,32.0,39.09375,224.0,2.8999023,0.89990234,0.89990234,134.0,7.419922,135.0,23.0,1968.0,3.0,3.0,SIP>=30,3.0
62.185,female,0.0,Lung Cancer,12.0,under $11k,35575.0,black,metastatic,0.799999714,0.6999998,no dnr,18.0,86.0,7.69921875,60.0,18.0,37.19531,224.0,4.3994141,0.19998169,0.89990234,140.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.390625
53.52197,female,0.0,COPD,12.0,$11-$25k,20893.0,white,no,0.899999619,0.6999998,no dnr,9.0,92.0,10.5996094,112.0,36.0,37.5,174.96875,3.2998047,0.29998779,0.69995117,139.0,7.369141,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),4.2832031
23.39999,female,1.0,ARF/MOSF w/Sepsis,11.0,$11-$25k,943804.0,hispanic,no,0.899999619,0.8999996,no dnr,96.0,87.0,5.19921875,144.0,45.0,37.29688,335.0,3.0,4.09960938,1.19995117,130.0,7.469727,135.0,23.0,1968.0,0.0,0.0,Coma or Intub,0.0
65.60999,female,0.0,CHF,12.0,under $11k,25467.0,white,no,0.699999809,0.5,no dnr,7.0,94.0,7.39941406,140.0,24.0,35.79688,390.4375,2.8999023,0.89990234,2.69970703,122.0,7.479492,135.0,23.0,1968.0,0.0,2.0,SIP>=30,2.0
70.28094,male,1.0,Cirrhosis,12.0,under $11k,28159.0,white,no,1.0,1.0,no dnr,14.0,106.0,10.3984375,74.0,20.0,37.0,224.0,3.0996094,4.69921875,3.0,129.0,7.419922,135.0,23.0,1968.0,1.0,1.0,<2 mo. follow-up,1.1668997
60.71997,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,63858.0,white,yes,0.699999809,0.5,dnr after sadm,4.0,47.0,14.7988281,80.0,14.0,35.79688,135.0,2.5996094,1.89990234,4.0,138.0,7.30957,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.6665039
77.00494,female,0.0,CHF,12.0,under $11k,15565.0,white,no,0.5,0.25,no dnr,11.0,99.0,8.59960938,80.0,24.0,36.5,224.0,2.8999023,0.89990234,1.0,138.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.0146484
42.05298,male,0.0,CHF,12.0,$11-$25k,24897.0,hispanic,no,0.799999714,0.5,no dnr,9.0,62.0,10.0996094,120.0,24.0,36.79688,224.0,4.5,1.0,1.29980469,140.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
60.75,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,254366.0,asian,no,0.699999809,0.5,dnr after sadm,6.0,63.0,17.5,150.0,32.0,38.69531,89.0,2.8999023,7.09960938,2.29980469,139.0,7.30957,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5249023
71.28796,male,1.0,CHF,15.0,under $11k,4854.0,white,no,0.699999809,0.5,dnr after sadm,1.0,63.0,7.29980469,82.0,12.0,36.19531,224.0,2.8999023,0.89990234,1.69995117,127.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
22.66899,female,0.0,CHF,15.0,under $11k,18751.0,hispanic,no,0.599999905,0.1999999,no dnr,9.0,35.0,6.69921875,115.0,40.0,36.39844,175.5,2.8999023,0.89990234,1.29980469,117.0,7.5,135.0,23.0,1968.0,4.0,1.0,adl>=4 (>=5 if sur),3.1831989
59.12399,female,0.0,ARF/MOSF w/Sepsis,11.0,$11-$25k,43164.0,white,no,0.699999809,0.5,no dnr,9.0,57.0,17.6992188,156.0,14.0,37.5,170.0,3.0996094,1.29980469,1.5,140.0,7.299805,135.0,23.0,1968.0,0.0,7.0,<2 mo. follow-up,7.0
63.896,male,0.0,Cirrhosis,12.0,>$50k,227392.0,hispanic,no,0.699999809,0.5,no dnr,55.0,72.0,8.59960938,105.0,18.0,38.39844,338.0625,2.3999023,9.0,1.0,135.0,7.469727,135.0,23.0,1968.0,3.0,5.0,SIP>=30,5.0
87.43097,male,1.0,CHF,12.0,under $11k,89889.0,white,no,0.699999809,0.5,dnr after sadm,14.0,75.0,13.3984375,135.0,8.0,37.79688,138.0,2.8999023,0.89990234,3.19970703,125.0,7.299805,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.5537109
78.89899,male,0.0,COPD,12.0,under $11k,40247.0,white,no,0.799999714,0.5,no dnr,22.0,94.0,8.79882812,75.0,26.0,36.5,326.0625,2.8999023,0.89990234,0.89990234,139.0,7.329102,135.0,23.0,1968.0,2.0,0.0,<2 mo. follow-up,0.0
83.64099,male,0.0,CHF,10.0,under $11k,25653.0,white,no,0.899999619,0.8999996,no dnr,12.0,63.0,10.6992188,62.0,28.0,39.39844,214.28125,2.8999023,1.0,2.5,131.0,7.439453,135.0,23.0,1968.0,1.0,1.0,<2 mo. follow-up,1.0
47.737,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,592486.0,black,no,0.699999809,0.5,no dnr,116.0,47.0,13.0996094,164.0,31.0,39.29688,52.0,2.8999023,0.89990234,3.0,130.0,7.139648,135.0,23.0,1968.0,0.0,1.0,Coma or Intub,1.0
78.84998,female,0.0,CHF,8.0,under $11k,9914.0,black,no,0.699999809,0.5,no dnr,9.0,114.0,8.3984375,78.0,20.0,37.79688,328.5625,3.8999023,0.79992676,1.29980469,137.0,7.459961,135.0,23.0,1968.0,4.0,6.0,SIP>=30,6.0
51.18399,male,0.0,CHF,6.0,under $11k,22621.0,black,no,0.799999714,0.5999999,no dnr,10.0,88.0,7.0,80.0,18.0,36.69531,224.0,2.8999023,3.5,1.09985352,126.0,7.419922,135.0,23.0,1968.0,1.0,1.0,no(M2 and SIP pres),1.1668997
61.45398,male,0.0,Colon Cancer,30.0,>$50k,60175.0,white,metastatic,0.949999809,0.75,no dnr,16.0,102.0,12.8984375,90.0,20.0,37.0,224.0,3.5996094,0.5,1.5,137.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.0556641
55.20297,male,0.0,CHF,15.0,under $11k,3035.0,other,no,0.799999714,0.6999998,no dnr,3.0,93.0,11.1992188,74.0,24.0,36.0,224.0,3.8999023,0.69995117,1.29980469,136.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
74.06396,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,44728.0,white,no,0.699999809,0.5,no dnr,11.0,115.0,10.0,95.0,12.0,37.5,113.84375,2.8999023,0.89990234,1.09985352,135.0,7.449219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.402832
90.90796,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,69364.0,white,no,0.199999928,0.1999999,dnr after sadm,13.0,133.0,16.296875,115.0,9.0,38.5,372.5,2.7998047,0.89990234,1.0,137.0,7.399414,135.0,23.0,1968.0,0.0,5.0,<2 mo. follow-up,5.0
38.94897,male,1.0,Cirrhosis,9.0,$11-$25k,133918.0,hispanic,no,0.75,0.5,dnr after sadm,23.0,64.0,12.0996094,102.0,18.0,36.39844,224.0,2.0,10.1992188,2.79980469,126.0,7.419922,135.0,23.0,1968.0,5.0,3.0,<2 mo. follow-up,3.0
65.14697,female,0.0,Lung Cancer,12.0,under $11k,5223.0,white,metastatic,0.699999809,0.5,no dnr,4.0,83.0,8.09960938,106.0,22.0,36.39844,224.0,2.8999023,0.89990234,0.69995117,136.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.4189453
51.62799,female,0.0,CHF,13.0,$25-$50k,23146.0,white,no,0.699999809,0.5,no dnr,8.0,65.0,15.8984375,88.0,16.0,36.29688,224.0,4.1992188,1.0,1.09985352,128.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
56.20499,male,0.0,Lung Cancer,12.0,under $11k,42041.0,white,metastatic,0.699999809,0.5,no dnr,20.0,107.0,8.19921875,92.0,20.0,37.19531,304.75,4.1992188,0.29998779,0.89990234,135.0,7.439453,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.7797852
65.88599,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,19662.0,white,no,0.899999619,0.8999996,no dnr,5.0,61.0,8.3984375,60.0,30.0,37.0,217.125,1.8999023,0.69995117,0.5,139.0,7.489258,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.237793
69.19598,male,0.0,CHF,14.0,$11-$25k,24859.0,asian,no,0.699999809,0.5,no dnr,9.0,47.0,13.7988281,70.0,20.0,36.79688,565.0,3.699707,0.69995117,2.39990234,126.0,7.5,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
77.74695,male,0.0,Lung Cancer,12.0,under $11k,16325.0,other,metastatic,0.699999809,0.5,no dnr,6.0,89.0,19.296875,80.0,18.0,36.89844,224.0,2.8999023,0.5,1.29980469,133.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
80.09595,male,0.0,CHF,12.0,$11-$25k,5293.0,white,no,0.699999809,0.5,no dnr,3.0,93.0,10.5996094,80.0,20.0,36.79688,224.0,2.8999023,0.89990234,0.69995117,131.0,7.419922,135.0,23.0,1968.0,5.0,6.0,SIP>=30,6.0
71.54596,male,0.0,Lung Cancer,20.0,>$50k,23304.0,white,metastatic,0.699999809,0.5,no dnr,7.0,120.0,3.5,89.0,26.0,36.89844,257.125,2.8999023,0.59997559,1.19995117,137.0,7.509766,135.0,23.0,1968.0,1.0,0.0,no(M2 and SIP pres),0.0
60.61899,male,0.0,CHF,14.0,under $11k,49079.0,white,no,0.949999809,0.8999996,no dnr,17.0,50.0,6.09960938,110.0,20.0,36.79688,224.0,3.699707,0.39996338,1.19995117,135.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
58.478,male,0.0,CHF,12.0,under $11k,3580.0,white,no,0.699999809,0.5,no dnr,4.0,106.0,9.09960938,88.0,36.0,36.39844,224.0,2.8999023,0.89990234,1.89990234,139.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.6030273
52.67899,male,0.0,CHF,16.0,under $11k,17110.0,asian,no,0.899999619,0.8999996,no dnr,5.0,60.0,3.59960938,150.0,16.0,36.79688,224.0,4.0996094,0.69995117,1.09985352,137.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
70.48596,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,149983.0,white,no,0.699999809,0.5,no dnr,37.0,62.0,14.0996094,80.0,15.0,38.5,146.0,2.3999023,0.39996338,1.09985352,134.0,7.449219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.6967773
50.58197,male,0.0,Cirrhosis,10.0,$25-$50k,9113.0,hispanic,no,0.699999809,0.5,no dnr,7.0,70.0,3.59960938,82.0,20.0,36.79688,385.6875,1.8999023,1.79980469,1.59985352,128.0,7.489258,135.0,23.0,1968.0,4.0,1.0,Coma or Intub,3.1831989
25.487,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,126732.0,white,yes,0.699999809,0.5,dnr after sadm,19.0,123.0,1.69995117,100.0,48.0,38.5,191.8125,3.0996094,9.0,2.29980469,143.0,7.40918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.3955078
88.69495,male,1.0,Coma,12.0,>$50k,24242.0,white,no,0.699999809,0.5,dnr after sadm,3.0,102.0,11.5996094,123.0,14.0,38.39844,397.125,3.0996094,0.69995117,5.69921875,135.0,7.40918,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
68.01898,male,0.0,MOSF w/Malig,12.0,under $11k,659433.0,white,metastatic,0.699999809,0.5,no dnr,81.0,70.0,12.5996094,115.0,10.0,37.5,218.0,2.5996094,7.69921875,2.79980469,134.0,7.479492,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.2172852
81.77698,female,0.0,Cirrhosis,7.0,under $11k,5405.0,black,no,0.699999809,0.7999997,no dnr,7.0,107.0,3.59960938,92.0,26.0,36.79688,224.0,2.199707,0.89990234,0.69995117,138.0,7.419922,135.0,23.0,1968.0,5.0,0.0,SIP>=30,0.0
71.86298,male,0.0,CHF,12.0,under $11k,3869.0,white,no,0.699999809,0.5,no dnr,3.0,87.0,8.09960938,80.0,20.0,36.09375,342.8125,2.8999023,0.89990234,1.5,138.0,7.439453,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.2963867
72.19696,female,0.0,CHF,12.0,under $11k,9991.0,black,no,0.699999809,0.5,no dnr,8.0,107.0,6.69921875,72.0,18.0,36.79688,224.0,2.8999023,0.89990234,2.29980469,141.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.4404297
53.40997,male,0.0,ARF/MOSF w/Sepsis,14.0,under $11k,102911.0,white,no,0.949999809,0.8999996,no dnr,12.0,113.0,25.5,120.0,25.0,37.29688,260.0,2.5,5.79980469,0.79992676,136.0,7.489258,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.5112305
34.35699,male,1.0,ARF/MOSF w/Sepsis,10.0,under $11k,110596.0,hispanic,no,0.199999928,0.007999994,no dnr,8.0,48.0,6.19921875,120.0,33.0,38.5,150.0,2.3999023,6.0,2.29980469,130.0,7.30957,135.0,23.0,1968.0,0.0,5.0,<2 mo. follow-up,5.0
56.66498,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,206651.0,white,no,0.5,0.5,dnr after sadm,10.0,63.0,18.5976562,125.0,30.0,38.5,148.0,2.8999023,16.796875,4.09960938,147.0,7.189453,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.3227539
53.67798,female,0.0,Cirrhosis,13.0,under $11k,14583.0,white,no,0.5,0.25,no dnr,11.0,113.0,7.5,100.0,24.0,37.0,224.0,2.0,19.8984375,1.29980469,137.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
55.32898,male,0.0,Lung Cancer,12.0,$25-$50k,11985.0,asian,metastatic,0.699999809,0.5,no dnr,6.0,93.0,10.5996094,112.0,20.0,37.19531,224.0,2.8999023,0.89990234,0.89990234,136.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
54.056,male,1.0,Coma,18.0,$25-$50k,46156.0,white,no,0.699999809,0.5,dnr after sadm,8.0,110.0,29.5976562,165.0,34.0,39.19531,223.3125,2.8999023,1.89990234,1.69995117,128.0,7.5,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
70.80396,male,1.0,ARF/MOSF w/Sepsis,10.0,$11-$25k,222230.0,hispanic,no,0.699999809,0.5,dnr after sadm,19.0,83.0,16.8984375,135.0,34.0,39.0,296.25,2.8999023,12.0996094,1.39990234,134.0,7.5,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.2109375
86.57098,female,1.0,Coma,12.0,under $11k,10662.0,white,yes,0.699999809,0.5,dnr after sadm,1.0,97.0,15.0996094,80.0,28.0,36.79688,24.0,2.8999023,0.89990234,1.19995117,133.0,7.239258,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.831543
52.44897,male,0.0,Lung Cancer,12.0,under $11k,10469.0,white,metastatic,0.699999809,0.5,no dnr,6.0,84.0,11.5,80.0,20.0,36.19531,224.0,4.5,0.29998779,1.0,136.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
50.97897,male,0.0,COPD,14.0,under $11k,27015.0,white,no,0.979999542,0.9499998,no dnr,9.0,122.0,9.09960938,110.0,32.0,36.5,124.48438,2.8999023,0.89990234,0.79992676,137.0,7.419922,135.0,23.0,1968.0,1.0,1.0,no(M2 and SIP pres),1.0
77.75995,male,1.0,CHF,14.0,under $11k,34038.0,white,no,0.699999809,0.5,no dnr,7.0,58.0,4.89941406,60.0,16.0,36.19531,224.0,4.2998047,0.89990234,1.59985352,133.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
54.18198,male,1.0,MOSF w/Malig,17.0,>$50k,40620.0,white,yes,0.0,0.0,dnr after sadm,4.0,60.0,4.5,190.0,40.0,39.5,90.0,1.6999512,0.5,1.19995117,130.0,7.30957,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
34.17398,female,1.0,ARF/MOSF w/Sepsis,13.0,under $11k,39002.0,white,no,0.099999964,0.0009999992,dnr after sadm,4.0,67.0,1.59985352,85.0,34.0,33.89844,46.0,2.8999023,1.89990234,0.29998779,128.0,7.399414,135.0,23.0,1968.0,0.0,3.0,<2 mo. follow-up,3.0
80.52295,male,0.0,CHF,12.0,under $11k,5853.0,white,no,0.699999809,0.5,no dnr,5.0,97.0,7.19921875,88.0,20.0,36.79688,319.0,4.0,0.69995117,3.19970703,136.0,7.489258,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.6611328
50.53,male,0.0,CHF,13.0,under $11k,18574.0,white,no,0.699999809,0.5,no dnr,6.0,66.0,4.89941406,80.0,24.0,36.69531,224.0,2.8999023,0.89990234,1.39990234,134.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.0595703
56.82397,female,0.0,COPD,12.0,under $11k,49730.0,black,yes,0.699999809,0.6499996,no dnr,15.0,70.0,22.0,60.0,19.0,37.0,165.6875,2.8999023,0.89990234,1.0,137.0,7.449219,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),3.105957
45.892,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,330735.0,black,no,0.699999809,0.5,no dnr,76.0,115.0,9.79882812,145.0,32.0,38.69531,510.0,2.0,0.29998779,0.89990234,136.0,7.40918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.6865234
69.71698,female,1.0,Coma,12.0,under $11k,21696.0,white,no,0.099999964,0.0009999992,dnr after sadm,3.0,115.0,14.0,95.0,16.0,36.39844,236.65625,2.8999023,0.39996338,1.79980469,141.0,7.469727,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.9838867
65.89996,male,0.0,ARF/MOSF w/Sepsis,11.0,$11-$25k,143419.0,white,no,0.799999714,0.7999997,no dnr,20.0,130.0,6.69921875,110.0,26.0,38.19531,365.0,2.0996094,0.19998169,1.19995117,131.0,7.5,135.0,23.0,1968.0,1.0,1.0,<2 mo. follow-up,1.1668997
38.491,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,111543.0,white,no,0.599999905,0.5999999,no dnr,21.0,123.0,12.8984375,125.0,38.0,39.79688,162.0,2.8999023,3.39990234,0.69995117,134.0,7.259766,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.4545898
65.53595,male,0.0,MOSF w/Malig,27.0,>$50k,61126.0,black,yes,0.5,0.5,no dnr,14.0,108.0,10.6992188,100.0,12.0,39.29688,220.0,2.2998047,0.89990234,1.79980469,136.0,7.40918,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.1010742
59.146,male,0.0,Lung Cancer,11.0,under $11k,17737.0,white,metastatic,0.5,0.09999996,no dnr,10.0,74.0,2.69970703,128.0,24.0,38.89844,224.0,2.8999023,1.19995117,0.89990234,138.0,7.419922,135.0,23.0,1968.0,3.0,3.0,<2 mo. follow-up,3.0
53.922,female,0.0,Colon Cancer,16.0,$25-$50k,46135.0,white,metastatic,0.899999619,0.5,no dnr,24.0,83.0,10.5,100.0,24.0,37.39844,224.0,4.5996094,0.39996338,0.79992676,135.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.050293
40.63199,male,0.0,CHF,1.0,$11-$25k,29551.0,hispanic,no,0.75,0.5999999,no dnr,13.0,95.0,10.5996094,94.0,26.0,36.0,224.0,2.8999023,0.89990234,1.5,140.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
65.67596,male,0.0,Lung Cancer,12.0,under $11k,57969.0,white,metastatic,0.799999714,0.3,dnr after sadm,12.0,64.0,11.3984375,134.0,32.0,38.79688,309.5,2.5996094,0.89990234,0.79992676,132.0,7.519531,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
53.10098,male,1.0,CHF,12.0,under $11k,15394.0,white,no,0.699999809,0.5,no dnr,4.0,43.0,13.2988281,150.0,22.0,36.69531,610.0,3.7998047,1.5,1.29980469,132.0,7.679688,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.8071289
43.28299,female,1.0,MOSF w/Malig,12.0,under $11k,100051.0,white,yes,0.5,0.3,dnr after sadm,3.0,87.0,0.29998779,140.0,44.0,38.5,259.125,2.699707,3.19970703,1.5,146.0,7.479492,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.5332031
35.14297,male,0.0,Lung Cancer,14.0,>$50k,7880.0,white,metastatic,0.699999809,0.5,no dnr,5.0,77.0,8.29882812,80.0,18.0,35.39844,224.0,2.8999023,0.89990234,0.89990234,137.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
51.49899,female,0.0,Cirrhosis,12.0,under $11k,5765.0,white,yes,0.699999809,0.5,no dnr,4.0,87.0,6.09960938,88.0,20.0,36.59375,366.625,2.2998047,2.0,1.19995117,130.0,7.549805,135.0,23.0,1968.0,0.0,3.0,<2 mo. follow-up,3.0
76.44897,male,0.0,ARF/MOSF w/Sepsis,11.0,under $11k,92307.0,white,no,0.5,0.5,no dnr,18.0,108.0,14.7988281,140.0,20.0,39.0,224.0,2.8999023,0.89990234,2.0,144.0,7.419922,135.0,23.0,1968.0,0.0,6.0,<2 mo. follow-up,6.0
81.24597,female,1.0,Coma,12.0,under $11k,15473.0,white,no,0.049999982,0.0001249999,dnr before sadm,0.0,58.0,8.5,70.0,30.0,37.5,178.0,2.5,1.5,2.29980469,135.0,7.369141,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,5.2402344
19.60599,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,413774.0,white,no,0.0,0.0,dnr after sadm,5.0,48.0,6.09960938,131.0,12.0,38.79688,156.25,4.3994141,16.3984375,1.09985352,155.0,7.519531,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.1264648
63.431,male,0.0,ARF/MOSF w/Sepsis,16.0,$11-$25k,409250.0,white,no,0.699999809,0.5999999,no dnr,61.0,90.0,3.39990234,130.0,20.0,37.09375,230.0,2.7998047,4.69921875,2.09960938,141.0,7.489258,135.0,23.0,1968.0,0.0,2.0,no(M2 and SIP pres),2.0
52.37198,male,0.0,COPD,12.0,under $11k,6622.0,black,no,1.0,1.0,no dnr,5.0,102.0,15.5,80.0,18.0,37.0,300.0,2.8999023,0.89990234,1.0,140.0,7.429688,135.0,23.0,1968.0,1.0,1.0,no(M2 and SIP pres),1.1668997
38.883,male,0.0,ARF/MOSF w/Sepsis,16.0,under $11k,34680.0,hispanic,no,0.599999905,0.5,no dnr,15.0,83.0,7.0,110.0,30.0,38.69531,257.125,3.5996094,0.09999084,0.69995117,133.0,7.449219,135.0,23.0,1968.0,0.0,6.0,adl>=4 (>=5 if sur),6.0
77.67596,male,1.0,MOSF w/Malig,12.0,under $11k,26620.0,white,metastatic,0.699999809,0.5,dnr after sadm,2.0,38.0,10.0996094,110.0,20.0,38.79688,207.6875,2.8999023,2.79980469,2.09960938,131.0,7.279297,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.7626953
75.96698,female,0.0,Lung Cancer,12.0,under $11k,12424.0,white,metastatic,0.699999809,0.5,dnr after sadm,5.0,107.0,25.5,100.0,20.0,36.39844,224.0,3.8999023,0.89990234,1.5,135.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
42.38699,female,1.0,MOSF w/Malig,12.0,under $11k,221026.0,white,yes,0.699999809,0.5,dnr after sadm,2.0,112.0,1.39990234,70.0,18.0,36.59375,144.0,4.5996094,7.5,3.89990234,143.0,7.459961,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.3369141
47.24698,female,0.0,Lung Cancer,16.0,under $11k,29076.0,asian,metastatic,0.899999619,0.5,no dnr,10.0,47.0,12.7988281,140.0,32.0,38.59375,246.9375,2.5996094,1.29980469,1.29980469,135.0,7.369141,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.9604492
69.66699,male,1.0,Cirrhosis,12.0,under $11k,122908.0,white,no,0.699999809,0.5,dnr after sadm,13.0,93.0,12.2988281,150.0,14.0,37.0,142.84375,2.3999023,5.39941406,0.89990234,138.0,7.279297,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5512695
57.58197,male,0.0,CHF,10.0,under $11k,26110.0,white,no,0.849999905,0.75,no dnr,10.0,65.0,5.0,125.0,26.0,36.89844,400.0,3.8999023,2.79980469,1.29980469,140.0,7.539062,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
50.64798,male,0.0,CHF,12.0,under $11k,23376.0,black,no,0.799999714,0.5,no dnr,10.0,67.0,5.29980469,115.0,30.0,36.79688,419.0,3.3999023,1.39990234,1.19995117,143.0,7.439453,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
60.07898,male,0.0,Colon Cancer,12.0,>$50k,22300.0,white,metastatic,0.949999809,0.75,no dnr,11.0,103.0,4.29980469,110.0,18.0,36.79688,283.3125,4.2998047,0.29998779,1.09985352,142.0,7.379883,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
67.47998,male,0.0,Colon Cancer,12.0,under $11k,11506.0,white,metastatic,0.989999771,0.75,no dnr,11.0,108.0,6.5,58.0,20.0,38.89844,224.0,4.0996094,0.29998779,1.5,143.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.2626953
62.875,male,0.0,Colon Cancer,14.0,>$50k,23575.0,white,metastatic,0.949999809,0.75,no dnr,9.0,96.0,12.5,120.0,24.0,39.0,224.0,4.5996094,0.19998169,0.79992676,137.0,7.419922,135.0,23.0,1968.0,2.0,1.0,no(M2 and SIP pres),1.8389997
74.10797,male,1.0,COPD,12.0,$11-$25k,73695.0,white,no,0.5,0.3999999,dnr after sadm,5.0,63.0,22.0,160.0,12.0,37.0,134.0,2.8999023,0.89990234,0.59997559,140.0,7.429688,135.0,23.0,1968.0,0.0,7.0,<2 mo. follow-up,7.0
66.73199,male,0.0,Colon Cancer,16.0,$25-$50k,30052.0,white,metastatic,0.699999809,0.5,no dnr,18.0,110.0,9.19921875,90.0,28.0,37.19531,224.0,3.8999023,0.5,0.89990234,140.0,7.419922,135.0,23.0,1968.0,1.0,1.0,no(M2 and SIP pres),1.1668997
71.39996,female,0.0,ARF/MOSF w/Sepsis,16.0,$25-$50k,163714.0,white,no,0.699999809,0.5,dnr after sadm,32.0,120.0,10.7988281,65.0,22.0,36.59375,86.65625,2.8999023,0.5,1.59985352,143.0,7.469727,135.0,23.0,1968.0,5.0,1.0,<2 mo. follow-up,3.855299
60.85699,female,0.0,Lung Cancer,12.0,under $11k,22052.0,white,metastatic,0.699999809,0.5,no dnr,9.0,98.0,3.79980469,110.0,20.0,37.5,196.0,4.1992188,0.09999084,1.09985352,136.0,7.40918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5507812
47.37598,female,1.0,MOSF w/Malig,12.0,$11-$25k,266998.0,white,yes,0.799999714,0.7999997,dnr after sadm,19.0,78.0,7.59960938,130.0,25.0,39.69531,152.0,2.8999023,1.19995117,4.59960938,145.0,7.379883,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
71.15094,female,1.0,CHF,10.0,$11-$25k,27021.0,black,no,0.699999809,0.5,dnr after sadm,10.0,127.0,6.69921875,110.0,24.0,37.5,455.5,2.8999023,1.0,3.5,140.0,7.40918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
64.24597,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,32157.0,hispanic,no,0.949999809,0.9499998,no dnr,15.0,77.0,33.59375,110.0,22.0,38.0,346.625,2.8999023,1.59985352,3.0,143.0,7.269531,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
21.63699,female,0.0,Colon Cancer,16.0,>$50k,17730.0,white,metastatic,0.949999809,0.8999996,no dnr,10.0,88.0,17.0976562,74.0,20.0,36.39844,224.0,2.8999023,4.19921875,0.89990234,138.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
60.58899,male,1.0,Lung Cancer,12.0,>$50k,17989.0,white,metastatic,0.699999809,0.5,dnr after sadm,6.0,117.0,12.3984375,135.0,26.0,36.5,224.0,2.8999023,0.29998779,1.09985352,133.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
55.20599,female,0.0,COPD,12.0,under $11k,28330.0,black,no,0.599999905,0.3999999,no dnr,13.0,93.0,5.79980469,95.0,26.0,37.29688,223.3125,2.8999023,0.89990234,0.69995117,142.0,7.379883,135.0,23.0,1968.0,6.0,6.0,adl>=4 (>=5 if sur),6.0
66.54596,male,1.0,ARF/MOSF w/Sepsis,15.0,>$50k,348628.0,white,no,0.949999809,0.9499998,dnr after sadm,45.0,67.0,19.6992188,150.0,20.0,39.39844,182.5,3.7998047,1.69995117,1.5,127.0,7.469727,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.9897461
66.66895,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,922581.0,asian,no,0.699999809,0.5,dnr after sadm,162.0,112.0,19.5,150.0,19.0,40.19531,177.5,2.5996094,4.09960938,0.89990234,148.0,7.489258,135.0,23.0,1968.0,0.0,1.0,Coma or Intub,2.265625
73.36597,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,536925.0,white,no,0.699999809,0.5,dnr after sadm,64.0,65.0,21.1992188,140.0,14.0,36.5,164.0,2.0,4.79980469,2.39990234,144.0,7.379883,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.1137695
37.59299,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,29615.0,white,no,0.799999714,0.5,no dnr,5.0,103.0,7.29980469,120.0,28.0,36.5,380.0,2.8999023,0.89990234,0.79992676,139.0,7.429688,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.9033203
61.34399,female,0.0,Colon Cancer,11.0,under $11k,30431.0,hispanic,metastatic,0.899999619,0.6999998,no dnr,9.0,140.0,9.79882812,70.0,26.0,37.5,380.0,3.199707,0.89990234,0.89990234,140.0,7.379883,135.0,23.0,1968.0,1.0,1.0,no(M2 and SIP pres),1.1668997
65.92499,male,0.0,Colon Cancer,16.0,>$50k,6228.0,asian,metastatic,0.5,0.1999999,no dnr,7.0,73.0,5.09960938,82.0,16.0,37.79688,224.0,3.7998047,0.39996338,1.0,137.0,7.419922,135.0,23.0,1968.0,2.0,0.0,no(M2 and SIP pres),0.0
47.33197,female,0.0,COPD,12.0,under $11k,35296.0,white,no,0.5,0.3999999,no dnr,8.0,73.0,12.0996094,140.0,36.0,36.19531,185.6875,2.8999023,0.89990234,0.39996338,133.0,7.339844,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,4.0380859
32.18298,female,0.0,CHF,12.0,under $11k,12924.0,white,no,0.699999809,0.5,no dnr,10.0,82.0,12.1992188,80.0,28.0,36.0,242.84375,2.8999023,0.89990234,1.39990234,134.0,7.519531,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.8623047
48.04398,male,1.0,ARF/MOSF w/Sepsis,18.0,under $11k,786088.0,white,no,0.399999857,0.1999999,dnr after sadm,47.0,107.0,21.5,150.0,30.0,37.79688,138.0,2.699707,16.8984375,1.39990234,143.0,7.469727,135.0,23.0,1968.0,0.0,3.0,<2 mo. follow-up,3.0
71.66296,female,1.0,Coma,12.0,under $11k,21598.0,white,no,0.009999998,9.999994e-07,dnr after sadm,5.0,113.0,10.1992188,110.0,20.0,39.89844,215.53125,2.8999023,0.89990234,0.89990234,127.0,7.439453,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.2768555
64.45197,male,0.0,CHF,12.0,under $11k,30265.0,white,no,0.099999964,0.0009999992,dnr after sadm,4.0,45.0,16.8984375,135.0,36.0,37.39844,108.15625,3.0,1.29980469,1.69995117,126.0,7.549805,135.0,23.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
24.515,female,0.0,ARF/MOSF w/Sepsis,10.0,under $11k,83772.0,hispanic,no,0.5,0.5,no dnr,19.0,120.0,5.69921875,110.0,28.0,37.5,69.0,2.8999023,0.89990234,0.89990234,140.0,7.5,135.0,23.0,1968.0,0.0,4.0,no(M2 and SIP pres),4.0
74.034,female,1.0,Colon Cancer,12.0,under $11k,6429.0,white,metastatic,0.699999809,0.5,dnr after sadm,1.0,73.0,18.3984375,104.0,24.0,36.19531,224.0,2.8999023,3.29980469,0.69995117,127.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.3735352
72.03296,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,61750.0,white,no,0.699999809,0.5,dnr after sadm,11.0,117.0,15.3984375,120.0,12.0,37.59375,60.0,3.0,0.29998779,1.69995117,138.0,7.319336,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.8081055
68.60797,male,0.0,CHF,12.0,under $11k,8303.0,white,no,0.799999714,0.6999998,no dnr,7.0,87.0,10.5996094,80.0,24.0,36.5,332.0,2.8999023,0.89990234,1.79980469,142.0,7.479492,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.9321289
59.40598,male,0.0,CHF,14.0,$11-$25k,157585.0,asian,no,0.699999809,0.5,no dnr,46.0,78.0,7.19921875,80.0,24.0,37.0,224.0,2.8999023,0.5,1.0,132.0,7.419922,135.0,23.0,1968.0,3.0,1.0,no(M2 and SIP pres),1.0
20.312,male,1.0,ARF/MOSF w/Sepsis,13.0,under $11k,99728.0,white,no,0.019999996,0.02,no dnr,7.0,117.0,6.29980469,160.0,26.0,40.09375,130.0,2.8999023,2.5,3.0,141.0,7.439453,135.0,23.0,1968.0,0.0,3.0,<2 mo. follow-up,3.0
80.19397,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,29857.0,white,no,0.049999982,0.0001249999,dnr after sadm,3.0,98.0,11.0996094,90.0,32.0,38.5,355.5,2.8999023,0.89990234,1.19995117,141.0,7.439453,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.9487305
42.06699,male,1.0,MOSF w/Malig,18.0,$11-$25k,137943.0,white,yes,0.699999809,0.5,no dnr,4.0,47.0,2.59960938,175.0,36.0,39.29688,244.875,3.0,4.79980469,5.39941406,135.0,7.449219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.2294922
23.81699,male,0.0,MOSF w/Malig,13.0,$25-$50k,245347.0,black,metastatic,0.699999809,0.5,dnr after sadm,3.0,127.0,17.0,140.0,28.0,37.89844,53.32812,2.8999023,0.89990234,1.39990234,135.0,7.429688,135.0,23.0,1968.0,0.0,2.0,adl>=4 (>=5 if sur),2.0
65.97095,male,0.0,CHF,12.0,under $11k,16273.0,white,yes,0.699999809,0.5,no dnr,6.0,52.0,8.8984375,80.0,32.0,36.39844,247.59375,3.5996094,1.79980469,1.19995117,136.0,7.479492,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.4047852
67.00098,male,0.0,CHF,12.0,under $11k,15242.0,white,no,0.75,0.5999999,no dnr,5.0,42.0,7.79980469,85.0,20.0,36.89844,224.0,3.5996094,0.19998169,1.39990234,138.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.1396484
58.09698,male,0.0,ARF/MOSF w/Sepsis,15.0,$25-$50k,150445.0,hispanic,no,0.699999809,0.5,no dnr,21.0,57.0,16.5976562,120.0,10.0,38.29688,192.0,3.199707,0.5,1.09985352,137.0,7.549805,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.3178711
34.99799,female,0.0,Coma,18.0,>$50k,8265.0,white,no,0.5,0.1999999,no dnr,15.0,103.0,10.0996094,115.0,20.0,37.39844,330.0,2.8999023,0.89990234,0.69995117,134.0,7.479492,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),1.0
65.96295,male,0.0,ARF/MOSF w/Sepsis,4.0,under $11k,181645.0,hispanic,no,0.699999809,0.5999999,no dnr,55.0,80.0,15.0996094,120.0,30.0,39.0,340.0,3.0996094,0.69995117,0.89990234,142.0,7.5,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.097168
43.85999,female,0.0,Cirrhosis,12.0,$11-$25k,186293.0,hispanic,no,0.5,0.3,no dnr,43.0,46.0,3.5,80.0,20.0,37.19531,300.0,2.3999023,38.3984375,1.89990234,138.0,7.469727,135.0,23.0,1968.0,7.0,3.0,<2 mo. follow-up,3.0
29.769,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,181539.0,asian,no,0.699999809,0.5,no dnr,34.0,110.0,16.0,120.0,30.0,37.69531,397.5,2.0,4.29980469,0.69995117,135.0,7.459961,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.1264648
52.71997,female,1.0,Cirrhosis,20.0,$11-$25k,45273.0,white,no,0.009999998,9.999994e-07,dnr after sadm,4.0,97.0,9.5,75.0,18.0,36.39844,290.4375,2.8999023,2.0,2.5,137.0,7.429688,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.0878906
26.24799,male,1.0,MOSF w/Malig,12.0,under $11k,260829.0,white,yes,0.699999809,0.5,dnr after sadm,3.0,35.0,0.04999542,40.0,52.0,36.69531,206.0,1.6999512,3.79980469,1.89990234,138.0,7.219727,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.0917969
66.75397,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,306038.0,white,no,0.699999809,0.5,no dnr,46.0,67.0,24.0976562,120.0,22.0,37.0,106.65625,2.8999023,0.89990234,1.29980469,139.0,7.509766,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.4399414
53.125,male,0.0,Lung Cancer,8.0,$11-$25k,13872.0,white,metastatic,0.699999809,0.5,no dnr,14.0,70.0,9.19921875,72.0,18.0,36.79688,376.1875,2.8999023,0.19998169,1.0,136.0,7.459961,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
70.74097,male,0.0,ARF/MOSF w/Sepsis,17.0,>$50k,72222.0,white,yes,0.699999809,0.5,no dnr,14.0,77.0,23.0,115.0,28.0,39.0,120.40625,2.7998047,0.09999084,1.19995117,135.0,7.5,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.4282227
54.67798,male,0.0,CHF,14.0,under $11k,38322.0,white,no,0.699999809,0.5,no dnr,12.0,58.0,10.5996094,65.0,18.0,36.09375,224.0,2.5,1.79980469,1.29980469,145.0,7.5,135.0,23.0,1968.0,3.0,1.0,<2 mo. follow-up,2.5110989
81.45398,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,92518.0,white,no,0.399999857,0.3,no dnr,30.0,60.0,8.3984375,75.0,40.0,38.89844,391.0,3.0,0.89990234,1.09985352,132.0,7.529297,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.4912109
58.27499,female,0.0,COPD,12.0,under $11k,161257.0,black,no,0.199999928,0.15,no dnr,40.0,77.0,16.5976562,115.0,12.0,37.29688,68.0,3.3999023,0.89990234,0.89990234,144.0,7.299805,135.0,23.0,1968.0,0.0,6.0,<2 mo. follow-up,6.0
36.96899,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,85027.0,other,no,0.699999809,0.5,dnr after sadm,1.0,111.0,21.6992188,120.0,70.0,39.89844,224.0,4.5,54.296875,5.69921875,138.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.4121094
44.47897,male,0.0,Cirrhosis,16.0,$25-$50k,12696.0,white,no,0.5,0.5,no dnr,8.0,100.0,4.69921875,82.0,18.0,36.79688,224.0,2.2998047,14.1992188,0.79992676,137.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
79.98096,male,0.0,Colon Cancer,16.0,>$50k,42514.0,white,metastatic,0.899999619,0.75,no dnr,13.0,115.0,4.19921875,70.0,22.0,38.39844,224.0,3.0996094,1.59985352,1.0,142.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
82.245,female,1.0,Coma,12.0,under $11k,73656.0,white,no,0.699999809,0.5,dnr after sadm,3.0,123.0,10.5996094,75.0,9.0,36.69531,295.0,2.8999023,0.89990234,1.19995117,140.0,7.479492,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.355957
38.49698,male,0.0,ARF/MOSF w/Sepsis,17.0,>$50k,463001.0,white,no,0.799999714,0.75,no dnr,62.0,73.0,10.0996094,130.0,18.0,38.59375,237.5,3.0996094,13.7988281,1.09985352,145.0,7.529297,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
59.37598,male,0.0,MOSF w/Malig,12.0,under $11k,64372.0,black,yes,0.5,0.3,no dnr,19.0,70.0,0.69995117,120.0,32.0,37.0,396.625,2.0996094,0.69995117,0.89990234,138.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
58.44998,male,0.0,CHF,20.0,under $11k,30148.0,white,no,0.989999771,0.9499998,no dnr,20.0,85.0,6.19921875,90.0,28.0,37.0,403.3125,2.8999023,0.89990234,1.69995117,133.0,7.5,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
83.30194,male,1.0,ARF/MOSF w/Sepsis,16.0,under $11k,49455.0,white,no,0.5,0.3,dnr after sadm,9.0,130.0,11.8984375,80.0,10.0,38.5,242.84375,2.8999023,0.89990234,1.0,138.0,7.509766,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.5644531
43.995,female,0.0,Cirrhosis,12.0,$11-$25k,260514.0,white,no,0.699999809,0.5999999,no dnr,50.0,80.0,20.8984375,130.0,20.0,36.29688,485.0,2.7998047,3.0,1.89990234,136.0,7.459961,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
50.09698,male,0.0,MOSF w/Malig,12.0,under $11k,29840.0,other,yes,0.799999714,0.6999998,no dnr,15.0,97.0,11.0996094,80.0,16.0,37.39844,419.0,2.8999023,0.69995117,1.19995117,136.0,7.449219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
80.18896,male,1.0,ARF/MOSF w/Sepsis,19.0,>$50k,257589.0,white,no,0.399999857,0.1999999,dnr after sadm,39.0,133.0,10.1992188,120.0,36.0,38.69531,204.4375,2.8999023,0.5,1.09985352,147.0,7.469727,135.0,23.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
40.20499,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,151181.0,white,yes,0.699999809,0.5,dnr after sadm,5.0,52.0,6.5,150.0,35.0,36.79688,122.0,2.699707,10.5996094,1.19995117,143.0,7.349609,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.0107422
57.01797,female,0.0,CHF,12.0,under $11k,12504.0,white,no,0.799999714,0.6999998,no dnr,5.0,93.0,12.1992188,88.0,18.0,37.19531,423.75,4.6992188,0.59997559,0.89990234,133.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.4633789
38.90799,female,0.0,ARF/MOSF w/Sepsis,13.0,under $11k,48336.0,white,no,0.899999619,0.8999996,no dnr,12.0,107.0,18.6992188,120.0,28.0,37.5,280.0,2.8999023,0.89990234,4.29980469,125.0,7.289062,135.0,23.0,1968.0,0.0,3.0,<2 mo. follow-up,3.0
75.54297,male,0.0,Colon Cancer,14.0,$25-$50k,18233.0,white,metastatic,0.949999809,0.7999997,no dnr,11.0,93.0,13.8984375,84.0,20.0,36.19531,224.0,2.8999023,1.19995117,1.0,136.0,7.419922,135.0,23.0,1968.0,2.0,0.0,no(M2 and SIP pres),0.0
34.80899,female,1.0,MOSF w/Malig,12.0,under $11k,71315.0,white,metastatic,0.699999809,0.5,dnr after sadm,5.0,62.0,0.69995117,135.0,60.0,38.5,82.0,2.5996094,6.09960938,0.5,141.0,7.40918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.0834961
73.72998,male,0.0,Colon Cancer,12.0,under $11k,41836.0,white,metastatic,0.699999809,0.5,no dnr,15.0,127.0,5.29980469,88.0,18.0,36.79688,224.0,4.2998047,1.69995117,1.09985352,141.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.1674805
42.543,male,1.0,MOSF w/Malig,12.0,under $11k,217970.0,white,yes,0.699999809,0.5,dnr after sadm,8.0,50.0,1.09985352,140.0,30.0,38.5,396.625,2.8999023,0.89990234,6.69921875,137.0,7.429688,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.6279297
68.70099,male,0.0,Lung Cancer,12.0,under $11k,8570.0,white,metastatic,0.699999809,0.5,no dnr,4.0,121.0,4.19921875,74.0,8.0,37.79688,224.0,2.8999023,0.89990234,1.0,137.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.2436523
73.56299,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,192983.0,white,yes,0.199999928,0.007999994,dnr after sadm,20.0,133.0,28.5976562,140.0,39.0,38.89844,61.0,2.8999023,0.89990234,0.79992676,132.0,7.399414,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.9082031
69.10297,female,0.0,Colon Cancer,12.0,under $11k,39080.0,white,metastatic,0.699999809,0.5,no dnr,12.0,97.0,10.6992188,115.0,28.0,37.29688,224.0,3.0,3.89990234,0.89990234,145.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.4438477
67.41095,male,1.0,Coma,12.0,under $11k,19247.0,white,no,0.699999809,0.5,dnr after sadm,4.0,35.0,13.0,140.0,10.0,41.0,171.40625,2.8999023,0.89990234,4.29980469,151.0,7.509766,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.9233398
79.72095,male,1.0,CHF,18.0,>$50k,23327.0,asian,no,0.699999809,0.5,dnr after sadm,2.0,33.0,8.09960938,100.0,16.0,36.19531,224.0,2.8999023,0.89990234,5.5,129.0,7.419922,135.0,23.0,1968.0,0.0,4.0,<2 mo. follow-up,4.0
48.35898,male,1.0,ARF/MOSF w/Sepsis,14.0,>$50k,60676.0,hispanic,no,0.049999982,0.0001249999,dnr after sadm,3.0,87.0,3.69970703,125.0,17.0,36.59375,90.65625,2.8999023,0.89990234,0.59997559,143.0,7.439453,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
60.67398,male,1.0,CHF,12.0,>$50k,481475.0,white,no,0.699999809,0.5,dnr after sadm,72.0,77.0,9.29882812,100.0,36.0,36.59375,127.5,2.8999023,0.89990234,2.59960938,125.0,7.529297,135.0,23.0,1968.0,0.0,3.0,adl>=4 (>=5 if sur),3.0
58.31897,female,0.0,Cirrhosis,12.0,under $11k,5877.0,hispanic,no,0.699999809,0.5,no dnr,5.0,87.0,4.89941406,80.0,20.0,37.19531,224.0,2.199707,4.79980469,1.0,135.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.1245117
59.88498,male,0.0,CHF,14.0,$25-$50k,25441.0,white,no,0.699999809,0.5,no dnr,11.0,67.0,9.29882812,110.0,18.0,36.79688,224.0,4.1992188,0.39996338,1.39990234,140.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
64.02698,male,0.0,CHF,12.0,under $11k,11926.0,white,no,0.699999809,0.5,no dnr,4.0,62.0,5.39941406,70.0,18.0,36.5,252.375,4.5996094,1.19995117,1.09985352,136.0,7.429688,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.6655273
34.461,female,1.0,MOSF w/Malig,12.0,under $11k,193371.0,white,yes,0.699999809,0.5,dnr after sadm,3.0,33.0,1.09985352,130.0,35.0,35.89844,80.0,2.5,0.89990234,1.29980469,141.0,7.369141,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.9511719
47.33499,female,0.0,Colon Cancer,12.0,under $11k,53037.0,white,metastatic,0.699999809,0.5,no dnr,26.0,93.0,10.0,100.0,20.0,38.59375,224.0,4.0,6.19921875,0.69995117,140.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.6083984
47.77798,female,0.0,Cirrhosis,12.0,under $11k,14867.0,other,no,0.699999809,0.5,no dnr,7.0,91.0,5.59960938,76.0,20.0,37.0,224.0,1.8999023,5.29980469,0.69995117,134.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.1303711
49.28998,male,1.0,ARF/MOSF w/Sepsis,16.0,$25-$50k,73143.0,white,no,0.5,0.5,no dnr,6.0,47.0,2.39990234,160.0,40.0,34.0,85.0,2.8999023,0.89990234,3.0,139.0,7.069336,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.1860352
51.573,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,121630.0,white,metastatic,0.699999809,0.5,dnr after sadm,22.0,98.0,10.0996094,85.0,28.0,37.19531,44.4375,3.3999023,1.89990234,1.29980469,133.0,7.40918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.3798828
73.90295,male,0.0,CHF,16.0,under $11k,6676.0,white,no,0.699999809,0.5,no dnr,4.0,100.0,14.8984375,100.0,20.0,36.79688,224.0,2.8999023,0.89990234,1.5,137.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.2524414
71.28497,male,0.0,Lung Cancer,12.0,under $11k,16142.0,white,metastatic,1.0,0.9499998,no dnr,7.0,95.0,16.0,70.0,22.0,37.5,495.1875,2.8999023,0.89990234,1.39990234,137.0,7.40918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5341797
55.29898,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,85170.0,white,no,0.699999809,0.5,no dnr,11.0,83.0,8.09960938,150.0,32.0,38.69531,350.0,2.8999023,0.89990234,0.89990234,130.0,7.489258,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.8974609
52.68997,male,0.0,MOSF w/Malig,12.0,under $11k,50315.0,white,metastatic,0.699999809,0.5,no dnr,8.0,125.0,15.5996094,118.0,36.0,37.0,310.0,2.8999023,0.89990234,0.89990234,141.0,7.469727,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.7290039
81.38794,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,207883.0,white,no,0.699999809,0.5,dnr after sadm,9.0,63.0,17.5,70.0,37.0,39.0,285.0,2.199707,3.19970703,4.19921875,138.0,7.449219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.1708984
49.29999,male,0.0,Cirrhosis,12.0,under $11k,241565.0,white,no,0.099999964,0.0009999992,no dnr,29.0,87.0,5.79980469,110.0,16.0,35.19531,194.28125,2.199707,4.0,3.09960938,148.0,7.439453,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.9243164
64.69299,male,0.0,Colon Cancer,12.0,$25-$50k,24410.0,white,metastatic,0.899999619,0.75,no dnr,9.0,67.0,9.8984375,110.0,12.0,37.5,215.0,4.5,0.79992676,1.09985352,135.0,7.449219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
61.67798,male,0.0,Colon Cancer,12.0,>$50k,18565.0,white,metastatic,0.899999619,0.7999997,no dnr,9.0,95.0,11.7988281,88.0,20.0,37.0,224.0,2.8999023,0.59997559,1.29980469,139.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.5693359
64.25195,male,0.0,CHF,6.0,under $11k,7339.0,white,no,0.699999809,0.5,no dnr,4.0,73.0,3.89990234,110.0,24.0,36.39844,256.625,2.8999023,0.89990234,1.5,136.0,7.339844,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.1958008
56.95798,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,80188.0,other,no,0.699999809,0.5,dnr after sadm,7.0,68.0,17.5,125.0,32.0,36.39844,193.875,2.8999023,35.0,9.09960938,146.0,7.479492,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5454102
29.71399,male,1.0,MOSF w/Malig,12.0,under $11k,55429.0,other,yes,0.699999809,0.5,dnr after sadm,7.0,120.0,2.69970703,55.0,14.0,36.09375,190.0,2.8999023,0.89990234,1.5,128.0,7.449219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.3691406
35.56998,female,0.0,MOSF w/Malig,19.0,>$50k,141926.0,black,yes,0.699999809,0.5,no dnr,33.0,113.0,0.04999542,120.0,28.0,37.59375,419.0,2.5,1.09985352,0.69995117,133.0,7.459961,135.0,23.0,1968.0,5.0,6.0,<2 mo. follow-up,6.0
38.42297,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,36468.0,black,no,0.699999809,0.5,no dnr,10.0,114.0,21.0,98.0,20.0,38.0,224.0,2.8999023,0.89990234,10.5,131.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.4711914
62.53497,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,188728.0,white,no,0.5,0.3999999,dnr after sadm,1.0,88.0,3.69970703,130.0,24.0,39.5,140.0,2.8999023,0.89990234,1.19995117,148.0,7.5,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.7363281
76.49597,male,1.0,Lung Cancer,12.0,under $11k,7422.0,white,metastatic,0.199999928,0.09999996,dnr after sadm,2.0,110.0,13.8984375,72.0,26.0,36.19531,209.0625,2.8999023,0.39996338,2.0,146.0,7.40918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.1860352
83.16199,male,1.0,Coma,12.0,under $11k,13767.0,white,no,0.699999809,0.5,dnr after sadm,2.0,93.0,18.0,150.0,32.0,37.89844,593.0,2.8999023,0.89990234,1.19995117,136.0,7.439453,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.2773438
57.52798,male,0.0,Coma,12.0,under $11k,82244.0,white,no,0.099999964,0.0009999992,no dnr,20.0,60.0,19.796875,75.0,15.0,36.89844,210.0,2.8999023,0.89990234,1.0,137.0,7.469727,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.3989258
73.66498,male,0.0,Colon Cancer,12.0,under $11k,9640.0,white,metastatic,0.599999905,0.1999999,dnr after sadm,1.0,93.0,3.5,84.0,20.0,36.39844,224.0,2.8999023,0.89990234,1.5,133.0,7.419922,135.0,23.0,1968.0,0.0,3.0,<2 mo. follow-up,3.0
46.51099,male,0.0,Cirrhosis,15.0,$25-$50k,603388.0,black,no,0.5,0.5,no dnr,74.0,67.0,17.5976562,110.0,36.0,39.0,420.0,1.5,31.5976562,5.5,137.0,7.629883,135.0,23.0,1968.0,0.0,6.0,adl>=4 (>=5 if sur),6.0
78.91895,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,219537.0,white,no,0.699999809,0.5,dnr after sadm,28.0,60.0,27.5976562,100.0,18.0,38.5,282.8125,2.699707,0.89990234,2.59960938,140.0,7.359375,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.2841797
68.91394,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,30869.0,white,no,0.699999809,0.5,no dnr,11.0,67.0,16.0976562,135.0,32.0,37.19531,222.84375,3.0996094,0.59997559,0.5,135.0,7.5,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.762207
42.29199,female,1.0,MOSF w/Malig,12.0,under $11k,161776.0,white,yes,0.699999809,0.5,dnr after sadm,4.0,42.0,14.2988281,115.0,35.0,38.39844,32.0,2.8999023,1.69995117,3.5,125.0,7.25,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.1401367
46.57898,male,0.0,CHF,22.0,under $11k,17254.0,black,no,0.699999809,0.5,no dnr,7.0,72.0,6.29980469,100.0,20.0,36.19531,224.0,2.8999023,0.89990234,1.59985352,136.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
54.03998,male,0.0,CHF,16.0,>$50k,135849.0,white,no,0.699999809,0.5,no dnr,15.0,68.0,5.29980469,110.0,12.0,36.09375,353.3125,3.0996094,1.79980469,1.19995117,129.0,7.529297,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
45.10599,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,35204.0,white,no,0.699999809,0.5,no dnr,8.0,92.0,8.0,120.0,36.0,37.09375,142.84375,2.8999023,0.89990234,1.29980469,134.0,7.5,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.7602539
87.46295,female,0.0,CHF,12.0,>$50k,12163.0,white,no,0.949999809,0.7999997,no dnr,10.0,93.0,8.3984375,84.0,20.0,36.39844,342.8125,2.8999023,0.89990234,0.79992676,126.0,7.489258,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),3.7792969
79.24695,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,174898.0,black,no,0.699999809,0.5,dnr after sadm,18.0,73.0,10.5996094,110.0,25.0,37.59375,115.0,2.0996094,0.89990234,1.09985352,135.0,7.5,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
39.73999,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,352017.0,other,no,0.699999809,0.5,no dnr,4.0,60.0,20.5976562,130.0,44.0,39.29688,238.0,3.2998047,11.0996094,4.59960938,146.0,7.429688,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.2241211
78.17395,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,372459.0,asian,no,0.699999809,0.5,dnr after sadm,5.0,45.0,10.5,120.0,28.0,36.89844,317.5,5.7998047,23.1992188,2.29980469,131.0,7.439453,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.9794922
79.13196,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,36811.0,white,metastatic,0.699999809,0.5,no dnr,13.0,47.0,18.1992188,90.0,22.0,37.19531,100.0,2.8999023,0.69995117,0.89990234,136.0,7.449219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,4.6357422
70.63898,male,0.0,ARF/MOSF w/Sepsis,18.0,under $11k,104045.0,white,no,0.149999976,0.003374999,no dnr,32.0,80.0,11.2988281,95.0,18.0,37.0,148.3125,4.1992188,0.69995117,5.79980469,139.0,7.229492,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
41.26498,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,597427.0,white,no,0.799999714,0.6999998,dnr after sadm,118.0,53.0,8.09960938,129.0,26.0,36.5,92.0,4.0,11.6992188,4.19921875,151.0,7.319336,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),3.331543
38.35699,female,0.0,Colon Cancer,12.0,under $11k,5573.0,white,metastatic,0.699999809,0.5,no dnr,5.0,71.0,8.3984375,80.0,16.0,36.79688,224.0,3.0,0.5,0.79992676,139.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.0043945
59.92099,male,0.0,Lung Cancer,12.0,under $11k,19491.0,black,metastatic,0.699999809,0.5,dnr after sadm,6.0,81.0,20.5976562,72.0,18.0,36.39844,118.35938,3.5996094,0.89990234,1.59985352,130.0,7.40918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.5507812
58.11899,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,40421.0,white,no,0.699999809,0.5,dnr after sadm,2.0,15.0,0.89990234,40.0,20.0,33.09375,245.0,2.0996094,1.39990234,2.69970703,127.0,7.40918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.1513672
35.25,female,0.0,MOSF w/Malig,12.0,under $11k,271731.0,white,yes,0.699999809,0.5,no dnr,38.0,60.0,6.79980469,135.0,33.0,39.0,128.875,3.0,0.19998169,5.5,133.0,7.519531,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.2861328
66.18994,female,0.0,ARF/MOSF w/Sepsis,15.0,under $11k,53786.0,white,no,0.699999809,0.5,no dnr,12.0,113.0,13.0996094,110.0,20.0,36.0,232.5,2.8999023,0.89990234,1.69995117,143.0,7.429688,135.0,23.0,1968.0,1.0,1.0,no(M2 and SIP pres),1.1668997
41.02698,male,1.0,ARF/MOSF w/Sepsis,16.0,under $11k,237244.0,white,no,0.799999714,0.6999998,dnr after sadm,16.0,57.0,4.0,120.0,18.0,35.19531,175.0,2.8999023,9.59960938,2.0,141.0,7.429688,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.1860352
54.93198,male,0.0,Cirrhosis,12.0,under $11k,25024.0,white,no,0.099999964,0.0009999992,no dnr,49.0,43.0,8.5,120.0,14.0,38.89844,763.25,2.8999023,0.89990234,3.79980469,145.0,7.55957,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.9755859
78.58997,male,1.0,Colon Cancer,12.0,under $11k,5871.0,black,metastatic,0.699999809,0.5,dnr after sadm,1.0,73.0,8.69921875,90.0,20.0,35.59375,224.0,2.8999023,0.89990234,1.0,144.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.1899414
82.21497,male,0.0,ARF/MOSF w/Sepsis,10.0,$11-$25k,135785.0,white,no,0.5,0.5,no dnr,37.0,63.0,9.3984375,50.0,14.0,36.59375,148.0,3.0996094,0.89990234,1.19995117,143.0,7.509766,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),1.0
40.34198,male,1.0,MOSF w/Malig,16.0,>$50k,370093.0,white,yes,0.699999809,0.5,dnr after sadm,37.0,57.0,1.29980469,140.0,16.0,38.69531,184.0,2.8999023,1.19995117,5.79980469,139.0,7.40918,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
60.84097,male,1.0,CHF,16.0,under $11k,173498.0,white,no,0.75,0.75,no dnr,23.0,63.0,10.6992188,110.0,18.0,37.09375,120.0,2.8999023,1.09985352,1.59985352,136.0,7.489258,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.7094727
67.82996,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,242746.0,white,yes,0.699999809,0.5,dnr after sadm,5.0,58.0,9.59960938,85.0,16.0,39.79688,65.0,2.8999023,0.89990234,5.69921875,145.0,7.279297,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.4858398
65.41296,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,86956.0,black,no,0.199999928,0.1999999,dnr after sadm,5.0,57.0,19.6992188,110.0,90.0,34.5,87.5,2.8999023,4.09960938,2.5,133.0,7.299805,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5546875
74.297,male,0.0,CHF,18.0,>$50k,19565.0,white,no,0.5,0.25,no dnr,7.0,62.0,6.5,80.0,18.0,37.0,41.0,2.8999023,0.89990234,2.09960938,134.0,7.169922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
61.78799,female,0.0,Lung Cancer,12.0,under $11k,4226.0,black,metastatic,0.699999809,0.5,no dnr,3.0,93.0,8.09960938,106.0,24.0,37.0,224.0,2.8999023,0.29998779,1.59985352,129.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.5039062
45.43198,male,1.0,MOSF w/Malig,16.0,$11-$25k,110902.0,hispanic,yes,0.699999809,0.5,dnr after sadm,7.0,63.0,11.7988281,120.0,32.0,37.69531,92.21875,2.2998047,0.89990234,1.69995117,136.0,7.5,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.4604492
62.45297,male,0.0,CHF,16.0,>$50k,269517.0,white,no,0.899999619,0.7999997,no dnr,43.0,63.0,7.89941406,100.0,20.0,36.59375,224.0,2.8999023,0.89990234,1.39990234,134.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
70.28094,male,0.0,Colon Cancer,12.0,under $11k,25535.0,white,metastatic,0.699999809,0.5,no dnr,12.0,87.0,20.5976562,76.0,20.0,36.59375,224.0,4.0996094,0.79992676,1.29980469,137.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.3105469
52.28497,female,0.0,ARF/MOSF w/Sepsis,16.0,>$50k,303548.0,white,no,0.699999809,0.6999998,no dnr,29.0,58.0,18.3984375,170.0,36.0,38.29688,173.3125,3.7998047,16.296875,1.5,141.0,7.479492,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
57.76599,male,0.0,CHF,12.0,under $11k,30477.0,black,no,1.0,0.7999997,no dnr,16.0,80.0,11.3984375,120.0,28.0,36.0,490.4375,2.8999023,3.5,1.29980469,136.0,7.55957,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.3032227
54.74298,male,1.0,MOSF w/Malig,12.0,under $11k,79089.0,white,yes,0.699999809,0.5,dnr after sadm,2.0,72.0,0.04999542,110.0,32.0,37.89844,91.65625,2.0,0.89990234,0.59997559,128.0,7.549805,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.3017578
54.78198,male,0.0,Lung Cancer,12.0,under $11k,7383.0,black,metastatic,0.699999809,0.5,no dnr,7.0,88.0,5.89941406,114.0,22.0,37.39844,224.0,2.8999023,0.89990234,1.19995117,139.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
46.69998,female,1.0,MOSF w/Malig,12.0,under $11k,105684.0,other,yes,0.699999809,0.5,dnr after sadm,2.0,28.0,0.09999084,135.0,35.0,36.09375,51.0,2.8999023,0.89990234,1.5,132.0,7.319336,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.8427734
36.59097,male,1.0,MOSF w/Malig,12.0,under $11k,80565.0,white,yes,0.699999809,0.5,dnr after sadm,2.0,58.0,0.5,140.0,40.0,38.89844,95.375,3.0,1.69995117,2.29980469,128.0,7.279297,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.6972656
83.39496,male,0.0,CHF,13.0,$11-$25k,3968.0,black,no,0.699999809,0.5,no dnr,5.0,77.0,5.69921875,80.0,22.0,37.19531,224.0,4.0996094,0.69995117,1.5,141.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
41.29797,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,182264.0,black,no,0.799999714,0.75,dnr after sadm,18.0,52.0,25.6992188,140.0,10.0,39.0,282.8125,2.5996094,0.39996338,4.69921875,128.0,7.40918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
90.13794,male,0.0,MOSF w/Malig,24.0,under $11k,124700.0,white,metastatic,0.0,0.0,dnr before sadm,-5.0,63.0,25.1992188,65.0,28.0,36.5,172.5,2.0,2.89990234,1.79980469,138.0,7.479492,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,5.7294922
20.09599,female,0.0,CHF,12.0,$11-$25k,51152.0,black,no,1.0,0.75,no dnr,18.0,63.0,16.5,125.0,32.0,39.0,224.0,2.8999023,0.89990234,1.39990234,130.0,7.419922,135.0,23.0,1968.0,0.0,2.0,no(M2 and SIP pres),2.0
38.92999,male,0.0,Cirrhosis,14.0,$25-$50k,4117.0,white,no,0.699999809,0.5,no dnr,4.0,96.0,6.89941406,92.0,22.0,38.39844,224.0,2.5996094,8.29882812,0.79992676,129.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
39.81897,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,79944.0,white,no,0.699999809,0.5,dnr after sadm,3.0,23.0,38.09375,135.0,48.0,36.39844,130.0,4.3994141,5.69921875,3.79980469,138.0,7.199219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.0444336
53.09497,female,1.0,Cirrhosis,12.0,under $11k,47800.0,white,no,0.699999809,0.5,dnr after sadm,1.0,65.0,22.1992188,195.0,22.0,40.0,150.0,2.8999023,34.5,2.29980469,137.0,7.519531,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.5976562
53.38498,female,0.0,ARF/MOSF w/Sepsis,11.0,under $11k,81459.0,white,no,0.699999809,0.5,no dnr,13.0,73.0,5.19921875,120.0,12.0,38.39844,190.0,3.8999023,0.29998779,7.39941406,128.0,7.359375,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.7265625
79.81396,male,0.0,ARF/MOSF w/Sepsis,13.0,$25-$50k,98268.0,white,no,0.5,0.5,dnr after sadm,7.0,102.0,15.8984375,135.0,12.0,38.5,122.0,2.8999023,2.79980469,2.69970703,144.0,7.30957,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),3.371582
68.45996,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,26493.0,black,metastatic,0.099999964,0.0009999992,dnr after sadm,1.0,100.0,7.29980469,60.0,22.0,37.79688,222.0,2.8999023,0.79992676,0.69995117,138.0,7.469727,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),3.9082031
52.52597,female,0.0,CHF,16.0,$11-$25k,20605.0,black,no,0.5,0.3,no dnr,8.0,63.0,6.0,65.0,20.0,36.39844,400.0,4.0,0.39996338,2.69970703,136.0,7.339844,135.0,23.0,1968.0,6.0,3.0,adl>=4 (>=5 if sur),3.0
62.50198,male,0.0,CHF,4.0,$11-$25k,8761.0,hispanic,no,0.899999619,0.7999997,no dnr,4.0,70.0,9.29882812,60.0,20.0,36.0,352.375,2.8999023,0.29998779,1.5,138.0,7.449219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5043945
57.02899,male,0.0,Cirrhosis,17.0,$11-$25k,145874.0,white,yes,0.5,0.0,dnr after sadm,17.0,67.0,5.09960938,130.0,25.0,37.0,212.5,2.5,8.3984375,1.09985352,136.0,7.55957,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
61.448,male,0.0,CHF,3.0,under $11k,13444.0,black,no,0.949999809,0.7999997,no dnr,8.0,117.0,7.0,82.0,28.0,36.59375,428.5625,3.8999023,1.09985352,1.19995117,139.0,7.469727,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
87.76697,female,0.0,COPD,16.0,under $11k,109552.0,white,no,0.5,0.3999999,dnr after sadm,1.0,55.0,23.796875,165.0,36.0,37.79688,273.3125,3.0,0.89990234,0.5,143.0,7.299805,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,4.4589844
65.71399,male,1.0,Coma,12.0,under $11k,45707.0,white,no,0.0,0.0,dnr after sadm,5.0,43.0,14.8984375,80.0,26.0,38.89844,174.0,2.8999023,9.8984375,7.69921875,137.0,7.449219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.753418
46.97098,female,0.0,COPD,9.0,under $11k,5975.0,hispanic,no,0.699999809,0.5,no dnr,4.0,112.0,8.19921875,72.0,20.0,37.59375,238.09375,2.8999023,0.89990234,0.79992676,139.0,7.419922,135.0,23.0,1968.0,2.0,1.0,<2 mo. follow-up,1.8389997
62.10797,male,0.0,CHF,7.0,under $11k,22091.0,white,no,0.5,0.3,no dnr,11.0,95.0,5.5,75.0,22.0,36.0,224.0,3.8999023,0.89990234,1.29980469,138.0,7.419922,135.0,23.0,1968.0,2.0,5.0,SIP>=30,5.0
81.99896,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,117689.0,white,no,0.75,0.5,dnr after sadm,13.0,65.0,31.1992188,50.0,26.0,36.79688,331.375,3.7998047,1.09985352,1.89990234,133.0,7.519531,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.9467773
62.53,female,0.0,Colon Cancer,12.0,under $11k,16862.0,white,metastatic,0.849999905,0.8999996,no dnr,16.0,97.0,5.09960938,96.0,20.0,37.39844,342.8125,3.7998047,0.79992676,0.79992676,134.0,7.489258,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
54.52197,female,0.0,CHF,13.0,>$50k,414803.0,white,no,0.799999714,0.5,no dnr,145.0,37.0,7.5,90.0,24.0,36.29688,122.5,3.3999023,1.59985352,1.39990234,135.0,7.469727,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
49.87,male,1.0,MOSF w/Malig,12.0,under $11k,59913.0,white,yes,0.699999809,0.5,dnr after sadm,4.0,57.0,0.09999084,165.0,28.0,41.19531,85.0,2.5,2.09960938,1.69995117,133.0,7.30957,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.2265625
61.69199,female,0.0,Colon Cancer,12.0,$11-$25k,75618.0,white,metastatic,0.849999905,0.6999998,no dnr,25.0,103.0,10.3984375,106.0,24.0,38.19531,224.0,3.7998047,0.29998779,2.39990234,141.0,7.419922,135.0,23.0,1968.0,6.0,1.0,no(M2 and SIP pres),4.5273972
39.14899,female,0.0,CHF,12.0,$25-$50k,147711.0,black,no,0.699999809,0.5999999,no dnr,37.0,58.0,6.19921875,105.0,34.0,36.69531,224.0,2.8999023,0.79992676,0.89990234,130.0,7.419922,135.0,23.0,1968.0,5.0,4.0,<2 mo. follow-up,4.0
50.45599,female,1.0,MOSF w/Malig,12.0,under $11k,202111.0,white,yes,0.699999809,0.5,dnr after sadm,5.0,63.0,0.89990234,115.0,16.0,38.19531,89.21875,2.7998047,4.19921875,2.39990234,143.0,7.459961,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5595703
50.57599,female,0.0,Cirrhosis,10.0,under $11k,303934.0,white,no,0.799999714,0.7999997,no dnr,46.0,55.0,5.29980469,75.0,12.0,36.19531,443.3125,2.199707,44.3984375,5.09960938,147.0,7.229492,135.0,23.0,1968.0,0.0,2.0,no(M2 and SIP pres),2.0
68.80798,female,0.0,CHF,14.0,under $11k,7354.0,black,no,0.949999809,0.8499999,no dnr,4.0,94.0,5.39941406,84.0,20.0,36.39844,576.0,2.8999023,0.89990234,1.69995117,128.0,7.459961,135.0,23.0,1968.0,4.0,1.0,SIP>=30,3.1831989
46.07797,male,0.0,Cirrhosis,18.0,>$50k,353422.0,white,metastatic,0.699999809,0.5,no dnr,41.0,63.0,3.59960938,170.0,10.0,35.29688,160.0,3.5996094,51.296875,5.0,147.0,7.589844,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
79.16498,female,0.0,CHF,12.0,under $11k,3974.0,white,no,0.899999619,0.7999997,no dnr,3.0,139.0,6.19921875,76.0,24.0,36.39844,466.625,2.8999023,0.89990234,1.0,141.0,7.459961,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.2495117
81.758,female,0.0,CHF,8.0,under $11k,22800.0,white,no,0.599999905,0.216,no dnr,15.0,110.0,11.1992188,80.0,24.0,36.39844,285.6875,2.8999023,0.29998779,1.59985352,128.0,7.519531,135.0,23.0,1968.0,0.0,6.0,<2 mo. follow-up,6.0
76.98798,female,0.0,COPD,16.0,under $11k,113045.0,white,no,0.5,0.3,dnr after sadm,7.0,48.0,12.0996094,170.0,28.0,36.5,155.0,2.8999023,0.89990234,0.59997559,134.0,7.40918,135.0,23.0,1968.0,0.0,5.0,<2 mo. follow-up,5.0
81.66498,female,1.0,ARF/MOSF w/Sepsis,17.0,$11-$25k,31827.0,white,no,0.699999809,0.5999999,dnr after sadm,2.0,97.0,22.0976562,100.0,24.0,38.39844,225.6875,2.8999023,0.89990234,1.0,135.0,7.449219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.6464844
54.26999,male,0.0,ARF/MOSF w/Sepsis,16.0,under $11k,44608.0,white,no,0.699999809,0.5,no dnr,13.0,107.0,7.09960938,125.0,28.0,36.0,120.40625,2.8999023,1.19995117,2.29980469,138.0,7.5,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
22.825,male,1.0,MOSF w/Malig,12.0,under $11k,254601.0,white,metastatic,0.699999809,0.5,dnr after sadm,10.0,43.0,2.89990234,145.0,28.0,38.69531,146.0,2.8999023,6.5,4.29980469,139.0,7.359375,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.9663086
58.43698,female,0.0,Colon Cancer,20.0,>$50k,14670.0,white,metastatic,0.75,0.25,dnr after sadm,2.0,65.0,7.19921875,72.0,12.0,37.0,224.0,3.7998047,0.69995117,0.69995117,135.0,7.419922,135.0,23.0,1968.0,2.0,1.0,<2 mo. follow-up,1.8389997
58.28598,male,0.0,Colon Cancer,14.0,>$50k,24073.0,white,metastatic,0.949999809,0.7999997,no dnr,10.0,81.0,11.7988281,72.0,22.0,38.89844,224.0,4.3994141,0.59997559,1.0,139.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
84.29297,female,0.0,CHF,12.0,under $11k,5110.0,white,no,0.899999619,0.7999997,no dnr,3.0,103.0,9.3984375,130.0,20.0,36.0,423.75,2.8999023,0.89990234,1.29980469,137.0,7.609375,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.0571289
47.01999,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,56169.0,white,no,0.5,0.3999999,dnr after sadm,9.0,28.0,10.0,110.0,26.0,36.29688,148.3125,2.8999023,0.89990234,12.0,149.0,7.479492,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.171875
42.28897,female,0.0,Cirrhosis,15.0,$11-$25k,6057.0,white,no,0.699999809,0.6999998,no dnr,6.0,70.0,2.59960938,72.0,20.0,37.0,224.0,2.7998047,11.8984375,0.89990234,133.0,7.419922,135.0,23.0,1968.0,1.0,1.0,no(M2 and SIP pres),1.1668997
86.37097,male,0.0,CHF,12.0,under $11k,14836.0,white,no,0.75,0.5,no dnr,14.0,107.0,4.29980469,80.0,20.0,36.79688,224.0,3.5996094,0.69995117,2.5,135.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,4.03125
72.23499,male,0.0,ARF/MOSF w/Sepsis,16.0,>$50k,23972.0,white,no,0.5,0.1999999,dnr after sadm,1.0,95.0,6.09960938,98.0,26.0,37.79688,83.32812,3.0,1.39990234,1.89990234,157.0,7.439453,135.0,23.0,1968.0,0.0,6.0,adl>=4 (>=5 if sur),6.0
85.35199,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,239683.0,white,no,0.049999982,0.0001249999,dnr before sadm,-1.0,33.0,14.0,120.0,35.0,35.89844,170.0,3.7998047,35.6953125,2.59960938,137.0,7.5,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
49.13898,female,0.0,Lung Cancer,12.0,under $11k,17775.0,black,metastatic,0.199999928,0.04999998,dnr after sadm,2.0,55.0,9.09960938,122.0,28.0,38.29688,224.0,2.8999023,0.89990234,0.69995117,129.0,7.419922,135.0,23.0,1968.0,3.0,5.0,adl>=4 (>=5 if sur),5.0
79.04395,female,1.0,COPD,12.0,under $11k,36520.0,white,yes,0.599999905,0.3999999,dnr after sadm,2.0,120.0,9.29882812,110.0,26.0,36.39844,110.0,3.699707,0.89990234,0.89990234,139.0,7.179688,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,4.4482422
41.61798,male,1.0,MOSF w/Malig,12.0,under $11k,161755.0,white,yes,0.199999928,1.0,dnr after sadm,9.0,127.0,3.19970703,200.0,38.0,36.39844,179.0,2.8999023,2.5,1.19995117,149.0,7.369141,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.9682617
25.49199,female,1.0,MOSF w/Malig,12.0,under $11k,359124.0,white,yes,0.199999928,0.1999999,dnr after sadm,3.0,103.0,2.79980469,145.0,46.0,39.0,109.32812,2.8999023,3.09960938,1.09985352,125.0,7.469727,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.6630859
50.754,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,448431.0,white,no,0.25,0.25,dnr after sadm,13.0,42.0,10.6992188,118.0,12.0,38.89844,270.0,3.5996094,13.6992188,1.69995117,131.0,7.509766,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.8657227
53.09198,female,0.0,Cirrhosis,12.0,>$50k,13434.0,white,no,0.899999619,0.8999996,no dnr,7.0,66.0,13.1992188,102.0,20.0,36.59375,224.0,2.3999023,5.29980469,1.19995117,124.0,7.419922,135.0,23.0,1968.0,1.0,0.0,no(M2 and SIP pres),0.0
75.80798,male,0.0,Lung Cancer,3.0,>$50k,73798.0,white,metastatic,0.399999857,0.04999998,dnr after sadm,12.0,137.0,29.1992188,160.0,56.0,38.0,146.0,2.7998047,0.89990234,1.09985352,143.0,7.469727,135.0,23.0,1968.0,0.0,4.0,<2 mo. follow-up,4.0
75.99695,male,1.0,ARF/MOSF w/Sepsis,13.0,$11-$25k,99364.0,white,no,0.699999809,0.5,dnr after sadm,6.0,52.0,23.296875,150.0,44.0,37.0,170.0,2.8999023,3.89990234,4.5,134.0,7.389648,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
54.491,male,0.0,Cirrhosis,12.0,under $11k,9974.0,white,no,1.0,1.0,no dnr,6.0,95.0,6.89941406,78.0,18.0,36.39844,224.0,2.3999023,5.59960938,0.89990234,125.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.3310547
27.51799,female,1.0,MOSF w/Malig,12.0,under $11k,132130.0,hispanic,yes,0.5,0.5,dnr after sadm,5.0,76.0,2.79980469,200.0,56.0,38.39844,277.0,2.8999023,1.39990234,2.69970703,136.0,7.289062,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
59.62198,male,0.0,Lung Cancer,12.0,>$50k,11765.0,white,metastatic,1.0,0.5,no dnr,4.0,96.0,11.6992188,104.0,20.0,36.19531,224.0,2.8999023,0.89990234,1.19995117,135.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
78.12695,female,1.0,ARF/MOSF w/Sepsis,11.0,$11-$25k,107073.0,white,no,0.0,0.0,no dnr,23.0,60.0,24.0976562,70.0,44.0,38.89844,96.65625,2.0,0.89990234,1.09985352,141.0,7.429688,135.0,23.0,1968.0,0.0,7.0,<2 mo. follow-up,7.0
30.023,male,0.0,ARF/MOSF w/Sepsis,15.0,$25-$50k,108131.0,white,no,0.699999809,0.5,no dnr,17.0,97.0,4.89941406,110.0,12.0,38.59375,267.5,3.0996094,5.79980469,1.09985352,141.0,7.439453,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.0869141
52.70099,female,0.0,Lung Cancer,14.0,$25-$50k,6521.0,white,metastatic,0.699999809,0.15,no dnr,4.0,80.0,9.19921875,64.0,20.0,36.39844,224.0,4.2998047,0.39996338,1.0,140.0,7.419922,135.0,23.0,1968.0,1.0,1.0,no(M2 and SIP pres),1.1668997
52.767,male,1.0,ARF/MOSF w/Sepsis,10.0,under $11k,45767.0,black,no,0.699999809,0.5,no dnr,11.0,77.0,17.0976562,115.0,24.0,38.19531,208.5625,3.3999023,4.0,5.39941406,145.0,7.449219,135.0,23.0,1968.0,0.0,5.0,<2 mo. follow-up,5.0
50.38199,female,0.0,CHF,11.0,under $11k,25748.0,black,no,0.75,0.5999999,no dnr,14.0,60.0,10.5996094,50.0,20.0,36.09375,224.0,2.8999023,0.89990234,0.79992676,138.0,7.419922,135.0,23.0,1968.0,0.0,5.0,adl>=4 (>=5 if sur),5.0
37.336,female,1.0,MOSF w/Malig,12.0,under $11k,168270.0,other,yes,0.799999714,0.7999997,dnr after sadm,3.0,57.0,1.89990234,140.0,14.0,38.5,231.65625,3.2998047,7.5,5.69921875,145.0,7.299805,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.4541016
65.57697,male,0.0,CHF,16.0,under $11k,42780.0,white,no,0.699999809,0.5,no dnr,10.0,52.0,3.79980469,70.0,30.0,38.29688,251.40625,2.8999023,0.89990234,1.5,142.0,7.529297,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
42.29398,male,1.0,Cirrhosis,12.0,under $11k,49389.0,white,no,0.049999982,0.0001249999,dnr after sadm,5.0,67.0,23.5976562,130.0,32.0,36.5,167.5,3.199707,8.0,2.59960938,134.0,7.529297,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.9550781
55.31799,female,0.0,Cirrhosis,12.0,$11-$25k,16717.0,white,no,0.5,0.3,no dnr,12.0,120.0,7.5,80.0,18.0,37.59375,224.0,2.5,3.69970703,0.59997559,121.0,7.419922,135.0,23.0,1968.0,2.0,1.0,<2 mo. follow-up,1.8389997
51.89899,female,1.0,MOSF w/Malig,12.0,under $11k,85777.0,white,metastatic,0.699999809,0.5,dnr before sadm,-9.0,40.0,3.79980469,120.0,34.0,38.19531,224.0,2.8999023,0.89990234,1.19995117,138.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.7719727
48.98599,male,1.0,Cirrhosis,12.0,under $11k,131400.0,white,no,0.699999809,0.5,dnr after sadm,10.0,60.0,16.3984375,115.0,36.0,38.0,132.0,2.3999023,4.19921875,1.0,138.0,7.549805,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.5107422
76.33398,male,0.0,CHF,7.0,under $11k,24988.0,white,no,0.699999809,0.5,no dnr,11.0,60.0,5.79980469,72.0,20.0,36.19531,224.0,4.0,2.09960938,1.5,144.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
24.493,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,149776.0,white,no,0.979999542,0.9799995,no dnr,37.0,108.0,29.796875,140.0,10.0,38.69531,394.25,2.2998047,7.59960938,0.79992676,132.0,7.449219,135.0,23.0,1968.0,0.0,0.0,SIP>=30,0.0
70.46698,female,0.0,ARF/MOSF w/Sepsis,16.0,$25-$50k,57539.0,other,no,0.799999714,0.6999998,no dnr,14.0,135.0,5.09960938,120.0,26.0,37.69531,195.90625,2.8999023,0.89990234,2.29980469,128.0,7.439453,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.690918
58.31897,male,0.0,MOSF w/Malig,23.0,under $11k,542326.0,white,yes,0.399999857,0.09999996,dnr before sadm,-1.0,112.0,4.29980469,205.0,15.0,37.69531,52.0,3.3999023,1.89990234,0.89990234,137.0,7.279297,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),2.6416016
80.25494,female,1.0,Coma,12.0,under $11k,14297.0,white,no,0.099999964,0.0009999992,dnr after sadm,4.0,127.0,13.5996094,135.0,32.0,38.89844,357.125,2.8999023,0.89990234,0.59997559,138.0,7.469727,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.5532227
67.58398,male,0.0,Lung Cancer,12.0,$11-$25k,10819.0,black,metastatic,0.599999905,0.3,no dnr,4.0,97.0,12.0,80.0,20.0,35.79688,224.0,2.8999023,0.89990234,1.19995117,135.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.7944336
40.96399,male,1.0,Cirrhosis,16.0,$11-$25k,93417.0,hispanic,no,0.699999809,0.5,dnr after sadm,7.0,70.0,2.29980469,95.0,14.0,36.69531,271.375,3.5996094,38.3984375,4.69921875,136.0,7.389648,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.1333008
26.683,female,0.0,ARF/MOSF w/Sepsis,11.0,under $11k,109747.0,other,no,0.699999809,0.5999999,no dnr,19.0,118.0,24.0976562,120.0,10.0,38.0,58.32812,2.3999023,12.5996094,1.39990234,136.0,7.449219,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
61.85397,female,1.0,MOSF w/Malig,11.0,under $11k,173968.0,white,yes,0.5,0.3999999,dnr after sadm,20.0,113.0,0.04999542,180.0,28.0,39.69531,352.375,2.0996094,2.29980469,1.79980469,134.0,7.549805,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.4663086
77.53595,male,1.0,Coma,12.0,under $11k,20078.0,white,no,0.699999809,0.5,dnr after sadm,2.0,40.0,10.3984375,55.0,10.0,35.59375,64.0,3.8999023,1.29980469,2.29980469,138.0,7.239258,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.9956055
70.03998,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,444556.0,white,yes,0.699999809,0.5,no dnr,35.0,93.0,10.5996094,105.0,32.0,39.0,288.0,4.0996094,3.59960938,1.09985352,132.0,7.269531,135.0,23.0,1968.0,0.0,4.0,<2 mo. follow-up,4.0
66.00098,male,0.0,CHF,12.0,$25-$50k,31463.0,white,no,0.599999905,0.5,no dnr,7.0,57.0,8.69921875,115.0,22.0,36.5,224.0,4.7998047,0.39996338,1.59985352,135.0,7.419922,135.0,23.0,1968.0,1.0,0.0,no(M2 and SIP pres),0.0
59.995,female,0.0,COPD,8.0,under $11k,41479.0,hispanic,yes,0.699999809,0.5999999,no dnr,14.0,77.0,4.19921875,95.0,40.0,36.19531,266.625,2.8999023,0.09999084,0.89990234,133.0,7.319336,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
49.91599,male,1.0,ARF/MOSF w/Sepsis,14.0,>$50k,220490.0,black,metastatic,0.099999964,0.0009999992,dnr after sadm,5.0,115.0,15.0,55.0,14.0,36.09375,136.65625,2.0,1.0,0.59997559,136.0,7.5,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.3061523
51.56699,female,0.0,Cirrhosis,12.0,under $11k,1435423.0,other,no,0.699999809,0.5,no dnr,6.0,58.0,10.5,72.0,24.0,36.0,224.0,2.199707,19.796875,2.09960938,126.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.4399414
55.13998,female,0.0,COPD,12.0,under $11k,7322.0,white,no,0.699999809,0.5,no dnr,4.0,71.0,7.59960938,84.0,20.0,36.79688,223.78125,2.8999023,0.89990234,0.69995117,136.0,7.439453,135.0,23.0,1968.0,1.0,5.0,adl>=4 (>=5 if sur),5.0
30.69099,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,138003.0,white,no,0.699999809,0.5,no dnr,19.0,110.0,17.1992188,150.0,45.0,38.69531,357.5,2.8999023,0.89990234,0.59997559,135.0,7.479492,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5795898
47.34799,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,23807.0,white,no,0.979999542,0.8999996,no dnr,6.0,77.0,14.2988281,100.0,45.0,38.09375,196.65625,2.8999023,0.59997559,0.59997559,143.0,7.469727,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.4794922
60.23297,male,0.0,Lung Cancer,12.0,under $11k,16410.0,other,metastatic,0.699999809,0.5,dnr after sadm,2.0,79.0,19.8984375,160.0,16.0,36.39844,228.5625,4.1992188,1.29980469,1.79980469,134.0,7.459961,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.3388672
37.08099,male,0.0,Cirrhosis,12.0,under $11k,7547.0,white,no,0.949999809,0.5,no dnr,7.0,105.0,7.59960938,100.0,22.0,38.79688,224.0,2.8999023,6.89941406,0.59997559,133.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.2421875
63.25,male,0.0,Lung Cancer,13.0,$25-$50k,15400.0,asian,metastatic,0.699999809,0.5,no dnr,5.0,87.0,11.1992188,100.0,30.0,38.0,224.0,4.5996094,0.5,0.89990234,134.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.8708496
51.87698,male,0.0,Lung Cancer,16.0,>$50k,22975.0,white,metastatic,0.699999809,0.5,no dnr,11.0,91.0,3.89990234,100.0,20.0,36.59375,285.6875,2.8999023,0.29998779,0.89990234,133.0,7.519531,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
69.50299,male,0.0,CHF,12.0,under $11k,45162.0,white,no,0.699999809,0.5,no dnr,13.0,53.0,14.5996094,110.0,20.0,36.89844,306.0,2.8999023,0.89990234,1.69995117,127.0,7.269531,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
84.43799,male,0.0,CHF,12.0,under $11k,25793.0,white,yes,0.799999714,0.1999999,no dnr,8.0,60.0,4.19921875,85.0,38.0,37.5,246.9375,2.8999023,0.29998779,1.0,131.0,7.589844,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.6225586
46.60397,male,0.0,Lung Cancer,16.0,>$50k,17707.0,white,metastatic,0.699999809,0.5,no dnr,6.0,60.0,7.69921875,134.0,22.0,38.79688,224.0,2.8999023,0.89990234,0.89990234,135.0,7.419922,135.0,23.0,1968.0,1.0,2.0,no(M2 and SIP pres),2.0
60.07397,female,1.0,Lung Cancer,12.0,under $11k,6149.0,white,metastatic,0.049999982,0.0001249999,dnr after sadm,2.0,107.0,10.8984375,116.0,24.0,36.0,228.0,2.8999023,0.89990234,0.39996338,144.0,7.489258,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.4169922
62.27197,male,1.0,ARF/MOSF w/Sepsis,16.0,under $11k,150556.0,white,no,0.699999809,0.5,dnr after sadm,6.0,68.0,6.79980469,140.0,36.0,38.0,369.5625,3.3999023,6.09960938,7.29980469,132.0,7.5,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
48.353,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,565876.0,white,no,0.699999809,0.5,dnr after sadm,2.0,20.0,49.8984375,135.0,24.0,36.29688,76.0,4.3994141,24.0976562,3.39990234,149.0,7.239258,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.8876953
78.33795,male,1.0,Coma,12.0,under $11k,31356.0,white,no,0.699999809,0.5,dnr after sadm,4.0,50.0,6.59960938,150.0,22.0,37.5,143.3125,2.8999023,0.89990234,2.09960938,128.0,7.40918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.2514648
58.14099,female,0.0,CHF,12.0,under $11k,4642.0,white,no,0.699999809,0.5,no dnr,3.0,117.0,9.09960938,105.0,24.0,36.5,252.375,2.8999023,0.89990234,0.89990234,140.0,7.289062,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5004883
60.87299,female,0.0,CHF,12.0,under $11k,29509.0,black,no,0.699999809,0.5,no dnr,11.0,67.0,9.79882812,75.0,20.0,36.29688,224.0,2.8999023,1.39990234,1.19995117,131.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),3.6489258
51.62198,male,1.0,MOSF w/Malig,10.0,under $11k,85043.0,black,yes,0.699999809,0.5,no dnr,4.0,57.0,0.04999542,145.0,40.0,40.0,178.0,2.8999023,2.19970703,7.79980469,133.0,7.289062,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.7714844
48.62399,female,0.0,MOSF w/Malig,16.0,$11-$25k,95852.0,white,metastatic,0.5,0.1999999,dnr after sadm,26.0,62.0,8.09960938,110.0,20.0,37.5,224.0,2.3999023,2.0,2.09960938,141.0,7.419922,135.0,23.0,1968.0,0.0,6.0,<2 mo. follow-up,6.0
29.63699,male,0.0,Coma,12.0,under $11k,168489.0,hispanic,yes,0.399999857,0.3,no dnr,20.0,67.0,17.3984375,40.0,14.0,35.89844,230.0,2.8999023,0.89990234,0.89990234,135.0,7.509766,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
54.146,male,0.0,Colon Cancer,16.0,>$50k,44109.0,white,metastatic,0.949999809,0.75,no dnr,11.0,117.0,18.3984375,90.0,14.0,37.0,224.0,5.0996094,3.0,1.0,133.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.1723633
68.16998,female,0.0,Cirrhosis,12.0,under $11k,38996.0,white,no,0.699999809,0.5,no dnr,11.0,97.0,19.3984375,110.0,22.0,37.0,282.8125,1.8999023,3.39990234,0.79992676,137.0,7.339844,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.621582
47.73398,male,0.0,CHF,15.0,under $11k,30953.0,black,no,0.75,0.6999998,no dnr,10.0,43.0,5.29980469,90.0,22.0,36.0,224.0,3.699707,3.09960938,1.19995117,126.0,7.419922,135.0,23.0,1968.0,6.0,1.0,no(M2 and SIP pres),4.5273972
91.84399,female,1.0,Coma,12.0,under $11k,11415.0,white,no,0.699999809,0.5,dnr after sadm,2.0,73.0,28.296875,100.0,36.0,35.29688,332.0,2.8999023,0.5,1.69995117,143.0,7.549805,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,4.0322266
59.39798,male,0.0,Colon Cancer,16.0,$25-$50k,8512.0,white,metastatic,0.899999619,0.3999999,no dnr,6.0,71.0,6.09960938,60.0,22.0,37.79688,224.0,3.3999023,0.89990234,0.89990234,139.0,7.419922,135.0,23.0,1968.0,1.0,1.0,no(M2 and SIP pres),1.1668997
49.59598,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,102876.0,white,no,0.699999809,0.5,dnr after sadm,9.0,50.0,15.1992188,170.0,24.0,39.29688,65.32812,4.1992188,24.1992188,7.09960938,143.0,7.479492,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.527832
51.086,female,0.0,ARF/MOSF w/Sepsis,10.0,$25-$50k,480519.0,hispanic,no,0.699999809,0.5,no dnr,69.0,110.0,18.6992188,130.0,20.0,39.19531,270.0,3.199707,11.5,1.5,150.0,7.519531,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),1.0
46.22598,male,0.0,CHF,12.0,under $11k,349052.0,hispanic,no,0.5,0.5,no dnr,46.0,61.0,13.5,145.0,8.0,38.39844,155.09375,2.8999023,1.39990234,1.0,129.0,7.5,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
76.77197,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,92775.0,white,no,0.699999809,0.5,no dnr,19.0,70.0,18.0976562,60.0,20.0,38.79688,151.65625,2.2998047,0.89990234,1.09985352,133.0,7.5,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.2773438
50.59497,male,1.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,93265.0,hispanic,no,0.699999809,0.5,no dnr,5.0,37.0,17.6992188,75.0,40.0,36.89844,143.0,1.5,21.0,3.0,134.0,7.079102,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,4.1542969
60.56897,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,75752.0,white,no,0.899999619,0.8999996,no dnr,13.0,60.0,13.0996094,72.0,10.0,38.39844,205.4375,2.8999023,0.89990234,0.69995117,135.0,7.449219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.6948242
43.21399,female,1.0,MOSF w/Malig,12.0,under $11k,43810.0,white,yes,0.099999964,0.0009999992,dnr after sadm,6.0,57.0,7.69921875,120.0,36.0,39.19531,150.0,2.8999023,0.89990234,1.89990234,134.0,7.5,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.7348633
82.63098,male,0.0,CHF,16.0,under $11k,7920.0,white,no,0.699999809,0.5,no dnr,5.0,77.0,19.3984375,70.0,22.0,36.39844,224.0,2.8999023,0.89990234,2.29980469,132.0,7.419922,135.0,23.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
80.23798,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,43960.0,white,no,0.599999905,0.5999999,no dnr,9.0,113.0,15.0,60.0,10.0,37.89844,142.5,2.8999023,0.89990234,1.09985352,136.0,7.459961,135.0,23.0,1968.0,0.0,2.0,adl>=4 (>=5 if sur),2.0
26.023,male,1.0,ARF/MOSF w/Sepsis,14.0,under $11k,166772.0,hispanic,yes,0.299999952,0.1999999,dnr after sadm,6.0,40.0,3.29980469,125.0,32.0,36.0,158.0,2.8999023,0.89990234,2.89990234,130.0,7.319336,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
22.72699,female,0.0,ARF/MOSF w/Sepsis,14.0,>$50k,23778.0,black,no,0.699999809,0.5,no dnr,7.0,99.0,6.79980469,112.0,40.0,38.5,140.8125,2.8999023,0.89990234,0.79992676,134.0,7.469727,135.0,23.0,1968.0,2.0,0.0,<2 mo. follow-up,0.0
52.67599,male,0.0,Lung Cancer,17.0,>$50k,22661.0,white,metastatic,0.949999809,0.6999998,no dnr,9.0,104.0,37.296875,78.0,16.0,37.79688,224.0,2.8999023,0.89990234,0.89990234,128.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
64.11798,female,0.0,Lung Cancer,12.0,under $11k,12023.0,black,metastatic,1.0,0.5,no dnr,8.0,109.0,10.5,78.0,16.0,36.39844,224.0,4.6992188,0.69995117,1.29980469,134.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.8193359
36.211,female,1.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,374053.0,black,yes,0.5,0.125,no dnr,17.0,130.0,7.39941406,125.0,14.0,37.5,87.5,3.2998047,18.5976562,2.5,142.0,7.439453,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.503418
29.588,male,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,563075.0,black,no,0.699999809,0.5,no dnr,93.0,115.0,1.89990234,120.0,38.0,35.79688,305.0,2.8999023,3.39990234,5.59960938,137.0,7.389648,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),3.7104492
63.95599,male,1.0,CHF,9.0,>$50k,68631.0,hispanic,no,0.799999714,0.5999999,dnr after sadm,19.0,68.0,8.09960938,100.0,16.0,36.0,224.0,2.8999023,2.19970703,1.59985352,125.0,7.419922,135.0,23.0,1968.0,5.0,1.0,<2 mo. follow-up,3.855299
70.90997,male,1.0,CHF,18.0,under $11k,13400.0,white,no,0.699999809,0.5,no dnr,8.0,93.0,10.0996094,72.0,20.0,36.0,224.0,4.6992188,0.89990234,2.5,138.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
66.63098,female,0.0,Cirrhosis,10.0,>$50k,14175.0,white,yes,0.849999905,0.5999999,no dnr,10.0,80.0,5.69921875,110.0,22.0,36.0,224.0,3.0,2.59960938,2.0,140.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),3.2807617
77.17499,female,0.0,Cirrhosis,12.0,under $11k,14976.0,white,no,0.899999619,0.5,no dnr,9.0,82.0,7.79980469,72.0,20.0,36.0,224.0,2.8999023,6.29980469,1.19995117,138.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.434082
60.54498,male,1.0,ARF/MOSF w/Sepsis,14.0,$25-$50k,283844.0,hispanic,no,0.75,0.75,dnr after sadm,14.0,107.0,10.5996094,125.0,35.0,38.5,202.0,1.6999512,9.29882812,1.19995117,143.0,7.389648,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.7592773
76.56696,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,308455.0,white,yes,0.199999928,0.09999996,dnr after sadm,27.0,108.0,10.3984375,145.0,32.0,38.29688,188.5625,1.6999512,7.09960938,1.19995117,136.0,7.489258,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.4482422
76.63495,male,0.0,CHF,11.0,$11-$25k,63938.0,white,no,0.799999714,0.5,no dnr,25.0,47.0,14.3984375,95.0,30.0,37.5,184.0,2.8999023,0.89990234,1.59985352,134.0,7.459961,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
51.20099,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,41580.0,asian,no,0.5,0.1999999,dnr after sadm,6.0,68.0,22.796875,110.0,24.0,37.89844,212.5,1.6999512,4.29980469,3.19970703,133.0,7.349609,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.6914062
20.24399,male,0.0,CHF,12.0,under $11k,11528.0,hispanic,no,0.799999714,0.5999999,no dnr,9.0,60.0,8.69921875,70.0,24.0,36.0,224.0,2.8999023,0.89990234,1.59985352,128.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.8491211
69.47296,female,0.0,Cirrhosis,12.0,>$50k,151788.0,white,no,0.699999809,0.5,no dnr,36.0,71.0,10.1992188,68.0,20.0,36.80469,224.0,2.5996094,18.5976562,1.59985352,126.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
76.76099,female,1.0,Lung Cancer,12.0,under $11k,18406.0,white,metastatic,0.699999809,0.5,dnr after sadm,5.0,67.0,11.3984375,92.0,20.0,36.39844,368.0,2.8999023,0.89990234,0.59997559,130.0,7.429688,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.887207
24.56699,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,392270.0,hispanic,no,0.199999928,0.007999994,no dnr,66.0,65.0,10.1992188,130.0,32.0,38.5,166.65625,2.8999023,0.79992676,8.79882812,137.0,7.369141,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
53.62097,female,0.0,Colon Cancer,12.0,under $11k,28094.0,white,metastatic,0.699999809,0.5,no dnr,10.0,80.0,9.69921875,105.0,22.0,38.19531,476.1875,2.8999023,0.89990234,1.19995117,140.0,7.40918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5981445
78.88794,male,1.0,MOSF w/Malig,13.0,>$50k,88377.0,white,metastatic,0.0,0.0,dnr after sadm,4.0,73.0,7.19921875,105.0,25.0,38.59375,198.0,2.8999023,0.89990234,1.69995117,147.0,7.5,135.0,23.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
68.40497,female,0.0,Lung Cancer,12.0,under $11k,32994.0,white,metastatic,0.199999928,0.0,no dnr,14.0,62.0,7.89941406,75.0,30.0,36.59375,257.125,2.8999023,0.89990234,1.79980469,136.0,7.459961,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
74.94299,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,345855.0,black,no,0.699999809,0.5,dnr after sadm,43.0,107.0,22.5,105.0,30.0,38.09375,300.0,2.8999023,1.09985352,1.09985352,131.0,7.519531,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.6743164
72.98798,female,1.0,Coma,12.0,under $11k,16404.0,asian,no,0.049999982,0.0001249999,dnr after sadm,3.0,45.0,28.3984375,185.0,36.0,38.29688,423.3125,3.3999023,0.59997559,1.0,141.0,7.469727,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.2197266
50.28897,female,0.0,Colon Cancer,12.0,under $11k,6673.0,white,metastatic,0.699999809,0.5,no dnr,4.0,83.0,9.3984375,84.0,20.0,38.0,224.0,2.8999023,0.59997559,1.39990234,136.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.871582
87.48297,female,0.0,CHF,12.0,under $11k,4969.0,white,no,0.699999809,0.5,dnr after sadm,1.0,83.0,13.3984375,60.0,18.0,36.79688,224.0,2.8999023,0.89990234,1.0,134.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.8491211
25.95799,male,1.0,ARF/MOSF w/Sepsis,12.0,>$50k,73645.0,white,yes,0.049999982,0.0001249999,dnr after sadm,4.0,123.0,2.19970703,115.0,32.0,35.29688,56.0,2.8999023,10.1992188,1.59985352,129.0,7.449219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.4125977
78.88794,female,0.0,ARF/MOSF w/Sepsis,7.0,under $11k,198860.0,white,no,0.699999809,0.5,no dnr,48.0,55.0,19.3984375,90.0,14.0,38.79688,160.0,2.699707,0.89990234,0.5,128.0,7.5,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.5380859
52.30099,male,0.0,Colon Cancer,12.0,under $11k,4510.0,white,metastatic,0.699999809,0.5,no dnr,4.0,87.0,7.69921875,62.0,20.0,36.19531,224.0,4.6992188,0.5,1.0,134.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.5620117
49.08698,male,1.0,ARF/MOSF w/Sepsis,14.0,under $11k,176752.0,white,no,0.099999964,0.0009999992,dnr after sadm,2.0,48.0,37.59375,145.0,28.0,38.29688,118.0,4.7998047,19.296875,4.69921875,142.0,7.389648,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.0224609
54.48599,female,0.0,Colon Cancer,15.0,under $11k,37609.0,white,metastatic,0.989999771,0.9499998,no dnr,11.0,73.0,12.7988281,120.0,30.0,37.0,388.5625,4.0,1.0,1.09985352,133.0,7.329102,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
32.70599,female,1.0,ARF/MOSF w/Sepsis,21.0,under $11k,1233213.0,white,no,0.699999809,0.5,no dnr,103.0,122.0,7.29980469,105.0,15.0,36.19531,192.5,4.0,9.5,3.79980469,149.0,7.449219,135.0,23.0,1968.0,0.0,3.0,<2 mo. follow-up,3.0
40.46799,female,0.0,ARF/MOSF w/Sepsis,12.0,>$50k,289233.0,white,no,0.5,0.5,no dnr,46.0,42.0,12.8984375,125.0,34.0,38.29688,155.0,2.8999023,0.59997559,0.79992676,135.0,7.509766,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
76.47095,male,1.0,ARF/MOSF w/Sepsis,12.0,>$50k,203430.0,asian,no,0.5,0.09999996,dnr after sadm,9.0,67.0,14.3984375,145.0,10.0,39.0,98.32812,2.199707,15.2988281,1.5,153.0,7.489258,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.0458984
64.20496,female,1.0,Cirrhosis,12.0,>$50k,103876.0,hispanic,no,0.199999928,0.75,dnr after sadm,13.0,52.0,17.5976562,110.0,38.0,36.0,165.0,2.3999023,2.69970703,1.39990234,135.0,7.459961,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
56.07397,female,0.0,ARF/MOSF w/Sepsis,14.0,$11-$25k,131009.0,white,no,0.699999809,0.5,no dnr,25.0,40.0,8.59960938,150.0,42.0,36.39844,166.0,3.2998047,5.69921875,1.5,149.0,7.399414,135.0,23.0,1968.0,0.0,4.0,SIP>=30,4.0
73.01794,female,0.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,57560.0,hispanic,no,0.949999809,0.9499998,no dnr,21.0,73.0,13.2988281,65.0,16.0,38.39844,390.0,2.8999023,0.89990234,1.0,120.0,7.439453,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
75.50195,female,0.0,Colon Cancer,12.0,$11-$25k,14005.0,white,metastatic,1.0,1.0,no dnr,13.0,104.0,12.8984375,70.0,22.0,36.39844,224.0,2.8999023,0.79992676,1.0,139.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
66.77594,female,0.0,Colon Cancer,12.0,under $11k,46753.0,white,metastatic,0.699999809,0.5,no dnr,12.0,73.0,15.2988281,105.0,10.0,38.0,223.3125,2.199707,0.19998169,0.69995117,136.0,7.40918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.3530273
52.30698,male,0.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,54390.0,black,no,0.5,0.5,no dnr,8.0,113.0,14.3984375,105.0,37.0,38.29688,245.6875,2.3999023,6.0,1.29980469,132.0,7.459961,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
50.17099,female,0.0,Lung Cancer,12.0,>$50k,13399.0,white,metastatic,0.699999809,0.5,no dnr,6.0,84.0,10.5996094,108.0,30.0,36.19531,224.0,2.8999023,0.89990234,1.19995117,140.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
47.18997,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,160900.0,other,no,0.699999809,0.5,no dnr,7.0,60.0,26.0976562,140.0,39.0,37.0,154.28125,2.8999023,7.89941406,2.19970703,148.0,7.429688,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.7456055
55.25497,female,1.0,Lung Cancer,12.0,under $11k,13593.0,black,metastatic,0.0,0.0,dnr after sadm,4.0,63.0,9.79882812,120.0,28.0,38.0,224.0,2.8999023,0.89990234,0.69995117,142.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,4.0058594
59.36798,male,0.0,CHF,12.0,>$50k,15494.0,white,no,0.699999809,0.5,no dnr,7.0,62.0,5.89941406,145.0,24.0,36.5,440.0,2.8999023,0.69995117,1.29980469,131.0,7.549805,135.0,23.0,1968.0,0.0,5.0,<2 mo. follow-up,5.0
63.22498,male,0.0,Colon Cancer,12.0,under $11k,34247.0,white,metastatic,0.899999619,0.5999999,no dnr,13.0,87.0,10.0,105.0,22.0,38.0,224.0,4.3994141,0.39996338,1.0,132.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.1767578
54.69699,male,1.0,MOSF w/Malig,18.0,>$50k,168940.0,white,yes,0.049999982,0.0001249999,dnr after sadm,4.0,82.0,0.59997559,115.0,34.0,36.5,171.40625,4.1992188,26.6992188,7.29980469,151.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.4682617
75.66095,male,0.0,CHF,12.0,under $11k,16067.0,white,no,0.949999809,0.5,no dnr,6.0,55.0,9.8984375,70.0,22.0,36.69531,224.0,3.5996094,1.0,2.59960938,135.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.421875
65.09198,female,0.0,Colon Cancer,12.0,>$50k,56695.0,white,metastatic,0.949999809,0.7999997,no dnr,17.0,120.0,6.79980469,100.0,28.0,37.5,182.0,4.3994141,0.29998779,1.0,139.0,7.359375,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
60.55298,male,0.0,Lung Cancer,12.0,under $11k,5619.0,white,metastatic,0.699999809,0.5,no dnr,5.0,83.0,4.5,78.0,20.0,36.89844,224.0,4.2998047,0.29998779,1.09985352,139.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.7854004
30.015,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,871855.0,white,no,0.699999809,0.5,no dnr,99.0,58.0,11.2988281,120.0,6.0,38.39844,290.0,3.699707,16.6992188,5.39941406,141.0,7.419922,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
35.92899,male,1.0,Colon Cancer,12.0,under $11k,39582.0,white,metastatic,0.5,0.04999998,dnr after sadm,16.0,85.0,5.09960938,64.0,10.0,36.19531,224.0,4.0996094,0.89990234,1.79980469,131.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.546875
54.84998,female,0.0,Lung Cancer,16.0,$11-$25k,3278.0,black,metastatic,0.699999809,0.5,dnr after sadm,1.0,100.0,7.89941406,80.0,18.0,36.0,224.0,2.8999023,0.89990234,0.79992676,136.0,7.419922,135.0,23.0,1968.0,3.0,1.0,SIP>=30,1.0
90.32196,female,0.0,ARF/MOSF w/Sepsis,16.0,under $11k,106419.0,white,no,0.199999928,0.15,dnr after sadm,7.0,68.0,11.0996094,45.0,12.0,37.0,237.5,2.8999023,0.89990234,1.0,133.0,7.459961,135.0,23.0,1968.0,0.0,7.0,<2 mo. follow-up,7.0
84.33899,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,271224.0,white,no,0.299999952,0.09999996,dnr after sadm,18.0,110.0,12.7988281,70.0,16.0,35.89844,134.6875,2.8999023,0.89990234,5.0,134.0,7.5,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.4804688
57.23999,male,0.0,Cirrhosis,19.0,>$50k,410745.0,white,no,0.599999905,0.5999999,no dnr,50.0,57.0,2.79980469,110.0,9.0,34.0,257.125,3.0,7.0,2.69970703,150.0,7.459961,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),3.9970703
38.80399,female,0.0,CHF,14.0,$25-$50k,133255.0,white,metastatic,0.699999809,0.5,no dnr,22.0,60.0,6.89941406,120.0,16.0,36.09375,224.0,3.3999023,0.29998779,2.19970703,137.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
72.46497,female,0.0,Lung Cancer,12.0,under $11k,5552.0,black,metastatic,0.699999809,0.5,no dnr,5.0,83.0,13.0,74.0,20.0,36.19531,224.0,2.8999023,0.89990234,0.79992676,135.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.6166992
92.60199,female,0.0,ARF/MOSF w/Sepsis,13.0,$25-$50k,50810.0,white,no,0.699999809,0.5999999,no dnr,16.0,120.0,22.296875,115.0,24.0,36.0,388.5625,2.199707,0.89990234,1.59985352,141.0,7.429688,135.0,23.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
59.69299,female,1.0,MOSF w/Malig,12.0,under $11k,71936.0,white,metastatic,0.099999964,0.0009999992,dnr after sadm,2.0,73.0,4.29980469,128.0,8.0,38.39844,95.0,2.8999023,0.89990234,1.69995117,155.0,7.369141,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.4375
52.767,male,0.0,Cirrhosis,12.0,>$50k,43499.0,white,no,0.599999905,0.6999998,no dnr,12.0,77.0,2.69970703,64.0,22.0,36.79688,224.0,2.699707,5.0,0.89990234,130.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
54.97098,female,0.0,COPD,8.0,>$50k,4936.0,black,no,0.699999809,0.5,no dnr,5.0,93.0,10.3984375,88.0,24.0,36.39844,272.0,2.8999023,0.29998779,1.09985352,135.0,7.389648,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
62.35699,male,0.0,Coma,12.0,under $11k,58097.0,white,no,0.699999809,0.5,no dnr,26.0,130.0,12.1992188,110.0,30.0,37.0,260.0,2.8999023,0.5,0.89990234,146.0,7.579102,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.0390625
82.01196,female,0.0,COPD,11.0,$11-$25k,45384.0,white,no,0.699999809,0.5,no dnr,18.0,63.0,19.3984375,110.0,32.0,36.29688,160.6875,3.8999023,0.19998169,2.0,153.0,7.369141,135.0,23.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
53.46997,female,0.0,CHF,9.0,under $11k,23440.0,white,no,0.5,0.1999999,no dnr,11.0,77.0,11.6992188,50.0,26.0,36.89844,360.0,2.8999023,0.39996338,2.5,140.0,7.439453,135.0,23.0,1968.0,2.0,3.0,no(M2 and SIP pres),3.0
21.092,male,1.0,Coma,12.0,>$50k,91295.0,white,no,0.049999982,0.0001249999,dnr after sadm,3.0,57.0,26.6992188,130.0,14.0,38.89844,463.3125,2.8999023,12.5,1.09985352,150.0,7.429688,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5375977
19.866,female,0.0,CHF,11.0,under $11k,120028.0,black,no,0.699999809,0.5,no dnr,22.0,47.0,11.5996094,120.0,28.0,38.0,224.0,3.199707,3.29980469,0.79992676,128.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
52.10999,female,0.0,ARF/MOSF w/Sepsis,21.0,under $11k,546390.0,white,no,0.899999619,0.7999997,no dnr,40.0,68.0,31.6992188,110.0,42.0,36.39844,135.53125,2.5,5.39941406,1.5,132.0,7.40918,135.0,23.0,1968.0,0.0,3.0,adl>=4 (>=5 if sur),3.0
69.66498,male,0.0,Lung Cancer,6.0,under $11k,9574.0,black,metastatic,0.699999809,0.5,no dnr,4.0,109.0,12.5,70.0,20.0,36.39844,224.0,4.3994141,0.19998169,1.19995117,136.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
66.409,female,0.0,CHF,14.0,>$50k,43722.0,white,no,0.799999714,0.5999999,no dnr,11.0,66.0,7.39941406,75.0,20.0,36.19531,224.0,2.5996094,1.29980469,1.0,131.0,7.419922,135.0,23.0,1968.0,5.0,4.0,no(M2 and SIP pres),4.0
39.84698,female,0.0,MOSF w/Malig,12.0,under $11k,47588.0,white,metastatic,0.25,0.015625,no dnr,17.0,71.0,6.19921875,120.0,22.0,36.39844,224.0,2.8999023,0.89990234,0.29998779,111.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),3.7070312
66.14099,male,1.0,COPD,16.0,>$50k,21075.0,white,no,0.799999714,0.6999998,dnr after sadm,1.0,108.0,14.0996094,132.0,32.0,36.59375,247.8125,2.8999023,0.89990234,1.0,137.0,7.289062,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,4.0595703
53.24597,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,231587.0,white,no,0.399999857,0.09999996,dnr after sadm,18.0,57.0,24.296875,150.0,37.0,36.0,283.625,2.8999023,15.5996094,2.29980469,142.0,7.40918,135.0,23.0,1968.0,0.0,5.0,<2 mo. follow-up,5.0
69.94098,male,0.0,CHF,18.0,>$50k,5631.0,white,no,0.949999809,0.8999996,no dnr,4.0,60.0,8.0,130.0,24.0,35.59375,323.75,2.8999023,0.89990234,1.19995117,138.0,7.539062,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
20.69299,male,0.0,ARF/MOSF w/Sepsis,11.0,under $11k,125185.0,white,no,0.989999771,0.9799995,no dnr,11.0,120.0,16.8984375,145.0,15.0,36.59375,187.75,2.8999023,0.59997559,8.8984375,134.0,7.439453,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
48.78598,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,96189.0,white,no,0.699999809,0.5,no dnr,16.0,127.0,22.796875,170.0,32.0,38.29688,328.0,2.8999023,0.89990234,1.29980469,153.0,7.359375,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.5883789
35.047,male,1.0,MOSF w/Malig,12.0,under $11k,155711.0,other,yes,0.699999809,0.5,dnr after sadm,6.0,65.0,16.3984375,125.0,40.0,36.89844,237.5,3.0996094,17.3984375,2.59960938,139.0,7.339844,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.3032227
72.01398,male,0.0,ARF/MOSF w/Sepsis,16.0,$25-$50k,173394.0,white,no,0.799999714,0.6999998,no dnr,46.0,110.0,23.296875,85.0,40.0,37.89844,140.8125,2.8999023,0.89990234,1.89990234,133.0,7.55957,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
42.823,female,1.0,MOSF w/Malig,15.0,under $11k,393995.0,white,metastatic,0.5,0.3499999,no dnr,74.0,67.0,3.29980469,130.0,50.0,39.59375,116.65625,2.5,0.89990234,1.5,149.0,7.329102,135.0,23.0,1968.0,0.0,1.0,Coma or Intub,1.0
63.84097,female,0.0,Colon Cancer,14.0,$25-$50k,13525.0,white,metastatic,0.699999809,0.5,no dnr,9.0,77.0,14.3984375,100.0,20.0,38.19531,224.0,2.8999023,0.39996338,0.89990234,132.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.6625977
62.59497,female,0.0,Cirrhosis,12.0,$11-$25k,30117.0,white,no,0.899999619,0.5,no dnr,15.0,82.0,7.5,78.0,20.0,37.79688,457.125,2.0,4.39941406,1.0,132.0,7.519531,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),1.0
70.823,female,0.0,CHF,14.0,under $11k,51017.0,white,no,0.699999809,0.5,no dnr,20.0,75.0,6.89941406,70.0,20.0,36.0,224.0,2.8999023,0.89990234,2.0,141.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
60.758,female,0.0,Colon Cancer,10.0,$25-$50k,24158.0,white,metastatic,0.699999809,0.5,no dnr,11.0,117.0,11.0996094,115.0,16.0,36.5,224.0,3.8999023,0.69995117,1.0,142.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5664062
76.03296,male,0.0,Colon Cancer,17.0,$25-$50k,14594.0,white,metastatic,0.699999809,0.5,no dnr,8.0,110.0,13.3984375,104.0,24.0,38.59375,224.0,2.8999023,0.89990234,1.19995117,136.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
62.42599,male,0.0,Lung Cancer,12.0,under $11k,9366.0,white,metastatic,0.699999809,0.5,no dnr,4.0,83.0,12.7988281,78.0,20.0,36.39844,224.0,2.8999023,0.89990234,1.0,138.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
58.58197,male,0.0,Cirrhosis,8.0,$11-$25k,44079.0,black,no,0.699999809,0.5,no dnr,8.0,67.0,8.3984375,76.0,20.0,37.89844,224.0,2.8999023,0.89990234,1.5,136.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),3.112793
38.155,male,0.0,ARF/MOSF w/Sepsis,16.0,under $11k,143906.0,white,no,0.5,0.5,no dnr,21.0,73.0,13.1992188,60.0,10.0,36.59375,142.0,2.5,0.59997559,6.5,131.0,7.379883,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
79.97797,female,1.0,ARF/MOSF w/Sepsis,15.0,under $11k,214894.0,white,no,0.699999809,0.5,no dnr,37.0,64.0,25.5,111.0,40.0,36.5,105.0,2.8999023,0.79992676,2.39990234,129.0,7.369141,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
72.71497,female,0.0,CHF,14.0,$11-$25k,76132.0,black,no,0.699999809,0.5,no dnr,17.0,105.0,7.5,110.0,26.0,36.5,224.0,2.8999023,0.89990234,1.0,138.0,7.419922,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
65.53894,female,0.0,Lung Cancer,14.0,$25-$50k,7769.0,white,metastatic,0.699999809,0.5,no dnr,6.0,125.0,9.59960938,88.0,22.0,36.39844,224.0,2.8999023,0.89990234,0.79992676,139.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
50.439,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,16863.0,black,no,0.799999714,0.6999998,dnr after sadm,3.0,82.0,2.09960938,60.0,26.0,36.0,366.625,2.8999023,1.29980469,9.09960938,130.0,7.489258,135.0,23.0,1968.0,1.0,1.0,<2 mo. follow-up,1.1668997
61.02698,male,0.0,Colon Cancer,13.0,under $11k,31943.0,white,metastatic,0.949999809,0.75,no dnr,10.0,100.0,10.1992188,128.0,28.0,38.19531,224.0,3.7998047,2.29980469,1.19995117,140.0,7.419922,135.0,23.0,1968.0,0.0,2.0,no(M2 and SIP pres),2.0
66.37097,male,0.0,CHF,12.0,$25-$50k,50099.0,white,no,0.699999809,0.5,no dnr,15.0,57.0,11.5996094,115.0,24.0,36.59375,224.0,2.8999023,0.89990234,1.59985352,130.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
54.08899,female,1.0,Lung Cancer,12.0,$11-$25k,23806.0,white,metastatic,0.699999809,0.5,dnr after sadm,4.0,87.0,27.5976562,128.0,30.0,36.19531,136.65625,2.8999023,0.89990234,0.79992676,138.0,7.479492,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
75.26398,female,0.0,ARF/MOSF w/Sepsis,16.0,under $11k,444915.0,white,no,0.5,0.3,no dnr,38.0,63.0,12.5,115.0,40.0,36.59375,195.0,3.2998047,0.89990234,1.09985352,142.0,7.269531,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),1.0
31.72099,male,0.0,MOSF w/Malig,20.0,under $11k,58405.0,white,metastatic,0.699999809,0.5,no dnr,10.0,73.0,7.5,110.0,28.0,36.29688,149.0625,2.7998047,0.89990234,1.0,134.0,7.449219,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
80.01099,male,0.0,ARF/MOSF w/Sepsis,13.0,$25-$50k,50808.0,white,no,0.25,0.09999996,dnr after sadm,1.0,63.0,15.2988281,100.0,28.0,38.0,277.75,2.8999023,0.89990234,1.09985352,148.0,7.519531,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.0786133
83.59497,male,0.0,ARF/MOSF w/Sepsis,19.0,>$50k,81350.0,white,no,0.699999809,0.5,no dnr,13.0,110.0,14.6992188,130.0,28.0,37.0,195.90625,2.8999023,0.89990234,1.0,133.0,7.489258,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
43.64697,female,0.0,ARF/MOSF w/Sepsis,12.0,>$50k,528848.0,white,no,0.699999809,0.5,no dnr,59.0,110.0,18.6992188,110.0,8.0,36.69531,390.0,2.3999023,0.69995117,2.5,127.0,7.399414,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),2.7421875
38.12198,female,0.0,Lung Cancer,12.0,under $11k,8624.0,white,metastatic,0.699999809,0.5,no dnr,6.0,76.0,4.69921875,82.0,20.0,37.19531,224.0,2.8999023,0.29998779,0.89990234,138.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.1303711
79.07495,female,0.0,CHF,7.0,under $11k,24141.0,white,no,0.699999809,0.5,no dnr,15.0,97.0,5.79980469,76.0,20.0,36.79688,224.0,2.8999023,0.89990234,2.69970703,139.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
84.91199,male,1.0,Cirrhosis,16.0,>$50k,30383.0,white,no,0.5,0.3,dnr after sadm,10.0,83.0,9.19921875,72.0,20.0,36.0,224.0,2.5,0.89990234,2.09960938,129.0,7.419922,135.0,23.0,1968.0,2.0,1.0,<2 mo. follow-up,1.0
74.64795,male,1.0,Coma,8.0,under $11k,34042.0,white,no,0.009999998,9.999994e-07,dnr after sadm,3.0,43.0,33.1953125,70.0,12.0,38.0,205.6875,3.0,0.89990234,1.0,135.0,7.469727,135.0,23.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
56.271,male,0.0,Lung Cancer,16.0,under $11k,15227.0,white,metastatic,0.699999809,0.5,no dnr,6.0,75.0,11.1992188,104.0,22.0,38.19531,426.0625,2.8999023,0.89990234,0.89990234,134.0,7.369141,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.3735352
75.23096,male,0.0,CHF,20.0,$25-$50k,29545.0,white,no,0.699999809,0.5,no dnr,12.0,68.0,6.59960938,70.0,24.0,36.69531,224.0,2.8999023,0.89990234,2.29980469,135.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
40.53098,female,0.0,Colon Cancer,11.0,>$50k,26039.0,hispanic,metastatic,0.979999542,0.9499998,no dnr,11.0,97.0,4.29980469,70.0,14.0,37.89844,224.0,4.3994141,1.19995117,0.79992676,140.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.2045898
74.40094,male,1.0,CHF,15.0,>$50k,22733.0,white,no,0.699999809,0.5,dnr after sadm,2.0,57.0,19.3984375,50.0,26.0,38.19531,436.6875,2.8999023,0.79992676,2.19970703,139.0,7.439453,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.5600586
77.67596,female,0.0,ARF/MOSF w/Sepsis,14.0,$11-$25k,25024.0,black,metastatic,0.699999809,0.5,no dnr,12.0,85.0,11.3984375,110.0,20.0,36.89844,260.0,2.5,0.89990234,1.19995117,134.0,7.449219,135.0,23.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
68.24597,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,162892.0,asian,no,0.699999809,0.5,no dnr,25.0,117.0,17.8984375,35.0,20.0,36.0,93.875,2.8999023,1.29980469,4.89941406,131.0,7.529297,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.1791992
38.32999,male,0.0,Cirrhosis,12.0,under $11k,6062.0,white,no,0.699999809,0.5,no dnr,5.0,113.0,8.8984375,72.0,20.0,37.0,224.0,2.8999023,3.89990234,1.0,141.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.1689453
48.36697,male,0.0,ARF/MOSF w/Sepsis,14.0,$11-$25k,74504.0,white,no,0.979999542,0.9799995,no dnr,16.0,80.0,8.29882812,115.0,28.0,39.39844,272.5,2.7998047,0.79992676,1.29980469,141.0,7.509766,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.2773438
80.87598,female,0.0,ARF/MOSF w/Sepsis,14.0,$25-$50k,147296.0,white,no,0.699999809,0.5,no dnr,46.0,113.0,26.1992188,119.0,24.0,38.19531,177.53125,1.8999023,1.59985352,1.89990234,135.0,7.449219,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
63.38699,male,0.0,Lung Cancer,12.0,under $11k,7253.0,white,metastatic,0.75,0.15,no dnr,3.0,79.0,12.3984375,82.0,20.0,36.39844,224.0,2.8999023,0.89990234,0.89990234,135.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.3168945
60.03598,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,142731.0,white,no,0.699999809,0.5,no dnr,10.0,60.0,13.2988281,125.0,8.0,38.5,138.15625,2.8999023,0.79992676,3.0,137.0,7.569336,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.7958984
71.45197,female,0.0,COPD,10.0,under $11k,29501.0,white,no,0.899999619,0.6999998,no dnr,10.0,87.0,15.1992188,78.0,26.0,36.0,200.0,2.8999023,0.89990234,1.0,125.0,7.299805,135.0,23.0,1968.0,0.0,6.0,no(M2 and SIP pres),6.0
32.95297,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,42572.0,white,no,0.5,0.5,no dnr,8.0,122.0,5.79980469,110.0,45.0,39.0,194.28125,2.699707,9.29882812,0.5,151.0,7.5,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.1787109
39.63898,male,0.0,Cirrhosis,13.0,under $11k,272602.0,white,no,0.699999809,0.5,no dnr,48.0,71.0,34.3984375,80.0,20.0,36.39844,404.75,2.5,29.5976562,5.89941406,122.0,7.30957,135.0,23.0,1968.0,5.0,0.0,SIP>=30,0.0
85.11694,male,0.0,CHF,8.0,$11-$25k,15112.0,white,yes,0.75,0.5,dnr after sadm,2.0,66.0,9.19921875,70.0,28.0,36.0,224.0,3.7998047,0.89990234,3.19970703,128.0,7.419922,135.0,23.0,1968.0,0.0,3.0,<2 mo. follow-up,3.0
68.87299,female,1.0,Lung Cancer,18.0,under $11k,9982.0,white,metastatic,0.049999982,0.0001249999,dnr after sadm,1.0,72.0,14.5,124.0,40.0,36.39844,147.5,2.8999023,0.09999084,0.39996338,138.0,7.489258,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.4711914
77.13599,male,1.0,Cirrhosis,19.0,$11-$25k,42561.0,white,no,0.099999964,0.0009999992,dnr after sadm,7.0,93.0,10.3984375,96.0,11.0,36.19531,236.71875,2.8999023,9.0,1.89990234,134.0,7.509766,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.3701172
61.99597,male,0.0,CHF,12.0,under $11k,26184.0,white,no,0.699999809,0.5,no dnr,9.0,66.0,5.79980469,70.0,26.0,36.0,224.0,2.8999023,1.29980469,1.39990234,131.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
50.97598,male,0.0,ARF/MOSF w/Sepsis,16.0,>$50k,93205.0,white,no,0.099999964,0.0009999992,dnr after sadm,8.0,138.0,14.2988281,120.0,16.0,38.29688,84.0,3.5996094,1.19995117,1.19995117,143.0,7.439453,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
53.45898,female,1.0,ARF/MOSF w/Sepsis,16.0,$25-$50k,1057324.0,white,no,0.099999964,0.0009999992,dnr after sadm,128.0,63.0,4.59960938,75.0,24.0,36.29688,270.0,3.2998047,29.6992188,5.09960938,137.0,7.469727,135.0,23.0,1968.0,0.0,2.0,adl>=4 (>=5 if sur),2.0
70.93994,male,0.0,CHF,12.0,under $11k,20186.0,asian,no,0.75,0.5,no dnr,7.0,57.0,6.5,60.0,28.0,36.39844,224.0,2.8999023,0.89990234,1.29980469,137.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
89.77399,male,0.0,CHF,8.0,under $11k,5897.0,white,no,0.699999809,0.5,no dnr,4.0,120.0,7.89941406,104.0,27.0,36.39844,224.0,2.8999023,0.19998169,1.19995117,136.0,7.419922,135.0,23.0,1968.0,2.0,1.0,<2 mo. follow-up,1.8389997
81.67596,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,125968.0,white,no,0.099999964,0.0009999992,dnr after sadm,13.0,58.0,16.0,60.0,10.0,37.19531,74.4375,2.8999023,0.89990234,0.89990234,135.0,7.429688,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.7275391
59.10199,male,0.0,CHF,7.0,$25-$50k,34775.0,hispanic,no,0.699999809,0.5,no dnr,8.0,55.0,8.09960938,85.0,28.0,36.29688,224.0,3.199707,3.0,1.29980469,134.0,7.419922,135.0,23.0,1968.0,2.0,2.0,<2 mo. follow-up,2.0
56.64099,female,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,20497.0,white,yes,0.699999809,0.5,no dnr,8.0,100.0,10.0996094,100.0,24.0,37.0,271.375,4.5,0.39996338,0.89990234,140.0,7.379883,135.0,23.0,1968.0,0.0,5.0,no(M2 and SIP pres),5.0
67.37,female,0.0,Cirrhosis,12.0,under $11k,50138.0,white,no,0.5,0.3999999,dnr after sadm,6.0,71.0,4.39941406,72.0,20.0,36.39844,224.0,2.5996094,1.89990234,4.69921875,140.0,7.419922,135.0,23.0,1968.0,5.0,1.0,adl>=4 (>=5 if sur),3.855299
57.46698,male,1.0,ARF/MOSF w/Sepsis,16.0,$11-$25k,150471.0,asian,yes,0.799999714,0.75,dnr after sadm,21.0,73.0,15.5996094,120.0,16.0,36.5,83.67188,2.8999023,3.79980469,0.79992676,141.0,7.449219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.2636719
68.87897,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,65136.0,black,no,0.599999905,0.3999999,no dnr,12.0,80.0,25.8984375,115.0,28.0,36.89844,224.0,2.199707,0.39996338,2.0,129.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.7280273
35.806,female,0.0,CHF,12.0,under $11k,20092.0,white,no,0.699999809,0.5,no dnr,5.0,50.0,8.69921875,135.0,24.0,35.89844,224.0,3.8999023,0.79992676,1.59985352,134.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.1542969
35.603,male,0.0,Colon Cancer,12.0,under $11k,41788.0,white,metastatic,0.699999809,0.5,no dnr,11.0,79.0,25.5976562,120.0,22.0,39.59375,224.0,3.0996094,0.39996338,0.79992676,133.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.9345703
43.47699,male,1.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,79576.0,hispanic,no,0.699999809,0.5,dnr after sadm,8.0,48.0,5.59960938,130.0,20.0,37.5,130.0,2.2998047,21.0976562,1.39990234,130.0,7.589844,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
58.68597,male,0.0,CHF,14.0,under $11k,16964.0,white,no,0.899999619,0.5999999,no dnr,7.0,57.0,10.5996094,75.0,24.0,36.29688,224.0,4.3994141,0.5,1.29980469,132.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
44.60797,female,1.0,Cirrhosis,8.0,under $11k,214817.0,hispanic,no,0.199999928,0.04999998,dnr after sadm,5.0,120.0,12.3984375,115.0,12.0,38.29688,280.0,2.8999023,9.59960938,0.79992676,137.0,7.489258,135.0,23.0,1968.0,0.0,7.0,<2 mo. follow-up,7.0
70.04797,male,0.0,Cirrhosis,14.0,$25-$50k,26738.0,white,no,0.699999809,0.5,no dnr,14.0,63.0,6.29980469,74.0,20.0,36.39844,266.625,1.5998535,1.09985352,1.19995117,135.0,7.529297,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
45.043,female,1.0,ARF/MOSF w/Sepsis,16.0,under $11k,194716.0,white,no,0.199999928,0.1999999,dnr after sadm,12.0,128.0,0.29998779,115.0,38.0,36.0,250.0,2.199707,0.69995117,2.19970703,148.0,7.469727,135.0,23.0,1968.0,0.0,4.0,<2 mo. follow-up,4.0
60.79398,female,0.0,ARF/MOSF w/Sepsis,10.0,under $11k,141714.0,white,no,0.699999809,0.5,no dnr,20.0,59.0,12.8984375,155.0,28.0,38.59375,119.98438,2.8999023,1.19995117,0.89990234,137.0,7.5,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
55.88199,female,0.0,Lung Cancer,14.0,under $11k,6593.0,black,metastatic,0.899999619,0.75,dnr after sadm,1.0,94.0,8.0,88.0,20.0,37.0,224.0,2.8999023,0.89990234,1.0,138.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.2241211
65.02899,female,0.0,CHF,12.0,under $11k,3087.0,black,metastatic,1.0,0.3,no dnr,3.0,103.0,10.5996094,68.0,26.0,35.79688,471.375,2.8999023,0.89990234,1.5,126.0,7.5,135.0,23.0,1968.0,2.0,6.0,<2 mo. follow-up,6.0
19.17,female,0.0,CHF,12.0,under $11k,166750.0,hispanic,yes,0.5,0.09999996,no dnr,30.0,46.0,16.1992188,170.0,47.0,36.0,31.66406,2.8999023,0.89990234,1.59985352,131.0,7.189453,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.340332
72.84296,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,196869.0,white,no,0.699999809,0.5,no dnr,11.0,50.0,10.1992188,120.0,10.0,36.79688,188.0,3.0,0.89990234,1.0,127.0,7.489258,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.65625
42.03699,male,1.0,Cirrhosis,20.0,>$50k,100295.0,white,no,0.5,0.5,dnr after sadm,28.0,77.0,6.79980469,82.0,20.0,36.39844,224.0,1.3999023,17.296875,2.0,128.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
59.806,female,0.0,COPD,14.0,$25-$50k,75895.0,asian,yes,0.599999905,0.3999999,no dnr,21.0,128.0,13.6992188,145.0,26.0,37.0,222.84375,2.8999023,0.89990234,0.69995117,143.0,7.349609,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
49.56097,male,1.0,Coma,16.0,>$50k,245849.0,black,no,0.699999809,0.5,dnr after sadm,13.0,102.0,22.3984375,100.0,12.0,38.29688,154.0,2.8999023,2.09960938,2.19970703,129.0,7.539062,135.0,23.0,1968.0,0.0,5.0,<2 mo. follow-up,5.0
51.93997,male,0.0,MOSF w/Malig,12.0,under $11k,280893.0,white,yes,0.5,0.3999999,dnr after sadm,9.0,63.0,5.69921875,110.0,18.0,39.19531,172.0,2.8999023,3.29980469,2.09960938,140.0,7.459961,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
55.24698,female,0.0,CHF,11.0,under $11k,6536.0,white,no,0.699999809,0.5,no dnr,4.0,87.0,9.19921875,84.0,20.0,36.0,257.125,2.8999023,0.5,1.19995117,140.0,7.509766,135.0,23.0,1968.0,2.0,1.0,<2 mo. follow-up,1.8389997
73.75494,male,0.0,MOSF w/Malig,12.0,under $11k,29426.0,black,metastatic,0.049999982,0.0001249999,dnr after sadm,1.0,50.0,17.3984375,104.0,28.0,38.39844,158.3125,2.0,0.5,2.09960938,153.0,7.199219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.8896484
47.93198,female,1.0,MOSF w/Malig,12.0,under $11k,92238.0,white,metastatic,0.199999928,0.09999996,dnr after sadm,4.0,60.0,0.04999542,150.0,40.0,36.29688,167.34375,2.5996094,2.19970703,2.89990234,129.0,7.399414,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.2519531
58.69699,female,0.0,CHF,12.0,$11-$25k,6849.0,hispanic,no,0.699999809,0.5,no dnr,3.0,100.0,5.89941406,80.0,28.0,36.59375,352.375,2.8999023,0.89990234,2.19970703,138.0,7.40918,135.0,23.0,1968.0,0.0,1.0,SIP>=30,2.371582
60.73099,male,0.0,ARF/MOSF w/Sepsis,16.0,under $11k,363112.0,hispanic,no,0.699999809,0.5,no dnr,50.0,107.0,8.09960938,70.0,24.0,36.29688,315.0,2.7998047,11.8984375,8.19921875,142.0,7.469727,135.0,23.0,1968.0,0.0,2.0,no(M2 and SIP pres),2.0
68.50397,male,0.0,MOSF w/Malig,16.0,>$50k,41674.0,white,yes,0.699999809,0.5999999,no dnr,9.0,69.0,3.0,70.0,26.0,38.19531,231.40625,2.8999023,2.39990234,1.19995117,131.0,7.459961,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
41.75497,female,1.0,Coma,16.0,>$50k,69323.0,white,no,0.699999809,0.5,dnr after sadm,6.0,40.0,31.5976562,120.0,26.0,38.59375,260.0,2.8999023,0.89990234,3.79980469,146.0,7.599609,135.0,23.0,1968.0,0.0,5.0,<2 mo. follow-up,5.0
48.14798,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,23166.0,white,no,0.599999905,0.5999999,no dnr,4.0,78.0,14.0996094,82.0,18.0,36.79688,86.0,2.8999023,0.69995117,1.0,138.0,7.40918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.1948242
48.564,male,0.0,MOSF w/Malig,19.0,under $11k,225659.0,white,yes,0.699999809,0.5,no dnr,44.0,103.0,0.09999084,110.0,20.0,39.5,208.15625,2.0,0.89990234,1.39990234,131.0,7.509766,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
45.51398,male,1.0,Cirrhosis,16.0,>$50k,323371.0,asian,no,0.799999714,0.3999999,dnr after sadm,39.0,94.0,9.19921875,82.0,18.0,36.19531,224.0,1.8999023,11.1992188,1.39990234,126.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
82.66699,female,0.0,Coma,12.0,under $11k,130916.0,white,yes,0.199999928,0.1999999,dnr after sadm,3.0,112.0,79.1875,55.0,18.0,38.5,212.5,2.8999023,0.89990234,0.69995117,125.0,7.519531,135.0,23.0,1968.0,0.0,7.0,adl>=4 (>=5 if sur),7.0
42.45599,male,0.0,ARF/MOSF w/Sepsis,10.0,>$50k,63445.0,hispanic,no,0.989999771,0.9899998,no dnr,20.0,113.0,9.19921875,110.0,33.0,38.29688,220.0,2.8999023,0.29998779,0.79992676,137.0,7.469727,135.0,23.0,1968.0,0.0,0.0,SIP>=30,0.0
70.20898,male,0.0,Lung Cancer,16.0,>$50k,9088.0,white,metastatic,0.649999619,0.5,no dnr,6.0,111.0,12.1992188,80.0,22.0,36.59375,224.0,2.8999023,0.89990234,1.0,137.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
40.39999,male,0.0,Lung Cancer,12.0,under $11k,12693.0,white,metastatic,0.899999619,0.5,no dnr,4.0,90.0,6.29980469,104.0,18.0,36.59375,224.0,2.8999023,0.89990234,0.89990234,139.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.730957
76.08997,male,0.0,CHF,8.0,under $11k,12254.0,white,no,0.899999619,0.7999997,no dnr,7.0,80.0,14.0,120.0,20.0,36.19531,260.0,2.8999023,0.89990234,0.79992676,142.0,7.449219,135.0,23.0,1968.0,6.0,1.0,<2 mo. follow-up,4.5273972
77.85895,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,89858.0,white,metastatic,0.25,0.04999998,dnr before sadm,-1.0,58.0,8.69921875,165.0,16.0,38.79688,91.10938,1.6999512,0.89990234,1.5,143.0,7.40918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.6572266
71.02295,male,1.0,ARF/MOSF w/Sepsis,13.0,under $11k,132772.0,white,no,0.099999964,0.0009999992,dnr after sadm,13.0,110.0,10.2988281,140.0,23.0,38.19531,126.3125,2.8999023,2.0,1.79980469,137.0,7.349609,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.4824219
30.35999,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,283773.0,black,no,0.75,0.75,no dnr,12.0,100.0,17.0,115.0,10.0,37.79688,332.5,2.199707,27.3984375,1.0,136.0,7.389648,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
76.74194,male,0.0,CHF,12.0,under $11k,14066.0,white,no,0.699999809,0.5,no dnr,5.0,58.0,7.79980469,70.0,20.0,36.5,224.0,2.8999023,0.89990234,1.59985352,135.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.9550781
76.97198,female,0.0,CHF,13.0,>$50k,11489.0,black,no,0.699999809,0.5,no dnr,6.0,85.0,4.69921875,100.0,20.0,36.5,352.375,2.8999023,0.89990234,1.59985352,139.0,7.449219,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
71.745,female,0.0,CHF,16.0,$11-$25k,9478.0,white,no,0.949999809,0.7999997,dnr after sadm,1.0,53.0,11.5,82.0,20.0,36.39844,224.0,2.8999023,0.89990234,2.09960938,139.0,7.419922,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),2.5449219
65.93298,female,0.0,CHF,13.0,under $11k,10227.0,asian,no,0.75,0.5,no dnr,4.0,103.0,8.69921875,134.0,24.0,36.0,260.8125,2.8999023,0.89990234,1.0,141.0,7.459961,135.0,23.0,1968.0,0.0,3.0,no(M2 and SIP pres),3.0
69.98199,female,0.0,CHF,12.0,under $11k,65732.0,black,no,0.059999973,0.0002159999,no dnr,15.0,63.0,11.1992188,110.0,26.0,36.5,241.65625,3.2998047,2.69970703,1.5,130.0,7.389648,135.0,23.0,1968.0,0.0,7.0,adl>=4 (>=5 if sur),7.0
82.14099,male,0.0,MOSF w/Malig,12.0,under $11k,113460.0,black,metastatic,0.799999714,0.5,dnr after sadm,12.0,75.0,9.19921875,70.0,22.0,36.5,107.14062,3.5996094,0.29998779,1.29980469,133.0,7.5,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,4.4794922
41.06198,female,0.0,ARF/MOSF w/Sepsis,15.0,$11-$25k,16536.0,black,no,0.899999619,0.8499999,no dnr,4.0,117.0,16.8984375,74.0,24.0,37.0,218.34375,2.8999023,0.89990234,1.0,130.0,7.379883,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.0395508
56.34998,female,0.0,COPD,12.0,under $11k,4944.0,white,no,0.699999809,0.5,no dnr,3.0,87.0,6.69921875,100.0,24.0,37.0,266.625,2.8999023,0.89990234,0.59997559,130.0,7.439453,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
67.72894,male,0.0,CHF,18.0,$11-$25k,32258.0,white,no,0.959999561,0.9199996,no dnr,9.0,110.0,7.59960938,65.0,24.0,36.5,224.0,2.8999023,0.79992676,1.29980469,137.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.9853516
51.18698,male,0.0,Colon Cancer,12.0,under $11k,30006.0,white,metastatic,0.099999964,0.0009999992,no dnr,10.0,120.0,11.3984375,140.0,20.0,39.5,224.0,2.8999023,0.29998779,1.69995117,135.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.5170898
48.43799,male,1.0,MOSF w/Malig,15.0,>$50k,275297.0,white,yes,0.699999809,0.5,dnr after sadm,9.0,58.0,0.59997559,170.0,26.0,39.89844,56.0,2.5996094,0.59997559,3.59960938,150.0,7.329102,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.2446289
63.573,female,1.0,MOSF w/Malig,12.0,$25-$50k,231839.0,white,metastatic,0.75,0.1999999,dnr after sadm,18.0,60.0,4.09960938,130.0,23.0,38.69531,107.6875,2.0,0.59997559,0.89990234,125.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.2402344
56.74197,male,0.0,Colon Cancer,18.0,$11-$25k,41129.0,white,metastatic,0.949999809,0.8499999,no dnr,12.0,98.0,10.5996094,82.0,20.0,36.39844,224.0,4.3994141,0.69995117,1.09985352,136.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
52.43799,male,0.0,CHF,12.0,$11-$25k,73122.0,white,no,0.849999905,0.7999997,no dnr,17.0,67.0,6.29980469,110.0,22.0,36.39844,457.125,2.8999023,0.89990234,0.89990234,134.0,7.489258,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
73.59094,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,25024.0,white,no,0.699999809,0.5,no dnr,124.0,68.0,27.5,110.0,12.0,38.5,90.90625,2.3999023,2.39990234,1.09985352,131.0,7.419922,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),2.7763672
56.50098,male,1.0,Cirrhosis,12.0,under $11k,95243.0,white,no,0.099999964,0.0009999992,dnr after sadm,7.0,123.0,16.8984375,115.0,9.0,37.0,273.3125,3.5996094,11.3984375,5.89941406,137.0,7.439453,135.0,23.0,1968.0,0.0,6.0,<2 mo. follow-up,6.0
45.22699,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,213989.0,white,no,0.699999809,0.5,no dnr,29.0,122.0,18.5,120.0,6.0,37.29688,504.0,2.8999023,0.89990234,0.69995117,132.0,7.489258,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.4370117
54.44498,male,1.0,ARF/MOSF w/Sepsis,18.0,>$50k,61442.0,white,no,0.099999964,0.0009999992,no dnr,5.0,30.0,6.79980469,145.0,20.0,39.19531,81.0,2.199707,12.6992188,0.59997559,131.0,7.349609,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5195312
85.36096,male,1.0,ARF/MOSF w/Sepsis,16.0,under $11k,51486.0,white,no,0.009999998,9.999994e-07,no dnr,3.0,40.0,18.0976562,30.0,25.0,38.0,294.0,2.8999023,2.5,2.69970703,131.0,7.229492,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
46.08099,male,0.0,CHF,14.0,under $11k,170570.0,hispanic,no,0.699999809,0.5,no dnr,31.0,67.0,10.5996094,50.0,16.0,37.79688,224.0,2.8999023,0.19998169,0.89990234,138.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
32.42697,female,1.0,ARF/MOSF w/Sepsis,11.0,under $11k,382471.0,white,no,0.099999964,0.0009999992,dnr after sadm,9.0,57.0,39.796875,120.0,36.0,35.09375,205.6875,1.7998047,16.8984375,2.19970703,134.0,7.399414,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,4.0322266
66.27496,male,0.0,Colon Cancer,20.0,>$50k,18606.0,white,metastatic,0.699999809,0.5,no dnr,8.0,83.0,13.3984375,68.0,20.0,38.0,224.0,3.199707,1.39990234,1.09985352,135.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
78.53796,female,0.0,COPD,16.0,$25-$50k,8697.0,white,no,0.899999619,0.8499999,no dnr,6.0,96.0,12.1992188,96.0,22.0,36.0,157.125,3.699707,0.59997559,1.19995117,142.0,7.399414,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
50.95099,female,1.0,MOSF w/Malig,12.0,under $11k,449923.0,black,yes,0.699999809,0.5,no dnr,43.0,63.0,19.3984375,125.0,14.0,39.39844,234.0,2.8999023,1.39990234,6.59960938,144.0,7.40918,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
39.81897,male,1.0,ARF/MOSF w/Sepsis,13.0,under $11k,54871.0,white,no,0.099999964,0.0009999992,no dnr,5.0,35.0,18.3984375,130.0,15.0,38.79688,100.0,2.0996094,20.296875,3.0,132.0,7.30957,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.3813477
31.34299,female,1.0,Coma,12.0,under $11k,148727.0,white,metastatic,0.699999809,0.5,no dnr,11.0,42.0,20.1992188,140.0,20.0,38.5,68.0,2.8999023,0.89990234,2.29980469,132.0,7.339844,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.6069336
73.14697,male,0.0,CHF,4.0,>$50k,20810.0,white,no,0.699999809,0.5,no dnr,11.0,70.0,8.59960938,65.0,28.0,36.0,224.0,2.8999023,0.89990234,2.0,138.0,7.419922,135.0,23.0,1968.0,0.0,4.0,no(M2 and SIP pres),4.0
73.70294,male,0.0,CHF,24.0,under $11k,14284.0,white,no,0.699999809,0.5,no dnr,7.0,77.0,5.29980469,92.0,28.0,38.09375,261.875,2.8999023,2.29980469,2.19970703,137.0,7.479492,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
71.75397,female,0.0,COPD,9.0,under $11k,135615.0,black,no,0.599999905,0.5,no dnr,25.0,60.0,15.3984375,110.0,10.0,38.19531,300.0,2.7998047,0.89990234,0.89990234,137.0,7.439453,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.8969727
63.59799,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,51942.0,white,yes,0.099999964,0.0009999992,dnr after sadm,2.0,30.0,50.59375,115.0,25.0,38.39844,56.0,2.5,22.796875,5.19921875,129.0,7.579102,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.206543
72.323,male,0.0,Colon Cancer,12.0,under $11k,36244.0,white,metastatic,0.599999905,0.1999999,dnr after sadm,9.0,81.0,16.296875,112.0,20.0,39.19531,224.0,3.0996094,0.89990234,0.79992676,128.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.3491211
44.12299,female,0.0,MOSF w/Malig,12.0,under $11k,293158.0,white,yes,0.5,0.5,no dnr,28.0,63.0,3.39990234,160.0,21.0,39.19531,348.0,2.8999023,9.0,4.89941406,135.0,7.40918,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
21.74899,male,0.0,ARF/MOSF w/Sepsis,13.0,under $11k,156314.0,white,no,0.699999809,0.5,no dnr,23.0,70.0,10.7988281,105.0,20.0,38.59375,206.09375,2.8999023,0.89990234,0.79992676,145.0,7.30957,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
67.85797,female,1.0,ARF/MOSF w/Sepsis,14.0,>$50k,234034.0,white,no,0.799999714,0.75,dnr after sadm,17.0,75.0,6.59960938,105.0,28.0,36.5,183.3125,2.0996094,0.89990234,1.0,144.0,7.489258,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
58.05099,female,0.0,Lung Cancer,12.0,under $11k,9864.0,black,metastatic,0.899999619,0.75,no dnr,6.0,79.0,10.2988281,100.0,24.0,37.39844,224.0,2.8999023,0.89990234,0.89990234,137.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.5302734
57.84799,male,1.0,MOSF w/Malig,14.0,$25-$50k,139623.0,white,yes,0.069999993,0.0003429998,no dnr,4.0,48.0,0.04999542,200.0,32.0,39.29688,75.54688,2.8999023,8.69921875,1.79980469,152.0,7.289062,135.0,23.0,1968.0,0.0,5.0,<2 mo. follow-up,5.0
72.56097,male,1.0,ARF/MOSF w/Sepsis,16.0,$25-$50k,301990.0,white,yes,0.5,0.125,dnr after sadm,22.0,70.0,15.7988281,110.0,22.0,36.09375,190.0,3.2998047,26.296875,2.39990234,135.0,7.469727,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
49.53,female,0.0,CHF,11.0,under $11k,10545.0,black,no,1.0,0.9499998,no dnr,4.0,103.0,6.19921875,86.0,24.0,36.89844,224.0,2.8999023,0.89990234,1.39990234,134.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.2373047
60.65399,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,475387.0,white,no,0.699999809,0.5,dnr after sadm,44.0,63.0,5.19921875,125.0,8.0,38.89844,114.0,2.3999023,1.5,1.79980469,137.0,7.399414,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.0224609
69.41797,male,1.0,Lung Cancer,14.0,$11-$25k,7194.0,asian,metastatic,0.699999809,0.5,dnr after sadm,2.0,73.0,10.5996094,62.0,34.0,39.19531,128.5625,3.0996094,0.29998779,1.09985352,133.0,7.479492,135.0,23.0,1968.0,0.0,6.0,<2 mo. follow-up,6.0
25.89699,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,251227.0,hispanic,yes,0.75,0.6999998,no dnr,28.0,153.0,7.09960938,110.0,24.0,35.89844,76.0,2.7998047,0.79992676,2.19970703,136.0,7.389648,135.0,23.0,1968.0,0.0,5.0,adl>=4 (>=5 if sur),5.0
47.43298,male,1.0,ARF/MOSF w/Sepsis,14.0,$11-$25k,169364.0,white,no,0.099999964,0.0009999992,dnr after sadm,6.0,73.0,5.09960938,115.0,24.0,36.89844,191.65625,2.199707,19.296875,1.69995117,141.0,7.519531,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.0639648
36.29797,male,0.0,Cirrhosis,12.0,under $11k,48925.0,white,no,0.899999619,0.8999996,no dnr,15.0,97.0,13.5,118.0,16.0,38.0,190.0,2.8999023,3.19970703,0.79992676,140.0,7.389648,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
63.07999,male,0.0,CHF,14.0,under $11k,29706.0,hispanic,no,0.699999809,0.5,no dnr,9.0,51.0,5.29980469,75.0,24.0,36.29688,224.0,2.5,1.19995117,1.29980469,128.0,7.469727,135.0,23.0,1968.0,1.0,3.0,no(M2 and SIP pres),3.0
61.77399,male,0.0,CHF,12.0,>$50k,21076.0,white,no,0.899999619,0.8499999,no dnr,9.0,110.0,6.0,70.0,16.0,36.59375,224.0,3.5996094,0.69995117,1.29980469,141.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
55.23297,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,233772.0,other,no,0.699999809,0.5,no dnr,19.0,60.0,11.2988281,115.0,8.0,36.39844,230.0,2.7998047,0.79992676,1.39990234,125.0,7.489258,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.7539062
72.42694,female,1.0,Cirrhosis,12.0,under $11k,69587.0,other,no,0.5,0.3999999,dnr after sadm,8.0,103.0,8.3984375,135.0,32.0,37.69531,172.5,3.0996094,4.69921875,1.29980469,153.0,7.40918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.1469727
80.38599,male,0.0,Colon Cancer,8.0,$25-$50k,11109.0,white,metastatic,0.899999619,0.3,no dnr,5.0,73.0,5.59960938,72.0,18.0,36.19531,224.0,2.8999023,0.89990234,1.09985352,135.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
74.12695,male,1.0,Coma,14.0,under $11k,22541.0,white,no,0.699999809,0.5,dnr after sadm,3.0,82.0,9.69921875,50.0,14.0,35.0,430.0,4.0996094,0.89990234,0.89990234,134.0,7.479492,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,4.6728516
34.32199,female,0.0,ARF/MOSF w/Sepsis,10.0,$11-$25k,271769.0,hispanic,no,0.799999714,0.5999999,no dnr,40.0,115.0,13.1992188,110.0,16.0,39.5,166.65625,2.8999023,0.69995117,7.39941406,136.0,7.359375,135.0,23.0,1968.0,0.0,6.0,adl>=4 (>=5 if sur),6.0
51.491,female,1.0,ARF/MOSF w/Sepsis,11.0,$11-$25k,1056280.0,white,no,0.699999809,0.5,dnr after sadm,88.0,63.0,39.0,135.0,36.0,37.09375,220.0,2.8999023,2.69970703,3.69970703,129.0,7.5,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
64.92499,female,0.0,CHF,5.0,under $11k,22303.0,hispanic,no,0.699999809,0.5,no dnr,6.0,60.0,7.5,135.0,28.0,36.39844,258.3125,2.8999023,0.69995117,0.79992676,142.0,7.329102,135.0,23.0,1968.0,3.0,3.0,<2 mo. follow-up,3.0
71.95599,male,0.0,CHF,12.0,under $11k,35928.0,asian,no,0.949999809,0.5999999,no dnr,10.0,55.0,6.19921875,105.0,24.0,39.19531,224.0,2.8999023,1.19995117,1.89990234,133.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.6972656
60.59097,female,0.0,Colon Cancer,12.0,$25-$50k,35397.0,white,metastatic,0.949999809,0.7999997,no dnr,12.0,81.0,7.5,120.0,22.0,38.39844,224.0,4.6992188,0.5,1.0,139.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
33.09,male,1.0,MOSF w/Malig,12.0,under $11k,216416.0,asian,yes,0.099999964,0.0009999992,no dnr,24.0,110.0,3.0,160.0,12.0,35.5,113.84375,2.8999023,0.5,0.5,135.0,7.469727,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.6982422
74.74896,male,0.0,CHF,12.0,under $11k,10758.0,white,no,0.899999619,0.5999999,no dnr,4.0,65.0,5.0,110.0,24.0,36.0,224.0,5.5,0.79992676,1.5,130.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.0253906
50.90198,male,0.0,CHF,14.0,$25-$50k,37558.0,white,no,0.899999619,0.75,no dnr,13.0,68.0,11.0,110.0,20.0,37.79688,224.0,4.1992188,1.39990234,1.29980469,132.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
55.866,male,0.0,CHF,16.0,$25-$50k,68122.0,white,no,0.5,0.5,no dnr,14.0,70.0,22.5976562,140.0,20.0,36.0,224.0,4.6992188,1.09985352,1.89990234,138.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
77.396,male,0.0,CHF,14.0,$25-$50k,9246.0,white,no,0.899999619,0.5999999,no dnr,6.0,80.0,9.29882812,80.0,20.0,37.09375,357.125,2.8999023,0.39996338,1.29980469,137.0,7.469727,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
63.017,male,0.0,ARF/MOSF w/Sepsis,8.0,$25-$50k,133878.0,white,no,0.799999714,0.6999998,no dnr,14.0,57.0,6.89941406,80.0,8.0,37.19531,144.0,2.5996094,0.89990234,0.89990234,137.0,7.449219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
41.974,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,328134.0,white,no,0.399999857,0.3999999,no dnr,53.0,50.0,5.69921875,135.0,30.0,35.09375,56.0,2.7998047,5.59960938,3.09960938,142.0,7.40918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.0996094
67.88495,male,1.0,ARF/MOSF w/Sepsis,18.0,$25-$50k,181177.0,white,no,0.5,0.5,no dnr,24.0,73.0,25.796875,110.0,22.0,36.39844,230.0,2.7998047,1.79980469,1.39990234,131.0,7.449219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.4399414
46.48297,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,95454.0,white,no,0.699999809,0.6999998,no dnr,16.0,75.0,10.2988281,130.0,48.0,38.0,427.0,2.8999023,0.89990234,0.79992676,141.0,7.30957,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.9467773
64.51697,male,0.0,CHF,9.0,under $11k,125379.0,white,no,0.699999809,0.5,no dnr,17.0,67.0,8.3984375,100.0,24.0,36.0,224.0,2.8999023,0.89990234,1.29980469,129.0,7.419922,135.0,23.0,1968.0,0.0,1.0,SIP>=30,0.4947999
65.711,female,0.0,ARF/MOSF w/Sepsis,12.0,>$50k,497053.0,white,no,0.699999809,0.5,no dnr,44.0,50.0,13.6992188,95.0,12.0,38.5,106.65625,3.5996094,2.39990234,5.0,144.0,7.5,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
73.42896,male,0.0,CHF,12.0,>$50k,79641.0,white,no,0.699999809,0.5,no dnr,14.0,53.0,19.3984375,80.0,20.0,36.39844,155.09375,2.8999023,0.89990234,1.39990234,137.0,7.259766,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
34.05899,female,0.0,ARF/MOSF w/Sepsis,16.0,under $11k,250630.0,black,no,0.949999809,0.8999996,no dnr,36.0,103.0,21.8984375,105.0,18.0,38.79688,257.5,2.8999023,0.89990234,0.5,133.0,7.469727,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
32.40198,female,1.0,MOSF w/Malig,17.0,$25-$50k,262612.0,white,yes,0.699999809,0.5,dnr after sadm,8.0,107.0,13.0996094,120.0,28.0,36.79688,142.5,2.8999023,36.0,3.89990234,142.0,7.509766,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
28.30099,male,0.0,CHF,12.0,under $11k,194198.0,white,no,0.699999809,0.5,no dnr,37.0,67.0,6.29980469,135.0,16.0,36.29688,224.0,2.8999023,0.89990234,1.59985352,139.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.690918
56.323,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,151266.0,white,no,0.699999809,0.5,no dnr,3.0,0.0,15.3984375,135.0,10.0,38.5,142.0,2.8999023,0.89990234,3.19970703,132.0,7.469727,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5961914
47.98099,female,0.0,Lung Cancer,18.0,under $11k,25024.0,white,metastatic,0.699999809,0.5,no dnr,9.0,72.0,8.29882812,100.0,20.0,37.19531,224.0,2.8999023,0.89990234,0.79992676,136.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.5249023
70.125,female,1.0,Coma,12.0,under $11k,96471.0,white,no,0.699999809,0.5,dnr after sadm,9.0,122.0,37.0,135.0,28.0,38.5,113.32812,2.8999023,0.89990234,1.19995117,140.0,7.539062,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.3598633
35.31799,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,212409.0,black,no,0.699999809,0.5,no dnr,18.0,70.0,11.0,130.0,22.0,38.89844,37.0,2.8999023,1.19995117,0.79992676,134.0,7.199219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.6660156
52.827,male,1.0,ARF/MOSF w/Sepsis,14.0,>$50k,116166.0,white,no,0.699999809,0.5,dnr after sadm,6.0,53.0,12.3984375,110.0,24.0,39.5,224.0,2.8999023,25.5976562,7.79980469,145.0,7.419922,135.0,23.0,1968.0,0.0,7.0,<2 mo. follow-up,7.0
68.64899,male,0.0,CHF,18.0,$11-$25k,75142.0,white,no,0.75,0.5999999,no dnr,20.0,65.0,20.796875,120.0,30.0,35.79688,253.03125,2.8999023,0.5,3.29980469,127.0,7.429688,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
69.52795,male,0.0,ARF/MOSF w/Sepsis,17.0,>$50k,122312.0,white,no,0.699999809,0.5,no dnr,14.0,68.0,19.3984375,110.0,40.0,39.5,295.0,2.199707,0.39996338,0.59997559,131.0,7.549805,135.0,23.0,1968.0,0.0,0.0,SIP>=30,0.0
63.05798,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,600192.0,white,no,0.699999809,0.5,no dnr,71.0,52.0,10.6992188,120.0,38.0,39.09375,198.0,2.8999023,0.89990234,2.09960938,140.0,7.449219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.199707
66.09198,male,0.0,Lung Cancer,18.0,>$50k,8272.0,asian,metastatic,0.75,0.25,no dnr,4.0,83.0,6.29980469,90.0,20.0,36.59375,224.0,2.8999023,0.89990234,0.79992676,132.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
70.48297,female,0.0,CHF,16.0,under $11k,19065.0,white,no,0.75,0.5999999,no dnr,9.0,53.0,6.89941406,110.0,22.0,36.19531,224.0,2.8999023,1.0,0.89990234,134.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
60.98599,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,864424.0,white,yes,0.699999809,0.5,no dnr,82.0,70.0,8.29882812,115.0,26.0,38.19531,187.5,2.2998047,0.79992676,0.89990234,136.0,7.5,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.4799805
85.862,female,1.0,COPD,12.0,$11-$25k,329169.0,white,no,0.699999809,0.5,dnr after sadm,2.0,128.0,11.2988281,155.0,14.0,36.19531,155.0,2.699707,0.89990234,1.79980469,137.0,7.469727,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.7705078
59.81097,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,401801.0,black,no,0.149999976,0.09999996,no dnr,63.0,93.0,28.296875,140.0,30.0,38.5,147.5,1.7998047,0.69995117,0.79992676,129.0,7.469727,135.0,23.0,1968.0,0.0,6.0,adl>=4 (>=5 if sur),6.0
56.65399,female,0.0,Colon Cancer,12.0,$25-$50k,61711.0,black,metastatic,0.799999714,0.6999998,no dnr,15.0,80.0,6.79980469,116.0,24.0,38.39844,224.0,3.5996094,4.69921875,0.89990234,136.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.2573242
82.086,male,0.0,CHF,12.0,$25-$50k,22899.0,other,no,0.699999809,0.5,no dnr,7.0,55.0,6.79980469,120.0,24.0,36.29688,224.0,2.8999023,0.89990234,2.09960938,135.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),3.9150391
33.5,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,158358.0,hispanic,no,0.949999809,0.8999996,no dnr,33.0,117.0,15.6992188,76.0,34.0,36.19531,280.0,1.5998535,0.19998169,0.89990234,130.0,7.379883,135.0,23.0,1968.0,5.0,0.0,SIP>=30,0.0
72.84094,male,0.0,Lung Cancer,12.0,under $11k,10314.0,white,metastatic,0.899999619,0.6999998,no dnr,4.0,87.0,5.5,80.0,18.0,36.0,224.0,2.8999023,1.09985352,1.09985352,129.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.465332
78.43695,female,1.0,ARF/MOSF w/Sepsis,10.0,under $11k,106126.0,white,no,0.299999952,0.1999999,no dnr,12.0,67.0,11.1992188,60.0,24.0,38.39844,71.26562,2.8999023,0.79992676,1.0,128.0,7.329102,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.5576172
78.00995,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,298193.0,white,no,0.699999809,0.5,no dnr,52.0,70.0,7.79980469,110.0,34.0,38.69531,267.5,2.8999023,0.89990234,0.89990234,130.0,7.459961,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.7758789
67.92596,female,0.0,Colon Cancer,12.0,under $11k,30406.0,white,metastatic,0.949999809,0.7999997,no dnr,11.0,108.0,28.1992188,108.0,20.0,36.59375,224.0,3.2998047,2.09960938,0.69995117,137.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.3935547
68.55597,male,0.0,CHF,14.0,$25-$50k,11855.0,white,no,0.699999809,0.5,no dnr,5.0,93.0,7.69921875,100.0,22.0,35.89844,295.1875,2.8999023,0.89990234,1.89990234,139.0,7.429688,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.421875
68.68195,male,0.0,Lung Cancer,12.0,$11-$25k,8686.0,white,metastatic,0.699999809,0.5,no dnr,5.0,83.0,1.59985352,100.0,24.0,36.39844,224.0,3.0,0.59997559,2.0,138.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.6171875
33.01297,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,77603.0,white,no,0.899999619,0.7999997,no dnr,12.0,133.0,10.5,100.0,8.0,38.19531,194.0,2.8999023,0.5,10.7988281,146.0,7.439453,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.7485352
55.96399,male,0.0,Cirrhosis,14.0,$25-$50k,193362.0,white,yes,0.799999714,0.5999999,no dnr,22.0,77.0,12.8984375,110.0,24.0,39.0,224.0,2.8999023,3.69970703,0.89990234,146.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
79.45496,female,0.0,CHF,16.0,>$50k,13703.0,white,no,0.699999809,0.5,no dnr,6.0,80.0,6.5,50.0,16.0,36.29688,224.0,2.8999023,0.89990234,1.19995117,137.0,7.419922,135.0,23.0,1968.0,1.0,1.0,no(M2 and SIP pres),1.1668997
60.37198,male,0.0,ARF/MOSF w/Sepsis,18.0,$25-$50k,234608.0,white,no,0.849999905,0.8499999,no dnr,20.0,132.0,7.79980469,110.0,10.0,38.39844,272.6875,2.0,3.0,1.19995117,136.0,7.459961,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
71.65796,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,477929.0,white,no,0.699999809,0.5,dnr after sadm,24.0,52.0,14.0,110.0,12.0,36.89844,152.0,2.8999023,0.89990234,4.19921875,143.0,7.459961,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.7861328
95.66095,female,0.0,CHF,10.0,under $11k,12435.0,white,no,0.699999809,0.5,no dnr,5.0,89.0,11.5996094,84.0,36.0,38.0,262.9375,3.199707,0.79992676,1.09985352,144.0,7.419922,135.0,23.0,1968.0,0.0,4.0,<2 mo. follow-up,4.0
61.88098,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,777314.0,white,no,0.5,0.5,dnr after sadm,31.0,60.0,19.796875,140.0,30.0,39.0,114.0,2.199707,1.19995117,2.79980469,131.0,7.239258,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.3334961
72.35297,female,1.0,CHF,13.0,$11-$25k,25184.0,white,no,0.699999809,0.5,no dnr,3.0,48.0,7.29980469,0.0,12.0,37.19531,388.0,3.199707,1.29980469,1.39990234,129.0,7.449219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.7695312
57.93597,male,1.0,Cirrhosis,12.0,under $11k,29521.0,white,no,0.299999952,0.09999996,dnr after sadm,4.0,73.0,11.7988281,108.0,20.0,36.59375,523.75,2.2998047,11.7988281,1.59985352,130.0,7.429688,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.8852539
47.82498,male,0.0,Cirrhosis,14.0,under $11k,29605.0,white,no,0.699999809,0.5,no dnr,12.0,84.0,2.89990234,80.0,16.0,35.59375,380.0,2.7998047,0.39996338,0.79992676,140.0,7.439453,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
70.14899,male,0.0,CHF,12.0,under $11k,12331.0,white,no,0.699999809,0.5,no dnr,5.0,73.0,7.59960938,90.0,18.0,36.0,224.0,2.8999023,1.09985352,1.09985352,140.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.0800781
50.44998,female,1.0,Coma,12.0,under $11k,28491.0,white,no,0.049999982,0.0001249999,dnr after sadm,3.0,63.0,28.0,160.0,30.0,40.89844,336.625,2.8999023,0.89990234,0.79992676,140.0,7.489258,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.6328125
72.0,female,0.0,CHF,12.0,under $11k,40390.0,black,no,0.75,0.6999998,no dnr,13.0,83.0,8.8984375,100.0,24.0,37.0,404.75,2.8999023,0.59997559,0.89990234,138.0,7.459961,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5849609
65.92999,female,0.0,CHF,12.0,under $11k,60355.0,white,yes,0.989999771,0.9799995,no dnr,16.0,63.0,7.09960938,50.0,20.0,36.5,224.0,2.8999023,0.89990234,2.09960938,140.0,7.419922,135.0,23.0,1968.0,2.0,1.0,<2 mo. follow-up,1.8389997
69.77997,male,0.0,CHF,16.0,$25-$50k,117036.0,white,no,0.699999809,0.5,no dnr,21.0,57.0,8.69921875,50.0,24.0,37.0,486.625,3.199707,0.89990234,1.29980469,133.0,7.489258,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.8129883
59.211,female,1.0,Lung Cancer,14.0,>$50k,8126.0,white,metastatic,0.009999998,9.999994e-07,dnr after sadm,1.0,60.0,1.29980469,90.0,20.0,37.19531,224.0,2.8999023,0.89990234,1.19995117,127.0,7.419922,135.0,23.0,1968.0,0.0,6.0,<2 mo. follow-up,6.0
32.27698,female,1.0,MOSF w/Malig,16.0,>$50k,175267.0,white,yes,0.199999928,0.09999996,dnr after sadm,5.0,117.0,11.5,120.0,40.0,36.0,171.40625,2.3999023,1.5,1.19995117,134.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.4165039
47.63898,female,0.0,Lung Cancer,13.0,under $11k,13877.0,white,metastatic,0.899999619,0.5,no dnr,9.0,77.0,1.19995117,80.0,20.0,36.59375,224.0,2.8999023,0.89990234,0.79992676,136.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
74.26398,male,0.0,CHF,14.0,>$50k,35636.0,white,no,0.699999809,0.5,no dnr,10.0,40.0,6.79980469,65.0,20.0,36.44531,224.0,2.8999023,0.89990234,1.5,131.0,7.419922,135.0,23.0,1968.0,1.0,0.0,<2 mo. follow-up,0.0
71.29895,male,1.0,Coma,14.0,under $11k,37330.0,white,no,0.099999964,0.0009999992,dnr after sadm,3.0,62.0,21.6992188,115.0,10.0,38.89844,317.125,2.8999023,0.5,1.09985352,132.0,7.509766,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5908203
78.05096,male,0.0,ARF/MOSF w/Sepsis,16.0,under $11k,167412.0,white,yes,0.699999809,0.5,no dnr,26.0,52.0,8.3984375,110.0,10.0,38.5,98.75,2.8999023,0.89990234,1.39990234,141.0,7.529297,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
82.88599,male,0.0,CHF,14.0,$11-$25k,8568.0,white,yes,0.649999619,0.5,no dnr,3.0,85.0,10.0996094,65.0,16.0,36.5,224.0,2.8999023,0.89990234,1.09985352,139.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
55.37,male,0.0,CHF,16.0,$25-$50k,30070.0,white,no,0.699999809,0.5,no dnr,7.0,80.0,6.79980469,100.0,28.0,35.69531,224.0,4.0,4.09960938,1.29980469,132.0,7.419922,135.0,23.0,1968.0,1.0,4.0,no(M2 and SIP pres),4.0
63.53198,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,188077.0,other,no,0.699999809,0.5,no dnr,19.0,138.0,6.79980469,100.0,28.0,36.39844,254.28125,2.8999023,0.89990234,0.59997559,136.0,7.489258,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.53125
72.32599,male,0.0,Cirrhosis,19.0,$25-$50k,21341.0,white,no,0.899999619,0.8999996,no dnr,8.0,71.0,4.59960938,86.0,16.0,36.39844,423.75,3.2998047,4.0,2.09960938,133.0,7.489258,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),3.8486328
50.64499,male,0.0,Cirrhosis,14.0,$11-$25k,27047.0,white,no,0.5,0.25,no dnr,4.0,77.0,10.8984375,72.0,22.0,36.19531,224.0,2.8999023,0.89990234,1.29980469,130.0,7.419922,135.0,23.0,1968.0,1.0,1.0,<2 mo. follow-up,1.1668997
44.37,female,1.0,Cirrhosis,11.0,$11-$25k,88231.0,white,no,0.699999809,0.5,dnr after sadm,8.0,102.0,38.0,70.0,32.0,36.39844,243.0,2.8999023,42.0,6.79980469,147.0,7.229492,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
52.75598,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,25511.0,white,no,0.099999964,0.0009999992,no dnr,3.0,38.0,15.3984375,0.0,0.0,38.19531,186.0,2.8999023,0.89990234,0.79992676,156.0,7.069336,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.9453125
63.27197,male,0.0,Lung Cancer,12.0,under $11k,11532.0,white,metastatic,0.799999714,0.5119996,dnr after sadm,4.0,101.0,8.19921875,78.0,20.0,36.0,224.0,2.8999023,0.89990234,0.89990234,131.0,7.419922,135.0,23.0,1968.0,1.0,5.0,<2 mo. follow-up,5.0
68.20294,female,0.0,Colon Cancer,14.0,under $11k,133944.0,white,metastatic,0.949999809,0.7999997,no dnr,44.0,113.0,15.5996094,108.0,28.0,37.19531,224.0,2.8999023,1.29980469,0.79992676,137.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
72.12598,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,127395.0,white,no,0.699999809,0.5,no dnr,8.0,113.0,13.2988281,140.0,37.0,38.0,181.625,2.8999023,0.89990234,1.0,147.0,7.479492,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,4.0605469
71.11298,female,1.0,Lung Cancer,11.0,under $11k,9606.0,black,metastatic,0.25,0.15,dnr after sadm,2.0,33.0,21.0976562,124.0,32.0,36.79688,403.3125,2.8999023,0.89990234,2.09960938,144.0,7.429688,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.7338867
63.836,female,0.0,CHF,12.0,>$50k,31055.0,white,no,0.799999714,0.6499996,no dnr,9.0,70.0,14.7988281,60.0,20.0,35.69531,186.65625,2.8999023,0.89990234,1.39990234,136.0,7.299805,135.0,23.0,1968.0,1.0,1.0,no(M2 and SIP pres),1.1668997
52.38599,male,0.0,MOSF w/Malig,14.0,under $11k,140565.0,white,yes,0.699999809,0.5,no dnr,12.0,65.0,1.0,100.0,26.0,39.19531,122.4375,2.8999023,3.69970703,0.79992676,133.0,7.5,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.3676758
86.04199,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,205980.0,white,no,0.699999809,0.5,dnr after sadm,12.0,115.0,0.59997559,110.0,12.0,36.89844,231.40625,2.8999023,0.89990234,1.19995117,144.0,7.5,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
80.646,female,0.0,CHF,13.0,under $11k,34235.0,white,no,0.699999809,0.5,no dnr,16.0,80.0,7.5,60.0,22.0,36.39844,328.5625,2.8999023,0.89990234,1.29980469,142.0,7.489258,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),3.2436523
70.034,male,0.0,CHF,16.0,under $11k,6528.0,white,no,0.699999809,0.5,no dnr,3.0,65.0,8.8984375,85.0,18.0,35.89844,224.0,2.8999023,0.89990234,2.59960938,136.0,7.419922,135.0,23.0,1968.0,2.0,1.0,no(M2 and SIP pres),1.8389997
65.99896,female,0.0,Cirrhosis,11.0,under $11k,53190.0,white,no,0.5,0.09999996,no dnr,27.0,75.0,6.89941406,96.0,24.0,38.19531,224.0,2.2998047,2.69970703,0.69995117,131.0,7.419922,135.0,23.0,1968.0,5.0,5.0,SIP>=30,5.0
70.59296,male,0.0,Lung Cancer,12.0,under $11k,17079.0,asian,metastatic,0.799999714,0.5999999,no dnr,6.0,78.0,0.5,100.0,16.0,36.79688,224.0,2.5,5.19921875,0.69995117,132.0,7.419922,135.0,23.0,1968.0,0.0,4.0,no(M2 and SIP pres),4.0
49.99597,female,1.0,Coma,14.0,under $11k,712554.0,white,no,0.699999809,0.5,dnr after sadm,86.0,48.0,17.296875,140.0,44.0,39.79688,220.0,2.8999023,4.5,1.39990234,151.0,7.429688,135.0,23.0,1968.0,0.0,6.0,adl>=4 (>=5 if sur),6.0
62.89899,female,0.0,CHF,16.0,$11-$25k,12826.0,black,no,0.699999809,0.5,no dnr,6.0,75.0,5.69921875,90.0,20.0,37.0,304.75,2.8999023,0.89990234,1.19995117,126.0,7.439453,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.1884766
55.87698,female,0.0,COPD,12.0,under $11k,55987.0,white,yes,0.699999809,0.5,dnr after sadm,2.0,63.0,11.7988281,95.0,10.0,37.69531,187.5,3.699707,0.5,2.0,137.0,7.299805,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.9853516
42.237,female,0.0,ARF/MOSF w/Sepsis,16.0,$25-$50k,41885.0,white,no,0.149999976,0.04999998,no dnr,9.0,100.0,7.29980469,82.0,24.0,35.19531,136.71875,2.8999023,5.19921875,1.19995117,137.0,7.439453,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
49.60999,female,0.0,Cirrhosis,14.0,>$50k,5215.0,white,no,0.899999619,0.7399998,no dnr,4.0,71.0,4.89941406,64.0,22.0,36.39844,224.0,2.2998047,1.5,1.09985352,139.0,7.419922,104.0,19.0,360.0,1.0,1.0,no(M2 and SIP pres),1.0
78.43695,female,0.0,COPD,12.0,under $11k,34499.0,white,no,0.399999857,0.1999999,dnr after sadm,2.0,63.0,14.7988281,72.0,24.0,37.59375,157.125,3.0,0.39996338,1.79980469,140.0,7.339844,74.0,35.0,2600.0,0.0,3.0,adl>=4 (>=5 if sur),3.0
55.98599,male,1.0,CHF,18.0,>$50k,90756.0,white,no,0.799999714,0.6999998,no dnr,27.0,80.0,8.5,74.0,20.0,35.59375,409.5,3.5996094,1.69995117,1.59985352,128.0,7.5,141.0,31.0,1875.0,0.0,0.0,<2 mo. follow-up,0.0
74.46698,female,1.0,ARF/MOSF w/Sepsis,14.0,$11-$25k,161673.0,white,yes,0.75,0.75,dnr after sadm,15.0,118.0,9.59960938,110.0,24.0,39.19531,280.9375,3.2998047,0.29998779,0.59997559,130.0,7.549805,116.0,3.0,3690.0,0.0,0.0,<2 mo. follow-up,0.0
44.90097,female,1.0,MOSF w/Malig,14.0,>$50k,307552.0,other,metastatic,0.75,0.5,dnr after sadm,23.0,62.0,16.8984375,95.0,26.0,36.29688,125.0,3.3999023,2.5,2.89990234,144.0,7.479492,433.0,40.0,1240.0,0.0,0.0,<2 mo. follow-up,0.0
44.383,male,0.0,ARF/MOSF w/Sepsis,20.0,>$50k,246214.0,white,no,0.199999928,0.09999996,no dnr,29.0,65.0,7.09960938,80.0,26.0,36.5,300.0,2.8999023,0.79992676,2.69970703,145.0,7.489258,139.0,29.0,5040.0,0.0,1.0,<2 mo. follow-up,2.4560547
26.51299,female,0.0,ARF/MOSF w/Sepsis,17.0,under $11k,87124.0,hispanic,no,0.699999809,0.5,no dnr,13.0,113.0,19.0,135.0,44.0,38.39844,95.375,2.8999023,2.5,0.69995117,133.0,7.5,114.0,7.0,6500.0,0.0,0.0,no(M2 and SIP pres),0.0
70.90796,male,1.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,390845.0,white,no,0.009999998,0.009999998,dnr after sadm,1.0,50.0,26.1992188,120.0,28.0,38.69531,392.5625,2.8999023,5.5,2.19970703,133.0,7.509766,213.0,65.0,5880.0,0.0,1.0,<2 mo. follow-up,3.4643555
63.64697,male,0.0,ARF/MOSF w/Sepsis,16.0,under $11k,142625.0,white,yes,0.75,0.5999999,no dnr,23.0,65.0,7.09960938,55.0,21.0,37.69531,237.125,2.199707,2.29980469,0.79992676,137.0,7.459961,215.0,12.0,5605.0,0.0,6.0,adl>=4 (>=5 if sur),6.0
72.54797,female,0.0,Colon Cancer,12.0,under $11k,10862.0,asian,metastatic,0.5,0.3,no dnr,5.0,69.0,5.19921875,72.0,20.0,36.39844,224.0,3.2998047,0.19998169,1.09985352,138.0,7.419922,135.0,13.0,2125.0,0.0,1.0,<2 mo. follow-up,1.8320312
81.24298,male,0.0,ARF/MOSF w/Sepsis,14.0,under $11k,172335.0,white,no,0.299999952,0.3,no dnr,26.0,60.0,14.5,110.0,12.0,38.69531,92.0,2.5,1.39990234,1.39990234,130.0,7.5,106.0,23.0,5075.0,0.0,2.0,no(M2 and SIP pres),2.0
34.59299,male,1.0,MOSF w/Malig,17.0,under $11k,118073.0,white,metastatic,0.599999905,0.3,dnr after sadm,7.0,97.0,21.5,146.0,32.0,39.0,280.9375,2.8999023,0.89990234,0.59997559,127.0,7.5,119.0,6.0,2159.0,0.0,7.0,<2 mo. follow-up,7.0
61.39398,male,0.0,CHF,14.0,$11-$25k,54893.0,white,no,0.799999714,0.6999998,no dnr,11.0,75.0,9.79882812,65.0,20.0,36.0,224.0,2.8999023,1.59985352,1.79980469,129.0,7.419922,80.0,63.0,2375.0,0.0,2.0,<2 mo. follow-up,2.0
76.05499,male,0.0,CHF,14.0,under $11k,7626.0,white,yes,0.599999905,0.5,no dnr,4.0,101.0,6.79980469,114.0,20.0,36.79688,224.0,2.8999023,0.59997559,1.69995117,139.0,7.419922,161.0,39.0,2390.0,6.0,1.0,no(M2 and SIP pres),4.5273438
49.49197,female,0.0,ARF/MOSF w/Sepsis,12.0,>$50k,177889.0,white,no,0.849999905,0.8499999,no dnr,26.0,105.0,13.0,110.0,30.0,39.29688,105.0,4.5,0.89990234,0.59997559,147.0,7.469727,105.0,25.0,1480.0,0.0,7.0,no(M2 and SIP pres),7.0
78.03699,male,0.0,CHF,12.0,$11-$25k,35566.0,white,yes,0.5,0.25,dnr after sadm,1.0,75.0,36.09375,70.0,22.0,36.0,414.25,2.8999023,0.89990234,2.5,135.0,7.489258,90.0,71.0,650.0,5.0,1.0,<2 mo. follow-up,3.8549805
54.02298,female,1.0,ARF/MOSF w/Sepsis,10.0,under $11k,676210.0,white,no,0.699999809,0.5,no dnr,46.0,55.0,12.8984375,115.0,46.0,39.19531,290.0,3.2998047,4.59960938,3.79980469,143.0,7.439453,74.0,95.0,160.0,0.0,0.0,<2 mo. follow-up,0.0
85.10297,female,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,62841.0,white,no,0.899999619,0.7999997,dnr before sadm,-4.0,73.0,10.0996094,105.0,24.0,38.0,83.32812,2.8999023,0.89990234,1.19995117,128.0,7.469727,353.0,20.0,2978.0,1.0,1.0,no(M2 and SIP pres),1.0
52.02197,male,0.0,ARF/MOSF w/Sepsis,16.0,$11-$25k,593198.0,hispanic,no,0.699999809,0.5,no dnr,52.0,108.0,3.79980469,55.0,32.0,38.39844,418.3125,2.8999023,3.59960938,1.5,145.0,7.419922,332.0,81.0,1760.0,0.0,7.0,no(M2 and SIP pres),7.0
86.62799,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,96480.0,white,no,0.699999809,0.5,no dnr,20.0,98.0,28.8984375,75.0,36.0,36.39844,142.0,2.8999023,0.89990234,1.0,150.0,7.519531,357.0,16.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
58.95398,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,298234.0,white,no,0.099999964,0.09999996,no dnr,11.0,135.0,5.59960938,95.0,10.0,39.09375,170.0,2.8999023,18.8984375,1.5,153.0,7.439453,182.0,76.0,1880.0,0.0,1.0,<2 mo. follow-up,3.206543
57.69699,male,0.0,Lung Cancer,16.0,>$50k,12827.0,white,metastatic,0.799999714,0.5,no dnr,4.0,112.0,11.6992188,80.0,16.0,37.0,224.0,3.2998047,0.29998779,1.0,141.0,7.419922,94.0,14.0,6360.0,0.0,1.0,no(M2 and SIP pres),0.494751
59.44397,male,1.0,Coma,24.0,>$50k,223643.0,white,no,0.699999809,0.5,dnr after sadm,17.0,142.0,19.296875,115.0,8.0,38.79688,317.75,2.8999023,1.89990234,1.09985352,144.0,7.509766,393.0,33.0,3050.0,0.0,0.0,<2 mo. follow-up,0.0
37.74698,male,1.0,ARF/MOSF w/Sepsis,16.0,$25-$50k,577381.0,white,no,0.0,0.0,dnr after sadm,13.0,62.0,9.19921875,145.0,12.0,37.89844,280.0,4.8994141,32.6953125,2.59960938,138.0,7.489258,129.0,71.0,12.0,0.0,3.0,<2 mo. follow-up,3.0
52.99698,male,1.0,ARF/MOSF w/Sepsis,16.0,>$50k,174687.0,white,no,0.5,0.5,dnr after sadm,3.0,42.0,6.79980469,105.0,29.0,35.5,307.5,2.8999023,6.39941406,8.0,145.0,7.389648,658.0,98.0,0.0,0.0,1.0,<2 mo. follow-up,3.7827148
76.28497,male,0.0,ARF/MOSF w/Sepsis,16.0,>$50k,141756.0,white,yes,0.699999809,0.5,no dnr,35.0,72.0,6.29980469,180.0,10.0,36.79688,64.0,2.0,0.89990234,0.79992676,129.0,7.5,165.0,26.0,3450.0,0.0,1.0,adl>=4 (>=5 if sur),1.0
57.53,female,0.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,261184.0,white,yes,0.5,0.6999998,no dnr,53.0,58.0,17.5,130.0,12.0,38.5,325.6875,2.5996094,0.5,4.09960938,125.0,7.429688,841.0,66.0,895.0,0.0,7.0,adl>=4 (>=5 if sur),7.0
70.20398,male,0.0,Lung Cancer,10.0,$25-$50k,10586.0,white,metastatic,1.0,0.5,no dnr,4.0,123.0,10.5996094,78.0,18.0,36.79688,224.0,2.8999023,0.89990234,0.89990234,137.0,7.419922,135.0,5.0,5170.0,0.0,0.0,SIP>=30,0.0
66.04498,male,0.0,Lung Cancer,13.0,>$50k,11532.0,white,metastatic,1.0,0.5,no dnr,4.0,79.0,11.5,80.0,16.0,36.79688,224.0,2.8999023,0.89990234,1.39990234,135.0,7.419922,135.0,15.0,5250.0,1.0,0.0,no(M2 and SIP pres),0.0
42.69397,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,76504.0,white,no,0.949999809,0.9499998,no dnr,11.0,103.0,2.39990234,125.0,26.0,39.29688,286.625,2.5,0.5,1.0,130.0,7.449219,123.0,12.0,2000.0,0.0,1.0,<2 mo. follow-up,3.315918
44.23297,male,0.0,ARF/MOSF w/Sepsis,10.0,under $11k,78031.0,hispanic,no,0.949999809,0.9499998,no dnr,7.0,72.0,19.1992188,75.0,36.0,38.89844,136.71875,2.5,3.79980469,1.29980469,143.0,7.459961,101.0,26.0,4005.0,0.0,0.0,no(M2 and SIP pres),0.0
49.892,male,1.0,ARF/MOSF w/Sepsis,14.0,under $11k,36044.0,white,yes,0.0,0.0,no dnr,7.0,70.0,2.29980469,125.0,35.0,37.89844,224.0,2.8999023,0.89990234,2.5,140.0,7.419922,135.0,52.0,1350.0,0.0,3.0,<2 mo. follow-up,3.0
20.523,male,0.0,MOSF w/Malig,12.0,$11-$25k,784726.0,other,yes,0.5,0.5,dnr after sadm,52.0,110.0,0.04999542,118.0,32.0,36.79688,236.65625,2.8999023,5.5,0.79992676,142.0,7.439453,251.0,30.0,3890.0,0.0,6.0,<2 mo. follow-up,6.0
62.5,female,0.0,Lung Cancer,9.0,under $11k,10163.0,white,metastatic,0.949999809,0.7999997,no dnr,4.0,113.0,6.5,80.0,20.0,36.0,224.0,3.7998047,0.89990234,0.89990234,138.0,7.419922,194.0,9.0,5700.0,5.0,1.0,no(M2 and SIP pres),3.8549805
37.47598,male,1.0,CHF,9.0,$11-$25k,270127.0,hispanic,no,0.699999809,0.5,no dnr,57.0,71.0,14.5996094,55.0,16.0,37.09375,224.0,2.8999023,2.59960938,1.29980469,131.0,7.419922,99.0,33.0,4275.0,1.0,0.0,<2 mo. follow-up,0.0
59.45499,female,0.0,ARF/MOSF w/Sepsis,16.0,>$50k,976623.0,white,no,0.799999714,0.7999997,no dnr,91.0,73.0,4.79980469,115.0,30.0,38.59375,312.5,4.5996094,1.59985352,3.69970703,142.0,7.379883,135.0,75.0,238.0,0.0,2.0,adl>=4 (>=5 if sur),2.0
66.26099,female,0.0,CHF,12.0,under $11k,11494.0,black,metastatic,0.849999905,0.5,no dnr,7.0,110.0,9.59960938,109.0,20.0,36.0,442.8125,4.5996094,0.89990234,1.29980469,137.0,7.469727,251.0,23.0,3420.0,0.0,1.0,<2 mo. follow-up,4.8818359
59.03598,male,0.0,CHF,20.0,>$50k,21359.0,white,no,0.699999809,0.5,no dnr,9.0,49.0,7.09960938,120.0,16.0,36.39844,224.0,2.8999023,0.89990234,2.89990234,132.0,7.419922,100.0,43.0,1770.0,0.0,0.0,no(M2 and SIP pres),0.0
60.271,male,1.0,ARF/MOSF w/Sepsis,16.0,$25-$50k,460668.0,white,yes,0.899999619,0.5999999,dnr after sadm,37.0,115.0,7.79980469,120.0,20.0,36.89844,224.0,2.8999023,0.89990234,1.69995117,143.0,7.419922,154.0,85.0,2850.0,0.0,3.0,<2 mo. follow-up,3.0
20.99699,male,1.0,Coma,14.0,under $11k,278242.0,asian,yes,0.699999809,0.5,dnr after sadm,1.0,60.0,27.5,85.0,24.0,35.0,54.0,2.3999023,20.5976562,4.09960938,150.0,6.939453,335.0,75.0,110.0,0.0,1.0,<2 mo. follow-up,3.309082
55.655,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,34920.0,white,no,0.75,0.75,no dnr,12.0,75.0,8.29882812,116.0,8.0,36.59375,419.0,3.699707,0.19998169,2.0,154.0,7.549805,111.0,63.0,2030.0,0.0,5.0,adl>=4 (>=5 if sur),5.0
45.43698,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,636886.0,white,no,0.399999857,0.5,no dnr,93.0,107.0,0.19998169,140.0,40.0,37.89844,178.0,2.8999023,3.0,0.5,134.0,7.299805,135.0,23.0,2050.0,0.0,1.0,<2 mo. follow-up,2.8330078
49.92499,male,0.0,Colon Cancer,17.0,>$50k,23578.0,white,metastatic,1.0,0.5,no dnr,14.0,70.0,11.0996094,120.0,20.0,39.59375,224.0,2.8999023,0.89990234,1.19995117,140.0,7.419922,135.0,23.0,3450.0,0.0,0.0,no(M2 and SIP pres),0.0
42.11899,female,0.0,ARF/MOSF w/Sepsis,16.0,under $11k,1086011.0,hispanic,no,0.699999809,0.5,no dnr,23.0,72.0,3.89990234,115.0,28.0,38.19531,311.0625,2.8999023,1.59985352,2.89990234,147.0,7.449219,78.0,64.0,151.0,0.0,0.0,no(M2 and SIP pres),0.0
75.08795,male,1.0,Coma,12.0,under $11k,157000.0,white,yes,0.699999809,0.5,no dnr,4.0,32.0,0.04999542,155.0,26.0,38.5,126.25,2.8999023,0.89990234,4.59960938,153.0,7.239258,67.0,112.0,0.0,0.0,1.0,<2 mo. follow-up,3.8095703
44.32599,male,0.0,CHF,14.0,under $11k,44950.0,black,no,0.949999809,0.8999996,no dnr,15.0,73.0,4.89941406,95.0,26.0,37.5,224.0,2.0996094,0.29998779,2.59960938,129.0,7.419922,154.0,51.0,2650.0,0.0,0.0,SIP>=30,0.0
75.17896,male,0.0,ARF/MOSF w/Sepsis,15.0,under $11k,191750.0,white,yes,0.5,0.9499998,no dnr,47.0,72.0,8.0,100.0,26.0,37.69531,172.5,2.8999023,0.89990234,6.19921875,142.0,7.449219,267.0,78.0,935.0,0.0,0.0,<2 mo. follow-up,0.0
51.452,female,0.0,Lung Cancer,12.0,$25-$50k,10606.0,white,metastatic,1.0,0.8999996,no dnr,6.0,73.0,3.39990234,80.0,20.0,36.19531,224.0,2.8999023,0.09999084,0.69995117,138.0,7.419922,135.0,8.0,6150.0,0.0,0.0,no(M2 and SIP pres),0.0
62.37598,male,1.0,MOSF w/Malig,18.0,>$50k,139026.0,black,yes,0.5,0.25,dnr after sadm,11.0,108.0,5.39941406,70.0,12.0,35.89844,153.03125,2.2998047,9.59960938,5.19921875,127.0,7.419922,186.0,101.0,1131.0,0.0,4.0,<2 mo. follow-up,4.0
54.47498,male,0.0,Lung Cancer,16.0,>$50k,94914.0,white,metastatic,0.799999714,0.5,no dnr,25.0,97.0,6.0,76.0,20.0,36.19531,224.0,4.0996094,0.5,1.09985352,138.0,7.419922,165.0,12.0,7500.0,0.0,0.0,no(M2 and SIP pres),0.0
52.62997,male,0.0,Colon Cancer,12.0,under $11k,12265.0,white,metastatic,0.799999714,0.5,no dnr,5.0,101.0,10.0,80.0,22.0,37.79688,224.0,3.7998047,0.39996338,1.09985352,132.0,7.419922,114.0,20.0,1075.0,0.0,1.0,no(M2 and SIP pres),1.857666
75.77496,female,0.0,CHF,13.0,under $11k,10782.0,white,no,0.979999542,0.8999996,no dnr,6.0,108.0,10.6992188,95.0,22.0,36.39844,224.0,2.8999023,0.89990234,0.89990234,137.0,7.419922,135.0,15.0,3450.0,0.0,1.0,<2 mo. follow-up,0.494751
76.961,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,88755.0,hispanic,no,0.75,0.6999998,no dnr,17.0,78.0,9.09960938,105.0,12.0,36.5,440.0,2.8999023,0.89990234,2.0,126.0,7.439453,159.0,30.0,7219.0,0.0,3.0,adl>=4 (>=5 if sur),3.0
54.71597,female,0.0,ARF/MOSF w/Sepsis,14.0,$25-$50k,31403.0,white,no,0.299999952,0.25,no dnr,10.0,100.0,26.296875,75.0,15.0,38.0,108.32812,2.3999023,1.39990234,2.19970703,132.0,7.369141,119.0,56.0,970.0,2.0,2.0,<2 mo. follow-up,2.0
79.70398,female,1.0,MOSF w/Malig,16.0,$11-$25k,56752.0,white,yes,0.5,0.3,dnr after sadm,9.0,60.0,22.0,110.0,36.0,36.09375,108.0,2.5996094,0.89990234,0.5,135.0,7.459961,135.0,16.0,1870.0,0.0,1.0,<2 mo. follow-up,3.6772461
53.36099,male,1.0,ARF/MOSF w/Sepsis,18.0,under $11k,314092.0,white,no,0.699999809,0.5,dnr after sadm,22.0,97.0,11.5996094,70.0,32.0,36.79688,313.3125,3.0996094,7.79980469,2.69970703,140.0,7.419922,286.0,96.0,7660.0,0.0,0.0,<2 mo. follow-up,0.0
73.94897,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,208988.0,asian,yes,0.149999976,0.04999998,dnr after sadm,8.0,62.0,6.19921875,115.0,30.0,38.0,127.5,2.8999023,0.39996338,2.69970703,135.0,7.509766,160.0,64.0,5055.0,0.0,1.0,<2 mo. follow-up,3.9243164
21.20999,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,73268.0,hispanic,no,0.699999809,0.5,no dnr,8.0,112.0,7.19921875,120.0,26.0,38.69531,291.375,1.5998535,13.7988281,0.69995117,140.0,7.459961,135.0,9.0,1325.0,0.0,1.0,<2 mo. follow-up,1.0
86.35199,female,1.0,ARF/MOSF w/Sepsis,16.0,$11-$25k,125804.0,white,no,0.25,0.25,dnr before sadm,-3.0,45.0,23.5,75.0,36.0,36.19531,97.0,2.7998047,0.89990234,2.0,131.0,7.379883,310.0,60.0,1262.0,0.0,0.0,<2 mo. follow-up,0.0
33.55197,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,26882.0,black,no,0.699999809,0.5,no dnr,6.0,113.0,15.6992188,125.0,28.0,39.29688,348.5625,2.8999023,0.89990234,1.0,133.0,7.429688,69.0,6.0,2060.0,0.0,1.0,no(M2 and SIP pres),3.2265625
64.58295,male,0.0,Lung Cancer,12.0,$25-$50k,5751.0,white,metastatic,0.699999809,0.5,no dnr,5.0,81.0,5.69921875,84.0,20.0,37.79688,224.0,2.8999023,0.89990234,0.79992676,140.0,7.419922,92.0,11.0,2775.0,0.0,0.0,<2 mo. follow-up,0.0
79.54596,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,30631.0,white,no,0.699999809,0.5999999,no dnr,5.0,60.0,15.3984375,25.0,32.0,38.29688,224.0,3.0,0.89990234,0.69995117,146.0,7.419922,189.0,11.0,422.0,0.0,1.0,<2 mo. follow-up,3.5649414
67.71497,female,0.0,ARF/MOSF w/Sepsis,14.0,>$50k,46447.0,white,no,0.989999771,0.9899998,no dnr,7.0,72.0,8.79882812,72.0,22.0,36.5,83.32812,2.3999023,0.69995117,0.89990234,133.0,7.539062,95.0,11.0,2050.0,2.0,1.0,no(M2 and SIP pres),1.8388672
48.73599,female,0.0,Lung Cancer,12.0,under $11k,117616.0,white,metastatic,0.799999714,0.5,no dnr,26.0,73.0,5.0,96.0,24.0,37.5,224.0,2.8999023,0.19998169,0.89990234,135.0,7.419922,88.0,9.0,4735.0,0.0,1.0,<2 mo. follow-up,3.0268555
63.79498,female,0.0,Lung Cancer,16.0,>$50k,11253.0,white,metastatic,0.899999619,0.5999999,no dnr,8.0,101.0,6.39941406,120.0,24.0,36.19531,224.0,4.1992188,0.39996338,0.89990234,140.0,7.419922,79.0,23.0,2200.0,4.0,1.0,adl>=4 (>=5 if sur),3.1831055
88.422,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,111560.0,white,no,0.699999809,0.5,no dnr,17.0,72.0,17.1992188,145.0,36.0,38.69531,148.3125,2.699707,0.39996338,1.09985352,146.0,7.479492,131.0,21.0,1975.0,0.0,1.0,<2 mo. follow-up,6.2734375
54.38199,male,1.0,ARF/MOSF w/Sepsis,13.0,$11-$25k,508881.0,white,yes,0.699999809,0.6999998,dnr after sadm,16.0,117.0,5.09960938,45.0,27.0,38.0,265.0,3.7998047,29.5,4.89941406,144.0,7.429688,140.0,99.0,619.0,0.0,2.0,<2 mo. follow-up,2.0
63.62198,male,0.0,CHF,14.0,under $11k,36522.0,white,no,0.899999619,0.75,no dnr,9.0,45.0,12.0,115.0,16.0,36.59375,224.0,2.8999023,0.89990234,1.0,131.0,7.419922,106.0,16.0,2960.0,0.0,1.0,no(M2 and SIP pres),1.0
35.52597,female,1.0,ARF/MOSF w/Sepsis,14.0,under $11k,190585.0,white,yes,0.199999928,0.1999999,dnr after sadm,6.0,135.0,5.0,120.0,20.0,36.5,153.3125,2.8999023,0.89990234,0.79992676,149.0,7.449219,399.0,26.0,1770.0,0.0,0.0,<2 mo. follow-up,0.0
80.46295,male,0.0,CHF,16.0,>$50k,13833.0,white,no,0.929999828,0.75,no dnr,5.0,82.0,5.5,80.0,20.0,36.5,224.0,3.199707,0.79992676,1.19995117,142.0,7.419922,91.0,26.0,2500.0,1.0,1.0,no(M2 and SIP pres),1.0
44.02499,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,35099.0,white,no,0.199999928,0.09999996,no dnr,6.0,75.0,11.1992188,100.0,10.0,37.5,328.5625,2.0,35.0,1.19995117,136.0,7.429688,106.0,19.0,3520.0,0.0,6.0,<2 mo. follow-up,6.0
35.26599,male,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,48956.0,white,no,0.799999714,0.7999997,no dnr,11.0,66.0,13.0996094,82.0,16.0,38.39844,245.0,2.7998047,0.09999084,0.79992676,148.0,7.319336,110.0,4.0,2870.0,6.0,6.0,SIP>=30,6.0
37.25098,male,1.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,83192.0,white,no,0.0,0.0,dnr after sadm,2.0,42.0,12.0,85.0,24.0,38.79688,70.0,3.699707,37.0,5.59960938,142.0,7.579102,110.0,49.0,0.0,0.0,1.0,<2 mo. follow-up,3.012207
62.133,male,1.0,CHF,12.0,>$50k,153171.0,white,no,0.699999809,0.6999998,no dnr,13.0,47.0,11.5,80.0,20.0,36.79688,224.0,2.8999023,0.89990234,3.0,132.0,7.419922,135.0,77.0,3885.0,0.0,1.0,<2 mo. follow-up,0.494751
32.64099,female,1.0,MOSF w/Malig,12.0,$11-$25k,358494.0,white,yes,0.849999905,0.5,dnr after sadm,34.0,107.0,0.09999084,78.0,20.0,38.0,224.0,2.8999023,2.0,2.19970703,137.0,7.419922,307.0,70.0,3475.0,0.0,0.0,<2 mo. follow-up,0.0
76.44098,male,0.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,23486.0,white,metastatic,0.899999619,0.7999997,no dnr,9.0,78.0,21.296875,84.0,16.0,36.0,250.0,3.0,0.39996338,5.5,131.0,7.40918,189.0,69.0,2560.0,0.0,0.0,no(M2 and SIP pres),0.0
77.59094,male,1.0,ARF/MOSF w/Sepsis,8.0,under $11k,355655.0,white,no,0.099999964,0.09999996,dnr after sadm,3.0,57.0,18.0,115.0,32.0,38.5,224.0,2.8999023,1.79980469,3.5,142.0,7.279297,137.0,73.0,1035.0,0.0,1.0,<2 mo. follow-up,3.7192383
51.09698,male,0.0,Lung Cancer,16.0,under $11k,37350.0,white,metastatic,1.0,1.0,no dnr,12.0,65.0,16.5976562,135.0,36.0,37.5,200.0,2.8999023,0.89990234,0.89990234,130.0,7.399414,126.0,9.0,2547.0,0.0,0.0,<2 mo. follow-up,0.0
95.70697,female,1.0,ARF/MOSF w/Sepsis,14.0,>$50k,16032.0,white,no,0.699999809,0.5,dnr before sadm,-1.0,65.0,35.09375,115.0,40.0,36.0,374.0,2.8999023,0.89990234,1.69995117,137.0,7.299805,395.0,44.0,20.0,0.0,1.0,<2 mo. follow-up,6.9287109
78.18799,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,18497.0,white,no,0.899999619,0.8999996,no dnr,5.0,98.0,10.0,98.0,20.0,37.0,348.5625,2.8999023,0.89990234,1.09985352,139.0,7.589844,114.0,8.0,1650.0,0.0,1.0,<2 mo. follow-up,4.9316406
61.142,male,0.0,ARF/MOSF w/Sepsis,22.0,$25-$50k,365437.0,black,no,0.799999714,0.5999999,no dnr,29.0,118.0,10.1992188,65.0,36.0,35.39844,167.5,3.3999023,2.79980469,6.29980469,136.0,7.469727,281.0,101.0,0.0,0.0,2.0,<2 mo. follow-up,2.0
84.99695,male,0.0,Coma,12.0,under $11k,19473.0,white,yes,0.049999982,0.0,dnr after sadm,2.0,119.0,14.0,82.0,20.0,38.39844,487.5,2.8999023,0.89990234,1.39990234,133.0,7.429688,170.0,20.0,850.0,0.0,1.0,<2 mo. follow-up,3.3886719
84.37195,female,0.0,ARF/MOSF w/Sepsis,10.0,under $11k,64321.0,white,no,0.099999964,0.04999998,dnr after sadm,3.0,58.0,13.6992188,145.0,12.0,39.39844,371.375,2.5,0.5,0.79992676,129.0,7.319336,157.0,30.0,3125.0,0.0,3.0,<2 mo. follow-up,3.0
77.99298,male,1.0,CHF,21.0,$25-$50k,90070.0,black,no,0.699999809,0.5,dnr after sadm,3.0,53.0,21.1992188,65.0,28.0,37.59375,246.65625,2.8999023,0.79992676,2.59960938,129.0,7.289062,108.0,73.0,162.0,0.0,1.0,<2 mo. follow-up,2.6665039
79.97797,male,1.0,ARF/MOSF w/Sepsis,10.0,$11-$25k,121331.0,white,no,0.099999964,0.04999998,dnr after sadm,11.0,58.0,9.29882812,70.0,12.0,38.19531,127.5,2.8999023,2.19970703,4.59960938,129.0,7.40918,97.0,87.0,2631.0,0.0,6.0,<2 mo. follow-up,6.0
79.06396,male,1.0,ARF/MOSF w/Sepsis,16.0,$25-$50k,107076.0,white,no,0.199999928,0.1999999,dnr after sadm,11.0,58.0,26.296875,165.0,22.0,38.0,73.0,2.199707,0.89990234,1.79980469,145.0,7.449219,189.0,38.0,1559.0,0.0,0.0,<2 mo. follow-up,0.0
45.043,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,30354.0,white,no,0.099999964,0.04999998,dnr after sadm,2.0,5.0,14.5,0.0,5.0,38.79688,120.0,3.2998047,1.79980469,4.39941406,124.0,7.719727,100.0,92.0,275.0,0.0,1.0,<2 mo. follow-up,1.6142578
50.155,male,0.0,ARF/MOSF w/Sepsis,12.0,>$50k,372270.0,white,no,0.799999714,0.6999998,no dnr,27.0,113.0,13.5996094,110.0,6.0,38.29688,267.5,2.7998047,4.19921875,2.69970703,137.0,7.419922,330.0,111.0,3826.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
56.211,female,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,135949.0,white,no,0.699999809,0.6999998,no dnr,24.0,65.0,11.5,45.0,14.0,38.5,270.0,2.8999023,1.09985352,3.69970703,139.0,7.459961,89.0,32.0,1965.0,0.0,5.0,adl>=4 (>=5 if sur),5.0
51.18698,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,56973.0,white,metastatic,0.0,0.0,dnr before sadm,-3.0,75.0,13.7988281,126.0,16.0,36.69531,114.28125,2.8999023,0.89990234,1.59985352,132.0,7.389648,164.0,13.0,3150.0,0.0,1.0,<2 mo. follow-up,2.8598633
47.95099,male,0.0,MOSF w/Malig,18.0,$11-$25k,53439.0,hispanic,metastatic,0.149999976,0.04999998,dnr after sadm,4.0,98.0,12.5,110.0,36.0,39.39844,419.0,1.7998047,0.89990234,1.59985352,134.0,7.369141,157.0,25.0,1450.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
100.24597,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,51328.0,white,no,0.0,0.0,dnr after sadm,3.0,22.0,15.5996094,130.0,26.0,36.5,56.0,2.2998047,12.8984375,2.29980469,145.0,7.359375,49.0,18.0,0.0,0.0,1.0,<2 mo. follow-up,4.1796875
75.95294,male,1.0,Coma,17.0,$11-$25k,13525.0,white,yes,0.699999809,0.5,dnr after sadm,2.0,100.0,100.0,76.0,28.0,40.69531,211.0,2.8999023,0.89990234,1.79980469,135.0,7.40918,179.0,32.0,1600.0,0.0,1.0,<2 mo. follow-up,3.0849609
36.39398,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,492853.0,black,no,0.699999809,0.5,no dnr,64.0,65.0,9.29882812,115.0,26.0,36.79688,224.0,2.8999023,0.89990234,1.5,150.0,7.419922,153.0,38.0,1467.0,0.0,5.0,<2 mo. follow-up,5.0
76.21399,female,0.0,COPD,14.0,under $11k,30490.0,white,no,0.699999809,0.5,no dnr,7.0,107.0,11.1992188,110.0,12.0,36.39844,65.0,2.8999023,0.19998169,1.19995117,143.0,7.299805,132.0,25.0,1600.0,2.0,3.0,no(M2 and SIP pres),3.0
87.05798,female,0.0,ARF/MOSF w/Sepsis,16.0,under $11k,202508.0,white,metastatic,0.849999905,0.8499999,no dnr,40.0,72.0,18.5976562,115.0,26.0,37.89844,206.09375,2.8999023,0.89990234,2.0,131.0,7.5,156.0,55.0,2990.0,0.0,5.0,adl>=4 (>=5 if sur),5.0
80.10095,female,0.0,ARF/MOSF w/Sepsis,16.0,$25-$50k,299289.0,white,yes,0.699999809,0.6999998,no dnr,37.0,132.0,12.7988281,115.0,28.0,36.79688,117.14062,2.5,0.59997559,0.69995117,136.0,7.399414,152.0,19.0,4355.0,0.0,0.0,<2 mo. follow-up,0.0
62.724,female,1.0,Coma,18.0,$11-$25k,109193.0,white,no,0.0,0.0,dnr after sadm,13.0,130.0,10.5,65.0,15.0,38.39844,146.0,3.699707,0.79992676,0.59997559,133.0,7.489258,150.0,5.0,2495.0,0.0,1.0,<2 mo. follow-up,2.4272461
81.50897,male,0.0,CHF,12.0,under $11k,13004.0,white,no,0.799999714,0.3999999,no dnr,7.0,111.0,6.19921875,80.0,26.0,36.0,224.0,2.8999023,0.89990234,1.89990234,140.0,7.419922,135.0,33.0,950.0,0.0,4.0,adl>=4 (>=5 if sur),4.0
32.08499,male,0.0,CHF,12.0,under $11k,162263.0,hispanic,no,0.5,0.25,no dnr,34.0,53.0,5.59960938,105.0,16.0,36.5,224.0,3.8999023,1.09985352,1.29980469,134.0,7.419922,103.0,27.0,4955.0,2.0,5.0,no(M2 and SIP pres),5.0
71.85498,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,95439.0,asian,no,0.099999964,0.04999998,dnr after sadm,7.0,55.0,11.5996094,105.0,32.0,36.5,134.0,2.3999023,1.59985352,4.29980469,125.0,7.419922,135.0,71.0,2795.0,0.0,0.0,<2 mo. follow-up,0.0
90.20697,female,0.0,ARF/MOSF w/Sepsis,9.0,$11-$25k,12549.0,white,no,0.699999809,0.5,no dnr,4.0,75.0,8.29882812,70.0,22.0,35.89844,134.6875,2.8999023,0.89990234,2.69970703,137.0,7.25,390.0,38.0,600.0,0.0,1.0,<2 mo. follow-up,0.494751
67.92896,female,0.0,CHF,8.0,under $11k,82258.0,hispanic,no,0.5,0.5,dnr after sadm,5.0,57.0,7.09960938,55.0,22.0,36.29688,224.0,2.8999023,0.89990234,0.89990234,134.0,7.419922,140.0,15.0,1890.0,1.0,1.0,SIP>=30,1.1667481
35.76498,female,0.0,ARF/MOSF w/Sepsis,13.0,$25-$50k,94457.0,white,no,0.599999905,0.6999998,no dnr,14.0,130.0,16.0,120.0,20.0,39.0,114.28125,2.5996094,0.5,0.59997559,136.0,7.40918,104.0,11.0,3540.0,0.0,5.0,no(M2 and SIP pres),5.0
73.75494,female,1.0,Coma,12.0,under $11k,334890.0,hispanic,yes,0.089999974,0.0007289997,dnr after sadm,12.0,125.0,0.04999542,125.0,40.0,38.89844,260.0,2.199707,1.89990234,0.79992676,152.0,7.509766,314.0,17.0,4755.0,0.0,5.0,<2 mo. follow-up,5.0
54.004,female,0.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,748973.0,white,no,0.099999964,0.09999996,no dnr,58.0,45.0,0.19998169,105.0,32.0,36.89844,202.0,3.2998047,4.5,3.59960938,142.0,7.359375,163.0,95.0,525.0,0.0,1.0,adl>=4 (>=5 if sur),1.0
52.51199,female,0.0,ARF/MOSF w/Sepsis,12.0,>$50k,69096.0,white,yes,0.989999771,0.9799995,no dnr,15.0,88.0,13.3984375,142.0,20.0,38.19531,256.625,1.3999023,0.89990234,0.69995117,136.0,7.359375,113.0,5.0,3400.0,0.0,3.0,no(M2 and SIP pres),3.0
38.168,female,0.0,ARF/MOSF w/Sepsis,20.0,$25-$50k,151909.0,hispanic,no,0.5,0.5,no dnr,23.0,102.0,27.1992188,140.0,26.0,38.09375,146.65625,2.0,0.79992676,1.89990234,151.0,7.259766,131.0,21.0,2665.0,0.0,1.0,SIP>=30,2.9682617
49.02399,female,1.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,64403.0,white,no,0.199999928,0.09999996,dnr after sadm,5.0,55.0,26.6992188,105.0,10.0,35.5,186.0,3.2998047,48.5,3.0,139.0,7.279297,164.0,83.0,645.0,0.0,0.0,<2 mo. follow-up,0.0
47.96198,male,0.0,COPD,14.0,under $11k,39258.0,white,no,0.949999809,0.9799995,no dnr,7.0,112.0,19.296875,135.0,40.0,37.89844,134.03125,3.3999023,0.79992676,0.79992676,136.0,7.40918,135.0,25.0,3950.0,1.0,1.0,<2 mo. follow-up,1.1667481
22.91299,male,0.0,ARF/MOSF w/Sepsis,13.0,under $11k,59999.0,black,no,0.899999619,0.9799995,no dnr,25.0,65.0,11.0996094,114.0,24.0,37.59375,224.0,2.5996094,0.89990234,1.09985352,141.0,7.419922,156.0,35.0,1330.0,0.0,7.0,adl>=4 (>=5 if sur),7.0
68.53894,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,246417.0,black,no,0.699999809,0.5,no dnr,29.0,87.0,8.59960938,115.0,6.0,38.69531,270.0,2.8999023,0.89990234,0.79992676,149.0,7.449219,166.0,13.0,2675.0,0.0,1.0,<2 mo. follow-up,2.4624023
94.80096,female,0.0,Lung Cancer,12.0,under $11k,11088.0,white,metastatic,0.25,0.04999998,no dnr,5.0,65.0,15.5,78.0,28.0,35.39844,224.0,2.8999023,0.89990234,0.79992676,133.0,7.419922,108.0,28.0,700.0,0.0,1.0,<2 mo. follow-up,4.578125
47.88498,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,165774.0,black,yes,0.699999809,0.5,no dnr,19.0,52.0,9.59960938,125.0,28.0,38.09375,175.0,2.199707,0.89990234,1.09985352,144.0,7.419922,290.0,26.0,2761.0,0.0,1.0,<2 mo. follow-up,3.1933594
52.98599,male,0.0,CHF,12.0,under $11k,24044.0,white,no,0.899999619,0.7999997,no dnr,8.0,68.0,7.69921875,115.0,28.0,39.09375,224.0,2.8999023,0.69995117,1.29980469,136.0,7.419922,135.0,12.0,3960.0,0.0,1.0,no(M2 and SIP pres),1.0
41.26199,male,0.0,ARF/MOSF w/Sepsis,16.0,>$50k,346799.0,white,no,0.799999714,0.7999997,no dnr,40.0,63.0,13.1992188,170.0,40.0,38.5,192.0,2.5,6.39941406,1.0,141.0,7.5,252.0,30.0,2010.0,0.0,1.0,no(M2 and SIP pres),1.0
60.96899,male,0.0,ARF/MOSF w/Sepsis,10.0,$11-$25k,156906.0,white,no,0.599999905,0.3999999,no dnr,14.0,47.0,14.6992188,105.0,30.0,37.69531,158.3125,2.8999023,1.0,1.29980469,141.0,7.539062,97.0,27.0,4730.0,0.0,5.0,no(M2 and SIP pres),5.0
71.84698,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,210555.0,white,no,0.199999928,0.1999999,no dnr,30.0,0.0,6.29980469,0.0,12.0,38.59375,345.0,2.5,0.69995117,4.89941406,133.0,7.399414,476.0,84.0,1941.0,0.0,1.0,<2 mo. follow-up,2.0454102
84.31799,male,0.0,ARF/MOSF w/Sepsis,18.0,>$50k,462018.0,asian,no,0.599999905,0.5,dnr after sadm,45.0,63.0,9.69921875,55.0,18.0,36.09375,191.40625,2.2998047,0.89990234,1.19995117,137.0,7.259766,135.0,29.0,1870.0,0.0,1.0,<2 mo. follow-up,2.8022461
38.21799,female,1.0,Coma,14.0,>$50k,97521.0,white,yes,0.75,0.6999998,dnr after sadm,4.0,118.0,15.8984375,126.0,44.0,37.79688,160.0,2.199707,26.3984375,1.89990234,127.0,7.40918,135.0,24.0,3275.0,0.0,5.0,<2 mo. follow-up,5.0
79.15698,female,1.0,Coma,15.0,$25-$50k,16231.0,white,yes,0.019999996,0.02,dnr after sadm,3.0,32.0,19.0976562,195.0,10.0,35.79688,266.625,2.8999023,0.89990234,2.09960938,145.0,7.569336,273.0,19.0,1628.0,0.0,1.0,<2 mo. follow-up,3.6679688
33.59097,male,0.0,ARF/MOSF w/Sepsis,16.0,$25-$50k,81881.0,hispanic,no,0.899999619,0.7999997,no dnr,10.0,81.0,2.09960938,95.0,16.0,37.59375,40.0,2.8999023,0.69995117,2.29980469,138.0,7.549805,120.0,38.0,2096.0,2.0,1.0,no(M2 and SIP pres),1.8388672
73.61798,male,1.0,MOSF w/Malig,16.0,>$50k,86043.0,white,metastatic,0.5,0.0,dnr after sadm,5.0,62.0,5.59960938,64.0,24.0,36.0,247.59375,2.0996094,0.69995117,0.79992676,134.0,7.509766,215.0,15.0,2410.0,0.0,5.0,<2 mo. follow-up,5.0
98.08899,female,1.0,Coma,16.0,under $11k,16613.0,white,no,0.149999976,0.15,dnr after sadm,1.0,82.0,10.0,135.0,24.0,36.0,190.0,2.8999023,0.89990234,0.39996338,139.0,7.549805,155.0,5.0,2525.0,0.0,1.0,<2 mo. follow-up,6.3632812
65.09497,female,0.0,ARF/MOSF w/Sepsis,18.0,under $11k,358169.0,white,no,0.599999905,0.5999999,no dnr,39.0,103.0,11.0996094,105.0,10.0,39.39844,240.0,3.7998047,0.89990234,0.69995117,136.0,7.539062,152.0,12.0,4090.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
67.39197,female,0.0,ARF/MOSF w/Sepsis,9.0,$11-$25k,213912.0,black,no,0.199999928,0.1999999,dnr after sadm,6.0,142.0,30.0,135.0,40.0,38.89844,576.625,2.3999023,1.0,3.0,143.0,7.239258,286.0,62.0,5785.0,0.0,0.0,<2 mo. follow-up,0.0
69.77698,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,88609.0,white,yes,0.699999809,0.5,no dnr,11.0,68.0,6.0,55.0,8.0,39.5,165.4375,2.8999023,0.89990234,1.0,136.0,7.459961,167.0,17.0,5420.0,0.0,1.0,<2 mo. follow-up,2.9160156
77.20496,female,0.0,COPD,12.0,under $11k,14068.0,white,no,0.899999619,0.7999997,no dnr,4.0,136.0,24.0976562,150.0,24.0,36.39844,553.0,2.8999023,0.89990234,1.0,134.0,7.199219,89.0,27.0,790.0,0.0,1.0,<2 mo. follow-up,3.659668
68.40796,female,0.0,COPD,12.0,under $11k,19252.0,white,no,0.799999714,0.75,no dnr,8.0,75.0,4.29980469,60.0,28.0,36.59375,339.125,2.8999023,0.59997559,1.09985352,141.0,7.369141,89.0,21.0,300.0,0.0,1.0,<2 mo. follow-up,4.4960938
74.25098,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,205063.0,white,no,0.199999928,0.15,dnr after sadm,27.0,52.0,12.0,155.0,10.0,39.59375,280.0,2.5,10.0996094,3.29980469,153.0,7.459961,93.0,100.0,7365.0,0.0,3.0,<2 mo. follow-up,3.0
35.92599,male,1.0,MOSF w/Malig,12.0,$25-$50k,389403.0,white,yes,0.699999809,0.6999998,dnr after sadm,36.0,48.0,2.0,115.0,32.0,39.09375,246.9375,2.0,2.39990234,4.19921875,148.0,7.459961,135.0,101.0,210.0,0.0,0.0,<2 mo. follow-up,0.0
61.952,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,451954.0,white,no,0.199999928,0.1999999,no dnr,51.0,65.0,32.6953125,115.0,37.0,39.09375,136.65625,2.8999023,0.89990234,5.0,143.0,7.469727,181.0,150.0,3060.0,0.0,1.0,Coma or Intub,3.0234375
75.87695,male,0.0,ARF/MOSF w/Sepsis,19.0,>$50k,39709.0,white,no,0.599999905,0.3,no dnr,9.0,68.0,7.39941406,95.0,8.0,37.69531,243.3125,2.8999023,0.89990234,1.29980469,133.0,7.549805,135.0,25.0,4468.0,0.0,1.0,no(M2 and SIP pres),2.2265625
50.034,female,1.0,MOSF w/Malig,12.0,under $11k,60562.0,white,yes,0.199999928,0.1999999,dnr after sadm,5.0,112.0,2.29980469,125.0,26.0,39.0,140.8125,2.8999023,3.19970703,2.29980469,143.0,7.289062,166.0,36.0,6295.0,0.0,1.0,<2 mo. follow-up,3.3105469
66.90796,female,0.0,ARF/MOSF w/Sepsis,15.0,under $11k,137219.0,white,metastatic,0.5,0.3,dnr after sadm,1.0,79.0,6.39941406,110.0,24.0,36.39844,138.75,2.8999023,0.89990234,1.0,132.0,7.509766,168.0,10.0,2620.0,0.0,5.0,<2 mo. follow-up,5.0
38.94299,female,1.0,Cirrhosis,12.0,under $11k,283724.0,asian,no,0.099999964,0.04999998,no dnr,16.0,118.0,10.5996094,115.0,34.0,36.5,178.0,2.8999023,50.09375,3.19970703,151.0,7.579102,261.0,65.0,1200.0,0.0,0.0,<2 mo. follow-up,0.0
32.07397,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,793804.0,hispanic,no,0.699999809,0.6999998,no dnr,99.0,62.0,2.5,130.0,35.0,33.69531,323.0,2.3999023,21.5,0.39996338,148.0,7.399414,296.0,33.0,2530.0,0.0,0.0,Coma or Intub,0.0
57.75198,female,0.0,CHF,11.0,under $11k,10350.0,black,no,0.699999809,0.5,no dnr,4.0,78.0,3.69970703,65.0,28.0,36.29688,224.0,2.8999023,0.89990234,1.89990234,139.0,7.419922,97.0,66.0,1350.0,1.0,1.0,SIP>=30,1.0
48.435,male,0.0,Colon Cancer,12.0,under $11k,18298.0,white,metastatic,0.699999809,0.5999999,no dnr,10.0,75.0,3.39990234,70.0,20.0,36.39844,224.0,2.8999023,0.5,1.0,142.0,7.419922,0.0,13.0,3700.0,0.0,1.0,<2 mo. follow-up,2.5161133
56.50897,male,1.0,Coma,12.0,$11-$25k,25303.0,white,yes,0.099999964,0.0,dnr after sadm,2.0,70.0,7.19921875,65.0,37.0,38.19531,203.3125,2.8999023,0.69995117,1.29980469,148.0,7.639648,126.0,30.0,3155.0,0.0,1.0,<2 mo. follow-up,2.1625977
48.47098,female,0.0,Lung Cancer,17.0,under $11k,41422.0,white,metastatic,0.5,0.1999999,dnr after sadm,1.0,69.0,12.7988281,112.0,24.0,36.19531,366.625,3.3999023,0.19998169,0.69995117,136.0,7.469727,184.0,9.0,2800.0,1.0,0.0,<2 mo. follow-up,0.0
23.24199,female,1.0,MOSF w/Malig,16.0,under $11k,636743.0,white,yes,0.0,0.0,dnr after sadm,4.0,142.0,2.09960938,65.0,14.0,38.39844,220.0,2.8999023,47.796875,3.0,141.0,7.389648,135.0,115.0,3750.0,0.0,1.0,<2 mo. follow-up,2.65625
84.91394,male,0.0,CHF,16.0,under $11k,42792.0,white,yes,0.5,0.25,no dnr,16.0,73.0,10.2988281,74.0,22.0,36.0,204.75,2.8999023,0.89990234,1.5,137.0,7.469727,135.0,36.0,1000.0,6.0,2.0,<2 mo. follow-up,2.0
57.28998,male,1.0,MOSF w/Malig,14.0,>$50k,433153.0,white,yes,0.599999905,0.1999999,dnr after sadm,19.0,142.0,1.79980469,130.0,36.0,36.0,297.125,2.8999023,2.0,0.79992676,138.0,7.429688,186.0,34.0,4203.0,0.0,0.0,<2 mo. follow-up,0.0
62.741,male,0.0,Cirrhosis,12.0,$11-$25k,17289.0,hispanic,no,0.899999619,0.7999997,no dnr,6.0,63.0,9.19921875,64.0,12.0,36.0,224.0,2.199707,3.79980469,0.89990234,133.0,7.419922,135.0,23.0,1150.0,1.0,1.0,no(M2 and SIP pres),1.1667481
73.91595,female,0.0,Colon Cancer,12.0,under $11k,37120.0,white,metastatic,0.299999952,0.09999996,no dnr,19.0,73.0,8.3984375,118.0,30.0,38.39844,224.0,2.0,2.19970703,0.69995117,133.0,7.419922,139.0,12.0,1410.0,0.0,5.0,<2 mo. follow-up,5.0
62.34598,male,1.0,ARF/MOSF w/Sepsis,14.0,$25-$50k,54050.0,white,no,0.599999905,0.5999999,no dnr,5.0,45.0,24.3984375,75.0,27.0,39.79688,115.0,2.0,1.79980469,1.19995117,146.0,7.55957,145.0,56.0,2540.0,0.0,0.0,<2 mo. follow-up,0.0
19.765,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,25024.0,hispanic,no,0.25,0.25,no dnr,6.0,45.0,18.796875,145.0,40.0,38.39844,402.8125,2.8999023,0.89990234,1.69995117,135.0,7.369141,302.0,71.0,1707.0,0.0,1.0,<2 mo. follow-up,2.1357422
62.965,male,0.0,CHF,12.0,under $11k,32473.0,white,no,0.949999809,0.9499998,no dnr,11.0,115.0,8.5,75.0,20.0,36.0,224.0,2.8999023,0.19998169,4.69921875,139.0,7.419922,104.0,50.0,1175.0,0.0,1.0,<2 mo. follow-up,3.5175781
51.98398,male,0.0,Colon Cancer,14.0,>$50k,30678.0,white,metastatic,0.899999619,0.08999997,no dnr,10.0,110.0,6.79980469,105.0,10.0,38.39844,224.0,2.8999023,0.5,1.19995117,140.0,7.419922,169.0,23.0,740.0,0.0,0.0,<2 mo. follow-up,0.0
78.62,female,0.0,Lung Cancer,12.0,under $11k,20276.0,white,metastatic,0.5,0.15,dnr after sadm,2.0,77.0,14.0,68.0,26.0,36.59375,323.75,2.8999023,0.89990234,1.29980469,126.0,7.579102,100.0,20.0,600.0,1.0,1.0,<2 mo. follow-up,1.1667481
46.51898,female,1.0,Coma,12.0,under $11k,79492.0,black,yes,0.699999809,0.5,dnr after sadm,9.0,122.0,19.0976562,125.0,27.0,38.59375,205.0,2.8999023,0.89990234,5.0,127.0,7.30957,88.0,49.0,3620.0,0.0,1.0,<2 mo. follow-up,3.140625
60.16699,male,1.0,MOSF w/Malig,12.0,under $11k,142620.0,white,yes,0.5,0.25,dnr after sadm,9.0,48.0,0.39996338,175.0,25.0,39.79688,301.375,1.7998047,0.29998779,0.29998779,143.0,7.489258,154.0,9.0,2310.0,0.0,2.0,<2 mo. follow-up,2.0
33.01297,female,1.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,25024.0,white,no,0.699999809,0.5,dnr after sadm,4.0,117.0,4.0,120.0,54.0,38.5,490.0,2.0,28.5,2.59960938,153.0,7.429688,256.0,115.0,2500.0,0.0,1.0,<2 mo. follow-up,3.2822266
53.71899,male,1.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,651870.0,white,no,0.799999714,0.7999997,no dnr,73.0,45.0,13.8984375,105.0,10.0,38.29688,402.5,2.8999023,0.89990234,5.39941406,135.0,7.5,235.0,77.0,2.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
38.87698,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,282625.0,white,no,0.5,0.5,no dnr,60.0,112.0,12.2988281,125.0,14.0,38.19531,155.0,2.8999023,0.89990234,2.29980469,142.0,7.509766,291.0,23.0,1405.0,0.0,1.0,SIP>=30,3.0825195
61.689,male,0.0,Colon Cancer,12.0,under $11k,16468.0,white,metastatic,0.699999809,0.5,no dnr,9.0,83.0,6.09960938,80.0,22.0,38.29688,224.0,2.8999023,0.89990234,1.0,135.0,7.419922,135.0,16.0,4520.0,0.0,1.0,<2 mo. follow-up,2.4331055
69.125,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,64500.0,white,no,0.979999542,0.9499998,no dnr,8.0,105.0,10.6992188,120.0,28.0,36.0,134.6875,2.8999023,0.19998169,0.79992676,140.0,7.40918,135.0,23.0,540.0,0.0,2.0,no(M2 and SIP pres),2.0
30.98399,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,175051.0,white,no,0.799999714,0.6999998,no dnr,19.0,115.0,6.09960938,45.0,18.0,39.39844,43.0,2.8999023,2.09960938,1.09985352,144.0,7.449219,127.0,17.0,2915.0,0.0,1.0,<2 mo. follow-up,2.6137695
62.75998,female,0.0,ARF/MOSF w/Sepsis,16.0,under $11k,985215.0,white,no,0.5,0.3999999,no dnr,107.0,112.0,6.09960938,125.0,28.0,36.5,305.0,3.8999023,6.0,2.89990234,146.0,7.509766,349.0,59.0,0.0,0.0,0.0,<2 mo. follow-up,0.0
62.28897,male,0.0,Colon Cancer,12.0,under $11k,34721.0,white,metastatic,1.0,1.0,no dnr,9.0,63.0,10.5996094,62.0,20.0,38.39844,224.0,2.8999023,0.89990234,1.19995117,140.0,7.419922,135.0,23.0,1900.0,0.0,0.0,<2 mo. follow-up,0.0
38.94299,male,0.0,ARF/MOSF w/Sepsis,14.0,>$50k,147307.0,white,no,0.899999619,0.8999996,no dnr,12.0,108.0,17.6992188,115.0,28.0,36.0,304.0,1.8999023,8.8984375,1.19995117,135.0,7.399414,330.0,22.0,1360.0,0.0,5.0,adl>=4 (>=5 if sur),5.0
53.314,female,0.0,ARF/MOSF w/Sepsis,14.0,$25-$50k,517087.0,asian,no,0.5,0.3,no dnr,71.0,60.0,22.8984375,105.0,26.0,38.79688,257.5,2.8999023,16.0,1.09985352,137.0,7.479492,228.0,19.0,3079.0,0.0,1.0,SIP>=30,3.1201172
67.63898,male,0.0,Lung Cancer,12.0,under $11k,21057.0,white,metastatic,0.799999714,0.5,no dnr,9.0,103.0,9.5,76.0,22.0,36.39844,224.0,2.8999023,0.89990234,1.09985352,135.0,7.419922,135.0,12.0,2595.0,0.0,0.0,SIP>=30,0.0
57.34698,male,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,139549.0,hispanic,no,0.599999905,0.5999999,no dnr,16.0,55.0,14.3984375,120.0,36.0,37.0,140.0,2.699707,0.39996338,1.0,136.0,7.399414,508.0,23.0,4170.0,0.0,6.0,no(M2 and SIP pres),6.0
40.14798,male,0.0,ARF/MOSF w/Sepsis,16.0,$11-$25k,172266.0,white,no,0.699999809,0.5,no dnr,14.0,123.0,8.59960938,115.0,24.0,37.0,222.5,3.0996094,3.59960938,0.89990234,145.0,7.449219,154.0,61.0,3550.0,0.0,0.0,no(M2 and SIP pres),0.0
60.37,female,0.0,Colon Cancer,12.0,>$50k,8439.0,white,metastatic,0.799999714,0.5,no dnr,6.0,73.0,10.0,80.0,20.0,38.5,224.0,2.8999023,0.39996338,0.69995117,136.0,7.419922,99.0,6.0,3550.0,0.0,0.0,no(M2 and SIP pres),0.0
22.741,male,0.0,Coma,17.0,$25-$50k,150904.0,hispanic,no,0.299999952,0.3,no dnr,20.0,115.0,17.6992188,125.0,20.0,39.0,61.0,2.3999023,3.09960938,1.79980469,145.0,7.549805,93.0,32.0,3290.0,0.0,0.0,no(M2 and SIP pres),0.0
33.67798,female,1.0,ARF/MOSF w/Sepsis,14.0,under $11k,758539.0,black,no,0.799999714,0.7999997,no dnr,26.0,118.0,13.2988281,105.0,36.0,37.79688,255.0,2.8999023,16.796875,3.89990234,147.0,7.469727,350.0,66.0,3025.0,0.0,0.0,<2 mo. follow-up,0.0
71.29095,male,1.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,117388.0,black,no,0.5,0.5,no dnr,5.0,55.0,11.8984375,100.0,32.0,38.39844,131.65625,2.8999023,0.89990234,7.5,146.0,7.449219,199.0,65.0,753.0,0.0,1.0,<2 mo. follow-up,2.4750977
59.452,female,0.0,Colon Cancer,12.0,under $11k,27070.0,white,metastatic,1.0,0.5,no dnr,7.0,97.0,9.59960938,74.0,20.0,38.89844,224.0,2.8999023,0.89990234,1.0,135.0,7.419922,135.0,13.0,2025.0,0.0,2.0,no(M2 and SIP pres),2.0
74.97894,female,1.0,MOSF w/Malig,18.0,$25-$50k,60987.0,white,metastatic,0.199999928,0.04999998,dnr after sadm,4.0,42.0,13.0996094,105.0,25.0,35.5,121.65625,3.2998047,20.0,2.29980469,135.0,7.489258,178.0,21.0,18.0,0.0,2.0,<2 mo. follow-up,2.0
75.67999,male,1.0,MOSF w/Malig,16.0,$25-$50k,122270.0,white,yes,0.649999619,0.25,dnr after sadm,6.0,115.0,0.29998779,120.0,6.0,37.79688,205.0,2.8999023,0.89990234,1.59985352,140.0,7.5,183.0,29.0,3102.0,0.0,0.0,<2 mo. follow-up,0.0
65.26196,female,0.0,Lung Cancer,12.0,>$50k,35260.0,white,metastatic,0.699999809,0.5,no dnr,14.0,115.0,10.5,100.0,20.0,39.0,224.0,4.1992188,0.29998779,1.0,139.0,7.419922,91.0,13.0,2050.0,1.0,1.0,no(M2 and SIP pres),1.0
65.74896,female,0.0,CHF,12.0,$11-$25k,34253.0,white,no,0.649999619,0.5,no dnr,10.0,62.0,10.2988281,70.0,22.0,36.19531,224.0,3.2998047,1.89990234,1.29980469,132.0,7.419922,119.0,17.0,5395.0,5.0,1.0,<2 mo. follow-up,3.8549805
75.97296,male,0.0,CHF,16.0,$25-$50k,51180.0,white,no,0.799999714,0.5999999,no dnr,13.0,68.0,13.3984375,70.0,22.0,39.0,224.0,2.8999023,0.89990234,4.0,142.0,7.419922,150.0,34.0,50.0,3.0,3.0,<2 mo. follow-up,3.0
72.33899,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,146792.0,white,no,0.949999809,0.8999996,no dnr,23.0,132.0,19.296875,75.0,16.0,37.69531,293.875,2.8999023,0.89990234,0.59997559,135.0,7.389648,149.0,18.0,1615.0,0.0,1.0,<2 mo. follow-up,1.0
70.62299,male,0.0,Lung Cancer,12.0,$25-$50k,48292.0,white,metastatic,0.599999905,0.1999999,no dnr,15.0,93.0,25.0976562,104.0,20.0,36.59375,224.0,3.2998047,0.29998779,1.29980469,129.0,7.419922,148.0,19.0,3250.0,0.0,0.0,<2 mo. follow-up,0.0
61.80698,female,0.0,COPD,20.0,>$50k,17086.0,white,yes,0.799999714,0.5999999,no dnr,9.0,73.0,10.0996094,102.0,32.0,35.79688,266.625,2.8999023,0.89990234,1.0,131.0,7.389648,135.0,17.0,2400.0,1.0,0.0,<2 mo. follow-up,0.0
68.758,female,0.0,Colon Cancer,16.0,under $11k,24338.0,white,metastatic,0.899999619,0.3999999,no dnr,9.0,79.0,8.5,76.0,36.0,40.5,224.0,2.8999023,0.59997559,0.69995117,136.0,7.419922,122.0,4.0,4450.0,0.0,0.0,<2 mo. follow-up,0.0
32.616,female,0.0,CHF,12.0,$11-$25k,8228.0,white,no,0.699999809,0.6999998,no dnr,4.0,67.0,7.89941406,120.0,26.0,37.5,224.0,2.8999023,0.89990234,1.29980469,139.0,7.419922,113.0,14.0,2150.0,0.0,0.0,no(M2 and SIP pres),0.0
78.48596,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,168174.0,white,no,0.899999619,0.7999997,no dnr,33.0,115.0,14.0,65.0,36.0,36.79688,320.0,2.8999023,0.89990234,0.5,125.0,7.55957,101.0,17.0,1660.0,0.0,1.0,<2 mo. follow-up,3.2768555
41.64798,female,0.0,Colon Cancer,14.0,>$50k,16011.0,white,metastatic,0.799999714,0.3,no dnr,6.0,77.0,10.5996094,76.0,22.0,37.69531,224.0,2.8999023,0.89990234,1.19995117,140.0,7.419922,135.0,23.0,1350.0,0.0,0.0,<2 mo. follow-up,0.0
55.58398,female,0.0,MOSF w/Malig,11.0,$11-$25k,25024.0,white,metastatic,0.5,0.5,no dnr,9.0,130.0,19.5,125.0,24.0,37.59375,81.10938,1.6999512,7.79980469,0.69995117,126.0,7.349609,188.0,22.0,6865.0,0.0,1.0,SIP>=30,2.9018555
64.32898,male,0.0,Lung Cancer,12.0,under $11k,7735.0,white,metastatic,0.899999619,0.7999997,no dnr,4.0,69.0,14.2988281,66.0,18.0,36.59375,224.0,2.8999023,0.89990234,1.19995117,141.0,7.419922,85.0,28.0,1968.0,0.0,1.0,<2 mo. follow-up,2.3125
77.77698,female,1.0,Coma,16.0,under $11k,63572.0,white,no,0.199999928,0.15,dnr after sadm,7.0,52.0,6.69921875,150.0,20.0,38.09375,164.0,3.0996094,0.5,3.29980469,132.0,7.379883,273.0,70.0,4352.0,0.0,1.0,<2 mo. follow-up,1.0
82.98999,male,0.0,CHF,8.0,$11-$25k,51711.0,white,no,0.799999714,0.6999998,no dnr,12.0,73.0,9.5,60.0,28.0,36.19531,224.0,3.8999023,1.0,1.89990234,139.0,7.419922,113.0,32.0,4750.0,0.0,0.0,no(M2 and SIP pres),0.0
72.77496,female,0.0,CHF,12.0,under $11k,28137.0,black,yes,0.849999905,0.75,no dnr,9.0,115.0,5.09960938,60.0,20.0,36.59375,224.0,2.8999023,0.79992676,0.79992676,135.0,7.419922,120.0,17.0,1170.0,3.0,4.0,adl>=4 (>=5 if sur),4.0
70.04498,female,0.0,COPD,9.0,under $11k,119685.0,black,no,0.599999905,0.5,no dnr,18.0,112.0,14.3984375,115.0,26.0,38.0,237.5,2.8999023,0.89990234,1.19995117,148.0,7.349609,330.0,22.0,982.0,0.0,5.0,adl>=4 (>=5 if sur),5.0
43.93198,male,0.0,ARF/MOSF w/Sepsis,16.0,under $11k,57142.0,white,no,0.899999619,0.8999996,no dnr,9.0,118.0,15.1992188,95.0,40.0,38.5,111.65625,2.8999023,0.89990234,2.89990234,151.0,7.15918,161.0,16.0,8115.0,0.0,1.0,no(M2 and SIP pres),1.0
70.61694,female,0.0,Coma,14.0,$25-$50k,75372.0,white,no,0.149999976,0.09999996,dnr after sadm,2.0,60.0,9.5,115.0,9.0,38.0,380.0,2.7998047,0.5,0.69995117,139.0,7.419922,150.0,5.0,1940.0,0.0,7.0,<2 mo. follow-up,7.0
38.07797,female,0.0,MOSF w/Malig,16.0,$11-$25k,51241.0,white,metastatic,0.96999979,0.6999998,no dnr,4.0,67.0,9.3984375,108.0,24.0,35.79688,410.0,2.199707,0.59997559,1.39990234,131.0,7.399414,104.0,37.0,2850.0,0.0,1.0,<2 mo. follow-up,2.4296875
38.90997,female,0.0,Cirrhosis,11.0,under $11k,19379.0,white,no,0.949999809,0.9499998,no dnr,5.0,72.0,6.5,75.0,24.0,37.59375,224.0,2.8999023,6.39941406,0.29998779,136.0,7.419922,89.0,6.0,2519.0,0.0,0.0,SIP>=30,0.0
27.29099,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,50203.0,white,no,0.75,0.75,no dnr,11.0,107.0,16.796875,125.0,35.0,39.39844,96.0,3.5996094,0.29998779,2.39990234,144.0,7.429688,128.0,28.0,1741.0,0.0,1.0,<2 mo. follow-up,3.1616211
20.85399,male,0.0,CHF,15.0,>$50k,20579.0,hispanic,no,0.799999714,0.6999998,no dnr,8.0,52.0,8.69921875,125.0,16.0,36.09375,224.0,2.8999023,1.0,1.59985352,137.0,7.419922,92.0,30.0,2825.0,0.0,0.0,no(M2 and SIP pres),0.0
55.767,male,0.0,Lung Cancer,12.0,under $11k,30453.0,white,metastatic,0.899999619,0.5,no dnr,10.0,52.0,14.7988281,112.0,32.0,39.69531,224.0,2.0,0.69995117,1.19995117,132.0,7.419922,85.0,19.0,1630.0,0.0,1.0,<2 mo. follow-up,3.7163086
42.09399,female,0.0,Lung Cancer,12.0,under $11k,43422.0,black,metastatic,0.949999809,0.5999999,no dnr,12.0,81.0,14.0,120.0,16.0,36.39844,224.0,4.1992188,0.09999084,1.0,139.0,7.419922,97.0,7.0,2220.0,2.0,3.0,<2 mo. follow-up,3.0
78.81995,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,436904.0,white,no,0.5,0.5,dnr after sadm,11.0,128.0,10.3984375,120.0,12.0,37.59375,143.75,2.7998047,0.89990234,2.69970703,146.0,7.40918,62.0,58.0,4600.0,0.0,6.0,<2 mo. follow-up,6.0
65.74695,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,130357.0,white,yes,0.799999714,0.3,no dnr,21.0,67.0,13.5996094,55.0,8.0,38.0,105.09375,2.8999023,20.0976562,1.29980469,135.0,7.5,135.0,23.0,4017.0,0.0,1.0,<2 mo. follow-up,3.0336914
50.01199,male,0.0,Lung Cancer,16.0,>$50k,9518.0,black,metastatic,0.799999714,0.6499996,dnr after sadm,2.0,69.0,55.0,76.0,20.0,36.39844,224.0,2.8999023,0.89990234,0.69995117,133.0,7.419922,135.0,20.0,2050.0,5.0,1.0,<2 mo. follow-up,3.8549805
23.24699,male,1.0,MOSF w/Malig,12.0,>$50k,419195.0,white,yes,0.199999928,0.09999996,no dnr,23.0,67.0,0.04999542,145.0,42.0,38.39844,144.875,2.8999023,8.69921875,1.69995117,145.0,7.289062,598.0,69.0,3920.0,0.0,0.0,<2 mo. follow-up,0.0
38.418,male,0.0,ARF/MOSF w/Sepsis,11.0,under $11k,257291.0,white,no,0.699999809,0.5,no dnr,34.0,65.0,12.5996094,55.0,16.0,39.0,160.0,2.8999023,0.89990234,0.79992676,133.0,7.459961,102.0,20.0,2745.0,0.0,1.0,<2 mo. follow-up,2.7998047
91.25299,female,0.0,CHF,14.0,under $11k,23547.0,white,no,0.899999619,0.7999997,no dnr,6.0,55.0,8.69921875,50.0,16.0,36.0,236.71875,2.8999023,0.89990234,1.69995117,125.0,7.139648,109.0,36.0,1475.0,0.0,0.0,<2 mo. follow-up,0.0
45.31097,male,0.0,Colon Cancer,12.0,$11-$25k,32838.0,white,metastatic,0.799999714,0.5,no dnr,11.0,125.0,7.89941406,74.0,22.0,38.5,224.0,2.8999023,2.39990234,0.69995117,140.0,7.419922,111.0,10.0,1800.0,0.0,1.0,<2 mo. follow-up,1.0
49.16898,male,0.0,ARF/MOSF w/Sepsis,13.0,$25-$50k,59761.0,white,no,0.699999809,0.5,dnr after sadm,2.0,55.0,14.7988281,115.0,20.0,36.29688,479.5625,3.0996094,0.89990234,6.79980469,130.0,7.349609,135.0,43.0,0.0,5.0,3.0,<2 mo. follow-up,3.0
27.058,male,1.0,ARF/MOSF w/Sepsis,16.0,under $11k,194402.0,white,no,0.25,0.25,dnr after sadm,10.0,38.0,5.79980469,165.0,14.0,35.5,118.75,2.8999023,4.69921875,5.5,148.0,7.089844,9.0,28.0,206.0,0.0,0.0,<2 mo. follow-up,0.0
65.99896,male,0.0,Colon Cancer,18.0,$25-$50k,3792.0,black,metastatic,0.25,0.04999998,no dnr,5.0,77.0,6.29980469,64.0,24.0,36.39844,224.0,3.7998047,1.39990234,1.29980469,124.0,7.419922,121.0,15.0,1935.0,0.0,1.0,<2 mo. follow-up,0.494751
70.03699,female,0.0,Lung Cancer,14.0,under $11k,14609.0,black,metastatic,0.199999928,0.0,dnr after sadm,1.0,73.0,10.6992188,136.0,32.0,39.09375,224.0,2.8999023,0.89990234,0.59997559,126.0,7.419922,162.0,8.0,2200.0,3.0,5.0,<2 mo. follow-up,5.0
60.504,male,1.0,Cirrhosis,13.0,under $11k,49985.0,white,no,0.299999952,0.15,dnr after sadm,8.0,62.0,15.1992188,60.0,22.0,36.39844,224.0,2.3999023,19.796875,3.39990234,145.0,7.419922,188.0,131.0,700.0,0.0,1.0,<2 mo. follow-up,3.0488281
29.53299,male,0.0,MOSF w/Malig,17.0,under $11k,102427.0,black,yes,0.899999619,0.5999999,no dnr,28.0,81.0,5.59960938,125.0,22.0,36.79688,224.0,2.8999023,0.89990234,1.29980469,138.0,7.419922,135.0,12.0,3000.0,0.0,1.0,<2 mo. follow-up,0.494751
53.07599,female,0.0,CHF,16.0,>$50k,29187.0,hispanic,metastatic,0.799999714,0.5999999,no dnr,7.0,55.0,8.69921875,100.0,18.0,36.0,224.0,2.8999023,1.5,0.79992676,135.0,7.419922,86.0,10.0,2080.0,1.0,4.0,adl>=4 (>=5 if sur),4.0
67.784,female,1.0,ARF/MOSF w/Sepsis,18.0,under $11k,411846.0,white,no,0.899999619,0.8999996,dnr after sadm,49.0,65.0,17.1992188,65.0,8.0,37.69531,351.0,2.699707,3.09960938,1.09985352,139.0,7.55957,94.0,9.0,1625.0,0.0,2.0,<2 mo. follow-up,2.0
53.26199,female,1.0,ARF/MOSF w/Sepsis,12.0,>$50k,203408.0,white,no,0.299999952,0.3,dnr after sadm,7.0,72.0,5.29980469,125.0,12.0,35.39844,85.0,2.8999023,12.0996094,1.59985352,143.0,7.419922,332.0,66.0,140.0,0.0,5.0,<2 mo. follow-up,5.0
59.17599,female,1.0,Coma,15.0,$25-$50k,31803.0,white,no,0.099999964,0.09999996,dnr after sadm,3.0,141.0,1.29980469,125.0,32.0,38.59375,207.5,2.0996094,0.59997559,0.69995117,137.0,7.519531,207.0,27.0,1448.0,0.0,0.0,<2 mo. follow-up,0.0
47.21997,male,0.0,CHF,14.0,under $11k,14827.0,white,no,0.849999905,0.7999997,no dnr,7.0,75.0,5.89941406,75.0,32.0,37.5,224.0,2.8999023,0.89990234,1.5,138.0,7.419922,102.0,19.0,2100.0,4.0,3.0,adl>=4 (>=5 if sur),3.0
54.021,male,0.0,Lung Cancer,12.0,under $11k,6533.0,white,metastatic,0.5,0.5,no dnr,4.0,65.0,3.89990234,56.0,12.0,38.0,224.0,2.8999023,0.29998779,0.89990234,140.0,7.419922,135.0,13.0,1225.0,0.0,1.0,<2 mo. follow-up,2.4956055
81.25397,female,0.0,Lung Cancer,12.0,$11-$25k,15945.0,white,metastatic,0.399999857,0.04999998,dnr after sadm,1.0,81.0,10.5996094,76.0,28.0,36.59375,224.0,2.8999023,0.89990234,1.19995117,140.0,7.419922,135.0,23.0,2800.0,3.0,4.0,adl>=4 (>=5 if sur),4.0
91.43896,female,0.0,ARF/MOSF w/Sepsis,14.0,>$50k,68103.0,white,no,0.399999857,0.09999996,dnr after sadm,7.0,75.0,9.5,75.0,37.0,36.5,562.75,2.0996094,0.5,1.09985352,134.0,7.599609,202.0,24.0,670.0,0.0,6.0,adl>=4 (>=5 if sur),6.0
65.31696,male,0.0,ARF/MOSF w/Sepsis,16.0,>$50k,80470.0,white,no,0.5,0.25,no dnr,3.0,65.0,12.0,65.0,22.0,37.59375,134.53125,2.2998047,0.89990234,9.3984375,132.0,7.389648,322.0,103.0,0.0,0.0,2.0,<2 mo. follow-up,2.0
48.94998,female,0.0,CHF,12.0,under $11k,12684.0,hispanic,no,0.949999809,0.9499998,no dnr,5.0,107.0,6.89941406,105.0,22.0,36.0,224.0,2.8999023,0.89990234,0.79992676,136.0,7.419922,105.0,12.0,2470.0,0.0,1.0,no(M2 and SIP pres),0.494751
54.853,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,272366.0,white,no,0.699999809,0.5,no dnr,37.0,72.0,8.5,125.0,26.0,39.39844,174.0,2.8999023,3.0,1.69995117,142.0,7.489258,122.0,32.0,3411.0,0.0,1.0,<2 mo. follow-up,3.4838867
75.16797,female,0.0,MOSF w/Malig,14.0,$25-$50k,31213.0,asian,metastatic,0.149999976,0.09999996,dnr after sadm,2.0,109.0,14.1992188,125.0,14.0,36.29688,357.125,2.8999023,0.89990234,1.09985352,125.0,7.479492,342.0,15.0,1656.0,0.0,4.0,<2 mo. follow-up,4.0
70.16296,male,0.0,CHF,16.0,$25-$50k,159568.0,white,no,0.699999809,0.5,no dnr,27.0,53.0,5.5,105.0,18.0,36.5,224.0,2.8999023,0.89990234,2.09960938,134.0,7.419922,107.0,29.0,3490.0,0.0,0.0,no(M2 and SIP pres),0.0
91.08795,female,0.0,ARF/MOSF w/Sepsis,20.0,>$50k,34662.0,white,no,0.599999905,0.5,dnr after sadm,1.0,110.0,11.7988281,105.0,33.0,38.0,330.0,2.8999023,0.89990234,0.89990234,145.0,7.589844,220.0,11.0,650.0,0.0,0.0,<2 mo. follow-up,0.0
50.76797,male,1.0,ARF/MOSF w/Sepsis,19.0,>$50k,312860.0,white,no,0.0,0.0,dnr after sadm,2.0,58.0,11.3984375,70.0,35.0,36.79688,109.07812,2.199707,19.796875,3.69970703,148.0,7.609375,206.0,50.0,0.0,0.0,0.0,<2 mo. follow-up,0.0
29.77399,male,0.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,333521.0,white,no,0.349999905,0.3499999,no dnr,36.0,65.0,25.296875,120.0,45.0,36.89844,168.0,2.199707,7.09960938,1.79980469,155.0,7.479492,184.0,53.0,1665.0,0.0,0.0,no(M2 and SIP pres),0.0
63.37,male,1.0,ARF/MOSF w/Sepsis,11.0,under $11k,65661.0,hispanic,no,0.5,0.5,dnr after sadm,5.0,55.0,6.19921875,55.0,24.0,36.0,80.0,3.2998047,42.0,4.59960938,145.0,7.199219,347.0,56.0,105.0,0.0,7.0,<2 mo. follow-up,7.0
38.80399,female,1.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,407955.0,hispanic,no,0.399999857,0.3999999,dnr after sadm,15.0,70.0,1.39990234,65.0,30.0,36.39844,287.5,2.3999023,24.296875,1.29980469,141.0,7.40918,167.0,51.0,1713.0,0.0,5.0,<2 mo. follow-up,5.0
77.50598,female,0.0,COPD,12.0,under $11k,32303.0,white,no,0.5,0.1999999,dnr before sadm,-1.0,70.0,11.2988281,68.0,22.0,37.5,250.0,2.8999023,1.29980469,0.69995117,145.0,7.429688,135.0,23.0,810.0,0.0,1.0,<2 mo. follow-up,4.3789062
65.90796,female,0.0,Colon Cancer,17.0,>$50k,9327.0,white,metastatic,0.899999619,0.5999999,no dnr,6.0,85.0,9.19921875,82.0,20.0,36.59375,224.0,3.199707,0.59997559,0.79992676,139.0,7.419922,135.0,9.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.984375
23.84399,female,0.0,MOSF w/Malig,15.0,$11-$25k,215913.0,hispanic,yes,0.799999714,0.6999998,no dnr,29.0,82.0,0.04999542,150.0,24.0,38.39844,224.0,2.8999023,0.89990234,0.79992676,137.0,7.419922,135.0,6.0,2250.0,0.0,0.0,no(M2 and SIP pres),0.0
58.724,male,1.0,ARF/MOSF w/Sepsis,20.0,>$50k,461154.0,white,no,0.5,0.5,dnr after sadm,19.0,58.0,9.8984375,115.0,26.0,39.0,116.0,2.7998047,8.5,2.09960938,139.0,7.149414,71.0,55.0,160.0,0.0,0.0,<2 mo. follow-up,0.0
79.71497,female,0.0,ARF/MOSF w/Sepsis,12.0,>$50k,241269.0,white,yes,0.75,0.6999998,no dnr,24.0,58.0,12.6992188,75.0,30.0,36.39844,268.0,2.699707,0.29998779,1.59985352,132.0,7.419922,164.0,30.0,3510.0,0.0,0.0,no(M2 and SIP pres),0.0
48.81897,male,1.0,Lung Cancer,16.0,under $11k,14258.0,black,metastatic,0.0,0.0,dnr after sadm,3.0,101.0,6.59960938,146.0,22.0,38.39844,120.40625,3.199707,0.19998169,0.89990234,141.0,7.429688,144.0,19.0,2600.0,0.0,4.0,<2 mo. follow-up,4.0
41.98798,male,0.0,ARF/MOSF w/Sepsis,14.0,>$50k,501348.0,white,no,0.599999905,0.5999999,no dnr,16.0,58.0,11.8984375,135.0,10.0,38.69531,252.5,4.6992188,1.09985352,6.09960938,139.0,7.40918,247.0,90.0,0.0,0.0,0.0,SIP>=30,0.0
79.04199,male,1.0,ARF/MOSF w/Sepsis,14.0,under $11k,274616.0,white,no,0.099999964,0.09999996,dnr after sadm,9.0,62.0,12.1992188,115.0,14.0,38.39844,105.0,2.8999023,11.2988281,1.19995117,138.0,7.449219,201.0,32.0,1925.0,0.0,0.0,<2 mo. follow-up,0.0
44.616,male,0.0,CHF,16.0,under $11k,71501.0,white,no,0.799999714,0.5999999,no dnr,16.0,42.0,7.5,105.0,14.0,36.0,224.0,3.0,3.19970703,1.09985352,126.0,7.419922,106.0,19.0,2625.0,4.0,5.0,<2 mo. follow-up,5.0
24.21899,male,1.0,MOSF w/Malig,13.0,under $11k,106744.0,black,yes,0.019999996,0.0,dnr after sadm,2.0,5.0,5.09960938,0.0,35.0,36.09375,420.0,2.8999023,0.89990234,4.89941406,138.0,7.069336,135.0,47.0,88.0,0.0,0.0,<2 mo. follow-up,0.0
66.146,male,1.0,CHF,17.0,$25-$50k,44384.0,white,no,0.699999809,0.5,no dnr,7.0,52.0,9.8984375,65.0,16.0,36.0,224.0,3.3999023,1.79980469,1.89990234,126.0,7.419922,204.0,51.0,650.0,0.0,0.0,<2 mo. follow-up,0.0
58.53,female,0.0,CHF,12.0,under $11k,8325.0,asian,no,0.799999714,0.6999998,no dnr,5.0,53.0,6.79980469,115.0,20.0,36.39844,224.0,3.8999023,2.19970703,2.0,136.0,7.419922,171.0,49.0,4050.0,0.0,1.0,<2 mo. follow-up,1.0
41.54999,male,0.0,CHF,21.0,under $11k,31741.0,white,no,0.799999714,0.6999998,no dnr,8.0,55.0,6.89941406,115.0,16.0,36.0,224.0,3.5996094,1.29980469,1.19995117,132.0,7.419922,88.0,13.0,3300.0,0.0,1.0,no(M2 and SIP pres),0.494751
75.146,female,0.0,Colon Cancer,12.0,under $11k,22930.0,white,metastatic,0.699999809,0.5,no dnr,8.0,72.0,10.3984375,84.0,20.0,37.79688,224.0,3.7998047,0.39996338,0.69995117,136.0,7.419922,147.0,7.0,1025.0,0.0,1.0,<2 mo. follow-up,2.5004883
21.922,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,407547.0,hispanic,no,0.5,0.5,no dnr,37.0,67.0,15.3984375,140.0,16.0,38.0,162.5,2.8999023,0.29998779,0.79992676,135.0,7.5,194.0,39.0,4920.0,0.0,1.0,no(M2 and SIP pres),2.0605469
58.09998,female,1.0,MOSF w/Malig,12.0,under $11k,197978.0,white,yes,0.099999964,0.04999998,dnr after sadm,2.0,37.0,0.19998169,115.0,4.0,36.79688,310.0,2.8999023,5.59960938,1.89990234,139.0,7.219727,211.0,74.0,114.0,0.0,1.0,<2 mo. follow-up,2.9145508
89.77997,male,1.0,Coma,12.0,under $11k,19078.0,white,no,0.699999809,0.5,dnr after sadm,1.0,78.0,17.296875,80.0,9.0,38.5,237.5,2.8999023,0.89990234,1.19995117,149.0,7.449219,107.0,39.0,350.0,0.0,1.0,<2 mo. follow-up,5.6455078
60.61298,male,0.0,CHF,12.0,$11-$25k,42604.0,hispanic,no,0.799999714,0.5999999,no dnr,12.0,55.0,5.79980469,45.0,16.0,36.19531,224.0,4.1992188,0.5,1.59985352,133.0,7.419922,119.0,25.0,2770.0,0.0,0.0,no(M2 and SIP pres),0.0
52.87097,male,0.0,ARF/MOSF w/Sepsis,11.0,$25-$50k,509887.0,white,no,0.599999905,0.5999999,no dnr,54.0,125.0,7.89941406,105.0,42.0,38.0,224.0,2.3999023,9.0,0.69995117,135.0,7.419922,184.0,45.0,2080.0,0.0,2.0,adl>=4 (>=5 if sur),2.0
94.55194,male,1.0,ARF/MOSF w/Sepsis,16.0,$11-$25k,40533.0,white,no,0.0,0.0,dnr after sadm,3.0,13.0,11.0996094,45.0,8.0,35.59375,202.5,3.2998047,3.19970703,2.0,147.0,7.329102,205.0,49.0,360.0,0.0,0.0,<2 mo. follow-up,0.0
29.53,female,0.0,ARF/MOSF w/Sepsis,15.0,$11-$25k,89501.0,asian,no,1.0,1.0,no dnr,32.0,65.0,28.1992188,74.0,22.0,36.59375,612.0,1.0998535,0.89990234,1.39990234,127.0,7.399414,158.0,38.0,600.0,0.0,0.0,SIP>=30,0.0
75.10999,male,0.0,Lung Cancer,14.0,$25-$50k,8323.0,asian,metastatic,0.5,0.15,dnr before sadm,-1.0,73.0,8.29882812,128.0,30.0,35.59375,224.0,2.8999023,0.89990234,2.09960938,135.0,7.419922,152.0,31.0,1475.0,2.0,1.0,<2 mo. follow-up,1.8388672
83.13495,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,47079.0,hispanic,yes,0.199999928,0.04999998,dnr after sadm,2.0,103.0,25.8984375,130.0,20.0,39.5,372.0,2.3999023,21.796875,1.39990234,140.0,7.419922,135.0,27.0,2900.0,0.0,1.0,<2 mo. follow-up,3.7661133
38.93799,male,1.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,1045982.0,hispanic,no,0.5,0.3,dnr after sadm,51.0,78.0,3.29980469,140.0,48.0,38.79688,212.5,1.7998047,0.39996338,1.09985352,146.0,7.369141,150.0,24.0,3970.0,0.0,6.0,<2 mo. follow-up,6.0
61.70599,female,1.0,ARF/MOSF w/Sepsis,10.0,under $11k,60681.0,white,no,0.799999714,0.6999998,dnr after sadm,6.0,58.0,15.5,165.0,38.0,38.59375,162.5,2.8999023,13.0996094,4.69921875,149.0,7.619141,94.0,86.0,70.0,0.0,5.0,<2 mo. follow-up,5.0
49.32199,female,0.0,ARF/MOSF w/Sepsis,14.0,>$50k,193938.0,white,no,0.899999619,0.7999997,no dnr,15.0,56.0,5.19921875,130.0,32.0,36.39844,224.0,2.8999023,0.89990234,1.89990234,135.0,7.419922,135.0,58.0,3210.0,0.0,0.0,no(M2 and SIP pres),0.0
72.26794,male,0.0,ARF/MOSF w/Sepsis,14.0,$25-$50k,77088.0,white,yes,0.899999619,0.8999996,no dnr,19.0,68.0,7.69921875,55.0,24.0,36.59375,202.84375,3.199707,0.29998779,2.59960938,130.0,7.509766,135.0,55.0,2608.0,0.0,1.0,no(M2 and SIP pres),1.0
59.81897,female,0.0,CHF,11.0,$25-$50k,12972.0,black,no,0.899999619,0.7999997,no dnr,4.0,84.0,16.796875,66.0,26.0,36.79688,323.75,2.8999023,0.89990234,1.29980469,139.0,7.389648,107.0,26.0,4000.0,0.0,0.0,<2 mo. follow-up,0.0
79.98895,male,0.0,COPD,13.0,$25-$50k,17986.0,black,no,0.699999809,0.6999998,no dnr,6.0,74.0,3.79980469,102.0,20.0,37.59375,195.21875,2.8999023,0.39996338,2.39990234,141.0,7.30957,86.0,30.0,4820.0,0.0,1.0,SIP>=30,0.494751
67.35699,male,0.0,CHF,20.0,>$50k,36549.0,white,no,0.549999714,0.3999999,no dnr,8.0,58.0,9.69921875,95.0,14.0,36.09375,224.0,3.0996094,0.79992676,1.5,130.0,7.419922,108.0,24.0,3100.0,4.0,1.0,no(M2 and SIP pres),3.1831055
70.29199,female,0.0,CHF,13.0,under $11k,22123.0,black,no,0.799999714,0.6999998,no dnr,9.0,103.0,7.29980469,115.0,24.0,37.0,224.0,3.2998047,1.09985352,1.09985352,140.0,7.419922,135.0,15.0,1970.0,2.0,0.0,SIP>=30,0.0
77.42096,female,1.0,Coma,12.0,under $11k,93782.0,white,no,0.0,0.0,dnr before sadm,0.0,72.0,41.5,80.0,14.0,35.5,122.5,2.8999023,0.09999084,0.39996338,119.0,7.599609,127.0,27.0,84.0,0.0,1.0,<2 mo. follow-up,3.1269531
82.29395,male,0.0,Coma,12.0,under $11k,39770.0,white,no,0.5,0.5,no dnr,6.0,62.0,21.5,65.0,50.0,38.29688,271.375,2.199707,0.89990234,1.19995117,147.0,7.429688,215.0,30.0,1590.0,0.0,1.0,<2 mo. follow-up,2.8618164
56.02698,male,0.0,CHF,14.0,$11-$25k,32470.0,white,no,0.949999809,0.8999996,no dnr,18.0,90.0,10.0996094,120.0,20.0,36.79688,224.0,3.7998047,0.89990234,3.29980469,141.0,7.419922,105.0,37.0,4130.0,1.0,1.0,SIP>=30,1.1667481
64.88397,male,1.0,ARF/MOSF w/Sepsis,14.0,$25-$50k,221993.0,white,no,0.599999905,0.5,no dnr,13.0,48.0,15.6992188,95.0,22.0,36.79688,224.0,2.8999023,0.89990234,3.09960938,127.0,7.419922,135.0,60.0,100.0,0.0,5.0,<2 mo. follow-up,5.0
33.60699,male,0.0,Coma,16.0,>$50k,53325.0,asian,no,0.5,0.3,no dnr,18.0,135.0,18.0976562,150.0,9.0,38.59375,427.5,4.0996094,0.69995117,0.89990234,133.0,7.429688,144.0,15.0,1305.0,0.0,0.0,no(M2 and SIP pres),0.0
88.91199,female,0.0,Coma,17.0,$25-$50k,43891.0,black,no,0.5,0.25,no dnr,11.0,131.0,15.0996094,150.0,8.0,38.0,371.375,2.8999023,0.89990234,0.89990234,134.0,7.399414,135.0,12.0,1830.0,0.0,5.0,adl>=4 (>=5 if sur),5.0
54.81198,male,0.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,653743.0,black,no,0.949999809,0.9499998,no dnr,54.0,111.0,24.5,60.0,10.0,36.69531,520.0,2.0996094,0.19998169,0.79992676,133.0,7.299805,194.0,34.0,3080.0,0.0,0.0,no(M2 and SIP pres),0.0
66.49396,male,0.0,Colon Cancer,12.0,under $11k,28819.0,white,metastatic,1.0,0.8999996,no dnr,7.0,99.0,10.5996094,100.0,22.0,38.0,136.71875,2.8999023,0.89990234,1.09985352,129.0,7.459961,135.0,11.0,2640.0,0.0,1.0,<2 mo. follow-up,2.890625
52.22198,male,0.0,MOSF w/Malig,14.0,under $11k,73669.0,asian,yes,0.799999714,0.5,no dnr,16.0,78.0,5.59960938,115.0,30.0,38.29688,614.25,2.8999023,1.29980469,1.09985352,128.0,7.479492,145.0,24.0,2260.0,0.0,1.0,adl>=4 (>=5 if sur),1.0
72.07397,male,0.0,CHF,13.0,$11-$25k,22723.0,white,no,0.599999905,0.1999999,no dnr,6.0,68.0,2.5,115.0,28.0,36.0,224.0,2.8999023,0.89990234,3.09960938,132.0,7.419922,135.0,48.0,500.0,0.0,3.0,no(M2 and SIP pres),3.0
41.95499,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,495977.0,white,no,0.5,0.5,no dnr,44.0,68.0,22.296875,120.0,33.0,38.5,141.0,2.2998047,1.79980469,0.5,131.0,7.349609,102.0,10.0,2656.0,0.0,3.0,no(M2 and SIP pres),3.0
46.78699,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,494827.0,hispanic,no,0.5,0.5,no dnr,38.0,105.0,7.19921875,120.0,10.0,37.79688,435.0,2.8999023,24.0,3.5,145.0,7.479492,180.0,72.0,4645.0,0.0,6.0,no(M2 and SIP pres),6.0
74.46399,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,44037.0,white,no,0.899999619,0.7999997,dnr after sadm,5.0,40.0,28.8984375,75.0,36.0,35.19531,64.70312,3.0996094,0.89990234,6.89941406,125.0,7.479492,254.0,115.0,3345.0,1.0,1.0,<2 mo. follow-up,1.0
60.06799,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,838218.0,asian,no,0.5,0.3,no dnr,122.0,64.0,9.29882812,134.0,26.0,38.0,224.0,1.7998047,1.89990234,1.69995117,123.0,7.419922,152.0,53.0,1825.0,0.0,1.0,<2 mo. follow-up,3.109375
63.37,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,140411.0,hispanic,no,1.0,0.9499998,no dnr,19.0,72.0,8.69921875,60.0,34.0,37.89844,224.0,2.8999023,0.89990234,0.79992676,126.0,7.419922,135.0,28.0,1585.0,0.0,0.0,Coma or Intub,0.0
66.77594,male,0.0,CHF,12.0,under $11k,13271.0,white,yes,0.699999809,0.5999999,no dnr,7.0,77.0,6.59960938,78.0,24.0,36.59375,406.0625,2.8999023,0.89990234,2.89990234,131.0,7.449219,162.0,53.0,2500.0,0.0,1.0,<2 mo. follow-up,3.9477539
27.12099,female,0.0,ARF/MOSF w/Sepsis,20.0,$25-$50k,69535.0,hispanic,no,0.299999952,0.09999996,no dnr,17.0,63.0,5.5,122.0,32.0,35.79688,195.90625,1.7998047,0.19998169,0.69995117,128.0,7.389648,82.0,8.0,3660.0,1.0,2.0,<2 mo. follow-up,2.0
77.40497,female,0.0,Colon Cancer,18.0,>$50k,39468.0,white,metastatic,0.949999809,0.5,no dnr,11.0,81.0,18.6992188,76.0,20.0,38.19531,224.0,2.8999023,0.89990234,1.0,137.0,7.419922,171.0,8.0,3300.0,0.0,0.0,no(M2 and SIP pres),0.0
78.55695,male,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,487176.0,asian,no,0.75,0.75,no dnr,81.0,55.0,16.1992188,175.0,12.0,39.0,65.0,2.8999023,0.89990234,1.09985352,134.0,7.219727,121.0,21.0,1840.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
40.84598,male,0.0,Cirrhosis,13.0,$11-$25k,33793.0,white,no,0.799999714,0.3299999,no dnr,14.0,99.0,7.29980469,130.0,24.0,38.39844,224.0,2.699707,6.39941406,1.69995117,131.0,7.419922,199.0,21.0,740.0,1.0,1.0,<2 mo. follow-up,1.1667481
66.27496,male,0.0,MOSF w/Malig,14.0,under $11k,69356.0,black,metastatic,0.5,0.3,no dnr,10.0,130.0,12.7988281,124.0,24.0,36.0,150.0,2.8999023,0.89990234,1.29980469,145.0,7.449219,135.0,21.0,2100.0,0.0,1.0,<2 mo. follow-up,1.0
61.59598,male,0.0,CHF,15.0,>$50k,32311.0,white,no,0.899999619,0.7999997,no dnr,8.0,55.0,7.09960938,135.0,24.0,36.59375,224.0,2.8999023,0.89990234,1.29980469,135.0,7.419922,135.0,13.0,500.0,0.0,0.0,<2 mo. follow-up,0.0
88.18298,female,0.0,CHF,12.0,under $11k,25625.0,white,yes,0.5,0.1999999,no dnr,7.0,70.0,5.89941406,65.0,28.0,36.5,187.75,2.8999023,0.89990234,1.19995117,142.0,7.439453,179.0,17.0,1480.0,0.0,1.0,<2 mo. follow-up,4.9394531
59.48499,male,0.0,CHF,12.0,$25-$50k,52138.0,white,no,0.599999905,0.3999999,no dnr,12.0,63.0,10.8984375,125.0,30.0,36.0,238.09375,2.8999023,1.39990234,0.79992676,131.0,7.469727,120.0,22.0,1660.0,0.0,0.0,no(M2 and SIP pres),0.0
50.66898,male,0.0,Colon Cancer,12.0,under $11k,76684.0,white,metastatic,0.699999809,0.5,no dnr,21.0,71.0,7.69921875,72.0,24.0,36.39844,224.0,3.0,0.69995117,1.09985352,134.0,7.419922,85.0,13.0,2400.0,0.0,1.0,<2 mo. follow-up,2.7949219
29.02399,female,0.0,ARF/MOSF w/Sepsis,10.0,under $11k,25024.0,hispanic,no,0.199999928,0.1999999,no dnr,94.0,42.0,13.8984375,135.0,25.0,39.09375,128.0,2.8999023,22.796875,3.79980469,141.0,7.609375,72.0,57.0,0.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
76.80194,female,1.0,ARF/MOSF w/Sepsis,10.0,$11-$25k,1226766.0,white,no,0.5,0.5,dnr after sadm,13.0,55.0,13.2988281,70.0,10.0,38.79688,140.0,2.8999023,0.89990234,3.69970703,146.0,7.519531,135.0,67.0,0.0,0.0,0.0,Coma or Intub,0.0
83.93994,male,0.0,CHF,14.0,>$50k,79139.0,white,no,0.799999714,0.6999998,no dnr,10.0,62.0,12.1992188,75.0,8.0,38.09375,285.0,2.8999023,0.89990234,1.5,138.0,7.429688,255.0,38.0,2674.0,0.0,0.0,no(M2 and SIP pres),0.0
91.61896,male,0.0,Coma,12.0,under $11k,10709.0,white,no,0.199999928,0.15,dnr before sadm,-1.0,69.0,10.3984375,80.0,24.0,38.0,224.0,2.8999023,0.89990234,1.0,140.0,7.419922,135.0,10.0,1125.0,0.0,7.0,adl>=4 (>=5 if sur),7.0
29.76299,female,0.0,ARF/MOSF w/Sepsis,13.0,under $11k,296857.0,white,no,0.899999619,0.8999996,no dnr,42.0,112.0,12.6992188,115.0,35.0,38.09375,92.53125,3.7998047,0.89990234,7.29980469,147.0,7.269531,212.0,70.0,730.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
58.60599,female,0.0,ARF/MOSF w/Sepsis,15.0,>$50k,538323.0,asian,no,0.599999905,0.5,no dnr,25.0,57.0,10.0,115.0,34.0,37.79688,323.3125,4.0996094,1.5,2.0,128.0,7.5,156.0,58.0,2708.0,0.0,0.0,no(M2 and SIP pres),0.0
40.78,male,0.0,ARF/MOSF w/Sepsis,18.0,$11-$25k,105330.0,white,no,0.799999714,0.7999997,no dnr,19.0,58.0,5.0,115.0,10.0,38.89844,234.0,2.8999023,1.59985352,1.09985352,132.0,7.459961,76.0,12.0,3055.0,0.0,0.0,no(M2 and SIP pres),0.0
92.64294,male,1.0,ARF/MOSF w/Sepsis,18.0,under $11k,26196.0,white,no,0.099999964,0.09999996,dnr after sadm,1.0,33.0,27.0,165.0,15.0,36.0,98.32812,3.3999023,1.09985352,1.09985352,139.0,7.469727,135.0,20.0,45.0,0.0,0.0,<2 mo. follow-up,0.0
45.80197,female,0.0,ARF/MOSF w/Sepsis,16.0,>$50k,215484.0,hispanic,no,0.699999809,0.5,no dnr,21.0,57.0,22.5,65.0,25.0,39.19531,97.14062,3.3999023,0.59997559,1.09985352,128.0,7.449219,106.0,11.0,4770.0,0.0,1.0,no(M2 and SIP pres),2.2841797
54.52399,female,1.0,MOSF w/Malig,12.0,$25-$50k,263308.0,white,yes,0.099999964,0.04999998,no dnr,7.0,115.0,0.04999542,175.0,38.0,39.5,495.8125,2.699707,7.39941406,0.59997559,151.0,7.549805,183.0,24.0,2120.0,0.0,0.0,<2 mo. follow-up,0.0
77.85895,male,0.0,CHF,12.0,under $11k,13403.0,white,yes,0.799999714,0.6999998,no dnr,6.0,83.0,6.39941406,76.0,28.0,35.59375,224.0,3.5996094,1.29980469,1.59985352,140.0,7.419922,135.0,25.0,2075.0,0.0,1.0,<2 mo. follow-up,3.0351562
30.53799,male,0.0,Lung Cancer,20.0,>$50k,17851.0,white,metastatic,1.0,0.75,no dnr,5.0,101.0,16.6992188,100.0,20.0,36.19531,224.0,3.3999023,0.19998169,0.89990234,135.0,7.419922,86.0,11.0,7800.0,0.0,1.0,<2 mo. follow-up,0.494751
66.05597,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,283022.0,white,no,0.399999857,0.3999999,dnr after sadm,13.0,108.0,38.8984375,45.0,28.0,36.0,377.75,2.699707,5.19921875,6.79980469,133.0,7.509766,140.0,57.0,30.0,0.0,1.0,<2 mo. follow-up,3.1586914
49.42398,female,0.0,ARF/MOSF w/Sepsis,18.0,$25-$50k,809561.0,white,no,0.099999964,0.5,dnr after sadm,42.0,45.0,5.59960938,105.0,33.0,38.0,304.0,2.0996094,1.5,1.79980469,140.0,7.429688,126.0,66.0,2705.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
47.93399,female,0.0,MOSF w/Malig,16.0,$25-$50k,64713.0,asian,yes,0.949999809,0.6999998,no dnr,12.0,85.0,30.1992188,65.0,34.0,36.29688,86.65625,2.8999023,0.89990234,3.69970703,131.0,7.389648,119.0,41.0,1535.0,0.0,0.0,no(M2 and SIP pres),0.0
77.28998,male,0.0,CHF,12.0,$11-$25k,4408.0,white,no,0.899999619,0.7999997,no dnr,4.0,65.0,5.79980469,68.0,16.0,36.0,224.0,2.8999023,0.89990234,1.39990234,130.0,7.419922,135.0,26.0,3220.0,0.0,1.0,no(M2 and SIP pres),0.494751
58.14398,male,0.0,CHF,12.0,under $11k,32904.0,hispanic,no,0.799999714,0.6999998,no dnr,10.0,57.0,9.09960938,70.0,24.0,36.5,224.0,3.699707,0.59997559,1.79980469,136.0,7.419922,102.0,25.0,4050.0,0.0,1.0,no(M2 and SIP pres),0.494751
58.09399,male,0.0,MOSF w/Malig,14.0,under $11k,75939.0,white,metastatic,0.199999928,0.09999996,no dnr,13.0,62.0,13.3984375,120.0,20.0,36.39844,224.0,2.8999023,0.89990234,2.19970703,134.0,7.419922,72.0,54.0,1207.0,0.0,0.0,<2 mo. follow-up,0.0
69.79895,female,1.0,ARF/MOSF w/Sepsis,16.0,$11-$25k,99643.0,white,no,0.0,0.0,dnr after sadm,6.0,45.0,17.3984375,115.0,24.0,35.59375,130.96875,2.5,17.796875,2.39990234,129.0,7.459961,97.0,50.0,80.0,0.0,0.0,<2 mo. follow-up,0.0
24.98299,female,0.0,ARF/MOSF w/Sepsis,18.0,under $11k,37548.0,white,no,0.699999809,0.5,no dnr,11.0,105.0,7.39941406,125.0,24.0,36.59375,224.0,2.8999023,3.19970703,3.39990234,132.0,7.419922,102.0,98.0,2920.0,1.0,0.0,<2 mo. follow-up,0.0
67.98395,male,0.0,Lung Cancer,16.0,>$50k,31422.0,white,metastatic,0.799999714,0.3999999,no dnr,9.0,64.0,7.59960938,66.0,24.0,36.0,226.65625,2.8999023,0.89990234,1.39990234,131.0,7.519531,135.0,16.0,2770.0,2.0,1.0,<2 mo. follow-up,1.8388672
31.94299,female,0.0,CHF,12.0,$11-$25k,27706.0,white,no,0.949999809,0.8999996,no dnr,9.0,53.0,7.29980469,105.0,16.0,36.39844,224.0,3.7998047,0.19998169,0.79992676,138.0,7.419922,135.0,16.0,2250.0,2.0,2.0,<2 mo. follow-up,2.0
54.461,male,1.0,ARF/MOSF w/Sepsis,16.0,>$50k,256932.0,white,no,0.5,0.5,no dnr,15.0,107.0,44.796875,135.0,28.0,37.89844,356.625,2.8999023,12.7988281,3.59960938,142.0,7.519531,191.0,90.0,3875.0,0.0,3.0,<2 mo. follow-up,3.0
63.91199,female,0.0,CHF,18.0,>$50k,3241.0,white,no,0.949999809,0.6499996,no dnr,3.0,107.0,9.79882812,68.0,20.0,36.5,224.0,3.3999023,0.19998169,2.39990234,139.0,7.419922,151.0,48.0,875.0,4.0,1.0,<2 mo. follow-up,3.1831055
58.15698,male,0.0,CHF,12.0,under $11k,8082.0,white,no,0.699999809,0.5,no dnr,4.0,72.0,11.1992188,75.0,20.0,36.19531,224.0,2.8999023,0.59997559,1.29980469,139.0,7.419922,112.0,18.0,2390.0,0.0,1.0,no(M2 and SIP pres),2.4472656
48.05698,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,22509.0,black,no,0.899999619,0.8499999,no dnr,4.0,130.0,13.6992188,95.0,28.0,38.19531,323.75,2.8999023,0.5,3.5,137.0,7.449219,151.0,47.0,2140.0,0.0,1.0,<2 mo. follow-up,3.4160156
76.23798,male,0.0,CHF,16.0,$11-$25k,22612.0,white,no,0.949999809,0.8999996,no dnr,7.0,65.0,11.2988281,55.0,20.0,38.09375,173.46875,2.8999023,0.89990234,1.29980469,135.0,7.389648,276.0,25.0,1875.0,0.0,0.0,<2 mo. follow-up,0.0
50.29999,female,0.0,ARF/MOSF w/Sepsis,6.0,under $11k,589642.0,hispanic,no,0.5,0.5,no dnr,93.0,70.0,21.1992188,120.0,26.0,36.09375,115.54688,2.699707,38.09375,1.59985352,131.0,7.469727,212.0,51.0,2786.0,0.0,1.0,SIP>=30,3.1318359
32.25699,male,0.0,Colon Cancer,12.0,under $11k,15115.0,white,metastatic,1.0,1.0,no dnr,8.0,78.0,5.5,68.0,20.0,36.39844,224.0,2.8999023,0.89990234,1.19995117,140.0,7.419922,135.0,23.0,2150.0,0.0,1.0,<2 mo. follow-up,2.4589844
80.87299,female,0.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,47516.0,white,no,0.5,0.5,no dnr,13.0,68.0,9.19921875,65.0,28.0,38.5,112.23438,2.8999023,0.89990234,0.69995117,138.0,7.329102,179.0,9.0,900.0,0.0,7.0,<2 mo. follow-up,7.0
35.50198,female,0.0,ARF/MOSF w/Sepsis,14.0,under $11k,86275.0,black,no,0.299999952,0.3,no dnr,14.0,68.0,2.69970703,115.0,26.0,39.5,118.51562,3.3999023,2.19970703,1.19995117,136.0,7.539062,174.0,24.0,3550.0,0.0,1.0,no(M2 and SIP pres),3.8613281
65.32495,male,1.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,51732.0,white,no,0.199999928,0.09999996,no dnr,4.0,52.0,8.8984375,175.0,10.0,38.79688,204.0,2.8999023,22.1992188,4.29980469,140.0,7.319336,78.0,80.0,760.0,0.0,1.0,<2 mo. follow-up,3.1479492
67.72296,male,0.0,CHF,12.0,under $11k,10358.0,white,yes,0.799999714,0.6999998,no dnr,4.0,63.0,5.39941406,80.0,24.0,36.0,224.0,2.8999023,0.89990234,1.19995117,136.0,7.419922,100.0,33.0,1620.0,1.0,1.0,no(M2 and SIP pres),1.1667481
65.02899,female,0.0,Coma,12.0,under $11k,64130.0,white,yes,0.849999905,0.7999997,no dnr,7.0,98.0,12.7988281,55.0,28.0,37.89844,300.0,2.8999023,0.89990234,0.59997559,138.0,7.5,263.0,14.0,5420.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
84.25995,male,0.0,ARF/MOSF w/Sepsis,14.0,under $11k,26395.0,white,no,0.5,0.1999999,dnr before sadm,0.0,74.0,7.79980469,118.0,12.0,36.39844,224.0,2.8999023,0.89990234,1.59985352,136.0,7.419922,77.0,26.0,970.0,0.0,6.0,<2 mo. follow-up,6.0
34.47198,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,19858.0,white,no,0.899999619,0.8999996,no dnr,4.0,83.0,8.69921875,105.0,32.0,36.59375,247.59375,2.8999023,0.89990234,0.89990234,135.0,7.5,149.0,16.0,1000.0,0.0,1.0,<2 mo. follow-up,2.8930664
42.24197,male,0.0,CHF,13.0,under $11k,22158.0,white,no,1.0,0.9899998,no dnr,6.0,66.0,7.69921875,115.0,20.0,35.89844,224.0,3.7998047,1.79980469,0.89990234,133.0,7.419922,103.0,17.0,5250.0,0.0,0.0,<2 mo. follow-up,0.0
44.00299,male,0.0,Lung Cancer,12.0,$11-$25k,9377.0,hispanic,metastatic,0.849999905,0.5,no dnr,5.0,95.0,10.0996094,100.0,22.0,36.5,224.0,2.8999023,0.19998169,0.79992676,134.0,7.419922,135.0,13.0,1900.0,1.0,1.0,SIP>=30,1.1667481
87.48798,male,0.0,CHF,12.0,under $11k,102946.0,white,yes,0.699999809,0.5,no dnr,17.0,70.0,7.09960938,55.0,20.0,36.0,224.0,2.8999023,0.89990234,1.0,127.0,7.419922,182.0,16.0,880.0,0.0,1.0,<2 mo. follow-up,4.2802734
82.33496,female,1.0,Coma,14.0,$25-$50k,29987.0,white,no,0.199999928,0.04999998,dnr after sadm,2.0,113.0,36.09375,116.0,22.0,38.89844,224.0,2.8999023,0.89990234,0.89990234,136.0,7.419922,112.0,11.0,425.0,0.0,1.0,<2 mo. follow-up,5.5546875
56.58298,female,0.0,CHF,11.0,under $11k,150141.0,white,no,0.899999619,0.8499999,no dnr,24.0,72.0,6.5,75.0,16.0,36.19531,224.0,4.0,0.39996338,1.5,136.0,7.419922,87.0,29.0,3225.0,0.0,1.0,no(M2 and SIP pres),1.0
18.11899,male,1.0,MOSF w/Malig,12.0,under $11k,262520.0,white,yes,0.039999992,0.0,dnr after sadm,7.0,62.0,0.19998169,130.0,30.0,38.69531,347.8125,1.6999512,0.89990234,0.89990234,155.0,7.349609,135.0,27.0,5565.0,0.0,0.0,<2 mo. follow-up,0.0
67.61395,female,0.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,212194.0,white,no,0.199999928,0.02,no dnr,42.0,105.0,11.5996094,105.0,8.0,37.89844,308.5625,2.8999023,1.89990234,2.5,133.0,7.569336,584.0,39.0,4630.0,1.0,1.0,SIP>=30,1.0
39.53699,female,0.0,ARF/MOSF w/Sepsis,13.0,$25-$50k,50949.0,white,yes,0.989999771,0.9899998,no dnr,9.0,105.0,12.5,75.0,45.0,37.89844,128.5625,2.8999023,0.89990234,0.59997559,132.0,7.459961,124.0,7.0,2850.0,0.0,0.0,no(M2 and SIP pres),0.0
34.103,female,0.0,CHF,12.0,under $11k,401408.0,hispanic,no,0.849999905,0.75,no dnr,53.0,48.0,11.6992188,120.0,16.0,36.0,423.75,2.8999023,0.89990234,0.89990234,131.0,7.469727,107.0,17.0,2725.0,0.0,0.0,no(M2 and SIP pres),0.0
85.53595,male,1.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,49143.0,white,no,0.199999928,0.009999998,dnr after sadm,3.0,57.0,18.0976562,112.0,40.0,36.29688,171.40625,2.8999023,0.89990234,1.79980469,143.0,7.389648,160.0,33.0,1100.0,0.0,1.0,<2 mo. follow-up,5.8476562
73.26996,female,0.0,COPD,4.0,under $11k,16373.0,white,no,0.5,0.3,no dnr,6.0,62.0,16.0,64.0,24.0,36.19531,209.5,2.8999023,0.29998779,0.59997559,141.0,7.339844,139.0,11.0,1630.0,0.0,2.0,<2 mo. follow-up,2.0
48.42697,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,49165.0,white,no,0.949999809,0.9499998,no dnr,11.0,102.0,14.3984375,105.0,35.0,38.5,156.0,2.3999023,0.89990234,0.59997559,144.0,7.479492,154.0,8.0,3140.0,0.0,1.0,<2 mo. follow-up,3.7768555
61.37698,male,0.0,Cirrhosis,12.0,$25-$50k,341731.0,white,no,0.099999964,0.0,no dnr,49.0,53.0,14.0,110.0,24.0,36.5,148.96875,3.0,35.0,6.39941406,148.0,7.469727,109.0,71.0,450.0,0.0,1.0,SIP>=30,3.8950195
41.487,male,0.0,Colon Cancer,12.0,under $11k,37940.0,black,metastatic,0.699999809,0.5,no dnr,11.0,108.0,3.5,135.0,24.0,37.89844,224.0,4.5,0.89990234,1.29980469,139.0,7.419922,90.0,12.0,3021.0,0.0,1.0,<2 mo. follow-up,2.1621094
66.91595,male,1.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,178495.0,white,yes,0.5,0.3,dnr after sadm,15.0,102.0,17.296875,55.0,6.0,39.39844,224.0,2.8999023,0.89990234,0.89990234,125.0,7.419922,353.0,14.0,1433.0,0.0,1.0,<2 mo. follow-up,3.0839844
31.20299,male,0.0,ARF/MOSF w/Sepsis,17.0,$25-$50k,209845.0,other,no,1.0,1.0,no dnr,31.0,115.0,17.6992188,145.0,28.0,40.0,138.0,2.8999023,2.29980469,0.89990234,130.0,7.459961,113.0,7.0,4995.0,0.0,0.0,<2 mo. follow-up,0.0
73.00195,male,0.0,ARF/MOSF w/Sepsis,16.0,>$50k,50658.0,white,no,0.599999905,0.5999999,no dnr,8.0,62.0,8.19921875,70.0,30.0,38.39844,308.5625,2.8999023,1.09985352,1.19995117,129.0,7.449219,368.0,18.0,2450.0,1.0,1.0,no(M2 and SIP pres),1.0
27.187,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,110216.0,hispanic,no,0.699999809,0.6999998,no dnr,14.0,55.0,7.69921875,125.0,10.0,36.0,448.0,2.2998047,0.29998779,4.59960938,133.0,7.40918,597.0,59.0,220.0,0.0,1.0,no(M2 and SIP pres),1.0
50.064,male,0.0,CHF,12.0,under $11k,13088.0,white,no,0.699999809,0.5,no dnr,7.0,55.0,8.5,60.0,16.0,36.0,224.0,2.8999023,0.89990234,1.5,127.0,7.419922,135.0,31.0,3900.0,0.0,1.0,<2 mo. follow-up,2.3662109
41.42599,male,0.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,275961.0,white,no,0.799999714,0.7999997,no dnr,17.0,102.0,21.5976562,125.0,28.0,37.89844,387.5,2.0996094,4.89941406,0.39996338,142.0,7.479492,128.0,19.0,4210.0,2.0,2.0,no(M2 and SIP pres),2.0
69.25397,female,1.0,Coma,16.0,$11-$25k,52100.0,white,no,0.299999952,0.15,dnr after sadm,6.0,128.0,19.296875,115.0,8.0,38.0,423.0,2.8999023,0.89990234,1.79980469,133.0,7.489258,400.0,39.0,2720.0,0.0,0.0,<2 mo. follow-up,0.0
64.54498,male,0.0,CHF,9.0,under $11k,36225.0,white,no,0.75,0.6999998,no dnr,11.0,50.0,6.09960938,60.0,16.0,36.5,224.0,2.8999023,0.89990234,3.09960938,131.0,7.419922,135.0,65.0,1550.0,0.0,1.0,<2 mo. follow-up,3.2719727
47.30499,male,1.0,ARF/MOSF w/Sepsis,14.0,$11-$25k,570603.0,white,no,0.199999928,0.6999998,no dnr,5.0,62.0,5.89941406,145.0,32.0,39.19531,122.09375,2.5,13.6992188,2.5,145.0,7.489258,140.0,115.0,2515.0,0.0,1.0,<2 mo. follow-up,4.6552734
72.82697,male,0.0,CHF,12.0,$11-$25k,7619.0,black,no,0.699999809,0.5,no dnr,3.0,77.0,7.29980469,85.0,18.0,36.69531,224.0,2.8999023,0.79992676,1.89990234,138.0,7.419922,94.0,30.0,200.0,0.0,0.0,SIP>=30,0.0
78.90497,male,0.0,CHF,10.0,under $11k,19787.0,white,no,0.989999771,0.8999996,no dnr,6.0,62.0,6.5,115.0,24.0,36.19531,224.0,2.8999023,0.89990234,1.09985352,138.0,7.419922,135.0,12.0,1125.0,0.0,0.0,<2 mo. follow-up,0.0
53.45697,female,0.0,ARF/MOSF w/Sepsis,14.0,$25-$50k,148758.0,black,no,0.199999928,0.1999999,no dnr,19.0,62.0,11.7988281,105.0,15.0,38.5,246.65625,2.699707,36.0,3.79980469,134.0,7.5,130.0,61.0,6365.0,0.0,0.0,no(M2 and SIP pres),0.0
34.439,female,0.0,MOSF w/Malig,12.0,under $11k,53540.0,black,yes,0.799999714,0.6999998,no dnr,7.0,118.0,2.39990234,112.0,12.0,36.39844,189.0,2.8999023,0.59997559,1.29980469,134.0,7.529297,135.0,15.0,2200.0,0.0,0.0,<2 mo. follow-up,0.0
52.36099,male,0.0,CHF,14.0,under $11k,18956.0,white,no,0.799999714,0.5,no dnr,5.0,68.0,16.3984375,110.0,22.0,36.5,224.0,4.5996094,0.89990234,2.59960938,141.0,7.419922,139.0,125.0,4050.0,0.0,0.0,no(M2 and SIP pres),0.0
44.13699,female,0.0,Lung Cancer,17.0,$25-$50k,84983.0,white,metastatic,0.5,0.1999999,no dnr,13.0,92.0,13.0,110.0,26.0,35.59375,257.125,2.8999023,0.89990234,0.59997559,134.0,7.5,128.0,20.0,820.0,0.0,1.0,<2 mo. follow-up,3.5
77.53595,male,0.0,COPD,12.0,under $11k,100611.0,white,no,0.799999714,0.6999998,no dnr,12.0,57.0,18.296875,135.0,10.0,38.19531,164.0,2.8999023,0.69995117,1.59985352,140.0,7.459961,165.0,22.0,2691.0,0.0,1.0,<2 mo. follow-up,4.2373047
54.61697,male,0.0,Lung Cancer,14.0,$25-$50k,20575.0,white,metastatic,0.899999619,0.6999998,no dnr,8.0,79.0,0.29998779,60.0,22.0,38.0,224.0,2.8999023,0.89990234,0.69995117,126.0,7.419922,135.0,11.0,3250.0,0.0,2.0,no(M2 and SIP pres),2.0
63.767,male,1.0,ARF/MOSF w/Sepsis,14.0,$25-$50k,177499.0,white,yes,0.5,0.09999996,dnr after sadm,5.0,62.0,14.2988281,95.0,25.0,36.59375,224.0,2.8999023,54.796875,4.59960938,132.0,7.419922,135.0,78.0,0.0,0.0,1.0,<2 mo. follow-up,4.4824219
49.21799,female,0.0,MOSF w/Malig,16.0,>$50k,21363.0,white,yes,0.049999982,0.04999998,dnr after sadm,2.0,67.0,41.1953125,158.0,34.0,36.39844,280.0,2.8999023,0.89990234,1.19995117,131.0,7.5,83.0,25.0,300.0,0.0,1.0,<2 mo. follow-up,2.2861328
86.83099,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,83218.0,white,no,0.25,0.1999999,dnr after sadm,6.0,37.0,15.5996094,65.0,10.0,38.59375,126.65625,2.8999023,0.89990234,3.69970703,131.0,7.479492,135.0,63.0,1088.0,0.0,5.0,<2 mo. follow-up,5.0
46.56799,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,95981.0,white,no,0.699999809,0.5,no dnr,9.0,70.0,15.5996094,125.0,16.0,36.5,224.0,2.8999023,0.89990234,2.09960938,133.0,7.419922,202.0,78.0,4360.0,0.0,1.0,<2 mo. follow-up,3.2910156
58.431,male,0.0,ARF/MOSF w/Sepsis,13.0,$25-$50k,97332.0,white,no,0.299999952,0.15,no dnr,16.0,110.0,15.0,115.0,31.0,35.89844,323.3125,2.3999023,3.39990234,2.69970703,131.0,7.379883,356.0,94.0,4225.0,0.0,0.0,no(M2 and SIP pres),0.0
74.49396,female,1.0,ARF/MOSF w/Sepsis,16.0,under $11k,56321.0,white,metastatic,0.75,0.5,dnr after sadm,2.0,60.0,39.1953125,120.0,30.0,37.29688,151.0,2.8999023,0.69995117,1.39990234,142.0,7.369141,244.0,27.0,175.0,0.0,1.0,<2 mo. follow-up,3.8999023
47.17599,female,1.0,MOSF w/Malig,14.0,>$50k,915302.0,white,metastatic,0.899999619,0.6999998,no dnr,73.0,110.0,8.5,125.0,28.0,36.09375,191.09375,2.8999023,1.5,5.19921875,134.0,7.429688,159.0,63.0,106.0,0.0,0.0,<2 mo. follow-up,0.0
71.42499,female,1.0,Cirrhosis,12.0,under $11k,60990.0,white,no,0.199999928,0.09999996,dnr after sadm,3.0,55.0,13.5996094,55.0,26.0,35.69531,120.75,1.2998047,8.69921875,0.59997559,148.0,7.489258,124.0,15.0,2990.0,0.0,1.0,<2 mo. follow-up,4.2353516
52.84097,female,0.0,ARF/MOSF w/Sepsis,14.0,$25-$50k,283898.0,white,no,0.899999619,0.7999997,no dnr,40.0,108.0,11.1992188,105.0,10.0,38.69531,405.0,2.699707,1.59985352,0.69995117,135.0,7.459961,168.0,17.0,2728.0,5.0,7.0,<2 mo. follow-up,7.0
65.81,male,0.0,Lung Cancer,18.0,$25-$50k,14638.0,white,metastatic,0.099999964,0.09999996,no dnr,4.0,79.0,7.29980469,136.0,22.0,38.39844,224.0,2.8999023,0.89990234,1.29980469,127.0,7.419922,96.0,12.0,720.0,0.0,0.0,<2 mo. follow-up,0.0
20.991,male,0.0,ARF/MOSF w/Sepsis,13.0,>$50k,69111.0,white,no,1.0,0.8999996,no dnr,8.0,65.0,17.3984375,95.0,26.0,38.5,135.0,2.8999023,0.39996338,10.0,146.0,7.439453,155.0,40.0,0.0,0.0,0.0,<2 mo. follow-up,0.0
79.56696,female,1.0,Coma,12.0,under $11k,54981.0,white,yes,0.0,0.0,dnr after sadm,9.0,107.0,20.8984375,70.0,14.0,38.39844,435.0,2.8999023,0.89990234,0.79992676,134.0,7.549805,135.0,10.0,1620.0,0.0,1.0,<2 mo. follow-up,3.2192383
42.36798,male,0.0,CHF,12.0,$25-$50k,26673.0,white,no,0.699999809,0.5,no dnr,7.0,55.0,9.19921875,110.0,20.0,36.19531,224.0,3.699707,0.89990234,1.39990234,128.0,7.419922,103.0,22.0,3225.0,0.0,0.0,<2 mo. follow-up,0.0
72.06299,female,0.0,CHF,9.0,under $11k,6761.0,hispanic,no,0.899999619,0.75,no dnr,4.0,123.0,6.39941406,82.0,26.0,36.39844,224.0,2.5,0.89990234,2.0,138.0,7.419922,242.0,25.0,1600.0,1.0,1.0,<2 mo. follow-up,1.0
84.04895,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,63995.0,white,no,0.099999964,0.04999998,dnr after sadm,6.0,62.0,23.6992188,65.0,42.0,36.09375,182.5,2.8999023,1.0,1.09985352,150.0,7.469727,135.0,54.0,1180.0,0.0,1.0,<2 mo. follow-up,4.2011719
41.33899,male,0.0,CHF,12.0,under $11k,27099.0,white,no,1.0,0.8999996,no dnr,8.0,62.0,7.59960938,115.0,22.0,37.5,224.0,3.5996094,0.29998779,1.39990234,136.0,7.419922,121.0,18.0,3350.0,0.0,1.0,<2 mo. follow-up,2.9267578
66.22595,male,1.0,ARF/MOSF w/Sepsis,18.0,$25-$50k,837022.0,white,no,0.199999928,0.09999996,no dnr,82.0,68.0,6.59960938,110.0,23.0,36.19531,312.5,2.8999023,26.0,3.0,149.0,7.439453,135.0,116.0,1540.0,0.0,2.0,<2 mo. follow-up,2.0
67.52899,male,0.0,CHF,12.0,under $11k,9941.0,other,no,0.699999809,0.5,no dnr,3.0,102.0,6.09960938,70.0,24.0,36.5,202.03125,2.8999023,0.89990234,1.39990234,139.0,7.359375,162.0,15.0,1968.0,2.0,7.0,<2 mo. follow-up,7.0
43.06097,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,727548.0,hispanic,no,0.599999905,0.5,no dnr,81.0,65.0,6.09960938,135.0,28.0,37.79688,132.5,2.8999023,1.09985352,1.19995117,134.0,7.509766,145.0,31.0,4425.0,0.0,1.0,adl>=4 (>=5 if sur),2.9472656
23.17,male,0.0,ARF/MOSF w/Sepsis,14.0,>$50k,26594.0,black,no,0.799999714,0.7999997,no dnr,9.0,103.0,22.0,96.0,28.0,38.0,155.09375,2.8999023,0.89990234,0.79992676,133.0,7.40918,135.0,8.0,2900.0,0.0,0.0,<2 mo. follow-up,0.0
84.99896,male,0.0,MOSF w/Malig,18.0,under $11k,18968.0,white,yes,0.799999714,0.5999999,no dnr,7.0,75.0,8.3984375,64.0,22.0,36.39844,108.15625,2.8999023,0.89990234,4.09960938,134.0,7.15918,276.0,61.0,1200.0,0.0,1.0,<2 mo. follow-up,0.494751
52.88397,male,0.0,ARF/MOSF w/Sepsis,19.0,>$50k,34829.0,white,no,0.799999714,0.6999998,no dnr,12.0,72.0,21.796875,75.0,28.0,37.5,140.8125,2.5,8.19921875,2.39990234,132.0,7.429688,108.0,58.0,3460.0,0.0,2.0,no(M2 and SIP pres),2.0
56.57498,male,0.0,CHF,16.0,$11-$25k,120213.0,asian,no,0.699999809,0.5,no dnr,13.0,49.0,4.59960938,65.0,20.0,36.19531,224.0,2.8999023,1.59985352,1.0,134.0,7.419922,135.0,24.0,2950.0,0.0,0.0,no(M2 and SIP pres),0.0
59.02499,male,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,84586.0,white,no,0.599999905,0.5,no dnr,12.0,68.0,5.19921875,110.0,8.0,36.39844,274.25,3.2998047,2.39990234,6.39941406,142.0,7.549805,424.0,76.0,255.0,0.0,7.0,<2 mo. follow-up,7.0
35.379,female,0.0,Colon Cancer,18.0,>$50k,30835.0,white,metastatic,1.0,0.9899998,no dnr,8.0,78.0,7.19921875,120.0,22.0,39.19531,224.0,2.5996094,0.19998169,0.89990234,139.0,7.419922,79.0,14.0,3730.0,0.0,0.0,<2 mo. follow-up,0.0
50.59799,male,0.0,ARF/MOSF w/Sepsis,14.0,$11-$25k,178970.0,white,yes,1.0,0.8999996,no dnr,22.0,128.0,19.6992188,55.0,14.0,38.59375,88.625,2.8999023,0.89990234,1.09985352,148.0,7.529297,151.0,32.0,3755.0,0.0,1.0,adl>=4 (>=5 if sur),2.9150391
39.52399,male,0.0,CHF,11.0,under $11k,8793.0,black,no,0.949999809,0.7999997,no dnr,4.0,72.0,4.39941406,115.0,20.0,36.09375,224.0,2.8999023,0.89990234,1.39990234,132.0,7.419922,82.0,22.0,5620.0,0.0,1.0,<2 mo. follow-up,2.2358398
51.702,female,0.0,ARF/MOSF w/Sepsis,13.0,$25-$50k,203761.0,white,no,0.899999619,0.8999996,no dnr,34.0,62.0,10.0996094,125.0,43.0,38.69531,154.0,2.7998047,0.89990234,1.09985352,146.0,7.469727,389.0,20.0,2220.0,0.0,1.0,<2 mo. follow-up,1.0
74.74896,female,1.0,ARF/MOSF w/Sepsis,8.0,under $11k,71884.0,hispanic,no,0.199999928,0.09999996,dnr after sadm,3.0,50.0,11.5,50.0,15.0,39.0,308.0,2.8999023,0.29998779,6.69921875,135.0,7.259766,238.0,53.0,0.0,0.0,0.0,<2 mo. follow-up,0.0
68.43799,male,0.0,MOSF w/Malig,15.0,>$50k,22713.0,white,metastatic,0.5,0.09999996,no dnr,7.0,68.0,9.5,75.0,22.0,38.59375,130.0,2.8999023,0.89990234,1.09985352,133.0,7.439453,173.0,19.0,2825.0,0.0,0.0,<2 mo. follow-up,0.0
26.754,female,0.0,Coma,12.0,under $11k,97238.0,other,no,0.699999809,0.3999999,no dnr,17.0,103.0,16.5,115.0,12.0,38.0,445.6875,2.8999023,0.89990234,0.59997559,141.0,7.569336,99.0,22.0,1435.0,0.0,1.0,<2 mo. follow-up,1.9611816
68.60797,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,98679.0,white,no,0.0,0.0,dnr after sadm,4.0,52.0,15.8984375,80.0,26.0,36.89844,108.5625,2.5996094,8.69921875,2.29980469,142.0,7.439453,364.0,43.0,0.0,0.0,0.0,<2 mo. follow-up,0.0
54.61697,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,144291.0,white,yes,0.899999619,0.8999996,no dnr,28.0,57.0,19.8984375,110.0,6.0,39.09375,222.84375,2.8999023,0.89990234,6.19921875,142.0,7.429688,96.0,36.0,5.0,5.0,1.0,<2 mo. follow-up,3.8549805
91.12695,female,0.0,CHF,17.0,$11-$25k,13810.0,white,no,0.899999619,0.8499999,no dnr,7.0,104.0,5.29980469,82.0,20.0,37.59375,224.0,2.8999023,0.89990234,1.0,140.0,7.419922,135.0,19.0,2705.0,0.0,0.0,no(M2 and SIP pres),0.0
75.047,female,1.0,Cirrhosis,12.0,under $11k,32043.0,white,no,0.699999809,0.5999999,no dnr,5.0,103.0,7.5,75.0,40.0,38.19531,740.0,2.699707,4.0,0.59997559,129.0,7.329102,323.0,7.0,2730.0,0.0,6.0,<2 mo. follow-up,6.0
65.29999,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,267914.0,white,metastatic,0.5,0.5,dnr after sadm,21.0,43.0,3.29980469,115.0,10.0,38.0,174.53125,2.7998047,0.69995117,7.19921875,142.0,7.489258,95.0,78.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
61.49197,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,270064.0,black,no,0.899999619,0.8999996,no dnr,39.0,72.0,19.3984375,115.0,34.0,38.5,292.5,2.8999023,0.89990234,1.69995117,148.0,7.55957,110.0,71.0,1118.0,0.0,1.0,<2 mo. follow-up,2.1645508
73.15796,male,0.0,Lung Cancer,12.0,under $11k,30093.0,white,metastatic,0.099999964,0.0,dnr after sadm,1.0,71.0,31.3984375,128.0,32.0,38.09375,347.5625,2.3999023,1.29980469,1.29980469,134.0,7.469727,119.0,23.0,4250.0,0.0,1.0,<2 mo. follow-up,4.3505859
57.36099,female,0.0,Lung Cancer,14.0,$11-$25k,7234.0,other,metastatic,0.5,0.09999996,dnr after sadm,1.0,109.0,4.39941406,96.0,28.0,36.39844,224.0,2.8999023,0.89990234,1.19995117,140.0,7.419922,135.0,23.0,600.0,5.0,5.0,<2 mo. follow-up,5.0
49.72998,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,225448.0,white,no,0.299999952,0.3,dnr after sadm,5.0,38.0,42.09375,140.0,24.0,38.09375,193.3125,1.5,0.59997559,7.0,134.0,7.369141,173.0,147.0,4625.0,5.0,6.0,adl>=4 (>=5 if sur),6.0
70.12994,male,0.0,CHF,16.0,>$50k,24386.0,white,no,0.5,0.1999999,no dnr,7.0,58.0,9.3984375,105.0,20.0,36.69531,224.0,2.8999023,0.5,1.69995117,136.0,7.419922,361.0,41.0,3780.0,1.0,1.0,no(M2 and SIP pres),1.0
61.79898,male,0.0,CHF,12.0,under $11k,286496.0,white,no,0.199999928,0.09999996,no dnr,71.0,38.0,11.3984375,105.0,22.0,36.09375,224.0,2.8999023,0.89990234,1.79980469,133.0,7.419922,135.0,52.0,2800.0,0.0,1.0,no(M2 and SIP pres),3.3452148
47.896,female,1.0,ARF/MOSF w/Sepsis,18.0,>$50k,25024.0,white,no,0.5,0.3,dnr after sadm,19.0,113.0,11.7988281,105.0,15.0,39.39844,168.0,2.8999023,9.19921875,0.5,134.0,7.5,135.0,17.0,2335.0,0.0,0.0,<2 mo. follow-up,0.0
52.129,male,0.0,CHF,13.0,$11-$25k,36250.0,white,no,0.299999952,0.09999996,no dnr,12.0,47.0,10.5996094,65.0,24.0,36.29688,224.0,4.2998047,2.59960938,2.0,134.0,7.419922,105.0,24.0,2445.0,0.0,1.0,<2 mo. follow-up,0.494751
51.461,female,1.0,Lung Cancer,12.0,under $11k,38782.0,white,metastatic,0.699999809,0.5,dnr after sadm,1.0,59.0,10.0,112.0,36.0,36.59375,224.0,2.8999023,0.89990234,1.0,141.0,7.419922,112.0,14.0,350.0,0.0,1.0,<2 mo. follow-up,3.2802734
59.95297,male,0.0,Cirrhosis,12.0,$11-$25k,37026.0,white,no,0.599999905,0.5,no dnr,9.0,108.0,36.6953125,130.0,28.0,37.89844,224.0,2.3999023,0.59997559,2.39990234,142.0,7.419922,122.0,71.0,510.0,1.0,2.0,adl>=4 (>=5 if sur),2.0
77.29999,female,0.0,Colon Cancer,12.0,>$50k,23099.0,white,metastatic,0.949999809,0.9499998,no dnr,8.0,71.0,13.0,72.0,14.0,36.19531,224.0,2.5,1.0,0.89990234,140.0,7.419922,135.0,23.0,1050.0,0.0,1.0,<2 mo. follow-up,0.494751
77.52496,male,1.0,Coma,10.0,$11-$25k,229171.0,white,no,0.949999809,0.75,dnr after sadm,16.0,55.0,15.1992188,105.0,32.0,35.29688,310.0,2.8999023,1.0,4.5,144.0,7.619141,151.0,123.0,302.0,0.0,1.0,<2 mo. follow-up,1.0
50.09399,male,0.0,CHF,13.0,$25-$50k,172027.0,white,no,0.5,0.5,no dnr,22.0,55.0,5.19921875,75.0,20.0,36.09375,224.0,2.8999023,0.89990234,2.69970703,126.0,7.419922,140.0,38.0,2000.0,0.0,1.0,no(M2 and SIP pres),0.494751
43.53998,female,1.0,ARF/MOSF w/Sepsis,14.0,$25-$50k,313131.0,white,no,0.5,0.04999998,dnr after sadm,23.0,78.0,24.5976562,155.0,12.0,38.0,136.0,2.8999023,6.59960938,0.59997559,134.0,7.509766,210.0,28.0,1675.0,0.0,0.0,<2 mo. follow-up,0.0
65.01794,male,0.0,ARF/MOSF w/Sepsis,16.0,$11-$25k,346376.0,white,no,0.5,0.5,no dnr,55.0,108.0,7.79980469,105.0,18.0,36.69531,127.26562,2.5,0.29998779,1.09985352,139.0,7.419922,93.0,17.0,5930.0,0.0,1.0,<2 mo. follow-up,1.0
75.55597,female,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,128893.0,white,no,0.949999809,0.9499998,no dnr,6.0,68.0,15.2988281,115.0,24.0,36.89844,200.0,2.5996094,0.89990234,0.79992676,131.0,7.5,155.0,25.0,2165.0,0.0,0.0,Coma or Intub,0.0
61.76599,female,0.0,ARF/MOSF w/Sepsis,13.0,under $11k,33585.0,black,yes,0.75,0.75,no dnr,6.0,84.0,6.79980469,75.0,26.0,36.5,217.125,2.8999023,9.0,0.69995117,134.0,7.439453,135.0,8.0,2350.0,0.0,0.0,<2 mo. follow-up,0.0
35.47198,male,1.0,MOSF w/Malig,16.0,$25-$50k,687411.0,white,yes,0.099999964,0.09999996,dnr after sadm,10.0,55.0,0.59997559,115.0,34.0,39.09375,142.5,1.6999512,14.0,1.79980469,147.0,7.469727,145.0,107.0,1508.0,0.0,1.0,<2 mo. follow-up,2.5102539
56.36697,male,1.0,ARF/MOSF w/Sepsis,6.0,under $11k,299542.0,hispanic,no,0.299999952,0.25,dnr after sadm,6.0,48.0,31.1992188,105.0,30.0,38.5,168.0,2.8999023,10.0996094,3.0,141.0,7.419922,170.0,73.0,0.0,0.0,0.0,<2 mo. follow-up,0.0
74.69995,female,0.0,ARF/MOSF w/Sepsis,11.0,under $11k,76763.0,black,no,0.699999809,0.5,dnr after sadm,14.0,52.0,8.29882812,65.0,36.0,36.79688,368.5,2.8999023,0.89990234,2.5,136.0,7.419922,98.0,48.0,1000.0,0.0,1.0,<2 mo. follow-up,1.0
46.09198,female,0.0,MOSF w/Malig,12.0,under $11k,545065.0,white,yes,0.199999928,0.09999996,no dnr,61.0,52.0,0.04999542,165.0,24.0,37.69531,275.5,2.8999023,3.89990234,3.5,146.0,7.359375,269.0,63.0,0.0,0.0,1.0,<2 mo. follow-up,3.6855469
53.27899,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,96262.0,white,yes,0.899999619,0.7999997,no dnr,14.0,123.0,12.1992188,130.0,28.0,37.89844,337.75,3.0,0.5,1.0,132.0,7.329102,125.0,5.0,3250.0,0.0,1.0,<2 mo. follow-up,3.3676758
53.06198,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,471833.0,asian,no,0.699999809,0.5,no dnr,24.0,63.0,4.89941406,125.0,12.0,36.19531,177.5,3.699707,9.5,2.09960938,142.0,7.299805,438.0,63.0,452.0,0.0,1.0,<2 mo. follow-up,2.6240234
69.133,male,1.0,ARF/MOSF w/Sepsis,14.0,$25-$50k,57562.0,asian,no,0.099999964,0.09999996,dnr after sadm,4.0,68.0,5.39941406,135.0,28.0,38.19531,80.0,2.8999023,0.59997559,1.19995117,133.0,7.459961,140.0,15.0,3010.0,0.0,3.0,<2 mo. follow-up,3.0
54.46997,male,1.0,ARF/MOSF w/Sepsis,18.0,>$50k,658861.0,hispanic,no,0.699999809,0.5,dnr after sadm,42.0,58.0,7.29980469,115.0,50.0,39.29688,116.0,3.0996094,3.59960938,2.5,163.0,7.419922,180.0,75.0,2151.0,0.0,1.0,<2 mo. follow-up,3.0800781
45.96298,female,1.0,ARF/MOSF w/Sepsis,14.0,>$50k,402858.0,white,no,0.799999714,0.7999997,dnr after sadm,9.0,118.0,4.09960938,115.0,24.0,38.0,502.8125,2.699707,4.09960938,1.69995117,138.0,7.419922,186.0,120.0,2110.0,0.0,3.0,<2 mo. follow-up,3.0
38.83099,female,1.0,ARF/MOSF w/Sepsis,13.0,$25-$50k,449656.0,white,no,0.5,0.3999999,dnr after sadm,17.0,45.0,1.39990234,180.0,18.0,39.5,106.0,1.8999023,12.5996094,1.59985352,151.0,7.40918,161.0,86.0,3590.0,0.0,0.0,<2 mo. follow-up,0.0
48.43799,female,0.0,ARF/MOSF w/Sepsis,12.0,>$50k,126356.0,white,no,0.849999905,0.8499999,no dnr,18.0,122.0,16.1992188,145.0,15.0,38.0,134.0,2.199707,0.29998779,1.09985352,145.0,7.319336,125.0,15.0,3975.0,0.0,0.0,<2 mo. follow-up,0.0
74.88794,female,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,367797.0,white,no,0.649999619,0.6499996,dnr after sadm,12.0,68.0,13.0,110.0,36.0,38.39844,167.5,3.199707,1.59985352,0.89990234,148.0,7.389648,178.0,37.0,2360.0,0.0,1.0,adl>=4 (>=5 if sur),1.0
68.08795,male,0.0,ARF/MOSF w/Sepsis,18.0,under $11k,543761.0,white,no,0.799999714,0.7999997,no dnr,69.0,67.0,18.0976562,75.0,12.0,36.59375,186.65625,2.8999023,2.39990234,5.0,129.0,7.489258,221.0,63.0,20.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
27.30199,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,147320.0,hispanic,no,0.899999619,0.8999996,no dnr,16.0,98.0,15.5996094,105.0,48.0,36.79688,197.9375,2.8999023,0.69995117,1.19995117,135.0,7.419922,177.0,22.0,3405.0,0.0,1.0,<2 mo. follow-up,3.5473633
64.66296,female,0.0,CHF,15.0,$11-$25k,82891.0,white,no,0.599999905,0.5,no dnr,25.0,58.0,12.1992188,145.0,26.0,36.19531,224.0,2.8999023,0.69995117,1.0,129.0,7.419922,92.0,13.0,1265.0,0.0,1.0,<2 mo. follow-up,0.494751
74.47998,male,0.0,CHF,12.0,under $11k,43115.0,hispanic,no,0.699999809,0.5,no dnr,16.0,73.0,7.5,70.0,28.0,36.0,224.0,2.8999023,0.89990234,1.39990234,142.0,7.419922,87.0,22.0,3450.0,4.0,0.0,no(M2 and SIP pres),0.0
56.96597,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,743890.0,white,yes,0.099999964,0.0,dnr after sadm,35.0,53.0,18.796875,115.0,22.0,39.5,200.0,2.8999023,24.1992188,3.89990234,137.0,7.549805,97.0,72.0,180.0,0.0,1.0,<2 mo. follow-up,2.800293
68.32599,male,0.0,ARF/MOSF w/Sepsis,19.0,>$50k,19224.0,white,no,0.949999809,0.8999996,no dnr,7.0,105.0,10.7988281,100.0,30.0,37.79688,224.0,2.8999023,0.89990234,1.19995117,130.0,7.419922,247.0,21.0,3350.0,0.0,1.0,no(M2 and SIP pres),0.494751
64.02997,male,1.0,CHF,12.0,>$50k,193563.0,white,no,0.699999809,0.5,dnr after sadm,28.0,62.0,4.5,65.0,22.0,36.5,173.3125,2.8999023,3.0,2.09960938,132.0,7.469727,110.0,34.0,3465.0,1.0,0.0,<2 mo. follow-up,0.0
56.01898,male,0.0,ARF/MOSF w/Sepsis,14.0,$25-$50k,25024.0,hispanic,no,0.799999714,0.5999999,no dnr,60.0,112.0,7.29980469,115.0,26.0,38.39844,224.0,2.8999023,4.79980469,2.79980469,136.0,7.419922,168.0,104.0,1000.0,0.0,7.0,<2 mo. follow-up,7.0
56.42697,female,1.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,25024.0,white,yes,0.699999809,0.6799998,dnr after sadm,55.0,128.0,23.1992188,160.0,28.0,38.89844,88.5625,2.8999023,1.0,1.19995117,145.0,7.40918,292.0,80.0,3495.0,0.0,0.0,<2 mo. follow-up,0.0
74.97296,female,0.0,CHF,9.0,under $11k,5306.0,black,no,0.949999809,0.75,no dnr,4.0,101.0,3.79980469,76.0,20.0,36.39844,224.0,2.8999023,0.89990234,1.89990234,141.0,7.419922,135.0,39.0,1670.0,6.0,1.0,<2 mo. follow-up,4.5273438
66.64197,female,0.0,Lung Cancer,10.0,under $11k,55841.0,white,metastatic,0.699999809,0.5,no dnr,15.0,46.0,8.8984375,160.0,32.0,36.0,224.0,3.3999023,0.39996338,0.59997559,139.0,7.419922,128.0,6.0,1075.0,0.0,1.0,<2 mo. follow-up,0.494751
37.25699,male,1.0,ARF/MOSF w/Sepsis,10.0,under $11k,188152.0,hispanic,yes,0.25,0.09999996,dnr after sadm,11.0,65.0,9.8984375,100.0,42.0,34.89844,87.5,2.8999023,31.5,4.19921875,146.0,7.429688,152.0,75.0,847.0,0.0,0.0,<2 mo. follow-up,0.0
59.70697,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,770591.0,white,no,0.5,0.3,dnr after sadm,9.0,58.0,3.09960938,125.0,35.0,39.5,110.0,2.8999023,0.79992676,1.09985352,139.0,7.5,135.0,35.0,3805.0,0.0,4.0,<2 mo. follow-up,4.0
57.91397,female,0.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,376476.0,white,no,0.699999809,0.6499996,no dnr,34.0,120.0,23.0,125.0,12.0,37.59375,130.0,2.8999023,0.89990234,1.19995117,136.0,7.449219,294.0,40.0,2770.0,0.0,2.0,adl>=4 (>=5 if sur),2.0
79.81396,male,0.0,ARF/MOSF w/Sepsis,16.0,$25-$50k,181788.0,white,no,0.349999905,0.3499999,no dnr,7.0,45.0,16.0,95.0,48.0,39.5,133.3125,2.8999023,6.29980469,1.19995117,152.0,7.479492,165.0,50.0,2496.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
80.49298,male,0.0,CHF,15.0,$25-$50k,27792.0,white,no,0.699999809,0.3429999,no dnr,9.0,78.0,16.0976562,85.0,28.0,38.19531,217.5,2.8999023,0.89990234,0.79992676,133.0,7.429688,115.0,10.0,1925.0,0.0,1.0,<2 mo. follow-up,2.3549805
63.56198,female,0.0,COPD,12.0,under $11k,56383.0,black,no,0.899999619,0.8499999,no dnr,8.0,85.0,7.69921875,72.0,24.0,36.5,224.0,2.8999023,0.89990234,1.39990234,142.0,7.419922,112.0,24.0,1215.0,0.0,0.0,<2 mo. follow-up,0.0
89.92499,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,215263.0,asian,no,0.699999809,0.3999999,no dnr,3.0,58.0,22.6992188,145.0,32.0,36.29688,227.5,3.2998047,0.39996338,2.69970703,131.0,7.399414,147.0,51.0,1880.0,0.0,1.0,<2 mo. follow-up,3.8125
75.64996,female,0.0,Lung Cancer,12.0,under $11k,9252.0,white,metastatic,0.699999809,0.5,no dnr,4.0,60.0,17.0976562,5.0,30.0,37.59375,305.0,2.2998047,4.5,2.59960938,138.0,7.319336,135.0,60.0,13.0,0.0,1.0,<2 mo. follow-up,2.3491211
52.33398,female,0.0,CHF,14.0,under $11k,44858.0,white,no,0.799999714,0.5999999,no dnr,15.0,71.0,5.5,80.0,24.0,36.59375,224.0,2.8999023,0.89990234,0.89990234,139.0,7.419922,135.0,17.0,1968.0,0.0,1.0,<2 mo. follow-up,0.494751
41.21298,female,0.0,Lung Cancer,14.0,$25-$50k,17155.0,white,metastatic,0.599999905,0.3,dnr after sadm,1.0,45.0,5.5,75.0,18.0,36.0,224.0,3.8999023,0.5,1.59985352,135.0,7.419922,186.0,21.0,1700.0,0.0,3.0,adl>=4 (>=5 if sur),3.0
62.60898,female,0.0,Lung Cancer,12.0,$11-$25k,36914.0,white,metastatic,1.0,1.0,no dnr,9.0,71.0,5.59960938,76.0,20.0,36.39844,224.0,2.8999023,2.0,0.59997559,133.0,7.419922,93.0,4.0,1850.0,0.0,1.0,no(M2 and SIP pres),3.484375
71.47198,male,0.0,CHF,18.0,>$50k,22851.0,white,no,0.799999714,0.75,no dnr,7.0,109.0,6.89941406,104.0,22.0,36.39844,460.0,2.8999023,0.89990234,0.89990234,134.0,7.399414,183.0,23.0,2075.0,0.0,2.0,<2 mo. follow-up,2.0
43.129,female,0.0,Lung Cancer,12.0,under $11k,32776.0,white,metastatic,1.0,0.75,no dnr,9.0,49.0,3.79980469,65.0,20.0,36.29688,224.0,2.8999023,0.89990234,2.19970703,126.0,7.419922,135.0,71.0,1575.0,0.0,1.0,<2 mo. follow-up,2.9306641
45.16098,male,1.0,Coma,12.0,under $11k,47000.0,white,no,0.099999964,0.09999996,dnr after sadm,4.0,73.0,10.5996094,80.0,16.0,38.19531,224.0,2.8999023,0.89990234,0.69995117,140.0,7.419922,87.0,10.0,2375.0,0.0,0.0,<2 mo. follow-up,0.0
55.76498,female,0.0,MOSF w/Malig,20.0,$25-$50k,84742.0,white,yes,0.699999809,0.5,no dnr,14.0,132.0,22.5976562,135.0,20.0,38.59375,148.875,3.3999023,0.39996338,2.39990234,148.0,7.359375,401.0,47.0,3975.0,0.0,1.0,<2 mo. follow-up,2.9794922
70.12695,male,1.0,ARF/MOSF w/Sepsis,16.0,under $11k,93405.0,white,no,0.299999952,0.3,dnr after sadm,8.0,62.0,4.59960938,135.0,38.0,39.39844,83.32812,2.8999023,0.79992676,0.69995117,146.0,7.339844,135.0,25.0,2095.0,0.0,2.0,<2 mo. follow-up,2.0
70.20697,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,480909.0,white,no,0.299999952,0.3,no dnr,59.0,68.0,17.8984375,145.0,24.0,36.69531,222.84375,2.5996094,0.5,0.79992676,131.0,7.439453,235.0,32.0,4750.0,0.0,4.0,Coma or Intub,4.0
65.87299,female,1.0,ARF/MOSF w/Sepsis,9.0,under $11k,349615.0,white,no,0.5,0.5,dnr after sadm,14.0,115.0,4.59960938,65.0,26.0,36.0,482.5,2.5,3.39990234,1.59985352,142.0,7.459961,253.0,66.0,2395.0,0.0,1.0,<2 mo. follow-up,1.0
37.77399,female,0.0,Lung Cancer,14.0,>$50k,124501.0,white,metastatic,0.799999714,0.5,no dnr,28.0,73.0,5.39941406,115.0,36.0,38.39844,225.0,2.8999023,0.89990234,5.5,149.0,7.439453,234.0,125.0,1400.0,0.0,0.0,<2 mo. follow-up,0.0
27.866,female,0.0,CHF,18.0,$25-$50k,34964.0,white,no,0.949999809,0.6999998,no dnr,10.0,69.0,7.19921875,74.0,20.0,37.89844,224.0,3.5996094,0.39996338,1.0,135.0,7.419922,84.0,5.0,7025.0,1.0,2.0,<2 mo. follow-up,2.0
46.51898,male,0.0,CHF,14.0,under $11k,466224.0,hispanic,no,0.25,0.25,no dnr,107.0,67.0,9.5,105.0,20.0,36.19531,224.0,4.1992188,1.0,1.39990234,140.0,7.419922,80.0,17.0,900.0,0.0,0.0,<2 mo. follow-up,0.0
75.461,female,0.0,CHF,12.0,under $11k,22979.0,black,no,0.799999714,0.6999998,no dnr,5.0,56.0,7.89941406,105.0,8.0,36.0,228.875,2.7998047,9.5,2.29980469,155.0,7.459961,184.0,59.0,1965.0,0.0,1.0,<2 mo. follow-up,3.3642578
66.50494,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,983206.0,white,no,0.949999809,0.6499996,dnr after sadm,31.0,114.0,7.09960938,70.0,30.0,36.59375,211.09375,2.8999023,0.89990234,0.89990234,145.0,7.339844,102.0,18.0,5650.0,0.0,1.0,Coma or Intub,2.8105469
49.89697,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,550783.0,black,no,0.699999809,0.5,no dnr,71.0,45.0,23.1992188,170.0,10.0,38.39844,100.0,2.8999023,0.89990234,2.29980469,134.0,7.319336,287.0,33.0,279.0,3.0,0.0,adl>=4 (>=5 if sur),0.0
45.08698,male,1.0,ARF/MOSF w/Sepsis,18.0,under $11k,385690.0,asian,no,0.049999982,0.04999998,dnr after sadm,5.0,77.0,15.8984375,80.0,20.0,36.29688,224.0,2.8999023,20.5976562,2.19970703,131.0,7.419922,76.0,11.0,2250.0,0.0,1.0,<2 mo. follow-up,3.7890625
71.849,male,0.0,CHF,12.0,under $11k,64436.0,white,no,0.299999952,0.3,no dnr,8.0,50.0,9.29882812,25.0,28.0,38.5,295.0,2.8999023,9.5,2.5,136.0,7.279297,135.0,89.0,1790.0,0.0,1.0,<2 mo. follow-up,2.8486328
56.88199,female,1.0,MOSF w/Malig,12.0,under $11k,25415.0,white,yes,0.0,0.0,dnr after sadm,4.0,49.0,12.3984375,135.0,16.0,36.69531,211.0,2.8999023,0.89990234,1.19995117,137.0,7.089844,135.0,18.0,3013.0,0.0,1.0,<2 mo. follow-up,2.9951172
39.02298,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,288218.0,black,no,0.099999964,0.009999998,dnr after sadm,18.0,78.0,25.796875,120.0,32.0,36.5,469.375,2.8999023,0.89990234,0.5,127.0,7.479492,135.0,13.0,3765.0,0.0,2.0,<2 mo. follow-up,2.0
56.10999,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,419661.0,white,no,0.5,0.5,dnr after sadm,26.0,113.0,0.09999084,135.0,12.0,35.79688,265.25,1.7998047,7.5,1.29980469,131.0,7.299805,617.0,30.0,3580.0,0.0,1.0,<2 mo. follow-up,2.902832
66.26398,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,210275.0,asian,no,0.849999905,0.8499999,no dnr,12.0,57.0,22.1992188,100.0,31.0,38.5,182.0,2.8999023,2.79980469,8.09960938,141.0,7.389648,513.0,87.0,12.0,0.0,1.0,<2 mo. follow-up,2.4750977
67.92596,female,1.0,MOSF w/Malig,12.0,under $11k,320408.0,white,yes,0.099999964,0.04999998,dnr after sadm,12.0,100.0,16.796875,110.0,10.0,39.0,224.0,2.8999023,1.0,0.59997559,135.0,7.419922,110.0,25.0,2305.0,0.0,1.0,<2 mo. follow-up,2.7646484
82.02594,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,122708.0,white,no,0.5,0.125,no dnr,26.0,63.0,9.09960938,108.0,8.0,37.89844,313.3125,2.8999023,0.89990234,0.89990234,138.0,7.479492,107.0,25.0,1800.0,0.0,1.0,Coma or Intub,3.4726562
55.13797,male,0.0,Lung Cancer,14.0,under $11k,29367.0,white,metastatic,1.0,1.0,no dnr,9.0,48.0,0.5,140.0,34.0,39.79688,120.0,2.8999023,0.89990234,0.79992676,157.0,7.379883,135.0,24.0,3935.0,0.0,0.0,<2 mo. follow-up,0.0
38.771,male,0.0,ARF/MOSF w/Sepsis,13.0,$25-$50k,27652.0,white,no,0.799999714,0.75,no dnr,4.0,55.0,18.0976562,175.0,31.0,36.0,260.0,2.8999023,0.89990234,1.79980469,137.0,7.469727,179.0,50.0,1337.0,0.0,1.0,no(M2 and SIP pres),2.1386719
23.76999,female,0.0,ARF/MOSF w/Sepsis,16.0,$11-$25k,54663.0,hispanic,no,0.899999619,0.8999996,no dnr,6.0,70.0,10.5996094,96.0,20.0,37.59375,309.5,4.0996094,0.29998779,0.79992676,135.0,7.429688,126.0,11.0,2890.0,0.0,0.0,<2 mo. follow-up,0.0
36.67398,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,288912.0,black,no,0.899999619,0.8999996,no dnr,4.0,103.0,5.0,120.0,34.0,39.0,224.0,2.699707,0.89990234,0.79992676,143.0,7.419922,135.0,14.0,2616.0,0.0,1.0,<2 mo. follow-up,2.5756836
89.82599,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,22772.0,white,no,0.299999952,0.1999999,dnr after sadm,3.0,77.0,16.3984375,118.0,28.0,36.19531,233.3125,2.8999023,0.69995117,1.09985352,133.0,7.469727,269.0,15.0,1075.0,0.0,1.0,<2 mo. follow-up,3.5668945
71.06396,male,0.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,88606.0,white,no,0.75,0.5999999,no dnr,15.0,40.0,13.2988281,115.0,36.0,38.79688,125.0,2.8999023,0.89990234,1.59985352,143.0,7.519531,135.0,29.0,1920.0,1.0,1.0,<2 mo. follow-up,1.0
84.46796,female,1.0,Coma,10.0,under $11k,9740.0,black,no,0.049999982,0.0,dnr after sadm,1.0,63.0,13.7988281,168.0,40.0,39.59375,178.3125,1.6999512,0.79992676,0.69995117,149.0,7.439453,147.0,32.0,2710.0,0.0,1.0,<2 mo. follow-up,5.7636719
93.46997,female,0.0,CHF,12.0,>$50k,13705.0,white,yes,0.699999809,0.5999999,dnr after sadm,2.0,59.0,13.0996094,68.0,24.0,38.19531,90.76562,2.8999023,0.89990234,1.59985352,142.0,7.469727,124.0,47.0,1750.0,0.0,0.0,SIP>=30,0.0
57.48898,male,1.0,Cirrhosis,12.0,under $11k,49892.0,white,yes,0.0,0.0,dnr after sadm,3.0,35.0,33.09375,155.0,30.0,38.59375,65.0,2.8999023,17.5,4.19921875,135.0,7.109375,151.0,48.0,34.0,0.0,1.0,<2 mo. follow-up,3.3417969
73.99896,female,0.0,COPD,12.0,under $11k,15322.0,white,no,0.5,0.5,dnr after sadm,1.0,50.0,30.6992188,55.0,36.0,35.5,224.0,2.8999023,1.29980469,2.29980469,122.0,7.419922,105.0,40.0,209.0,0.0,1.0,no(M2 and SIP pres),3.0947266
57.43997,female,0.0,Colon Cancer,12.0,$25-$50k,50645.0,white,metastatic,0.399999857,0.1999999,no dnr,12.0,78.0,11.0996094,70.0,20.0,37.89844,223.3125,2.2998047,0.89990234,1.59985352,137.0,7.419922,102.0,41.0,2540.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
70.45599,female,1.0,Coma,11.0,>$50k,52477.0,black,no,0.199999928,0.15,dnr after sadm,4.0,110.0,15.0996094,155.0,44.0,36.59375,680.0,2.5996094,0.89990234,1.59985352,131.0,7.459961,114.0,47.0,15.0,0.0,0.0,<2 mo. follow-up,0.0
63.88199,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,178201.0,white,no,0.5,0.5,no dnr,8.0,70.0,7.39941406,45.0,28.0,36.09375,224.0,2.8999023,0.89990234,1.5,139.0,7.419922,90.0,28.0,1175.0,0.0,1.0,<2 mo. follow-up,3.230957
46.00699,male,1.0,MOSF w/Malig,14.0,$25-$50k,135769.0,white,yes,0.049999982,0.04999998,dnr after sadm,2.0,45.0,22.6992188,125.0,28.0,35.19531,168.0,2.8999023,4.5,3.69970703,143.0,7.259766,180.0,55.0,10.0,0.0,1.0,<2 mo. follow-up,3.2695312
63.07999,female,0.0,CHF,12.0,under $11k,11751.0,white,no,0.899999619,0.7999997,no dnr,4.0,73.0,11.0996094,102.0,26.0,36.19531,224.0,2.8999023,0.89990234,0.89990234,131.0,7.419922,346.0,12.0,3150.0,0.0,1.0,<2 mo. follow-up,2.2646484
64.34796,male,0.0,Cirrhosis,14.0,under $11k,7934.0,hispanic,no,0.699999809,0.5,no dnr,6.0,63.0,3.69970703,136.0,32.0,36.19531,224.0,2.5,0.89990234,0.79992676,133.0,7.419922,135.0,15.0,1250.0,2.0,1.0,<2 mo. follow-up,1.8388672
52.02698,male,0.0,ARF/MOSF w/Sepsis,14.0,>$50k,287368.0,white,no,0.5,0.5,no dnr,19.0,112.0,14.3984375,140.0,34.0,39.19531,182.5,2.8999023,0.89990234,1.29980469,135.0,7.529297,279.0,36.0,1770.0,0.0,0.0,no(M2 and SIP pres),0.0
59.75598,male,0.0,Cirrhosis,14.0,>$50k,29213.0,white,no,0.599999905,0.3999999,no dnr,6.0,113.0,12.5996094,135.0,49.0,39.5,130.0,2.8999023,0.89990234,1.39990234,143.0,7.479492,148.0,24.0,1710.0,0.0,1.0,no(M2 and SIP pres),2.7348633
72.80194,male,0.0,ARF/MOSF w/Sepsis,16.0,>$50k,226908.0,white,no,0.75,0.75,no dnr,20.0,57.0,6.09960938,155.0,25.0,37.39844,118.65625,2.8999023,1.79980469,0.89990234,131.0,7.419922,135.0,21.0,695.0,0.0,1.0,<2 mo. follow-up,2.4453125
73.68695,male,0.0,Lung Cancer,12.0,under $11k,14124.0,white,metastatic,0.009999998,0.0,dnr after sadm,2.0,63.0,10.5996094,65.0,20.0,36.29688,224.0,2.8999023,0.89990234,1.0,133.0,7.419922,462.0,18.0,3600.0,0.0,1.0,<2 mo. follow-up,3.9892578
70.508,female,0.0,MOSF w/Malig,12.0,under $11k,42089.0,white,yes,0.699999809,0.5,dnr before sadm,-1.0,75.0,9.8984375,74.0,20.0,36.39844,224.0,2.8999023,8.5,1.19995117,134.0,7.419922,135.0,23.0,1430.0,0.0,1.0,<2 mo. follow-up,1.9824219
55.50198,male,0.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,338671.0,white,no,0.0,0.0,no dnr,44.0,58.0,22.296875,115.0,44.0,38.09375,330.0,2.8999023,25.5976562,3.0,142.0,7.5,211.0,136.0,4520.0,0.0,0.0,no(M2 and SIP pres),0.0
63.94299,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,252684.0,hispanic,no,0.899999619,0.7999997,no dnr,34.0,67.0,9.79882812,96.0,22.0,38.19531,224.0,2.8999023,3.39990234,0.69995117,133.0,7.419922,181.0,8.0,2625.0,1.0,1.0,<2 mo. follow-up,1.1667481
47.47998,female,0.0,ARF/MOSF w/Sepsis,14.0,$25-$50k,339838.0,white,no,0.899999619,0.8999996,no dnr,30.0,62.0,12.5,135.0,37.0,38.59375,347.5,2.8999023,0.89990234,1.5,152.0,7.589844,304.0,33.0,2712.0,0.0,1.0,<2 mo. follow-up,0.494751
50.51099,female,0.0,ARF/MOSF w/Sepsis,15.0,$25-$50k,131648.0,white,no,0.949999809,0.7999997,no dnr,25.0,70.0,14.7988281,82.0,22.0,36.39844,224.0,3.0996094,4.29980469,0.79992676,136.0,7.419922,113.0,15.0,800.0,0.0,1.0,<2 mo. follow-up,0.494751
66.771,female,0.0,Colon Cancer,12.0,under $11k,18716.0,white,metastatic,1.0,0.7999997,no dnr,9.0,82.0,9.69921875,96.0,24.0,38.0,224.0,2.8999023,0.89990234,2.69970703,138.0,7.419922,135.0,37.0,4250.0,0.0,1.0,<2 mo. follow-up,0.494751
51.85199,male,0.0,MOSF w/Malig,14.0,$25-$50k,54700.0,white,metastatic,0.699999809,0.5,dnr after sadm,14.0,52.0,17.8984375,105.0,26.0,38.69531,145.6875,2.5996094,0.89990234,1.29980469,136.0,7.519531,164.0,23.0,3800.0,0.0,0.0,<2 mo. follow-up,0.0
58.63397,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,145518.0,hispanic,yes,0.75,0.75,no dnr,17.0,65.0,10.3984375,125.0,24.0,36.59375,186.65625,2.5996094,7.19921875,1.09985352,143.0,7.479492,345.0,54.0,1690.0,0.0,0.0,<2 mo. follow-up,0.0
74.41797,female,0.0,ARF/MOSF w/Sepsis,15.0,>$50k,243036.0,white,yes,0.799999714,0.6999998,no dnr,8.0,122.0,1.59985352,65.0,24.0,38.09375,248.96875,2.8999023,10.1992188,0.79992676,137.0,7.449219,152.0,32.0,5290.0,0.0,1.0,<2 mo. follow-up,2.7583008
60.01398,male,0.0,Colon Cancer,16.0,>$50k,54862.0,white,metastatic,0.899999619,0.6999998,no dnr,15.0,99.0,40.796875,120.0,24.0,37.89844,254.65625,2.8999023,4.09960938,0.79992676,139.0,7.529297,107.0,8.0,3320.0,0.0,1.0,no(M2 and SIP pres),2.5766602
34.53799,female,1.0,Cirrhosis,12.0,>$50k,318788.0,hispanic,no,0.989999771,0.9899998,no dnr,28.0,72.0,14.0996094,78.0,22.0,38.0,224.0,2.8999023,0.89990234,0.79992676,138.0,7.419922,135.0,4.0,1150.0,0.0,6.0,<2 mo. follow-up,6.0
79.25494,male,0.0,ARF/MOSF w/Sepsis,14.0,under $11k,194939.0,white,no,0.899999619,0.8999996,dnr after sadm,8.0,100.0,15.8984375,106.0,14.0,36.39844,90.0,2.8999023,0.5,1.0,135.0,7.459961,177.0,15.0,1200.0,0.0,1.0,<2 mo. follow-up,4.1640625
59.409,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,618719.0,white,no,0.699999809,0.5,no dnr,36.0,62.0,31.6992188,115.0,10.0,35.79688,168.0,2.8999023,2.69970703,2.59960938,138.0,7.419922,96.0,29.0,3240.0,0.0,1.0,<2 mo. follow-up,2.7148438
46.31598,female,0.0,ARF/MOSF w/Sepsis,14.0,under $11k,123254.0,black,no,0.949999809,0.9499998,no dnr,11.0,67.0,28.3984375,115.0,40.0,38.29688,360.0,2.8999023,0.89990234,1.89990234,137.0,7.439453,207.0,84.0,2360.0,0.0,1.0,<2 mo. follow-up,2.4165039
73.10895,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,258088.0,asian,no,0.399999857,0.25,no dnr,23.0,78.0,11.0,116.0,24.0,38.39844,224.0,3.199707,1.69995117,1.09985352,138.0,7.419922,142.0,8.0,850.0,0.0,1.0,<2 mo. follow-up,3.5952148
72.28699,male,1.0,ARF/MOSF w/Sepsis,11.0,under $11k,235312.0,white,no,0.699999809,0.5,dnr after sadm,3.0,69.0,4.89941406,72.0,14.0,37.79688,224.0,2.8999023,3.39990234,0.59997559,135.0,7.419922,93.0,6.0,1950.0,0.0,0.0,<2 mo. follow-up,0.0
51.72897,female,0.0,CHF,12.0,under $11k,11742.0,white,no,0.899999619,0.8499999,no dnr,6.0,107.0,11.0996094,55.0,10.0,36.39844,365.0,2.2998047,1.09985352,0.79992676,132.0,7.459961,148.0,14.0,2655.0,0.0,1.0,no(M2 and SIP pres),0.494751
52.89499,female,0.0,ARF/MOSF w/Sepsis,18.0,>$50k,110588.0,white,no,0.099999964,0.09999996,no dnr,15.0,55.0,11.0996094,105.0,10.0,38.5,250.0,3.0,4.5,3.59960938,148.0,7.539062,212.0,57.0,3988.0,0.0,0.0,no(M2 and SIP pres),0.0
44.31799,male,0.0,ARF/MOSF w/Sepsis,11.0,$11-$25k,500747.0,white,no,0.899999619,0.7999997,no dnr,27.0,72.0,27.0,145.0,40.0,38.79688,202.0,2.8999023,1.19995117,0.59997559,136.0,7.389648,135.0,10.0,4580.0,0.0,2.0,adl>=4 (>=5 if sur),2.0
75.87695,male,0.0,COPD,12.0,under $11k,247610.0,white,no,0.599999905,0.5,dnr after sadm,12.0,35.0,17.296875,185.0,10.0,37.69531,245.0,2.8999023,0.89990234,3.89990234,133.0,7.369141,186.0,46.0,3790.0,0.0,1.0,<2 mo. follow-up,2.9624023
69.46198,male,0.0,ARF/MOSF w/Sepsis,15.0,$25-$50k,156624.0,white,no,0.5,0.5,no dnr,16.0,156.0,112.1875,135.0,35.0,38.29688,100.0,2.8999023,0.89990234,3.5,139.0,7.279297,135.0,73.0,0.0,0.0,1.0,no(M2 and SIP pres),2.7578125
42.44998,female,0.0,Lung Cancer,17.0,>$50k,10409.0,white,metastatic,0.599999905,0.1999999,no dnr,3.0,70.0,7.0,100.0,26.0,35.89844,224.0,4.0,0.89990234,1.19995117,136.0,7.419922,104.0,13.0,2400.0,0.0,1.0,<2 mo. follow-up,2.4477539
66.98999,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,501448.0,white,no,0.599999905,0.5,no dnr,85.0,67.0,35.6953125,130.0,28.0,38.59375,345.6875,3.199707,2.39990234,4.5,134.0,7.519531,135.0,166.0,5435.0,0.0,1.0,<2 mo. follow-up,2.8271484
63.36798,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,294992.0,white,no,0.799999714,0.7999997,no dnr,33.0,115.0,11.1992188,55.0,26.0,36.39844,224.0,2.3999023,10.2988281,1.0,138.0,7.419922,140.0,49.0,2960.0,0.0,0.0,no(M2 and SIP pres),0.0
61.741,male,1.0,ARF/MOSF w/Sepsis,14.0,$25-$50k,337918.0,white,no,0.75,0.75,no dnr,10.0,63.0,11.7988281,155.0,25.0,38.0,173.0,2.8999023,0.89990234,1.29980469,134.0,7.289062,188.0,24.0,3185.0,0.0,1.0,<2 mo. follow-up,3.7597656
68.23297,male,0.0,MOSF w/Malig,16.0,>$50k,110698.0,white,yes,0.5,0.125,no dnr,16.0,67.0,5.59960938,125.0,23.0,38.0,107.04688,3.8999023,4.19921875,3.29980469,139.0,7.399414,231.0,42.0,990.0,0.0,2.0,adl>=4 (>=5 if sur),2.0
70.04199,male,0.0,Colon Cancer,12.0,$11-$25k,22080.0,white,metastatic,0.899999619,0.7999997,no dnr,8.0,115.0,11.6992188,112.0,24.0,36.79688,224.0,2.8999023,0.89990234,0.69995117,138.0,7.419922,135.0,7.0,570.0,0.0,0.0,no(M2 and SIP pres),0.0
71.36798,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,86494.0,white,no,0.199999928,0.8999996,dnr after sadm,9.0,70.0,7.0,110.0,14.0,36.5,373.3125,2.8999023,1.69995117,2.09960938,137.0,7.329102,69.0,110.0,2210.0,0.0,1.0,<2 mo. follow-up,2.8989258
43.25497,male,0.0,ARF/MOSF w/Sepsis,15.0,$25-$50k,186516.0,white,no,0.799999714,0.7999997,no dnr,11.0,62.0,14.6992188,125.0,26.0,38.59375,173.3125,2.8999023,2.29980469,1.89990234,145.0,7.429688,241.0,38.0,1926.0,1.0,1.0,no(M2 and SIP pres),1.1667481
73.90594,male,0.0,Colon Cancer,12.0,under $11k,12433.0,white,metastatic,0.299999952,0.5,dnr after sadm,3.0,62.0,15.3984375,75.0,6.0,35.39844,87.0,2.3999023,28.0976562,1.39990234,130.0,7.439453,145.0,22.0,3695.0,0.0,1.0,<2 mo. follow-up,2.9345703
59.19498,male,0.0,CHF,12.0,$11-$25k,31431.0,white,no,0.599999905,0.3,no dnr,8.0,140.0,15.0996094,110.0,50.0,38.0,193.3125,2.8999023,0.89990234,1.19995117,142.0,7.549805,160.0,22.0,3355.0,5.0,4.0,adl>=4 (>=5 if sur),4.0
70.81195,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,213777.0,white,yes,0.799999714,0.6499996,dnr after sadm,7.0,115.0,10.5,106.0,24.0,38.5,224.0,3.8999023,1.0,1.0,134.0,7.419922,82.0,9.0,2950.0,0.0,2.0,<2 mo. follow-up,2.0
73.98499,female,0.0,ARF/MOSF w/Sepsis,10.0,$11-$25k,140801.0,black,no,0.699999809,0.5,no dnr,9.0,57.0,34.1953125,110.0,24.0,35.69531,165.28125,3.0996094,3.0,3.29980469,133.0,7.469727,70.0,54.0,4600.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
70.41797,female,0.0,Colon Cancer,14.0,under $11k,22418.0,hispanic,metastatic,1.0,0.9499998,no dnr,8.0,71.0,15.0,80.0,24.0,35.79688,120.0,2.8999023,4.09960938,1.69995117,135.0,7.379883,131.0,67.0,1304.0,1.0,1.0,no(M2 and SIP pres),1.1667481
79.93195,female,1.0,ARF/MOSF w/Sepsis,18.0,under $11k,207417.0,white,no,0.599999905,0.5,dnr after sadm,21.0,84.0,8.3984375,58.0,24.0,35.79688,224.0,2.199707,0.89990234,0.59997559,133.0,7.419922,135.0,10.0,1968.0,0.0,6.0,<2 mo. follow-up,6.0
66.62299,female,0.0,ARF/MOSF w/Sepsis,13.0,>$50k,53890.0,white,no,0.899999619,0.8999996,no dnr,7.0,52.0,10.5996094,100.0,22.0,36.5,224.0,2.8999023,1.09985352,1.79980469,127.0,7.419922,118.0,67.0,2310.0,0.0,0.0,<2 mo. follow-up,0.0
58.69998,female,1.0,ARF/MOSF w/Sepsis,16.0,under $11k,208373.0,white,no,0.849999905,0.8499999,dnr after sadm,13.0,68.0,23.0976562,125.0,12.0,37.79688,395.0,2.8999023,0.89990234,0.69995117,136.0,7.40918,215.0,10.0,1950.0,0.0,1.0,<2 mo. follow-up,1.0
29.26999,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,272792.0,hispanic,no,0.599999905,0.5999999,dnr after sadm,9.0,105.0,14.5996094,65.0,24.0,38.5,224.0,2.8999023,0.89990234,0.79992676,132.0,7.419922,89.0,17.0,2230.0,0.0,1.0,<2 mo. follow-up,3.0727539
36.26797,female,0.0,ARF/MOSF w/Sepsis,21.0,>$50k,262040.0,white,no,0.949999809,0.9499998,no dnr,22.0,67.0,13.5,100.0,24.0,38.19531,224.0,3.5996094,0.5,0.89990234,136.0,7.419922,135.0,9.0,1600.0,0.0,0.0,no(M2 and SIP pres),0.0
97.23999,male,0.0,CHF,12.0,under $11k,19291.0,white,no,0.799999714,0.05999997,no dnr,10.0,73.0,10.2988281,83.0,20.0,37.09375,252.375,3.699707,0.5,1.69995117,136.0,7.369141,138.0,19.0,1968.0,0.0,6.0,<2 mo. follow-up,6.0
44.37198,male,0.0,MOSF w/Malig,14.0,>$50k,174634.0,white,yes,0.599999905,0.5,no dnr,22.0,65.0,13.6992188,80.0,27.0,37.69531,300.0,2.8999023,0.89990234,0.79992676,135.0,7.419922,135.0,19.0,4165.0,0.0,0.0,no(M2 and SIP pres),0.0
62.06198,male,0.0,Coma,16.0,>$50k,105947.0,white,no,0.75,0.6999998,no dnr,13.0,117.0,8.19921875,108.0,22.0,36.59375,224.0,2.8999023,0.89990234,0.69995117,139.0,7.419922,135.0,5.0,2000.0,0.0,1.0,no(M2 and SIP pres),1.8569336
57.97699,male,1.0,MOSF w/Malig,12.0,under $11k,70163.0,white,yes,0.699999809,0.5,dnr after sadm,3.0,113.0,25.3984375,155.0,60.0,39.69531,91.42188,1.7998047,0.69995117,0.79992676,135.0,7.349609,262.0,14.0,5101.0,0.0,1.0,<2 mo. follow-up,3.3110352
75.96698,male,0.0,COPD,0.0,$11-$25k,21141.0,white,yes,0.849999905,0.7999997,no dnr,7.0,105.0,6.19921875,115.0,10.0,38.0,228.0,3.0,8.79882812,1.59985352,155.0,7.5,259.0,99.0,6920.0,2.0,1.0,<2 mo. follow-up,1.8388672
71.99695,female,0.0,Coma,12.0,under $11k,155313.0,white,no,0.5,0.5,no dnr,21.0,105.0,15.5,135.0,26.0,39.0,340.0,2.8999023,0.89990234,0.79992676,125.0,7.529297,114.0,16.0,4950.0,0.0,1.0,<2 mo. follow-up,2.0209961
31.403,female,0.0,ARF/MOSF w/Sepsis,21.0,>$50k,84726.0,white,no,0.799999714,0.7999997,no dnr,14.0,99.0,11.8984375,76.0,24.0,36.39844,224.0,2.8999023,0.89990234,1.19995117,133.0,7.419922,131.0,19.0,1400.0,0.0,1.0,<2 mo. follow-up,2.734375
59.87097,male,0.0,Colon Cancer,12.0,under $11k,20640.0,white,metastatic,0.899999619,0.5,no dnr,6.0,102.0,0.04999542,65.0,24.0,36.39844,452.0,2.8999023,1.5,0.69995117,130.0,7.489258,135.0,16.0,3400.0,0.0,1.0,no(M2 and SIP pres),2.0478516
71.12897,female,0.0,COPD,13.0,$11-$25k,57493.0,white,no,0.75,0.75,no dnr,8.0,58.0,14.0996094,115.0,28.0,38.0,415.0,2.8999023,1.29980469,1.89990234,135.0,7.40918,301.0,30.0,1640.0,0.0,1.0,Coma or Intub,3.3452148
69.19397,male,0.0,CHF,12.0,under $11k,23046.0,white,yes,0.899999619,0.75,dnr after sadm,3.0,133.0,19.8984375,155.0,33.0,37.89844,177.53125,2.3999023,18.1992188,2.19970703,144.0,7.449219,135.0,85.0,2665.0,0.0,4.0,<2 mo. follow-up,4.0
64.02197,male,0.0,Colon Cancer,12.0,under $11k,50669.0,white,metastatic,1.0,0.6499996,no dnr,12.0,71.0,10.5996094,82.0,20.0,36.0,278.25,2.8999023,0.89990234,1.0,131.0,7.449219,135.0,18.0,4875.0,0.0,1.0,<2 mo. follow-up,3.3325195
71.49097,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,136072.0,black,no,0.199999928,0.1999999,no dnr,13.0,75.0,22.5976562,75.0,11.0,38.59375,455.0,2.8999023,0.89990234,0.59997559,142.0,7.55957,150.0,15.0,840.0,0.0,1.0,<2 mo. follow-up,3.0576172
45.19598,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,481895.0,white,no,0.599999905,0.5999999,no dnr,27.0,62.0,2.19970703,115.0,56.0,36.19531,193.875,2.8999023,2.59960938,0.79992676,134.0,7.439453,171.0,12.0,8210.0,0.0,1.0,<2 mo. follow-up,2.9648438
28.627,male,0.0,CHF,10.0,under $11k,30279.0,hispanic,no,0.5,0.5,no dnr,8.0,85.0,15.2988281,120.0,14.0,38.59375,224.0,2.8999023,0.89990234,0.89990234,137.0,7.419922,136.0,12.0,850.0,0.0,0.0,<2 mo. follow-up,0.0
54.14099,male,0.0,Cirrhosis,12.0,under $11k,13221.0,white,no,0.799999714,0.7999997,no dnr,5.0,98.0,17.0976562,135.0,39.0,36.5,225.6875,2.8999023,0.89990234,1.0,130.0,7.389648,224.0,23.0,2487.0,0.0,1.0,<2 mo. follow-up,3.0756836
46.04199,female,0.0,Colon Cancer,12.0,under $11k,15981.0,white,metastatic,0.699999809,0.5999999,no dnr,6.0,51.0,10.5996094,95.0,20.0,35.89844,224.0,2.8999023,0.89990234,1.69995117,128.0,7.419922,135.0,27.0,2750.0,0.0,1.0,<2 mo. follow-up,1.9838867
71.19495,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,141913.0,white,yes,0.5,0.3,dnr before sadm,-27.0,72.0,14.0996094,125.0,32.0,37.89844,183.65625,3.2998047,0.89990234,1.39990234,140.0,7.169922,196.0,13.0,2140.0,0.0,0.0,no(M2 and SIP pres),0.0
60.25998,female,0.0,Lung Cancer,12.0,under $11k,23886.0,white,metastatic,1.0,1.0,no dnr,7.0,50.0,7.19921875,75.0,8.0,36.39844,187.5,2.8999023,0.89990234,3.39990234,149.0,7.529297,138.0,93.0,2970.0,0.0,1.0,<2 mo. follow-up,3.3417969
68.68695,male,0.0,CHF,12.0,>$50k,7975.0,white,no,0.599999905,0.5999999,no dnr,5.0,113.0,11.5,110.0,32.0,36.69531,176.0,2.2998047,2.09960938,1.5,132.0,7.449219,173.0,23.0,3785.0,0.0,1.0,no(M2 and SIP pres),0.494751
58.741,male,0.0,CHF,8.0,under $11k,33382.0,white,no,0.899999619,0.6999998,no dnr,9.0,47.0,8.19921875,105.0,20.0,35.79688,224.0,3.7998047,2.69970703,1.29980469,130.0,7.419922,112.0,17.0,3650.0,3.0,4.0,<2 mo. follow-up,4.0
71.89294,male,0.0,CHF,31.0,>$50k,4750.0,white,no,1.0,0.8999996,no dnr,4.0,83.0,8.0,80.0,16.0,37.0,224.0,2.8999023,8.8984375,1.29980469,132.0,7.419922,135.0,21.0,760.0,0.0,1.0,no(M2 and SIP pres),2.1518555
62.34399,male,0.0,CHF,14.0,$25-$50k,145561.0,white,yes,0.75,0.6999998,no dnr,17.0,93.0,6.59960938,126.0,24.0,38.39844,224.0,2.8999023,0.79992676,0.89990234,140.0,7.419922,113.0,9.0,3975.0,0.0,0.0,no(M2 and SIP pres),0.0
60.66299,female,1.0,MOSF w/Malig,12.0,under $11k,233830.0,white,yes,0.099999964,0.09999996,dnr after sadm,5.0,100.0,0.89990234,110.0,24.0,36.19531,218.34375,2.8999023,0.89990234,0.89990234,130.0,7.529297,135.0,17.0,3800.0,0.0,1.0,<2 mo. follow-up,2.8022461
50.40097,male,0.0,ARF/MOSF w/Sepsis,9.0,under $11k,81871.0,other,no,0.949999809,0.8999996,no dnr,7.0,77.0,12.0996094,114.0,24.0,36.0,224.0,2.8999023,0.89990234,1.19995117,140.0,7.419922,135.0,23.0,1550.0,0.0,1.0,<2 mo. follow-up,1.8530273
51.52399,female,0.0,Lung Cancer,14.0,under $11k,21235.0,white,metastatic,0.0,0.0,dnr before sadm,-1.0,72.0,10.5996094,75.0,16.0,36.5,224.0,2.8999023,0.89990234,1.5,142.0,7.419922,135.0,26.0,3855.0,0.0,1.0,<2 mo. follow-up,3.5327148
52.71698,male,1.0,Coma,20.0,>$50k,75660.0,black,no,0.5,0.5,dnr after sadm,8.0,50.0,6.19921875,75.0,20.0,36.79688,224.0,2.8999023,0.89990234,1.19995117,137.0,7.419922,135.0,35.0,3185.0,0.0,0.0,<2 mo. follow-up,0.0
64.64899,female,0.0,Lung Cancer,12.0,$11-$25k,29507.0,white,metastatic,1.0,1.0,no dnr,10.0,73.0,8.09960938,70.0,20.0,36.0,224.0,2.8999023,0.89990234,1.59985352,141.0,7.419922,135.0,30.0,3300.0,0.0,1.0,no(M2 and SIP pres),2.8950195
73.51996,female,0.0,Colon Cancer,12.0,under $11k,13121.0,white,metastatic,0.699999809,0.5,no dnr,8.0,68.0,35.8984375,120.0,28.0,36.0,224.0,2.8999023,0.89990234,1.19995117,136.0,7.419922,135.0,21.0,2790.0,0.0,1.0,<2 mo. follow-up,2.8608398
63.685,female,1.0,Coma,11.0,$11-$25k,207959.0,white,yes,0.299999952,0.1999999,dnr after sadm,18.0,52.0,0.04999542,105.0,10.0,35.69531,131.0,2.8999023,15.0996094,3.09960938,142.0,7.239258,326.0,32.0,0.0,0.0,3.0,<2 mo. follow-up,3.0
66.33295,male,0.0,ARF/MOSF w/Sepsis,14.0,under $11k,933220.0,white,no,0.5,0.5,no dnr,118.0,62.0,7.79980469,100.0,36.0,38.29688,315.0,2.8999023,0.89990234,0.79992676,136.0,7.449219,135.0,13.0,2430.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
38.76498,male,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,143626.0,white,no,0.899999619,0.8999996,no dnr,10.0,61.0,5.5,116.0,12.0,36.19531,224.0,2.8999023,0.89990234,0.69995117,143.0,7.419922,135.0,9.0,1550.0,0.0,0.0,<2 mo. follow-up,0.0
65.55798,male,0.0,Cirrhosis,21.0,$11-$25k,9123.0,white,no,1.0,0.8999996,no dnr,6.0,122.0,110.0,55.0,14.0,38.69531,165.0,2.8999023,0.89990234,2.0,143.0,7.469727,281.0,25.0,2380.0,0.0,1.0,no(M2 and SIP pres),0.494751
46.56,female,1.0,ARF/MOSF w/Sepsis,12.0,>$50k,149633.0,white,no,0.199999928,0.09999996,dnr after sadm,6.0,72.0,6.19921875,76.0,20.0,37.79688,224.0,2.8999023,0.89990234,1.19995117,140.0,7.419922,135.0,23.0,1850.0,0.0,2.0,<2 mo. follow-up,2.0
67.89294,female,0.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,269491.0,white,no,0.799999714,0.6999998,no dnr,20.0,76.0,9.3984375,72.0,20.0,36.0,224.0,2.8999023,0.39996338,1.09985352,141.0,7.419922,135.0,18.0,1400.0,0.0,0.0,no(M2 and SIP pres),0.0
58.24197,male,0.0,Colon Cancer,12.0,$11-$25k,11848.0,white,metastatic,0.0,0.0,dnr after sadm,1.0,92.0,3.39990234,105.0,26.0,36.0,224.0,1.5,17.0,2.09960938,126.0,7.419922,84.0,66.0,875.0,0.0,1.0,adl>=4 (>=5 if sur),2.4750977
68.65997,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,71707.0,white,no,0.899999619,0.8999996,no dnr,4.0,60.0,25.1992188,105.0,28.0,38.0,332.5,2.8999023,0.89990234,3.19970703,142.0,7.489258,212.0,49.0,585.0,0.0,0.0,<2 mo. follow-up,0.0
53.49197,female,0.0,ARF/MOSF w/Sepsis,4.0,under $11k,199060.0,hispanic,no,0.099999964,0.04999998,no dnr,13.0,65.0,9.3984375,95.0,6.0,36.29688,455.0,2.8999023,6.89941406,1.89990234,149.0,7.539062,73.0,53.0,2945.0,0.0,5.0,<2 mo. follow-up,5.0
70.71295,female,0.0,Colon Cancer,12.0,under $11k,35262.0,white,metastatic,1.0,0.9499998,no dnr,10.0,77.0,4.79980469,78.0,20.0,35.69531,224.0,3.8999023,3.0,1.5,138.0,7.419922,111.0,31.0,1825.0,0.0,1.0,<2 mo. follow-up,2.4257812
68.73895,male,1.0,ARF/MOSF w/Sepsis,16.0,$25-$50k,58336.0,white,no,0.049999982,0.04999998,dnr after sadm,4.0,52.0,6.59960938,115.0,40.0,38.59375,270.0,2.8999023,46.0,3.69970703,143.0,7.449219,340.0,95.0,424.0,0.0,1.0,<2 mo. follow-up,2.9160156
60.87097,male,0.0,Colon Cancer,12.0,under $11k,11670.0,white,metastatic,0.899999619,0.1999999,no dnr,5.0,65.0,6.59960938,75.0,8.0,38.0,224.0,3.2998047,3.0,3.5,135.0,7.419922,106.0,101.0,3360.0,0.0,1.0,<2 mo. follow-up,3.1943359
77.14398,male,0.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,328863.0,white,yes,0.5,0.5,no dnr,24.0,74.0,9.09960938,110.0,18.0,36.0,224.0,2.0,0.29998779,0.69995117,120.0,7.419922,84.0,8.0,900.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
61.92999,male,0.0,Cirrhosis,8.0,under $11k,7500.0,hispanic,no,0.5,0.0,no dnr,6.0,72.0,8.09960938,55.0,20.0,36.19531,91.65625,2.8999023,0.59997559,1.39990234,138.0,7.419922,135.0,26.0,1636.0,0.0,1.0,no(M2 and SIP pres),0.494751
43.05798,female,0.0,ARF/MOSF w/Sepsis,16.0,>$50k,94436.0,white,no,0.5,0.09999996,no dnr,15.0,70.0,26.0976562,110.0,28.0,35.5,302.5,2.8999023,22.5976562,2.19970703,133.0,7.349609,223.0,77.0,1885.0,0.0,1.0,no(M2 and SIP pres),2.9926758
54.47998,male,0.0,MOSF w/Malig,12.0,under $11k,19860.0,white,metastatic,0.049999982,0.009999998,no dnr,6.0,65.0,8.59960938,75.0,24.0,38.09375,224.0,2.8999023,0.5,1.19995117,138.0,7.419922,95.0,18.0,4085.0,0.0,1.0,<2 mo. follow-up,0.494751
80.323,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,51079.0,white,no,0.699999809,0.5,dnr after sadm,3.0,99.0,7.0,79.0,28.0,36.39844,252.375,2.8999023,0.89990234,0.79992676,137.0,7.449219,95.0,15.0,1925.0,0.0,1.0,<2 mo. follow-up,6.4658203
32.28198,male,1.0,MOSF w/Malig,13.0,under $11k,226262.0,hispanic,yes,0.5,0.3,dnr after sadm,11.0,52.0,28.3984375,70.0,34.0,35.79688,184.0,2.2998047,27.6992188,4.5,145.0,7.449219,207.0,66.0,35.0,0.0,0.0,<2 mo. follow-up,0.0
44.73099,male,1.0,ARF/MOSF w/Sepsis,18.0,under $11k,800959.0,white,no,0.5,0.5,dnr after sadm,33.0,109.0,6.19921875,85.0,28.0,36.59375,313.3125,2.8999023,0.89990234,1.0,134.0,7.459961,154.0,16.0,3350.0,0.0,0.0,<2 mo. follow-up,0.0
49.44598,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,53642.0,hispanic,yes,0.699999809,0.5,dnr before sadm,0.0,60.0,29.0,120.0,24.0,36.0,120.0,2.8999023,3.09960938,8.5,142.0,7.429688,146.0,89.0,55.0,0.0,1.0,<2 mo. follow-up,4.1162109
68.07098,male,0.0,ARF/MOSF w/Sepsis,6.0,$11-$25k,96931.0,white,yes,0.899999619,0.8999996,no dnr,12.0,71.0,4.69921875,78.0,20.0,36.79688,224.0,2.8999023,1.59985352,1.19995117,127.0,7.419922,282.0,30.0,2100.0,0.0,1.0,<2 mo. follow-up,2.5209961
61.71899,male,0.0,CHF,12.0,under $11k,205874.0,white,no,0.919999599,0.8499999,no dnr,28.0,75.0,20.8984375,104.0,30.0,38.59375,173.3125,2.8999023,1.09985352,1.19995117,138.0,7.479492,135.0,23.0,2050.0,1.0,1.0,<2 mo. follow-up,1.1667481
63.15097,male,1.0,CHF,10.0,$11-$25k,276936.0,white,no,0.5,0.25,dnr after sadm,40.0,98.0,11.6992188,50.0,20.0,35.5,224.0,2.8999023,0.89990234,1.29980469,149.0,7.419922,429.0,37.0,2085.0,5.0,1.0,<2 mo. follow-up,1.0
58.68597,female,0.0,Lung Cancer,12.0,$11-$25k,18292.0,black,metastatic,1.0,1.0,no dnr,6.0,57.0,44.0,125.0,35.0,36.0,233.3125,2.8999023,0.89990234,1.0,136.0,7.449219,415.0,34.0,1870.0,0.0,0.0,no(M2 and SIP pres),0.0
65.19598,male,1.0,ARF/MOSF w/Sepsis,18.0,>$50k,25024.0,white,no,0.5,0.3299999,dnr after sadm,11.0,122.0,30.3984375,125.0,12.0,36.59375,300.0,2.8999023,0.89990234,4.0,145.0,7.419922,95.0,119.0,694.0,0.0,1.0,<2 mo. follow-up,1.0
62.81998,male,0.0,CHF,12.0,$11-$25k,62304.0,white,no,0.799999714,0.5999999,no dnr,19.0,67.0,25.3984375,75.0,10.0,36.09375,375.0,4.0,7.79980469,2.29980469,133.0,7.349609,89.0,46.0,2785.0,0.0,0.0,<2 mo. follow-up,0.0
90.35699,male,0.0,CHF,5.0,$11-$25k,9994.0,white,no,0.899999619,0.75,no dnr,6.0,66.0,10.5,38.0,24.0,35.29688,224.0,3.7998047,1.79980469,2.0,139.0,7.419922,105.0,29.0,2225.0,0.0,1.0,<2 mo. follow-up,0.494751
58.98199,male,0.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,267221.0,asian,no,0.899999619,0.7999997,no dnr,8.0,57.0,7.79980469,105.0,12.0,36.59375,163.5,2.3999023,36.3984375,5.19921875,135.0,7.109375,98.0,48.0,240.0,0.0,1.0,no(M2 and SIP pres),1.0
79.896,male,1.0,Coma,12.0,under $11k,73135.0,white,no,0.099999964,0.04999998,dnr after sadm,1.0,127.0,18.6992188,120.0,38.0,38.59375,208.15625,2.8999023,0.89990234,1.69995117,130.0,7.489258,135.0,19.0,3186.0,0.0,1.0,<2 mo. follow-up,5.7919922
77.74396,female,1.0,CHF,18.0,under $11k,34096.0,white,no,0.949999809,0.7999997,no dnr,12.0,57.0,5.89941406,135.0,22.0,36.89844,224.0,3.5996094,0.79992676,1.19995117,134.0,7.419922,135.0,25.0,3120.0,5.0,5.0,<2 mo. follow-up,5.0
72.05194,male,0.0,CHF,12.0,under $11k,27158.0,hispanic,no,0.5,0.5,no dnr,9.0,57.0,7.09960938,65.0,28.0,36.5,224.0,2.8999023,0.29998779,1.19995117,132.0,7.419922,135.0,13.0,2810.0,0.0,1.0,no(M2 and SIP pres),3.253418
61.49799,female,0.0,Lung Cancer,12.0,under $11k,6507.0,white,metastatic,0.399999857,0.04999998,no dnr,4.0,97.0,10.5996094,110.0,22.0,37.89844,224.0,2.8999023,0.89990234,1.19995117,140.0,7.419922,136.0,23.0,3100.0,0.0,0.0,<2 mo. follow-up,0.0
53.26797,female,1.0,ARF/MOSF w/Sepsis,16.0,$11-$25k,309174.0,white,no,0.699999809,0.5,no dnr,21.0,55.0,27.5976562,95.0,10.0,38.69531,267.5,2.8999023,13.0,3.69970703,132.0,7.55957,135.0,61.0,0.0,0.0,1.0,<2 mo. follow-up,0.494751
67.16998,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,326479.0,white,no,0.5,0.5,dnr after sadm,22.0,73.0,14.1992188,55.0,24.0,36.5,224.0,2.5996094,0.69995117,1.59985352,135.0,7.419922,165.0,37.0,4220.0,0.0,1.0,<2 mo. follow-up,2.9189453
86.41998,male,1.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,88769.0,white,no,0.5,0.5,dnr after sadm,2.0,65.0,11.8984375,124.0,52.0,39.39844,224.0,2.8999023,0.89990234,0.79992676,136.0,7.419922,116.0,22.0,1425.0,0.0,1.0,<2 mo. follow-up,4.0419922
48.76898,male,0.0,ARF/MOSF w/Sepsis,14.0,>$50k,318152.0,white,no,0.899999619,0.7999997,no dnr,27.0,70.0,10.5996094,55.0,20.0,36.0,224.0,2.8999023,0.89990234,2.0,139.0,7.419922,117.0,40.0,1745.0,0.0,0.0,no(M2 and SIP pres),0.0
41.12799,female,0.0,Coma,14.0,$25-$50k,141917.0,white,no,0.699999809,0.5,dnr after sadm,22.0,107.0,1.89990234,60.0,26.0,38.0,336.625,2.699707,0.69995117,1.59985352,133.0,7.459961,98.0,16.0,2313.0,0.0,7.0,<2 mo. follow-up,7.0
52.31998,male,0.0,CHF,16.0,>$50k,14200.0,white,no,0.899999619,0.7999997,no dnr,4.0,63.0,7.0,75.0,40.0,38.0,67.76562,1.8999023,0.59997559,1.09985352,132.0,7.519531,113.0,26.0,1496.0,0.0,1.0,no(M2 and SIP pres),2.1513672
71.75397,male,0.0,ARF/MOSF w/Sepsis,18.0,under $11k,198019.0,white,no,0.849999905,0.8499999,no dnr,38.0,71.0,8.09960938,66.0,22.0,35.59375,224.0,2.8999023,0.79992676,1.0,140.0,7.419922,413.0,18.0,2975.0,0.0,5.0,<2 mo. follow-up,5.0
64.41595,female,1.0,ARF/MOSF w/Sepsis,10.0,$11-$25k,81959.0,hispanic,no,0.699999809,0.5,dnr after sadm,10.0,65.0,10.7988281,70.0,32.0,36.39844,376.1875,2.8999023,0.89990234,1.19995117,140.0,7.399414,156.0,24.0,1925.0,0.0,7.0,<2 mo. follow-up,7.0
56.66299,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,184814.0,white,no,0.699999809,0.5,no dnr,17.0,66.0,12.3984375,64.0,22.0,36.39844,224.0,3.7998047,0.89990234,0.79992676,136.0,7.419922,260.0,14.0,2350.0,0.0,1.0,<2 mo. follow-up,2.5776367
20.73099,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,25024.0,hispanic,no,0.5,0.5,no dnr,21.0,48.0,15.7988281,100.0,24.0,38.0,273.3125,2.8999023,0.89990234,1.5,130.0,7.539062,135.0,24.0,1745.0,0.0,1.0,no(M2 and SIP pres),2.8066406
77.31097,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,318057.0,black,yes,0.849999905,0.7999997,no dnr,56.0,50.0,9.5,135.0,13.0,39.39844,196.0,1.5998535,1.79980469,0.89990234,135.0,7.369141,236.0,21.0,1800.0,0.0,0.0,no(M2 and SIP pres),0.0
56.03299,male,1.0,ARF/MOSF w/Sepsis,18.0,$11-$25k,52414.0,white,no,0.699999809,0.5,dnr after sadm,3.0,78.0,12.0,115.0,36.0,36.79688,71.65625,2.8999023,0.89990234,3.89990234,128.0,7.489258,145.0,73.0,2350.0,0.0,0.0,<2 mo. follow-up,0.0
76.42999,male,0.0,Lung Cancer,12.0,>$50k,29862.0,white,metastatic,0.949999809,0.5,no dnr,11.0,70.0,14.6992188,75.0,10.0,38.19531,212.0,2.8999023,1.59985352,3.09960938,152.0,7.519531,492.0,111.0,2264.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
69.58795,male,0.0,Lung Cancer,16.0,under $11k,9532.0,other,metastatic,0.799999714,0.5999999,no dnr,5.0,65.0,17.5976562,165.0,26.0,38.39844,85.0,2.8999023,0.89990234,1.0,132.0,7.359375,253.0,18.0,1440.0,0.0,1.0,<2 mo. follow-up,2.340332
70.32996,female,0.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,65043.0,white,metastatic,0.799999714,0.5,no dnr,15.0,62.0,9.69921875,65.0,20.0,36.19531,224.0,3.8999023,0.59997559,0.89990234,139.0,7.419922,124.0,18.0,1660.0,0.0,1.0,<2 mo. follow-up,1.0
68.34497,female,0.0,ARF/MOSF w/Sepsis,16.0,>$50k,118074.0,white,no,0.799999714,0.7999997,no dnr,16.0,85.0,20.296875,125.0,30.0,38.59375,315.5,2.8999023,0.89990234,2.89990234,147.0,7.429688,101.0,68.0,2545.0,0.0,1.0,<2 mo. follow-up,2.8154297
76.76099,male,0.0,CHF,16.0,$25-$50k,82924.0,white,no,0.779999733,0.6799998,no dnr,24.0,73.0,5.89941406,75.0,10.0,38.29688,186.0,2.8999023,0.89990234,1.39990234,152.0,7.339844,135.0,38.0,548.0,2.0,2.0,<2 mo. follow-up,2.0
58.823,female,0.0,CHF,14.0,$11-$25k,58144.0,white,no,0.799999714,0.6999998,no dnr,12.0,98.0,19.5,115.0,29.0,38.69531,585.0,2.8999023,0.69995117,0.59997559,131.0,7.519531,172.0,12.0,3055.0,0.0,1.0,<2 mo. follow-up,3.0629883
31.79999,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,285267.0,black,no,0.699999809,0.5999999,dnr after sadm,21.0,115.0,14.6992188,140.0,24.0,39.29688,402.5,2.8999023,5.29980469,1.09985352,128.0,7.459961,221.0,18.0,3765.0,0.0,2.0,<2 mo. follow-up,2.0
55.32898,male,0.0,CHF,14.0,>$50k,39435.0,white,no,0.849999905,0.6999998,no dnr,11.0,82.0,20.1992188,110.0,26.0,37.39844,137.5,2.2998047,0.89990234,1.39990234,140.0,7.429688,104.0,12.0,1148.0,0.0,0.0,<2 mo. follow-up,0.0
55.35098,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,559190.0,white,no,0.5,0.5,no dnr,24.0,65.0,12.0996094,115.0,31.0,37.79688,220.0,2.699707,46.5,7.79980469,138.0,7.5,184.0,96.0,328.0,0.0,1.0,<2 mo. follow-up,3.6201172
40.05197,female,0.0,Colon Cancer,14.0,under $11k,26709.0,asian,metastatic,0.399999857,0.1999999,no dnr,11.0,77.0,13.6992188,80.0,20.0,36.59375,224.0,2.8999023,0.89990234,1.19995117,134.0,7.419922,135.0,14.0,2900.0,0.0,1.0,no(M2 and SIP pres),0.494751
33.043,male,0.0,ARF/MOSF w/Sepsis,11.0,$11-$25k,584811.0,hispanic,no,0.5,0.5,no dnr,62.0,83.0,3.0,104.0,22.0,39.19531,224.0,2.8999023,0.79992676,1.29980469,138.0,7.419922,144.0,15.0,2750.0,0.0,1.0,no(M2 and SIP pres),3.3510742
75.20898,female,0.0,CHF,14.0,under $11k,16236.0,hispanic,no,0.899999619,0.6999998,no dnr,7.0,67.0,20.5976562,55.0,25.0,36.0,371.0,2.8999023,0.29998779,1.19995117,129.0,7.609375,289.0,25.0,1466.0,0.0,0.0,no(M2 and SIP pres),0.0
59.55099,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,49137.0,white,metastatic,0.199999928,0.03999999,dnr after sadm,1.0,68.0,13.6992188,145.0,32.0,37.69531,344.0,2.8999023,0.89990234,0.79992676,140.0,7.539062,133.0,14.0,2183.0,0.0,1.0,<2 mo. follow-up,3.3422852
65.30298,male,1.0,Coma,16.0,under $11k,114803.0,white,no,0.099999964,0.09999996,dnr after sadm,7.0,46.0,8.09960938,75.0,22.0,36.5,224.0,3.3999023,2.09960938,1.29980469,130.0,7.419922,108.0,35.0,3113.0,0.0,1.0,<2 mo. follow-up,1.0
34.31299,male,1.0,ARF/MOSF w/Sepsis,14.0,under $11k,109897.0,white,no,0.199999928,0.04999998,dnr after sadm,1.0,49.0,5.0,55.0,22.0,35.79688,224.0,2.8999023,0.89990234,0.69995117,124.0,7.419922,135.0,25.0,3550.0,0.0,1.0,<2 mo. follow-up,1.0
68.51495,female,0.0,Coma,16.0,under $11k,269996.0,white,no,0.75,0.75,no dnr,28.0,60.0,25.5976562,65.0,34.0,38.5,247.5,2.8999023,0.19998169,5.59960938,136.0,7.469727,135.0,79.0,0.0,0.0,0.0,Coma or Intub,0.0
70.56494,female,0.0,Lung Cancer,20.0,under $11k,13976.0,white,metastatic,0.949999809,0.6999998,no dnr,6.0,63.0,10.3984375,75.0,16.0,36.29688,224.0,3.699707,2.39990234,1.5,126.0,7.419922,94.0,24.0,3625.0,0.0,1.0,no(M2 and SIP pres),2.3232422
59.31,female,0.0,Cirrhosis,12.0,under $11k,45458.0,white,no,0.5,0.3999999,no dnr,16.0,132.0,2.39990234,125.0,44.0,37.79688,182.0,2.8999023,1.19995117,4.39941406,140.0,7.339844,356.0,91.0,492.0,0.0,1.0,<2 mo. follow-up,4.1611328
35.17297,male,1.0,MOSF w/Malig,12.0,$11-$25k,194955.0,hispanic,yes,0.009999998,0.0,dnr after sadm,4.0,106.0,8.69921875,76.0,14.0,37.5,224.0,2.8999023,0.29998779,0.79992676,132.0,7.419922,85.0,11.0,1800.0,0.0,0.0,<2 mo. follow-up,0.0
60.39999,male,0.0,MOSF w/Malig,10.0,under $11k,81201.0,white,metastatic,0.699999809,0.5,no dnr,7.0,128.0,31.3984375,125.0,25.0,39.0,192.0,2.5,6.09960938,0.79992676,151.0,7.439453,99.0,32.0,6065.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
37.96298,male,1.0,ARF/MOSF w/Sepsis,13.0,$11-$25k,569861.0,white,no,0.049999982,0.04999998,dnr after sadm,10.0,63.0,6.69921875,105.0,20.0,36.0,224.0,2.8999023,0.89990234,1.89990234,137.0,7.419922,135.0,42.0,1875.0,0.0,0.0,<2 mo. follow-up,0.0
56.56097,male,0.0,ARF/MOSF w/Sepsis,16.0,>$50k,690753.0,white,no,0.199999928,0.1999999,no dnr,48.0,72.0,9.79882812,72.0,28.0,36.39844,224.0,2.8999023,0.89990234,0.69995117,136.0,7.419922,159.0,7.0,3625.0,0.0,1.0,<2 mo. follow-up,2.6245117
65.29999,female,0.0,Lung Cancer,12.0,under $11k,14436.0,white,metastatic,0.699999809,0.5,no dnr,4.0,122.0,6.19921875,145.0,8.0,38.89844,476.1875,2.8999023,2.89990234,2.39990234,130.0,7.569336,135.0,54.0,2518.0,0.0,1.0,<2 mo. follow-up,3.4487305
84.08496,male,0.0,CHF,16.0,>$50k,29939.0,white,no,0.799999714,0.5999999,no dnr,12.0,117.0,19.5,103.0,24.0,36.19531,224.0,2.8999023,0.89990234,1.89990234,134.0,7.419922,175.0,46.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
71.05798,female,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,178983.0,white,yes,0.799999714,0.6999998,no dnr,33.0,115.0,1.59985352,35.0,50.0,37.59375,72.5,2.8999023,5.19921875,0.79992676,137.0,7.419922,192.0,32.0,1075.0,0.0,0.0,no(M2 and SIP pres),0.0
36.33099,male,1.0,Coma,12.0,under $11k,191073.0,white,no,0.099999964,0.09999996,dnr after sadm,10.0,120.0,12.7988281,125.0,30.0,39.19531,224.0,2.8999023,0.89990234,0.69995117,131.0,7.419922,146.0,14.0,2795.0,0.0,1.0,<2 mo. follow-up,2.7856445
78.26996,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,155711.0,white,yes,0.5,0.3999999,no dnr,6.0,73.0,0.19998169,72.0,24.0,38.19531,224.0,2.8999023,0.89990234,0.59997559,132.0,7.419922,135.0,6.0,2150.0,0.0,2.0,Coma or Intub,2.0
83.49597,male,0.0,ARF/MOSF w/Sepsis,9.0,under $11k,174489.0,white,yes,0.5,0.5,no dnr,21.0,103.0,7.09960938,67.0,24.0,36.09375,220.0,2.8999023,0.39996338,1.0,140.0,7.359375,169.0,18.0,1968.0,0.0,1.0,<2 mo. follow-up,4.5117188
48.58298,male,0.0,CHF,12.0,under $11k,222936.0,white,no,0.799999714,0.7999997,no dnr,30.0,68.0,9.8984375,98.0,24.0,36.19531,224.0,2.3999023,7.39941406,0.59997559,143.0,7.419922,103.0,3.0,3800.0,0.0,1.0,<2 mo. follow-up,3.1904297
63.33499,male,0.0,Colon Cancer,16.0,>$50k,43200.0,white,metastatic,1.0,0.5,no dnr,10.0,105.0,9.3984375,50.0,26.0,39.0,480.0,2.8999023,0.89990234,0.69995117,132.0,7.509766,271.0,10.0,2570.0,0.0,1.0,<2 mo. follow-up,1.0
34.53497,female,1.0,MOSF w/Malig,12.0,under $11k,437598.0,hispanic,yes,0.349999905,0.25,dnr after sadm,10.0,110.0,4.59960938,62.0,24.0,36.79688,224.0,2.8999023,0.89990234,1.29980469,138.0,7.419922,366.0,33.0,4400.0,0.0,1.0,<2 mo. follow-up,4.1826172
53.69699,male,0.0,CHF,12.0,$25-$50k,155191.0,white,no,0.699999809,0.5,no dnr,21.0,65.0,8.8984375,125.0,10.0,38.39844,176.0,3.0996094,32.0,4.79980469,141.0,7.419922,178.0,61.0,12.0,0.0,0.0,<2 mo. follow-up,0.0
46.89099,female,0.0,CHF,12.0,$11-$25k,108058.0,white,no,0.949999809,0.9299998,no dnr,10.0,108.0,2.09960938,135.0,26.0,38.29688,142.0,2.8999023,0.59997559,5.79980469,132.0,7.299805,135.0,50.0,1045.0,1.0,0.0,<2 mo. follow-up,0.0
66.89099,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,223592.0,white,no,0.799999714,0.75,no dnr,22.0,107.0,18.0976562,66.0,24.0,38.0,224.0,2.8999023,0.89990234,0.89990234,136.0,7.419922,170.0,6.0,1175.0,0.0,1.0,<2 mo. follow-up,3.0917969
31.17599,female,1.0,ARF/MOSF w/Sepsis,11.0,$11-$25k,558904.0,hispanic,no,0.699999809,0.5,dnr after sadm,14.0,70.0,10.5996094,70.0,20.0,36.5,521.625,2.8999023,0.89990234,1.79980469,131.0,7.429688,157.0,19.0,2050.0,0.0,7.0,<2 mo. follow-up,7.0
77.55499,female,0.0,Coma,12.0,under $11k,168806.0,white,no,0.399999857,0.3,dnr after sadm,4.0,43.0,14.8984375,125.0,10.0,38.0,360.0,1.3999023,0.59997559,2.59960938,133.0,7.319336,398.0,36.0,5960.0,0.0,3.0,<2 mo. follow-up,3.0
36.70099,female,1.0,Coma,14.0,$11-$25k,139607.0,white,yes,0.199999928,0.1999999,no dnr,6.0,53.0,1.79980469,125.0,30.0,34.79688,445.6875,2.8999023,0.29998779,2.39990234,134.0,7.389648,211.0,18.0,34.0,0.0,1.0,<2 mo. follow-up,3.4394531
52.24899,male,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,154101.0,white,no,0.899999619,0.8999996,no dnr,25.0,112.0,10.2988281,120.0,40.0,35.89844,332.0,2.8999023,0.89990234,1.79980469,138.0,7.469727,135.0,48.0,3240.0,0.0,0.0,<2 mo. follow-up,0.0
80.23499,female,1.0,MOSF w/Malig,12.0,under $11k,22474.0,other,metastatic,0.099999964,0.0,no dnr,5.0,67.0,0.5,120.0,24.0,38.19531,224.0,2.3999023,1.09985352,1.19995117,135.0,7.419922,226.0,33.0,5400.0,0.0,1.0,<2 mo. follow-up,3.253418
47.49298,male,0.0,Colon Cancer,12.0,>$50k,32899.0,white,metastatic,1.0,0.8999996,no dnr,7.0,62.0,12.5,65.0,29.0,37.89844,66.25,2.8999023,0.89990234,1.29980469,142.0,7.489258,126.0,31.0,2175.0,0.0,0.0,no(M2 and SIP pres),0.0
64.75,male,0.0,ARF/MOSF w/Sepsis,17.0,>$50k,161773.0,white,yes,0.799999714,0.7999997,no dnr,18.0,70.0,9.09960938,125.0,20.0,36.5,224.0,2.8999023,0.89990234,1.29980469,130.0,7.419922,135.0,26.0,4940.0,0.0,1.0,<2 mo. follow-up,3.2602539
39.78098,male,0.0,ARF/MOSF w/Sepsis,14.0,>$50k,87541.0,white,yes,0.949999809,0.9499998,no dnr,13.0,102.0,11.0996094,80.0,24.0,36.39844,224.0,2.8999023,1.29980469,1.19995117,136.0,7.419922,161.0,16.0,1425.0,0.0,1.0,<2 mo. follow-up,0.494751
79.70398,female,0.0,CHF,14.0,$11-$25k,28450.0,white,no,0.799999714,0.6999998,no dnr,5.0,65.0,0.04999542,145.0,12.0,36.19531,421.25,1.8999023,5.59960938,3.19970703,148.0,7.5,374.0,90.0,1356.0,0.0,0.0,no(M2 and SIP pres),0.0
64.25696,male,0.0,ARF/MOSF w/Sepsis,14.0,under $11k,52715.0,white,no,0.899999619,0.75,no dnr,8.0,62.0,7.39941406,70.0,14.0,36.19531,224.0,2.8999023,0.89990234,1.5,137.0,7.419922,135.0,13.0,2095.0,0.0,0.0,no(M2 and SIP pres),0.0
48.375,female,0.0,Lung Cancer,19.0,>$50k,19535.0,white,metastatic,0.849999905,0.5,no dnr,10.0,48.0,15.8984375,145.0,8.0,38.09375,130.0,3.2998047,1.69995117,0.79992676,146.0,7.5,198.0,20.0,4120.0,0.0,1.0,<2 mo. follow-up,0.494751
52.293,male,0.0,Colon Cancer,18.0,>$50k,24621.0,white,metastatic,0.75,0.09999996,no dnr,11.0,140.0,12.0996094,65.0,34.0,38.19531,159.15625,4.5996094,1.59985352,0.79992676,132.0,7.419922,180.0,28.0,1635.0,0.0,0.0,<2 mo. follow-up,0.0
69.91595,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,269095.0,white,yes,0.699999809,0.5,no dnr,28.0,130.0,12.0996094,145.0,26.0,39.39844,334.0,2.0996094,34.0,2.59960938,156.0,7.609375,648.0,96.0,1775.0,0.0,1.0,<2 mo. follow-up,3.4599609
60.20499,female,0.0,ARF/MOSF w/Sepsis,14.0,>$50k,189109.0,asian,yes,0.5,0.25,no dnr,17.0,72.0,19.5976562,115.0,32.0,37.5,197.9375,2.8999023,0.89990234,1.69995117,155.0,7.539062,468.0,69.0,2455.0,0.0,0.0,no(M2 and SIP pres),0.0
60.91699,female,0.0,Lung Cancer,16.0,under $11k,13116.0,white,metastatic,0.799999714,0.3999999,no dnr,5.0,128.0,6.5,120.0,36.0,38.59375,127.5,2.2998047,36.0,3.0,129.0,7.539062,135.0,69.0,213.0,0.0,1.0,no(M2 and SIP pres),2.2416992
53.75198,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,345497.0,white,no,0.899999619,0.7999997,no dnr,15.0,67.0,22.796875,130.0,10.0,37.89844,200.0,2.8999023,0.79992676,0.89990234,138.0,7.479492,227.0,16.0,1245.0,0.0,1.0,<2 mo. follow-up,2.5043945
30.53799,male,0.0,ARF/MOSF w/Sepsis,16.0,$25-$50k,130205.0,white,no,0.799999714,0.7999997,no dnr,9.0,82.0,1.5,115.0,30.0,37.59375,176.1875,2.8999023,0.89990234,1.0,123.0,7.479492,173.0,26.0,1700.0,1.0,1.0,<2 mo. follow-up,1.0
73.84796,female,1.0,ARF/MOSF w/Sepsis,18.0,$11-$25k,77209.0,hispanic,no,0.5,0.3999999,dnr after sadm,8.0,94.0,6.29980469,106.0,24.0,36.59375,224.0,4.1992188,0.5,1.09985352,138.0,7.419922,78.0,16.0,1900.0,0.0,1.0,<2 mo. follow-up,4.2841797
63.93399,female,1.0,Colon Cancer,14.0,under $11k,39476.0,white,metastatic,0.5,0.0,dnr after sadm,8.0,131.0,6.29980469,116.0,25.0,38.19531,197.125,2.8999023,0.89990234,2.29980469,147.0,7.459961,135.0,23.0,5658.0,0.0,6.0,<2 mo. follow-up,6.0
71.69299,female,1.0,ARF/MOSF w/Sepsis,16.0,$11-$25k,164001.0,white,no,0.099999964,0.09999996,dnr after sadm,2.0,137.0,11.8984375,75.0,24.0,38.89844,224.0,2.8999023,1.39990234,4.69921875,126.0,7.419922,135.0,90.0,5200.0,0.0,5.0,<2 mo. follow-up,5.0
69.56897,male,0.0,COPD,8.0,under $11k,35691.0,black,no,0.899999619,0.6999998,no dnr,10.0,117.0,11.6992188,175.0,16.0,36.09375,157.125,2.8999023,0.89990234,2.09960938,138.0,7.269531,184.0,43.0,1699.0,6.0,5.0,<2 mo. follow-up,5.0
71.12396,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,227604.0,black,no,0.099999964,0.04999998,dnr after sadm,2.0,111.0,8.0,110.0,30.0,36.39844,197.5,2.8999023,0.89990234,0.79992676,136.0,7.449219,265.0,14.0,1150.0,0.0,1.0,<2 mo. follow-up,3.0898438
65.52997,female,0.0,CHF,8.0,under $11k,32728.0,black,no,0.75,0.6999998,no dnr,13.0,75.0,8.8984375,78.0,22.0,36.79688,224.0,2.8999023,0.89990234,0.79992676,138.0,7.419922,135.0,23.0,3100.0,1.0,0.0,<2 mo. follow-up,0.0
60.65997,female,0.0,Coma,12.0,under $11k,59110.0,hispanic,metastatic,0.0,0.0,dnr before sadm,-1.0,103.0,6.69921875,78.0,22.0,38.5,224.0,2.8999023,0.5,1.0,140.0,7.419922,86.0,11.0,1050.0,0.0,1.0,<2 mo. follow-up,2.8994141
75.16199,male,0.0,CHF,20.0,>$50k,43004.0,white,no,0.949999809,0.8999996,no dnr,12.0,50.0,10.5996094,95.0,32.0,37.5,367.5,1.7998047,10.1992188,2.19970703,142.0,7.439453,200.0,112.0,3425.0,1.0,0.0,no(M2 and SIP pres),0.0
60.72299,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,165860.0,white,no,0.75,0.6999998,dnr after sadm,11.0,143.0,0.04999542,135.0,36.0,35.5,540.0,3.0,0.89990234,1.5,135.0,7.55957,135.0,29.0,2480.0,0.0,1.0,<2 mo. follow-up,3.6044922
54.67499,male,0.0,Colon Cancer,16.0,>$50k,32539.0,white,metastatic,0.799999714,0.5,no dnr,10.0,73.0,5.19921875,76.0,24.0,36.39844,224.0,2.8999023,0.89990234,1.09985352,136.0,7.419922,135.0,3.0,2400.0,0.0,1.0,<2 mo. follow-up,2.9594727
56.00299,male,0.0,CHF,10.0,under $11k,130715.0,white,no,0.799999714,0.6999998,no dnr,24.0,68.0,46.5,150.0,40.0,39.29688,130.0,3.0,16.0976562,2.29980469,150.0,7.539062,300.0,63.0,2420.0,0.0,0.0,<2 mo. follow-up,0.0
58.54599,female,0.0,CHF,12.0,under $11k,11516.0,white,yes,1.0,0.6999998,no dnr,6.0,72.0,7.79980469,135.0,10.0,36.69531,391.8125,2.8999023,0.39996338,0.69995117,136.0,7.519531,103.0,7.0,5660.0,0.0,1.0,<2 mo. follow-up,3.3901367
78.27496,female,1.0,Coma,12.0,under $11k,63413.0,asian,no,0.199999928,0.5,no dnr,7.0,52.0,12.8984375,120.0,40.0,39.79688,148.875,3.3999023,0.89990234,3.59960938,143.0,7.459961,135.0,87.0,73.0,0.0,1.0,<2 mo. follow-up,2.3945312
79.07495,female,0.0,CHF,12.0,under $11k,14921.0,white,yes,0.599999905,0.3999999,dnr before sadm,-1.0,69.0,9.69921875,120.0,16.0,36.79688,224.0,1.7998047,0.89990234,0.59997559,140.0,7.419922,135.0,16.0,1968.0,0.0,3.0,no(M2 and SIP pres),3.0
71.146,male,0.0,CHF,19.0,>$50k,8208.0,white,no,0.799999714,0.6999998,no dnr,3.0,52.0,22.296875,125.0,24.0,36.19531,224.0,3.0996094,0.89990234,1.79980469,138.0,7.419922,135.0,47.0,1925.0,0.0,1.0,no(M2 and SIP pres),2.4311523
47.20898,male,0.0,CHF,12.0,$25-$50k,120554.0,white,no,0.949999809,0.9199996,no dnr,16.0,163.0,17.0,116.0,22.0,36.0,300.0,2.8999023,0.89990234,1.19995117,139.0,7.379883,282.0,26.0,1925.0,0.0,0.0,<2 mo. follow-up,0.0
52.97198,male,0.0,CHF,9.0,$25-$50k,109462.0,white,no,0.699999809,0.5499997,no dnr,5.0,52.0,44.5,150.0,14.0,38.29688,225.4375,3.0,25.796875,4.89941406,142.0,7.419922,94.0,76.0,28.0,0.0,3.0,SIP>=30,3.0
59.28299,female,1.0,MOSF w/Malig,12.0,$11-$25k,263478.0,black,yes,0.599999905,0.5999999,dnr after sadm,26.0,105.0,6.19921875,105.0,24.0,36.79688,224.0,2.8999023,0.89990234,1.09985352,139.0,7.419922,92.0,14.0,4950.0,0.0,5.0,<2 mo. follow-up,5.0
66.92096,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,259419.0,hispanic,no,0.199999928,0.1999999,no dnr,3.0,103.0,20.1992188,105.0,20.0,36.79688,224.0,2.8999023,0.89990234,0.69995117,141.0,7.419922,172.0,9.0,1750.0,0.0,0.0,<2 mo. follow-up,0.0
44.89297,female,0.0,Colon Cancer,12.0,>$50k,25024.0,white,metastatic,0.899999619,0.3,no dnr,7.0,55.0,12.7988281,75.0,12.0,38.29688,224.0,3.3999023,0.89990234,1.69995117,138.0,7.419922,128.0,30.0,1920.0,0.0,1.0,<2 mo. follow-up,0.494751
52.323,male,0.0,CHF,14.0,$11-$25k,108450.0,white,no,0.899999619,0.8499999,no dnr,13.0,55.0,11.2988281,35.0,10.0,35.0,262.5,1.8999023,20.5,1.69995117,138.0,7.40918,229.0,55.0,2211.0,0.0,1.0,no(M2 and SIP pres),3.3037109
41.60699,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,590617.0,hispanic,no,0.099999964,0.04999998,dnr after sadm,12.0,83.0,10.8984375,76.0,16.0,36.59375,224.0,2.5996094,1.0,0.89990234,137.0,7.419922,100.0,11.0,2840.0,0.0,1.0,<2 mo. follow-up,2.734375
53.50299,male,0.0,CHF,14.0,>$50k,150298.0,white,no,0.799999714,0.6999998,no dnr,17.0,63.0,12.6992188,125.0,26.0,39.09375,224.0,3.699707,1.29980469,1.29980469,138.0,7.419922,154.0,14.0,2670.0,0.0,0.0,<2 mo. follow-up,0.0
73.24799,male,0.0,Cirrhosis,18.0,under $11k,12039.0,white,no,0.299999952,0.3,dnr after sadm,2.0,107.0,6.89941406,75.0,20.0,36.0,224.0,2.8999023,0.89990234,1.89990234,142.0,7.419922,167.0,40.0,2850.0,0.0,1.0,<2 mo. follow-up,2.6772461
74.17395,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,322777.0,white,no,0.899999619,0.8999996,dnr after sadm,22.0,42.0,23.3984375,105.0,10.0,36.29688,316.0,2.8999023,0.89990234,2.0,135.0,7.25,135.0,40.0,2650.0,0.0,1.0,<2 mo. follow-up,2.5429688
57.49799,male,1.0,ARF/MOSF w/Sepsis,17.0,>$50k,347324.0,white,no,0.199999928,0.04999998,dnr after sadm,6.0,70.0,6.19921875,70.0,20.0,36.5,224.0,2.8999023,0.89990234,2.79980469,139.0,7.419922,135.0,59.0,1175.0,0.0,0.0,<2 mo. follow-up,0.0
72.20294,male,0.0,Lung Cancer,18.0,$11-$25k,38812.0,white,metastatic,0.649999619,0.3999999,no dnr,9.0,72.0,6.39941406,75.0,22.0,37.0,224.0,2.8999023,0.89990234,2.39990234,131.0,7.419922,153.0,77.0,600.0,0.0,1.0,no(M2 and SIP pres),3.4951172
57.98199,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,461451.0,asian,no,0.099999964,0.5,dnr after sadm,31.0,75.0,12.8984375,75.0,22.0,38.0,145.0,2.699707,3.59960938,1.09985352,132.0,7.619141,160.0,28.0,3700.0,0.0,1.0,<2 mo. follow-up,2.9321289
54.88599,male,0.0,CHF,14.0,under $11k,39274.0,black,no,0.799999714,0.7999997,no dnr,10.0,65.0,14.1992188,65.0,16.0,35.59375,224.0,2.8999023,0.89990234,1.59985352,125.0,7.419922,135.0,35.0,3550.0,0.0,0.0,no(M2 and SIP pres),0.0
31.84099,female,0.0,Colon Cancer,12.0,under $11k,34588.0,white,metastatic,1.0,0.8999996,no dnr,9.0,82.0,0.59997559,115.0,12.0,39.0,224.0,2.8999023,0.59997559,1.89990234,136.0,7.419922,261.0,46.0,2915.0,0.0,1.0,<2 mo. follow-up,0.494751
55.43298,female,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,35245.0,white,no,0.899999619,0.7999997,no dnr,9.0,0.0,24.1992188,0.0,0.0,36.19531,274.25,1.1999512,10.0996094,2.79980469,142.0,7.349609,135.0,92.0,14.0,0.0,6.0,SIP>=30,6.0
86.55396,male,0.0,Coma,7.0,under $11k,139613.0,white,no,0.699999809,0.5,no dnr,10.0,65.0,17.796875,104.0,32.0,36.79688,148.3125,2.8999023,0.89990234,1.0,144.0,7.489258,118.0,21.0,2075.0,0.0,0.0,<2 mo. follow-up,0.0
36.89297,female,0.0,ARF/MOSF w/Sepsis,16.0,under $11k,556242.0,black,no,0.949999809,0.9499998,no dnr,54.0,83.0,2.5,80.0,22.0,35.79688,224.0,4.1992188,0.79992676,0.79992676,133.0,7.419922,135.0,3.0,3000.0,0.0,5.0,<2 mo. follow-up,5.0
68.51196,male,0.0,ARF/MOSF w/Sepsis,14.0,under $11k,265912.0,black,no,0.699999809,0.5999999,no dnr,58.0,55.0,6.5,115.0,16.0,35.89844,224.0,2.8999023,0.89990234,1.79980469,137.0,7.419922,135.0,26.0,1375.0,0.0,5.0,SIP>=30,5.0
34.23999,female,0.0,CHF,12.0,$11-$25k,120821.0,white,no,0.949999809,0.8999996,no dnr,18.0,58.0,10.5996094,115.0,31.0,38.19531,162.5,3.8999023,31.0,4.19921875,135.0,7.489258,174.0,83.0,0.0,0.0,1.0,no(M2 and SIP pres),0.494751
75.28296,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,542002.0,white,no,0.699999809,0.5,no dnr,50.0,55.0,8.69921875,70.0,20.0,36.09375,224.0,3.3999023,1.0,1.59985352,135.0,7.419922,135.0,38.0,2425.0,0.0,1.0,<2 mo. follow-up,2.8818359
77.54999,female,0.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,382453.0,white,no,0.199999928,0.1999999,no dnr,51.0,67.0,14.7988281,74.0,22.0,36.19531,224.0,3.2998047,3.89990234,3.09960938,136.0,7.419922,85.0,80.0,590.0,0.0,1.0,<2 mo. follow-up,2.7924805
30.97899,male,0.0,Coma,12.0,under $11k,229100.0,hispanic,no,0.75,0.75,no dnr,39.0,75.0,14.2988281,120.0,44.0,39.0,157.125,2.199707,0.79992676,1.69995117,139.0,7.509766,438.0,32.0,2635.0,0.0,0.0,no(M2 and SIP pres),0.0
63.63898,female,1.0,ARF/MOSF w/Sepsis,16.0,$11-$25k,902281.0,hispanic,no,0.099999964,0.09999996,dnr after sadm,46.0,57.0,23.8984375,105.0,9.0,36.59375,256.0,2.8999023,38.3984375,3.29980469,138.0,7.439453,109.0,66.0,1965.0,0.0,1.0,<2 mo. follow-up,3.065918
46.935,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,160986.0,white,yes,0.949999809,0.8999996,no dnr,28.0,75.0,10.5996094,60.0,14.0,36.0,224.0,2.8999023,0.89990234,0.69995117,133.0,7.419922,202.0,22.0,1968.0,0.0,1.0,<2 mo. follow-up,4.4863281
45.27597,female,0.0,CHF,12.0,under $11k,76227.0,black,no,0.5,0.3999999,no dnr,14.0,75.0,11.2988281,75.0,25.0,38.19531,215.0,2.2998047,2.09960938,1.69995117,134.0,7.509766,135.0,30.0,1651.0,0.0,1.0,<2 mo. follow-up,3.1689453
39.86899,male,1.0,MOSF w/Malig,12.0,under $11k,497787.0,white,yes,0.049999982,0.0,dnr after sadm,29.0,62.0,6.5,115.0,24.0,36.5,224.0,2.8999023,0.89990234,0.79992676,136.0,7.419922,188.0,19.0,3600.0,0.0,1.0,<2 mo. follow-up,2.5600586
65.73596,male,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,195264.0,white,no,0.699999809,0.5999999,no dnr,23.0,71.0,4.19921875,120.0,24.0,38.39844,224.0,3.699707,2.39990234,0.59997559,139.0,7.419922,138.0,6.0,3350.0,0.0,1.0,no(M2 and SIP pres),3.4580078
49.34198,female,1.0,Coma,22.0,$25-$50k,201340.0,hispanic,no,0.5,0.5,dnr after sadm,7.0,115.0,31.796875,95.0,16.0,36.79688,524.0,2.8999023,0.89990234,1.19995117,155.0,6.959961,651.0,14.0,2400.0,0.0,5.0,<2 mo. follow-up,5.0
59.35397,female,0.0,Colon Cancer,18.0,under $11k,30984.0,white,metastatic,1.0,0.8999996,no dnr,9.0,108.0,11.0,135.0,10.0,37.0,227.5,2.8999023,0.89990234,2.19970703,153.0,7.509766,125.0,59.0,1852.0,0.0,0.0,no(M2 and SIP pres),0.0
73.52795,female,0.0,COPD,12.0,under $11k,5988.0,white,no,0.899999619,0.7999997,no dnr,5.0,97.0,16.296875,140.0,28.0,36.59375,226.65625,2.8999023,0.89990234,0.59997559,137.0,7.529297,135.0,3.0,2416.0,0.0,1.0,<2 mo. follow-up,2.5693359
71.18695,male,1.0,ARF/MOSF w/Sepsis,20.0,>$50k,201762.0,asian,no,0.399999857,0.09999996,dnr after sadm,6.0,52.0,4.89941406,60.0,24.0,33.39844,224.0,2.8999023,0.89990234,4.19921875,144.0,7.419922,117.0,43.0,759.0,0.0,1.0,<2 mo. follow-up,1.0
60.22198,male,0.0,CHF,12.0,under $11k,53341.0,black,no,0.799999714,0.5,no dnr,16.0,65.0,11.5,70.0,24.0,35.89844,224.0,2.8999023,0.89990234,0.89990234,134.0,7.419922,104.0,18.0,2675.0,0.0,1.0,<2 mo. follow-up,3.3642578
75.29895,male,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,361878.0,white,yes,0.5,0.4499998,no dnr,54.0,60.0,15.2988281,110.0,10.0,36.5,112.0,2.8999023,0.89990234,5.19921875,136.0,7.519531,165.0,130.0,1136.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
66.53497,male,0.0,CHF,12.0,under $11k,22157.0,asian,no,0.599999905,0.5,no dnr,7.0,62.0,31.1992188,155.0,22.0,38.29688,93.84375,1.5998535,0.29998779,0.69995117,135.0,7.389648,175.0,21.0,4280.0,0.0,1.0,<2 mo. follow-up,2.8154297
20.29599,female,1.0,MOSF w/Malig,12.0,under $11k,355578.0,hispanic,metastatic,0.899999619,0.8999996,no dnr,40.0,122.0,21.1992188,155.0,10.0,38.0,224.0,3.7998047,0.5,1.19995117,143.0,7.419922,122.0,8.0,2397.0,0.0,1.0,<2 mo. follow-up,1.0
68.82098,female,0.0,COPD,12.0,under $11k,21750.0,white,no,0.799999714,0.5,no dnr,7.0,113.0,38.59375,105.0,9.0,38.0,342.5,4.0996094,15.3984375,4.39941406,133.0,7.449219,123.0,170.0,0.0,4.0,6.0,<2 mo. follow-up,6.0
60.29797,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,51183.0,white,no,0.699999809,0.5,no dnr,11.0,82.0,13.7988281,120.0,32.0,39.59375,590.0,3.7998047,0.89990234,0.79992676,136.0,7.469727,135.0,8.0,2735.0,0.0,1.0,<2 mo. follow-up,2.7836914
87.35394,female,0.0,CHF,12.0,under $11k,11602.0,white,no,0.949999809,0.8499999,dnr after sadm,1.0,47.0,20.5,154.0,38.0,35.59375,138.75,2.8999023,0.79992676,7.69921875,152.0,7.429688,224.0,125.0,0.0,0.0,1.0,no(M2 and SIP pres),5.25
58.32999,female,0.0,MOSF w/Malig,8.0,under $11k,57209.0,white,metastatic,0.699999809,0.5,dnr after sadm,1.0,113.0,14.2988281,150.0,30.0,36.39844,161.21875,3.7998047,0.59997559,6.19921875,130.0,7.40918,408.0,62.0,0.0,0.0,6.0,adl>=4 (>=5 if sur),6.0
79.12897,female,0.0,COPD,13.0,under $11k,25770.0,white,no,0.899999619,0.5,no dnr,9.0,52.0,0.04999542,115.0,14.0,37.5,226.0625,2.8999023,18.5,2.09960938,134.0,7.399414,111.0,58.0,3149.0,2.0,1.0,<2 mo. follow-up,1.8388672
41.09799,male,0.0,ARF/MOSF w/Sepsis,13.0,$25-$50k,43026.0,hispanic,no,0.899999619,0.8999996,no dnr,8.0,57.0,13.3984375,140.0,10.0,36.39844,230.0,3.0996094,2.0,2.89990234,151.0,7.439453,153.0,108.0,2420.0,0.0,0.0,<2 mo. follow-up,0.0
72.13995,male,1.0,Lung Cancer,12.0,$11-$25k,30670.0,black,metastatic,0.299999952,0.09999996,dnr after sadm,2.0,130.0,8.19921875,110.0,6.0,37.5,370.0,2.5996094,0.89990234,0.89990234,144.0,7.579102,333.0,8.0,3020.0,0.0,1.0,<2 mo. follow-up,1.0
40.74698,male,0.0,ARF/MOSF w/Sepsis,16.0,under $11k,310749.0,white,no,0.5,0.3999999,no dnr,64.0,69.0,7.5,74.0,16.0,36.39844,224.0,2.8999023,0.59997559,1.09985352,135.0,7.419922,78.0,12.0,1525.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
66.67798,male,1.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,192030.0,hispanic,yes,0.5,0.09999996,dnr after sadm,18.0,89.0,8.0,86.0,22.0,36.79688,392.0,2.8999023,0.89990234,0.89990234,132.0,7.399414,135.0,13.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
32.008,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,348165.0,hispanic,no,0.5,0.3,dnr after sadm,5.0,52.0,18.5,135.0,16.0,38.09375,98.5625,2.8999023,33.5,2.69970703,144.0,7.489258,249.0,76.0,3850.0,0.0,1.0,<2 mo. follow-up,3.8959961
62.32397,female,1.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,916502.0,white,no,0.899999619,0.7999997,dnr after sadm,64.0,65.0,11.6992188,80.0,24.0,35.89844,224.0,2.8999023,1.29980469,2.0,137.0,7.419922,147.0,79.0,4330.0,0.0,3.0,adl>=4 (>=5 if sur),3.0
54.96799,male,0.0,MOSF w/Malig,14.0,under $11k,347848.0,white,metastatic,0.549999714,0.5,no dnr,43.0,70.0,36.296875,170.0,47.0,37.59375,124.48438,2.8999023,0.89990234,1.79980469,149.0,7.469727,279.0,43.0,1494.0,0.0,1.0,SIP>=30,1.0
40.82098,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,58518.0,white,no,0.5,0.5,no dnr,12.0,62.0,5.79980469,105.0,16.0,36.0,224.0,2.8999023,0.89990234,1.79980469,133.0,7.419922,202.0,71.0,2120.0,0.0,0.0,no(M2 and SIP pres),0.0
69.48096,female,0.0,Colon Cancer,11.0,under $11k,30978.0,hispanic,metastatic,1.0,0.8999996,no dnr,11.0,32.0,0.04999542,155.0,22.0,39.0,224.0,2.8999023,1.19995117,1.09985352,133.0,7.419922,135.0,10.0,7750.0,0.0,0.0,<2 mo. follow-up,0.0
58.793,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,234692.0,white,yes,0.5,0.5,dnr after sadm,4.0,111.0,10.1992188,104.0,34.0,36.0,122.5,2.8999023,0.89990234,0.89990234,138.0,7.30957,135.0,22.0,49.0,0.0,1.0,<2 mo. follow-up,1.9633789
52.22699,female,0.0,Coma,7.0,under $11k,192402.0,white,no,0.699999809,0.5,no dnr,22.0,72.0,6.59960938,115.0,12.0,38.29688,547.5,2.8999023,0.89990234,4.09960938,143.0,7.119141,395.0,50.0,2535.0,0.0,1.0,no(M2 and SIP pres),2.2666016
94.54895,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,88695.0,black,no,0.149999976,0.04999998,dnr after sadm,7.0,107.0,13.7988281,64.0,24.0,36.79688,195.21875,3.5996094,0.89990234,0.89990234,140.0,7.349609,175.0,13.0,1500.0,0.0,6.0,<2 mo. follow-up,6.0
49.70599,male,0.0,ARF/MOSF w/Sepsis,11.0,$11-$25k,910119.0,hispanic,no,0.299999952,0.3,no dnr,73.0,132.0,15.7988281,110.0,46.0,36.79688,190.46875,2.8999023,0.89990234,1.89990234,142.0,7.509766,114.0,38.0,2200.0,0.0,0.0,no(M2 and SIP pres),0.0
77.06494,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,26899.0,white,no,0.699999809,0.5,dnr after sadm,1.0,137.0,5.89941406,65.0,24.0,36.0,247.59375,2.8999023,0.89990234,0.79992676,135.0,7.469727,92.0,19.0,2200.0,0.0,1.0,<2 mo. follow-up,5.4121094
65.95996,male,1.0,MOSF w/Malig,12.0,under $11k,68139.0,white,yes,0.199999928,0.5,no dnr,8.0,62.0,17.5,55.0,0.0,36.19531,206.65625,2.8999023,1.29980469,2.39990234,142.0,7.40918,139.0,39.0,5210.0,0.0,6.0,<2 mo. follow-up,6.0
42.82797,male,0.0,ARF/MOSF w/Sepsis,20.0,>$50k,85800.0,white,no,0.5,0.5,no dnr,14.0,78.0,7.79980469,125.0,28.0,36.09375,224.0,2.8999023,0.39996338,1.39990234,135.0,7.419922,199.0,46.0,1687.0,0.0,0.0,no(M2 and SIP pres),0.0
86.71594,female,0.0,ARF/MOSF w/Sepsis,14.0,under $11k,25502.0,white,no,0.949999809,0.8499999,no dnr,11.0,35.0,13.0,120.0,26.0,38.5,128.0,3.8999023,2.09960938,7.89941406,138.0,7.429688,119.0,88.0,0.0,0.0,0.0,no(M2 and SIP pres),0.0
68.07397,male,0.0,COPD,8.0,$11-$25k,66904.0,white,yes,0.5,0.1999999,no dnr,9.0,73.0,6.29980469,75.0,22.0,36.5,260.0,2.8999023,1.09985352,1.0,134.0,7.5,135.0,6.0,2622.0,5.0,6.0,<2 mo. follow-up,6.0
50.56299,male,0.0,Coma,16.0,>$50k,232891.0,white,no,0.5,0.5,no dnr,31.0,102.0,20.8984375,125.0,54.0,38.59375,435.0,2.8999023,0.89990234,1.09985352,145.0,7.25,100.0,13.0,5400.0,0.0,1.0,<2 mo. follow-up,2.1708984
60.54498,male,1.0,MOSF w/Malig,16.0,>$50k,239928.0,white,yes,0.199999928,0.15,dnr after sadm,12.0,108.0,22.0,125.0,35.0,36.39844,224.0,2.8999023,11.3984375,2.09960938,146.0,7.519531,220.0,73.0,3100.0,0.0,4.0,<2 mo. follow-up,4.0
45.81497,female,0.0,ARF/MOSF w/Sepsis,12.0,>$50k,1161504.0,hispanic,no,0.299999952,0.15,no dnr,168.0,67.0,5.69921875,145.0,36.0,39.59375,291.8125,2.8999023,0.89990234,1.19995117,135.0,7.5,108.0,20.0,1561.0,0.0,0.0,no(M2 and SIP pres),0.0
81.57397,male,0.0,CHF,16.0,$25-$50k,19878.0,white,yes,0.899999619,0.75,no dnr,9.0,62.0,6.5,115.0,27.0,38.5,192.0,2.8999023,0.89990234,1.09985352,131.0,7.369141,502.0,20.0,4590.0,2.0,1.0,adl>=4 (>=5 if sur),1.8388672
83.35895,female,1.0,Coma,12.0,$25-$50k,22522.0,white,no,0.149999976,0.09999996,dnr after sadm,2.0,107.0,6.19921875,100.0,20.0,38.19531,224.0,4.2998047,0.39996338,1.0,140.0,7.419922,102.0,14.0,1445.0,0.0,7.0,<2 mo. follow-up,7.0
79.65796,male,0.0,Lung Cancer,11.0,under $11k,10991.0,black,metastatic,0.799999714,0.3999999,dnr after sadm,1.0,38.0,1.0,145.0,40.0,39.19531,78.75,2.8999023,10.0,2.69970703,130.0,7.5,117.0,81.0,1315.0,6.0,5.0,adl>=4 (>=5 if sur),5.0
18.502,female,0.0,ARF/MOSF w/Sepsis,10.0,under $11k,327791.0,hispanic,no,0.599999905,0.5999999,no dnr,44.0,115.0,15.0996094,125.0,20.0,38.5,224.0,5.6992188,0.89990234,0.69995117,149.0,7.419922,151.0,20.0,3865.0,0.0,1.0,SIP>=30,2.4863281
62.52197,male,1.0,ARF/MOSF w/Sepsis,16.0,$11-$25k,279274.0,hispanic,yes,0.149999976,0.04999998,dnr after sadm,11.0,48.0,15.2988281,105.0,6.0,36.19531,303.3125,3.2998047,1.09985352,2.5,142.0,7.399414,169.0,43.0,2025.0,0.0,7.0,<2 mo. follow-up,7.0
66.15198,male,0.0,CHF,12.0,$11-$25k,80163.0,black,no,0.949999809,0.8499999,no dnr,22.0,115.0,2.29980469,125.0,28.0,38.79688,356.0,2.8999023,17.5976562,1.09985352,136.0,7.379883,243.0,34.0,5026.0,5.0,4.0,adl>=4 (>=5 if sur),4.0
86.37097,male,0.0,CHF,12.0,under $11k,9019.0,white,no,0.899999619,0.75,dnr after sadm,2.0,70.0,7.5,65.0,20.0,36.0,266.625,2.8999023,0.89990234,0.79992676,143.0,7.5,322.0,16.0,1350.0,0.0,1.0,<2 mo. follow-up,5.9873047
59.31,female,0.0,MOSF w/Malig,14.0,>$50k,63881.0,white,yes,0.899999619,0.6999998,no dnr,11.0,62.0,2.29980469,105.0,31.0,39.29688,162.0,2.199707,2.29980469,1.59985352,151.0,7.549805,148.0,78.0,2126.0,5.0,5.0,SIP>=30,5.0
68.34198,male,1.0,COPD,8.0,under $11k,25024.0,white,no,0.75,0.75,no dnr,9.0,58.0,15.1992188,90.0,12.0,36.29688,224.0,2.8999023,8.0,5.79980469,145.0,7.419922,135.0,130.0,2145.0,0.0,1.0,<2 mo. follow-up,1.0
26.14099,male,1.0,MOSF w/Malig,14.0,under $11k,87952.0,hispanic,yes,0.849999905,0.8499999,dnr after sadm,7.0,75.0,23.5,76.0,20.0,37.0,242.84375,2.8999023,0.89990234,1.09985352,132.0,7.439453,136.0,24.0,4200.0,0.0,0.0,<2 mo. follow-up,0.0
51.26099,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,230224.0,white,no,0.799999714,0.3999999,dnr before sadm,0.0,102.0,17.296875,95.0,20.0,36.0,116.3125,3.199707,1.39990234,1.5,136.0,7.419922,180.0,39.0,2295.0,0.0,1.0,<2 mo. follow-up,5.6826172
67.09399,female,0.0,COPD,14.0,under $11k,433012.0,white,yes,1.0,1.0,no dnr,68.0,125.0,14.3984375,55.0,8.0,38.89844,322.5,2.8999023,0.89990234,0.69995117,134.0,7.469727,315.0,15.0,2055.0,0.0,4.0,<2 mo. follow-up,4.0
60.26599,female,0.0,CHF,12.0,$25-$50k,13646.0,black,no,0.75,0.5999999,no dnr,5.0,65.0,15.0,125.0,40.0,38.89844,262.8125,2.8999023,0.89990234,0.79992676,152.0,7.519531,244.0,30.0,2795.0,0.0,1.0,<2 mo. follow-up,0.494751
72.375,female,0.0,COPD,18.0,>$50k,53913.0,white,no,0.649999619,0.6499996,no dnr,11.0,46.0,30.796875,170.0,48.0,36.39844,255.0,2.8999023,0.89990234,5.09960938,140.0,7.359375,158.0,89.0,349.0,0.0,1.0,<2 mo. follow-up,5.0234375
47.60599,female,0.0,ARF/MOSF w/Sepsis,16.0,>$50k,174923.0,white,yes,0.849999905,0.6999998,no dnr,20.0,83.0,6.29980469,100.0,22.0,38.0,224.0,2.8999023,0.89990234,1.5,138.0,7.419922,135.0,22.0,2850.0,0.0,0.0,<2 mo. follow-up,0.0
65.25397,female,0.0,Coma,18.0,$25-$50k,149859.0,white,no,0.549999714,0.5,no dnr,17.0,58.0,14.7988281,75.0,38.0,37.89844,526.5,2.8999023,0.89990234,0.79992676,141.0,7.389648,144.0,11.0,1150.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
54.103,male,0.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,467237.0,white,no,0.049999982,0.04999998,no dnr,52.0,63.0,6.59960938,78.0,20.0,37.89844,224.0,2.8999023,0.89990234,1.29980469,138.0,7.419922,152.0,21.0,1500.0,0.0,0.0,<2 mo. follow-up,0.0
65.71698,female,1.0,ARF/MOSF w/Sepsis,18.0,>$50k,460259.0,asian,no,0.699999809,0.6999998,no dnr,41.0,65.0,14.1992188,140.0,15.0,39.5,182.21875,1.7998047,3.0,0.5,141.0,7.389648,236.0,8.0,3835.0,0.0,1.0,<2 mo. follow-up,1.0
83.06598,female,0.0,ARF/MOSF w/Sepsis,18.0,under $11k,118843.0,black,metastatic,0.5,0.15,no dnr,17.0,72.0,3.0,70.0,31.0,38.09375,135.0,2.8999023,2.79980469,0.89990234,148.0,7.539062,398.0,41.0,4700.0,0.0,1.0,<2 mo. follow-up,1.0
85.45099,male,1.0,ARF/MOSF w/Sepsis,20.0,under $11k,65216.0,white,yes,0.299999952,0.3,no dnr,7.0,78.0,10.8984375,125.0,22.0,38.19531,122.4375,2.8999023,0.29998779,4.89941406,133.0,7.319336,373.0,117.0,1475.0,0.0,1.0,<2 mo. follow-up,4.5664062
74.37396,male,0.0,CHF,6.0,$11-$25k,23855.0,white,no,0.799999714,0.5,no dnr,10.0,75.0,9.29882812,64.0,12.0,36.59375,224.0,3.3999023,1.19995117,1.59985352,134.0,7.419922,97.0,24.0,2950.0,0.0,0.0,no(M2 and SIP pres),0.0
67.81696,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,56904.0,white,yes,0.099999964,0.0,dnr after sadm,2.0,113.0,0.04999542,130.0,11.0,39.09375,224.0,1.8999023,0.89990234,0.5,135.0,7.419922,114.0,15.0,4684.0,0.0,7.0,<2 mo. follow-up,7.0
76.099,female,0.0,COPD,19.0,$11-$25k,53633.0,white,metastatic,0.599999905,0.5,no dnr,9.0,75.0,15.7988281,115.0,10.0,36.39844,222.5,2.8999023,4.19921875,0.79992676,133.0,7.419922,135.0,20.0,2420.0,0.0,0.0,no(M2 and SIP pres),0.0
63.978,female,0.0,Colon Cancer,13.0,$11-$25k,21967.0,white,metastatic,0.799999714,0.5,no dnr,11.0,73.0,0.59997559,70.0,14.0,39.09375,153.03125,2.8999023,3.19970703,1.59985352,141.0,7.399414,135.0,30.0,3295.0,1.0,1.0,<2 mo. follow-up,1.1667481
80.50397,male,1.0,Coma,12.0,under $11k,23637.0,white,no,0.899999619,0.8999996,dnr before sadm,-1.0,48.0,10.8984375,55.0,10.0,36.19531,41.0,2.8999023,0.89990234,0.89990234,134.0,7.549805,109.0,20.0,2460.0,0.0,1.0,<2 mo. follow-up,4.5996094
60.69299,male,0.0,CHF,15.0,under $11k,8561.0,white,no,0.899999619,0.7999997,no dnr,3.0,72.0,21.296875,115.0,24.0,38.19531,272.0,2.8999023,0.89990234,0.69995117,135.0,7.30957,173.0,7.0,2180.0,0.0,0.0,no(M2 and SIP pres),0.0
72.01898,male,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,136226.0,white,no,0.849999905,0.7999997,no dnr,24.0,78.0,5.29980469,80.0,20.0,36.0,224.0,2.8999023,0.89990234,1.09985352,139.0,7.419922,110.0,16.0,3800.0,0.0,0.0,<2 mo. follow-up,0.0
54.73798,male,0.0,CHF,12.0,under $11k,156205.0,white,no,0.599999905,0.5,no dnr,17.0,62.0,13.1992188,115.0,35.0,37.89844,103.32812,2.8999023,0.89990234,0.39996338,126.0,7.319336,135.0,2.0,1000.0,0.0,1.0,no(M2 and SIP pres),1.0
45.85898,female,0.0,Coma,12.0,under $11k,502025.0,white,no,0.5,0.3999999,no dnr,34.0,106.0,17.5976562,105.0,26.0,36.89844,301.0,2.8999023,0.89990234,0.39996338,143.0,7.619141,209.0,28.0,1590.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
63.53998,male,1.0,ARF/MOSF w/Sepsis,10.0,$25-$50k,647638.0,hispanic,no,0.049999982,0.02,dnr after sadm,21.0,120.0,10.2988281,120.0,25.0,37.79688,210.0,2.8999023,0.89990234,1.19995117,142.0,7.5,135.0,15.0,3445.0,0.0,0.0,<2 mo. follow-up,0.0
84.70599,female,1.0,ARF/MOSF w/Sepsis,19.0,>$50k,26000.0,white,yes,0.699999809,0.3999999,dnr after sadm,2.0,67.0,15.8984375,175.0,14.0,39.19531,135.6875,4.1992188,9.59960938,2.79980469,156.0,7.459961,196.0,83.0,6910.0,0.0,1.0,<2 mo. follow-up,5.8369141
63.017,male,0.0,Lung Cancer,27.0,>$50k,26494.0,white,metastatic,1.0,0.5999999,no dnr,9.0,132.0,21.296875,105.0,24.0,38.0,288.5625,2.2998047,1.0,0.79992676,130.0,7.439453,135.0,24.0,6603.0,0.0,1.0,<2 mo. follow-up,0.494751
30.741,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,364515.0,black,no,0.599999905,0.3999999,no dnr,56.0,68.0,12.6992188,95.0,29.0,36.79688,250.0,2.8999023,0.89990234,1.0,137.0,7.5,147.0,22.0,2028.0,0.0,0.0,no(M2 and SIP pres),0.0
29.10899,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,44220.0,white,no,0.75,0.6999998,no dnr,8.0,60.0,19.296875,135.0,20.0,37.0,70.0,2.5996094,0.89990234,2.5,131.0,7.239258,92.0,80.0,1109.0,0.0,1.0,<2 mo. follow-up,3.0449219
59.31,male,0.0,Colon Cancer,15.0,>$50k,25024.0,white,metastatic,1.0,0.9499998,no dnr,9.0,69.0,8.5,105.0,24.0,36.0,224.0,4.1992188,0.79992676,1.19995117,142.0,7.419922,117.0,18.0,1810.0,0.0,1.0,no(M2 and SIP pres),1.8730469
49.76898,female,1.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,25024.0,white,no,0.5,0.5,dnr after sadm,46.0,45.0,7.89941406,125.0,28.0,37.79688,322.8125,2.5996094,0.89990234,8.19921875,143.0,7.40918,293.0,58.0,0.0,0.0,1.0,adl>=4 (>=5 if sur),3.3203125
47.978,male,0.0,CHF,12.0,under $11k,23716.0,white,no,0.899999619,0.7999997,no dnr,6.0,122.0,9.5,120.0,30.0,38.0,75.5,2.8999023,0.89990234,0.89990234,132.0,7.519531,135.0,19.0,2560.0,0.0,1.0,<2 mo. follow-up,2.3818359
65.17999,male,1.0,ARF/MOSF w/Sepsis,14.0,>$50k,218454.0,white,no,0.099999964,0.09999996,dnr after sadm,4.0,73.0,10.0,136.0,20.0,38.59375,224.0,2.8999023,0.09999084,0.69995117,135.0,7.419922,135.0,13.0,4500.0,0.0,1.0,<2 mo. follow-up,1.0
69.92694,male,0.0,ARF/MOSF w/Sepsis,13.0,under $11k,94568.0,white,yes,0.599999905,0.3999999,no dnr,20.0,83.0,17.8984375,95.0,24.0,38.29688,150.0,2.8999023,0.69995117,1.29980469,149.0,7.5,431.0,37.0,3850.0,0.0,1.0,SIP>=30,3.5058594
66.57599,male,1.0,Colon Cancer,12.0,$25-$50k,4971.0,white,metastatic,0.699999809,0.5,dnr after sadm,1.0,64.0,13.8984375,64.0,24.0,36.79688,81.65625,2.7998047,20.3984375,2.39990234,131.0,7.449219,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
42.23999,male,1.0,Cirrhosis,12.0,under $11k,16101.0,white,no,0.899999619,0.7999997,dnr after sadm,4.0,67.0,15.0,92.0,20.0,34.69531,224.0,2.3999023,30.5976562,4.59960938,117.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
61.13599,male,0.0,Colon Cancer,12.0,under $11k,7688.0,white,metastatic,0.099999964,0.0009999992,dnr after sadm,1.0,90.0,10.3984375,90.0,25.0,37.0,224.0,2.5996094,0.79992676,1.79980469,139.0,7.419922,135.0,23.0,1968.0,2.0,1.0,<2 mo. follow-up,1.0
71.18994,male,0.0,COPD,8.0,under $11k,3214.0,black,yes,0.989999771,0.9799995,no dnr,4.0,107.0,15.2988281,78.0,28.0,36.29688,400.0,2.8999023,0.89990234,1.59985352,142.0,7.449219,135.0,23.0,1968.0,0.0,1.0,SIP>=30,2.578125
59.59799,male,0.0,Lung Cancer,15.0,under $11k,7063.0,white,metastatic,0.899999619,0.5,no dnr,7.0,82.0,18.0,92.0,32.0,38.0,308.0,3.0996094,0.89990234,0.79992676,124.0,7.479492,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.402832
65.81,male,0.0,CHF,15.0,under $11k,7104.0,black,no,1.0,1.0,no dnr,8.0,113.0,5.39941406,100.0,20.0,37.59375,380.9375,4.5,0.89990234,1.79980469,143.0,7.479492,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
67.88495,female,0.0,CHF,7.0,under $11k,7143.0,white,no,0.949999809,0.75,dnr after sadm,1.0,60.0,11.1992188,64.0,25.0,36.0,252.0,4.0,0.59997559,5.39941406,129.0,7.5,135.0,23.0,1968.0,1.0,1.0,<2 mo. follow-up,1.1668997
42.70499,male,0.0,Lung Cancer,14.0,$11-$25k,6662.0,white,metastatic,0.699999809,0.3,no dnr,5.0,73.0,7.5,72.0,24.0,36.19531,224.0,2.699707,0.19998169,0.69995117,136.0,7.419922,135.0,23.0,1968.0,5.0,6.0,<2 mo. follow-up,6.0
79.35095,male,0.0,CHF,7.0,under $11k,10774.0,white,yes,0.799999714,0.5,no dnr,10.0,101.0,10.6992188,74.0,16.0,36.09375,155.09375,4.2998047,0.89990234,1.89990234,131.0,7.359375,135.0,23.0,1968.0,2.0,1.0,<2 mo. follow-up,1.0
34.14398,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,44464.0,white,no,0.829999924,0.8299999,dnr after sadm,13.0,45.0,17.0976562,158.0,40.0,37.5,121.65625,2.7998047,3.5,1.39990234,145.0,7.539062,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,4.1367188
85.12799,female,0.0,COPD,10.0,under $11k,11331.0,hispanic,no,0.899999619,0.7999997,no dnr,8.0,76.0,7.09960938,102.0,24.0,36.59375,209.5,3.0996094,0.39996338,0.89990234,134.0,7.5,135.0,23.0,1968.0,2.0,1.0,<2 mo. follow-up,1.8389997
80.33398,male,0.0,CHF,12.0,under $11k,15306.0,white,no,0.699999809,0.5,no dnr,9.0,56.0,14.1992188,75.0,20.0,37.0,337.0,3.5996094,0.89990234,1.19995117,142.0,7.399414,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.8393555
62.84497,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,79451.0,white,no,0.699999809,0.5,dnr after sadm,5.0,40.0,18.0976562,158.0,28.0,37.59375,240.0,2.8999023,0.89990234,4.5,135.0,7.439453,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.3706055
56.91199,male,0.0,Lung Cancer,15.0,$25-$50k,13620.0,white,metastatic,0.5,0.09999996,dnr before sadm,-1.0,60.0,7.09960938,140.0,40.0,38.29688,304.75,3.0,0.59997559,0.79992676,136.0,7.439453,135.0,23.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
44.47897,female,0.0,Lung Cancer,13.0,$25-$50k,25121.0,white,metastatic,0.5,0.3999999,dnr after sadm,1.0,67.0,8.09960938,107.0,8.0,36.29688,381.625,2.3999023,0.39996338,1.39990234,136.0,7.339844,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),3.9077148
29.13599,male,0.0,MOSF w/Malig,18.0,under $11k,20860.0,white,yes,0.199999928,0.04999998,dnr after sadm,1.0,67.0,27.8984375,112.0,24.0,38.29688,224.0,1.8999023,3.69970703,1.09985352,118.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
82.06396,male,0.0,CHF,12.0,under $11k,3265.0,white,no,0.599999905,0.5,no dnr,4.0,70.0,16.8984375,80.0,20.0,36.09375,290.4375,2.8999023,0.89990234,1.5,135.0,7.489258,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
54.63699,male,0.0,CHF,12.0,under $11k,10749.0,white,no,0.5,0.1999999,no dnr,12.0,79.0,10.0996094,124.0,42.0,40.09375,227.5,4.0996094,1.0,1.19995117,132.0,7.489258,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.4262695
90.89099,female,0.0,Colon Cancer,11.0,under $11k,13201.0,other,metastatic,0.5,0.09999996,dnr after sadm,1.0,81.0,7.0,80.0,20.0,36.5,323.75,3.5996094,0.89990234,1.59985352,135.0,7.30957,135.0,23.0,1968.0,2.0,2.0,<2 mo. follow-up,2.0
70.80396,female,0.0,Lung Cancer,12.0,under $11k,13253.0,white,metastatic,0.699999809,0.09999996,dnr after sadm,1.0,73.0,11.7988281,120.0,28.0,36.09375,395.1875,3.3999023,0.5,1.19995117,135.0,7.449219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
82.11896,female,0.0,CHF,14.0,under $11k,3189.0,white,no,1.0,0.75,no dnr,3.0,92.0,6.29980469,60.0,24.0,36.29688,224.0,2.8999023,0.89990234,1.59985352,136.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),3.9838867
30.03999,male,0.0,ARF/MOSF w/Sepsis,12.0,>$50k,17692.0,black,no,0.849999905,0.8499999,no dnr,12.0,89.0,9.69921875,102.0,24.0,38.69531,224.0,2.2998047,0.39996338,0.5,146.0,7.419922,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),2.2026367
83.65796,female,0.0,CHF,16.0,under $11k,6931.0,white,no,0.5,0.125,dnr after sadm,1.0,95.0,18.6992188,104.0,25.0,37.29688,504.0625,2.8999023,0.89990234,1.19995117,146.0,7.5,135.0,23.0,1968.0,1.0,3.0,no(M2 and SIP pres),3.0
77.66699,male,1.0,CHF,15.0,under $11k,16398.0,white,no,0.799999714,0.5119996,no dnr,20.0,69.0,9.8984375,74.0,16.0,36.79688,204.0,4.1992188,0.89990234,2.29980469,137.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.9882812
93.75494,female,0.0,CHF,12.0,under $11k,10622.0,white,no,0.949999809,0.8999996,dnr after sadm,1.0,66.0,5.09960938,140.0,36.0,38.69531,224.0,3.7998047,0.89990234,1.79980469,136.0,7.419922,135.0,23.0,1968.0,0.0,7.0,adl>=4 (>=5 if sur),7.0
63.48499,female,0.0,Lung Cancer,12.0,$11-$25k,22166.0,black,metastatic,0.649999619,0.3499999,dnr after sadm,1.0,53.0,20.296875,112.0,20.0,37.29688,224.0,2.699707,0.5,0.79992676,133.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
58.63898,male,0.0,CHF,12.0,$25-$50k,17714.0,white,yes,0.5,0.02,no dnr,15.0,49.0,14.5,118.0,32.0,36.19531,243.3125,3.2998047,1.29980469,1.09985352,124.0,7.459961,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
84.10095,female,0.0,ARF/MOSF w/Sepsis,8.0,under $11k,42058.0,white,no,0.699999809,0.5,no dnr,42.0,65.0,18.3984375,44.0,24.0,37.29688,388.0,2.199707,1.09985352,1.89990234,142.0,7.329102,135.0,23.0,1968.0,0.0,6.0,no(M2 and SIP pres),6.0
51.52399,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,9931.0,white,no,0.989999771,0.9799995,no dnr,10.0,63.0,3.59960938,98.0,40.0,39.09375,302.5,3.0,0.39996338,0.59997559,136.0,7.439453,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.4150391
95.56494,female,0.0,CHF,8.0,under $11k,4417.0,white,no,0.949999809,0.8999996,no dnr,5.0,77.0,12.6992188,160.0,28.0,36.69531,460.0,4.0,1.19995117,1.69995117,144.0,7.459961,135.0,23.0,1968.0,0.0,2.0,adl>=4 (>=5 if sur),2.0
55.42499,female,0.0,Lung Cancer,13.0,under $11k,10085.0,white,metastatic,0.199999928,0.0,dnr after sadm,2.0,73.0,8.0,104.0,24.0,37.0,224.0,2.5996094,0.89990234,0.79992676,128.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),3.2207031
53.42099,male,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,14593.0,white,no,0.949999809,0.9499998,no dnr,9.0,83.0,13.5996094,78.0,32.0,38.29688,224.0,2.7998047,0.89990234,1.0,138.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
84.33099,male,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,17909.0,white,no,0.599999905,0.5,no dnr,12.0,75.0,10.3984375,68.0,16.0,38.5,108.0,3.7998047,0.29998779,1.39990234,142.0,7.40918,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
57.23199,female,0.0,Lung Cancer,9.0,$11-$25k,4652.0,asian,metastatic,0.899999619,0.6999998,no dnr,5.0,107.0,7.5,100.0,18.0,36.89844,224.0,4.1992188,0.89990234,0.89990234,142.0,7.419922,135.0,23.0,1968.0,2.0,0.0,no(M2 and SIP pres),0.0
46.74597,female,0.0,ARF/MOSF w/Sepsis,16.0,under $11k,94302.0,white,no,0.299999952,0.3,no dnr,45.0,103.0,3.09960938,158.0,10.0,39.59375,200.0,2.199707,3.59960938,0.69995117,132.0,7.279297,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
87.20099,female,0.0,CHF,12.0,under $11k,21775.0,white,no,0.799999714,0.7999997,no dnr,23.0,67.0,8.19921875,88.0,24.0,38.0,453.0,2.8999023,0.89990234,1.59985352,139.0,7.459961,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
80.29596,female,1.0,COPD,10.0,under $11k,11442.0,white,no,0.299999952,0.09999996,no dnr,7.0,98.0,5.0,40.0,24.0,38.0,200.0,2.8999023,0.5,0.59997559,141.0,7.359375,135.0,23.0,1968.0,5.0,2.0,<2 mo. follow-up,2.0
78.26099,male,0.0,COPD,12.0,under $11k,13574.0,white,no,0.5,0.3,dnr before sadm,-1.0,75.0,7.0,103.0,20.0,38.0,127.5,2.8999023,0.89990234,1.09985352,128.0,7.509766,135.0,23.0,1968.0,2.0,1.0,no(M2 and SIP pres),1.8389997
75.99695,male,0.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,81626.0,white,no,0.699999809,0.5,no dnr,39.0,112.0,9.29882812,83.0,18.0,38.39844,196.0,3.0,0.89990234,3.79980469,139.0,7.399414,135.0,23.0,1968.0,1.0,1.0,adl>=4 (>=5 if sur),1.1668997
60.86798,male,0.0,ARF/MOSF w/Sepsis,4.0,under $11k,259334.0,white,no,0.699999809,0.5999999,no dnr,128.0,129.0,10.2988281,114.0,28.0,37.19531,376.625,2.8999023,0.89990234,10.8984375,134.0,7.339844,135.0,23.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
57.11697,male,0.0,Lung Cancer,12.0,>$50k,8150.0,white,metastatic,0.799999714,0.3999999,no dnr,5.0,93.0,6.69921875,84.0,20.0,38.0,224.0,2.8999023,0.39996338,1.0,142.0,7.419922,135.0,23.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
67.38898,male,0.0,COPD,12.0,under $11k,6146.0,white,no,0.599999905,0.3999999,no dnr,5.0,80.0,10.5996094,80.0,24.0,36.69531,224.0,2.8999023,0.89990234,1.29980469,144.0,7.419922,135.0,23.0,1968.0,6.0,1.0,<2 mo. follow-up,4.5273972
71.90094,male,0.0,ARF/MOSF w/Sepsis,15.0,under $11k,27244.0,white,yes,0.699999809,0.5,no dnr,9.0,75.0,6.69921875,58.0,12.0,36.0,214.28125,2.8999023,0.39996338,1.89990234,137.0,7.399414,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
21.20999,male,0.0,ARF/MOSF w/Sepsis,14.0,under $11k,6719.0,white,no,0.699999809,0.5,no dnr,5.0,129.0,8.29882812,70.0,26.0,36.19531,306.625,3.0996094,0.29998779,12.3984375,156.0,7.239258,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
53.67297,male,1.0,Coma,17.0,$11-$25k,6521.0,black,no,0.049999982,0.0001249999,dnr after sadm,2.0,33.0,5.09960938,0.0,0.0,35.19531,211.65625,3.199707,0.5,2.39990234,145.0,7.379883,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.2983398
71.45197,female,0.0,CHF,10.0,under $11k,4995.0,black,no,0.899999619,0.6999998,no dnr,5.0,110.0,4.59960938,66.0,20.0,36.79688,176.65625,2.8999023,0.29998779,1.5,141.0,7.179688,135.0,23.0,1968.0,2.0,1.0,no(M2 and SIP pres),1.8389997
76.15094,male,1.0,Lung Cancer,12.0,under $11k,16484.0,white,metastatic,0.199999928,0.04999998,dnr after sadm,1.0,77.0,9.5,100.0,22.0,36.69531,224.0,2.699707,0.39996338,0.69995117,128.0,7.419922,135.0,23.0,1968.0,7.0,4.0,<2 mo. follow-up,4.0
64.99396,male,0.0,CHF,17.0,$11-$25k,7826.0,white,no,0.799999714,0.75,no dnr,6.0,73.0,4.0,114.0,20.0,36.19531,224.0,2.8999023,0.89990234,1.29980469,137.0,7.419922,135.0,23.0,1968.0,0.0,0.0,SIP>=30,0.0
37.81,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,57170.0,white,no,0.599999905,0.5999999,no dnr,17.0,47.0,17.8984375,147.0,40.0,38.89844,80.0,2.2998047,0.89990234,2.29980469,138.0,7.369141,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
42.01498,male,0.0,ARF/MOSF w/Sepsis,17.0,under $11k,9923.0,white,no,0.899999619,0.7999997,no dnr,8.0,73.0,7.59960938,50.0,16.0,36.79688,309.5,4.6992188,1.29980469,0.59997559,135.0,7.449219,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
62.84698,male,1.0,MOSF w/Malig,14.0,under $11k,46029.0,white,metastatic,0.599999905,0.216,dnr after sadm,22.0,63.0,32.3984375,66.0,28.0,36.79688,200.0,2.8999023,1.09985352,4.09960938,128.0,7.399414,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
74.77899,male,0.0,CHF,9.0,under $11k,10348.0,white,no,0.799999714,0.6999998,no dnr,7.0,65.0,11.1992188,68.0,22.0,36.0,224.0,2.8999023,0.89990234,1.59985352,135.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
79.67694,female,1.0,ARF/MOSF w/Sepsis,14.0,under $11k,27784.0,white,no,0.399999857,0.1999999,dnr after sadm,1.0,73.0,12.2988281,77.0,22.0,36.29688,296.625,2.8999023,0.29998779,2.39990234,137.0,7.449219,135.0,23.0,1968.0,6.0,5.0,<2 mo. follow-up,5.0
24.78,female,0.0,ARF/MOSF w/Sepsis,15.0,under $11k,20322.0,black,no,0.989999771,0.9899998,no dnr,13.0,60.0,13.1992188,115.0,28.0,37.0,204.0625,2.8999023,0.89990234,0.59997559,137.0,7.459961,135.0,23.0,1968.0,0.0,4.0,<2 mo. follow-up,4.0
72.95294,male,0.0,Lung Cancer,14.0,$11-$25k,13340.0,white,metastatic,0.699999809,0.5,dnr after sadm,1.0,62.0,7.69921875,62.0,16.0,36.5,224.0,3.5996094,0.69995117,0.79992676,132.0,7.419922,135.0,23.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
31.56699,male,0.0,ARF/MOSF w/Sepsis,18.0,under $11k,46374.0,white,yes,1.0,0.9899998,no dnr,43.0,57.0,17.6992188,130.0,34.0,39.59375,167.34375,2.699707,0.79992676,1.5,138.0,7.379883,135.0,23.0,1968.0,1.0,1.0,<2 mo. follow-up,1.0
56.961,male,0.0,Cirrhosis,16.0,$25-$50k,19128.0,white,no,0.799999714,0.6999998,no dnr,17.0,71.0,6.0,77.0,32.0,37.0,306.625,2.5,2.5,0.79992676,135.0,7.429688,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
85.31995,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,10257.0,white,no,0.099999964,0.0009999992,dnr after sadm,2.0,57.0,11.7988281,155.0,8.0,38.69531,310.0,3.199707,0.39996338,1.5,140.0,7.259766,135.0,23.0,1968.0,0.0,4.0,<2 mo. follow-up,4.0
65.70599,female,1.0,Colon Cancer,12.0,under $11k,2924.0,white,metastatic,0.699999809,0.5,dnr after sadm,1.0,53.0,0.29998779,112.0,30.0,36.69531,661.625,1.6999512,1.09985352,1.39990234,141.0,7.289062,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
87.19196,female,1.0,ARF/MOSF w/Sepsis,9.0,under $11k,15135.0,white,no,0.0,0.0,dnr after sadm,1.0,30.0,23.6992188,55.0,10.0,37.59375,197.5,2.8999023,0.89990234,2.5,130.0,7.289062,135.0,23.0,1968.0,0.0,6.0,<2 mo. follow-up,6.0
73.35199,male,0.0,Cirrhosis,12.0,under $11k,16690.0,white,no,0.699999809,0.5,no dnr,12.0,73.0,8.29882812,88.0,32.0,38.19531,350.0,2.699707,0.89990234,0.89990234,146.0,7.439453,135.0,23.0,1968.0,1.0,1.0,no(M2 and SIP pres),1.0
88.89795,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,15777.0,white,no,0.5,0.5,dnr after sadm,1.0,56.0,6.59960938,51.0,12.0,37.59375,247.59375,2.5,0.29998779,0.39996338,140.0,7.429688,135.0,23.0,1968.0,0.0,6.0,<2 mo. follow-up,6.0
68.26294,male,0.0,Lung Cancer,12.0,under $11k,5599.0,white,metastatic,0.5,0.09999996,dnr before sadm,-1.0,77.0,13.1992188,110.0,28.0,36.0,224.0,2.8999023,0.59997559,1.0,135.0,7.419922,135.0,23.0,1968.0,3.0,1.0,<2 mo. follow-up,2.5110989
72.47595,male,0.0,CHF,8.0,under $11k,55572.0,white,no,0.5,0.3999999,dnr after sadm,28.0,61.0,6.09960938,97.0,9.0,38.39844,156.0,2.8999023,0.89990234,2.5,135.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
64.54999,female,0.0,Lung Cancer,15.0,$11-$25k,10349.0,white,metastatic,0.699999809,0.5,dnr after sadm,3.0,83.0,8.0,90.0,20.0,37.0,224.0,3.3999023,0.29998779,0.79992676,134.0,7.419922,135.0,23.0,1968.0,4.0,1.0,<2 mo. follow-up,3.1831989
77.32495,male,0.0,MOSF w/Malig,16.0,>$50k,12638.0,white,yes,0.0,0.0,no dnr,7.0,107.0,100.0,82.0,30.0,37.69531,122.5,2.8999023,1.5,1.5,146.0,7.439453,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
73.91095,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,46732.0,white,no,0.5,0.3999999,dnr after sadm,13.0,77.0,9.69921875,80.0,30.0,38.39844,166.0,2.8999023,0.89990234,1.09985352,133.0,7.349609,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5981445
61.43997,female,0.0,Cirrhosis,11.0,under $11k,9601.0,black,no,0.899999619,0.7999997,no dnr,12.0,77.0,6.19921875,94.0,16.0,36.0,224.0,2.8999023,0.89990234,18.3984375,137.0,7.419922,135.0,23.0,1968.0,5.0,3.0,no(M2 and SIP pres),3.0
74.33795,male,0.0,COPD,12.0,under $11k,6024.0,white,no,0.799999714,0.3999999,dnr after sadm,1.0,81.0,9.5,84.0,32.0,37.29688,195.21875,2.8999023,0.89990234,1.0,142.0,7.319336,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),3.0766602
51.461,female,0.0,Cirrhosis,8.0,under $11k,30321.0,white,no,0.699999809,0.5,no dnr,27.0,73.0,8.578125,140.0,22.0,38.59375,384.0,2.199707,17.6992188,1.59985352,135.0,7.379883,135.0,23.0,1968.0,0.0,1.0,SIP>=30,3.5332031
61.98499,male,0.0,Colon Cancer,20.0,$11-$25k,3503.0,white,metastatic,0.5,0.09999996,no dnr,5.0,93.0,10.5996094,60.0,20.0,37.0,224.0,2.8999023,0.89990234,1.29980469,138.0,7.419922,135.0,23.0,1968.0,3.0,2.0,no(M2 and SIP pres),2.0
89.36597,male,0.0,CHF,12.0,under $11k,4119.0,white,no,0.899999619,0.5,dnr after sadm,2.0,73.0,4.89941406,74.0,28.0,36.09375,276.0,2.8999023,0.89990234,1.29980469,144.0,7.419922,135.0,23.0,1968.0,6.0,1.0,adl>=4 (>=5 if sur),4.5273972
85.85596,male,0.0,COPD,12.0,under $11k,10144.0,white,no,0.699999809,0.5,no dnr,12.0,105.0,3.29980469,78.0,22.0,35.89844,233.3125,2.8999023,0.89990234,3.0,140.0,7.289062,135.0,23.0,1968.0,5.0,3.0,adl>=4 (>=5 if sur),3.0
83.69299,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,8571.0,white,no,0.699999809,0.5,dnr before sadm,-1.0,60.0,9.3984375,64.0,24.0,38.29688,266.625,2.8999023,0.89990234,0.59997559,142.0,7.449219,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),4.7822266
50.36798,male,0.0,Lung Cancer,20.0,>$50k,10558.0,white,metastatic,0.779999733,0.09999996,no dnr,7.0,103.0,11.0996094,96.0,24.0,38.19531,224.0,3.8999023,0.89990234,1.19995117,138.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
69.435,male,0.0,CHF,12.0,>$50k,2722.0,white,no,0.699999809,0.5,no dnr,3.0,92.0,10.6992188,74.0,20.0,36.39844,388.0,2.8999023,0.89990234,2.59960938,136.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.9543457
81.57196,female,1.0,CHF,12.0,under $11k,42506.0,white,yes,0.699999809,0.5,dnr after sadm,26.0,113.0,6.89941406,134.0,42.0,38.59375,304.0,2.699707,0.59997559,0.89990234,132.0,7.40918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.2646484
75.16498,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,19845.0,white,yes,0.799999714,0.5999999,dnr before sadm,-1.0,83.0,6.69921875,60.0,24.0,36.19531,188.3125,3.199707,1.09985352,2.19970703,141.0,7.339844,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.3955078
28.411,female,0.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,15781.0,white,no,0.949999809,0.9399996,no dnr,11.0,57.0,8.3984375,117.0,44.0,38.39844,177.5,3.5996094,0.39996338,0.69995117,137.0,7.399414,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.3706055
75.80298,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,20469.0,white,no,0.699999809,0.5,no dnr,15.0,130.0,20.0,126.0,36.0,38.59375,289.0,2.8999023,0.89990234,1.79980469,143.0,7.399414,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),3.3759766
40.77798,male,0.0,ARF/MOSF w/Sepsis,17.0,$11-$25k,15497.0,white,no,0.949999809,0.7999997,no dnr,10.0,61.0,15.0,110.0,26.0,36.29688,386.625,2.2998047,0.89990234,2.0,136.0,7.269531,135.0,23.0,1968.0,1.0,0.0,<2 mo. follow-up,0.0
63.10699,male,0.0,CHF,12.0,under $11k,40364.0,white,no,0.899999619,0.6999998,no dnr,11.0,106.0,7.29980469,62.0,6.0,34.79688,341.0,2.8999023,0.89990234,1.19995117,134.0,7.509766,135.0,23.0,1968.0,2.0,1.0,no(M2 and SIP pres),1.8389997
81.40997,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,15727.0,white,no,0.699999809,0.3999999,no dnr,11.0,61.0,5.19921875,89.0,11.0,36.39844,210.1875,2.8999023,0.89990234,1.19995117,139.0,7.439453,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),2.9394531
83.51495,female,1.0,Coma,12.0,under $11k,21857.0,white,no,0.0,0.0,dnr after sadm,6.0,133.0,18.796875,105.0,38.0,37.29688,208.0,2.8999023,0.89990234,2.29980469,133.0,7.40918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
46.27798,male,0.0,Lung Cancer,16.0,$25-$50k,6112.0,white,metastatic,0.949999809,0.8999996,no dnr,5.0,93.0,8.69921875,110.0,20.0,36.19531,224.0,3.2998047,0.89990234,0.89990234,140.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
65.06494,male,0.0,Lung Cancer,12.0,$11-$25k,9324.0,white,metastatic,0.799999714,0.5,no dnr,6.0,87.0,7.79980469,70.0,20.0,37.0,224.0,3.199707,0.5,1.19995117,140.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
71.84399,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,247553.0,white,no,0.899999619,0.8999996,dnr after sadm,17.0,108.0,13.2988281,112.0,37.0,40.19531,308.0,2.8999023,0.89990234,0.69995117,145.0,7.459961,135.0,23.0,1968.0,0.0,5.0,adl>=4 (>=5 if sur),5.0
57.85599,female,0.0,Lung Cancer,11.0,$11-$25k,6191.0,black,metastatic,0.699999809,0.5,no dnr,4.0,99.0,6.09960938,80.0,20.0,36.59375,224.0,2.8999023,0.89990234,1.19995117,144.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.9558106
91.35394,female,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,9472.0,black,no,0.5,0.3,dnr after sadm,1.0,77.0,7.69921875,104.0,26.0,37.29688,593.25,1.7998047,0.69995117,1.39990234,156.0,7.419922,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),6.2675781
84.32599,male,0.0,CHF,12.0,under $11k,8797.0,white,no,0.699999809,0.3429999,no dnr,11.0,82.0,8.69921875,58.0,28.0,37.0,360.0,2.8999023,0.89990234,3.39990234,140.0,7.399414,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
69.74097,male,0.0,Colon Cancer,12.0,$11-$25k,6911.0,white,metastatic,0.5,0.09999996,dnr after sadm,1.0,96.0,13.1992188,94.0,18.0,37.5,224.0,2.3999023,25.5976562,1.29980469,132.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
77.75995,male,1.0,CHF,12.0,under $11k,35881.0,white,no,0.799999714,0.6999998,dnr after sadm,23.0,44.0,7.89941406,76.0,24.0,35.79688,376.1875,2.8999023,0.89990234,1.59985352,136.0,7.5,135.0,23.0,1968.0,1.0,3.0,<2 mo. follow-up,3.0
50.59,male,0.0,ARF/MOSF w/Sepsis,17.0,>$50k,49205.0,white,no,0.299999952,0.3,no dnr,26.0,43.0,3.79980469,78.0,10.0,36.19531,142.0,2.0996094,0.39996338,7.0,132.0,7.089844,135.0,23.0,1968.0,0.0,0.0,SIP>=30,0.0
73.336,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,50127.0,white,no,0.799999714,0.7999997,no dnr,25.0,109.0,12.2988281,66.0,26.0,38.19531,147.5,3.0996094,2.39990234,1.39990234,135.0,7.489258,135.0,23.0,1968.0,0.0,4.0,adl>=4 (>=5 if sur),4.0
82.60394,female,0.0,ARF/MOSF w/Sepsis,8.0,under $11k,38687.0,white,yes,0.899999619,0.7999997,no dnr,31.0,57.0,8.0,49.0,22.0,36.39844,300.0,3.3999023,0.5,2.29980469,134.0,7.439453,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
52.49597,male,0.0,ARF/MOSF w/Sepsis,12.0,>$50k,12827.0,white,no,0.959999561,0.9499998,no dnr,10.0,116.0,5.0,51.0,24.0,36.59375,148.96875,2.199707,1.29980469,2.19970703,138.0,7.349609,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
82.34094,male,1.0,Cirrhosis,4.0,under $11k,4338.0,white,no,0.599999905,0.3,dnr after sadm,4.0,87.0,15.0,124.0,23.0,38.79688,246.40625,3.199707,7.19921875,1.09985352,136.0,7.529297,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.7255859
39.896,male,0.0,Cirrhosis,12.0,under $11k,5221.0,white,no,0.699999809,0.5,no dnr,5.0,93.0,5.09960938,104.0,28.0,37.29688,224.0,1.7998047,1.0,1.29980469,136.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.8635254
70.83899,male,0.0,COPD,8.0,under $11k,15529.0,white,no,0.799999714,0.75,no dnr,10.0,53.0,4.79980469,52.0,28.0,36.59375,200.0,3.5996094,0.19998169,0.79992676,137.0,7.429688,135.0,23.0,1968.0,0.0,1.0,SIP>=30,0.4947999
66.61694,male,0.0,Colon Cancer,12.0,under $11k,21410.0,white,metastatic,0.5,0.09999996,dnr after sadm,4.0,86.0,2.69970703,60.0,8.0,36.89844,224.0,3.3999023,0.59997559,0.89990234,141.0,7.419922,135.0,23.0,1968.0,7.0,1.0,<2 mo. follow-up,1.0
45.06998,female,0.0,Lung Cancer,16.0,$25-$50k,11897.0,white,metastatic,0.799999714,0.5,no dnr,11.0,81.0,9.3984375,80.0,20.0,37.79688,224.0,2.5996094,0.89990234,0.89990234,136.0,7.419922,135.0,23.0,1968.0,0.0,2.0,no(M2 and SIP pres),2.0
54.28299,female,0.0,ARF/MOSF w/Sepsis,10.0,$25-$50k,15118.0,white,no,0.799999714,0.6499996,no dnr,10.0,50.0,10.0,155.0,40.0,37.29688,95.0,3.0,1.79980469,0.89990234,140.0,7.289062,135.0,23.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
68.44897,male,1.0,ARF/MOSF w/Sepsis,16.0,$11-$25k,357428.0,white,no,0.199999928,0.08999997,no dnr,172.0,107.0,15.6992188,88.0,18.0,37.5,188.3125,2.0996094,7.79980469,7.0,134.0,7.40918,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),1.0
87.09698,female,0.0,CHF,12.0,under $11k,42836.0,white,no,0.699999809,0.5,no dnr,27.0,104.0,24.5976562,80.0,34.0,38.0,355.0625,2.8999023,0.59997559,0.89990234,130.0,7.40918,135.0,23.0,1968.0,2.0,2.0,no(M2 and SIP pres),2.0
90.81195,female,0.0,CHF,12.0,under $11k,40846.0,white,no,0.899999619,0.5,no dnr,11.0,111.0,8.3984375,48.0,16.0,36.89844,293.3125,3.699707,0.39996338,1.69995117,138.0,7.429688,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
46.72699,female,0.0,Cirrhosis,9.0,under $11k,2666.0,white,no,0.699999809,0.5,no dnr,4.0,77.0,9.8984375,80.0,20.0,37.59375,224.0,2.8999023,1.09985352,0.89990234,143.0,7.419922,135.0,23.0,1968.0,1.0,1.0,no(M2 and SIP pres),1.1668997
65.20197,male,1.0,Cirrhosis,14.0,under $11k,14254.0,white,no,0.699999809,0.08999997,dnr after sadm,2.0,77.0,13.1992188,54.0,24.0,35.69531,182.59375,2.2998047,3.0,0.79992676,142.0,7.469727,135.0,23.0,1968.0,0.0,4.0,<2 mo. follow-up,4.0
48.94998,male,0.0,CHF,12.0,$25-$50k,34640.0,white,no,0.699999809,0.5,no dnr,25.0,43.0,6.09960938,69.0,20.0,36.09375,480.0,4.5996094,0.89990234,1.39990234,133.0,7.439453,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
80.70599,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,9764.0,white,no,0.599999905,0.5,dnr after sadm,1.0,78.0,8.09960938,73.0,28.0,37.5,204.0,3.8999023,0.89990234,2.79980469,147.0,6.959961,135.0,23.0,1968.0,0.0,5.0,<2 mo. follow-up,5.0
60.31497,female,0.0,CHF,10.0,under $11k,26095.0,black,no,0.699999809,0.5999999,no dnr,23.0,69.0,8.59960938,76.0,24.0,36.89844,224.0,4.0996094,1.39990234,1.29980469,134.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
80.64099,female,0.0,COPD,12.0,under $11k,8667.0,white,no,0.899999619,0.7999997,no dnr,9.0,93.0,11.5,84.0,22.0,36.69531,191.28125,3.199707,0.89990234,1.59985352,136.0,7.369141,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,4.3330078
67.47998,female,0.0,Colon Cancer,11.0,under $11k,7020.0,white,metastatic,0.799999714,0.25,no dnr,8.0,96.0,6.29980469,80.0,20.0,37.59375,224.0,2.8999023,0.5,1.5,139.0,7.419922,135.0,23.0,1968.0,1.0,1.0,no(M2 and SIP pres),1.0
77.758,male,1.0,ARF/MOSF w/Sepsis,16.0,$11-$25k,17610.0,white,no,0.399999857,0.0,dnr after sadm,7.0,49.0,7.19921875,94.0,36.0,34.19531,320.0,3.5996094,1.59985352,6.5,136.0,7.429688,135.0,23.0,1968.0,0.0,5.0,<2 mo. follow-up,5.0
36.27698,female,0.0,ARF/MOSF w/Sepsis,11.0,under $11k,20110.0,white,no,0.599999905,0.5999999,no dnr,11.0,54.0,18.296875,76.0,14.0,35.79688,195.0,2.7998047,0.59997559,0.79992676,139.0,7.439453,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
80.75,male,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,25860.0,white,yes,0.949999809,0.8499999,no dnr,23.0,100.0,11.3984375,100.0,26.0,37.79688,322.5,2.8999023,1.19995117,1.29980469,148.0,7.359375,135.0,23.0,1968.0,1.0,2.0,no(M2 and SIP pres),2.0
68.323,female,0.0,COPD,12.0,under $11k,33471.0,white,yes,0.899999619,0.7999997,no dnr,17.0,67.0,9.59960938,122.0,26.0,37.79688,227.5,2.8999023,0.89990234,1.09985352,132.0,7.40918,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
71.63599,female,0.0,COPD,7.0,under $11k,10530.0,white,no,0.899999619,0.8499999,no dnr,14.0,63.0,8.69921875,76.0,30.0,36.29688,240.0,2.8999023,0.89990234,1.19995117,143.0,7.339844,135.0,23.0,1968.0,2.0,4.0,no(M2 and SIP pres),4.0
70.76495,male,0.0,COPD,11.0,$11-$25k,8711.0,white,no,0.949999809,0.7999997,no dnr,10.0,83.0,10.6992188,108.0,32.0,36.09375,188.5625,2.8999023,0.89990234,1.0,141.0,7.359375,135.0,23.0,1968.0,2.0,0.0,no(M2 and SIP pres),0.0
89.487,female,0.0,COPD,12.0,under $11k,3584.0,white,no,0.899999619,0.6999998,no dnr,3.0,100.0,14.3984375,86.0,18.0,37.29688,200.0,2.8999023,0.89990234,0.59997559,138.0,7.329102,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
55.80298,female,0.0,COPD,12.0,under $11k,3057.0,white,no,0.799999714,0.5,dnr after sadm,2.0,90.0,7.5,110.0,25.0,37.59375,208.0,2.8999023,0.89990234,0.5,139.0,7.349609,135.0,23.0,1968.0,4.0,6.0,adl>=4 (>=5 if sur),6.0
72.59698,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,17419.0,white,no,1.0,0.9899998,no dnr,14.0,63.0,4.29980469,102.0,28.0,37.5,365.0,2.7998047,0.89990234,1.69995117,139.0,7.399414,135.0,23.0,1968.0,0.0,4.0,adl>=4 (>=5 if sur),4.0
79.62994,female,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,11895.0,white,no,0.699999809,0.5,dnr after sadm,1.0,75.0,11.0996094,101.0,26.0,37.19531,141.65625,2.8999023,0.89990234,0.79992676,147.0,7.139648,135.0,23.0,1968.0,0.0,3.0,no(M2 and SIP pres),3.0
71.54297,female,1.0,MOSF w/Malig,12.0,under $11k,31316.0,white,yes,0.149999976,0.1199999,dnr after sadm,5.0,60.0,1.29980469,136.0,32.0,36.0,371.375,1.6999512,0.09999084,1.79980469,145.0,7.469727,135.0,23.0,1968.0,0.0,5.0,<2 mo. follow-up,5.0
42.78998,female,1.0,MOSF w/Malig,12.0,under $11k,19185.0,white,yes,0.0,0.0,dnr after sadm,4.0,49.0,3.89990234,128.0,28.0,34.5,436.0,2.8999023,8.5,3.89990234,138.0,7.209961,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5180664
73.91895,female,0.0,CHF,7.0,under $11k,4780.0,white,no,0.899999619,0.7999997,no dnr,6.0,97.0,10.5996094,76.0,24.0,37.69531,256.625,2.8999023,0.89990234,2.79980469,139.0,7.439453,135.0,23.0,1968.0,1.0,5.0,<2 mo. follow-up,5.0
67.37598,male,0.0,ARF/MOSF w/Sepsis,14.0,>$50k,21696.0,white,no,0.949999809,1.0,no dnr,13.0,75.0,11.5,150.0,8.0,38.59375,121.65625,2.8999023,0.89990234,2.0,134.0,7.459961,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
77.06995,female,0.0,CHF,10.0,under $11k,3634.0,white,no,0.5,0.3,no dnr,6.0,117.0,9.5,74.0,16.0,36.29688,224.0,4.1992188,0.5,2.89990234,135.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
72.10095,male,0.0,CHF,12.0,under $11k,24014.0,white,no,0.25,0.09999996,dnr after sadm,3.0,70.0,3.29980469,72.0,20.0,36.29688,224.0,3.199707,0.89990234,5.29980469,128.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
96.422,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,17637.0,white,no,0.5,0.5,dnr after sadm,8.0,51.0,20.5976562,80.0,28.0,36.09375,250.0,2.7998047,0.89990234,3.09960938,128.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,4.890625
70.034,female,0.0,CHF,8.0,$11-$25k,69542.0,white,no,0.899999619,0.8999996,no dnr,47.0,111.0,13.0996094,80.0,32.0,35.89844,224.0,4.0,0.89990234,1.59985352,141.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
65.51697,male,0.0,Lung Cancer,12.0,under $11k,8659.0,white,metastatic,0.899999619,0.5,no dnr,6.0,80.0,7.09960938,86.0,20.0,37.5,224.0,4.1992188,0.89990234,1.29980469,138.0,7.419922,135.0,23.0,1968.0,1.0,0.0,no(M2 and SIP pres),0.0
91.67694,male,1.0,ARF/MOSF w/Sepsis,14.0,under $11k,14107.0,white,yes,0.099999964,0.0009999992,dnr after sadm,4.0,46.0,15.0996094,50.0,26.0,37.69531,185.0,3.199707,0.69995117,3.09960938,136.0,7.289062,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
36.53699,male,0.0,ARF/MOSF w/Sepsis,13.0,$25-$50k,117256.0,white,no,0.699999809,0.5,no dnr,62.0,108.0,8.8984375,110.0,8.0,39.29688,202.0,1.8999023,1.89990234,1.19995117,133.0,7.389648,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),1.0
81.284,female,0.0,CHF,12.0,>$50k,5025.0,white,no,0.899999619,0.5,dnr before sadm,0.0,105.0,7.89941406,58.0,28.0,36.29688,304.75,3.699707,0.89990234,1.0,142.0,7.489258,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
71.16498,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,17918.0,white,no,0.949999809,0.8499999,no dnr,13.0,73.0,5.79980469,68.0,27.0,37.79688,266.625,2.5996094,0.89990234,1.5,138.0,7.449219,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
62.64499,female,0.0,Colon Cancer,12.0,under $11k,9016.0,white,metastatic,0.25,0.04999998,dnr after sadm,1.0,80.0,8.8984375,70.0,25.0,37.0,224.0,2.7998047,29.0,0.69995117,142.0,7.419922,135.0,23.0,1968.0,7.0,7.0,<2 mo. follow-up,7.0
39.31299,female,0.0,MOSF w/Malig,12.0,under $11k,24390.0,white,yes,0.699999809,0.5,no dnr,12.0,135.0,7.19921875,150.0,42.0,37.5,285.6875,2.699707,2.59960938,3.09960938,144.0,7.299805,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
77.24799,female,1.0,Lung Cancer,12.0,under $11k,41185.0,white,metastatic,0.5,0.3,dnr after sadm,7.0,93.0,18.1992188,72.0,26.0,37.0,224.0,4.0,0.69995117,1.19995117,134.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
41.02698,male,1.0,Cirrhosis,18.0,>$50k,57856.0,white,no,0.5,0.3,dnr after sadm,38.0,73.0,15.0,110.0,24.0,37.0,224.0,2.8999023,50.6953125,5.0,135.0,7.419922,135.0,23.0,1968.0,1.0,1.0,<2 mo. follow-up,1.1668997
77.96594,female,0.0,COPD,15.0,$11-$25k,14553.0,white,no,0.799999714,0.5999999,dnr after sadm,4.0,95.0,10.2988281,94.0,28.0,37.79688,277.75,2.8999023,0.89990234,2.5,142.0,7.429688,135.0,23.0,1968.0,0.0,3.0,SIP>=30,3.0
62.63898,male,0.0,Lung Cancer,16.0,$11-$25k,26939.0,black,metastatic,0.799999714,0.3,dnr after sadm,7.0,135.0,9.79882812,48.0,15.0,36.5,224.0,4.0,0.59997559,1.09985352,133.0,7.419922,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
68.27698,male,0.0,Colon Cancer,16.0,under $11k,5046.0,white,metastatic,0.899999619,0.1999999,no dnr,6.0,97.0,20.0,72.0,20.0,37.19531,224.0,3.7998047,0.39996338,2.19970703,136.0,7.419922,135.0,23.0,1968.0,2.0,2.0,no(M2 and SIP pres),2.0
68.64099,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,50918.0,white,metastatic,0.599999905,0.3,no dnr,19.0,74.0,14.5996094,117.0,41.0,38.29688,415.0,2.8999023,0.89990234,0.89990234,146.0,7.439453,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
64.43298,male,1.0,COPD,20.0,under $11k,5135.0,white,metastatic,0.199999928,0.5,dnr after sadm,2.0,115.0,29.8984375,80.0,40.0,36.0,210.0,3.199707,0.89990234,0.89990234,149.0,7.529297,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
86.65295,male,0.0,CHF,12.0,under $11k,4723.0,white,no,0.899999619,0.7999997,no dnr,7.0,71.0,6.5,80.0,42.0,35.79688,252.375,4.0,1.59985352,1.69995117,143.0,7.439453,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
67.409,male,0.0,CHF,12.0,under $11k,9601.0,white,yes,0.949999809,0.8999996,no dnr,12.0,97.0,10.3984375,69.0,27.0,36.0,224.0,2.8999023,0.89990234,1.29980469,144.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5053711
71.79999,male,0.0,ARF/MOSF w/Sepsis,21.0,under $11k,31459.0,white,no,0.899999619,0.5999999,no dnr,14.0,53.0,11.8984375,49.0,24.0,37.39844,280.9375,2.8999023,0.89990234,1.0,138.0,7.479492,135.0,23.0,1968.0,1.0,0.0,no(M2 and SIP pres),0.0
84.85999,male,0.0,COPD,10.0,under $11k,8570.0,black,no,0.979999542,0.8999996,no dnr,10.0,103.0,14.3984375,80.0,22.0,37.79688,224.0,2.8999023,0.89990234,1.39990234,142.0,7.389648,135.0,23.0,1968.0,3.0,1.0,no(M2 and SIP pres),2.5110989
76.06,male,1.0,COPD,14.0,under $11k,35239.0,white,no,0.949999809,0.75,dnr after sadm,14.0,61.0,9.79882812,118.0,12.0,38.19531,111.65625,2.8999023,1.29980469,1.59985352,136.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
78.672,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,10477.0,white,no,0.899999619,0.7999997,dnr after sadm,1.0,109.0,10.2988281,111.0,32.0,37.89844,420.0,2.7998047,0.79992676,0.89990234,143.0,7.399414,135.0,23.0,1968.0,0.0,5.0,adl>=4 (>=5 if sur),5.0
30.55199,male,0.0,Cirrhosis,12.0,under $11k,76135.0,black,no,0.549999714,0.4499998,no dnr,32.0,63.0,15.1992188,126.0,20.0,38.19531,392.0,2.0996094,3.79980469,1.0,140.0,7.439453,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
50.396,female,0.0,COPD,5.0,under $11k,4530.0,black,no,0.989999771,0.9499998,no dnr,5.0,51.0,14.3984375,92.0,24.0,37.0,185.6875,2.8999023,0.89990234,1.29980469,134.0,7.289062,135.0,23.0,1968.0,1.0,1.0,no(M2 and SIP pres),1.0
56.00299,female,0.0,Lung Cancer,12.0,>$50k,10614.0,white,metastatic,0.949999809,0.75,no dnr,8.0,116.0,6.0,74.0,28.0,36.69531,224.0,3.2998047,0.89990234,0.59997559,139.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
76.33698,female,0.0,COPD,8.0,under $11k,9457.0,white,no,0.899999619,0.7999997,no dnr,13.0,87.0,9.59960938,122.0,36.0,38.5,340.0,2.8999023,0.89990234,0.89990234,143.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),3.0761719
59.21399,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,33298.0,black,no,0.699999809,0.5,no dnr,12.0,105.0,13.5,100.0,40.0,38.59375,130.0,2.8999023,0.89990234,1.79980469,138.0,7.479492,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
66.34595,female,0.0,COPD,11.0,under $11k,4751.0,white,no,0.949999809,0.9199996,dnr after sadm,1.0,97.0,10.5,100.0,32.0,36.59375,303.3125,2.8999023,0.89990234,1.09985352,139.0,7.349609,135.0,23.0,1968.0,6.0,3.0,no(M2 and SIP pres),3.0
61.48099,female,0.0,CHF,4.0,$11-$25k,21507.0,white,no,0.899999619,0.7999997,no dnr,25.0,105.0,8.79882812,98.0,32.0,37.09375,255.53125,2.8999023,0.89990234,1.0,140.0,7.459961,135.0,23.0,1968.0,0.0,5.0,no(M2 and SIP pres),5.0
63.27399,male,0.0,CHF,10.0,$11-$25k,7418.0,white,metastatic,1.0,0.8999996,no dnr,8.0,63.0,9.19921875,100.0,25.0,36.59375,466.625,3.699707,1.09985352,1.29980469,135.0,7.40918,135.0,23.0,1968.0,0.0,5.0,no(M2 and SIP pres),5.0
79.64996,male,0.0,COPD,15.0,under $11k,4776.0,white,no,0.799999714,0.5999999,no dnr,6.0,85.0,7.29980469,86.0,20.0,36.79688,588.25,2.8999023,0.89990234,0.89990234,145.0,7.439453,135.0,23.0,1968.0,0.0,4.0,no(M2 and SIP pres),4.0
62.51599,female,0.0,COPD,12.0,under $11k,134421.0,black,no,0.899999619,0.75,no dnr,72.0,143.0,7.19921875,130.0,32.0,38.19531,262.9375,2.8999023,0.89990234,1.19995117,141.0,7.299805,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
57.60999,male,0.0,Lung Cancer,12.0,$25-$50k,14797.0,white,metastatic,0.5,0.09999996,dnr after sadm,2.0,81.0,2.79980469,78.0,22.0,35.69531,224.0,2.8999023,0.5,1.09985352,141.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
85.50598,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,24531.0,white,no,0.899999619,0.7999997,dnr after sadm,14.0,107.0,10.5996094,55.0,44.0,38.19531,134.6875,2.8999023,0.89990234,1.89990234,143.0,7.449219,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
68.29297,male,0.0,CHF,15.0,$11-$25k,4825.0,white,no,0.949999809,0.75,no dnr,6.0,63.0,8.59960938,61.0,20.0,36.09375,319.0,3.699707,0.39996338,2.19970703,138.0,7.479492,135.0,23.0,1968.0,1.0,0.0,<2 mo. follow-up,0.0
88.28699,female,0.0,COPD,10.0,under $11k,7485.0,white,no,0.899999619,0.8999996,no dnr,9.0,69.0,5.5,80.0,14.0,36.09375,484.0,2.8999023,0.89990234,0.69995117,129.0,7.349609,135.0,23.0,1968.0,4.0,6.0,SIP>=30,6.0
80.32898,female,0.0,Colon Cancer,10.0,under $11k,6066.0,white,metastatic,0.5,0.1999999,dnr after sadm,1.0,123.0,7.09960938,60.0,42.0,38.19531,224.0,2.7998047,0.59997559,4.09960938,144.0,7.419922,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
25.92999,male,0.0,ARF/MOSF w/Sepsis,9.0,under $11k,31526.0,white,no,0.699999809,0.5,no dnr,9.0,145.0,15.7988281,120.0,20.0,36.09375,136.0,2.8999023,0.89990234,12.1992188,135.0,7.199219,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
85.15796,female,0.0,CHF,12.0,under $11k,5272.0,white,no,0.699999809,0.5,dnr after sadm,1.0,55.0,6.59960938,62.0,40.0,35.39844,428.5625,2.8999023,0.89990234,1.29980469,138.0,7.489258,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.1811523
40.375,male,0.0,COPD,10.0,under $11k,3558.0,hispanic,no,0.899999619,0.7999997,no dnr,4.0,83.0,9.8984375,80.0,20.0,36.69531,130.0,4.1992188,0.39996338,1.0,143.0,6.969727,135.0,23.0,1968.0,0.0,1.0,SIP>=30,1.0
65.53595,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,38225.0,white,no,0.949999809,0.8999996,no dnr,50.0,53.0,12.3984375,77.0,24.0,39.29688,185.6875,2.5,0.29998779,1.0,143.0,7.419922,135.0,23.0,1968.0,4.0,3.0,SIP>=30,3.0
59.35098,female,0.0,Lung Cancer,16.0,>$50k,14557.0,white,metastatic,0.799999714,0.5,no dnr,13.0,100.0,6.09960938,108.0,24.0,36.79688,224.0,2.8999023,0.29998779,0.69995117,145.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.0551758
69.95996,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,33506.0,white,no,0.799999714,0.6999998,no dnr,23.0,113.0,8.29882812,63.0,26.0,38.09375,175.5,2.5,0.69995117,2.59960938,153.0,7.439453,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
83.35394,male,0.0,CHF,16.0,under $11k,6006.0,white,yes,0.899999619,0.5,no dnr,8.0,80.0,11.5996094,68.0,24.0,36.29688,224.0,3.5996094,0.5,1.5,134.0,7.419922,135.0,23.0,1968.0,0.0,3.0,no(M2 and SIP pres),3.0
62.17697,female,0.0,CHF,6.0,under $11k,5648.0,black,no,0.949999809,0.8999996,no dnr,5.0,63.0,10.3984375,104.0,28.0,36.79688,224.0,2.0996094,0.29998779,2.39990234,146.0,7.419922,135.0,23.0,1968.0,6.0,1.0,no(M2 and SIP pres),4.5273972
64.63196,female,0.0,CHF,12.0,under $11k,14478.0,white,metastatic,0.599999905,0.4499998,dnr after sadm,6.0,43.0,6.59960938,120.0,38.0,34.79688,418.5,3.5996094,0.89990234,1.29980469,126.0,7.489258,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
77.98798,female,1.0,COPD,12.0,under $11k,28654.0,white,no,0.5,0.25,dnr after sadm,7.0,50.0,9.59960938,112.0,8.0,38.39844,332.5,3.199707,0.89990234,0.5,136.0,7.389648,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
25.782,male,0.0,ARF/MOSF w/Sepsis,18.0,$25-$50k,9020.0,other,no,1.0,0.9499998,no dnr,7.0,73.0,5.5,76.0,24.0,39.09375,224.0,2.7998047,0.19998169,1.29980469,140.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
92.95599,female,1.0,COPD,8.0,under $11k,16444.0,white,no,0.049999982,0.0001249999,dnr after sadm,10.0,68.0,8.59960938,68.0,24.0,36.79688,422.1875,2.8999023,0.89990234,1.79980469,145.0,7.379883,135.0,23.0,1968.0,2.0,2.0,<2 mo. follow-up,2.0
81.56897,female,0.0,CHF,12.0,$25-$50k,6537.0,white,no,0.989999771,0.9799995,no dnr,8.0,69.0,10.6992188,78.0,22.0,36.09375,252.0,2.8999023,0.89990234,1.69995117,140.0,7.519531,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
65.06195,female,0.0,Lung Cancer,12.0,under $11k,3867.0,white,metastatic,0.699999809,0.5,no dnr,5.0,107.0,9.79882812,98.0,28.0,36.59375,224.0,3.2998047,0.59997559,1.19995117,142.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.2426758
72.047,female,0.0,Colon Cancer,16.0,$25-$50k,7914.0,black,metastatic,0.299999952,0.1999999,no dnr,10.0,73.0,2.39990234,76.0,20.0,37.0,224.0,2.8999023,0.89990234,0.89990234,138.0,7.419922,135.0,23.0,1968.0,1.0,0.0,no(M2 and SIP pres),0.0
77.97894,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,8999.0,white,metastatic,0.949999809,0.75,no dnr,7.0,105.0,17.5976562,130.0,26.0,36.0,332.0,3.2998047,0.89990234,6.29980469,137.0,7.429688,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
70.44995,male,1.0,Coma,20.0,under $11k,25671.0,white,no,0.099999964,0.0009999992,dnr after sadm,2.0,81.0,10.7988281,104.0,38.0,39.0,345.0,2.8999023,0.89990234,1.39990234,139.0,7.429688,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
67.95099,female,1.0,Colon Cancer,12.0,under $11k,33734.0,white,metastatic,0.799999714,0.5,dnr after sadm,5.0,73.0,10.1992188,78.0,16.0,36.5,224.0,3.5996094,0.39996338,1.59985352,137.0,7.419922,135.0,23.0,1968.0,1.0,1.0,<2 mo. follow-up,1.1668997
75.33197,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,180272.0,white,no,0.699999809,0.5,dnr after sadm,45.0,44.0,43.09375,105.0,14.0,36.09375,265.0,1.5,4.59960938,7.59960938,128.0,7.329102,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
76.646,female,0.0,COPD,16.0,>$50k,12745.0,white,no,0.799999714,0.5,dnr after sadm,1.0,84.0,5.29980469,76.0,30.0,36.59375,238.09375,2.8999023,0.5,0.39996338,144.0,7.379883,135.0,23.0,1968.0,0.0,7.0,<2 mo. follow-up,7.0
81.28699,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,12674.0,white,no,0.899999619,0.75,no dnr,12.0,74.0,10.8984375,60.0,22.0,36.59375,408.0,3.2998047,0.59997559,2.5,137.0,7.459961,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,5.4804688
93.91394,female,1.0,COPD,12.0,under $11k,13570.0,white,no,0.0,0.0,dnr after sadm,1.0,42.0,13.1992188,127.0,26.0,38.29688,234.0,2.8999023,0.89990234,1.39990234,140.0,7.269531,135.0,23.0,1968.0,0.0,4.0,<2 mo. follow-up,4.0
80.72296,female,0.0,COPD,12.0,under $11k,7633.0,white,no,0.799999714,0.6999998,dnr after sadm,1.0,112.0,7.0,160.0,28.0,38.19531,161.65625,4.0996094,0.89990234,2.59960938,141.0,7.089844,135.0,23.0,1968.0,0.0,4.0,adl>=4 (>=5 if sur),4.0
60.35599,male,1.0,Colon Cancer,12.0,under $11k,13863.0,white,metastatic,0.699999809,0.5,dnr after sadm,3.0,49.0,8.19921875,130.0,36.0,35.09375,224.0,2.3999023,20.1992188,2.79980469,137.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.2954102
60.34497,male,1.0,ARF/MOSF w/Sepsis,11.0,$11-$25k,86807.0,white,no,0.799999714,0.7999997,no dnr,18.0,51.0,11.5996094,102.0,8.0,38.79688,168.0,2.8999023,0.89990234,1.29980469,147.0,7.259766,135.0,23.0,1968.0,0.0,4.0,<2 mo. follow-up,4.0
93.77399,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,15581.0,white,no,0.049999982,0.0001249999,dnr after sadm,2.0,50.0,3.89990234,60.0,25.0,36.69531,155.0,3.0,0.29998779,0.89990234,145.0,7.359375,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,5.1074219
70.82794,female,0.0,MOSF w/Malig,12.0,under $11k,14896.0,white,metastatic,0.199999928,0.03999999,dnr after sadm,2.0,56.0,14.2988281,102.0,40.0,38.09375,114.0,2.7998047,0.59997559,0.59997559,138.0,7.429688,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.4926758
69.76898,female,1.0,Lung Cancer,12.0,under $11k,9542.0,white,metastatic,0.5,0.09999996,dnr after sadm,2.0,70.0,67.296875,116.0,38.0,36.79688,338.0625,2.8999023,0.39996338,0.89990234,143.0,7.459961,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
46.349,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,100904.0,white,no,0.699999809,0.5,dnr after sadm,8.0,57.0,23.796875,102.0,12.0,37.0,268.3125,2.3999023,39.296875,3.89990234,138.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.762207
61.14697,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,23298.0,white,no,0.699999809,0.5,no dnr,12.0,120.0,11.0,62.0,30.0,38.0,234.6875,3.0,0.89990234,6.19921875,140.0,7.319336,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.2729492
51.13998,male,0.0,ARF/MOSF w/Sepsis,6.0,under $11k,7438.0,white,no,0.979999542,0.9699998,no dnr,6.0,63.0,7.09960938,75.0,28.0,36.39844,256.0,2.8999023,0.5,0.89990234,139.0,7.459961,135.0,23.0,1968.0,2.0,0.0,adl>=4 (>=5 if sur),0.0
59.69598,male,0.0,Colon Cancer,12.0,under $11k,40846.0,white,metastatic,0.699999809,0.5,no dnr,30.0,56.0,8.0,80.0,15.0,36.69531,224.0,3.699707,0.39996338,1.09985352,145.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.3588867
73.31995,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,28079.0,white,no,1.0,0.9499998,no dnr,25.0,99.0,10.0996094,102.0,42.0,38.09375,144.875,2.5,0.5,0.79992676,142.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.4248047
35.76199,male,0.0,ARF/MOSF w/Sepsis,15.0,$11-$25k,14027.0,white,no,0.899999619,0.8999996,no dnr,12.0,53.0,14.5,106.0,22.0,38.0,212.21875,2.2998047,1.5,1.09985352,138.0,7.469727,135.0,23.0,1968.0,2.0,1.0,no(M2 and SIP pres),1.8389997
77.35797,female,0.0,COPD,12.0,under $11k,28820.0,white,no,0.5,0.5,dnr after sadm,1.0,37.0,10.5,92.0,40.0,37.59375,170.0,2.5,0.39996338,1.09985352,153.0,7.399414,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),3.2709961
83.57794,male,1.0,ARF/MOSF w/Sepsis,0.0,under $11k,65318.0,white,yes,0.699999809,0.5,dnr after sadm,11.0,67.0,19.1992188,130.0,34.0,38.79688,74.0,1.7998047,0.89990234,2.79980469,133.0,7.40918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
82.80096,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,35464.0,white,no,0.899999619,0.6999998,no dnr,20.0,64.0,13.5,54.0,24.0,37.39844,190.0,2.8999023,0.89990234,1.69995117,134.0,7.439453,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
58.82498,male,0.0,Lung Cancer,12.0,under $11k,5670.0,black,metastatic,0.949999809,0.75,no dnr,5.0,103.0,3.39990234,64.0,20.0,36.59375,224.0,3.7998047,0.19998169,1.0,141.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
77.56097,female,0.0,CHF,12.0,under $11k,5333.0,hispanic,yes,0.949999809,0.9499998,no dnr,7.0,107.0,7.79980469,78.0,24.0,35.79688,224.0,2.8999023,0.89990234,1.39990234,137.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
53.70297,female,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,91986.0,white,no,0.699999809,0.6499996,no dnr,47.0,65.0,18.296875,150.0,10.0,38.29688,164.0,2.8999023,0.89990234,0.59997559,137.0,7.509766,135.0,23.0,1968.0,0.0,1.0,SIP>=30,1.0
78.43695,female,1.0,MOSF w/Malig,14.0,$25-$50k,17635.0,white,metastatic,0.199999928,0.09999996,dnr after sadm,5.0,49.0,1.39990234,140.0,24.0,39.0,138.0,1.7998047,1.59985352,1.09985352,144.0,7.319336,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
52.68997,male,0.0,COPD,12.0,$25-$50k,11201.0,white,no,0.989999771,0.8999996,no dnr,10.0,110.0,13.0996094,120.0,30.0,36.69531,192.84375,2.8999023,0.69995117,0.89990234,137.0,7.389648,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
44.30399,female,1.0,Cirrhosis,12.0,under $11k,56112.0,black,no,0.099999964,0.0009999992,dnr after sadm,20.0,59.0,12.3984375,139.0,21.0,39.09375,432.0,3.2998047,5.89941406,0.89990234,138.0,7.40918,135.0,23.0,1968.0,7.0,0.0,<2 mo. follow-up,0.0
82.09399,male,1.0,ARF/MOSF w/Sepsis,16.0,under $11k,15079.0,white,no,0.0,0.0,dnr after sadm,5.0,0.0,11.5,0.0,0.0,35.59375,306.0,2.8999023,0.69995117,2.29980469,135.0,7.269531,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
44.48199,female,0.0,CHF,12.0,$25-$50k,13559.0,white,no,0.75,0.3999999,no dnr,7.0,51.0,10.5,122.0,20.0,37.0,352.375,2.8999023,0.89990234,0.59997559,135.0,7.469727,135.0,23.0,1968.0,1.0,1.0,no(M2 and SIP pres),1.0
75.086,male,1.0,ARF/MOSF w/Sepsis,10.0,under $11k,38936.0,white,metastatic,0.5,0.04999998,dnr after sadm,14.0,55.0,13.1992188,118.0,12.0,38.5,101.42188,2.8999023,0.89990234,0.69995117,141.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
63.93399,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,39951.0,white,no,0.25,0.5,no dnr,18.0,49.0,10.7988281,122.0,38.0,38.79688,174.0,2.5996094,0.89990234,5.19921875,139.0,7.349609,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
73.336,male,1.0,Lung Cancer,8.0,under $11k,6528.0,white,metastatic,0.099999964,0.0009999992,dnr after sadm,1.0,79.0,4.69921875,100.0,24.0,36.79688,433.3125,3.3999023,0.59997559,0.79992676,134.0,7.359375,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
57.21799,male,0.0,Lung Cancer,7.0,under $11k,6209.0,white,metastatic,1.0,0.5,no dnr,5.0,106.0,6.59960938,88.0,20.0,36.79688,224.0,3.8999023,0.89990234,1.19995117,141.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
64.58899,male,0.0,CHF,12.0,under $11k,20287.0,white,no,0.799999714,0.5999999,dnr after sadm,8.0,75.0,6.59960938,80.0,24.0,36.59375,490.0,3.5996094,1.29980469,1.5,130.0,7.459961,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5820312
73.73297,male,0.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,35954.0,white,no,0.75,0.5999999,no dnr,18.0,105.0,9.8984375,112.0,28.0,39.09375,332.0,2.3999023,0.89990234,2.0,143.0,7.5,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
61.01599,male,0.0,MOSF w/Malig,14.0,$11-$25k,43814.0,white,metastatic,0.699999809,0.5,dnr after sadm,16.0,48.0,4.0,118.0,34.0,38.0,372.0,2.8999023,1.5,1.29980469,148.0,7.40918,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
43.26898,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,11032.0,white,no,0.009999998,9.999994e-07,no dnr,4.0,43.0,28.0,140.0,26.0,39.0,72.0,2.2998047,4.0,3.79980469,137.0,7.279297,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.1391602
61.63397,male,0.0,CHF,8.0,under $11k,13547.0,white,no,0.899999619,0.7999997,no dnr,11.0,85.0,7.19921875,160.0,24.0,36.09375,224.0,2.8999023,2.39990234,1.59985352,141.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
83.30194,male,0.0,CHF,12.0,under $11k,3822.0,white,no,0.899999619,0.5,dnr after sadm,1.0,71.0,10.3984375,54.0,24.0,35.59375,290.0,2.8999023,0.89990234,2.39990234,139.0,7.449219,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
83.01996,female,0.0,ARF/MOSF w/Sepsis,15.0,under $11k,21266.0,white,no,0.899999619,0.7999997,no dnr,20.0,53.0,17.5,68.0,32.0,36.5,156.0,2.5996094,1.19995117,0.59997559,140.0,7.369141,135.0,23.0,1968.0,3.0,0.0,no(M2 and SIP pres),0.0
49.28699,female,0.0,ARF/MOSF w/Sepsis,14.0,under $11k,106935.0,black,no,0.849999905,0.8999996,no dnr,31.0,75.0,17.3984375,112.0,0.0,38.5,146.0,2.8999023,0.89990234,3.19970703,149.0,7.389648,135.0,23.0,1968.0,0.0,2.0,SIP>=30,2.0
65.46198,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,68682.0,white,no,0.099999964,0.0009999992,dnr after sadm,9.0,63.0,16.5,75.0,20.0,38.59375,140.0,2.8999023,1.29980469,5.69921875,137.0,7.349609,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
75.63898,male,0.0,CHF,7.0,$25-$50k,5284.0,white,no,0.75,0.75,no dnr,7.0,105.0,5.39941406,68.0,24.0,37.0,235.0,2.8999023,0.89990234,2.5,142.0,7.449219,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
54.43698,male,0.0,CHF,14.0,$25-$50k,12503.0,white,no,0.5,0.125,no dnr,8.0,75.0,10.0,106.0,24.0,36.39844,300.0,2.8999023,0.89990234,1.39990234,138.0,7.469727,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
49.61499,female,1.0,MOSF w/Malig,12.0,under $11k,42791.0,white,metastatic,0.5,0.09999996,dnr after sadm,8.0,55.0,23.1992188,150.0,10.0,39.19531,140.0,1.8999023,0.89990234,0.5,146.0,7.359375,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5019531
40.68698,female,1.0,Lung Cancer,14.0,>$50k,26951.0,asian,metastatic,0.099999964,0.0009999992,dnr after sadm,5.0,83.0,5.79980469,80.0,28.0,36.29688,224.0,2.7998047,1.89990234,1.69995117,136.0,7.419922,135.0,23.0,1968.0,1.0,0.0,<2 mo. follow-up,0.0
41.448,male,0.0,Cirrhosis,16.0,>$50k,15982.0,white,no,0.899999619,0.7999997,no dnr,13.0,57.0,9.5,60.0,40.0,36.19531,224.0,2.0996094,2.69970703,0.59997559,137.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
75.34296,male,0.0,CHF,12.0,$11-$25k,5532.0,black,no,0.699999809,0.5,no dnr,7.0,100.0,6.69921875,60.0,20.0,37.0,242.84375,2.8999023,0.79992676,1.69995117,139.0,7.429688,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
69.35797,female,0.0,COPD,14.0,under $11k,4764.0,white,no,0.75,0.75,no dnr,6.0,98.0,8.29882812,80.0,24.0,37.0,259.25,2.8999023,0.89990234,1.39990234,140.0,7.469727,135.0,23.0,1968.0,5.0,4.0,SIP>=30,4.0
54.43399,male,0.0,Lung Cancer,12.0,under $11k,4818.0,black,metastatic,0.699999809,0.5,dnr before sadm,-1.0,100.0,13.3984375,120.0,20.0,37.79688,224.0,3.199707,0.59997559,0.89990234,142.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.2055664
75.07996,female,0.0,COPD,5.0,under $11k,39957.0,white,no,0.189999938,0.1899999,dnr after sadm,6.0,117.0,11.5,64.0,6.0,38.39844,206.65625,3.0,0.89990234,1.59985352,142.0,7.349609,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
54.66397,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,96588.0,white,no,0.5,0.3,no dnr,8.0,57.0,3.09960938,140.0,26.0,35.79688,160.0,3.0,33.0,3.69970703,132.0,7.379883,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.9960938
72.40497,male,0.0,ARF/MOSF w/Sepsis,10.0,under $11k,48378.0,white,no,0.929999828,0.8999996,no dnr,10.0,69.0,12.6992188,110.0,28.0,39.0,220.0,2.8999023,0.89990234,0.89990234,143.0,7.469727,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
75.12695,female,0.0,COPD,9.0,under $11k,53401.0,white,no,0.799999714,0.3999999,no dnr,16.0,87.0,6.69921875,70.0,26.0,35.19531,217.375,2.8999023,0.39996338,1.5,144.0,7.329102,135.0,23.0,1968.0,5.0,7.0,SIP>=30,7.0
65.05096,male,0.0,Lung Cancer,16.0,$25-$50k,6174.0,white,metastatic,0.5,0.3,no dnr,8.0,85.0,4.79980469,72.0,18.0,36.29688,224.0,3.5996094,0.79992676,0.79992676,147.0,7.419922,135.0,23.0,1968.0,4.0,0.0,SIP>=30,0.0
62.35498,male,1.0,ARF/MOSF w/Sepsis,20.0,under $11k,45424.0,white,no,0.5,0.5,dnr after sadm,26.0,55.0,2.19970703,105.0,28.0,38.69531,179.5625,3.2998047,0.69995117,2.29980469,132.0,7.469727,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
51.767,female,1.0,Colon Cancer,12.0,under $11k,6608.0,white,metastatic,0.099999964,0.0009999992,dnr after sadm,1.0,70.0,15.1992188,128.0,22.0,36.59375,224.0,2.5,12.2988281,0.69995117,137.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
72.64099,male,0.0,ARF/MOSF w/Sepsis,12.0,>$50k,30733.0,white,no,0.949999809,0.8499999,no dnr,22.0,74.0,12.7988281,76.0,24.0,36.09375,217.5,2.0,1.69995117,3.89990234,131.0,7.339844,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
87.70996,female,0.0,ARF/MOSF w/Sepsis,16.0,under $11k,46354.0,white,no,0.5,0.25,no dnr,27.0,61.0,17.5976562,107.0,28.0,36.19531,124.48438,3.3999023,0.79992676,2.5,136.0,7.299805,135.0,23.0,1968.0,0.0,3.0,adl>=4 (>=5 if sur),3.0
80.159,male,0.0,ARF/MOSF w/Sepsis,11.0,$25-$50k,131511.0,white,no,0.949999809,0.8999996,dnr after sadm,30.0,80.0,18.0,80.0,32.0,38.09375,98.0,2.8999023,0.89990234,1.89990234,141.0,7.399414,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),1.0
57.51999,female,0.0,Lung Cancer,12.0,$11-$25k,6630.0,white,metastatic,0.899999619,0.5999999,no dnr,6.0,83.0,6.89941406,104.0,24.0,36.69531,224.0,3.8999023,0.5,1.09985352,142.0,7.419922,135.0,23.0,1968.0,0.0,3.0,no(M2 and SIP pres),3.0
74.51599,male,1.0,Lung Cancer,14.0,under $11k,3122.0,white,metastatic,0.5,0.0,dnr after sadm,1.0,100.0,7.89941406,60.0,5.0,36.09375,224.0,3.699707,0.69995117,1.29980469,147.0,7.419922,135.0,23.0,1968.0,0.0,3.0,<2 mo. follow-up,3.0
67.034,male,0.0,COPD,12.0,$11-$25k,25793.0,white,no,0.949999809,0.7999997,no dnr,13.0,70.0,13.2988281,54.0,26.0,36.69531,240.0,3.3999023,0.59997559,1.19995117,137.0,7.399414,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
65.53894,male,0.0,CHF,19.0,>$50k,10474.0,white,no,0.75,0.5,no dnr,10.0,85.0,5.59960938,92.0,22.0,37.19531,385.6875,2.8999023,0.89990234,1.5,136.0,7.5,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
76.44397,female,0.0,CHF,12.0,under $11k,5718.0,white,no,0.909999847,0.9099998,no dnr,7.0,117.0,8.09960938,70.0,20.0,36.09375,211.09375,2.7998047,0.89990234,3.5,141.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
75.27698,male,0.0,CHF,12.0,under $11k,6045.0,white,no,0.949999809,0.75,no dnr,7.0,65.0,11.3984375,64.0,22.0,37.59375,197.5,2.8999023,0.89990234,1.69995117,145.0,7.479492,135.0,23.0,1968.0,3.0,0.0,<2 mo. follow-up,0.0
84.41595,male,0.0,COPD,4.0,under $11k,11238.0,white,no,0.799999714,0.6999998,no dnr,8.0,57.0,8.19921875,61.0,34.0,37.59375,197.5,3.0,0.89990234,1.69995117,135.0,7.40918,135.0,23.0,1968.0,0.0,3.0,no(M2 and SIP pres),3.0
82.09399,male,1.0,COPD,12.0,under $11k,13125.0,white,yes,0.099999964,0.0009999992,dnr after sadm,2.0,68.0,13.3984375,85.0,40.0,37.19531,185.6875,2.3999023,0.69995117,2.0,132.0,7.529297,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,5.2265625
78.25598,female,1.0,Coma,12.0,under $11k,7774.0,white,no,0.0,0.0,no dnr,4.0,67.0,10.5996094,128.0,4.0,41.09375,224.0,2.8999023,0.89990234,1.19995117,140.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.7348633
81.56299,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,15296.0,white,no,0.949999809,0.8999996,no dnr,14.0,54.0,7.5,59.0,24.0,38.69531,330.0,2.8999023,0.89990234,0.79992676,129.0,7.439453,135.0,23.0,1968.0,1.0,0.0,no(M2 and SIP pres),0.0
61.306,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,74086.0,white,no,0.019999996,7.999995e-06,dnr after sadm,1.0,41.0,34.3984375,210.0,24.0,38.39844,96.25,3.0,0.89990234,1.39990234,144.0,7.30957,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.1899414
70.68896,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,49259.0,white,no,0.799999714,0.7999997,dnr after sadm,14.0,46.0,14.0,126.0,10.0,36.59375,153.03125,2.7998047,0.59997559,4.5,140.0,7.229492,135.0,23.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
89.31396,male,1.0,COPD,12.0,under $11k,26630.0,white,no,0.599999905,0.3,dnr before sadm,-1.0,123.0,10.8984375,62.0,28.0,38.09375,286.625,3.0996094,0.89990234,1.79980469,148.0,7.5,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
63.58099,male,0.0,Colon Cancer,12.0,under $11k,5187.0,white,metastatic,0.75,0.3999999,dnr after sadm,3.0,93.0,12.7988281,98.0,24.0,36.59375,224.0,2.5,10.3984375,1.0,133.0,7.419922,135.0,23.0,1968.0,4.0,1.0,no(M2 and SIP pres),3.1831989
92.29797,female,0.0,CHF,12.0,under $11k,19765.0,white,no,0.799999714,0.5499997,dnr after sadm,1.0,97.0,15.2988281,80.0,24.0,36.19531,233.3125,3.2998047,1.0,2.39990234,144.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.9008789
74.409,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,26899.0,white,no,0.799999714,0.5999999,dnr after sadm,2.0,47.0,12.0996094,67.0,20.0,38.89844,320.0,2.8999023,0.89990234,1.09985352,137.0,7.379883,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
88.172,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,6992.0,white,no,0.699999809,0.5,dnr after sadm,2.0,0.0,10.6992188,0.0,30.0,36.39844,312.5,2.8999023,1.29980469,5.59960938,126.0,7.389648,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.8625488
82.32697,male,1.0,COPD,12.0,under $11k,15828.0,white,no,0.0,0.0,dnr after sadm,5.0,42.0,17.3984375,104.0,32.0,36.39844,218.0,2.8999023,1.59985352,2.69970703,145.0,7.329102,135.0,23.0,1968.0,0.0,6.0,<2 mo. follow-up,6.0
95.41394,female,0.0,ARF/MOSF w/Sepsis,8.0,under $11k,21600.0,white,no,0.299999952,0.3,no dnr,16.0,57.0,8.19921875,77.0,40.0,38.89844,90.0,2.8999023,0.69995117,1.59985352,148.0,7.069336,135.0,23.0,1968.0,4.0,4.0,adl>=4 (>=5 if sur),4.0
76.12598,male,0.0,COPD,12.0,$25-$50k,4546.0,white,no,0.899999619,0.7999997,no dnr,5.0,107.0,3.29980469,80.0,21.0,37.19531,230.0,2.8999023,0.89990234,1.09985352,131.0,7.379883,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
86.49097,male,0.0,ARF/MOSF w/Sepsis,19.0,under $11k,110134.0,white,no,0.75,0.75,no dnr,114.0,131.0,8.59960938,78.0,28.0,36.69531,85.0,2.5996094,0.59997559,0.69995117,140.0,7.529297,135.0,23.0,1968.0,0.0,7.0,adl>=4 (>=5 if sur),7.0
70.21796,male,1.0,ARF/MOSF w/Sepsis,14.0,$11-$25k,27165.0,white,no,0.699999809,0.5,dnr after sadm,9.0,80.0,3.0,100.0,26.0,35.0,404.75,2.199707,1.89990234,8.19921875,135.0,7.539062,135.0,23.0,1968.0,3.0,0.0,<2 mo. follow-up,0.0
69.84796,female,0.0,COPD,12.0,under $11k,27437.0,hispanic,yes,0.75,0.5,dnr after sadm,3.0,50.0,15.0,63.0,10.0,38.0,225.0,3.7998047,0.19998169,0.59997559,137.0,7.379883,135.0,23.0,1968.0,0.0,2.0,no(M2 and SIP pres),2.0
48.909,male,0.0,COPD,6.0,under $11k,162243.0,white,no,0.5,0.5,no dnr,111.0,47.0,18.296875,121.0,10.0,33.29688,249.0,2.5996094,1.39990234,1.19995117,138.0,7.339844,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
70.65295,male,0.0,Colon Cancer,5.0,$25-$50k,8013.0,white,metastatic,0.75,0.5,no dnr,8.0,77.0,8.69921875,60.0,28.0,37.89844,224.0,2.8999023,0.89990234,1.0,143.0,7.419922,135.0,23.0,1968.0,0.0,2.0,no(M2 and SIP pres),2.0
39.12698,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,19532.0,white,no,0.989999771,0.9499998,no dnr,18.0,68.0,17.3984375,144.0,28.0,38.39844,424.0,2.8999023,0.89990234,1.19995117,136.0,7.439453,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
69.21295,female,1.0,COPD,12.0,under $11k,19470.0,white,no,0.5,0.3999999,no dnr,9.0,53.0,21.8984375,165.0,38.0,36.89844,203.6875,4.0996094,0.89990234,2.39990234,134.0,7.399414,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
19.75099,male,0.0,ARF/MOSF w/Sepsis,14.0,under $11k,8945.0,black,no,0.989999771,0.9899998,no dnr,6.0,113.0,14.5996094,112.0,24.0,37.09375,245.0,2.8999023,0.89990234,0.89990234,137.0,7.389648,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.6252441
65.87799,female,1.0,ARF/MOSF w/Sepsis,14.0,>$50k,10435.0,white,no,0.699999809,0.5,no dnr,4.0,47.0,15.0996094,110.0,22.0,39.19531,150.0,2.0,2.5,1.59985352,145.0,7.329102,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.1923828
85.89996,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,9867.0,white,no,0.5,0.09999996,dnr after sadm,2.0,57.0,8.69921875,64.0,20.0,37.39844,224.0,2.699707,1.79980469,0.79992676,142.0,7.419922,135.0,23.0,1968.0,0.0,7.0,adl>=4 (>=5 if sur),7.0
77.73895,male,1.0,ARF/MOSF w/Sepsis,20.0,$25-$50k,298360.0,white,no,0.989999771,0.8999996,dnr after sadm,120.0,132.0,10.3984375,115.0,8.0,38.19531,141.65625,3.5996094,0.89990234,2.59960938,138.0,7.369141,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
88.03595,female,0.0,ARF/MOSF w/Sepsis,10.0,under $11k,15815.0,white,no,0.699999809,0.5,no dnr,17.0,71.0,5.5,76.0,45.0,38.5,388.0,2.8999023,0.5,1.69995117,137.0,7.40918,135.0,23.0,1968.0,1.0,1.0,no(M2 and SIP pres),1.0
71.66595,female,0.0,COPD,14.0,>$50k,7804.0,white,no,0.899999619,0.6999998,no dnr,7.0,71.0,7.29980469,74.0,20.0,36.29688,542.75,3.7998047,0.89990234,1.29980469,137.0,7.389648,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
70.31897,female,0.0,Lung Cancer,12.0,$25-$50k,4416.0,white,metastatic,0.699999809,0.5,no dnr,4.0,60.0,5.19921875,80.0,20.0,37.79688,224.0,2.8999023,1.09985352,0.59997559,135.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.9909668
69.14398,male,0.0,COPD,12.0,under $11k,10137.0,white,no,0.949999809,0.6499996,no dnr,9.0,83.0,6.5,76.0,32.0,36.19531,337.0,4.0,0.5,0.79992676,137.0,7.389648,135.0,23.0,1968.0,3.0,1.0,no(M2 and SIP pres),1.0
80.87097,female,0.0,COPD,12.0,under $11k,10512.0,white,no,0.799999714,0.6999998,no dnr,9.0,77.0,17.296875,134.0,28.0,36.5,190.46875,2.8999023,0.89990234,0.89990234,136.0,7.339844,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
72.67596,male,0.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,11472.0,white,no,0.799999714,0.7999997,no dnr,7.0,67.0,10.5996094,62.0,26.0,36.09375,471.625,2.8999023,1.0,1.79980469,134.0,7.509766,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
90.11597,female,0.0,COPD,5.0,under $11k,10945.0,white,no,0.899999619,0.6999998,dnr after sadm,1.0,93.0,5.39941406,82.0,28.0,37.0,285.6875,2.8999023,0.89990234,1.09985352,144.0,7.269531,135.0,23.0,1968.0,5.0,1.0,<2 mo. follow-up,3.855299
91.88995,female,0.0,CHF,12.0,>$50k,5870.0,white,no,0.199999928,0.09999996,dnr after sadm,1.0,75.0,8.69921875,60.0,24.0,36.69531,400.0,4.5996094,0.89990234,1.89990234,135.0,7.259766,135.0,23.0,1968.0,0.0,3.0,no(M2 and SIP pres),3.0
85.29498,male,1.0,ARF/MOSF w/Sepsis,6.0,under $11k,22704.0,black,no,0.099999964,0.0009999992,dnr after sadm,3.0,63.0,19.1992188,138.0,46.0,39.29688,173.3125,3.199707,1.19995117,0.79992676,132.0,7.429688,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
78.06195,male,0.0,CHF,6.0,under $11k,12894.0,white,no,0.799999714,0.5999999,no dnr,16.0,65.0,5.19921875,98.0,32.0,36.19531,224.0,3.2998047,0.5,1.59985352,134.0,7.419922,135.0,23.0,1968.0,0.0,5.0,<2 mo. follow-up,5.0
77.36896,male,1.0,ARF/MOSF w/Sepsis,10.0,$11-$25k,159774.0,white,no,0.949999809,0.7999997,dnr after sadm,68.0,43.0,5.69921875,189.0,16.0,36.59375,153.03125,2.2998047,0.89990234,0.79992676,136.0,7.399414,135.0,23.0,1968.0,4.0,3.0,no(M2 and SIP pres),3.0
57.47598,female,0.0,MOSF w/Malig,12.0,under $11k,27525.0,hispanic,metastatic,0.799999714,0.5,no dnr,17.0,111.0,6.19921875,110.0,26.0,36.79688,250.0,2.8999023,0.89990234,1.29980469,149.0,7.519531,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),0.4947999
75.12097,female,0.0,ARF/MOSF w/Sepsis,16.0,under $11k,171895.0,white,no,0.599999905,0.3999999,no dnr,121.0,53.0,15.5996094,160.0,8.0,36.39844,248.0,3.3999023,1.79980469,2.0,146.0,7.209961,135.0,23.0,1968.0,0.0,5.0,SIP>=30,5.0
36.16397,male,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,90237.0,white,no,0.699999809,0.5,no dnr,44.0,127.0,11.0,102.0,14.0,38.5,191.65625,2.8999023,0.89990234,0.89990234,134.0,7.449219,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
76.10999,male,0.0,ARF/MOSF w/Sepsis,0.0,under $11k,21743.0,white,no,0.75,0.25,no dnr,11.0,113.0,12.7988281,70.0,28.0,38.79688,103.0,2.8999023,0.89990234,1.39990234,143.0,7.489258,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),5.4404297
87.13995,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,19842.0,white,yes,0.099999964,0.0009999992,dnr after sadm,4.0,43.0,7.09960938,114.0,12.0,38.19531,285.0,4.0,1.19995117,2.09960938,143.0,7.439453,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.121582
76.80194,female,0.0,COPD,12.0,under $11k,32927.0,white,no,0.799999714,0.6499996,no dnr,13.0,72.0,16.0976562,102.0,28.0,38.09375,177.53125,2.8999023,0.89990234,1.39990234,138.0,7.509766,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
85.62097,female,0.0,CHF,12.0,$25-$50k,13883.0,white,no,0.979999542,1.0,no dnr,17.0,53.0,5.69921875,69.0,30.0,38.0,126.51562,2.8999023,0.59997559,1.69995117,136.0,7.369141,135.0,23.0,1968.0,1.0,0.0,SIP>=30,0.0
82.83099,female,0.0,COPD,12.0,$25-$50k,7412.0,white,no,0.899999619,0.5999999,dnr after sadm,2.0,65.0,10.5996094,71.0,35.0,36.89844,220.0,3.7998047,0.5,3.0,140.0,7.379883,135.0,23.0,1968.0,6.0,1.0,adl>=4 (>=5 if sur),4.5273972
67.26099,female,0.0,COPD,14.0,$11-$25k,9286.0,black,no,0.899999619,0.8499999,no dnr,8.0,113.0,6.89941406,90.0,24.0,37.79688,421.625,3.2998047,0.29998779,1.5,144.0,7.379883,135.0,23.0,1968.0,1.0,1.0,<2 mo. follow-up,1.0
78.07794,female,0.0,COPD,15.0,$25-$50k,13959.0,white,no,0.799999714,0.5999999,dnr after sadm,1.0,67.0,4.69921875,80.0,20.0,36.69531,220.0,2.8999023,0.89990234,0.79992676,133.0,7.5,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
48.05698,female,1.0,MOSF w/Malig,19.0,>$50k,9250.0,white,metastatic,0.699999809,0.5,dnr after sadm,3.0,49.0,1.5,124.0,44.0,34.59375,145.0,2.7998047,0.59997559,0.69995117,130.0,7.439453,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
70.75195,female,0.0,Lung Cancer,12.0,under $11k,19308.0,white,metastatic,0.799999714,0.6999998,no dnr,20.0,103.0,12.8984375,76.0,16.0,36.69531,224.0,3.3999023,0.5,0.89990234,141.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.953125
85.06494,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,15635.0,white,no,0.899999619,0.7999997,no dnr,13.0,50.0,11.8984375,85.0,20.0,37.89844,235.0,3.5996094,0.5,0.79992676,133.0,7.319336,135.0,23.0,1968.0,1.0,0.0,no(M2 and SIP pres),0.0
43.21399,female,0.0,Cirrhosis,21.0,>$50k,22535.0,white,no,0.599999905,0.3299999,no dnr,10.0,58.0,11.2988281,132.0,56.0,38.89844,261.875,2.3999023,2.59960938,0.39996338,145.0,7.509766,135.0,23.0,1968.0,0.0,3.0,<2 mo. follow-up,3.0
61.862,female,0.0,CHF,12.0,under $11k,139856.0,black,no,0.699999809,0.6499996,dnr after sadm,6.0,53.0,11.8984375,69.0,32.0,38.69531,316.0,2.7998047,0.89990234,6.69921875,137.0,7.229492,135.0,23.0,1968.0,0.0,2.0,SIP>=30,2.0
55.64099,male,0.0,Lung Cancer,14.0,under $11k,12424.0,white,metastatic,0.5,0.25,no dnr,11.0,103.0,7.0,88.0,16.0,37.79688,224.0,2.8999023,0.39996338,1.19995117,133.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
57.35199,male,0.0,Lung Cancer,12.0,$25-$50k,5977.0,white,metastatic,0.5,0.1999999,no dnr,5.0,70.0,0.79992676,100.0,26.0,38.79688,328.5625,2.8999023,0.89990234,1.5,133.0,7.479492,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.2036133
55.66098,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,30821.0,white,no,0.5,0.1999999,no dnr,12.0,53.0,13.5996094,109.0,32.0,39.09375,118.32812,2.8999023,0.89990234,0.79992676,134.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
27.228,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,95692.0,white,no,0.949999809,0.7999997,no dnr,100.0,106.0,13.8984375,135.0,22.0,37.89844,236.65625,2.8999023,0.89990234,1.09985352,145.0,7.439453,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.6665039
64.76898,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,67778.0,white,no,0.299999952,0.25,no dnr,44.0,59.0,16.1992188,67.0,32.0,38.09375,185.6875,2.7998047,0.39996338,8.8984375,144.0,7.459961,135.0,23.0,1968.0,0.0,0.0,SIP>=30,0.0
89.05695,female,1.0,ARF/MOSF w/Sepsis,20.0,under $11k,21707.0,white,no,0.049999982,0.0001249999,dnr after sadm,2.0,59.0,8.5,115.0,36.0,38.39844,235.0,3.7998047,0.89990234,1.19995117,150.0,7.419922,135.0,23.0,1968.0,0.0,7.0,<2 mo. follow-up,7.0
75.625,male,0.0,COPD,12.0,under $11k,33324.0,black,no,0.899999619,0.8999996,dnr after sadm,16.0,72.0,8.59960938,73.0,16.0,36.0,237.125,3.199707,0.39996338,1.0,135.0,7.399414,135.0,23.0,1968.0,7.0,1.0,<2 mo. follow-up,5.1994972
51.56998,female,0.0,COPD,14.0,$25-$50k,7933.0,white,no,0.979999542,0.9799995,no dnr,8.0,73.0,12.6992188,110.0,25.0,38.29688,329.625,2.8999023,0.69995117,0.69995117,146.0,7.399414,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
76.18896,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,58865.0,white,no,0.299999952,0.09999996,dnr after sadm,5.0,57.0,10.1992188,63.0,6.0,38.19531,294.25,3.7998047,0.39996338,0.69995117,132.0,7.439453,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
64.66498,female,0.0,Lung Cancer,15.0,under $11k,3253.0,white,metastatic,0.799999714,0.5999999,no dnr,4.0,117.0,6.5,72.0,28.0,36.39844,224.0,2.8999023,0.89990234,1.09985352,137.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
89.62598,female,0.0,COPD,16.0,>$50k,6769.0,white,no,1.0,0.7999997,no dnr,6.0,93.0,15.3984375,80.0,40.0,36.09375,220.0,3.3999023,0.5,1.69995117,139.0,7.469727,135.0,23.0,1968.0,2.0,5.0,SIP>=30,5.0
71.77295,male,0.0,Colon Cancer,12.0,$25-$50k,6365.0,white,metastatic,0.049999982,0.0001249999,dnr after sadm,3.0,103.0,2.39990234,76.0,20.0,37.79688,224.0,2.199707,0.5,0.89990234,142.0,7.419922,135.0,23.0,1968.0,3.0,5.0,<2 mo. follow-up,5.0
77.72998,female,0.0,COPD,16.0,under $11k,2752.0,white,no,0.949999809,0.8499999,no dnr,3.0,120.0,7.59960938,60.0,24.0,36.19531,380.0,2.8999023,0.89990234,1.09985352,144.0,7.469727,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.2114258
52.961,male,1.0,Lung Cancer,12.0,under $11k,8388.0,black,metastatic,0.049999982,0.0001249999,dnr before sadm,-1.0,83.0,32.1953125,112.0,16.0,37.39844,224.0,2.7998047,1.09985352,0.69995117,142.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
62.25098,female,0.0,COPD,12.0,under $11k,5801.0,white,no,0.699999809,0.5,no dnr,5.0,110.0,17.296875,100.0,20.0,36.69531,176.65625,3.8999023,0.39996338,1.19995117,143.0,7.30957,135.0,23.0,1968.0,1.0,0.0,no(M2 and SIP pres),0.0
63.54797,female,0.0,COPD,12.0,under $11k,35637.0,white,no,0.799999714,0.5999999,no dnr,18.0,147.0,8.19921875,115.0,6.0,37.79688,140.0,4.1992188,1.5,1.39990234,148.0,7.299805,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
71.30695,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,35785.0,white,no,0.75,0.6999998,dnr after sadm,4.0,68.0,10.1992188,103.0,32.0,38.39844,61.0,2.8999023,0.89990234,1.59985352,134.0,7.489258,135.0,23.0,1968.0,0.0,5.0,SIP>=30,5.0
70.15497,male,0.0,Lung Cancer,14.0,$11-$25k,4469.0,white,metastatic,0.5,0.09999996,no dnr,4.0,80.0,20.296875,90.0,20.0,37.79688,224.0,3.2998047,0.5,0.69995117,137.0,7.419922,135.0,23.0,1968.0,1.0,0.0,<2 mo. follow-up,0.0
61.98798,male,0.0,MOSF w/Malig,14.0,$11-$25k,20414.0,white,yes,0.75,0.5,no dnr,7.0,52.0,5.5,110.0,12.0,38.89844,145.0,1.6999512,1.69995117,1.89990234,131.0,7.30957,135.0,23.0,1968.0,0.0,0.0,SIP>=30,0.0
75.737,female,0.0,CHF,12.0,under $11k,11378.0,white,no,0.989999771,0.9699998,no dnr,7.0,77.0,13.0996094,100.0,20.0,37.19531,295.1875,2.8999023,0.89990234,0.89990234,139.0,7.439453,135.0,23.0,1968.0,1.0,2.0,no(M2 and SIP pres),2.0
57.09198,male,0.0,ARF/MOSF w/Sepsis,7.0,under $11k,40735.0,white,no,0.899999619,0.9499998,no dnr,15.0,58.0,6.69921875,110.0,24.0,38.59375,280.0,2.8999023,0.89990234,0.89990234,136.0,7.489258,135.0,23.0,1968.0,5.0,0.0,no(M2 and SIP pres),0.0
83.55896,male,0.0,COPD,12.0,under $11k,9225.0,white,no,0.899999619,0.75,no dnr,7.0,107.0,16.796875,60.0,25.0,36.69531,117.5,2.8999023,0.89990234,1.5,144.0,7.279297,135.0,23.0,1968.0,1.0,1.0,no(M2 and SIP pres),1.0
53.54999,male,0.0,CHF,16.0,>$50k,47802.0,white,no,0.989999771,0.9899998,no dnr,22.0,77.0,7.5,63.0,24.0,36.69531,170.0,2.8999023,0.89990234,1.89990234,144.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
66.58698,male,0.0,Lung Cancer,13.0,>$50k,7248.0,white,metastatic,0.899999619,0.6499996,no dnr,6.0,100.0,3.0,100.0,20.0,35.59375,224.0,3.0996094,0.19998169,1.09985352,137.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
89.16095,male,1.0,ARF/MOSF w/Sepsis,13.0,under $11k,74657.0,white,no,0.849999905,0.75,dnr after sadm,57.0,47.0,9.09960938,72.0,26.0,38.39844,203.3125,2.8999023,0.89990234,2.5,138.0,7.269531,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),1.0
85.45697,male,0.0,ARF/MOSF w/Sepsis,8.0,under $11k,31884.0,white,yes,0.799999714,0.6499996,dnr after sadm,10.0,46.0,10.1992188,105.0,28.0,36.29688,346.625,2.2998047,1.29980469,1.5,138.0,7.269531,135.0,23.0,1968.0,0.0,4.0,<2 mo. follow-up,4.0
66.53296,male,0.0,ARF/MOSF w/Sepsis,9.0,$11-$25k,14115.0,white,no,0.799999714,0.6999998,no dnr,9.0,55.0,7.0,68.0,24.0,38.79688,252.5,2.8999023,0.29998779,1.5,141.0,7.389648,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
64.34998,female,1.0,Colon Cancer,12.0,under $11k,4814.0,white,metastatic,0.099999964,0.0009999992,dnr after sadm,1.0,93.0,11.7988281,100.0,20.0,36.09375,224.0,1.8999023,4.39941406,0.89990234,146.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.1054688
91.23895,female,1.0,ARF/MOSF w/Sepsis,16.0,under $11k,49254.0,white,yes,0.049999982,0.0001249999,dnr after sadm,16.0,47.0,8.79882812,47.0,8.0,36.89844,230.0,2.8999023,0.5,1.29980469,137.0,7.369141,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.5141602
52.43799,male,0.0,Lung Cancer,12.0,under $11k,3754.0,white,metastatic,0.5,0.09999996,no dnr,4.0,90.0,10.5,90.0,20.0,37.79688,342.8125,4.0996094,2.09960938,1.29980469,136.0,7.489258,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.921875
69.68695,female,0.0,Lung Cancer,16.0,>$50k,7594.0,white,metastatic,0.699999809,0.5,no dnr,6.0,97.0,4.09960938,100.0,20.0,38.19531,280.9375,2.8999023,0.89990234,1.0,144.0,7.439453,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
68.01099,female,0.0,ARF/MOSF w/Sepsis,13.0,$25-$50k,65515.0,white,no,0.5,0.5,no dnr,40.0,53.0,11.1992188,70.0,8.0,38.59375,182.0,2.8999023,0.89990234,1.09985352,157.0,7.429688,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
78.00995,male,1.0,COPD,12.0,under $11k,55591.0,white,no,0.5,0.3999999,dnr after sadm,20.0,117.0,16.8984375,70.0,20.0,35.59375,169.5625,3.5996094,0.39996338,1.69995117,146.0,7.319336,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.7246094
66.57599,male,0.0,Lung Cancer,10.0,$11-$25k,28609.0,hispanic,metastatic,0.699999809,0.5,dnr after sadm,1.0,87.0,13.3984375,60.0,20.0,37.0,224.0,3.5996094,0.59997559,0.89990234,133.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.8164062
71.55096,male,0.0,Lung Cancer,13.0,under $11k,4155.0,white,metastatic,0.5,0.1999999,dnr after sadm,1.0,60.0,12.5996094,110.0,25.0,36.79688,323.75,3.0996094,0.39996338,1.0,143.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
93.63196,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,20328.0,white,yes,0.5,0.09999996,dnr after sadm,6.0,55.0,12.0996094,62.0,36.0,36.79688,177.5,2.8999023,0.79992676,2.19970703,139.0,7.379883,135.0,23.0,1968.0,0.0,6.0,<2 mo. follow-up,6.0
55.51498,male,0.0,Lung Cancer,8.0,$11-$25k,4136.0,white,metastatic,1.0,0.8999996,no dnr,3.0,100.0,11.6992188,92.0,20.0,36.69531,224.0,2.8999023,0.89990234,0.79992676,137.0,7.419922,135.0,23.0,1968.0,0.0,1.0,SIP>=30,1.0
84.80499,female,0.0,CHF,14.0,$25-$50k,13374.0,white,no,0.899999619,0.5,dnr after sadm,10.0,107.0,6.0,80.0,20.0,35.59375,276.0,3.0,0.5,2.39990234,136.0,7.5,135.0,23.0,1968.0,0.0,7.0,<2 mo. follow-up,7.0
46.08398,female,0.0,Lung Cancer,12.0,under $11k,9901.0,black,metastatic,0.5,0.1999999,dnr after sadm,1.0,93.0,12.6992188,76.0,16.0,36.69531,224.0,3.5996094,0.39996338,1.0,135.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
53.99597,male,0.0,ARF/MOSF w/Sepsis,9.0,under $11k,14066.0,black,no,1.0,0.9499998,no dnr,11.0,64.0,11.6992188,110.0,25.0,38.09375,179.5625,2.8999023,0.89990234,0.79992676,136.0,7.449219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.565918
44.89499,female,0.0,ARF/MOSF w/Sepsis,15.0,$25-$50k,176328.0,white,no,0.149999976,0.003374999,no dnr,63.0,53.0,41.1953125,130.0,22.0,36.39844,50.0,1.8999023,1.19995117,1.5,129.0,7.279297,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
67.75098,male,1.0,MOSF w/Malig,8.0,under $11k,46516.0,white,yes,0.75,0.5,dnr after sadm,8.0,57.0,12.1992188,145.0,14.0,36.89844,211.65625,2.8999023,0.5,11.7988281,138.0,7.319336,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
75.159,female,1.0,COPD,12.0,$25-$50k,24431.0,white,no,0.049999982,0.0001249999,dnr after sadm,6.0,43.0,29.3984375,127.0,24.0,34.59375,195.0,2.7998047,0.89990234,1.19995117,132.0,7.40918,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
69.59094,male,0.0,CHF,11.0,under $11k,5894.0,white,no,0.799999714,0.5999999,no dnr,6.0,63.0,11.0,80.0,25.0,35.59375,224.0,2.8999023,1.59985352,2.19970703,135.0,7.489258,135.0,23.0,1968.0,0.0,0.0,SIP>=30,0.0
31.76999,male,0.0,Lung Cancer,12.0,under $11k,33867.0,white,metastatic,0.799999714,0.25,no dnr,23.0,72.0,16.796875,124.0,20.0,39.39844,224.0,2.8999023,0.89990234,0.59997559,133.0,7.419922,135.0,23.0,1968.0,5.0,2.0,adl>=4 (>=5 if sur),2.0
74.83398,female,1.0,CHF,12.0,under $11k,10763.0,white,no,0.699999809,0.5,dnr after sadm,1.0,70.0,11.8984375,100.0,50.0,36.09375,263.3125,2.199707,0.39996338,0.79992676,142.0,7.429688,135.0,23.0,1968.0,0.0,4.0,<2 mo. follow-up,4.0
74.66699,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,46033.0,white,no,0.5,0.5,no dnr,25.0,52.0,13.0,113.0,32.0,37.59375,120.0,2.0996094,0.39996338,2.0,150.0,7.479492,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
69.68097,female,0.0,Lung Cancer,20.0,>$50k,6840.0,white,metastatic,0.949999809,0.75,no dnr,6.0,77.0,10.5996094,74.0,20.0,36.79688,224.0,3.199707,0.29998779,1.0,139.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
75.66895,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,20399.0,white,no,0.899999619,0.6999998,no dnr,8.0,108.0,5.59960938,78.0,24.0,36.59375,173.3125,2.699707,0.89990234,1.79980469,140.0,7.389648,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
70.09698,male,0.0,COPD,14.0,$11-$25k,6388.0,white,no,0.96999979,0.9699998,no dnr,4.0,60.0,10.0996094,60.0,20.0,36.09375,361.875,2.8999023,0.89990234,1.09985352,144.0,7.319336,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
79.05499,female,0.0,COPD,12.0,under $11k,9388.0,white,metastatic,0.099999964,0.0009999992,dnr before sadm,-1.0,97.0,0.59997559,76.0,32.0,36.09375,190.0,3.0996094,0.69995117,0.59997559,147.0,7.389648,135.0,23.0,1968.0,5.0,5.0,adl>=4 (>=5 if sur),5.0
69.06195,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,12943.0,white,no,0.899999619,0.7999997,no dnr,9.0,69.0,9.3984375,72.0,24.0,37.89844,348.0,3.0996094,1.09985352,4.09960938,143.0,7.30957,135.0,23.0,1968.0,1.0,0.0,no(M2 and SIP pres),0.0
83.29596,female,0.0,CHF,13.0,under $11k,47413.0,white,no,0.899999619,0.75,no dnr,23.0,47.0,5.29980469,121.0,24.0,37.79688,224.0,3.8999023,0.29998779,1.29980469,146.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
61.30298,male,0.0,ARF/MOSF w/Sepsis,15.0,under $11k,37775.0,other,no,0.699999809,0.5,no dnr,17.0,68.0,10.0,65.0,32.0,39.09375,177.5,3.0996094,0.79992676,1.29980469,141.0,7.379883,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
90.073,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,9664.0,white,yes,0.799999714,0.5999999,dnr before sadm,-1.0,120.0,4.79980469,59.0,16.0,36.19531,425.0,3.5996094,0.19998169,1.5,132.0,7.369141,135.0,23.0,1968.0,4.0,2.0,no(M2 and SIP pres),2.0
72.59698,male,1.0,ARF/MOSF w/Sepsis,17.0,$11-$25k,65724.0,white,no,0.399999857,0.1999999,no dnr,3.0,50.0,28.0976562,120.0,12.0,36.69531,100.0,2.5996094,0.89990234,3.5,129.0,7.30957,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
89.28094,male,0.0,MOSF w/Malig,8.0,under $11k,15407.0,white,yes,0.199999928,0.09999996,dnr after sadm,2.0,50.0,45.0,116.0,28.0,36.09375,199.96875,3.0,0.89990234,5.79980469,140.0,7.299805,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
78.39795,male,0.0,COPD,12.0,under $11k,7293.0,hispanic,no,0.699999809,0.5,no dnr,5.0,117.0,8.79882812,65.0,24.0,37.19531,283.3125,2.8999023,0.89990234,1.79980469,138.0,7.429688,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
63.44098,female,0.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,13301.0,white,no,0.75,0.5,no dnr,7.0,53.0,14.1992188,100.0,24.0,37.69531,355.0,3.5996094,0.79992676,4.39941406,136.0,7.429688,135.0,23.0,1968.0,0.0,4.0,no(M2 and SIP pres),4.0
70.90997,male,0.0,ARF/MOSF w/Sepsis,9.0,under $11k,14078.0,white,no,0.699999809,0.5,no dnr,7.0,57.0,9.5,112.0,26.0,38.59375,224.46875,2.8999023,0.89990234,1.0,136.0,7.519531,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
48.48499,male,0.0,ARF/MOSF w/Sepsis,9.0,under $11k,9580.0,white,no,0.799999714,0.7999997,no dnr,8.0,63.0,6.0,58.0,26.0,35.59375,428.5625,3.0,3.0,0.5,128.0,7.459961,135.0,23.0,1968.0,1.0,0.0,no(M2 and SIP pres),0.0
75.75897,male,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,101328.0,black,no,0.799999714,0.6999998,no dnr,67.0,153.0,12.2988281,130.0,8.0,37.79688,145.0,2.8999023,0.89990234,2.19970703,134.0,7.40918,135.0,23.0,1968.0,2.0,0.0,SIP>=30,0.0
84.57495,male,0.0,CHF,12.0,under $11k,19696.0,white,no,0.899999619,0.8999996,dnr after sadm,9.0,107.0,8.19921875,64.0,32.0,36.09375,224.0,3.7998047,1.5,2.09960938,145.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.3823242
88.50696,male,1.0,CHF,12.0,under $11k,8194.0,white,no,0.899999619,0.7999997,dnr after sadm,1.0,83.0,7.89941406,80.0,25.0,37.79688,390.4375,3.8999023,1.69995117,2.29980469,133.0,7.459961,135.0,23.0,1968.0,0.0,6.0,<2 mo. follow-up,6.0
71.82495,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,52016.0,white,no,0.699999809,0.5,dnr after sadm,1.0,77.0,11.6992188,70.0,32.0,39.39844,119.0,2.3999023,0.29998779,1.79980469,138.0,7.30957,135.0,23.0,1968.0,0.0,3.0,<2 mo. follow-up,3.0
61.19098,male,0.0,COPD,12.0,under $11k,27367.0,white,no,0.899999619,0.8999996,no dnr,15.0,100.0,16.0,80.0,25.0,36.09375,273.3125,4.0,0.79992676,1.39990234,136.0,7.429688,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),3.9931641
89.04297,male,1.0,ARF/MOSF w/Sepsis,12.0,>$50k,58008.0,hispanic,no,0.5,0.5,dnr after sadm,6.0,59.0,12.5,120.0,33.0,38.59375,168.0,2.8999023,0.39996338,1.0,146.0,7.389648,135.0,23.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
58.50198,male,0.0,Cirrhosis,14.0,$25-$50k,18372.0,white,no,0.799999714,0.7999997,no dnr,12.0,77.0,3.19970703,70.0,20.0,39.59375,242.84375,2.7998047,4.29980469,0.59997559,136.0,7.509766,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.262207
81.02698,female,0.0,COPD,9.0,>$50k,11976.0,white,no,0.799999714,0.6999998,no dnr,10.0,53.0,5.69921875,80.0,20.0,36.09375,266.625,2.8999023,0.89990234,0.89990234,141.0,7.479492,135.0,23.0,1968.0,1.0,3.0,no(M2 and SIP pres),3.0
76.10699,female,0.0,COPD,12.0,$25-$50k,27917.0,white,no,0.799999714,0.7999997,no dnr,14.0,107.0,13.6992188,78.0,8.0,37.69531,237.5,3.199707,0.29998779,1.59985352,138.0,7.339844,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
71.91498,female,0.0,COPD,18.0,$11-$25k,21983.0,white,metastatic,0.699999809,0.5,no dnr,17.0,103.0,1.79980469,80.0,25.0,36.09375,252.375,2.8999023,0.89990234,1.09985352,142.0,7.479492,135.0,23.0,1968.0,1.0,1.0,adl>=4 (>=5 if sur),1.0
75.41394,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,45105.0,white,metastatic,0.5,0.3999999,dnr after sadm,7.0,63.0,15.0,112.0,22.0,38.79688,185.0,2.8999023,0.89990234,1.29980469,141.0,7.389648,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
90.08398,female,0.0,COPD,12.0,under $11k,18263.0,white,no,0.599999905,0.15,no dnr,15.0,97.0,3.79980469,70.0,20.0,37.0,162.84375,2.8999023,0.89990234,1.59985352,150.0,7.379883,135.0,23.0,1968.0,0.0,5.0,adl>=4 (>=5 if sur),5.0
78.96796,female,0.0,ARF/MOSF w/Sepsis,0.0,$11-$25k,16741.0,white,no,0.899999619,0.75,no dnr,13.0,58.0,7.69921875,65.0,24.0,35.59375,136.71875,2.8999023,0.69995117,1.39990234,133.0,7.519531,135.0,23.0,1968.0,5.0,7.0,no(M2 and SIP pres),7.0
69.66199,female,0.0,Lung Cancer,12.0,under $11k,41995.0,white,metastatic,0.949999809,0.7999997,no dnr,22.0,117.0,9.29882812,80.0,25.0,36.5,340.0,3.199707,0.39996338,1.09985352,136.0,7.5,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.0629883
47.866,male,0.0,CHF,9.0,>$50k,9214.0,white,no,0.899999619,0.5999999,no dnr,8.0,70.0,5.09960938,80.0,16.0,36.69531,224.0,4.0,0.89990234,1.59985352,144.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
70.20099,male,0.0,ARF/MOSF w/Sepsis,14.0,$25-$50k,9812.0,white,no,0.899999619,0.8999996,no dnr,7.0,77.0,19.0976562,68.0,30.0,38.89844,159.15625,2.8999023,0.89990234,1.29980469,136.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
64.30396,male,0.0,Coma,16.0,>$50k,15716.0,white,yes,0.799999714,0.8999996,no dnr,16.0,77.0,8.8984375,62.0,28.0,37.79688,352.0,4.1992188,1.5,1.29980469,134.0,7.539062,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.2578125
78.95099,female,0.0,COPD,12.0,under $11k,19168.0,black,no,0.899999619,0.75,no dnr,13.0,117.0,7.44921875,150.0,26.0,36.09375,448.0,2.8999023,0.89990234,1.09985352,134.0,7.399414,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
62.56,male,0.0,Coma,18.0,>$50k,44236.0,black,no,0.699999809,0.5999999,dnr after sadm,7.0,135.0,14.5,140.0,28.0,38.29688,126.51562,3.2998047,0.89990234,1.79980469,146.0,7.459961,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
73.25397,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,54799.0,white,no,0.899999619,0.8999996,no dnr,16.0,49.0,12.5996094,76.0,24.0,38.39844,123.32812,2.8999023,0.89990234,1.29980469,132.0,7.489258,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
71.32898,female,1.0,Coma,12.0,under $11k,75051.0,white,no,0.75,0.25,dnr after sadm,14.0,67.0,16.5976562,110.0,32.0,38.79688,346.0,2.3999023,0.89990234,1.0,148.0,7.459961,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.871582
55.431,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,19018.0,white,yes,0.799999714,0.7999997,dnr after sadm,6.0,130.0,1.39990234,140.0,12.0,38.29688,121.42188,2.5996094,1.5,0.69995117,140.0,7.399414,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.7421875
47.26898,male,0.0,Cirrhosis,12.0,under $11k,4884.0,white,no,0.699999809,0.5,no dnr,3.0,80.0,12.2988281,80.0,30.0,36.69531,456.0,2.7998047,2.59960938,0.69995117,134.0,7.349609,135.0,23.0,1968.0,1.0,1.0,<2 mo. follow-up,1.1668997
64.77795,male,0.0,Lung Cancer,10.0,under $11k,25747.0,white,metastatic,0.5,0.1999999,dnr after sadm,3.0,81.0,14.5996094,110.0,32.0,34.79688,267.3125,2.5996094,0.69995117,0.59997559,135.0,7.439453,135.0,23.0,1968.0,7.0,5.0,adl>=4 (>=5 if sur),5.0
75.72894,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,168004.0,white,no,0.5,0.09999996,no dnr,34.0,70.0,6.5,80.0,38.0,36.59375,157.0,2.3999023,0.89990234,1.69995117,150.0,7.359375,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.6513672
83.61896,male,0.0,ARF/MOSF w/Sepsis,16.0,under $11k,23847.0,white,no,0.799999714,0.6999998,dnr after sadm,9.0,65.0,10.1992188,65.0,26.0,35.79688,240.0,3.0,0.59997559,1.69995117,138.0,7.5,135.0,23.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
83.59796,male,1.0,Coma,12.0,under $11k,8071.0,white,no,0.009999998,9.999994e-07,dnr before sadm,-1.0,93.0,12.3984375,100.0,20.0,38.29688,488.3125,3.699707,0.59997559,1.5,144.0,7.40918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5795898
82.46399,female,0.0,CHF,12.0,under $11k,7544.0,white,yes,0.0,0.0,dnr after sadm,4.0,73.0,6.79980469,70.0,20.0,35.59375,508.0,3.199707,0.59997559,2.39990234,141.0,7.339844,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.9868164
73.62097,male,0.0,Colon Cancer,12.0,under $11k,5234.0,white,metastatic,0.899999619,0.5,no dnr,5.0,40.0,12.7988281,80.0,20.0,38.79688,224.0,2.8999023,1.19995117,1.0,137.0,7.419922,135.0,23.0,1968.0,0.0,5.0,<2 mo. follow-up,5.0
47.35098,female,0.0,CHF,12.0,$25-$50k,7408.0,white,no,0.949999809,0.7999997,no dnr,6.0,68.0,12.1992188,78.0,28.0,36.29688,187.75,2.8999023,0.89990234,3.5,136.0,7.40918,135.0,23.0,1968.0,1.0,1.0,no(M2 and SIP pres),1.0
79.06598,male,1.0,ARF/MOSF w/Sepsis,9.0,under $11k,46932.0,white,yes,0.049999982,0.0001249999,dnr before sadm,0.0,63.0,17.0,100.0,7.0,35.59375,266.625,3.5996094,2.89990234,2.59960938,127.0,7.269531,135.0,23.0,1968.0,0.0,3.0,<2 mo. follow-up,3.0
77.21594,male,0.0,ARF/MOSF w/Sepsis,16.0,>$50k,46000.0,white,no,0.199999928,0.09999996,dnr after sadm,1.0,44.0,9.3984375,107.0,8.0,36.19531,214.0,2.8999023,0.89990234,1.19995117,136.0,7.339844,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
46.06198,male,0.0,Cirrhosis,19.0,>$50k,10061.0,white,no,0.5,0.5999999,no dnr,8.0,69.0,5.29980469,112.0,22.0,37.89844,224.0,3.8999023,3.09960938,0.79992676,140.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
75.92297,female,0.0,COPD,12.0,$11-$25k,8348.0,white,no,0.949999809,0.8499999,no dnr,7.0,77.0,8.0,80.0,25.0,36.69531,271.375,2.8999023,0.89990234,1.0,139.0,7.379883,135.0,23.0,1968.0,6.0,2.0,no(M2 and SIP pres),2.0
77.93298,male,0.0,ARF/MOSF w/Sepsis,9.0,under $11k,18693.0,white,no,0.799999714,0.7999997,no dnr,13.0,57.0,9.5,69.0,20.0,36.79688,206.09375,2.2998047,0.69995117,5.39941406,138.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
81.07898,female,0.0,COPD,12.0,under $11k,55945.0,white,no,0.599999905,0.5,no dnr,31.0,53.0,12.3984375,64.0,42.0,36.89844,150.0,3.699707,0.79992676,1.09985352,145.0,7.30957,135.0,23.0,1968.0,0.0,4.0,<2 mo. follow-up,4.0
28.25699,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,22529.0,white,no,0.899999619,0.8999996,no dnr,7.0,138.0,12.7988281,102.0,28.0,38.19531,166.65625,3.0,1.29980469,0.89990234,138.0,7.479492,135.0,23.0,1968.0,1.0,1.0,<2 mo. follow-up,1.1668997
77.30597,male,0.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,11137.0,white,no,0.899999619,0.75,no dnr,10.0,100.0,5.0,59.0,22.0,35.59375,224.0,3.0,0.39996338,2.59960938,142.0,7.419922,135.0,23.0,1968.0,0.0,6.0,adl>=4 (>=5 if sur),6.0
83.51294,male,0.0,CHF,12.0,$11-$25k,4691.0,white,no,0.799999714,0.6999998,dnr after sadm,3.0,93.0,8.29882812,70.0,25.0,36.09375,396.0,3.699707,0.89990234,2.09960938,142.0,7.299805,135.0,23.0,1968.0,0.0,5.0,adl>=4 (>=5 if sur),5.0
68.24097,female,0.0,CHF,15.0,under $11k,5608.0,white,no,0.799999714,0.6999998,no dnr,6.0,73.0,3.79980469,60.0,20.0,37.19531,347.5625,2.8999023,2.39990234,1.19995117,136.0,7.489258,135.0,23.0,1968.0,2.0,3.0,<2 mo. follow-up,3.0
78.245,female,1.0,COPD,12.0,under $11k,69147.0,white,no,0.949999809,0.75,dnr after sadm,17.0,53.0,17.296875,107.0,8.0,35.59375,320.0,2.8999023,0.5,1.09985352,143.0,7.369141,135.0,23.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
60.77197,male,0.0,CHF,12.0,under $11k,8159.0,white,no,0.75,0.6999998,no dnr,7.0,111.0,7.19921875,64.0,20.0,36.39844,336.625,4.5996094,1.09985352,1.79980469,141.0,7.549805,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
67.96997,male,0.0,MOSF w/Malig,12.0,under $11k,27302.0,black,metastatic,0.799999714,0.6999998,no dnr,11.0,145.0,17.3984375,70.0,24.0,38.19531,193.875,2.8999023,0.89990234,5.5,138.0,7.40918,135.0,23.0,1968.0,1.0,0.0,no(M2 and SIP pres),0.0
75.38098,male,0.0,ARF/MOSF w/Sepsis,12.0,>$50k,25486.0,white,no,0.799999714,0.6999998,no dnr,17.0,115.0,6.5,59.0,24.0,37.89844,486.0,2.5,0.5,1.69995117,141.0,7.509766,135.0,23.0,1968.0,0.0,2.0,no(M2 and SIP pres),2.0
61.56299,male,0.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,7588.0,white,no,1.0,1.0,no dnr,4.0,103.0,7.79980469,70.0,20.0,36.09375,447.5625,3.0996094,0.69995117,1.09985352,140.0,7.579102,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
69.23199,female,0.0,Colon Cancer,12.0,under $11k,37893.0,black,metastatic,0.75,0.5,dnr after sadm,9.0,100.0,0.79992676,80.0,15.0,37.79688,224.0,2.699707,1.89990234,0.69995117,140.0,7.419922,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
89.32794,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,86069.0,white,no,0.299999952,0.28,dnr after sadm,16.0,53.0,4.09960938,230.0,12.0,39.69531,142.0,2.0996094,5.39941406,1.0,146.0,7.349609,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.0795898
84.35297,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,19014.0,white,no,0.5,0.3999999,no dnr,16.0,65.0,14.3984375,68.0,26.0,38.09375,385.125,3.0,0.59997559,0.5,133.0,7.439453,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.1708984
73.63397,male,1.0,ARF/MOSF w/Sepsis,10.0,$11-$25k,21516.0,white,yes,0.5,0.09999996,no dnr,11.0,120.0,17.5,90.0,35.0,37.69531,224.0,3.199707,0.89990234,1.09985352,145.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
87.41699,female,0.0,ARF/MOSF w/Sepsis,9.0,under $11k,25572.0,white,metastatic,0.899999619,0.6999998,dnr after sadm,1.0,70.0,13.3984375,59.0,28.0,36.09375,404.0,2.3999023,0.79992676,1.5,130.0,7.459961,135.0,23.0,1968.0,0.0,2.0,no(M2 and SIP pres),2.0
75.34296,female,0.0,COPD,12.0,under $11k,81770.0,white,no,0.799999714,0.5,dnr after sadm,16.0,58.0,5.5,98.0,24.0,36.69531,196.40625,3.8999023,0.79992676,0.59997559,130.0,7.389648,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.2998047
78.53497,female,0.0,COPD,12.0,under $11k,10645.0,white,no,0.099999964,0.0009999992,dnr before sadm,-1.0,77.0,10.0,70.0,20.0,36.59375,195.0,2.8999023,0.89990234,0.5,137.0,7.179688,135.0,23.0,1968.0,0.0,7.0,<2 mo. follow-up,7.0
67.06396,female,0.0,COPD,12.0,under $11k,15291.0,hispanic,no,0.5,0.3,no dnr,10.0,62.0,11.5,68.0,16.0,36.79688,392.0,2.8999023,0.39996338,4.39941406,133.0,7.339844,135.0,23.0,1968.0,0.0,3.0,adl>=4 (>=5 if sur),3.0
76.28497,male,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,12633.0,white,no,0.799999714,0.5999999,no dnr,10.0,58.0,13.0996094,60.0,24.0,36.59375,285.6875,2.2998047,0.59997559,1.5,139.0,7.319336,135.0,23.0,1968.0,3.0,3.0,adl>=4 (>=5 if sur),3.0
95.58099,male,1.0,ARF/MOSF w/Sepsis,4.0,under $11k,27548.0,black,yes,0.699999809,0.5,dnr after sadm,22.0,58.0,4.0,78.0,30.0,34.89844,416.625,2.0996094,0.29998779,1.39990234,144.0,7.429688,135.0,23.0,1968.0,0.0,5.0,<2 mo. follow-up,5.0
60.79398,male,0.0,CHF,12.0,under $11k,26174.0,black,no,0.699999809,0.5,dnr after sadm,1.0,80.0,6.09960938,100.0,25.0,35.59375,224.0,2.8999023,0.89990234,1.89990234,149.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
52.28497,male,0.0,COPD,12.0,under $11k,10612.0,white,no,0.949999809,0.8999996,no dnr,7.0,104.0,17.3984375,101.0,28.0,36.29688,257.125,2.8999023,0.89990234,0.69995117,138.0,7.389648,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
58.32199,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,75398.0,white,no,0.599999905,0.4499998,dnr after sadm,4.0,55.0,10.5,58.0,24.0,38.79688,224.0,2.8999023,0.89990234,1.09985352,133.0,7.369141,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
83.46899,female,0.0,COPD,14.0,$11-$25k,7015.0,white,no,0.899999619,0.7999997,dnr after sadm,1.0,107.0,6.69921875,60.0,25.0,35.59375,404.3125,2.8999023,0.89990234,0.59997559,138.0,7.399414,135.0,23.0,1968.0,1.0,0.0,adl>=4 (>=5 if sur),0.0
65.46997,female,1.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,216883.0,white,no,0.899999619,0.7999997,dnr after sadm,115.0,61.0,17.0,128.0,10.0,36.0,132.5,2.2998047,0.89990234,1.0,136.0,7.419922,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
77.008,male,0.0,CHF,9.0,under $11k,11872.0,white,no,0.949999809,0.7999997,no dnr,8.0,80.0,10.2988281,80.0,20.0,35.59375,357.125,2.8999023,0.89990234,1.5,139.0,7.399414,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
85.37195,male,1.0,Coma,16.0,$25-$50k,18329.0,white,no,0.5,0.1999999,dnr after sadm,2.0,123.0,8.19921875,136.0,34.0,38.0,84.0,3.3999023,1.0,1.79980469,143.0,7.439453,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,4.3955078
83.16199,male,0.0,Lung Cancer,15.0,under $11k,18052.0,white,metastatic,0.399999857,0.3,dnr after sadm,1.0,123.0,6.5,110.0,20.0,36.39844,228.0,2.8999023,0.89990234,1.09985352,136.0,7.459961,135.0,23.0,1968.0,1.0,1.0,<2 mo. follow-up,1.1668997
65.91595,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,14437.0,white,no,0.699999809,0.5,dnr after sadm,3.0,30.0,13.6992188,0.0,0.0,38.79688,255.0,2.8999023,0.89990234,6.29980469,137.0,7.289062,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.0917969
79.22498,male,0.0,ARF/MOSF w/Sepsis,13.0,$11-$25k,12608.0,white,no,0.899999619,0.75,no dnr,9.0,103.0,5.29980469,60.0,20.0,35.79688,328.0,2.5,0.59997559,1.5,137.0,7.40918,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
78.09998,male,0.0,COPD,14.0,under $11k,14896.0,white,yes,0.699999809,0.1999999,no dnr,13.0,80.0,5.5,100.0,25.0,36.29688,147.5,3.8999023,0.89990234,1.39990234,140.0,7.339844,135.0,23.0,1968.0,1.0,2.0,no(M2 and SIP pres),2.0
59.88797,female,0.0,ARF/MOSF w/Sepsis,18.0,under $11k,18408.0,white,yes,0.799999714,0.03999999,no dnr,13.0,50.0,24.1992188,74.0,12.0,36.29688,224.0,3.3999023,0.5,3.09960938,143.0,7.419922,135.0,23.0,1968.0,1.0,1.0,SIP>=30,1.0
59.27197,female,0.0,CHF,12.0,$25-$50k,9120.0,white,no,0.699999809,0.5999999,no dnr,9.0,73.0,7.89941406,70.0,20.0,36.09375,304.75,3.699707,1.09985352,1.39990234,143.0,7.419922,135.0,23.0,1968.0,2.0,1.0,SIP>=30,1.0
63.25299,male,0.0,Colon Cancer,12.0,$25-$50k,4324.0,white,metastatic,0.299999952,0.1999999,no dnr,3.0,103.0,10.5996094,100.0,20.0,36.69531,224.0,3.199707,6.39941406,0.69995117,131.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
69.125,female,0.0,CHF,12.0,$11-$25k,6270.0,white,no,0.949999809,0.7999997,no dnr,6.0,113.0,6.5,70.0,20.0,36.69531,396.0,2.8999023,0.89990234,4.0,136.0,7.329102,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
71.461,female,0.0,Lung Cancer,23.0,$25-$50k,9665.0,white,metastatic,0.899999619,0.6999998,no dnr,7.0,107.0,8.29882812,108.0,32.0,37.89844,224.0,3.0996094,0.5,1.09985352,139.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
87.24194,male,1.0,ARF/MOSF w/Sepsis,6.0,under $11k,18381.0,white,no,0.5,0.3999999,dnr after sadm,2.0,47.0,9.59960938,66.0,10.0,37.69531,220.0,2.699707,0.69995117,4.29980469,142.0,7.269531,135.0,23.0,1968.0,0.0,7.0,<2 mo. follow-up,7.0
57.79898,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,129188.0,white,yes,0.5,0.5,no dnr,55.0,49.0,15.7988281,50.0,10.0,38.09375,155.0,2.8999023,0.39996338,0.59997559,130.0,7.399414,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.171875
72.62695,male,0.0,COPD,12.0,under $11k,15794.0,white,no,0.949999809,0.6999998,dnr after sadm,6.0,130.0,11.1992188,109.0,40.0,36.69531,416.0,2.8999023,0.89990234,1.29980469,134.0,7.369141,135.0,23.0,1968.0,1.0,0.0,SIP>=30,0.0
69.21594,male,0.0,CHF,12.0,under $11k,5314.0,white,no,0.799999714,0.6999998,no dnr,5.0,73.0,7.19921875,80.0,25.0,37.19531,248.0,2.8999023,0.69995117,2.89990234,137.0,7.459961,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
49.87299,female,1.0,MOSF w/Malig,14.0,under $11k,35115.0,white,metastatic,0.299999952,0.1999999,dnr after sadm,7.0,43.0,2.69970703,128.0,32.0,35.89844,205.0,2.5,0.59997559,0.59997559,136.0,7.389648,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5141602
81.19098,male,0.0,ARF/MOSF w/Sepsis,7.0,$25-$50k,68286.0,white,no,0.899999619,0.5999999,no dnr,61.0,57.0,7.09960938,51.0,24.0,37.89844,496.0,2.5,0.39996338,3.59960938,150.0,7.459961,135.0,23.0,1968.0,1.0,1.0,SIP>=30,1.1668997
50.19598,female,0.0,Cirrhosis,2.0,>$50k,31479.0,white,no,1.0,1.0,no dnr,23.0,103.0,12.1992188,80.0,20.0,36.09375,224.0,3.699707,0.69995117,3.79980469,125.0,7.419922,135.0,23.0,1968.0,1.0,1.0,no(M2 and SIP pres),1.1668997
69.12299,male,1.0,ARF/MOSF w/Sepsis,10.0,under $11k,53798.0,white,no,0.799999714,0.6999998,dnr after sadm,8.0,110.0,6.69921875,70.0,12.0,38.29688,107.14062,2.8999023,0.89990234,6.19921875,142.0,7.429688,135.0,23.0,1968.0,0.0,4.0,<2 mo. follow-up,4.0
82.35699,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,209565.0,black,no,0.5,0.25,dnr after sadm,1.0,137.0,21.8984375,100.0,20.0,37.79688,323.75,3.5996094,1.0,1.19995117,135.0,7.399414,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.0576172
52.57797,female,0.0,Cirrhosis,11.0,under $11k,7638.0,white,no,0.899999619,0.7999997,no dnr,7.0,67.0,6.79980469,70.0,15.0,37.0,180.9375,2.7998047,0.79992676,1.09985352,138.0,7.379883,135.0,23.0,1968.0,1.0,1.0,<2 mo. follow-up,1.1668997
71.79498,male,0.0,COPD,18.0,$11-$25k,46839.0,white,no,0.599999905,0.5,dnr after sadm,10.0,61.0,11.1992188,68.0,10.0,37.69531,152.5,3.199707,0.69995117,0.69995117,136.0,7.419922,135.0,23.0,1968.0,0.0,4.0,adl>=4 (>=5 if sur),4.0
38.66699,female,0.0,Cirrhosis,9.0,under $11k,46790.0,black,no,0.399999857,0.3999999,no dnr,21.0,43.0,29.0976562,43.0,8.0,35.59375,217.0,2.3999023,11.0996094,0.5,137.0,7.359375,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
77.85394,female,0.0,COPD,17.0,under $11k,8190.0,white,no,1.0,1.0,no dnr,7.0,63.0,7.89941406,80.0,20.0,36.69531,261.875,2.8999023,0.89990234,0.79992676,133.0,7.369141,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.0913086
70.45898,female,0.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,21065.0,white,no,0.899999619,0.8999996,no dnr,14.0,61.0,8.8984375,65.0,36.0,38.29688,256.625,3.0,1.19995117,1.5,137.0,7.359375,135.0,23.0,1968.0,1.0,0.0,no(M2 and SIP pres),0.0
77.435,male,1.0,COPD,12.0,under $11k,5085.0,white,no,0.5,0.25,dnr after sadm,1.0,77.0,7.59960938,120.0,40.0,39.09375,140.0,2.8999023,0.89990234,0.89990234,139.0,7.349609,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,5.7724609
83.30194,female,0.0,ARF/MOSF w/Sepsis,14.0,under $11k,25474.0,white,no,0.799999714,0.7999997,no dnr,12.0,59.0,14.5996094,160.0,24.0,38.5,256.625,2.8999023,0.69995117,2.39990234,141.0,7.369141,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
77.42896,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,93900.0,white,no,0.699999809,0.5,dnr after sadm,32.0,49.0,16.3984375,131.0,32.0,36.39844,187.75,2.0996094,0.79992676,1.29980469,155.0,7.379883,135.0,23.0,1968.0,0.0,5.0,<2 mo. follow-up,5.0
90.57599,female,1.0,CHF,12.0,under $11k,9106.0,white,no,0.949999809,0.8499999,dnr after sadm,3.0,73.0,5.5,60.0,25.0,35.39844,224.0,3.699707,0.89990234,1.69995117,142.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.7075195
54.237,female,0.0,Cirrhosis,10.0,under $11k,3979.0,white,no,0.699999809,0.5,no dnr,3.0,80.0,6.59960938,80.0,20.0,36.39844,504.75,2.0996094,6.5,0.79992676,129.0,7.449219,135.0,23.0,1968.0,1.0,0.0,no(M2 and SIP pres),0.0
83.10199,male,0.0,CHF,14.0,under $11k,3464.0,white,yes,0.699999809,0.5,no dnr,4.0,117.0,5.0,50.0,20.0,36.69531,336.625,2.8999023,0.89990234,1.69995117,141.0,7.429688,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
66.92096,female,0.0,COPD,16.0,>$50k,13139.0,white,no,0.979999542,0.8999996,no dnr,8.0,56.0,6.59960938,109.0,8.0,37.89844,180.0,2.3999023,0.89990234,0.59997559,141.0,7.40918,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
73.487,female,0.0,Colon Cancer,12.0,under $11k,8837.0,black,metastatic,0.199999928,0.0,dnr before sadm,-1.0,109.0,9.5,72.0,20.0,36.09375,224.0,2.5,0.39996338,1.0,134.0,7.419922,135.0,23.0,1968.0,4.0,2.0,<2 mo. follow-up,2.0
66.52399,female,0.0,MOSF w/Malig,12.0,$25-$50k,26499.0,black,metastatic,0.0,0.0,dnr after sadm,1.0,49.0,11.7988281,129.0,40.0,38.59375,175.0,4.0996094,2.5,1.69995117,147.0,7.479492,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.737793
41.12299,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,78089.0,black,no,0.25,0.25,dnr after sadm,5.0,121.0,13.6992188,63.0,32.0,39.29688,416.625,2.0,1.5,2.0,142.0,7.449219,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
64.81299,male,0.0,CHF,10.0,under $11k,12726.0,white,no,0.5,0.1999999,dnr after sadm,7.0,70.0,8.69921875,60.0,20.0,35.59375,323.75,2.8999023,0.89990234,5.19921875,125.0,7.259766,135.0,23.0,1968.0,2.0,1.0,<2 mo. follow-up,1.8389997
82.15698,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,40355.0,white,no,0.699999809,0.5,dnr after sadm,6.0,59.0,5.39941406,60.0,26.0,37.69531,276.625,3.699707,0.89990234,2.19970703,142.0,7.449219,135.0,23.0,1968.0,4.0,6.0,adl>=4 (>=5 if sur),6.0
83.16199,male,1.0,ARF/MOSF w/Sepsis,19.0,under $11k,13316.0,white,no,0.699999809,0.5,no dnr,4.0,43.0,9.5,120.0,38.0,38.39844,123.32812,4.0996094,1.09985352,2.59960938,141.0,7.339844,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.8325195
68.19995,female,0.0,ARF/MOSF w/Sepsis,14.0,>$50k,83351.0,white,no,0.049999982,0.0001249999,no dnr,43.0,49.0,8.3984375,145.0,10.0,38.59375,105.0,3.2998047,0.69995117,3.29980469,137.0,7.369141,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),2.0317383
47.58899,male,0.0,Cirrhosis,10.0,$25-$50k,6175.0,white,no,1.0,0.8999996,no dnr,7.0,80.0,5.29980469,80.0,20.0,37.0,224.0,2.8999023,5.0,0.79992676,131.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
74.05896,female,0.0,Colon Cancer,12.0,$25-$50k,9658.0,white,metastatic,0.699999809,0.3,no dnr,10.0,100.0,6.79980469,80.0,20.0,36.09375,224.0,2.699707,2.79980469,10.3984375,135.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
64.83496,female,1.0,Coma,18.0,$11-$25k,14380.0,asian,no,0.0,0.0,dnr after sadm,3.0,56.0,9.79882812,47.0,6.0,38.09375,393.3125,2.5996094,0.89990234,0.79992676,136.0,7.40918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
34.51297,male,0.0,Coma,12.0,under $11k,123827.0,white,yes,1.0,1.0,no dnr,61.0,57.0,2.0,58.0,12.0,33.5,178.0,2.2998047,0.89990234,1.39990234,142.0,7.40918,135.0,23.0,1968.0,0.0,6.0,adl>=4 (>=5 if sur),6.0
85.54999,male,0.0,CHF,12.0,under $11k,11059.0,white,no,0.799999714,0.5999999,dnr after sadm,1.0,63.0,8.59960938,66.0,24.0,35.59375,319.0,2.8999023,0.89990234,3.19970703,129.0,7.449219,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),4.5273438
75.10999,male,0.0,Colon Cancer,16.0,>$50k,17967.0,white,metastatic,1.0,0.5999999,no dnr,17.0,80.0,5.29980469,60.0,25.0,38.89844,224.0,2.8999023,1.0,1.29980469,132.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
70.25098,male,0.0,COPD,12.0,under $11k,21914.0,white,yes,0.899999619,0.7999997,no dnr,10.0,57.0,17.5,117.0,8.0,38.29688,125.0,2.8999023,0.89990234,1.19995117,139.0,7.469727,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
80.35895,female,0.0,CHF,12.0,$11-$25k,6528.0,white,yes,1.0,0.8999996,no dnr,6.0,70.0,4.29980469,80.0,35.0,37.0,211.09375,2.8999023,0.89990234,1.09985352,140.0,7.40918,135.0,23.0,1968.0,1.0,0.0,no(M2 and SIP pres),0.0
52.10397,male,1.0,MOSF w/Malig,12.0,$25-$50k,18313.0,white,yes,0.199999928,0.09999996,dnr after sadm,4.0,60.0,0.09999084,120.0,8.0,36.59375,182.84375,2.199707,0.89990234,1.69995117,138.0,7.449219,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
83.461,male,1.0,ARF/MOSF w/Sepsis,20.0,$25-$50k,177467.0,white,no,0.0,0.0,dnr after sadm,87.0,43.0,3.19970703,120.0,32.0,36.5,231.65625,2.199707,0.79992676,2.89990234,128.0,7.319336,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
75.33197,female,1.0,ARF/MOSF w/Sepsis,9.0,$11-$25k,88774.0,white,no,0.899999619,0.8999996,dnr after sadm,24.0,64.0,19.5,110.0,26.0,36.09375,253.03125,2.8999023,0.39996338,1.39990234,126.0,7.429688,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
84.47894,male,0.0,COPD,12.0,under $11k,12504.0,white,yes,0.75,0.5,no dnr,11.0,105.0,10.1992188,68.0,24.0,36.89844,224.0,2.8999023,0.5,1.79980469,138.0,7.429688,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),4.2509766
85.48096,female,0.0,COPD,12.0,under $11k,5872.0,white,no,0.799999714,0.5999999,no dnr,5.0,67.0,21.296875,70.0,20.0,36.69531,332.0,2.8999023,0.89990234,1.29980469,144.0,7.339844,135.0,23.0,1968.0,3.0,1.0,<2 mo. follow-up,2.5110989
64.06,female,0.0,Lung Cancer,14.0,$11-$25k,4562.0,white,metastatic,0.699999809,0.5,no dnr,3.0,75.0,7.79980469,100.0,18.0,36.89844,224.0,3.8999023,0.39996338,0.69995117,134.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
55.896,female,1.0,Colon Cancer,14.0,under $11k,39582.0,white,metastatic,0.949999809,0.6999998,dnr before sadm,0.0,127.0,8.09960938,60.0,22.0,37.69531,224.0,4.0996094,0.39996338,1.39990234,139.0,7.419922,135.0,23.0,1968.0,0.0,5.0,<2 mo. follow-up,5.0
65.29797,male,0.0,Colon Cancer,14.0,$25-$50k,13669.0,white,metastatic,0.5,0.15,dnr after sadm,5.0,60.0,12.2988281,90.0,20.0,36.69531,224.0,2.8999023,0.89990234,0.79992676,140.0,7.419922,135.0,23.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
80.77496,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,82763.0,white,yes,0.199999928,0.04999998,dnr after sadm,4.0,53.0,18.5976562,73.0,22.0,38.39844,383.3125,2.8999023,0.89990234,7.39941406,139.0,7.359375,135.0,23.0,1968.0,6.0,6.0,<2 mo. follow-up,6.0
74.46698,female,1.0,MOSF w/Malig,12.0,under $11k,46365.0,white,metastatic,0.0,0.0,dnr after sadm,3.0,47.0,3.39990234,154.0,52.0,36.29688,284.0,2.8999023,0.89990234,0.59997559,139.0,7.369141,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.8374023
74.875,female,0.0,ARF/MOSF w/Sepsis,18.0,under $11k,18145.0,black,no,0.799999714,0.3,no dnr,15.0,62.0,7.09960938,70.0,32.0,37.89844,620.0,4.1992188,0.89990234,0.89990234,154.0,7.379883,135.0,23.0,1968.0,0.0,5.0,adl>=4 (>=5 if sur),5.0
46.448,male,0.0,Coma,12.0,under $11k,102951.0,white,no,0.5,0.5,dnr after sadm,5.0,39.0,8.79882812,130.0,8.0,34.0,162.5,2.5996094,0.89990234,0.79992676,144.0,7.379883,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.6599121
36.36099,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,49378.0,white,no,0.5,0.5,no dnr,19.0,57.0,8.5,100.0,34.0,39.29688,171.65625,2.2998047,5.0,0.79992676,148.0,7.439453,135.0,23.0,1968.0,4.0,3.0,no(M2 and SIP pres),3.0
84.758,female,0.0,COPD,12.0,under $11k,55554.0,white,no,0.899999619,0.8999996,dnr after sadm,1.0,70.0,5.79980469,100.0,9.0,37.89844,343.0,2.8999023,0.89990234,1.0,132.0,7.449219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.980957
73.09497,male,0.0,COPD,12.0,under $11k,3231.0,white,no,0.899999619,0.7999997,no dnr,4.0,110.0,9.29882812,60.0,20.0,37.0,324.0,4.3994141,0.29998779,1.09985352,140.0,7.379883,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,4.6621094
87.836,female,1.0,ARF/MOSF w/Sepsis,8.0,under $11k,7485.0,white,no,0.0,0.0,dnr after sadm,3.0,57.0,14.2988281,111.0,14.0,37.89844,376.625,3.7998047,0.89990234,1.19995117,139.0,7.469727,135.0,23.0,1968.0,0.0,4.0,<2 mo. follow-up,4.0
65.21796,male,1.0,Cirrhosis,12.0,$25-$50k,56488.0,white,no,0.699999809,0.5,dnr after sadm,6.0,45.0,11.3984375,120.0,8.0,37.69531,104.0,2.3999023,1.89990234,2.89990234,136.0,7.339844,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
39.159,male,1.0,Lung Cancer,14.0,$11-$25k,8814.0,white,metastatic,0.009999998,9.999994e-07,dnr after sadm,3.0,52.0,31.0976562,140.0,28.0,38.19531,121.65625,1.8999023,0.5,0.59997559,139.0,7.449219,135.0,23.0,1968.0,0.0,3.0,<2 mo. follow-up,3.0
61.23999,female,1.0,Cirrhosis,8.0,under $11k,104725.0,black,no,0.799999714,0.5999999,no dnr,28.0,129.0,6.79980469,70.0,16.0,36.09375,224.0,2.199707,0.89990234,0.79992676,143.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
85.05396,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,143520.0,white,no,0.649999619,0.5,dnr after sadm,1.0,50.0,6.59960938,48.0,37.0,38.09375,237.5,2.8999023,0.89990234,3.0,144.0,7.30957,135.0,23.0,1968.0,0.0,4.0,adl>=4 (>=5 if sur),4.0
80.54999,female,0.0,ARF/MOSF w/Sepsis,9.0,under $11k,51714.0,white,no,0.899999619,0.7999997,dnr after sadm,1.0,63.0,10.5996094,39.0,28.0,36.09375,224.0,2.8999023,0.89990234,2.09960938,134.0,7.419922,135.0,23.0,1968.0,0.0,4.0,<2 mo. follow-up,4.0
73.30298,male,1.0,COPD,12.0,under $11k,73250.0,white,yes,0.5,0.5,dnr after sadm,32.0,57.0,9.09960938,132.0,38.0,36.5,250.0,2.8999023,0.89990234,0.69995117,137.0,7.379883,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.6767578
66.89899,female,1.0,ARF/MOSF w/Sepsis,9.0,under $11k,87649.0,white,no,0.699999809,0.6999998,no dnr,33.0,130.0,11.8984375,110.0,24.0,39.09375,138.0,2.8999023,0.89990234,3.0,145.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
62.04498,male,0.0,CHF,12.0,under $11k,102951.0,white,no,0.799999714,0.6999998,no dnr,23.0,77.0,9.19921875,80.0,25.0,36.69531,203.3125,3.199707,0.79992676,1.19995117,135.0,7.469727,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
91.00098,female,1.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,25116.0,white,no,0.299999952,0.15,dnr after sadm,2.0,41.0,17.796875,67.0,27.0,35.69531,320.0,2.8999023,0.89990234,2.79980469,121.0,7.469727,135.0,23.0,1968.0,0.0,3.0,<2 mo. follow-up,3.0
70.86694,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,20128.0,white,no,0.849999905,0.75,no dnr,13.0,57.0,10.5996094,52.0,22.0,39.29688,171.40625,2.5,1.89990234,0.79992676,139.0,7.439453,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
80.80798,male,1.0,MOSF w/Malig,12.0,under $11k,21600.0,white,yes,0.039999992,6.399996e-05,dnr after sadm,6.0,40.0,99.0,174.0,48.0,36.29688,95.0,2.0996094,0.89990234,1.39990234,146.0,7.469727,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
39.01398,male,0.0,ARF/MOSF w/Sepsis,16.0,$25-$50k,143863.0,white,no,0.949999809,0.9499998,no dnr,54.0,47.0,12.5,120.0,46.0,36.59375,145.0,2.7998047,4.69921875,6.19921875,134.0,7.40918,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
96.29297,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,23315.0,white,yes,0.949999809,0.8999996,no dnr,11.0,115.0,3.59960938,59.0,24.0,37.69531,409.5,3.199707,0.89990234,3.89990234,138.0,7.379883,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
60.96399,female,0.0,CHF,12.0,under $11k,7831.0,white,no,0.949999809,0.7999997,no dnr,7.0,60.0,10.6992188,60.0,20.0,36.69531,360.0,2.8999023,0.89990234,1.19995117,135.0,7.399414,135.0,23.0,1968.0,4.0,1.0,SIP>=30,3.1831989
57.892,male,0.0,Lung Cancer,12.0,under $11k,3803.0,black,metastatic,0.5,0.3,no dnr,4.0,71.0,4.79980469,110.0,24.0,37.09375,266.625,2.8999023,0.89990234,1.09985352,139.0,7.489258,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
79.43097,female,0.0,Colon Cancer,19.0,$11-$25k,41940.0,white,metastatic,0.699999809,0.5,dnr after sadm,1.0,87.0,5.29980469,109.0,20.0,36.09375,224.0,2.8999023,1.0,0.89990234,131.0,7.419922,135.0,23.0,1968.0,0.0,5.0,<2 mo. follow-up,5.0
84.25494,male,0.0,CHF,12.0,under $11k,4931.0,white,no,0.979999542,0.7999997,no dnr,5.0,73.0,9.59960938,80.0,20.0,36.69531,392.0,2.8999023,0.89990234,1.89990234,135.0,7.459961,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
62.97897,male,0.0,COPD,12.0,under $11k,42691.0,black,no,0.949999809,0.8999996,no dnr,9.0,125.0,14.6992188,119.0,24.0,36.29688,292.0,2.8999023,0.89990234,0.59997559,139.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
75.34296,male,0.0,Colon Cancer,12.0,under $11k,15764.0,white,metastatic,0.5,0.125,no dnr,12.0,67.0,9.59960938,80.0,20.0,40.0,224.0,3.7998047,0.89990234,1.09985352,138.0,7.419922,135.0,23.0,1968.0,1.0,1.0,<2 mo. follow-up,1.0
65.20697,female,0.0,MOSF w/Malig,13.0,$25-$50k,27314.0,white,yes,0.599999905,0.09999996,dnr after sadm,2.0,40.0,0.29998779,180.0,22.0,35.59375,381.625,4.0,0.89990234,0.69995117,135.0,7.419922,135.0,23.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
75.45197,male,1.0,CHF,12.0,$25-$50k,27479.0,white,no,0.899999619,0.7999997,dnr after sadm,20.0,44.0,8.69921875,64.0,26.0,35.59375,276.1875,2.8999023,0.59997559,2.59960938,137.0,7.569336,135.0,23.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
74.17096,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,24406.0,white,no,0.299999952,0.1999999,no dnr,5.0,66.0,7.39941406,60.0,10.0,38.79688,180.0,2.7998047,0.89990234,1.0,143.0,7.40918,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
55.31799,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,91472.0,white,no,0.75,0.6999998,dnr after sadm,21.0,66.0,15.0,51.0,10.0,39.09375,161.65625,2.8999023,1.5,2.29980469,141.0,7.40918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
61.06998,female,0.0,COPD,12.0,>$50k,37517.0,white,no,0.989999771,0.9899998,no dnr,10.0,67.0,12.8984375,70.0,10.0,36.39844,118.0,2.8999023,0.89990234,0.59997559,142.0,7.489258,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
76.57996,male,0.0,ARF/MOSF w/Sepsis,16.0,under $11k,46322.0,white,yes,0.399999857,0.09999996,no dnr,17.0,56.0,15.2988281,110.0,12.0,38.29688,170.0,2.8999023,13.8984375,3.09960938,137.0,7.379883,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
91.47198,female,0.0,MOSF w/Malig,17.0,>$50k,58579.0,white,yes,0.299999952,0.1999999,dnr after sadm,9.0,53.0,1.59985352,120.0,26.0,36.19531,390.0,2.8999023,0.89990234,1.0,138.0,7.5,135.0,23.0,1968.0,0.0,4.0,adl>=4 (>=5 if sur),4.0
22.31099,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,69109.0,white,no,0.199999928,0.5,no dnr,53.0,110.0,9.29882812,120.0,10.0,39.0,434.6875,2.8999023,0.89990234,0.89990234,135.0,7.449219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
60.40799,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,26252.0,white,no,0.849999905,0.5999999,no dnr,11.0,63.0,11.0,96.0,12.0,37.89844,282.125,2.5996094,0.89990234,0.79992676,138.0,7.359375,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
77.15497,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,84411.0,white,no,0.5,0.125,no dnr,19.0,45.0,19.5,38.0,24.0,34.79688,200.0,2.0,1.89990234,1.89990234,146.0,7.489258,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
72.95599,male,0.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,16094.0,white,no,0.899999619,0.6999998,no dnr,9.0,42.0,5.69921875,80.0,24.0,37.5,359.25,3.8999023,1.09985352,8.09960938,135.0,7.439453,135.0,23.0,1968.0,1.0,0.0,no(M2 and SIP pres),0.0
30.021,female,1.0,ARF/MOSF w/Sepsis,13.0,under $11k,257474.0,white,no,0.299999952,0.3999999,dnr after sadm,20.0,73.0,0.19998169,104.0,32.0,38.19531,224.0,2.3999023,0.89990234,0.69995117,141.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
66.72699,female,0.0,ARF/MOSF w/Sepsis,8.0,under $11k,57971.0,white,no,0.899999619,0.8999996,no dnr,25.0,69.0,5.19921875,52.0,28.0,36.39844,169.375,3.199707,0.89990234,4.79980469,145.0,7.349609,135.0,23.0,1968.0,2.0,1.0,no(M2 and SIP pres),1.0
72.45996,female,1.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,21265.0,white,no,0.199999928,0.15,dnr after sadm,3.0,43.0,21.5,111.0,42.0,38.69531,275.0,2.3999023,0.09999084,0.79992676,144.0,7.289062,135.0,23.0,1968.0,0.0,7.0,<2 mo. follow-up,7.0
59.737,male,0.0,Lung Cancer,14.0,$25-$50k,8897.0,white,metastatic,0.699999809,0.6999998,no dnr,5.0,117.0,6.5,120.0,25.0,36.09375,224.0,3.199707,0.89990234,1.0,139.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
75.28497,female,1.0,ARF/MOSF w/Sepsis,16.0,$25-$50k,63906.0,white,no,0.5,0.3,dnr after sadm,1.0,49.0,16.0976562,116.0,28.0,35.79688,163.25,2.699707,1.59985352,1.69995117,149.0,7.449219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
60.46799,male,1.0,MOSF w/Malig,16.0,>$50k,110493.0,white,yes,0.019999996,7.999995e-06,dnr after sadm,20.0,49.0,36.1953125,116.0,10.0,35.39844,142.84375,2.3999023,1.89990234,6.09960938,148.0,7.279297,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.0361328
86.17096,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,215811.0,white,no,0.699999809,0.8999996,no dnr,95.0,50.0,12.5996094,38.0,24.0,38.89844,96.65625,3.199707,0.79992676,0.79992676,137.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.4326172
79.98395,male,1.0,COPD,14.0,>$50k,18895.0,white,no,0.699999809,0.5999999,dnr after sadm,6.0,45.0,11.6992188,150.0,35.0,35.89844,213.3125,2.3999023,0.79992676,1.69995117,138.0,7.439453,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
53.65598,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,16865.0,hispanic,no,0.989999771,0.9899998,no dnr,11.0,60.0,9.69921875,69.0,40.0,38.89844,224.0,2.2998047,2.89990234,1.39990234,132.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
67.51794,female,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,23680.0,white,no,1.0,0.09999996,no dnr,18.0,78.0,12.0,100.0,38.0,37.59375,93.0,3.0,3.29980469,1.5,137.0,7.349609,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
83.50696,female,0.0,Colon Cancer,12.0,under $11k,8183.0,white,metastatic,0.899999619,0.5999999,no dnr,7.0,103.0,6.89941406,60.0,20.0,36.09375,224.0,4.3994141,0.69995117,1.19995117,138.0,7.419922,135.0,23.0,1968.0,1.0,0.0,no(M2 and SIP pres),0.0
68.22198,male,0.0,CHF,14.0,$11-$25k,4646.0,white,no,0.699999809,0.5,no dnr,4.0,80.0,7.39941406,90.0,25.0,36.19531,224.0,4.0,0.89990234,1.69995117,141.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
64.72296,female,0.0,COPD,12.0,$11-$25k,20184.0,white,no,0.899999619,0.8999996,no dnr,13.0,57.0,14.6992188,101.0,36.0,36.19531,116.3125,3.0,0.5,0.79992676,136.0,7.439453,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
87.04199,female,0.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,17585.0,white,no,0.699999809,0.5,no dnr,13.0,52.0,17.0,116.0,30.0,37.89844,125.70312,2.7998047,0.29998779,2.39990234,145.0,7.449219,135.0,23.0,1968.0,0.0,5.0,adl>=4 (>=5 if sur),5.0
81.85895,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,25693.0,white,no,0.949999809,0.7999997,no dnr,15.0,110.0,10.8984375,110.0,14.0,37.79688,240.0,2.8999023,0.89990234,0.79992676,143.0,7.40918,135.0,23.0,1968.0,1.0,2.0,no(M2 and SIP pres),2.0
74.61694,female,1.0,COPD,12.0,under $11k,19026.0,white,no,0.5,0.3,dnr after sadm,8.0,65.0,12.8984375,120.0,35.0,36.59375,262.5,2.8999023,0.69995117,0.59997559,141.0,7.379883,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,5.2617188
53.59299,female,0.0,Lung Cancer,15.0,under $11k,7058.0,white,metastatic,0.949999809,0.7999997,no dnr,6.0,103.0,13.6992188,100.0,20.0,36.79688,224.0,4.0996094,0.29998779,1.0,141.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
57.84497,male,0.0,CHF,16.0,under $11k,29955.0,white,no,0.949999809,0.8999996,no dnr,22.0,80.0,4.89941406,127.0,25.0,35.89844,342.8125,3.699707,2.09960938,1.19995117,146.0,7.399414,135.0,23.0,1968.0,2.0,0.0,no(M2 and SIP pres),0.0
78.60596,male,0.0,ARF/MOSF w/Sepsis,18.0,under $11k,18683.0,white,no,0.949999809,0.8999996,no dnr,15.0,109.0,11.5,73.0,26.0,39.69531,224.0,4.0,1.09985352,1.39990234,133.0,7.419922,135.0,23.0,1968.0,1.0,5.0,no(M2 and SIP pres),5.0
43.38898,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,25196.0,black,no,0.899999619,0.8999996,no dnr,17.0,65.0,6.09960938,110.0,20.0,37.89844,420.0,3.199707,1.39990234,0.69995117,139.0,7.389648,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
59.34799,male,0.0,ARF/MOSF w/Sepsis,12.0,>$50k,29852.0,white,yes,0.299999952,0.09999996,no dnr,18.0,55.0,13.1992188,68.0,13.0,35.59375,128.3125,3.699707,1.29980469,0.89990234,140.0,7.459961,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
78.67798,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,19026.0,white,no,0.699999809,0.5999999,no dnr,7.0,59.0,7.39941406,60.0,8.0,37.69531,390.0,2.0996094,0.69995117,3.5,147.0,7.439453,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
75.52899,female,0.0,CHF,12.0,$11-$25k,13975.0,white,no,0.199999928,0.5,no dnr,13.0,73.0,4.19921875,80.0,20.0,37.0,224.0,2.8999023,0.89990234,2.39990234,136.0,7.479492,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
47.59198,male,0.0,ARF/MOSF w/Sepsis,14.0,$25-$50k,57841.0,white,no,0.399999857,0.3999999,no dnr,27.0,113.0,22.296875,136.0,10.0,39.39844,275.5,2.5,2.0,2.0,147.0,7.349609,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
82.63696,female,0.0,COPD,15.0,under $11k,87279.0,white,no,0.849999905,0.7999997,dnr after sadm,1.0,60.0,9.09960938,74.0,34.0,36.5,192.5625,3.7998047,0.5,0.89990234,139.0,7.489258,135.0,23.0,1968.0,2.0,1.0,adl>=4 (>=5 if sur),1.8389997
68.87097,female,0.0,Lung Cancer,12.0,under $11k,8578.0,white,metastatic,0.699999809,0.5,no dnr,6.0,83.0,4.5,100.0,20.0,38.09375,224.0,3.2998047,0.69995117,0.79992676,136.0,7.539062,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
83.11597,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,27727.0,white,no,0.699999809,0.5,dnr after sadm,2.0,53.0,14.5,63.0,24.0,36.09375,103.32812,3.199707,0.79992676,1.09985352,145.0,7.479492,135.0,23.0,1968.0,0.0,4.0,adl>=4 (>=5 if sur),4.0
70.21997,female,1.0,Coma,14.0,>$50k,14317.0,white,no,0.699999809,0.5,dnr after sadm,3.0,42.0,11.8984375,108.0,9.0,32.29688,54.0,2.199707,4.39941406,2.79980469,136.0,7.449219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
65.92999,male,0.0,ARF/MOSF w/Sepsis,16.0,$25-$50k,88955.0,white,no,0.799999714,0.7999997,no dnr,45.0,57.0,10.5,170.0,28.0,38.69531,138.0,2.8999023,0.89990234,1.0,142.0,7.429688,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
50.97598,male,0.0,ARF/MOSF w/Sepsis,18.0,under $11k,74681.0,black,yes,0.699999809,0.5,no dnr,74.0,82.0,10.0996094,106.0,26.0,36.0,225.0,2.5,0.29998779,0.89990234,134.0,7.449219,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),3.2895508
43.047,female,0.0,COPD,18.0,under $11k,6616.0,white,no,0.979999542,0.9799995,no dnr,5.0,107.0,9.79882812,70.0,25.0,35.59375,214.28125,2.8999023,0.89990234,1.0,143.0,7.429688,135.0,23.0,1968.0,1.0,1.0,no(M2 and SIP pres),1.1668997
54.793,female,1.0,MOSF w/Malig,12.0,$11-$25k,48801.0,white,yes,0.599999905,0.5,dnr after sadm,22.0,123.0,0.09999084,170.0,38.0,39.59375,224.0,2.5,0.69995117,1.09985352,144.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
59.64398,female,1.0,MOSF w/Malig,12.0,$11-$25k,20609.0,hispanic,metastatic,0.149999976,0.07999998,dnr after sadm,5.0,45.0,6.29980469,112.0,38.0,37.89844,118.32812,3.0996094,0.89990234,0.59997559,138.0,7.30957,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
75.45795,female,0.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,207683.0,white,no,0.699999809,0.5,dnr after sadm,9.0,123.0,7.39941406,101.0,8.0,38.59375,79.0,3.0,0.89990234,2.19970703,154.0,7.459961,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
75.65198,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,32199.0,white,no,0.699999809,0.5,dnr after sadm,1.0,68.0,9.69921875,125.0,20.0,39.39844,132.0,2.8999023,0.89990234,0.69995117,139.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5561523
79.27698,female,0.0,COPD,10.0,under $11k,14304.0,white,no,0.75,0.5,dnr after sadm,1.0,60.0,16.296875,100.0,20.0,37.79688,311.625,3.2998047,0.69995117,1.69995117,135.0,7.399414,135.0,23.0,1968.0,0.0,5.0,adl>=4 (>=5 if sur),5.0
73.51996,female,0.0,Lung Cancer,12.0,under $11k,6003.0,white,metastatic,0.899999619,0.7999997,dnr after sadm,3.0,100.0,21.8984375,80.0,20.0,36.69531,224.0,2.8999023,0.69995117,0.59997559,136.0,7.439453,135.0,23.0,1968.0,1.0,0.0,<2 mo. follow-up,0.0
41.52197,male,0.0,Lung Cancer,11.0,under $11k,15020.0,white,metastatic,0.75,0.09999996,no dnr,12.0,101.0,6.5,72.0,14.0,35.89844,224.0,4.0,0.89990234,1.0,141.0,7.419922,135.0,23.0,1968.0,1.0,0.0,no(M2 and SIP pres),0.0
81.25098,female,0.0,COPD,12.0,under $11k,45228.0,white,no,0.099999964,0.0009999992,dnr after sadm,1.0,67.0,4.39941406,63.0,38.0,36.69531,257.125,3.2998047,0.39996338,3.39990234,144.0,7.259766,135.0,23.0,1968.0,0.0,1.0,SIP>=30,4.5458984
46.59497,male,0.0,Cirrhosis,15.0,under $11k,21756.0,white,no,0.099999964,0.0009999992,dnr after sadm,7.0,57.0,12.0996094,118.0,24.0,36.09375,328.5625,2.8999023,36.5,5.39941406,136.0,7.40918,135.0,23.0,1968.0,1.0,1.0,no(M2 and SIP pres),1.0
77.52496,male,0.0,MOSF w/Malig,18.0,under $11k,16099.0,white,yes,0.899999619,0.6999998,no dnr,10.0,110.0,0.89990234,110.0,28.0,36.09375,270.0,2.8999023,3.79980469,1.69995117,136.0,7.479492,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
56.71997,male,0.0,ARF/MOSF w/Sepsis,22.0,under $11k,16069.0,white,no,0.989999771,0.8999996,no dnr,8.0,135.0,11.0996094,142.0,68.0,37.79688,205.0,3.3999023,1.59985352,1.09985352,142.0,7.449219,135.0,23.0,1968.0,1.0,0.0,no(M2 and SIP pres),0.0
70.73499,male,0.0,ARF/MOSF w/Sepsis,8.0,>$50k,61059.0,white,no,0.699999809,0.5,no dnr,58.0,61.0,7.09960938,52.0,28.0,37.89844,151.0,2.8999023,0.89990234,1.59985352,134.0,7.369141,135.0,23.0,1968.0,0.0,2.0,no(M2 and SIP pres),2.0
77.53296,female,0.0,COPD,12.0,under $11k,10496.0,white,no,0.699999809,0.5,no dnr,7.0,67.0,26.0976562,132.0,42.0,36.19531,223.78125,3.8999023,0.89990234,1.0,138.0,7.329102,135.0,23.0,1968.0,1.0,0.0,no(M2 and SIP pres),0.0
85.20496,male,0.0,COPD,12.0,under $11k,21089.0,white,yes,0.899999619,0.5,no dnr,7.0,56.0,5.19921875,70.0,25.0,36.09375,175.5,2.8999023,0.89990234,1.0,140.0,7.359375,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
47.61398,female,0.0,ARF/MOSF w/Sepsis,16.0,under $11k,11252.0,white,no,0.5,0.5,no dnr,5.0,63.0,6.69921875,72.0,24.0,37.79688,137.5,2.8999023,0.5,0.89990234,143.0,7.569336,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
75.78094,female,0.0,MOSF w/Malig,12.0,under $11k,30913.0,white,yes,0.699999809,0.5,dnr after sadm,2.0,51.0,58.1953125,59.0,26.0,35.29688,197.5,3.0996094,2.19970703,2.0,132.0,7.40918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.9829102
74.95697,male,1.0,ARF/MOSF w/Sepsis,16.0,>$50k,131184.0,white,no,0.799999714,0.7999997,dnr after sadm,18.0,123.0,10.1992188,80.0,6.0,36.29688,121.65625,2.8999023,0.89990234,1.5,138.0,7.479492,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.1328125
74.32196,male,0.0,CHF,12.0,$11-$25k,3623.0,white,no,0.699999809,0.5,no dnr,4.0,97.0,11.5,70.0,32.0,37.09375,400.0,4.0,0.69995117,2.0,142.0,7.489258,135.0,23.0,1968.0,2.0,1.0,SIP>=30,1.0
64.19696,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,104074.0,white,yes,0.75,0.5999999,dnr after sadm,9.0,46.0,19.1992188,123.0,12.0,39.09375,175.0,3.5996094,0.89990234,0.29998779,137.0,7.379883,135.0,23.0,1968.0,0.0,7.0,<2 mo. follow-up,7.0
58.65799,male,0.0,COPD,12.0,$11-$25k,21228.0,white,no,0.949999809,0.9499998,no dnr,17.0,73.0,11.0996094,80.0,20.0,35.59375,196.65625,4.3994141,0.89990234,1.09985352,141.0,7.359375,135.0,23.0,1968.0,1.0,0.0,SIP>=30,0.0
93.34998,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,22396.0,white,no,0.5,0.3999999,no dnr,17.0,70.0,7.5,58.0,8.0,36.09375,325.0,2.8999023,1.69995117,1.69995117,143.0,7.369141,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,4.5322266
67.10199,male,1.0,CHF,14.0,under $11k,26499.0,white,no,0.799999714,0.5999999,no dnr,22.0,117.0,11.7988281,100.0,20.0,36.09375,368.0,4.0,0.79992676,2.79980469,135.0,7.519531,135.0,23.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
51.45499,female,0.0,ARF/MOSF w/Sepsis,13.0,under $11k,36074.0,white,no,0.949999809,0.9499998,no dnr,14.0,67.0,6.79980469,62.0,8.0,36.09375,141.40625,2.5996094,1.39990234,0.59997559,134.0,7.389648,135.0,23.0,1968.0,0.0,3.0,no(M2 and SIP pres),3.0
65.08698,male,0.0,CHF,12.0,under $11k,5422.0,white,no,0.699999809,0.5,no dnr,5.0,83.0,7.79980469,100.0,20.0,37.79688,648.125,2.8999023,0.89990234,1.19995117,136.0,7.40918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5957031
84.48199,male,1.0,COPD,6.0,$11-$25k,227626.0,white,no,1.0,1.0,no dnr,106.0,107.0,16.3984375,120.0,32.0,37.79688,223.0,2.8999023,0.89990234,1.29980469,146.0,7.389648,135.0,23.0,1968.0,1.0,0.0,adl>=4 (>=5 if sur),0.0
42.82797,male,1.0,ARF/MOSF w/Sepsis,15.0,under $11k,16096.0,black,no,0.0,0.0,no dnr,4.0,40.0,32.1953125,135.0,37.0,35.69531,125.0,2.199707,5.69921875,8.29882812,143.0,7.269531,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.9831543
80.45697,female,1.0,MOSF w/Malig,13.0,under $11k,12819.0,white,yes,0.099999964,0.0009999992,dnr after sadm,2.0,46.0,0.09999084,128.0,35.0,36.29688,190.0,3.3999023,2.09960938,0.89990234,127.0,7.469727,135.0,23.0,1968.0,0.0,5.0,<2 mo. follow-up,5.0
58.28598,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,34635.0,white,no,0.699999809,0.5,dnr after sadm,3.0,43.0,35.5,120.0,14.0,40.39844,106.65625,2.0996094,0.89990234,2.39990234,131.0,7.399414,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.4492188
67.01196,male,1.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,94528.0,white,no,0.849999905,0.8499999,no dnr,19.0,55.0,21.3984375,120.0,12.0,38.59375,186.0,2.8999023,0.89990234,4.19921875,140.0,7.359375,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
70.03998,female,0.0,Lung Cancer,12.0,under $11k,12519.0,white,metastatic,0.699999809,0.5,dnr after sadm,1.0,77.0,5.79980469,70.0,25.0,36.09375,224.0,3.7998047,1.39990234,0.69995117,143.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.9023438
99.28497,male,1.0,CHF,17.0,under $11k,118924.0,white,no,0.299999952,0.1999999,no dnr,53.0,45.0,13.1992188,70.0,10.0,36.39844,212.5,2.8999023,1.69995117,2.29980469,132.0,7.489258,135.0,23.0,1968.0,0.0,7.0,<2 mo. follow-up,7.0
52.504,female,0.0,COPD,12.0,under $11k,15466.0,white,yes,1.0,0.9499998,no dnr,11.0,71.0,19.3984375,140.0,24.0,36.09375,288.0,2.8999023,0.89990234,0.89990234,143.0,7.329102,135.0,23.0,1968.0,2.0,1.0,no(M2 and SIP pres),1.0
68.99097,female,1.0,Colon Cancer,6.0,$25-$50k,9864.0,white,metastatic,0.5,0.09999996,dnr after sadm,1.0,53.0,7.69921875,72.0,10.0,35.79688,224.0,2.5,0.59997559,1.09985352,137.0,7.419922,135.0,23.0,1968.0,0.0,5.0,<2 mo. follow-up,5.0
59.49298,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,40197.0,black,no,1.0,0.7999997,no dnr,26.0,137.0,18.0976562,119.0,32.0,35.79688,273.4375,5.0,0.59997559,1.5,138.0,7.359375,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
86.61694,male,0.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,16228.0,white,no,1.0,0.6999998,no dnr,13.0,53.0,12.6992188,66.0,32.0,36.09375,280.0,4.5,1.79980469,1.29980469,143.0,7.40918,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
26.56,female,1.0,MOSF w/Malig,16.0,under $11k,97294.0,white,yes,0.199999928,0.1999999,dnr after sadm,15.0,49.0,5.5,118.0,10.0,36.39844,137.5,2.199707,1.29980469,0.69995117,144.0,7.399414,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.1289062
51.39999,male,0.0,Coma,12.0,$25-$50k,28600.0,white,no,0.75,0.6999998,no dnr,15.0,47.0,4.19921875,126.0,10.0,38.29688,88.0,2.8999023,2.0,0.59997559,133.0,7.449219,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
70.62598,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,82196.0,white,no,0.799999714,0.1999999,no dnr,29.0,71.0,7.09960938,62.0,24.0,36.69531,266.625,2.8999023,0.39996338,3.89990234,141.0,7.489258,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
44.17499,male,0.0,Colon Cancer,13.0,$11-$25k,45066.0,white,metastatic,0.75,0.3,no dnr,35.0,66.0,9.3984375,116.0,24.0,38.89844,504.75,2.0996094,1.0,0.59997559,134.0,7.439453,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
75.01996,male,0.0,MOSF w/Malig,12.0,$25-$50k,24165.0,white,metastatic,0.199999928,0.09999996,no dnr,12.0,57.0,5.09960938,51.0,10.0,38.0,150.0,4.0996094,0.89990234,1.69995117,144.0,7.149414,135.0,23.0,1968.0,0.0,3.0,<2 mo. follow-up,3.0
69.09796,male,0.0,ARF/MOSF w/Sepsis,16.0,under $11k,18468.0,white,no,0.949999809,0.8499999,no dnr,7.0,63.0,7.39941406,100.0,9.0,36.29688,113.0,2.8999023,1.0,1.29980469,135.0,7.489258,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,4.8164062
79.66095,female,0.0,ARF/MOSF w/Sepsis,15.0,under $11k,26312.0,white,no,0.929999828,0.8499999,no dnr,8.0,54.0,10.0,67.0,16.0,38.0,236.71875,2.5,0.89990234,0.89990234,142.0,7.449219,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
81.23798,male,0.0,CHF,14.0,$11-$25k,3806.0,white,no,0.949999809,0.8999996,no dnr,4.0,83.0,11.0,60.0,20.0,35.59375,336.0,2.8999023,0.89990234,1.89990234,142.0,7.5,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
71.30695,female,0.0,CHF,12.0,$11-$25k,31908.0,white,yes,0.5,0.3999999,no dnr,18.0,64.0,15.8984375,72.0,30.0,39.19531,68.0,2.8999023,0.89990234,1.19995117,133.0,7.469727,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
82.39294,male,0.0,MOSF w/Malig,9.0,$11-$25k,9332.0,white,yes,0.949999809,0.7999997,no dnr,8.0,73.0,8.8984375,70.0,25.0,37.79688,188.0,3.199707,0.89990234,1.09985352,142.0,7.399414,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
71.00098,female,1.0,COPD,12.0,$11-$25k,20870.0,white,yes,0.299999952,0.09999996,dnr after sadm,2.0,103.0,6.69921875,70.0,30.0,37.79688,100.0,3.0996094,0.29998779,1.59985352,132.0,7.459961,135.0,23.0,1968.0,6.0,6.0,<2 mo. follow-up,6.0
91.03894,male,0.0,COPD,10.0,$11-$25k,27902.0,white,no,0.5,0.3,dnr after sadm,3.0,97.0,9.59960938,120.0,50.0,37.19531,175.5,3.2998047,0.89990234,1.29980469,144.0,7.379883,135.0,23.0,1968.0,0.0,3.0,SIP>=30,3.0
48.78,female,0.0,Lung Cancer,10.0,under $11k,10689.0,white,metastatic,0.699999809,0.5,no dnr,7.0,61.0,5.0,120.0,24.0,36.89844,224.0,3.199707,0.29998779,0.69995117,145.0,7.469727,135.0,23.0,1968.0,0.0,0.0,SIP>=30,0.0
76.18597,male,0.0,ARF/MOSF w/Sepsis,10.0,under $11k,25469.0,black,no,0.649999619,0.5,dnr after sadm,1.0,54.0,10.3984375,71.0,24.0,35.0,432.0,2.8999023,0.5,2.39990234,125.0,7.509766,135.0,23.0,1968.0,7.0,2.0,<2 mo. follow-up,2.0
84.62994,female,0.0,COPD,9.0,under $11k,6414.0,white,no,0.5,0.3999999,dnr before sadm,-1.0,80.0,9.8984375,60.0,30.0,36.09375,190.46875,3.5996094,0.89990234,1.19995117,138.0,7.449219,135.0,23.0,1968.0,0.0,5.0,<2 mo. follow-up,5.0
93.62897,female,0.0,CHF,12.0,under $11k,4975.0,white,no,0.75,0.5999999,dnr after sadm,1.0,67.0,5.79980469,70.0,20.0,36.09375,224.0,2.8999023,0.89990234,0.89990234,132.0,7.389648,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,4.3154297
86.18799,female,1.0,Lung Cancer,12.0,under $11k,26902.0,black,metastatic,0.099999964,0.0009999992,dnr after sadm,2.0,100.0,8.69921875,100.0,25.0,36.09375,224.0,3.0,0.39996338,0.69995117,131.0,7.419922,135.0,23.0,1968.0,0.0,3.0,<2 mo. follow-up,3.0
76.53894,female,1.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,56726.0,white,metastatic,0.5,0.09999996,dnr after sadm,11.0,50.0,9.79882812,48.0,42.0,38.0,170.0,3.199707,0.89990234,0.69995117,134.0,7.419922,135.0,23.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
80.79095,female,0.0,COPD,12.0,$11-$25k,21055.0,white,no,0.949999809,0.7999997,no dnr,8.0,83.0,12.8984375,80.0,20.0,38.0,390.0,2.8999023,0.89990234,0.89990234,144.0,7.389648,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
49.85397,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,31619.0,white,yes,0.299999952,0.3,no dnr,14.0,43.0,11.3984375,114.0,10.0,39.29688,154.0,2.2998047,0.59997559,0.29998779,147.0,7.389648,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.3754883
94.10797,female,0.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,21424.0,white,no,0.5,0.5,dnr after sadm,1.0,70.0,9.29882812,80.0,20.0,36.69531,295.0,2.8999023,0.39996338,1.09985352,140.0,7.299805,135.0,23.0,1968.0,4.0,1.0,<2 mo. follow-up,3.1831989
97.83997,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,49040.0,white,no,0.199999928,0.1999999,dnr after sadm,6.0,103.0,8.19921875,105.0,48.0,37.59375,124.0,2.0,1.0,1.29980469,142.0,7.469727,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
66.51294,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,8567.0,white,yes,0.899999619,0.8999996,no dnr,7.0,72.0,8.8984375,60.0,16.0,36.19531,140.0,5.1992188,1.79980469,1.09985352,137.0,7.359375,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
29.618,female,0.0,ARF/MOSF w/Sepsis,14.0,under $11k,69945.0,white,no,0.979999542,0.9799995,no dnr,23.0,58.0,6.5,124.0,8.0,38.09375,353.3125,3.5996094,0.89990234,0.59997559,136.0,7.449219,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
72.10095,male,0.0,CHF,12.0,$11-$25k,4571.0,white,no,0.799999714,0.6999998,no dnr,5.0,120.0,11.3984375,80.0,25.0,35.59375,224.0,4.1992188,0.59997559,2.79980469,139.0,7.419922,135.0,23.0,1968.0,2.0,1.0,<2 mo. follow-up,1.8389997
43.16998,male,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,97562.0,white,no,0.5,0.5,no dnr,34.0,60.0,12.3984375,58.0,12.0,39.59375,97.14062,2.8999023,0.59997559,1.5,146.0,7.429688,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
80.01599,female,1.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,105850.0,white,no,0.049999982,0.0001249999,dnr before sadm,-3.0,62.0,13.0,62.0,8.0,37.79688,153.3125,2.8999023,0.89990234,4.5,128.0,7.389648,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
54.26099,female,1.0,MOSF w/Malig,12.0,$25-$50k,13516.0,black,metastatic,0.699999809,0.5,dnr after sadm,4.0,53.0,19.5976562,74.0,22.0,37.69531,386.625,2.5996094,8.59960938,2.89990234,149.0,7.359375,135.0,23.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
54.33499,female,0.0,ARF/MOSF w/Sepsis,9.0,under $11k,18839.0,black,no,1.0,1.0,no dnr,12.0,45.0,10.7988281,118.0,28.0,39.09375,490.4375,2.699707,0.89990234,1.89990234,153.0,7.40918,135.0,23.0,1968.0,0.0,2.0,no(M2 and SIP pres),2.0
85.16095,female,1.0,CHF,12.0,$25-$50k,27344.0,white,no,0.5,0.3,dnr after sadm,5.0,57.0,7.0,56.0,20.0,34.79688,396.0,3.3999023,1.5,2.89990234,142.0,7.419922,135.0,23.0,1968.0,5.0,1.0,<2 mo. follow-up,3.855299
52.19199,female,0.0,ARF/MOSF w/Sepsis,12.0,>$50k,20742.0,white,no,0.949999809,0.8999996,no dnr,16.0,103.0,9.59960938,66.0,22.0,36.0,403.6875,3.2998047,0.5,12.3984375,143.0,7.379883,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
74.72095,male,0.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,6934.0,white,no,0.989999771,0.9899998,no dnr,6.0,120.0,8.19921875,80.0,20.0,37.5,309.0,4.3994141,0.29998779,1.5,142.0,7.279297,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
88.32898,male,1.0,ARF/MOSF w/Sepsis,15.0,under $11k,21473.0,white,no,0.299999952,0.3,no dnr,8.0,40.0,13.3984375,55.0,10.0,37.19531,192.5,2.5,0.89990234,1.39990234,133.0,7.489258,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
77.82599,female,0.0,ARF/MOSF w/Sepsis,16.0,$25-$50k,59663.0,white,no,0.699999809,0.3999999,dnr before sadm,-4.0,60.0,5.79980469,49.0,24.0,36.19531,300.0,2.7998047,0.89990234,1.89990234,137.0,7.449219,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
82.35498,female,0.0,Coma,18.0,$25-$50k,5849.0,white,no,0.5,0.25,dnr after sadm,1.0,113.0,6.29980469,60.0,20.0,36.39844,224.0,2.8999023,0.89990234,1.0,139.0,7.419922,135.0,23.0,1968.0,0.0,7.0,adl>=4 (>=5 if sur),7.0
87.61096,male,0.0,CHF,8.0,under $11k,77925.0,white,no,0.399999857,0.1999999,dnr after sadm,1.0,107.0,9.3984375,60.0,20.0,36.59375,218.5,2.8999023,0.89990234,2.09960938,145.0,7.479492,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),1.0
50.81497,female,0.0,CHF,12.0,$11-$25k,6782.0,black,no,0.979999542,0.9499998,no dnr,6.0,73.0,4.5,70.0,20.0,36.69531,224.0,2.7998047,0.29998779,5.69921875,139.0,7.389648,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
34.54099,female,0.0,ARF/MOSF w/Sepsis,19.0,under $11k,55377.0,white,no,0.979999542,0.9799995,no dnr,21.0,63.0,7.79980469,142.0,14.0,38.39844,202.0,3.0996094,0.79992676,1.29980469,139.0,7.429688,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
83.08795,female,1.0,ARF/MOSF w/Sepsis,16.0,under $11k,43926.0,black,no,0.599999905,0.3999999,dnr after sadm,1.0,43.0,26.0976562,120.0,24.0,34.69531,504.0,2.2998047,0.29998779,6.29980469,149.0,7.359375,135.0,23.0,1968.0,0.0,7.0,<2 mo. follow-up,7.0
67.53198,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,25469.0,white,no,0.699999809,0.5,no dnr,15.0,52.0,5.29980469,64.0,8.0,37.79688,195.0,3.0,0.89990234,0.69995117,134.0,7.179688,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.0639648
64.13696,male,0.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,50784.0,white,yes,0.949999809,0.8999996,no dnr,19.0,70.0,13.0,125.0,33.0,38.19531,296.0,2.8999023,0.89990234,1.09985352,135.0,7.429688,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
89.83698,female,0.0,ARF/MOSF w/Sepsis,13.0,$11-$25k,11439.0,white,no,0.699999809,0.5,no dnr,8.0,123.0,5.59960938,80.0,30.0,36.19531,118.32812,3.0,0.39996338,3.89990234,144.0,7.449219,135.0,23.0,1968.0,1.0,1.0,<2 mo. follow-up,1.0
57.20697,male,0.0,Colon Cancer,14.0,$25-$50k,18587.0,white,metastatic,0.989999771,0.5,no dnr,12.0,77.0,5.69921875,70.0,15.0,36.09375,224.0,4.6992188,0.5,1.09985352,136.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
84.50897,male,1.0,Coma,6.0,under $11k,29340.0,white,no,0.25,0.15,dnr after sadm,9.0,69.0,7.39941406,158.0,30.0,38.19531,420.0,2.3999023,0.5,1.29980469,149.0,7.439453,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
80.91998,female,0.0,COPD,12.0,under $11k,16313.0,white,no,0.899999619,0.5,dnr after sadm,8.0,67.0,8.69921875,128.0,8.0,37.79688,206.65625,2.8999023,0.89990234,0.5,135.0,7.40918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,4.3994141
70.23999,female,0.0,ARF/MOSF w/Sepsis,11.0,$11-$25k,19161.0,white,no,0.699999809,0.3,no dnr,15.0,64.0,8.19921875,64.0,20.0,38.09375,130.59375,2.8999023,0.89990234,1.19995117,135.0,7.469727,135.0,23.0,1968.0,2.0,1.0,no(M2 and SIP pres),1.0
44.04898,female,0.0,Colon Cancer,12.0,$25-$50k,7996.0,black,metastatic,0.5,0.1999999,no dnr,6.0,103.0,17.6992188,120.0,24.0,39.39844,224.0,2.2998047,1.19995117,0.69995117,134.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
84.70898,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,22238.0,white,no,0.599999905,0.5,no dnr,10.0,117.0,10.6992188,70.0,26.0,36.19531,471.625,3.8999023,0.5,2.79980469,145.0,7.419922,135.0,23.0,1968.0,0.0,7.0,adl>=4 (>=5 if sur),7.0
22.61699,female,0.0,ARF/MOSF w/Sepsis,16.0,>$50k,77442.0,white,no,0.949999809,0.9499998,no dnr,19.0,63.0,5.79980469,126.0,8.0,38.19531,503.3125,2.8999023,0.89990234,0.5,135.0,7.419922,135.0,23.0,1968.0,0.0,0.0,SIP>=30,0.0
61.07898,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,106796.0,white,no,0.649999619,0.5,no dnr,34.0,47.0,6.39941406,66.0,6.0,36.09375,253.3125,2.699707,0.39996338,0.39996338,136.0,7.349609,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.4936523
70.36597,female,0.0,Lung Cancer,12.0,under $11k,6223.0,white,metastatic,0.899999619,0.7999997,no dnr,6.0,83.0,5.09960938,84.0,20.0,36.69531,224.0,2.8999023,0.89990234,0.89990234,144.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.637207
38.448,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,88669.0,white,no,0.799999714,0.7999997,dnr after sadm,29.0,119.0,4.59960938,64.0,20.0,37.79688,204.75,3.199707,0.09999084,3.59960938,142.0,7.359375,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.8059082
43.23898,male,0.0,ARF/MOSF w/Sepsis,13.0,$11-$25k,40025.0,white,no,0.799999714,0.6999998,no dnr,11.0,70.0,16.5976562,70.0,38.0,39.29688,190.0,2.8999023,1.39990234,0.89990234,134.0,7.339844,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.980957
69.45898,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,54062.0,white,no,0.75,0.5999999,no dnr,7.0,45.0,19.296875,120.0,46.0,39.09375,248.0,2.2998047,0.89990234,1.19995117,149.0,7.519531,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.4765625
80.37195,female,1.0,ARF/MOSF w/Sepsis,16.0,$25-$50k,28526.0,white,no,0.0,0.0,no dnr,7.0,61.0,13.0996094,133.0,12.0,38.69531,215.0,1.7998047,0.5,0.79992676,142.0,7.389648,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
55.93198,female,0.0,ARF/MOSF w/Sepsis,14.0,under $11k,25230.0,black,no,0.899999619,0.8999996,no dnr,10.0,61.0,10.0,110.0,6.0,36.59375,216.0,2.5,0.29998779,2.79980469,134.0,7.469727,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
46.10797,male,0.0,ARF/MOSF w/Sepsis,14.0,under $11k,421711.0,white,no,0.75,0.75,no dnr,226.0,51.0,15.6992188,140.0,43.0,38.89844,202.5,2.199707,1.59985352,0.89990234,153.0,7.439453,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),2.1748047
50.64499,male,0.0,Cirrhosis,17.0,under $11k,8764.0,white,no,0.699999809,0.5,no dnr,7.0,97.0,5.29980469,80.0,20.0,37.0,224.0,2.8999023,1.89990234,1.5,134.0,7.419922,135.0,23.0,1968.0,6.0,1.0,no(M2 and SIP pres),1.0
62.48599,female,1.0,Colon Cancer,12.0,under $11k,7395.0,white,metastatic,0.699999809,0.5,dnr after sadm,1.0,70.0,22.0,110.0,22.0,35.59375,224.0,2.199707,14.0,0.69995117,134.0,7.419922,135.0,23.0,1968.0,5.0,1.0,<2 mo. follow-up,3.855299
54.32999,male,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,46721.0,white,no,1.0,1.0,no dnr,9.0,75.0,13.3984375,110.0,30.0,38.29688,178.0,2.8999023,0.89990234,0.69995117,134.0,7.349609,135.0,23.0,1968.0,2.0,1.0,no(M2 and SIP pres),1.0
65.65594,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,32779.0,white,yes,0.75,0.5,no dnr,14.0,58.0,5.19921875,137.0,30.0,38.39844,230.0,3.3999023,0.89990234,0.5,134.0,7.399414,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.0800781
84.16998,female,1.0,Coma,12.0,under $11k,9943.0,white,no,0.099999964,0.0009999992,dnr before sadm,0.0,69.0,13.3984375,112.0,24.0,38.89844,120.0,4.0,1.09985352,1.69995117,144.0,7.429688,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
64.47595,male,0.0,Lung Cancer,16.0,>$50k,6831.0,white,metastatic,0.75,0.0,no dnr,6.0,109.0,7.19921875,96.0,16.0,35.89844,224.0,3.2998047,1.39990234,1.09985352,136.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
64.211,male,0.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,67530.0,white,no,0.5,0.25,no dnr,33.0,118.0,9.5,68.0,12.0,38.0,67.5,2.8999023,0.29998779,6.79980469,136.0,7.419922,135.0,23.0,1968.0,0.0,3.0,adl>=4 (>=5 if sur),3.0
65.59094,female,0.0,ARF/MOSF w/Sepsis,12.0,>$50k,33458.0,white,no,0.899999619,0.8999996,no dnr,19.0,53.0,7.79980469,80.0,38.0,39.69531,126.65625,3.2998047,0.29998779,0.59997559,138.0,7.509766,135.0,23.0,1968.0,0.0,2.0,no(M2 and SIP pres),2.0
52.62097,male,1.0,MOSF w/Malig,20.0,>$50k,97248.0,white,yes,0.049999982,0.0001249999,dnr after sadm,2.0,46.0,80.59375,72.0,28.0,37.89844,87.14062,2.8999023,1.79980469,3.69970703,125.0,7.349609,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
55.32898,female,0.0,Lung Cancer,12.0,under $11k,36321.0,white,metastatic,0.899999619,0.5,dnr after sadm,13.0,103.0,8.5,70.0,20.0,35.69531,224.0,4.0996094,0.59997559,0.59997559,137.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.2285156
68.81,female,1.0,COPD,12.0,under $11k,3666.0,white,metastatic,0.019999996,7.999995e-06,dnr after sadm,1.0,60.0,12.3984375,120.0,20.0,35.59375,219.03125,2.8999023,0.89990234,0.59997559,131.0,7.30957,135.0,23.0,1968.0,0.0,4.0,<2 mo. follow-up,4.0
61.62097,female,0.0,Lung Cancer,12.0,>$50k,6666.0,white,metastatic,0.799999714,0.5999999,no dnr,6.0,97.0,4.39941406,100.0,20.0,36.09375,224.0,4.5996094,0.89990234,0.69995117,142.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
76.56897,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,29690.0,white,no,0.899999619,0.7999997,no dnr,19.0,53.0,5.39941406,63.0,30.0,38.59375,220.0,2.8999023,0.5,0.79992676,136.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
73.85596,male,1.0,Coma,12.0,$25-$50k,17288.0,white,no,0.049999982,0.0001249999,dnr after sadm,5.0,71.0,11.0,114.0,8.0,38.5,232.5,3.699707,0.69995117,0.79992676,135.0,7.449219,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
84.27698,male,0.0,ARF/MOSF w/Sepsis,16.0,under $11k,53017.0,white,no,0.799999714,0.7999997,no dnr,22.0,63.0,29.796875,60.0,6.0,35.59375,166.0,2.8999023,0.89990234,1.79980469,138.0,7.439453,135.0,23.0,1968.0,5.0,0.0,no(M2 and SIP pres),0.0
51.92297,female,0.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,30647.0,white,no,0.989999771,0.9799995,no dnr,13.0,100.0,6.89941406,65.0,16.0,38.19531,198.0,2.8999023,0.79992676,0.69995117,139.0,7.279297,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
72.90594,male,0.0,CHF,13.0,under $11k,19699.0,white,no,0.949999809,0.8999996,no dnr,12.0,129.0,12.0,100.0,12.0,36.19531,270.0,2.8999023,0.89990234,2.19970703,139.0,7.429688,135.0,23.0,1968.0,0.0,2.0,no(M2 and SIP pres),2.0
59.09097,male,0.0,Lung Cancer,12.0,under $11k,13003.0,white,metastatic,0.0,0.0,dnr after sadm,1.0,87.0,10.0,100.0,25.0,36.69531,224.0,2.8999023,0.5,0.69995117,134.0,7.419922,135.0,23.0,1968.0,0.0,6.0,<2 mo. follow-up,6.0
83.35095,female,0.0,CHF,12.0,under $11k,13550.0,white,no,0.799999714,0.75,no dnr,11.0,110.0,7.69921875,70.0,25.0,36.59375,224.0,2.8999023,0.89990234,2.09960938,140.0,7.419922,135.0,23.0,1968.0,3.0,5.0,<2 mo. follow-up,5.0
63.59198,male,0.0,Colon Cancer,17.0,>$50k,12101.0,black,metastatic,0.299999952,0.09999996,no dnr,8.0,117.0,18.5,80.0,20.0,35.19531,224.0,2.7998047,4.39941406,0.69995117,131.0,7.419922,135.0,23.0,1968.0,5.0,5.0,adl>=4 (>=5 if sur),5.0
21.28099,female,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,32860.0,black,no,0.899999619,0.7999997,no dnr,22.0,68.0,17.0976562,136.0,30.0,40.29688,359.25,2.8999023,0.89990234,0.69995117,141.0,7.399414,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
89.10095,male,1.0,ARF/MOSF w/Sepsis,7.0,under $11k,116854.0,white,no,0.799999714,0.75,no dnr,90.0,53.0,21.5976562,110.0,24.0,38.09375,156.0,3.2998047,0.69995117,1.29980469,128.0,7.369141,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),1.0
74.65796,female,0.0,ARF/MOSF w/Sepsis,8.0,under $11k,26459.0,white,no,0.849999905,0.7999997,no dnr,23.0,53.0,31.3984375,120.0,36.0,36.09375,392.5625,2.8999023,0.39996338,2.29980469,128.0,7.399414,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
70.935,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,28416.0,white,no,0.5,0.3,dnr after sadm,1.0,73.0,18.1992188,98.0,22.0,36.29688,294.25,2.199707,0.59997559,0.89990234,139.0,7.399414,135.0,23.0,1968.0,4.0,4.0,no(M2 and SIP pres),4.0
40.099,male,1.0,ARF/MOSF w/Sepsis,10.0,under $11k,27665.0,black,no,0.699999809,0.6999998,dnr after sadm,5.0,55.0,23.296875,106.0,42.0,38.09375,160.0,2.0,25.6992188,1.89990234,143.0,7.379883,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
75.09698,male,1.0,ARF/MOSF w/Sepsis,8.0,$11-$25k,41196.0,white,no,0.049999982,0.0001249999,dnr after sadm,6.0,52.0,26.796875,113.0,8.0,40.09375,317.0,2.8999023,0.89990234,2.0,145.0,7.549805,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.090332
65.62396,male,0.0,Lung Cancer,8.0,under $11k,37795.0,white,metastatic,0.849999905,0.75,dnr after sadm,20.0,73.0,0.89990234,140.0,24.0,38.29688,224.0,2.8999023,0.89990234,1.39990234,134.0,7.489258,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
39.61899,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,12213.0,white,no,0.699999809,0.5,no dnr,7.0,43.0,4.59960938,74.0,20.0,38.39844,466.625,2.0996094,0.39996338,0.39996338,132.0,7.469727,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.4155273
96.70599,male,0.0,COPD,12.0,under $11k,7407.0,white,no,0.75,0.75,dnr before sadm,-1.0,103.0,3.29980469,70.0,25.0,37.0,417.125,3.0996094,0.29998779,1.19995117,138.0,7.379883,135.0,23.0,1968.0,0.0,6.0,adl>=4 (>=5 if sur),6.0
88.159,male,0.0,ARF/MOSF w/Sepsis,8.0,$11-$25k,59176.0,white,no,0.099999964,0.0009999992,dnr after sadm,2.0,60.0,7.89941406,69.0,10.0,38.79688,232.5,2.5,1.09985352,0.89990234,140.0,7.399414,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
73.08698,male,0.0,CHF,12.0,$25-$50k,19910.0,white,yes,0.399999857,0.1999999,dnr after sadm,1.0,83.0,11.8984375,80.0,25.0,36.69531,305.0,3.0996094,1.09985352,2.29980469,134.0,7.40918,135.0,23.0,1968.0,4.0,3.0,<2 mo. follow-up,3.0
74.55695,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,50568.0,white,no,0.699999809,0.5999999,no dnr,28.0,52.0,11.5,64.0,10.0,38.19531,191.40625,2.8999023,1.09985352,1.89990234,138.0,7.40918,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
76.271,female,0.0,MOSF w/Malig,16.0,under $11k,79339.0,white,yes,0.699999809,0.5,dnr after sadm,2.0,62.0,7.39941406,113.0,26.0,38.5,59.0,2.199707,0.89990234,1.19995117,130.0,7.459961,135.0,23.0,1968.0,0.0,1.0,SIP>=30,1.0
85.39398,female,0.0,ARF/MOSF w/Sepsis,14.0,under $11k,10243.0,white,no,0.5,0.1999999,no dnr,9.0,100.0,10.5996094,65.0,24.0,38.69531,288.0,2.8999023,0.89990234,0.59997559,132.0,7.469727,135.0,23.0,1968.0,0.0,5.0,adl>=4 (>=5 if sur),5.0
65.77698,male,0.0,Lung Cancer,12.0,under $11k,13376.0,white,metastatic,0.899999619,0.8499999,no dnr,10.0,73.0,9.8984375,110.0,15.0,35.59375,224.0,1.8999023,0.89990234,0.89990234,137.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.2402344
95.00098,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,51385.0,white,no,0.699999809,0.5,dnr after sadm,25.0,109.0,5.0,68.0,24.0,36.29688,230.0,3.0996094,0.39996338,10.2988281,144.0,7.15918,135.0,23.0,1968.0,5.0,2.0,no(M2 and SIP pres),2.0
95.65796,male,0.0,ARF/MOSF w/Sepsis,7.0,under $11k,12752.0,white,yes,0.799999714,0.5999999,no dnr,6.0,97.0,7.39941406,100.0,25.0,36.69531,386.625,2.699707,0.89990234,1.0,141.0,7.469727,135.0,23.0,1968.0,6.0,2.0,adl>=4 (>=5 if sur),2.0
81.93597,male,0.0,ARF/MOSF w/Sepsis,14.0,under $11k,23223.0,white,no,0.75,0.5999999,no dnr,17.0,69.0,14.2988281,70.0,28.0,38.0,450.0,3.5996094,1.0,1.69995117,136.0,7.419922,135.0,23.0,1968.0,0.0,6.0,adl>=4 (>=5 if sur),6.0
31.034,male,1.0,ARF/MOSF w/Sepsis,8.0,under $11k,71576.0,white,no,0.5,0.5,dnr after sadm,21.0,50.0,13.0,122.0,8.0,33.39844,240.0,2.699707,0.39996338,0.59997559,138.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.3056641
85.52997,female,0.0,COPD,12.0,under $11k,76341.0,white,no,0.699999809,0.5,no dnr,17.0,121.0,17.3984375,118.0,30.0,37.79688,276.0,3.5996094,0.39996338,0.5,135.0,7.269531,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
84.42395,female,0.0,CHF,14.0,$11-$25k,8777.0,white,no,0.399999857,0.09999996,no dnr,7.0,68.0,8.59960938,58.0,28.0,37.79688,402.0,2.8999023,0.69995117,1.0,136.0,7.459961,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
43.62997,female,0.0,ARF/MOSF w/Sepsis,20.0,>$50k,44202.0,white,no,0.949999809,0.9499998,no dnr,34.0,53.0,11.1992188,110.0,26.0,38.89844,557.125,2.0996094,0.69995117,0.79992676,132.0,7.399414,135.0,23.0,1968.0,7.0,1.0,SIP>=30,5.1994972
59.48798,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,54994.0,black,no,0.899999619,0.8999996,no dnr,33.0,60.0,30.0,135.0,44.0,38.69531,97.5,2.2998047,0.79992676,0.79992676,132.0,7.40918,135.0,23.0,1968.0,0.0,1.0,SIP>=30,2.6298828
36.22699,male,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,37450.0,white,no,0.699999809,0.5,no dnr,16.0,111.0,11.3984375,120.0,22.0,38.69531,201.0,4.0,1.0,1.19995117,136.0,7.539062,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.453125
86.68896,male,0.0,ARF/MOSF w/Sepsis,13.0,under $11k,63310.0,white,no,0.199999928,0.09999996,no dnr,31.0,113.0,25.0976562,70.0,40.0,38.5,224.0,2.5,1.09985352,2.0,142.0,7.419922,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),1.0
84.15594,male,0.0,ARF/MOSF w/Sepsis,17.0,under $11k,21427.0,white,no,0.699999809,0.5,no dnr,15.0,67.0,6.5,60.0,24.0,38.69531,108.32812,4.5996094,0.69995117,1.29980469,123.0,7.40918,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
78.54895,male,0.0,Lung Cancer,11.0,under $11k,2752.0,white,metastatic,0.699999809,0.5,no dnr,3.0,83.0,3.69970703,80.0,20.0,36.69531,224.0,2.8999023,0.89990234,0.79992676,131.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
86.80597,male,1.0,ARF/MOSF w/Sepsis,20.0,>$50k,46091.0,white,no,0.199999928,0.09999996,dnr after sadm,2.0,43.0,9.5,66.0,12.0,38.09375,150.0,2.7998047,0.59997559,5.69921875,136.0,7.30957,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
73.82599,male,0.0,CHF,12.0,$25-$50k,10333.0,white,no,0.899999619,0.7999997,no dnr,10.0,70.0,10.5996094,108.0,25.0,36.69531,323.75,2.8999023,0.89990234,1.59985352,138.0,7.469727,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
62.92999,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,48246.0,white,no,0.5,0.5,no dnr,19.0,111.0,14.6992188,115.0,28.0,37.89844,150.0,2.3999023,0.89990234,1.0,149.0,7.369141,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.6669922
55.06897,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,8824.0,other,yes,0.899999619,0.8999996,no dnr,4.0,63.0,12.1992188,103.0,12.0,38.29688,187.75,3.0996094,0.89990234,1.39990234,142.0,7.439453,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
72.91199,male,0.0,CHF,12.0,under $11k,3901.0,white,no,0.699999809,0.5,no dnr,4.0,73.0,10.0,80.0,20.0,36.69531,102.5,2.8999023,0.59997559,1.09985352,135.0,7.439453,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.3696289
84.72595,female,0.0,COPD,12.0,under $11k,29354.0,white,no,0.149999976,0.04999998,dnr after sadm,2.0,50.0,10.0,48.0,8.0,36.29688,248.5625,2.8999023,0.89990234,1.5,146.0,7.489258,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),1.0
41.43698,female,0.0,MOSF w/Malig,18.0,>$50k,23016.0,white,yes,0.799999714,0.5,no dnr,7.0,76.0,0.29998779,80.0,24.0,36.09375,224.0,2.5,1.09985352,1.19995117,139.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
55.97299,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,20538.0,other,no,0.989999771,0.9899998,no dnr,15.0,63.0,9.3984375,115.0,40.0,36.09375,128.3125,3.0,1.0,0.89990234,135.0,7.359375,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
85.01294,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,12527.0,white,no,0.699999809,0.5,dnr after sadm,4.0,49.0,0.79992676,75.0,8.0,36.0,366.625,2.0,0.29998779,1.29980469,129.0,7.299805,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.8486328
76.09296,male,0.0,MOSF w/Malig,12.0,under $11k,9274.0,white,yes,1.0,1.0,no dnr,7.0,97.0,7.5,70.0,20.0,36.09375,223.78125,2.8999023,0.79992676,1.29980469,136.0,7.399414,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
76.70898,female,0.0,Colon Cancer,12.0,under $11k,4285.0,white,metastatic,0.75,0.1999999,no dnr,4.0,83.0,7.59960938,80.0,20.0,38.89844,224.0,4.0,0.39996338,0.69995117,136.0,7.419922,135.0,23.0,1968.0,1.0,1.0,<2 mo. follow-up,1.1668997
79.96399,male,1.0,ARF/MOSF w/Sepsis,8.0,under $11k,31577.0,white,metastatic,0.799999714,0.5,dnr after sadm,1.0,83.0,9.09960938,80.0,20.0,35.59375,180.0,2.199707,0.89990234,0.59997559,135.0,7.469727,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
78.60394,female,0.0,ARF/MOSF w/Sepsis,7.0,under $11k,54833.0,white,no,1.0,1.0,no dnr,21.0,120.0,10.7988281,68.0,8.0,38.09375,232.5,2.8999023,0.69995117,3.29980469,145.0,7.339844,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
67.73395,female,0.0,Cirrhosis,12.0,under $11k,9907.0,white,no,0.299999952,0.1999999,no dnr,7.0,113.0,6.69921875,54.0,12.0,35.89844,642.75,2.699707,3.5,0.79992676,142.0,7.469727,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
84.68396,female,0.0,ARF/MOSF w/Sepsis,8.0,under $11k,28225.0,white,no,0.599999905,0.5,dnr after sadm,2.0,77.0,10.8984375,132.0,26.0,36.09375,120.0,2.8999023,0.79992676,2.5,141.0,7.30957,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
63.59799,male,0.0,CHF,12.0,under $11k,15332.0,white,no,0.899999619,0.5999999,no dnr,7.0,63.0,10.1992188,70.0,28.0,36.59375,224.0,3.5996094,0.79992676,1.0,139.0,7.479492,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
86.75397,female,1.0,COPD,12.0,under $11k,87011.0,white,no,0.849999905,0.6999998,dnr after sadm,10.0,51.0,17.0,65.0,38.0,36.19531,146.40625,2.8999023,0.19998169,2.79980469,142.0,7.30957,135.0,23.0,1968.0,2.0,2.0,<2 mo. follow-up,2.0
77.65094,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,29557.0,white,no,0.75,0.5999999,no dnr,21.0,71.0,9.3984375,63.0,8.0,37.79688,108.23438,2.5996094,0.79992676,2.79980469,139.0,7.439453,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
78.87195,male,0.0,ARF/MOSF w/Sepsis,14.0,$11-$25k,59878.0,white,no,0.75,0.75,no dnr,30.0,117.0,7.5,50.0,8.0,38.39844,128.0,2.8999023,0.89990234,1.09985352,144.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
83.20294,female,0.0,CHF,12.0,$11-$25k,8495.0,white,no,0.949999809,0.7999997,no dnr,7.0,77.0,8.29882812,70.0,20.0,36.09375,304.75,3.3999023,0.89990234,1.0,141.0,7.469727,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
85.30597,female,0.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,23144.0,white,yes,0.979999542,0.9411917,no dnr,12.0,60.0,41.0,80.0,31.0,36.79688,114.0,2.8999023,0.89990234,1.0,134.0,7.5,135.0,23.0,1968.0,1.0,0.0,no(M2 and SIP pres),0.0
77.23999,male,0.0,CHF,12.0,$11-$25k,4915.0,white,yes,0.799999714,0.5999999,no dnr,5.0,73.0,6.09960938,80.0,20.0,36.09375,224.0,2.8999023,0.89990234,1.59985352,140.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
86.13599,female,0.0,CHF,12.0,under $11k,9257.0,white,no,0.899999619,0.8499999,no dnr,9.0,103.0,10.5996094,80.0,20.0,36.09375,544.0,3.699707,0.89990234,1.69995117,139.0,7.489258,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.1557617
85.51398,female,0.0,CHF,9.0,under $11k,6524.0,white,no,0.949999809,0.5,dnr after sadm,3.0,83.0,4.79980469,70.0,20.0,36.69531,408.3125,3.8999023,0.89990234,1.69995117,138.0,7.389648,135.0,23.0,1968.0,2.0,2.0,no(M2 and SIP pres),2.0
35.96997,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,7688.0,white,no,0.699999809,0.5,no dnr,5.0,73.0,15.0996094,80.0,20.0,37.79688,125.0,2.699707,0.29998779,0.89990234,143.0,7.429688,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.6083984
79.86896,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,18921.0,white,no,0.75,0.75,dnr after sadm,3.0,49.0,5.79980469,74.0,28.0,36.59375,230.59375,2.7998047,0.89990234,1.09985352,128.0,7.479492,135.0,23.0,1968.0,1.0,0.0,no(M2 and SIP pres),0.0
65.91595,male,0.0,Coma,12.0,$11-$25k,29515.0,white,no,0.899999619,0.7999997,no dnr,12.0,123.0,7.89941406,102.0,10.0,36.79688,224.0,3.2998047,0.29998779,1.0,137.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
83.37,male,0.0,ARF/MOSF w/Sepsis,17.0,under $11k,71015.0,white,no,0.75,0.75,no dnr,35.0,55.0,18.796875,63.0,28.0,36.0,428.0,2.0996094,0.5,1.39990234,135.0,7.5,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
63.91498,male,0.0,Cirrhosis,12.0,under $11k,10359.0,white,no,0.899999619,0.6999998,no dnr,10.0,73.0,7.89941406,70.0,20.0,36.69531,224.0,3.3999023,0.79992676,2.19970703,129.0,7.419922,135.0,23.0,1968.0,6.0,1.0,SIP>=30,4.5273972
61.25897,female,0.0,Lung Cancer,19.0,under $11k,13490.0,black,metastatic,0.399999857,0.5,dnr after sadm,1.0,87.0,10.5996094,110.0,10.0,36.69531,404.75,3.0,0.89990234,0.59997559,131.0,7.449219,135.0,23.0,1968.0,1.0,1.0,SIP>=30,1.1668997
68.52295,male,0.0,Lung Cancer,7.0,under $11k,9748.0,white,metastatic,0.5,0.02,dnr after sadm,1.0,97.0,5.39941406,100.0,20.0,36.09375,224.0,3.5996094,0.89990234,1.0,144.0,7.419922,135.0,23.0,1968.0,0.0,7.0,<2 mo. follow-up,7.0
86.64795,male,0.0,COPD,20.0,>$50k,8987.0,white,no,0.599999905,0.3999999,dnr after sadm,2.0,90.0,13.3984375,80.0,30.0,36.09375,204.0,3.699707,0.59997559,1.69995117,146.0,7.449219,135.0,23.0,1968.0,1.0,5.0,<2 mo. follow-up,5.0
67.43298,male,0.0,CHF,10.0,under $11k,29192.0,white,no,0.599999905,0.5,no dnr,20.0,53.0,7.89941406,60.0,22.0,35.89844,532.0,2.8999023,0.89990234,1.59985352,136.0,7.449219,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
85.06195,female,1.0,COPD,12.0,under $11k,38155.0,white,no,0.899999619,0.6999998,dnr after sadm,13.0,68.0,12.5996094,120.0,8.0,38.69531,163.3125,2.5,0.5,0.59997559,142.0,7.479492,135.0,23.0,1968.0,6.0,1.0,<2 mo. follow-up,4.5273972
55.42499,male,0.0,Lung Cancer,12.0,under $11k,7515.0,black,metastatic,0.599999905,0.09999996,no dnr,6.0,100.0,4.09960938,100.0,20.0,36.09375,224.0,3.2998047,0.89990234,1.0,144.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
68.63794,male,0.0,CHF,12.0,under $11k,6801.0,white,yes,0.899999619,0.5999999,no dnr,5.0,53.0,15.8984375,70.0,20.0,35.59375,224.0,3.699707,0.89990234,1.39990234,140.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),3.1088867
68.03595,male,0.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,27335.0,white,metastatic,0.899999619,0.7999997,dnr after sadm,7.0,57.0,5.09960938,82.0,28.0,38.29688,98.32812,2.8999023,0.89990234,0.79992676,139.0,7.469727,135.0,23.0,1968.0,7.0,5.0,no(M2 and SIP pres),5.0
62.198,female,0.0,ARF/MOSF w/Sepsis,9.0,under $11k,62019.0,white,no,0.75,0.5,no dnr,32.0,45.0,20.8984375,132.0,8.0,41.29688,162.5,2.699707,0.89990234,1.0,139.0,7.509766,135.0,23.0,1968.0,0.0,1.0,SIP>=30,3.1210938
87.72296,female,0.0,ARF/MOSF w/Sepsis,16.0,under $11k,16386.0,white,no,0.799999714,0.5999999,dnr after sadm,5.0,61.0,10.2988281,58.0,16.0,37.79688,224.0,2.8999023,0.89990234,0.69995117,137.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
62.24197,male,0.0,CHF,11.0,under $11k,9470.0,black,metastatic,0.5,0.3,no dnr,6.0,83.0,5.5,80.0,20.0,36.09375,316.0,3.199707,0.69995117,1.0,139.0,7.429688,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
66.80396,female,0.0,Lung Cancer,12.0,$11-$25k,9066.0,white,metastatic,0.899999619,0.5,no dnr,8.0,66.0,6.09960938,104.0,24.0,37.39844,224.0,3.7998047,0.89990234,1.0,142.0,7.429688,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
56.71198,male,0.0,COPD,6.0,under $11k,6969.0,white,no,0.979999542,0.9499998,no dnr,6.0,97.0,14.0996094,70.0,30.0,36.09375,232.0,2.8999023,0.89990234,1.0,141.0,7.359375,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
32.58899,male,0.0,ARF/MOSF w/Sepsis,11.0,$11-$25k,40281.0,white,no,0.949999809,0.9499998,no dnr,18.0,113.0,12.5996094,110.0,32.0,38.69531,130.0,2.8999023,1.0,0.89990234,139.0,7.379883,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
72.83496,female,0.0,COPD,12.0,under $11k,20707.0,hispanic,no,0.199999928,0.1999999,no dnr,14.0,64.0,11.7988281,110.0,8.0,37.89844,248.3125,3.2998047,0.39996338,2.0,134.0,7.439453,135.0,23.0,1968.0,4.0,4.0,SIP>=30,4.0
93.02399,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,24818.0,white,no,0.099999964,0.0009999992,dnr after sadm,3.0,47.0,10.8984375,68.0,10.0,37.89844,210.1875,3.0,1.0,2.39990234,132.0,7.369141,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.2661133
52.27698,female,1.0,MOSF w/Malig,14.0,$11-$25k,15833.0,white,metastatic,0.099999964,0.0009999992,dnr after sadm,4.0,43.0,14.1992188,140.0,36.0,36.29688,145.0,1.5,0.39996338,0.39996338,141.0,7.259766,135.0,23.0,1968.0,0.0,5.0,<2 mo. follow-up,5.0
66.50195,male,0.0,COPD,12.0,under $11k,17841.0,white,metastatic,0.799999714,0.5,dnr after sadm,1.0,93.0,8.59960938,120.0,20.0,36.09375,142.5,3.8999023,0.59997559,0.89990234,139.0,7.429688,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,4.4257812
47.258,male,0.0,Lung Cancer,12.0,under $11k,30794.0,white,metastatic,0.5,0.125,dnr after sadm,9.0,93.0,10.5996094,110.0,20.0,37.0,224.0,2.8999023,0.89990234,1.19995117,140.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
75.20294,male,0.0,CHF,13.0,under $11k,15884.0,white,no,0.989999771,0.3,no dnr,13.0,70.0,7.79980469,70.0,20.0,35.0,224.0,3.0996094,0.89990234,1.5,140.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
47.81699,female,0.0,Lung Cancer,12.0,$25-$50k,11059.0,white,metastatic,0.899999619,0.5,no dnr,4.0,74.0,7.5,80.0,16.0,36.89844,224.0,4.0,0.39996338,1.0,141.0,7.419922,135.0,23.0,1968.0,0.0,1.0,SIP>=30,0.4947999
64.29596,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,26732.0,white,no,0.699999809,0.5,no dnr,15.0,55.0,7.89941406,70.0,28.0,38.29688,197.5,3.2998047,0.39996338,0.59997559,141.0,7.359375,135.0,23.0,1968.0,4.0,6.0,adl>=4 (>=5 if sur),6.0
62.987,female,0.0,Cirrhosis,12.0,under $11k,35581.0,black,no,0.399999857,0.06399995,dnr after sadm,3.0,40.0,3.0,66.0,10.0,36.29688,219.0,2.7998047,6.89941406,0.69995117,135.0,7.319336,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.4702148
44.42697,female,0.0,ARF/MOSF w/Sepsis,13.0,under $11k,58145.0,black,no,0.199999928,0.09999996,dnr after sadm,28.0,130.0,15.0996094,111.0,10.0,39.19531,142.5,2.5996094,0.19998169,6.0,142.0,7.479492,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
60.715,male,0.0,Colon Cancer,20.0,under $11k,4972.0,white,metastatic,0.989999771,0.8999996,no dnr,5.0,103.0,5.39941406,80.0,20.0,36.09375,224.0,2.8999023,0.89990234,0.89990234,134.0,7.419922,135.0,23.0,1968.0,3.0,2.0,SIP>=30,2.0
20.04399,female,1.0,Coma,12.0,under $11k,26400.0,white,no,0.699999809,0.5,no dnr,8.0,160.0,30.6992188,173.0,12.0,40.39844,217.5,2.8999023,0.5,3.0,134.0,7.469727,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.3530273
76.38098,male,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,91340.0,white,no,0.899999619,0.7999997,dnr after sadm,13.0,80.0,8.0,110.0,36.0,39.39844,161.0,2.8999023,0.89990234,1.29980469,145.0,7.489258,135.0,23.0,1968.0,0.0,3.0,adl>=4 (>=5 if sur),3.0
83.05298,male,0.0,COPD,19.0,$11-$25k,11650.0,white,no,0.799999714,0.75,no dnr,9.0,51.0,6.19921875,53.0,16.0,36.89844,237.03125,4.0996094,0.39996338,2.0,142.0,7.5,135.0,23.0,1968.0,0.0,0.0,SIP>=30,0.0
44.42999,male,0.0,ARF/MOSF w/Sepsis,5.0,under $11k,23510.0,white,no,0.989999771,0.9899998,no dnr,15.0,103.0,8.29882812,68.0,24.0,38.59375,148.0,3.199707,1.79980469,1.09985352,145.0,7.379883,135.0,23.0,1968.0,3.0,1.0,SIP>=30,2.5110989
74.86896,female,1.0,Coma,14.0,under $11k,4332.0,white,metastatic,0.049999982,0.0001249999,dnr after sadm,1.0,123.0,12.3984375,80.0,40.0,35.39844,385.0,2.8999023,0.89990234,1.0,132.0,7.449219,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
63.77298,male,0.0,COPD,14.0,under $11k,5000.0,hispanic,no,0.699999809,0.5,no dnr,3.0,83.0,7.69921875,104.0,30.0,36.69531,271.375,4.0,0.69995117,1.5,141.0,7.399414,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.9560547
86.51099,female,0.0,Coma,12.0,under $11k,5779.0,white,no,0.199999928,0.09999996,dnr before sadm,-1.0,97.0,19.296875,70.0,20.0,38.19531,224.0,2.8999023,0.89990234,0.89990234,138.0,7.419922,135.0,23.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
76.88397,male,0.0,COPD,7.0,under $11k,19659.0,other,no,0.399999857,0.1999999,dnr before sadm,-1.0,83.0,7.89941406,100.0,25.0,36.09375,150.0,2.8999023,0.89990234,1.09985352,138.0,7.30957,135.0,23.0,1968.0,1.0,1.0,no(M2 and SIP pres),1.1668997
73.89996,female,0.0,Lung Cancer,12.0,under $11k,32118.0,white,metastatic,0.5,0.3,dnr after sadm,5.0,103.0,2.39990234,60.0,20.0,36.09375,224.0,2.8999023,0.89990234,0.79992676,141.0,7.419922,135.0,23.0,1968.0,5.0,4.0,SIP>=30,4.0
41.57999,female,0.0,MOSF w/Malig,18.0,>$50k,35673.0,white,metastatic,0.979999542,0.8499999,no dnr,17.0,53.0,0.09999084,124.0,35.0,38.5,228.0,2.199707,2.89990234,0.89990234,145.0,7.389648,135.0,23.0,1968.0,0.0,0.0,SIP>=30,0.0
87.79498,female,0.0,COPD,12.0,$11-$25k,13337.0,white,no,0.899999619,0.75,dnr before sadm,-1.0,117.0,4.5,70.0,40.0,36.09375,233.3125,2.8999023,0.89990234,1.59985352,142.0,7.419922,135.0,23.0,1968.0,0.0,3.0,no(M2 and SIP pres),3.0
23.379,female,0.0,ARF/MOSF w/Sepsis,13.0,under $11k,17374.0,white,no,0.989999771,0.9899998,no dnr,10.0,77.0,14.2988281,110.0,30.0,38.89844,120.0,2.7998047,0.89990234,0.79992676,138.0,7.40918,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
84.12897,female,1.0,Coma,16.0,under $11k,23860.0,white,no,0.0,0.0,dnr after sadm,3.0,53.0,9.29882812,110.0,35.0,35.0,140.0,3.0,0.89990234,1.19995117,148.0,7.319336,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
94.26996,female,1.0,Coma,12.0,>$50k,5610.0,white,yes,0.0,0.0,dnr after sadm,1.0,43.0,32.8984375,70.0,30.0,35.59375,552.0,3.0996094,0.69995117,1.79980469,151.0,7.609375,135.0,23.0,1968.0,0.0,7.0,<2 mo. follow-up,7.0
60.71698,male,0.0,ARF/MOSF w/Sepsis,9.0,under $11k,83838.0,white,no,0.899999619,0.8999996,no dnr,25.0,63.0,14.1992188,67.0,28.0,38.89844,96.65625,3.699707,0.89990234,1.5,144.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
83.97797,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,37408.0,white,no,0.049999982,0.0001249999,dnr after sadm,2.0,33.0,15.5996094,140.0,18.0,39.19531,186.65625,1.8999023,1.09985352,6.79980469,129.0,7.389648,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.7636719
94.06195,male,1.0,ARF/MOSF w/Sepsis,14.0,under $11k,60663.0,white,no,0.25,0.09999996,no dnr,44.0,47.0,10.7988281,59.0,28.0,36.59375,519.0,2.3999023,0.69995117,3.29980469,145.0,7.349609,135.0,23.0,1968.0,0.0,7.0,<2 mo. follow-up,7.0
74.42798,female,0.0,CHF,13.0,under $11k,6553.0,white,no,0.949999809,0.75,no dnr,6.0,73.0,5.5,60.0,15.0,35.59375,257.125,3.0996094,0.59997559,1.29980469,143.0,7.479492,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.1777344
72.70898,male,0.0,COPD,12.0,$11-$25k,32712.0,white,no,0.75,0.5999999,no dnr,19.0,105.0,11.3984375,81.0,10.0,38.19531,150.0,3.7998047,0.59997559,2.0,133.0,7.449219,135.0,23.0,1968.0,0.0,2.0,no(M2 and SIP pres),2.0
76.849,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,43883.0,white,yes,0.099999964,0.0009999992,dnr after sadm,6.0,57.0,12.6992188,80.0,28.0,38.69531,157.125,2.8999023,0.89990234,0.69995117,138.0,7.479492,135.0,23.0,1968.0,0.0,3.0,<2 mo. follow-up,3.0
76.435,male,0.0,CHF,12.0,under $11k,12933.0,white,yes,0.799999714,0.5,dnr before sadm,-1.0,53.0,10.1992188,70.0,25.0,36.09375,113.32812,2.8999023,0.89990234,2.29980469,137.0,7.369141,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
77.74896,male,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,37301.0,white,no,0.75,0.75,no dnr,26.0,60.0,21.296875,140.0,12.0,36.39844,143.75,2.8999023,0.89990234,3.39990234,147.0,7.459961,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),3.675293
24.36699,male,1.0,Coma,16.0,under $11k,32558.0,white,no,0.899999619,0.8999996,dnr after sadm,8.0,125.0,5.09960938,150.0,14.0,39.39844,196.0,2.5,0.59997559,0.69995117,145.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
33.33899,female,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,9397.0,hispanic,no,0.989999771,0.9899998,no dnr,8.0,83.0,7.0,70.0,20.0,36.09375,300.0,3.2998047,1.0,0.89990234,135.0,7.469727,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
67.948,female,0.0,CHF,12.0,$25-$50k,3707.0,white,no,0.899999619,0.5999999,no dnr,3.0,80.0,6.69921875,70.0,20.0,37.39844,240.0,4.2998047,0.89990234,1.09985352,144.0,7.40918,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
78.38495,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,55119.0,white,no,0.5,0.3999999,dnr after sadm,3.0,61.0,11.5,55.0,12.0,36.09375,486.1875,2.8999023,0.5,1.89990234,148.0,7.369141,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.2392578
70.00696,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,52072.0,white,yes,0.899999619,0.8999996,no dnr,33.0,44.0,37.8984375,78.0,40.0,38.59375,228.5625,1.8999023,1.29980469,1.39990234,139.0,7.339844,135.0,23.0,1968.0,2.0,1.0,no(M2 and SIP pres),1.0
85.85394,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,16619.0,white,no,0.699999809,0.6999998,no dnr,13.0,53.0,4.19921875,70.0,30.0,36.69531,105.0,2.8999023,0.89990234,0.89990234,142.0,7.349609,135.0,23.0,1968.0,2.0,5.0,<2 mo. follow-up,5.0
95.50995,male,1.0,Coma,15.0,$11-$25k,8418.0,white,yes,0.009999998,9.999994e-07,dnr before sadm,-1.0,83.0,34.796875,100.0,30.0,38.59375,224.0,4.1992188,1.09985352,1.39990234,136.0,7.419922,135.0,23.0,1968.0,0.0,3.0,<2 mo. follow-up,3.0
61.57199,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,17562.0,white,no,0.949999809,0.9499998,no dnr,13.0,53.0,8.0,69.0,30.0,38.79688,264.0,3.199707,0.39996338,0.89990234,139.0,7.469727,135.0,23.0,1968.0,1.0,1.0,no(M2 and SIP pres),1.0
76.67096,male,1.0,CHF,16.0,>$50k,28454.0,white,no,0.899999619,0.75,dnr after sadm,10.0,73.0,8.3984375,76.0,24.0,36.59375,224.0,3.2998047,1.5,1.29980469,136.0,7.419922,135.0,23.0,1968.0,1.0,0.0,<2 mo. follow-up,0.0
65.88599,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,50062.0,white,no,0.5,0.6999998,dnr after sadm,19.0,45.0,11.0,72.0,38.0,38.5,244.4375,2.699707,1.09985352,2.5,141.0,7.40918,135.0,23.0,1968.0,3.0,3.0,<2 mo. follow-up,3.0
80.27698,female,0.0,COPD,12.0,under $11k,4464.0,white,no,0.949999809,0.8999996,no dnr,4.0,107.0,11.3984375,60.0,20.0,35.59375,332.0,2.8999023,0.89990234,1.0,140.0,7.359375,135.0,23.0,1968.0,1.0,1.0,no(M2 and SIP pres),1.0
80.47095,male,0.0,CHF,19.0,under $11k,10981.0,white,no,0.899999619,0.8999996,no dnr,9.0,83.0,7.0,60.0,15.0,36.69531,410.0,4.0,0.5,1.69995117,138.0,7.459961,135.0,23.0,1968.0,6.0,1.0,no(M2 and SIP pres),1.0
85.06494,male,0.0,ARF/MOSF w/Sepsis,5.0,$11-$25k,21711.0,white,no,0.149999976,0.04999998,dnr after sadm,5.0,113.0,5.89941406,110.0,30.0,38.09375,306.625,2.199707,1.89990234,0.89990234,144.0,7.419922,135.0,23.0,1968.0,0.0,3.0,adl>=4 (>=5 if sur),3.0
78.32196,male,0.0,COPD,16.0,$11-$25k,16940.0,white,no,0.699999809,0.5999999,no dnr,12.0,128.0,12.5,59.0,36.0,37.09375,172.5,3.3999023,0.29998779,3.39990234,138.0,7.419922,135.0,23.0,1968.0,0.0,0.0,SIP>=30,0.0
52.26797,female,0.0,Lung Cancer,12.0,under $11k,3133.0,white,metastatic,0.699999809,0.5,no dnr,4.0,83.0,11.3984375,100.0,20.0,36.09375,224.0,3.2998047,0.5,0.79992676,138.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.1723633
50.20898,female,0.0,Lung Cancer,14.0,$25-$50k,17041.0,white,metastatic,0.899999619,0.08999997,dnr after sadm,6.0,80.0,9.5,72.0,20.0,36.79688,224.0,4.6992188,0.39996338,0.5,135.0,7.419922,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
63.228,male,1.0,MOSF w/Malig,16.0,>$50k,33619.0,white,yes,0.199999928,0.09999996,dnr after sadm,8.0,53.0,2.89990234,56.0,12.0,38.39844,63.0,3.0,2.19970703,3.39990234,138.0,7.339844,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
68.58899,male,0.0,ARF/MOSF w/Sepsis,17.0,$25-$50k,52123.0,white,no,0.899999619,0.5999999,no dnr,13.0,70.0,15.1992188,70.0,22.0,38.5,484.0,3.3999023,0.89990234,1.5,136.0,7.439453,135.0,23.0,1968.0,1.0,0.0,no(M2 and SIP pres),0.0
79.06897,female,0.0,CHF,12.0,under $11k,12777.0,white,no,0.899999619,0.7999997,no dnr,10.0,87.0,11.3984375,80.0,20.0,36.69531,271.375,2.8999023,0.89990234,1.19995117,141.0,7.419922,135.0,23.0,1968.0,3.0,0.0,no(M2 and SIP pres),0.0
83.39996,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,61748.0,white,no,0.799999714,0.5999999,dnr after sadm,16.0,73.0,4.89941406,137.0,40.0,36.09375,224.0,3.2998047,1.39990234,2.29980469,150.0,7.449219,135.0,23.0,1968.0,0.0,2.0,adl>=4 (>=5 if sur),2.0
33.922,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,25613.0,white,no,0.699999809,0.3999999,no dnr,17.0,65.0,16.5,130.0,24.0,38.09375,284.0,2.2998047,8.29882812,0.79992676,141.0,7.549805,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.7705078
63.29398,male,0.0,ARF/MOSF w/Sepsis,19.0,under $11k,21501.0,white,no,0.699999809,0.5999999,no dnr,11.0,63.0,5.59960938,80.0,14.0,36.79688,207.5,2.7998047,0.5,5.89941406,135.0,7.359375,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
96.42694,female,0.0,COPD,12.0,under $11k,5218.0,white,no,0.699999809,0.5,no dnr,5.0,103.0,14.1992188,80.0,20.0,36.69531,251.65625,2.8999023,1.29980469,1.39990234,144.0,7.329102,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),3.3037109
69.43994,male,1.0,COPD,9.0,under $11k,18031.0,white,no,0.089999974,0.0007289997,no dnr,5.0,50.0,26.0,105.0,24.0,38.0,118.875,2.8999023,0.89990234,1.59985352,136.0,7.259766,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.7158203
63.625,female,0.0,COPD,12.0,under $11k,11290.0,white,no,0.5,0.3,dnr after sadm,1.0,93.0,8.59960938,100.0,20.0,36.69531,344.4375,2.8999023,0.89990234,0.79992676,142.0,7.319336,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
69.30597,male,0.0,Coma,8.0,$11-$25k,28125.0,black,yes,0.049999982,0.0001249999,no dnr,15.0,74.0,10.5,74.0,42.0,36.39844,124.0,3.3999023,2.19970703,1.5,138.0,7.459961,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
85.51996,male,0.0,ARF/MOSF w/Sepsis,8.0,under $11k,10072.0,white,metastatic,0.899999619,0.7999997,no dnr,8.0,61.0,14.7988281,58.0,30.0,36.09375,314.25,3.0996094,0.89990234,1.09985352,140.0,7.489258,135.0,23.0,1968.0,1.0,0.0,<2 mo. follow-up,0.0
81.44299,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,52123.0,white,yes,0.5,0.3999999,dnr after sadm,9.0,61.0,15.0,69.0,24.0,38.29688,106.65625,2.699707,0.69995117,1.39990234,135.0,7.509766,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
75.44098,female,0.0,ARF/MOSF w/Sepsis,16.0,$25-$50k,17626.0,black,yes,0.949999809,0.9299998,no dnr,9.0,69.0,10.8984375,70.0,14.0,36.19531,128.0,3.2998047,1.29980469,3.69970703,141.0,7.449219,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
63.978,female,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,79417.0,white,no,0.949999809,0.8999996,no dnr,35.0,77.0,16.5,80.0,4.0,36.39844,268.0,2.8999023,0.89990234,0.69995117,139.0,7.389648,135.0,23.0,1968.0,2.0,1.0,no(M2 and SIP pres),1.0
38.80399,male,0.0,Colon Cancer,10.0,$25-$50k,4218.0,white,metastatic,0.899999619,0.8999996,no dnr,3.0,99.0,10.5996094,120.0,26.0,37.89844,224.0,3.5996094,0.89990234,0.69995117,136.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.734375
72.40497,female,0.0,MOSF w/Malig,12.0,under $11k,16955.0,white,yes,0.979999542,0.7999997,no dnr,10.0,113.0,93.890625,85.0,34.0,38.09375,232.25,4.1992188,0.19998169,0.89990234,140.0,7.359375,135.0,23.0,1968.0,1.0,0.0,no(M2 and SIP pres),0.0
72.10095,male,1.0,MOSF w/Malig,16.0,under $11k,29317.0,white,yes,0.009999998,9.999994e-07,dnr after sadm,1.0,100.0,63.0,80.0,32.0,35.69531,161.21875,2.8999023,0.89990234,1.5,146.0,7.429688,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
80.27399,male,0.0,Colon Cancer,16.0,>$50k,7562.0,white,metastatic,0.979999542,0.7999997,no dnr,8.0,97.0,4.59960938,80.0,20.0,36.69531,224.0,2.8999023,0.89990234,1.19995117,140.0,7.419922,135.0,23.0,1968.0,3.0,1.0,no(M2 and SIP pres),1.0
67.03595,male,1.0,Colon Cancer,8.0,under $11k,16195.0,white,metastatic,0.199999928,0.02,dnr after sadm,7.0,117.0,19.5976562,110.0,30.0,35.69531,316.3125,2.699707,9.5,1.29980469,136.0,7.40918,135.0,23.0,1968.0,3.0,1.0,<2 mo. follow-up,1.0
43.66098,male,0.0,ARF/MOSF w/Sepsis,9.0,under $11k,19138.0,white,no,0.899999619,0.7999997,no dnr,11.0,133.0,5.29980469,80.0,20.0,36.69531,224.0,2.199707,0.89990234,5.29980469,136.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
66.04498,male,1.0,MOSF w/Malig,16.0,under $11k,11598.0,white,metastatic,0.0,0.0,dnr after sadm,3.0,33.0,23.796875,40.0,44.0,36.39844,105.0,2.199707,2.19970703,4.19921875,127.0,7.389648,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.175293
83.06396,male,0.0,Cirrhosis,11.0,under $11k,17204.0,white,yes,0.5,0.3299999,dnr after sadm,4.0,68.0,13.2988281,60.0,20.0,35.59375,224.0,2.8999023,2.0,2.29980469,131.0,7.419922,135.0,23.0,1968.0,1.0,0.0,no(M2 and SIP pres),0.0
89.67297,female,1.0,MOSF w/Malig,30.0,$25-$50k,19612.0,white,yes,0.5,0.3999999,dnr after sadm,1.0,120.0,19.3984375,78.0,28.0,37.89844,170.0,2.8999023,0.89990234,4.19921875,136.0,7.389648,135.0,23.0,1968.0,1.0,1.0,<2 mo. follow-up,1.1668997
84.51996,female,0.0,CHF,13.0,$11-$25k,5884.0,white,yes,0.949999809,0.9499998,no dnr,5.0,117.0,9.29882812,45.0,28.0,36.69531,223.3125,3.199707,0.39996338,1.19995117,143.0,7.369141,135.0,23.0,1968.0,1.0,0.0,no(M2 and SIP pres),0.0
71.88794,male,0.0,CHF,14.0,under $11k,4909.0,white,no,0.979999542,0.9499998,no dnr,6.0,83.0,5.39941406,70.0,20.0,35.59375,224.0,2.8999023,0.89990234,2.19970703,133.0,7.419922,135.0,23.0,1968.0,5.0,1.0,SIP>=30,3.855299
75.67395,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,61867.0,white,no,0.75,0.5999999,dnr after sadm,3.0,45.0,25.1992188,160.0,48.0,39.29688,342.8125,2.5,0.79992676,1.89990234,142.0,7.269531,135.0,23.0,1968.0,1.0,1.0,<2 mo. follow-up,1.1668997
100.13098,female,0.0,CHF,4.0,under $11k,4485.0,black,yes,0.699999809,0.5999999,no dnr,5.0,77.0,6.0,60.0,15.0,36.09375,224.0,3.699707,0.89990234,1.09985352,141.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),3.3823242
41.771,male,1.0,Cirrhosis,14.0,under $11k,97144.0,hispanic,no,0.599999905,0.5,dnr after sadm,20.0,70.0,11.1992188,70.0,10.0,38.09375,162.0,1.6999512,5.5,0.79992676,132.0,7.449219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
54.36798,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,35856.0,white,no,0.599999905,0.5999999,no dnr,14.0,61.0,7.59960938,150.0,52.0,39.29688,102.5,2.5,0.39996338,1.19995117,134.0,7.229492,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
71.43896,female,0.0,COPD,12.0,under $11k,25724.0,white,yes,0.599999905,0.5,dnr after sadm,7.0,100.0,12.2988281,100.0,15.0,36.09375,355.0,3.7998047,0.29998779,2.59960938,141.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
66.10297,male,0.0,COPD,12.0,$25-$50k,6726.0,white,no,0.699999809,0.5,no dnr,4.0,63.0,10.7988281,54.0,14.0,36.29688,219.03125,2.8999023,1.39990234,1.09985352,142.0,7.379883,135.0,23.0,1968.0,1.0,0.0,no(M2 and SIP pres),0.0
72.30096,male,1.0,ARF/MOSF w/Sepsis,9.0,under $11k,63943.0,black,no,0.699999809,0.5,dnr after sadm,9.0,63.0,30.0976562,119.0,38.0,35.19531,151.65625,2.199707,1.0,7.79980469,132.0,7.319336,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
72.81,female,1.0,Coma,12.0,under $11k,20721.0,white,no,0.099999964,0.0009999992,dnr after sadm,9.0,43.0,22.3984375,120.0,28.0,38.69531,324.4375,2.199707,0.89990234,3.69970703,142.0,7.379883,135.0,23.0,1968.0,0.0,7.0,<2 mo. follow-up,7.0
75.258,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,34405.0,white,yes,0.5,0.5,dnr after sadm,5.0,44.0,21.3984375,108.0,16.0,38.19531,135.0,2.8999023,0.89990234,1.19995117,145.0,7.399414,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
74.72699,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,35196.0,white,no,0.199999928,0.1999999,dnr after sadm,2.0,49.0,14.2988281,120.0,34.0,38.29688,148.3125,2.8999023,0.19998169,3.39990234,136.0,7.359375,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5004883
66.97095,female,0.0,COPD,12.0,under $11k,26628.0,white,no,0.699999809,0.5999999,no dnr,18.0,62.0,8.3984375,110.0,8.0,37.89844,162.5,3.7998047,0.89990234,0.89990234,143.0,7.349609,135.0,23.0,1968.0,3.0,4.0,no(M2 and SIP pres),4.0
87.86298,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,28359.0,white,no,0.849999905,0.5,dnr before sadm,-1.0,53.0,5.19921875,66.0,36.0,35.59375,188.0,3.5996094,0.79992676,7.19921875,137.0,7.329102,135.0,23.0,1968.0,4.0,1.0,no(M2 and SIP pres),3.1831989
87.06097,female,0.0,COPD,12.0,under $11k,9141.0,white,no,0.799999714,0.5999999,dnr after sadm,1.0,83.0,6.79980469,60.0,20.0,36.09375,185.6875,2.8999023,0.19998169,1.29980469,142.0,7.269531,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
60.745,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,14478.0,black,yes,0.75,0.5,no dnr,9.0,42.0,11.1992188,112.0,16.0,38.09375,524.0,2.7998047,1.19995117,1.0,144.0,7.399414,135.0,23.0,1968.0,0.0,6.0,adl>=4 (>=5 if sur),6.0
52.86499,female,0.0,Lung Cancer,11.0,>$50k,20940.0,white,metastatic,0.5,0.3,dnr after sadm,3.0,80.0,15.7988281,70.0,30.0,37.69531,224.0,2.8999023,0.19998169,0.79992676,141.0,7.419922,135.0,23.0,1968.0,3.0,5.0,<2 mo. follow-up,5.0
69.04895,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,49859.0,white,no,0.599999905,0.5499997,dnr after sadm,11.0,63.0,8.69921875,110.0,8.0,36.19531,130.0,2.8999023,0.89990234,8.09960938,134.0,7.399414,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
66.31097,female,0.0,COPD,12.0,under $11k,56614.0,white,no,0.399999857,0.3,no dnr,18.0,62.0,7.5,69.0,24.0,36.79688,163.25,3.7998047,0.89990234,3.09960938,134.0,7.429688,135.0,23.0,1968.0,4.0,1.0,no(M2 and SIP pres),3.1831989
71.86896,male,0.0,ARF/MOSF w/Sepsis,16.0,>$50k,195312.0,white,no,0.699999809,0.5,dnr after sadm,2.0,59.0,4.0,62.0,5.0,39.09375,195.0,2.199707,0.5,0.5,131.0,7.469727,135.0,23.0,1968.0,0.0,5.0,no(M2 and SIP pres),5.0
67.92096,male,0.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,12316.0,white,yes,0.5,0.3,no dnr,9.0,77.0,22.1992188,80.0,25.0,36.09375,367.5,2.8999023,1.19995117,0.89990234,141.0,7.479492,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
77.24298,male,0.0,COPD,12.0,$25-$50k,4298.0,white,yes,1.0,0.8999996,no dnr,4.0,87.0,12.3984375,80.0,20.0,36.09375,395.0,2.8999023,0.89990234,1.69995117,139.0,7.329102,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.8388672
66.97095,female,0.0,ARF/MOSF w/Sepsis,8.0,under $11k,11884.0,black,yes,0.899999619,0.8999996,dnr before sadm,-1.0,47.0,9.79882812,98.0,11.0,36.29688,486.625,4.5,0.5,0.5,168.0,7.319336,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
31.05299,female,0.0,MOSF w/Malig,12.0,$11-$25k,238115.0,white,yes,0.699999809,0.5,no dnr,50.0,51.0,0.89990234,134.0,12.0,38.29688,132.0,1.7998047,1.79980469,2.0,145.0,7.339844,135.0,23.0,1968.0,0.0,3.0,adl>=4 (>=5 if sur),3.0
63.452,male,1.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,30733.0,white,no,0.96999979,0.9799995,no dnr,8.0,76.0,12.0996094,104.0,32.0,39.29688,116.65625,2.7998047,0.89990234,0.79992676,132.0,7.459961,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
61.29999,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,148632.0,white,no,0.25,0.1999999,dnr after sadm,19.0,50.0,39.296875,110.0,8.0,33.69531,61.0,2.8999023,3.29980469,1.29980469,132.0,7.349609,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.4887695
55.78897,male,0.0,Lung Cancer,12.0,under $11k,19538.0,white,metastatic,0.149999976,0.04999998,no dnr,16.0,113.0,7.29980469,96.0,32.0,38.69531,171.65625,3.0996094,0.39996338,1.09985352,139.0,7.5,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.2353516
87.25494,female,0.0,COPD,12.0,under $11k,16061.0,white,no,0.5,0.09999996,no dnr,10.0,67.0,8.59960938,100.0,16.0,36.89844,224.0,2.8999023,0.89990234,1.19995117,138.0,7.419922,135.0,19.0,750.0,0.0,2.0,no(M2 and SIP pres),2.0
46.30298,female,0.0,Lung Cancer,12.0,$25-$50k,14642.0,white,metastatic,0.899999619,0.6999998,no dnr,4.0,73.0,13.5,105.0,23.0,38.19531,100.0,2.8999023,0.89990234,3.69970703,127.0,7.389648,135.0,78.0,3100.0,0.0,1.0,no(M2 and SIP pres),2.7387695
83.67096,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,12886.0,white,no,0.75,0.6999998,dnr after sadm,4.0,50.0,12.0996094,105.0,16.0,36.09375,224.0,3.5996094,1.19995117,1.29980469,125.0,7.419922,135.0,39.0,5180.0,1.0,1.0,<2 mo. follow-up,1.1667481
49.69498,male,0.0,ARF/MOSF w/Sepsis,9.0,under $11k,15399.0,black,no,0.949999809,0.9199996,no dnr,10.0,102.0,14.7988281,130.0,30.0,39.0,155.0,2.8999023,0.89990234,0.5,130.0,7.5,147.0,13.0,1530.0,0.0,0.0,SIP>=30,0.0
82.237,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,41176.0,white,yes,0.899999619,0.6999998,no dnr,14.0,68.0,0.79992676,120.0,18.0,38.09375,152.0,2.0996094,6.29980469,2.5,127.0,7.289062,215.0,77.0,2010.0,2.0,1.0,SIP>=30,1.0
74.40399,female,0.0,Cirrhosis,16.0,>$50k,12160.0,white,no,0.919999599,0.6999998,no dnr,8.0,63.0,21.0,124.0,36.0,36.0,319.0,2.699707,0.59997559,1.19995117,147.0,7.359375,226.0,44.0,1027.0,3.0,1.0,no(M2 and SIP pres),2.5107422
85.224,male,1.0,ARF/MOSF w/Sepsis,20.0,>$50k,67876.0,white,yes,0.299999952,0.3,dnr after sadm,4.0,81.0,9.59960938,100.0,20.0,38.39844,224.0,2.8999023,0.89990234,0.79992676,132.0,7.419922,108.0,12.0,2650.0,0.0,7.0,<2 mo. follow-up,7.0
87.60797,female,1.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,93347.0,white,no,0.799999714,0.5999999,dnr after sadm,24.0,112.0,6.29980469,115.0,10.0,35.0,230.0,2.3999023,16.0976562,1.79980469,145.0,7.449219,296.0,34.0,1494.0,0.0,1.0,<2 mo. follow-up,1.0
68.18896,female,0.0,COPD,14.0,under $11k,81038.0,white,no,0.75,0.6999998,no dnr,37.0,55.0,6.5,45.0,10.0,36.29688,224.0,2.8999023,0.89990234,0.39996338,141.0,7.419922,135.0,16.0,1775.0,0.0,3.0,no(M2 and SIP pres),3.0
58.46698,male,0.0,Cirrhosis,19.0,>$50k,6816.0,white,no,0.899999619,0.75,no dnr,5.0,79.0,11.6992188,72.0,16.0,38.0,224.0,2.8999023,0.69995117,0.89990234,138.0,7.419922,135.0,23.0,3900.0,0.0,1.0,SIP>=30,1.0
72.62396,female,0.0,Lung Cancer,8.0,under $11k,29597.0,white,metastatic,0.149999976,0.03999999,dnr after sadm,2.0,127.0,7.79980469,130.0,52.0,38.5,224.0,2.0,0.89990234,0.5,131.0,7.419922,191.0,16.0,4185.0,0.0,0.0,<2 mo. follow-up,0.0
85.05096,male,0.0,COPD,19.0,under $11k,27225.0,white,no,0.949999809,0.7999997,no dnr,19.0,58.0,6.0,125.0,28.0,38.09375,150.0,2.8999023,0.89990234,1.39990234,133.0,7.489258,135.0,28.0,3400.0,2.0,0.0,no(M2 and SIP pres),0.0
88.86798,female,0.0,Coma,12.0,under $11k,4313.0,white,no,0.009999998,0.009999998,dnr before sadm,-1.0,53.0,42.09375,75.0,12.0,38.89844,67.0,2.8999023,8.09960938,5.5,155.0,7.419922,391.0,98.0,1968.0,0.0,1.0,<2 mo. follow-up,3.0161133
73.39899,male,0.0,Cirrhosis,10.0,under $11k,5160.0,hispanic,no,0.5,0.3,dnr after sadm,2.0,68.0,0.79992676,120.0,24.0,38.0,297.125,2.3999023,0.79992676,2.09960938,141.0,7.429688,74.0,21.0,4070.0,3.0,1.0,adl>=4 (>=5 if sur),2.5107422
90.28296,male,1.0,Coma,8.0,under $11k,18727.0,white,no,0.0,0.0,dnr after sadm,2.0,67.0,6.39941406,46.0,22.0,36.89844,251.0,2.8999023,0.89990234,1.89990234,137.0,7.439453,126.0,28.0,1370.0,0.0,1.0,<2 mo. follow-up,3.4916992
69.125,female,0.0,COPD,9.0,under $11k,8771.0,black,no,0.899999619,0.8999996,no dnr,9.0,93.0,6.5,80.0,20.0,36.09375,224.0,2.8999023,0.89990234,1.0,139.0,7.419922,107.0,17.0,6050.0,0.0,1.0,no(M2 and SIP pres),1.0
58.987,female,0.0,Colon Cancer,16.0,$25-$50k,6447.0,white,metastatic,0.199999928,0.02,dnr after sadm,1.0,50.0,8.09960938,50.0,28.0,38.09375,171.40625,4.3994141,0.79992676,1.39990234,139.0,7.449219,109.0,27.0,440.0,0.0,3.0,<2 mo. follow-up,3.0
73.15796,female,0.0,COPD,16.0,under $11k,18381.0,white,no,0.849999905,0.7999997,no dnr,11.0,107.0,11.0996094,80.0,25.0,36.09375,375.0,2.5,0.89990234,8.09960938,130.0,7.359375,191.0,69.0,110.0,2.0,1.0,SIP>=30,1.8388672
93.04895,male,0.0,ARF/MOSF w/Sepsis,8.0,under $11k,16645.0,white,yes,0.899999619,0.75,no dnr,8.0,73.0,14.6992188,72.0,20.0,35.79688,422.1875,3.2998047,0.89990234,2.29980469,142.0,7.429688,126.0,44.0,2140.0,1.0,1.0,no(M2 and SIP pres),1.0
62.31097,female,1.0,Coma,12.0,under $11k,47340.0,black,yes,0.899999619,0.8999996,dnr after sadm,13.0,107.0,4.59960938,80.0,20.0,36.79688,224.0,2.3999023,1.5,0.79992676,141.0,7.419922,70.0,7.0,650.0,0.0,7.0,<2 mo. follow-up,7.0
78.87195,female,0.0,ARF/MOSF w/Sepsis,8.0,under $11k,63298.0,white,no,0.25,0.04999998,dnr after sadm,16.0,67.0,9.8984375,70.0,8.0,35.89844,267.5,2.0996094,0.89990234,5.29980469,133.0,7.359375,163.0,97.0,39.0,0.0,6.0,<2 mo. follow-up,6.0
48.77798,female,0.0,Lung Cancer,12.0,under $11k,7376.0,white,metastatic,0.799999714,0.5,no dnr,5.0,63.0,12.3984375,70.0,34.0,35.59375,315.0,2.8999023,0.89990234,1.89990234,135.0,7.379883,258.0,90.0,775.0,3.0,1.0,SIP>=30,2.5107422
75.15399,female,0.0,ARF/MOSF w/Sepsis,12.0,>$50k,51018.0,white,no,0.949999809,0.9499998,no dnr,11.0,53.0,11.0996094,62.0,10.0,38.19531,410.0,2.7998047,0.19998169,0.69995117,128.0,7.40918,96.0,14.0,2820.0,0.0,0.0,no(M2 and SIP pres),0.0
95.33496,female,0.0,COPD,12.0,>$50k,18790.0,white,no,0.799999714,0.5,dnr after sadm,2.0,60.0,4.29980469,80.0,15.0,36.69531,224.0,2.2998047,7.69921875,1.0,133.0,7.419922,76.0,23.0,1150.0,0.0,4.0,no(M2 and SIP pres),4.0
43.44998,male,0.0,MOSF w/Malig,14.0,$25-$50k,67444.0,white,metastatic,0.5,0.1999999,no dnr,16.0,103.0,10.5996094,96.0,12.0,36.59375,224.0,3.2998047,0.39996338,0.59997559,132.0,7.419922,168.0,8.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
77.81494,male,1.0,CHF,12.0,under $11k,5391.0,white,no,0.699999809,0.5,dnr after sadm,3.0,100.0,14.5996094,100.0,25.0,36.69531,323.75,3.8999023,0.89990234,1.09985352,140.0,7.329102,181.0,18.0,1700.0,0.0,1.0,<2 mo. follow-up,6.0683594
64.85394,male,1.0,MOSF w/Malig,16.0,>$50k,57305.0,white,yes,0.299999952,0.15,dnr after sadm,8.0,70.0,12.2988281,100.0,30.0,39.39844,224.0,2.8999023,0.89990234,0.79992676,139.0,7.419922,143.0,11.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
73.17999,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,15118.0,white,no,1.0,0.8999996,no dnr,9.0,67.0,11.5,100.0,20.0,36.09375,292.0,2.699707,0.79992676,1.5,130.0,7.479492,305.0,49.0,935.0,0.0,0.0,no(M2 and SIP pres),0.0
77.24298,male,0.0,COPD,15.0,$25-$50k,9213.0,white,no,0.599999905,0.25,dnr before sadm,0.0,63.0,2.19970703,60.0,15.0,40.29688,317.5,3.0996094,0.89990234,2.5,145.0,7.479492,215.0,64.0,1205.0,0.0,0.0,no(M2 and SIP pres),0.0
91.16797,female,1.0,COPD,14.0,$11-$25k,22895.0,white,no,0.5,0.5,dnr after sadm,6.0,67.0,6.59960938,80.0,20.0,36.09375,173.3125,2.8999023,0.89990234,0.79992676,136.0,7.259766,106.0,6.0,1968.0,0.0,6.0,<2 mo. follow-up,6.0
45.10599,male,0.0,ARF/MOSF w/Sepsis,14.0,under $11k,132956.0,white,yes,0.5,0.5,no dnr,46.0,77.0,2.19970703,130.0,20.0,36.09375,224.0,2.8999023,0.89990234,0.89990234,135.0,7.419922,99.0,4.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
73.61798,female,0.0,Lung Cancer,14.0,$25-$50k,21745.0,white,metastatic,0.299999952,0.09999996,dnr after sadm,3.0,57.0,10.0,67.0,5.0,36.29688,210.0,2.7998047,0.19998169,0.69995117,149.0,7.459961,162.0,14.0,501.0,0.0,4.0,<2 mo. follow-up,4.0
87.45197,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,40903.0,white,no,0.799999714,0.7999997,no dnr,27.0,53.0,5.79980469,56.0,16.0,36.79688,362.9375,2.7998047,0.29998779,3.19970703,137.0,7.379883,339.0,64.0,1705.0,0.0,1.0,no(M2 and SIP pres),1.0
72.10999,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,82805.0,white,no,0.5,0.3999999,dnr after sadm,14.0,50.0,13.5,68.0,30.0,36.09375,396.625,2.8999023,0.29998779,1.5,150.0,7.389648,306.0,22.0,855.0,0.0,1.0,<2 mo. follow-up,5.9599609
67.01196,male,0.0,Colon Cancer,13.0,$11-$25k,4505.0,white,metastatic,0.899999619,0.3,no dnr,5.0,57.0,78.796875,67.0,11.0,35.69531,509.5,1.8999023,0.39996338,4.79980469,138.0,7.329102,150.0,111.0,353.0,0.0,0.0,<2 mo. follow-up,0.0
67.258,female,0.0,CHF,12.0,$11-$25k,4037.0,white,yes,0.699999809,0.5,no dnr,4.0,77.0,6.69921875,80.0,20.0,39.39844,224.0,2.699707,0.5,0.59997559,135.0,7.419922,118.0,3.0,1968.0,2.0,2.0,no(M2 and SIP pres),2.0
63.59198,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,55293.0,white,no,0.699999809,0.6999998,dnr after sadm,11.0,63.0,11.1992188,60.0,8.0,36.19531,116.0,2.8999023,0.89990234,1.39990234,150.0,7.439453,158.0,43.0,3081.0,0.0,1.0,<2 mo. follow-up,0.494751
38.81198,male,1.0,ARF/MOSF w/Sepsis,17.0,$25-$50k,46577.0,white,no,0.0,0.0,dnr after sadm,9.0,111.0,7.5,50.0,8.0,35.79688,362.5,2.8999023,0.89990234,0.79992676,146.0,7.379883,83.0,10.0,3226.0,0.0,0.0,<2 mo. follow-up,0.0
72.03595,female,0.0,CHF,14.0,under $11k,18033.0,white,no,0.75,0.75,no dnr,10.0,40.0,0.5,135.0,30.0,36.69531,110.0,1.5,3.69970703,1.0,142.0,7.429688,156.0,30.0,2810.0,5.0,1.0,SIP>=30,1.0
94.04199,female,0.0,COPD,12.0,under $11k,12115.0,white,no,0.199999928,0.04999998,dnr after sadm,1.0,43.0,6.59960938,71.0,38.0,35.59375,309.5,3.699707,0.89990234,2.5,137.0,7.419922,39.0,139.0,364.0,2.0,6.0,SIP>=30,6.0
58.29398,female,0.0,Lung Cancer,16.0,>$50k,9432.0,white,metastatic,0.949999809,0.5,no dnr,7.0,52.0,3.39990234,72.0,14.0,39.89844,95.70312,1.5,0.5,1.29980469,142.0,7.469727,288.0,39.0,1095.0,0.0,1.0,SIP>=30,0.494751
79.76996,male,0.0,CHF,11.0,$11-$25k,13059.0,white,no,0.799999714,0.1999999,dnr after sadm,1.0,63.0,3.0,50.0,25.0,37.5,352.375,4.3994141,0.39996338,1.39990234,139.0,7.439453,86.0,11.0,1025.0,0.0,1.0,no(M2 and SIP pres),1.0
93.5,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,17669.0,white,no,0.699999809,0.5,no dnr,11.0,100.0,8.69921875,100.0,20.0,36.09375,246.0,3.3999023,0.39996338,1.89990234,137.0,7.269531,211.0,34.0,1175.0,0.0,1.0,<2 mo. follow-up,3.5712891
64.98596,male,0.0,COPD,12.0,under $11k,15358.0,white,no,0.949999809,0.8999996,no dnr,11.0,63.0,10.8984375,49.0,36.0,35.79688,215.0,2.5,0.5,1.09985352,138.0,7.399414,122.0,24.0,2900.0,0.0,1.0,<2 mo. follow-up,3.2094727
79.21997,male,1.0,COPD,12.0,$11-$25k,26546.0,white,yes,0.949999809,0.6999998,no dnr,13.0,60.0,12.5,130.0,8.0,38.5,276.0,2.2998047,0.69995117,1.0,144.0,7.439453,148.0,11.0,3310.0,0.0,0.0,<2 mo. follow-up,0.0
73.16095,female,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,31648.0,white,metastatic,0.5,0.1999999,dnr after sadm,1.0,69.0,10.3984375,97.0,22.0,36.69531,148.5625,2.7998047,0.29998779,6.5,136.0,7.319336,82.0,37.0,1968.0,2.0,6.0,adl>=4 (>=5 if sur),6.0
64.53094,female,0.0,Colon Cancer,12.0,under $11k,6520.0,white,metastatic,0.789999962,0.25,no dnr,5.0,127.0,15.3984375,70.0,30.0,37.89844,280.0,2.2998047,0.89990234,0.69995117,153.0,7.379883,299.0,31.0,2035.0,0.0,0.0,<2 mo. follow-up,0.0
96.02496,male,0.0,CHF,0.0,$11-$25k,5425.0,white,no,0.799999714,0.5,no dnr,6.0,52.0,11.7988281,63.0,10.0,38.59375,70.0,2.5996094,0.5,1.59985352,136.0,7.469727,270.0,35.0,2215.0,0.0,1.0,no(M2 and SIP pres),1.0
79.61395,female,1.0,ARF/MOSF w/Sepsis,17.0,$11-$25k,49723.0,white,no,0.5,0.5,dnr after sadm,5.0,97.0,7.79980469,80.0,20.0,36.69531,224.0,3.0996094,1.69995117,1.09985352,138.0,7.419922,88.0,23.0,300.0,0.0,1.0,<2 mo. follow-up,1.0
80.383,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,65194.0,white,no,0.199999928,0.1999999,no dnr,21.0,67.0,12.0,70.0,20.0,36.09375,280.9375,2.699707,0.89990234,1.0,139.0,7.519531,103.0,13.0,1475.0,0.0,1.0,<2 mo. follow-up,3.8051758
72.82098,male,1.0,ARF/MOSF w/Sepsis,16.0,>$50k,9040.0,white,yes,0.089999974,0.08999997,dnr after sadm,3.0,115.0,30.5976562,130.0,38.0,36.69531,142.84375,3.199707,0.5,0.69995117,145.0,7.479492,259.0,25.0,1485.0,0.0,1.0,<2 mo. follow-up,2.3725586
62.17899,male,0.0,CHF,12.0,under $11k,12723.0,white,no,0.849999905,0.7999997,no dnr,7.0,69.0,14.0996094,82.0,32.0,38.09375,71.0,2.2998047,0.89990234,2.29980469,136.0,7.389648,151.0,31.0,1975.0,0.0,1.0,<2 mo. follow-up,2.1552734
91.59998,female,0.0,COPD,12.0,under $11k,6892.0,white,no,0.75,0.5,dnr before sadm,-1.0,110.0,6.79980469,80.0,24.0,38.09375,220.0,3.0,0.79992676,6.0,140.0,7.329102,106.0,75.0,855.0,0.0,1.0,<2 mo. follow-up,6.7988281
63.70398,female,0.0,COPD,13.0,under $11k,14808.0,white,no,0.949999809,0.9499998,dnr after sadm,3.0,70.0,11.7988281,80.0,25.0,37.0,344.0,4.0,1.09985352,1.5,134.0,7.549805,127.0,61.0,700.0,1.0,1.0,no(M2 and SIP pres),1.1667481
49.94098,male,0.0,CHF,12.0,under $11k,6022.0,white,no,0.699999809,0.5999999,no dnr,6.0,73.0,6.5,70.0,20.0,36.69531,224.0,2.8999023,0.5,0.5,139.0,7.419922,101.0,12.0,1968.0,0.0,1.0,<2 mo. follow-up,2.3305664
80.65698,female,1.0,Coma,12.0,under $11k,52292.0,white,no,0.5,0.3999999,dnr after sadm,13.0,107.0,6.59960938,50.0,25.0,36.09375,186.1875,2.8999023,0.89990234,4.5,138.0,7.5,179.0,70.0,1900.0,0.0,0.0,<2 mo. follow-up,0.0
73.185,male,0.0,COPD,12.0,>$50k,21289.0,white,no,0.799999714,0.5,dnr after sadm,2.0,58.0,14.0996094,107.0,28.0,39.09375,330.0,2.8999023,0.89990234,0.79992676,134.0,7.40918,252.0,16.0,1500.0,0.0,0.0,<2 mo. follow-up,0.0
92.35297,female,0.0,CHF,18.0,$25-$50k,4530.0,white,yes,0.75,0.3999999,no dnr,5.0,77.0,15.2988281,80.0,20.0,36.69531,200.0,2.8999023,0.89990234,1.09985352,137.0,7.40918,169.0,26.0,1250.0,4.0,3.0,no(M2 and SIP pres),3.0
71.06897,female,0.0,COPD,12.0,under $11k,9867.0,white,no,0.989999771,0.9799995,no dnr,8.0,107.0,14.1992188,110.0,26.0,36.5,313.0,2.8999023,0.89990234,1.0,137.0,7.429688,246.0,28.0,607.0,0.0,1.0,<2 mo. follow-up,5.0332031
70.69098,female,1.0,Colon Cancer,12.0,under $11k,15326.0,white,metastatic,0.299999952,0.09999996,dnr after sadm,3.0,58.0,11.6992188,74.0,8.0,37.89844,180.0,3.3999023,0.89990234,1.19995117,142.0,7.389648,151.0,24.0,2885.0,0.0,7.0,<2 mo. follow-up,7.0
81.45898,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,38340.0,white,no,0.599999905,0.5999999,no dnr,24.0,78.0,12.1992188,76.0,16.0,37.79688,224.0,3.199707,0.39996338,1.09985352,138.0,7.419922,83.0,19.0,1968.0,2.0,2.0,no(M2 and SIP pres),2.0
56.85999,female,0.0,COPD,12.0,under $11k,31629.0,white,no,0.75,0.5999999,no dnr,22.0,60.0,5.59960938,80.0,20.0,36.09375,224.0,2.8999023,0.89990234,1.19995117,129.0,7.419922,109.0,18.0,1968.0,4.0,1.0,no(M2 and SIP pres),1.0
53.43698,female,1.0,Lung Cancer,12.0,under $11k,4094.0,white,metastatic,0.0,0.0,dnr before sadm,-1.0,65.0,16.5976562,126.0,20.0,36.89844,140.0,2.199707,0.29998779,0.89990234,149.0,7.40918,265.0,35.0,2447.0,0.0,1.0,<2 mo. follow-up,2.5229492
34.72098,male,0.0,ARF/MOSF w/Sepsis,19.0,$11-$25k,8854.0,white,no,0.899999619,0.8999996,no dnr,5.0,133.0,26.296875,134.0,22.0,36.09375,236.71875,3.3999023,1.39990234,4.5,147.0,7.389648,111.0,125.0,1355.0,0.0,1.0,no(M2 and SIP pres),1.6228027
49.65399,female,0.0,ARF/MOSF w/Sepsis,13.0,under $11k,45260.0,white,yes,0.949999809,0.8999996,dnr after sadm,2.0,43.0,5.89941406,111.0,15.0,38.59375,336.0,2.3999023,1.19995117,5.39941406,151.0,7.389648,99.0,70.0,285.0,0.0,6.0,adl>=4 (>=5 if sur),6.0
46.78198,male,0.0,COPD,12.0,$25-$50k,7958.0,hispanic,no,0.979999542,0.9599996,no dnr,7.0,109.0,6.89941406,65.0,20.0,36.59375,524.0,2.8999023,0.89990234,1.69995117,139.0,7.509766,224.0,30.0,2100.0,2.0,0.0,no(M2 and SIP pres),0.0
63.836,male,0.0,Lung Cancer,12.0,under $11k,17745.0,white,metastatic,0.899999619,0.5,no dnr,4.0,77.0,3.79980469,80.0,25.0,35.59375,224.0,3.2998047,1.59985352,2.09960938,138.0,7.419922,92.0,53.0,825.0,0.0,1.0,<2 mo. follow-up,2.2768555
76.47894,male,1.0,ARF/MOSF w/Sepsis,16.0,>$50k,26124.0,white,yes,0.299999952,0.3,no dnr,8.0,110.0,16.3984375,70.0,25.0,36.69531,180.0,3.2998047,0.89990234,0.5,136.0,7.399414,167.0,17.0,1590.0,0.0,0.0,<2 mo. follow-up,0.0
66.04498,female,0.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,162830.0,white,no,0.899999619,0.8499999,no dnr,76.0,70.0,6.5,80.0,25.0,36.69531,319.0,4.1992188,1.19995117,1.59985352,134.0,7.529297,106.0,24.0,1500.0,0.0,1.0,adl>=4 (>=5 if sur),1.987793
65.487,male,0.0,CHF,14.0,under $11k,40260.0,white,no,0.299999952,0.1999999,dnr after sadm,17.0,47.0,16.0,70.0,10.0,40.19531,382.0,3.699707,2.5,2.19970703,145.0,7.459961,219.0,60.0,1072.0,0.0,1.0,SIP>=30,1.0
74.98999,female,0.0,ARF/MOSF w/Sepsis,12.0,>$50k,51049.0,white,no,0.5,0.4499998,no dnr,11.0,100.0,9.3984375,100.0,30.0,36.09375,385.125,3.199707,0.89990234,0.69995117,141.0,7.239258,155.0,19.0,775.0,0.0,0.0,no(M2 and SIP pres),0.0
71.00897,female,1.0,Coma,12.0,under $11k,24582.0,white,no,0.5,0.5,dnr after sadm,1.0,57.0,27.796875,80.0,20.0,36.09375,252.375,2.8999023,0.89990234,1.09985352,132.0,7.459961,90.0,30.0,1100.0,0.0,6.0,<2 mo. follow-up,6.0
82.26099,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,79617.0,white,yes,0.5,0.3,dnr after sadm,8.0,107.0,4.79980469,100.0,20.0,36.09375,498.3125,3.8999023,0.29998779,0.89990234,135.0,7.359375,90.0,18.0,1968.0,0.0,3.0,adl>=4 (>=5 if sur),3.0
77.06494,female,0.0,CHF,11.0,$11-$25k,4731.0,white,no,0.899999619,0.7999997,no dnr,4.0,67.0,20.1992188,90.0,20.0,36.5,404.75,3.7998047,4.09960938,1.79980469,143.0,7.549805,89.0,44.0,1968.0,7.0,3.0,no(M2 and SIP pres),3.0
79.91498,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,35208.0,white,no,0.0,0.0,dnr after sadm,3.0,41.0,15.3984375,109.0,28.0,37.69531,436.625,3.0,0.59997559,1.69995117,138.0,7.369141,82.0,36.0,2340.0,0.0,1.0,<2 mo. follow-up,3.675293
80.05499,female,0.0,ARF/MOSF w/Sepsis,16.0,under $11k,63531.0,white,no,0.699999809,0.6499996,no dnr,27.0,51.0,17.5,84.0,29.0,36.29688,122.4375,3.699707,0.89990234,1.29980469,136.0,7.359375,200.0,21.0,3070.0,0.0,0.0,no(M2 and SIP pres),0.0
72.25494,male,0.0,Lung Cancer,12.0,under $11k,5886.0,black,metastatic,0.699999809,0.5,dnr after sadm,1.0,40.0,15.6992188,144.0,4.0,37.19531,105.0,2.8999023,0.89990234,0.89990234,141.0,7.289062,209.0,13.0,1968.0,0.0,1.0,<2 mo. follow-up,3.1450195
41.172,female,0.0,Colon Cancer,12.0,$25-$50k,15770.0,white,metastatic,0.5,0.25,dnr after sadm,6.0,63.0,7.59960938,72.0,16.0,38.29688,305.0,3.3999023,0.89990234,0.69995117,141.0,7.419922,107.0,15.0,4640.0,0.0,2.0,<2 mo. follow-up,2.0
64.04395,male,0.0,Colon Cancer,12.0,under $11k,2867.0,white,metastatic,0.699999809,0.09999996,no dnr,3.0,109.0,7.09960938,129.0,22.0,39.39844,246.65625,2.8999023,0.59997559,1.19995117,146.0,7.289062,418.0,23.0,3230.0,0.0,1.0,no(M2 and SIP pres),0.494751
30.29999,female,0.0,ARF/MOSF w/Sepsis,15.0,>$50k,47058.0,black,yes,0.849999905,0.75,no dnr,12.0,107.0,8.29882812,110.0,20.0,37.79688,247.59375,2.8999023,0.89990234,1.19995117,141.0,7.399414,106.0,13.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
79.49896,female,0.0,Colon Cancer,14.0,under $11k,6147.0,white,metastatic,0.299999952,0.0,dnr after sadm,1.0,77.0,6.89941406,80.0,20.0,37.0,224.0,4.0,0.29998779,0.89990234,135.0,7.419922,98.0,8.0,4300.0,0.0,1.0,adl>=4 (>=5 if sur),2.4311523
83.00598,female,0.0,Coma,12.0,under $11k,23863.0,white,metastatic,0.099999964,0.0,dnr after sadm,1.0,67.0,26.296875,72.0,23.0,39.09375,123.32812,2.199707,0.89990234,2.89990234,135.0,7.359375,147.0,63.0,2535.0,0.0,1.0,<2 mo. follow-up,3.2202148
75.21399,male,1.0,ARF/MOSF w/Sepsis,9.0,under $11k,14546.0,white,yes,0.0,0.0,dnr after sadm,1.0,40.0,15.5,110.0,50.0,38.19531,144.0,2.8999023,5.09960938,0.69995117,139.0,7.509766,113.0,16.0,778.0,0.0,1.0,<2 mo. follow-up,5.1630859
62.09198,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,102751.0,white,no,0.299999952,0.25,no dnr,5.0,107.0,7.89941406,100.0,20.0,35.59375,261.875,3.8999023,1.39990234,3.09960938,132.0,7.5,89.0,45.0,1650.0,0.0,1.0,<2 mo. follow-up,1.8996582
80.24896,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,28091.0,white,no,0.049999982,0.04999998,no dnr,6.0,127.0,14.1992188,180.0,36.0,38.09375,138.0,2.8999023,0.89990234,0.59997559,134.0,7.5,173.0,9.0,2540.0,0.0,1.0,<2 mo. follow-up,2.2250977
86.38995,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,17556.0,white,no,0.699999809,0.5,dnr after sadm,1.0,123.0,16.8984375,120.0,24.0,38.5,240.0,2.8999023,0.89990234,0.69995117,148.0,7.429688,121.0,13.0,810.0,0.0,1.0,<2 mo. follow-up,3.9760742
91.25299,female,1.0,ARF/MOSF w/Sepsis,8.0,under $11k,12313.0,white,no,0.5,0.25,dnr after sadm,4.0,55.0,9.79882812,120.0,6.0,38.0,218.0,2.199707,0.89990234,1.89990234,148.0,7.40918,79.0,41.0,632.0,0.0,1.0,<2 mo. follow-up,3.5063477
70.78198,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,29158.0,white,no,0.5,0.5,no dnr,20.0,73.0,11.2988281,80.0,20.0,37.79688,224.0,2.8999023,0.39996338,1.0,138.0,7.419922,130.0,19.0,1968.0,1.0,0.0,<2 mo. follow-up,0.0
82.034,female,1.0,ARF/MOSF w/Sepsis,8.0,under $11k,27756.0,black,no,0.5,0.3999999,dnr after sadm,2.0,66.0,6.39941406,70.0,40.0,36.09375,80.0,2.699707,0.5,3.39990234,138.0,7.439453,247.0,85.0,860.0,0.0,5.0,<2 mo. follow-up,5.0
82.55396,female,1.0,ARF/MOSF w/Sepsis,14.0,under $11k,58079.0,white,no,0.899999619,0.75,dnr after sadm,10.0,107.0,7.69921875,80.0,24.0,38.0,224.0,2.8999023,0.89990234,1.0,135.0,7.419922,275.0,16.0,975.0,0.0,1.0,<2 mo. follow-up,5.2138672
84.01898,male,0.0,CHF,14.0,$25-$50k,3200.0,white,no,0.899999619,0.7999997,no dnr,3.0,100.0,11.0996094,100.0,20.0,37.0,224.0,2.8999023,0.89990234,0.59997559,136.0,7.419922,172.0,11.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.7324219
80.02698,female,0.0,COPD,12.0,under $11k,29207.0,white,no,0.599999905,0.5999999,no dnr,18.0,103.0,33.0,60.0,15.0,37.0,224.0,3.0996094,1.5,0.79992676,152.0,7.539062,176.0,13.0,54.5,0.0,0.0,no(M2 and SIP pres),0.0
75.31598,female,0.0,Coma,12.0,under $11k,34680.0,black,no,0.25,0.09999996,dnr after sadm,2.0,57.0,11.5996094,80.0,20.0,37.29688,224.0,2.8999023,1.19995117,1.19995117,133.0,7.419922,328.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),1.0
76.487,male,0.0,Cirrhosis,15.0,under $11k,17185.0,white,yes,0.75,0.5999999,dnr after sadm,1.0,57.0,2.59960938,114.0,32.0,37.79688,224.0,3.2998047,4.59960938,2.19970703,135.0,7.419922,98.0,31.0,350.0,0.0,0.0,SIP>=30,0.0
68.97998,male,0.0,COPD,12.0,under $11k,4894.0,white,yes,0.799999714,0.75,no dnr,3.0,83.0,14.5,100.0,25.0,36.09375,224.0,2.699707,0.89990234,0.89990234,135.0,7.419922,157.0,24.0,1968.0,1.0,2.0,SIP>=30,2.0
67.45795,female,0.0,Lung Cancer,14.0,under $11k,8469.0,white,metastatic,0.299999952,0.09999996,no dnr,8.0,99.0,26.8984375,68.0,20.0,37.69531,281.625,3.0,0.5,0.89990234,141.0,7.269531,171.0,20.0,1968.0,0.0,0.0,SIP>=30,0.0
64.30096,female,0.0,Colon Cancer,16.0,>$50k,5613.0,white,metastatic,0.899999619,0.5999999,no dnr,5.0,49.0,13.5996094,121.0,36.0,37.69531,316.625,3.199707,3.29980469,5.09960938,145.0,7.379883,155.0,8.798828,860.0,0.0,0.0,no(M2 and SIP pres),0.0
87.25299,female,0.0,COPD,12.0,under $11k,22466.0,white,no,0.75,0.6999998,no dnr,14.0,60.0,13.6992188,120.0,44.0,38.19531,231.65625,2.8999023,0.59997559,1.09985352,150.0,7.329102,233.0,23.0,1166.0,0.0,0.0,SIP>=30,0.0
73.92694,male,0.0,CHF,16.0,under $11k,14982.0,white,no,0.759999752,0.5999999,dnr before sadm,-1.0,73.0,9.69921875,65.0,8.0,38.59375,122.5,2.8999023,0.89990234,1.39990234,143.0,7.179688,265.0,36.0,1005.0,2.0,0.0,SIP>=30,0.0
81.85095,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,52814.0,white,no,0.099999964,0.04999998,no dnr,20.0,47.0,9.59960938,70.0,24.0,37.89844,162.84375,1.8999023,0.89990234,0.69995117,139.0,7.319336,178.0,19.0,1255.0,0.0,0.0,no(M2 and SIP pres),0.0
72.52594,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,64956.0,black,no,0.019999996,0.0,no dnr,26.0,55.0,9.8984375,112.0,40.0,38.19531,165.28125,4.1992188,0.59997559,1.09985352,136.0,7.30957,282.0,24.0,1930.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
72.35895,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,33427.0,white,no,0.799999714,0.7999997,no dnr,20.0,109.0,10.5996094,82.0,20.0,37.79688,373.3125,2.3999023,0.89990234,1.19995117,141.0,7.399414,101.0,28.0,2350.0,0.0,0.0,no(M2 and SIP pres),0.0
83.49896,male,1.0,ARF/MOSF w/Sepsis,16.0,>$50k,30052.0,white,yes,0.199999928,0.09999996,dnr after sadm,1.0,111.0,7.0,58.0,28.0,33.79688,388.0,2.3999023,4.5,5.5,135.0,7.25,80.0,56.0,48.0,0.0,2.0,<2 mo. follow-up,2.0
77.35797,male,0.0,MOSF w/Malig,12.0,>$50k,12651.0,white,yes,0.899999619,0.8999996,no dnr,8.0,57.0,6.09960938,120.0,40.0,37.69531,94.0,2.8999023,0.89990234,1.39990234,148.0,7.379883,140.0,66.0,758.0,0.0,2.0,no(M2 and SIP pres),2.0
61.81198,female,0.0,COPD,12.0,under $11k,48864.0,white,no,0.899999619,0.8499999,no dnr,20.0,107.0,3.89990234,60.0,20.0,36.69531,447.5625,4.0996094,0.89990234,5.09960938,138.0,7.379883,79.0,42.0,1850.0,0.0,2.0,no(M2 and SIP pres),2.0
85.172,male,1.0,MOSF w/Malig,20.0,>$50k,12742.0,white,yes,0.049999982,0.0,dnr before sadm,-1.0,66.0,17.3984375,120.0,33.0,37.69531,135.0,3.199707,0.89990234,1.29980469,140.0,7.449219,118.0,43.0,1340.0,0.0,1.0,<2 mo. follow-up,2.7807617
77.63995,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,19449.0,black,no,0.699999809,0.5,dnr after sadm,6.0,100.0,10.5996094,80.0,30.0,39.39844,224.0,2.8999023,0.89990234,1.19995117,140.0,7.419922,135.0,23.0,600.0,0.0,1.0,<2 mo. follow-up,3.6835938
69.33899,male,0.0,ARF/MOSF w/Sepsis,14.0,$11-$25k,54183.0,white,no,0.5,0.5,no dnr,16.0,103.0,5.59960938,80.0,20.0,37.79688,423.75,2.199707,1.79980469,1.29980469,145.0,7.469727,109.0,26.0,500.0,0.0,1.0,<2 mo. follow-up,1.0
35.116,male,1.0,ARF/MOSF w/Sepsis,20.0,under $11k,38566.0,black,no,0.799999714,0.7999997,dnr after sadm,4.0,76.0,6.89941406,72.0,26.0,36.5,304.0,3.699707,0.89990234,1.09985352,143.0,7.469727,96.0,10.0,1490.0,0.0,6.0,<2 mo. follow-up,6.0
91.93396,female,1.0,ARF/MOSF w/Sepsis,15.0,under $11k,95204.0,white,no,0.149999976,0.09999996,dnr after sadm,1.0,65.0,6.29980469,108.0,26.0,37.09375,146.9375,2.8999023,0.89990234,1.19995117,140.0,7.329102,96.0,17.0,1800.0,0.0,2.0,<2 mo. follow-up,2.0
81.29999,female,0.0,COPD,6.0,under $11k,7211.0,white,no,0.5,0.5,dnr after sadm,1.0,83.0,2.39990234,60.0,20.0,36.29688,224.0,2.5,1.09985352,0.89990234,141.0,7.419922,89.0,4.0,950.0,0.0,1.0,SIP>=30,3.7529297
57.61298,female,0.0,Lung Cancer,14.0,>$50k,13214.0,white,metastatic,0.899999619,0.6999998,no dnr,4.0,101.0,18.296875,69.0,20.0,36.29688,249.0,3.8999023,0.89990234,1.5,140.0,7.179688,203.0,47.0,2650.0,0.0,1.0,no(M2 and SIP pres),0.494751
83.74799,female,0.0,COPD,12.0,under $11k,5225.0,white,yes,0.799999714,0.5,no dnr,5.0,67.0,17.0,100.0,25.0,36.39844,264.0,3.3999023,1.09985352,2.59960938,136.0,7.429688,145.0,77.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.494751
81.50897,male,0.0,ARF/MOSF w/Sepsis,17.0,>$50k,23306.0,white,no,0.75,0.75,no dnr,17.0,37.0,8.3984375,56.0,8.0,38.59375,63.0,3.0996094,1.29980469,2.19970703,136.0,7.339844,109.0,37.0,1530.0,0.0,6.0,adl>=4 (>=5 if sur),6.0
74.26697,male,0.0,COPD,8.0,under $11k,26839.0,white,no,0.799999714,0.7999997,no dnr,19.0,43.0,6.09960938,105.0,8.0,38.39844,317.5,2.8999023,0.39996338,0.5,147.0,7.399414,276.0,10.0,2975.0,0.0,1.0,adl>=4 (>=5 if sur),0.494751
75.98596,male,0.0,Lung Cancer,12.0,under $11k,51147.0,white,metastatic,0.899999619,0.5999999,dnr after sadm,26.0,110.0,8.5,60.0,36.0,38.89844,254.0,2.7998047,0.89990234,0.79992676,134.0,7.419922,120.0,16.0,2400.0,0.0,1.0,<2 mo. follow-up,2.6210938
87.59497,female,1.0,COPD,12.0,under $11k,53912.0,white,no,0.5,0.1999999,no dnr,23.0,56.0,0.69995117,102.0,30.0,39.19531,251.65625,2.8999023,1.0,2.39990234,135.0,7.5,93.0,44.0,780.0,0.0,7.0,<2 mo. follow-up,7.0
80.77197,female,0.0,COPD,12.0,under $11k,12938.0,white,no,0.899999619,0.6999998,no dnr,9.0,55.0,4.69921875,55.0,38.0,35.19531,280.0,3.3999023,0.79992676,0.89990234,139.0,7.539062,196.0,10.0,2050.0,1.0,0.0,SIP>=30,0.0
79.36499,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,15161.0,white,no,0.399999857,0.3,dnr after sadm,1.0,63.0,15.2988281,60.0,8.0,37.79688,68.75,2.8999023,2.0,1.19995117,135.0,7.439453,213.0,47.0,2500.0,0.0,1.0,<2 mo. follow-up,2.8666992
42.98199,male,0.0,CHF,16.0,>$50k,8715.0,white,no,0.899999619,0.75,no dnr,8.0,58.0,2.29980469,134.0,40.0,39.09375,484.0,2.8999023,0.89990234,3.69970703,136.0,7.439453,80.0,108.0,1935.0,1.0,2.0,<2 mo. follow-up,2.0
51.64999,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,33418.0,white,no,0.899999619,0.8999996,no dnr,14.0,52.0,10.5996094,70.0,8.0,38.09375,196.0,2.2998047,0.89990234,1.89990234,145.0,7.429688,315.0,37.0,1610.0,0.0,0.0,no(M2 and SIP pres),0.0
78.64496,female,0.0,Colon Cancer,12.0,under $11k,7249.0,white,metastatic,0.799999714,0.3999999,no dnr,8.0,65.0,12.5,150.0,14.0,35.39844,224.0,2.8999023,0.79992676,1.69995117,144.0,7.419922,145.0,21.0,4345.0,0.0,1.0,adl>=4 (>=5 if sur),1.0
55.48297,male,0.0,Lung Cancer,12.0,>$50k,15966.0,white,metastatic,0.949999809,0.5999999,no dnr,4.0,142.0,15.0996094,50.0,24.0,36.19531,224.0,2.199707,1.89990234,3.09960938,141.0,7.419922,167.0,46.0,1990.0,0.0,1.0,no(M2 and SIP pres),1.9882812
39.784,female,1.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,23300.0,white,no,0.5,0.5,no dnr,5.0,73.0,22.5976562,110.0,14.0,36.69531,190.0,1.3999023,0.89990234,4.0,129.0,7.369141,77.0,62.0,1460.0,0.0,0.0,<2 mo. follow-up,0.0
68.31195,female,1.0,CHF,9.0,under $11k,11437.0,white,no,0.099999964,0.0,dnr after sadm,2.0,107.0,11.3984375,70.0,20.0,37.79688,171.40625,2.8999023,0.89990234,1.69995117,143.0,7.389648,107.0,31.0,1968.0,0.0,6.0,<2 mo. follow-up,6.0
42.74597,male,0.0,Cirrhosis,16.0,>$50k,11712.0,white,yes,0.949999809,0.75,no dnr,9.0,85.0,3.59960938,72.0,16.0,37.39844,224.0,3.5996094,0.89990234,0.89990234,137.0,7.419922,114.0,9.0,3200.0,0.0,0.0,no(M2 and SIP pres),0.0
82.70496,female,0.0,COPD,12.0,under $11k,7815.0,white,no,0.5,0.3,no dnr,7.0,103.0,6.79980469,100.0,25.0,36.69531,229.625,2.8999023,0.89990234,1.19995117,137.0,7.379883,92.0,24.0,1575.0,1.0,1.0,no(M2 and SIP pres),1.1667481
65.10095,female,0.0,ARF/MOSF w/Sepsis,15.0,under $11k,19496.0,hispanic,no,0.949999809,0.9499998,no dnr,12.0,120.0,10.0996094,51.0,26.0,37.89844,242.84375,3.199707,0.29998779,1.59985352,149.0,7.459961,86.0,44.0,1968.0,0.0,1.0,<2 mo. follow-up,0.494751
77.68097,female,0.0,COPD,12.0,under $11k,7278.0,white,no,0.799999714,0.5999999,dnr before sadm,-1.0,67.0,10.5,80.0,20.0,36.09375,256.0,3.2998047,0.89990234,1.59985352,140.0,7.459961,95.0,23.0,5000.0,0.0,2.0,<2 mo. follow-up,2.0
47.12097,male,0.0,Cirrhosis,11.0,under $11k,18732.0,white,no,0.769999981,0.7999997,no dnr,8.0,107.0,7.29980469,100.0,25.0,38.89844,224.0,4.3994141,0.89990234,0.79992676,136.0,7.419922,197.0,13.0,1950.0,0.0,2.0,SIP>=30,2.0
50.60098,male,0.0,COPD,12.0,under $11k,5799.0,white,no,0.899999619,0.8499999,no dnr,4.0,65.0,9.3984375,72.0,8.0,36.59375,197.5,2.7998047,0.39996338,1.0,137.0,7.369141,132.0,49.0,1020.0,0.0,1.0,<2 mo. follow-up,2.1162109
89.70795,female,1.0,Coma,12.0,under $11k,4730.0,white,yes,0.699999809,0.5,dnr before sadm,-1.0,93.0,10.1992188,80.0,20.0,36.09375,285.6875,2.8999023,0.89990234,1.29980469,143.0,7.40918,109.0,31.0,575.0,0.0,1.0,<2 mo. follow-up,5.0732422
44.58899,male,0.0,ARF/MOSF w/Sepsis,14.0,$11-$25k,43026.0,white,no,0.849999905,0.7999997,no dnr,13.0,102.0,5.29980469,73.0,30.0,37.59375,176.65625,2.8999023,0.29998779,1.0,134.0,7.369141,508.0,26.0,1760.0,0.0,0.0,no(M2 and SIP pres),0.0
23.33499,female,1.0,MOSF w/Malig,13.0,under $11k,118566.0,white,yes,0.899999619,0.5999999,dnr after sadm,21.0,47.0,6.59960938,120.0,35.0,36.69531,224.0,2.8999023,0.89990234,1.29980469,138.0,7.419922,99.0,21.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
57.629,female,0.0,Cirrhosis,12.0,$11-$25k,36754.0,white,no,0.5,0.3499999,no dnr,17.0,58.0,21.1992188,99.0,24.0,37.0,132.5,2.8999023,0.5,0.79992676,137.0,7.329102,230.0,10.0,1990.0,0.0,0.0,no(M2 and SIP pres),0.0
83.75397,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,21739.0,white,no,0.799999714,0.5,no dnr,11.0,113.0,10.5996094,68.0,20.0,36.19531,224.0,2.8999023,0.89990234,1.19995117,140.0,7.419922,135.0,23.0,1100.0,0.0,1.0,<2 mo. follow-up,6.5097656
44.64297,male,0.0,CHF,12.0,under $11k,39916.0,black,no,0.5,0.5,no dnr,14.0,97.0,6.09960938,64.0,16.0,36.69531,224.0,2.8999023,0.89990234,1.29980469,141.0,7.419922,189.0,16.0,1968.0,7.0,4.0,<2 mo. follow-up,4.0
89.23999,female,0.0,CHF,14.0,under $11k,5975.0,white,yes,0.949999809,0.8999996,dnr before sadm,-1.0,55.0,25.796875,139.0,26.0,39.29688,67.0,1.8999023,0.79992676,0.89990234,144.0,7.319336,72.0,42.0,1193.0,0.0,0.0,SIP>=30,0.0
40.73599,male,0.0,Cirrhosis,12.0,under $11k,20281.0,white,no,0.5,0.3,no dnr,11.0,43.0,80.0,50.0,20.0,37.79688,224.0,3.0,0.59997559,2.5,139.0,7.419922,100.0,115.0,625.0,0.0,1.0,<2 mo. follow-up,2.8046875
89.5,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,14752.0,white,no,0.799999714,0.6999998,no dnr,7.0,71.0,5.29980469,110.0,21.0,37.5,224.0,3.3999023,3.79980469,1.0,138.0,7.419922,92.0,20.0,1850.0,2.0,2.0,no(M2 and SIP pres),2.0
83.98395,female,0.0,ARF/MOSF w/Sepsis,8.0,under $11k,13372.0,white,no,0.25,0.1999999,dnr after sadm,2.0,59.0,10.3984375,68.0,26.0,36.39844,320.0,3.699707,0.79992676,1.09985352,134.0,7.30957,103.0,19.0,2030.0,0.0,1.0,no(M2 and SIP pres),6.015625
77.92694,female,0.0,ARF/MOSF w/Sepsis,9.0,under $11k,25184.0,white,no,0.75,0.75,no dnr,17.0,122.0,6.69921875,76.0,16.0,36.89844,151.65625,4.0996094,0.89990234,1.09985352,140.0,7.459961,96.0,18.0,3570.0,1.0,0.0,no(M2 and SIP pres),0.0
64.28198,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,18119.0,white,no,0.899999619,0.8999996,no dnr,12.0,109.0,13.0,100.0,34.0,37.69531,251.84375,3.7998047,0.89990234,1.09985352,137.0,7.329102,250.0,34.0,1100.0,1.0,1.0,SIP>=30,1.0
61.823,female,0.0,Coma,18.0,>$50k,73012.0,hispanic,no,0.299999952,0.3,no dnr,42.0,52.0,1.09985352,64.0,30.0,36.29688,224.0,2.5,7.89941406,0.59997559,139.0,7.419922,110.0,15.0,1040.0,0.0,0.0,Coma or Intub,0.0
28.25999,female,0.0,ARF/MOSF w/Sepsis,11.0,under $11k,30418.0,white,no,0.899999619,0.8999996,no dnr,10.0,83.0,5.69921875,60.0,20.0,35.59375,239.125,4.0,0.5,0.89990234,138.0,7.369141,171.0,11.0,1968.0,5.0,0.0,no(M2 and SIP pres),0.0
83.11798,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,24810.0,white,no,0.5,0.3999999,no dnr,18.0,77.0,26.0976562,60.0,32.0,36.09375,361.875,3.2998047,1.29980469,2.39990234,145.0,7.489258,330.0,37.0,1968.0,0.0,0.0,SIP>=30,0.0
59.41998,female,0.0,Colon Cancer,19.0,under $11k,14652.0,white,metastatic,1.0,0.7999997,no dnr,9.0,57.0,13.1992188,120.0,12.0,39.19531,266.0,4.6992188,0.39996338,0.79992676,138.0,7.399414,129.0,8.0,1180.0,0.0,0.0,no(M2 and SIP pres),0.0
67.06396,female,0.0,ARF/MOSF w/Sepsis,14.0,under $11k,36505.0,white,no,0.849999905,0.7999997,no dnr,14.0,126.0,8.19921875,134.0,25.0,38.09375,152.0,3.3999023,2.0,3.39990234,130.0,7.389648,167.0,58.0,1971.0,0.0,1.0,no(M2 and SIP pres),1.0
78.94598,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,67914.0,white,no,0.699999809,0.3429999,no dnr,20.0,48.0,15.2988281,106.0,8.0,36.19531,113.75,2.5,6.29980469,1.39990234,149.0,7.469727,165.0,18.0,2235.0,0.0,1.0,<2 mo. follow-up,2.6767578
43.42499,male,0.0,CHF,11.0,under $11k,6695.0,black,no,0.949999809,0.8999996,no dnr,6.0,51.0,14.7988281,68.0,8.0,38.59375,262.5,2.699707,0.29998779,0.89990234,140.0,7.40918,321.0,26.0,1080.0,3.0,1.0,SIP>=30,2.5107422
46.80099,male,0.0,Cirrhosis,16.0,under $11k,26374.0,white,no,0.5,0.3,dnr after sadm,15.0,66.0,7.89941406,108.0,26.0,35.89844,286.625,2.3999023,0.89990234,1.79980469,126.0,7.5,184.0,45.0,2500.0,3.0,1.0,<2 mo. follow-up,2.5107422
71.31799,male,0.0,Cirrhosis,12.0,$11-$25k,12882.0,white,no,0.5,0.5,dnr before sadm,0.0,93.0,5.59960938,60.0,15.0,36.09375,318.3125,4.3994141,0.89990234,2.0,139.0,7.359375,108.0,34.0,370.0,0.0,0.0,no(M2 and SIP pres),0.0
62.29398,female,0.0,COPD,12.0,under $11k,34399.0,white,no,0.879999638,0.77,dnr before sadm,-1.0,67.0,16.796875,80.0,20.0,38.39844,224.0,2.0,15.5996094,1.5,142.0,7.419922,65.0,33.0,1370.0,0.0,1.0,<2 mo. follow-up,3.7045898
41.008,male,0.0,Cirrhosis,15.0,under $11k,16407.0,white,no,0.899999619,0.6999998,no dnr,7.0,110.0,5.89941406,60.0,16.0,36.19531,297.125,4.6992188,0.59997559,2.29980469,144.0,7.419922,107.0,45.0,1795.0,0.0,1.0,no(M2 and SIP pres),0.494751
53.03198,male,0.0,ARF/MOSF w/Sepsis,20.0,$25-$50k,19707.0,white,no,0.949999809,0.9499998,no dnr,10.0,62.0,7.19921875,42.0,16.0,36.09375,319.0,2.8999023,0.89990234,1.5,139.0,7.379883,125.0,35.0,1170.0,0.0,0.0,no(M2 and SIP pres),0.0
95.60596,female,0.0,ARF/MOSF w/Sepsis,4.0,under $11k,10736.0,white,yes,0.5,0.3999999,dnr before sadm,-1.0,74.0,10.3984375,62.0,10.0,38.09375,373.3125,2.7998047,0.5,5.69921875,132.0,7.229492,104.0,78.0,1510.0,0.0,1.0,no(M2 and SIP pres),1.0
62.88599,female,0.0,ARF/MOSF w/Sepsis,16.0,$25-$50k,12771.0,white,no,0.799999714,0.6999998,no dnr,4.0,127.0,10.2988281,120.0,35.0,40.0,204.75,3.3999023,0.59997559,1.09985352,139.0,7.429688,151.0,12.0,2300.0,0.0,4.0,no(M2 and SIP pres),4.0
62.12698,female,0.0,ARF/MOSF w/Sepsis,14.0,$25-$50k,52812.0,hispanic,no,0.799999714,0.5999999,no dnr,23.0,153.0,14.5996094,125.0,36.0,39.59375,438.0625,2.8999023,0.89990234,1.19995117,134.0,7.5,220.0,16.0,1055.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
50.82498,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,23926.0,black,yes,0.649999619,0.3499999,dnr before sadm,0.0,111.0,14.0,110.0,44.0,37.89844,136.65625,2.8999023,0.89990234,0.59997559,141.0,7.399414,93.0,18.0,3400.0,2.0,6.0,<2 mo. follow-up,6.0
77.26495,male,1.0,ARF/MOSF w/Sepsis,8.0,$11-$25k,28082.0,white,no,0.299999952,0.3,dnr after sadm,5.0,55.0,12.3984375,114.0,30.0,38.69531,136.71875,3.7998047,0.69995117,2.69970703,136.0,7.459961,262.0,61.0,1156.0,0.0,4.0,<2 mo. follow-up,4.0
44.92297,female,1.0,MOSF w/Malig,16.0,$11-$25k,23066.0,white,metastatic,0.299999952,0.09999996,dnr after sadm,7.0,103.0,16.296875,120.0,25.0,38.89844,224.0,2.8999023,0.89990234,0.79992676,135.0,7.419922,154.0,11.0,1795.0,0.0,1.0,<2 mo. follow-up,2.4384766
49.85397,male,1.0,MOSF w/Malig,24.0,>$50k,39151.0,white,metastatic,0.25,0.15,dnr after sadm,5.0,57.0,11.7988281,120.0,26.0,39.19531,128.0,2.7998047,0.59997559,0.79992676,133.0,7.419922,128.0,9.0,2279.0,0.0,0.0,<2 mo. follow-up,0.0
88.81598,female,0.0,ARF/MOSF w/Sepsis,8.0,under $11k,8938.0,white,no,0.799999714,0.5,no dnr,4.0,43.0,17.296875,130.0,14.0,38.69531,140.0,2.8999023,0.89990234,1.79980469,136.0,7.30957,189.0,27.0,1300.0,0.0,1.0,adl>=4 (>=5 if sur),6.2636719
90.76794,female,0.0,COPD,12.0,under $11k,27955.0,white,no,0.5,0.3999999,dnr after sadm,3.0,80.0,6.39941406,80.0,20.0,35.59375,347.5625,2.2998047,0.79992676,1.19995117,139.0,7.369141,113.0,14.0,3400.0,0.0,2.0,adl>=4 (>=5 if sur),2.0
94.07495,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,13122.0,white,no,0.699999809,0.5,dnr after sadm,1.0,50.0,13.5996094,110.0,20.0,36.09375,224.0,2.199707,11.2988281,0.69995117,130.0,7.419922,157.0,13.0,850.0,0.0,1.0,<2 mo. follow-up,1.0
61.91397,female,1.0,ARF/MOSF w/Sepsis,9.0,$11-$25k,69577.0,white,no,0.299999952,0.3,dnr after sadm,18.0,73.0,2.79980469,80.0,20.0,36.09375,224.0,2.0,3.5,0.69995117,131.0,7.419922,294.0,13.0,1968.0,0.0,7.0,<2 mo. follow-up,7.0
68.60797,female,0.0,ARF/MOSF w/Sepsis,13.0,>$50k,85343.0,white,no,0.799999714,0.7999997,no dnr,19.0,100.0,12.3984375,108.0,32.0,36.59375,225.6875,2.8999023,0.89990234,0.69995117,141.0,7.379883,202.0,10.0,2280.0,0.0,0.0,<2 mo. follow-up,0.0
62.327,male,1.0,Lung Cancer,12.0,under $11k,4703.0,white,metastatic,0.049999982,0.009999998,dnr before sadm,-1.0,57.0,8.19921875,74.0,24.0,37.79688,224.0,2.8999023,0.89990234,1.29980469,130.0,7.419922,169.0,39.0,900.0,0.0,1.0,<2 mo. follow-up,2.7363281
77.86694,female,1.0,ARF/MOSF w/Sepsis,8.0,under $11k,7696.0,white,yes,0.099999964,0.06999999,dnr after sadm,2.0,60.0,8.79882812,52.0,50.0,38.79688,171.0,2.5996094,0.69995117,0.89990234,141.0,7.369141,96.0,14.0,3450.0,0.0,1.0,<2 mo. follow-up,3.5195312
32.84598,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,79142.0,hispanic,no,0.899999619,0.8999996,no dnr,30.0,100.0,12.8984375,70.0,20.0,35.89844,357.125,3.7998047,1.09985352,0.69995117,125.0,7.509766,237.0,14.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
70.70795,male,0.0,ARF/MOSF w/Sepsis,9.0,$11-$25k,165432.0,white,yes,0.699999809,0.5,no dnr,35.0,105.0,10.7988281,180.0,20.0,37.89844,640.0,3.0996094,1.39990234,0.79992676,143.0,7.269531,102.0,6.0,2750.0,0.0,0.0,SIP>=30,0.0
58.81198,female,0.0,Lung Cancer,18.0,under $11k,6654.0,white,metastatic,0.949999809,0.75,no dnr,6.0,117.0,11.5,80.0,9.0,39.29688,185.0,2.8999023,0.89990234,1.29980469,144.0,7.489258,110.0,15.0,1273.0,0.0,0.0,no(M2 and SIP pres),0.0
74.11096,female,0.0,ARF/MOSF w/Sepsis,14.0,under $11k,99474.0,white,no,0.899999619,0.6999998,no dnr,48.0,83.0,3.0,100.0,20.0,36.69531,224.0,2.8999023,0.89990234,3.5,142.0,7.419922,70.0,66.0,1100.0,0.0,7.0,adl>=4 (>=5 if sur),7.0
65.89197,female,0.0,MOSF w/Malig,12.0,under $11k,13944.0,white,yes,0.699999809,0.5,no dnr,5.0,109.0,24.1992188,113.0,24.0,36.39844,356.0,1.5998535,26.796875,3.89990234,150.0,7.419922,153.0,147.0,1600.0,0.0,1.0,<2 mo. follow-up,2.152832
83.40295,male,0.0,CHF,12.0,under $11k,44009.0,white,no,0.899999619,0.75,no dnr,18.0,54.0,9.5,145.0,12.0,38.79688,161.65625,2.5996094,0.29998779,0.69995117,153.0,7.349609,144.0,26.0,3155.0,0.0,1.0,<2 mo. follow-up,3.1352539
72.099,female,0.0,ARF/MOSF w/Sepsis,14.0,under $11k,6312.0,white,yes,0.699999809,0.5,no dnr,3.0,54.0,4.69921875,76.0,28.0,38.19531,107.5,2.5996094,1.0,0.69995117,141.0,7.439453,221.0,26.0,4745.0,2.0,1.0,adl>=4 (>=5 if sur),1.8388672
72.81,female,0.0,ARF/MOSF w/Sepsis,14.0,$11-$25k,9466.0,white,yes,0.849999905,0.6499996,no dnr,6.0,110.0,7.69921875,70.0,20.0,35.89844,114.0,3.5996094,0.89990234,1.19995117,146.0,7.259766,90.0,23.0,2631.0,0.0,1.0,no(M2 and SIP pres),2.3208008
68.99896,female,0.0,Lung Cancer,16.0,>$50k,11272.0,white,metastatic,0.5,0.1999999,no dnr,8.0,137.0,7.0,56.0,50.0,37.89844,293.3125,2.8999023,0.89990234,0.79992676,141.0,7.399414,166.0,20.0,1610.0,2.0,2.0,<2 mo. follow-up,2.0
89.46997,male,0.0,ARF/MOSF w/Sepsis,10.0,>$50k,43497.0,white,no,0.699999809,0.6999998,dnr after sadm,1.0,97.0,10.3984375,60.0,20.0,36.09375,131.65625,2.8999023,0.89990234,1.59985352,143.0,7.30957,94.0,40.0,1600.0,0.0,1.0,no(M2 and SIP pres),1.0
45.741,male,0.0,Coma,8.0,under $11k,35265.0,white,no,0.5,0.5,no dnr,23.0,139.0,10.5996094,104.0,60.0,38.29688,297.5,2.0,0.29998779,7.29980469,140.0,7.359375,121.0,69.0,1150.0,0.0,7.0,adl>=4 (>=5 if sur),7.0
62.11899,male,0.0,COPD,17.0,$25-$50k,12604.0,white,yes,0.949999809,0.9499998,no dnr,9.0,55.0,12.3984375,72.0,24.0,36.69531,240.0,3.3999023,0.89990234,2.19970703,145.0,7.529297,105.0,43.0,3990.0,1.0,1.0,no(M2 and SIP pres),1.0
86.75995,female,0.0,ARF/MOSF w/Sepsis,8.0,under $11k,108592.0,white,no,0.599999905,0.5999999,dnr after sadm,12.0,73.0,4.39941406,130.0,30.0,36.09375,224.0,2.0,0.89990234,1.09985352,145.0,7.419922,281.0,25.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
82.12994,female,0.0,COPD,8.0,under $11k,44671.0,white,no,0.75,0.6599998,dnr after sadm,6.0,39.0,13.5996094,125.0,34.0,38.39844,148.96875,3.0996094,1.39990234,2.59960938,136.0,7.359375,110.0,94.0,107.0,2.0,1.0,<2 mo. follow-up,1.0
64.01398,female,0.0,COPD,12.0,under $11k,12940.0,black,no,0.899999619,0.7999997,no dnr,10.0,121.0,10.8984375,106.0,12.0,38.29688,157.0,2.8999023,0.29998779,0.79992676,143.0,7.399414,145.0,12.0,1625.0,2.0,1.0,no(M2 and SIP pres),1.0
41.66498,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,71676.0,black,no,0.799999714,0.7999997,no dnr,23.0,107.0,6.59960938,110.0,10.0,39.19531,190.0,2.8999023,0.89990234,1.19995117,149.0,7.439453,136.0,18.0,4890.0,0.0,0.0,no(M2 and SIP pres),0.0
73.599,male,1.0,MOSF w/Malig,16.0,$11-$25k,179085.0,white,metastatic,0.949999809,0.6999998,dnr after sadm,39.0,81.0,6.79980469,76.0,20.0,37.39844,224.0,2.8999023,0.89990234,0.59997559,137.0,7.419922,115.0,10.0,4202.0,0.0,0.0,<2 mo. follow-up,0.0
76.08795,male,0.0,ARF/MOSF w/Sepsis,11.0,under $11k,45370.0,black,no,0.849999905,0.5999999,dnr after sadm,7.0,47.0,5.79980469,60.0,42.0,36.09375,80.0,2.8999023,0.39996338,0.29998779,141.0,7.399414,102.0,3.0,3195.0,0.0,0.0,<2 mo. follow-up,0.0
84.13995,female,1.0,ARF/MOSF w/Sepsis,12.0,>$50k,51665.0,white,no,0.25,0.25,no dnr,6.0,70.0,2.5,108.0,15.0,36.69531,224.0,2.0,0.89990234,0.39996338,137.0,7.419922,155.0,11.0,3000.0,0.0,0.0,<2 mo. follow-up,0.0
41.314,female,0.0,CHF,11.0,under $11k,10240.0,white,no,0.949999809,0.7999997,no dnr,10.0,77.0,5.69921875,60.0,20.0,36.09375,224.0,3.8999023,0.59997559,2.79980469,139.0,7.419922,115.0,70.0,1200.0,2.0,1.0,<2 mo. follow-up,1.8388672
68.81598,male,1.0,CHF,16.0,$25-$50k,22629.0,white,no,0.899999619,0.6999998,dnr after sadm,14.0,72.0,18.3984375,68.0,16.0,35.89844,224.0,1.6999512,0.89990234,0.69995117,137.0,7.419922,68.0,15.0,310.0,2.0,3.0,<2 mo. follow-up,3.0
53.46997,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,23618.0,white,no,0.349999905,0.27,no dnr,12.0,77.0,5.69921875,60.0,20.0,35.59375,548.0,3.3999023,0.29998779,2.89990234,136.0,7.299805,54.0,63.0,780.0,1.0,0.0,SIP>=30,0.0
57.35498,male,0.0,Lung Cancer,10.0,under $11k,27340.0,white,metastatic,0.899999619,0.5,dnr after sadm,1.0,77.0,8.19921875,70.0,25.0,36.09375,224.0,2.8999023,0.39996338,0.69995117,132.0,7.419922,94.0,10.0,1550.0,3.0,1.0,<2 mo. follow-up,1.0
79.15094,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,53562.0,white,yes,0.299999952,0.3,dnr after sadm,5.0,123.0,12.5,67.0,25.0,36.09375,170.0,2.8999023,0.89990234,1.89990234,138.0,7.449219,92.0,27.0,2170.0,0.0,5.0,adl>=4 (>=5 if sur),5.0
77.133,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,7707.0,white,no,0.899999619,0.8499999,no dnr,6.0,103.0,10.5,44.0,6.0,37.89844,214.0,2.8999023,0.5,2.69970703,145.0,7.399414,440.0,81.0,615.0,1.0,0.0,no(M2 and SIP pres),0.0
63.72299,male,0.0,Cirrhosis,9.0,under $11k,12741.0,white,no,0.599999905,0.3999999,dnr after sadm,4.0,107.0,12.0,80.0,25.0,35.59375,224.0,2.8999023,0.89990234,1.09985352,136.0,7.419922,181.0,18.0,5800.0,0.0,0.0,<2 mo. follow-up,0.0
72.30896,male,0.0,ARF/MOSF w/Sepsis,13.0,$11-$25k,32851.0,white,yes,0.75,0.5,no dnr,7.0,77.0,11.1992188,80.0,20.0,36.09375,476.1875,2.5,0.59997559,4.19921875,147.0,7.40918,77.0,107.0,400.0,0.0,0.0,no(M2 and SIP pres),0.0
56.20798,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,58257.0,white,yes,0.599999905,0.5,no dnr,19.0,49.0,18.796875,120.0,44.0,36.39844,173.46875,3.5996094,0.89990234,1.89990234,135.0,7.429688,92.0,46.0,1520.0,0.0,1.0,<2 mo. follow-up,2.831543
90.448,female,0.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,23279.0,white,no,0.799999714,0.5999999,no dnr,11.0,77.0,12.3984375,120.0,25.0,38.59375,368.0,2.8999023,0.69995117,1.0,136.0,7.419922,103.0,11.0,850.0,0.0,1.0,no(M2 and SIP pres),1.0
68.08795,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,24806.0,white,no,0.949999809,0.7999997,no dnr,14.0,55.0,12.0,98.0,10.0,36.09375,78.75,2.8999023,1.29980469,7.69921875,135.0,7.349609,163.0,50.0,3800.0,0.0,1.0,<2 mo. follow-up,2.7832031
79.51495,female,1.0,ARF/MOSF w/Sepsis,7.0,$11-$25k,38930.0,white,yes,0.099999964,0.04999998,dnr after sadm,4.0,77.0,5.59960938,70.0,35.0,38.0,204.0,2.8999023,0.89990234,0.69995117,131.0,7.399414,168.0,19.0,948.0,0.0,1.0,<2 mo. follow-up,3.2685547
42.62299,female,0.0,Lung Cancer,13.0,under $11k,7367.0,white,metastatic,0.989999771,0.7999997,no dnr,6.0,57.0,19.796875,70.0,20.0,36.09375,433.3125,2.199707,0.5,1.39990234,142.0,7.479492,93.0,41.0,1968.0,2.0,3.0,<2 mo. follow-up,3.0
83.99695,male,0.0,CHF,7.0,under $11k,7790.0,white,yes,0.699999809,0.5,no dnr,6.0,47.0,21.0,134.0,10.0,34.79688,62.0,2.0,0.19998169,2.29980469,136.0,7.399414,165.0,34.0,2948.0,1.0,0.0,no(M2 and SIP pres),0.0
33.89697,male,0.0,Coma,12.0,under $11k,46364.0,white,no,0.699999809,0.5,no dnr,24.0,47.0,8.59960938,100.0,20.0,36.09375,224.0,4.0,1.59985352,0.79992676,135.0,7.439453,107.0,15.0,1100.0,0.0,1.0,<2 mo. follow-up,1.9265137
71.51495,male,1.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,18491.0,white,no,0.75,0.3,dnr after sadm,1.0,77.0,9.29882812,80.0,25.0,36.69531,224.0,2.7998047,3.69970703,1.19995117,127.0,7.419922,197.0,28.0,800.0,0.0,2.0,<2 mo. follow-up,2.0
82.87994,male,0.0,COPD,8.0,under $11k,8872.0,white,no,0.899999619,0.5999999,dnr after sadm,1.0,103.0,6.19921875,49.0,24.0,38.39844,152.5,3.0996094,9.19921875,0.5,149.0,7.399414,331.0,15.0,1260.0,0.0,1.0,no(M2 and SIP pres),3.8188477
31.806,female,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,21303.0,black,no,0.949999809,0.9499998,no dnr,13.0,71.0,11.5,84.0,16.0,38.39844,224.0,2.3999023,0.29998779,0.69995117,131.0,7.419922,134.0,9.0,1800.0,1.0,0.0,<2 mo. follow-up,0.0
83.995,male,0.0,CHF,12.0,under $11k,4725.0,white,no,0.799999714,0.6999998,no dnr,5.0,60.0,23.0,60.0,30.0,38.19531,178.3125,2.0996094,0.89990234,1.0,129.0,7.449219,276.0,17.0,2495.0,0.0,1.0,no(M2 and SIP pres),1.0
43.64398,male,1.0,Cirrhosis,12.0,under $11k,61249.0,white,no,0.299999952,0.3,dnr after sadm,14.0,100.0,6.79980469,80.0,20.0,37.19531,478.3125,3.2998047,0.19998169,1.09985352,137.0,7.419922,189.0,19.0,1150.0,0.0,0.0,<2 mo. follow-up,0.0
54.103,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,149841.0,white,no,0.299999952,0.3,no dnr,66.0,63.0,13.5,70.0,20.0,36.59375,224.0,1.7998047,6.5,2.79980469,137.0,7.419922,132.0,82.0,980.0,2.0,1.0,SIP>=30,1.0
60.40799,male,0.0,CHF,11.0,$25-$50k,3982.0,white,no,0.899999619,0.75,no dnr,3.0,62.0,9.79882812,55.0,28.0,36.39844,121.65625,2.8999023,0.89990234,1.19995117,137.0,7.469727,123.0,25.0,1905.0,0.0,1.0,no(M2 and SIP pres),0.494751
83.56195,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,37685.0,white,yes,0.799999714,0.6999998,no dnr,8.0,63.0,10.2988281,97.0,28.0,38.29688,136.71875,2.8999023,0.89990234,0.39996338,136.0,7.469727,88.0,12.0,920.0,2.0,2.0,no(M2 and SIP pres),2.0
82.35999,male,0.0,ARF/MOSF w/Sepsis,24.0,>$50k,56254.0,white,no,0.899999619,0.6999998,no dnr,10.0,110.0,14.7988281,67.0,24.0,36.09375,173.3125,4.0996094,0.59997559,1.89990234,135.0,7.369141,88.0,35.0,2380.0,0.0,0.0,no(M2 and SIP pres),0.0
61.90598,male,0.0,ARF/MOSF w/Sepsis,14.0,$11-$25k,43792.0,white,no,0.899999619,0.6999998,no dnr,26.0,81.0,7.09960938,116.0,24.0,38.0,144.875,2.8999023,0.89990234,0.79992676,134.0,7.479492,185.0,7.0,1850.0,1.0,1.0,<2 mo. follow-up,1.0
54.784,female,0.0,Lung Cancer,12.0,$11-$25k,15991.0,white,metastatic,0.799999714,0.5,no dnr,4.0,113.0,15.5,126.0,38.0,36.29688,230.0,2.0,0.89990234,0.59997559,142.0,7.429688,231.0,7.0,1421.0,0.0,0.0,no(M2 and SIP pres),0.0
74.85297,male,1.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,44102.0,white,no,0.0,0.0,dnr after sadm,2.0,77.0,8.09960938,76.0,18.0,36.79688,224.0,3.3999023,0.39996338,1.0,142.0,7.419922,100.0,7.0,3250.0,0.0,1.0,<2 mo. follow-up,4.2832031
73.18799,female,0.0,CHF,12.0,under $11k,45490.0,white,no,0.799999714,0.7999997,no dnr,28.0,77.0,7.09960938,50.0,25.0,36.09375,261.875,2.8999023,0.89990234,1.59985352,145.0,7.439453,114.0,25.0,1968.0,1.0,5.0,SIP>=30,5.0
54.16599,female,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,193965.0,white,no,0.5,0.5,no dnr,75.0,77.0,14.0996094,108.0,22.0,38.69531,212.5,2.8999023,1.89990234,0.89990234,142.0,7.419922,100.0,27.0,1875.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
81.97095,male,0.0,ARF/MOSF w/Sepsis,3.0,under $11k,141760.0,white,no,0.799999714,0.7999997,no dnr,41.0,131.0,18.0,66.0,4.0,38.39844,379.0,3.0996094,1.09985352,11.2988281,137.0,7.229492,135.0,72.0,375.0,0.0,1.0,no(M2 and SIP pres),2.3037109
95.05298,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,20485.0,white,no,0.049999982,0.04999998,no dnr,12.0,67.0,6.09960938,80.0,25.0,36.09375,188.0,2.8999023,0.89990234,1.29980469,142.0,7.349609,103.0,24.0,2250.0,6.0,0.0,no(M2 and SIP pres),0.0
89.84796,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,50121.0,white,no,0.199999928,0.09999996,dnr before sadm,0.0,59.0,22.0976562,132.0,34.0,37.59375,142.84375,4.1992188,0.39996338,0.89990234,137.0,7.399414,153.0,10.0,1450.0,0.0,1.0,<2 mo. follow-up,5.8251953
20.821,male,0.0,ARF/MOSF w/Sepsis,14.0,$25-$50k,92095.0,white,no,0.799999714,0.7999997,no dnr,19.0,73.0,4.89941406,70.0,25.0,36.09375,390.4375,2.8999023,0.89990234,1.5,141.0,7.5,103.0,35.0,800.0,0.0,6.0,adl>=4 (>=5 if sur),6.0
76.91699,male,1.0,ARF/MOSF w/Sepsis,5.0,$11-$25k,10552.0,black,no,0.099999964,0.0,dnr after sadm,2.0,113.0,6.29980469,43.0,12.0,36.19531,105.0,2.8999023,3.29980469,0.69995117,144.0,7.5,145.0,14.0,3660.0,0.0,6.0,<2 mo. follow-up,6.0
85.336,male,0.0,COPD,8.0,under $11k,12972.0,white,no,0.699999809,0.5,dnr before sadm,-1.0,73.0,15.5996094,135.0,28.0,40.19531,230.0,2.0996094,0.39996338,0.5,158.0,7.379883,148.0,3.299805,1870.0,0.0,3.0,adl>=4 (>=5 if sur),3.0
87.75397,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,53522.0,white,yes,0.099999964,0.04999998,dnr after sadm,1.0,76.0,20.796875,70.0,28.0,36.09375,224.0,3.0,0.89990234,1.09985352,141.0,7.419922,116.0,21.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
70.28894,male,1.0,MOSF w/Malig,12.0,under $11k,24749.0,white,metastatic,0.699999809,0.5,dnr after sadm,2.0,122.0,13.5996094,71.0,24.0,38.19531,144.875,2.8999023,0.89990234,0.69995117,141.0,7.509766,116.0,32.0,3066.0,0.0,1.0,<2 mo. follow-up,2.7548828
60.40198,female,0.0,COPD,11.0,under $11k,5828.0,black,no,0.989999771,0.9899998,no dnr,5.0,50.0,12.1992188,61.0,28.0,38.09375,143.3125,2.5996094,1.89990234,1.0,138.0,7.439453,112.0,9.0,5625.0,0.0,1.0,no(M2 and SIP pres),0.494751
74.11597,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,55886.0,white,yes,0.199999928,0.09999996,dnr after sadm,10.0,62.0,8.69921875,64.0,12.0,37.79688,376.1875,1.7998047,11.6992188,1.59985352,138.0,7.399414,98.0,37.0,1968.0,0.0,1.0,<2 mo. follow-up,3.237793
87.633,male,0.0,COPD,12.0,$11-$25k,56611.0,white,metastatic,0.899999619,0.75,no dnr,34.0,83.0,3.5,80.0,30.0,37.0,224.0,4.5996094,0.39996338,0.89990234,138.0,7.419922,91.0,9.0,4900.0,0.0,2.0,SIP>=30,2.0
83.08295,female,1.0,Coma,12.0,under $11k,5078.0,white,yes,0.0,0.0,dnr after sadm,1.0,34.0,18.3984375,41.0,8.0,35.39844,238.0,2.8999023,0.89990234,2.39990234,137.0,7.399414,292.0,27.0,340.0,0.0,1.0,<2 mo. follow-up,1.0
78.63898,female,0.0,Lung Cancer,12.0,under $11k,23239.0,white,metastatic,0.799999714,0.3999999,dnr after sadm,1.0,70.0,5.39941406,80.0,25.0,36.09375,233.3125,3.699707,0.59997559,6.69921875,139.0,7.319336,201.0,83.0,3105.0,0.0,0.0,no(M2 and SIP pres),0.0
91.92297,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,27153.0,white,no,0.699999809,0.5,dnr after sadm,2.0,141.0,22.0976562,123.0,34.0,38.0,155.0,3.2998047,0.59997559,0.79992676,141.0,7.5,172.0,13.0,1730.0,0.0,2.0,<2 mo. follow-up,2.0
79.01196,male,0.0,ARF/MOSF w/Sepsis,10.0,under $11k,18246.0,white,yes,1.0,1.0,no dnr,9.0,63.0,8.29882812,80.0,30.0,37.79688,257.125,2.199707,0.89990234,3.89990234,142.0,7.339844,207.0,116.0,1720.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
31.82999,male,0.0,CHF,15.0,under $11k,8811.0,white,no,0.849999905,0.75,no dnr,6.0,115.0,14.0,120.0,28.0,38.29688,224.0,2.8999023,0.89990234,6.29980469,138.0,7.419922,102.0,83.0,3330.0,0.0,1.0,no(M2 and SIP pres),0.494751
66.06995,male,0.0,Lung Cancer,9.0,under $11k,9945.0,white,metastatic,0.799999714,0.3999999,no dnr,6.0,76.0,5.89941406,80.0,24.0,36.69531,224.0,3.3999023,2.0,1.0,143.0,7.419922,110.0,15.0,410.0,2.0,0.0,<2 mo. follow-up,0.0
68.75299,female,1.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,25024.0,white,no,0.099999964,0.09999996,no dnr,8.0,110.0,7.69921875,120.0,34.0,37.79688,224.0,1.8999023,0.69995117,0.5,135.0,7.449219,137.0,5.0,3565.0,0.0,1.0,<2 mo. follow-up,1.0
91.81696,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,13455.0,white,no,0.849999905,0.5,dnr after sadm,3.0,68.0,11.5996094,70.0,28.0,37.69531,342.8125,3.5996094,1.09985352,13.0996094,152.0,7.439453,151.0,178.0,241.0,0.0,7.0,adl>=4 (>=5 if sur),7.0
71.59796,female,0.0,COPD,12.0,under $11k,36646.0,black,no,0.899999619,0.7999997,no dnr,18.0,67.0,20.1992188,100.0,40.0,38.29688,224.0,2.8999023,0.5,1.0,139.0,7.419922,161.0,14.0,1968.0,1.0,3.0,no(M2 and SIP pres),3.0
40.60199,male,0.0,Cirrhosis,12.0,under $11k,11743.0,black,no,0.599999905,0.3999999,dnr after sadm,5.0,60.0,8.69921875,120.0,14.0,34.29688,158.0,1.7998047,0.89990234,1.69995117,132.0,7.40918,215.0,50.0,2535.0,0.0,1.0,SIP>=30,3.7875977
55.85199,female,0.0,ARF/MOSF w/Sepsis,16.0,$25-$50k,340910.0,white,no,0.799999714,0.7999997,no dnr,110.0,33.0,0.5,150.0,12.0,38.69531,60.0,4.1992188,1.19995117,1.69995117,140.0,7.319336,159.0,22.0,450.0,0.0,1.0,no(M2 and SIP pres),1.9328613
64.51495,male,0.0,Lung Cancer,12.0,under $11k,14429.0,white,metastatic,0.699999809,0.5,no dnr,11.0,113.0,7.5,70.0,25.0,36.69531,280.9375,2.8999023,0.89990234,1.0,141.0,7.369141,153.0,19.0,1968.0,0.0,1.0,<2 mo. follow-up,3.1210938
67.409,male,0.0,ARF/MOSF w/Sepsis,14.0,under $11k,49973.0,white,yes,0.799999714,0.7999997,no dnr,13.0,68.0,9.3984375,74.0,8.0,38.09375,145.0,2.0996094,0.89990234,1.29980469,144.0,7.5,123.0,30.0,3263.0,0.0,0.0,no(M2 and SIP pres),0.0
77.74695,female,0.0,CHF,12.0,$11-$25k,3228.0,white,no,0.799999714,0.5999999,no dnr,4.0,80.0,16.6992188,80.0,20.0,36.09375,261.875,3.8999023,0.79992676,1.5,140.0,7.339844,80.0,35.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.0966797
85.91895,female,0.0,CHF,16.0,>$50k,16137.0,white,no,0.699999809,0.5,dnr after sadm,2.0,103.0,9.59960938,80.0,20.0,38.89844,402.0,2.8999023,0.89990234,1.5,137.0,7.439453,170.0,25.0,1885.0,0.0,3.0,adl>=4 (>=5 if sur),3.0
40.17499,female,0.0,ARF/MOSF w/Sepsis,16.0,$25-$50k,9842.0,white,no,0.899999619,0.8999996,no dnr,6.0,76.0,5.09960938,64.0,12.0,36.39844,224.0,4.2998047,0.29998779,1.09985352,137.0,7.419922,93.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
78.448,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,19295.0,white,no,0.599999905,0.3999999,no dnr,10.0,49.0,13.0996094,117.0,8.0,38.29688,198.0,2.5,0.79992676,0.79992676,134.0,7.429688,93.0,11.0,2277.0,0.0,1.0,SIP>=30,2.5576172
85.55798,female,1.0,CHF,12.0,$11-$25k,12845.0,white,metastatic,0.199999928,0.09999996,dnr after sadm,3.0,113.0,15.6992188,70.0,14.0,39.09375,409.5,2.8999023,0.89990234,2.09960938,136.0,7.399414,281.0,38.0,1270.0,0.0,6.0,<2 mo. follow-up,6.0
86.89398,female,0.0,ARF/MOSF w/Sepsis,9.0,under $11k,50008.0,white,no,0.699999809,0.5,dnr after sadm,8.0,80.0,10.2988281,110.0,30.0,36.09375,237.5,3.7998047,1.09985352,1.39990234,135.0,7.449219,87.0,24.0,1879.0,0.0,1.0,adl>=4 (>=5 if sur),4.1533203
67.26099,male,1.0,Lung Cancer,12.0,under $11k,17966.0,white,metastatic,0.699999809,0.5,dnr after sadm,5.0,100.0,24.6992188,80.0,25.0,36.09375,436.0,3.199707,0.89990234,1.0,129.0,7.429688,124.0,14.0,1968.0,0.0,1.0,<2 mo. follow-up,2.7294922
68.94696,male,0.0,MOSF w/Malig,8.0,$11-$25k,16339.0,black,metastatic,0.799999714,0.5999999,no dnr,7.0,70.0,12.1992188,120.0,10.0,36.29688,96.25,2.2998047,0.79992676,4.89941406,132.0,7.219727,103.0,50.0,0.0,7.0,4.0,no(M2 and SIP pres),4.0
74.92999,male,0.0,Lung Cancer,7.0,under $11k,6121.0,white,metastatic,0.699999809,0.09999996,no dnr,4.0,65.0,10.5996094,56.0,30.0,38.69531,183.65625,2.3999023,0.89990234,1.09985352,135.0,7.389648,306.0,28.0,1350.0,0.0,3.0,<2 mo. follow-up,3.0
85.99298,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,10742.0,white,no,0.199999928,0.09999996,dnr after sadm,2.0,67.0,13.5,60.0,6.0,38.79688,136.65625,4.0996094,0.79992676,2.0,142.0,7.419922,157.0,24.0,645.0,0.0,0.0,<2 mo. follow-up,0.0
87.82196,female,1.0,ARF/MOSF w/Sepsis,14.0,under $11k,32606.0,white,no,0.199999928,0.1999999,dnr after sadm,3.0,83.0,3.89990234,80.0,20.0,36.09375,224.0,1.5,1.69995117,0.89990234,129.0,7.419922,125.0,11.0,1968.0,0.0,6.0,<2 mo. follow-up,6.0
88.53699,female,0.0,CHF,16.0,>$50k,26190.0,white,no,0.699999809,0.6999998,dnr after sadm,10.0,110.0,8.5,110.0,14.0,38.39844,314.0,2.7998047,0.39996338,0.5,150.0,7.339844,300.0,25.0,1335.0,1.0,4.0,<2 mo. follow-up,4.0
63.064,female,0.0,COPD,14.0,$11-$25k,4934.0,white,no,1.0,0.9799995,no dnr,5.0,80.0,6.09960938,100.0,20.0,37.39844,224.0,2.8999023,0.39996338,1.0,136.0,7.419922,111.0,10.0,600.0,2.0,1.0,no(M2 and SIP pres),1.8388672
71.15094,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,179736.0,white,no,0.899999619,0.8999996,no dnr,100.0,105.0,9.8984375,102.0,24.0,38.5,171.40625,2.5996094,1.19995117,1.19995117,137.0,7.5,200.0,24.0,3400.0,0.0,1.0,adl>=4 (>=5 if sur),3.0981445
41.16098,female,0.0,MOSF w/Malig,12.0,$25-$50k,21183.0,white,metastatic,0.5,0.1999999,dnr after sadm,3.0,73.0,9.59960938,60.0,20.0,36.09375,358.3125,2.8999023,0.89990234,1.79980469,137.0,7.349609,222.0,30.0,1850.0,0.0,1.0,no(M2 and SIP pres),1.0
45.43198,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,123970.0,black,no,0.949999809,0.9499998,no dnr,23.0,100.0,15.0996094,80.0,20.0,38.29688,626.625,2.8999023,0.59997559,3.89990234,132.0,7.359375,277.0,86.0,950.0,0.0,1.0,<2 mo. follow-up,2.7319336
91.13794,female,0.0,CHF,12.0,under $11k,5236.0,white,no,0.399999857,0.1999999,dnr before sadm,-1.0,117.0,5.59960938,72.0,20.0,38.19531,218.3125,3.699707,0.39996338,0.89990234,133.0,7.349609,85.0,10.0,2100.0,0.0,1.0,<2 mo. follow-up,6.0927734
81.13599,female,0.0,CHF,12.0,under $11k,38685.0,white,yes,0.799999714,0.6999998,dnr after sadm,2.0,60.0,9.79882812,62.0,24.0,38.39844,480.0,2.699707,1.79980469,1.19995117,149.0,7.449219,719.0,63.0,700.0,1.0,0.0,<2 mo. follow-up,0.0
58.349,female,0.0,MOSF w/Malig,14.0,$11-$25k,12365.0,white,metastatic,0.899999619,0.5,no dnr,11.0,53.0,8.8984375,96.0,33.0,35.79688,136.71875,2.5996094,1.59985352,1.89990234,138.0,7.419922,187.0,41.0,1855.0,0.0,0.0,no(M2 and SIP pres),0.0
90.48596,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,14422.0,white,no,0.699999809,0.5,dnr before sadm,-1.0,133.0,9.29882812,82.0,24.0,36.79688,432.0,2.8999023,0.5,1.79980469,147.0,7.379883,247.0,29.0,1435.0,0.0,3.0,<2 mo. follow-up,3.0
45.95798,male,0.0,ARF/MOSF w/Sepsis,12.0,>$50k,31723.0,white,yes,0.699999809,0.5,no dnr,15.0,111.0,0.09999084,140.0,28.0,36.29688,380.0,2.0,0.79992676,3.5,142.0,7.359375,235.0,69.0,2250.0,0.0,0.0,no(M2 and SIP pres),0.0
78.58698,male,0.0,ARF/MOSF w/Sepsis,11.0,under $11k,31302.0,white,no,0.799999714,0.5,dnr before sadm,-1.0,80.0,2.29980469,68.0,16.0,36.09375,556.0,2.2998047,2.39990234,2.0,154.0,7.459961,90.0,33.0,1920.0,0.0,7.0,adl>=4 (>=5 if sur),7.0
53.12799,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,92751.0,black,no,0.899999619,0.8999996,no dnr,45.0,76.0,11.7988281,72.0,16.0,36.5,224.0,3.0996094,0.39996338,1.09985352,138.0,7.419922,127.0,22.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
82.04797,female,0.0,CHF,6.0,under $11k,16409.0,white,yes,0.849999905,0.8499999,no dnr,9.0,107.0,18.1992188,68.0,30.0,36.69531,224.0,3.0996094,1.09985352,3.69970703,150.0,7.419922,179.0,99.0,2003.0,0.0,1.0,no(M2 and SIP pres),0.494751
47.95297,female,1.0,Lung Cancer,12.0,$11-$25k,12930.0,black,metastatic,0.099999964,0.09999996,dnr after sadm,2.0,51.0,7.09960938,50.0,6.0,35.59375,74.0,2.8999023,0.89990234,3.0,135.0,7.339844,72.0,105.0,1024.0,0.0,0.0,<2 mo. follow-up,0.0
73.758,female,0.0,ARF/MOSF w/Sepsis,10.0,under $11k,46212.0,white,yes,0.599999905,0.5999999,dnr after sadm,8.0,61.0,11.1992188,62.0,24.0,38.29688,120.0,3.7998047,0.89990234,2.29980469,138.0,7.419922,142.0,43.0,1072.0,0.0,1.0,no(M2 and SIP pres),1.0
88.23297,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,8650.0,white,no,1.0,0.9499998,no dnr,5.0,83.0,11.3984375,100.0,25.0,36.09375,224.0,2.8999023,0.89990234,1.59985352,135.0,7.419922,97.0,47.0,2100.0,0.0,1.0,no(M2 and SIP pres),0.494751
61.74899,male,1.0,MOSF w/Malig,13.0,$25-$50k,13353.0,white,metastatic,0.699999809,0.5,dnr after sadm,1.0,73.0,12.8984375,100.0,24.0,37.39844,363.25,2.3999023,0.89990234,2.09960938,135.0,7.389648,234.0,37.0,1145.0,0.0,1.0,<2 mo. follow-up,2.3730469
88.00299,female,0.0,Coma,14.0,under $11k,102276.0,white,no,0.5,0.3,dnr after sadm,27.0,57.0,0.79992676,128.0,36.0,39.39844,328.0,2.5996094,0.59997559,0.79992676,136.0,7.489258,112.0,10.0,2100.0,0.0,1.0,<2 mo. follow-up,1.0
76.92798,female,0.0,Lung Cancer,12.0,under $11k,14385.0,white,metastatic,0.899999619,0.5999999,no dnr,7.0,50.0,21.0,110.0,8.0,38.19531,195.0,2.8999023,0.89990234,2.89990234,141.0,7.40918,68.0,17.0,2100.0,0.0,1.0,no(M2 and SIP pres),2.375
67.31299,female,0.0,COPD,11.0,under $11k,13149.0,white,no,0.799999714,0.6499996,no dnr,9.0,67.0,8.09960938,60.0,15.0,36.09375,403.3125,2.8999023,0.89990234,1.29980469,139.0,7.359375,119.0,21.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
76.14197,female,0.0,COPD,12.0,$11-$25k,7858.0,white,no,1.0,1.0,no dnr,6.0,70.0,16.3984375,80.0,30.0,37.0,224.0,4.0,0.89990234,0.89990234,134.0,7.419922,111.0,8.0,1050.0,1.0,1.0,no(M2 and SIP pres),1.1667481
66.63898,female,0.0,COPD,12.0,under $11k,7222.0,black,no,0.699999809,0.5,no dnr,6.0,71.0,3.69970703,74.0,20.0,38.09375,419.0,2.8999023,0.89990234,0.59997559,139.0,7.449219,101.0,3.0,3900.0,0.0,0.0,<2 mo. follow-up,0.0
79.50696,female,0.0,CHF,14.0,$11-$25k,4092.0,white,no,0.899999619,0.7999997,no dnr,4.0,52.0,13.5996094,107.0,24.0,37.79688,230.59375,3.3999023,0.89990234,2.0,141.0,7.40918,388.0,52.0,1780.0,0.0,1.0,no(M2 and SIP pres),0.494751
44.06299,male,0.0,MOSF w/Malig,13.0,$11-$25k,106706.0,black,yes,0.75,0.5,no dnr,10.0,56.0,7.39941406,117.0,8.0,38.09375,442.5,2.8999023,0.89990234,1.0,138.0,7.439453,97.0,12.0,2111.0,1.0,1.0,no(M2 and SIP pres),1.1667481
54.56497,female,1.0,Coma,13.0,>$50k,90807.0,white,no,0.009999998,0.009999998,no dnr,27.0,49.0,15.5996094,70.0,24.0,40.09375,120.0,3.0996094,0.5,2.79980469,156.0,7.199219,355.0,85.0,1980.0,0.0,0.0,<2 mo. follow-up,0.0
70.49097,male,0.0,ARF/MOSF w/Sepsis,11.0,under $11k,129379.0,white,no,0.5,0.3999999,no dnr,37.0,113.0,21.796875,120.0,34.0,38.79688,293.875,2.8999023,0.89990234,0.79992676,148.0,7.519531,150.0,10.0,1265.0,0.0,0.0,no(M2 and SIP pres),0.0
50.12997,male,0.0,MOSF w/Malig,12.0,under $11k,103700.0,other,yes,0.699999809,0.5,no dnr,32.0,45.0,10.6992188,75.0,14.0,38.0,363.3125,2.8999023,1.29980469,2.69970703,141.0,7.619141,173.0,47.0,3105.0,0.0,1.0,no(M2 and SIP pres),1.0
76.85699,female,0.0,ARF/MOSF w/Sepsis,16.0,$11-$25k,26843.0,white,no,0.799999714,0.7999997,no dnr,16.0,69.0,11.7988281,100.0,24.0,36.59375,224.0,3.5996094,0.69995117,0.69995117,137.0,7.419922,129.0,7.0,1800.0,1.0,0.0,SIP>=30,0.0
67.42499,female,0.0,Colon Cancer,12.0,$11-$25k,20324.0,white,metastatic,0.929999828,0.6999998,no dnr,15.0,53.0,10.2988281,113.0,14.0,38.29688,166.65625,2.0996094,0.89990234,0.89990234,138.0,7.379883,140.0,18.0,2130.0,1.0,0.0,no(M2 and SIP pres),0.0
76.19696,male,0.0,ARF/MOSF w/Sepsis,8.0,under $11k,18925.0,white,yes,0.899999619,0.5,no dnr,8.0,127.0,15.2988281,49.0,29.0,36.09375,286.625,3.5996094,1.39990234,0.79992676,137.0,7.40918,136.0,15.0,2210.0,5.0,1.0,adl>=4 (>=5 if sur),3.8549805
63.81699,female,0.0,COPD,16.0,under $11k,18628.0,white,no,0.799999714,0.7999997,dnr before sadm,-1.0,50.0,29.1992188,110.0,32.0,36.59375,270.0,2.2998047,0.89990234,1.0,145.0,7.289062,122.0,30.0,995.0,0.0,3.0,SIP>=30,3.0
76.01398,female,0.0,COPD,8.0,under $11k,8725.0,white,no,0.799999714,0.5999999,dnr before sadm,0.0,67.0,7.5,70.0,20.0,38.39844,663.25,2.8999023,0.89990234,0.69995117,141.0,7.469727,89.0,16.0,750.0,4.0,5.0,SIP>=30,5.0
67.63898,female,0.0,COPD,18.0,under $11k,17103.0,white,no,0.989999771,0.9699998,no dnr,11.0,70.0,12.0,80.0,25.0,36.69531,224.0,2.8999023,0.89990234,2.79980469,137.0,7.419922,104.0,66.0,1968.0,1.0,1.0,no(M2 and SIP pres),1.1667481
44.58298,female,0.0,COPD,12.0,under $11k,39887.0,black,no,0.699999809,0.5,no dnr,24.0,71.0,16.6992188,80.0,30.0,38.09375,260.0,3.7998047,1.09985352,1.29980469,137.0,7.289062,166.0,26.0,3500.0,0.0,1.0,no(M2 and SIP pres),2.9350586
73.42896,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,103441.0,white,no,0.399999857,0.09999996,dnr after sadm,3.0,87.0,18.5,80.0,20.0,36.69531,488.3125,2.8999023,0.89990234,1.09985352,138.0,7.359375,137.0,26.0,600.0,0.0,1.0,<2 mo. follow-up,2.2182617
61.366,female,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,66701.0,white,no,0.799999714,0.6999998,no dnr,26.0,83.0,15.7988281,80.0,20.0,36.39844,248.0,4.0996094,0.39996338,0.89990234,137.0,7.389648,170.0,20.0,2400.0,0.0,0.0,no(M2 and SIP pres),0.0
82.92999,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,20326.0,white,no,0.75,0.5999999,no dnr,14.0,73.0,7.19921875,60.0,15.0,35.79688,224.0,2.8999023,0.89990234,2.0,142.0,7.419922,105.0,41.0,1275.0,3.0,0.0,no(M2 and SIP pres),0.0
83.88196,female,0.0,ARF/MOSF w/Sepsis,15.0,under $11k,83738.0,black,no,0.199999928,0.1999999,no dnr,35.0,111.0,2.79980469,105.0,38.0,36.69531,151.65625,2.5996094,1.69995117,3.79980469,145.0,7.40918,340.0,73.0,3525.0,0.0,0.0,no(M2 and SIP pres),0.0
68.50397,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,36125.0,white,no,0.299999952,0.3,dnr after sadm,6.0,67.0,22.5,120.0,40.0,35.69531,190.0,2.8999023,0.89990234,0.89990234,145.0,7.469727,140.0,8.0,596.0,0.0,0.0,<2 mo. follow-up,0.0
74.91595,male,0.0,CHF,14.0,under $11k,6488.0,white,no,0.699999809,0.5999999,no dnr,5.0,64.0,22.1992188,72.0,8.0,36.39844,122.0,2.8999023,0.89990234,1.09985352,132.0,7.429688,263.0,18.0,1655.0,0.0,1.0,<2 mo. follow-up,1.0
41.26797,male,1.0,ARF/MOSF w/Sepsis,16.0,under $11k,54511.0,white,no,0.5,0.5,dnr after sadm,11.0,51.0,0.89990234,108.0,31.0,35.59375,245.6875,2.5,1.0,1.0,141.0,7.40918,133.0,17.0,2000.0,0.0,0.0,<2 mo. follow-up,0.0
90.18799,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,56886.0,white,no,0.899999619,0.8999996,no dnr,31.0,110.0,15.0,80.0,20.0,37.19531,169.375,3.0,0.89990234,1.69995117,139.0,7.299805,103.0,30.0,3175.0,1.0,0.0,no(M2 and SIP pres),0.0
62.80899,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,110359.0,white,no,0.5,0.3,no dnr,53.0,83.0,2.79980469,72.0,18.0,36.29688,224.0,2.8999023,0.59997559,1.0,133.0,7.419922,94.0,9.0,2500.0,0.0,0.0,<2 mo. follow-up,0.0
81.862,male,0.0,ARF/MOSF w/Sepsis,8.0,$11-$25k,13348.0,white,yes,0.949999809,0.8999996,no dnr,7.0,53.0,10.8984375,80.0,15.0,38.89844,224.0,1.8999023,0.89990234,13.1992188,141.0,7.419922,96.0,52.0,0.0,1.0,1.0,no(M2 and SIP pres),1.0
92.59998,male,0.0,CHF,12.0,under $11k,4591.0,white,yes,0.699999809,0.5,no dnr,4.0,63.0,14.5996094,120.0,30.0,36.69531,216.65625,3.699707,0.5,0.79992676,145.0,7.359375,100.0,9.0,1968.0,0.0,1.0,SIP>=30,0.494751
63.23297,male,0.0,Colon Cancer,9.0,under $11k,21338.0,white,metastatic,0.949999809,0.5,dnr after sadm,10.0,103.0,14.8984375,80.0,20.0,36.09375,142.84375,2.8999023,0.89990234,1.0,136.0,7.339844,115.0,39.0,2300.0,1.0,0.0,no(M2 and SIP pres),0.0
37.16599,male,0.0,Cirrhosis,12.0,under $11k,41987.0,white,no,0.5,0.3999999,no dnr,35.0,97.0,14.0,80.0,25.0,36.69531,204.75,2.8999023,0.89990234,1.09985352,143.0,7.369141,131.0,16.0,1968.0,1.0,3.0,no(M2 and SIP pres),3.0
75.409,male,0.0,ARF/MOSF w/Sepsis,9.0,under $11k,33492.0,white,no,0.899999619,0.8499999,no dnr,8.0,66.0,6.39941406,116.0,8.0,36.09375,222.0,3.0,1.19995117,3.79980469,142.0,7.209961,112.0,58.0,4150.0,0.0,1.0,no(M2 and SIP pres),0.494751
72.534,male,0.0,COPD,8.0,under $11k,6225.0,white,yes,0.299999952,0.09999996,no dnr,5.0,61.0,23.1992188,130.0,10.0,38.69531,270.0,2.8999023,0.89990234,1.19995117,147.0,7.389648,155.0,46.0,2159.0,0.0,4.0,<2 mo. follow-up,4.0
80.66296,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,67475.0,white,no,0.099999964,0.09999996,dnr after sadm,16.0,69.0,12.0996094,125.0,28.0,35.59375,149.0,3.699707,0.89990234,6.19921875,123.0,7.179688,159.0,89.0,1395.0,0.0,1.0,<2 mo. follow-up,2.2944336
75.90698,male,0.0,ARF/MOSF w/Sepsis,16.0,$25-$50k,61597.0,white,no,0.049999982,0.04999998,no dnr,21.0,63.0,7.59960938,64.0,26.0,36.59375,285.0,2.8999023,0.89990234,1.0,141.0,7.399414,130.0,23.0,1350.0,0.0,0.0,SIP>=30,0.0
88.99396,male,0.0,COPD,16.0,under $11k,16074.0,white,no,0.699999809,0.5,dnr before sadm,-1.0,55.0,33.0,76.0,11.0,36.19531,88.0,2.0,0.89990234,0.69995117,147.0,7.379883,116.0,11.0,3531.0,0.0,1.0,no(M2 and SIP pres),0.494751
52.73398,male,0.0,Coma,12.0,under $11k,70943.0,white,no,0.5,0.5,dnr after sadm,54.0,45.0,2.09960938,118.0,20.0,38.69531,98.75,3.5996094,4.0,2.5,138.0,7.279297,121.0,54.0,1300.0,0.0,1.0,<2 mo. follow-up,1.7128906
80.37195,female,0.0,ARF/MOSF w/Sepsis,17.0,$25-$50k,42111.0,white,no,0.849999905,0.7999997,no dnr,21.0,107.0,7.0,70.0,20.0,36.09375,206.65625,3.7998047,0.89990234,1.29980469,144.0,7.469727,95.0,16.0,2200.0,0.0,1.0,SIP>=30,2.8959961
80.24097,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,26305.0,white,yes,0.899999619,0.8999996,no dnr,16.0,43.0,5.89941406,117.0,42.0,39.19531,108.0,2.5996094,0.5,1.29980469,136.0,7.439453,215.0,19.0,3770.0,1.0,0.0,no(M2 and SIP pres),0.0
50.46698,male,0.0,COPD,10.0,under $11k,11153.0,black,yes,0.699999809,0.5999999,no dnr,8.0,60.0,15.8984375,60.0,24.0,36.29688,91.65625,2.2998047,0.89990234,1.69995117,139.0,7.429688,113.0,34.0,3075.0,0.0,0.0,no(M2 and SIP pres),0.0
70.20898,male,0.0,Cirrhosis,12.0,$25-$50k,18113.0,white,no,0.799999714,0.5999999,no dnr,14.0,103.0,5.19921875,68.0,22.0,37.69531,263.3125,2.8999023,0.89990234,3.5,131.0,7.40918,245.0,65.0,2395.0,1.0,2.0,SIP>=30,2.0
79.71497,female,0.0,COPD,12.0,under $11k,18665.0,white,yes,0.5,0.1999999,dnr before sadm,-1.0,59.0,10.5996094,69.0,20.0,36.69531,178.3125,3.5996094,1.79980469,2.39990234,138.0,7.15918,85.0,33.0,850.0,0.0,7.0,<2 mo. follow-up,7.0
38.39798,male,0.0,ARF/MOSF w/Sepsis,15.0,under $11k,308151.0,white,no,0.5,0.5,no dnr,127.0,103.0,5.59960938,70.0,20.0,36.69531,224.0,2.8999023,0.89990234,1.69995117,143.0,7.419922,103.0,32.0,1310.0,0.0,3.0,adl>=4 (>=5 if sur),3.0
72.487,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,86066.0,black,no,0.699999809,0.5,dnr before sadm,0.0,63.0,6.09960938,80.0,20.0,36.09375,224.0,2.8999023,1.59985352,1.89990234,135.0,7.419922,98.0,27.0,2000.0,0.0,1.0,<2 mo. follow-up,4.9462891
71.17896,female,0.0,Lung Cancer,16.0,$25-$50k,17762.0,black,metastatic,0.75,0.5,no dnr,12.0,56.0,26.0976562,72.0,28.0,36.09375,224.0,1.2998047,24.3984375,2.39990234,112.0,7.419922,477.0,28.0,1040.0,0.0,0.0,no(M2 and SIP pres),0.0
63.767,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,59345.0,white,no,0.5,0.75,no dnr,26.0,80.0,6.19921875,80.0,20.0,36.09375,266.625,2.5,0.89990234,0.89990234,134.0,7.5,124.0,11.0,1100.0,1.0,0.0,no(M2 and SIP pres),0.0
91.98395,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,5355.0,white,no,0.699999809,0.5,dnr after sadm,1.0,107.0,8.29882812,80.0,15.0,36.09375,484.0,2.5,0.89990234,2.39990234,138.0,7.339844,192.0,36.0,1300.0,0.0,1.0,no(M2 and SIP pres),2.6958008
70.87994,male,0.0,Lung Cancer,12.0,under $11k,5514.0,white,metastatic,0.799999714,0.3,no dnr,6.0,119.0,9.59960938,140.0,12.0,34.59375,150.0,2.199707,0.89990234,0.79992676,144.0,7.429688,90.0,54.0,2955.0,4.0,5.0,<2 mo. follow-up,5.0
77.65399,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,14591.0,white,no,0.899999619,0.7999997,no dnr,10.0,53.0,13.1992188,72.0,10.0,38.29688,80.0,2.5996094,0.89990234,2.59960938,130.0,7.319336,121.0,62.0,2362.0,0.0,1.0,<2 mo. follow-up,3.1147461
59.58398,male,0.0,MOSF w/Malig,20.0,>$50k,106109.0,white,metastatic,0.899999619,0.7999997,no dnr,48.0,61.0,7.5,112.0,40.0,37.59375,122.4375,3.199707,0.89990234,0.89990234,141.0,7.399414,139.0,39.0,1130.0,0.0,0.0,no(M2 and SIP pres),0.0
42.69998,male,0.0,COPD,14.0,under $11k,6088.0,hispanic,no,0.979999542,0.9599996,no dnr,4.0,107.0,12.3984375,111.0,36.0,38.79688,156.0,3.699707,0.89990234,0.89990234,145.0,7.459961,105.0,31.0,1640.0,0.0,1.0,<2 mo. follow-up,0.494751
40.745,male,0.0,ARF/MOSF w/Sepsis,17.0,$11-$25k,21615.0,white,no,0.699999809,0.6499996,no dnr,12.0,60.0,20.796875,114.0,32.0,37.89844,220.0,2.8999023,0.89990234,1.19995117,134.0,7.479492,116.0,23.0,2878.0,0.0,1.0,<2 mo. follow-up,0.494751
84.58899,male,0.0,CHF,17.0,$25-$50k,12772.0,white,no,0.75,0.5,no dnr,7.0,53.0,22.5976562,69.0,28.0,38.0,234.28125,3.0996094,0.5,6.69921875,127.0,7.369141,162.0,84.0,2260.0,0.0,0.0,no(M2 and SIP pres),0.0
38.21997,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,165549.0,black,no,0.699999809,0.5999999,no dnr,65.0,113.0,6.89941406,65.0,13.0,36.29688,224.0,3.699707,0.5,0.89990234,139.0,7.419922,176.0,11.0,2400.0,0.0,1.0,no(M2 and SIP pres),2.4521484
66.57098,female,0.0,MOSF w/Malig,8.0,under $11k,21336.0,hispanic,yes,1.0,0.8999996,no dnr,17.0,83.0,6.09960938,80.0,20.0,36.09375,224.0,3.2998047,1.69995117,1.59985352,138.0,7.419922,65.0,30.0,300.0,2.0,0.0,no(M2 and SIP pres),0.0
72.09296,female,1.0,Coma,12.0,$11-$25k,92723.0,black,no,0.799999714,0.75,dnr after sadm,12.0,93.0,8.69921875,70.0,20.0,36.09375,224.0,2.8999023,0.39996338,6.5,133.0,7.419922,111.0,97.0,1200.0,0.0,2.0,<2 mo. follow-up,2.0
42.99799,male,0.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,58702.0,white,no,0.5,0.5,no dnr,23.0,55.0,16.8984375,78.0,10.0,35.0,65.0,2.0,0.59997559,0.59997559,137.0,7.389648,144.0,4.0,1906.0,0.0,0.0,<2 mo. follow-up,0.0
68.88196,male,0.0,COPD,13.0,$11-$25k,8507.0,white,metastatic,0.799999714,0.5999999,no dnr,7.0,60.0,11.5996094,80.0,36.0,33.79688,96.65625,2.5,2.09960938,2.39990234,149.0,7.529297,85.0,54.0,1735.0,1.0,0.0,no(M2 and SIP pres),0.0
70.20398,female,0.0,COPD,11.0,$11-$25k,6931.0,white,no,0.949999809,0.8999996,no dnr,6.0,107.0,4.59960938,69.0,28.0,38.19531,224.0,2.8999023,0.89990234,1.5,134.0,7.419922,333.0,17.0,3480.0,2.0,1.0,no(M2 and SIP pres),1.8388672
92.33899,female,0.0,ARF/MOSF w/Sepsis,18.0,under $11k,34012.0,white,no,0.75,0.75,no dnr,24.0,52.0,8.5,81.0,8.0,38.89844,295.0,2.8999023,0.89990234,1.09985352,139.0,7.419922,101.0,18.0,2212.0,0.0,1.0,SIP>=30,0.494751
85.34399,female,0.0,Coma,12.0,under $11k,41743.0,white,yes,0.299999952,0.09999996,dnr after sadm,1.0,93.0,6.79980469,60.0,20.0,37.59375,318.0,2.8999023,0.89990234,1.0,141.0,7.5,95.0,26.0,1968.0,0.0,3.0,adl>=4 (>=5 if sur),3.0
87.71497,male,1.0,Coma,12.0,under $11k,7018.0,white,no,0.699999809,0.5,dnr after sadm,1.0,80.0,20.5976562,110.0,25.0,37.79688,224.0,2.5996094,0.89990234,1.19995117,133.0,7.419922,93.0,21.0,1475.0,0.0,1.0,<2 mo. follow-up,2.1518555
49.155,male,0.0,Cirrhosis,16.0,>$50k,46039.0,white,no,0.799999714,0.75,dnr after sadm,13.0,60.0,22.1992188,108.0,30.0,38.59375,135.0,2.8999023,1.39990234,1.0,136.0,7.319336,164.0,26.0,2140.0,3.0,3.0,<2 mo. follow-up,3.0
87.44397,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,7418.0,white,yes,0.0,0.0,dnr after sadm,1.0,45.0,7.69921875,54.0,26.0,38.79688,170.0,2.0,7.39941406,0.89990234,139.0,7.379883,88.0,40.0,2450.0,0.0,1.0,<2 mo. follow-up,2.8549805
71.74799,female,0.0,ARF/MOSF w/Sepsis,16.0,under $11k,68313.0,white,no,0.599999905,0.5,no dnr,16.0,74.0,6.0,72.0,24.0,36.79688,176.1875,2.8999023,0.89990234,0.79992676,137.0,7.289062,98.0,8.0,1650.0,0.0,0.0,no(M2 and SIP pres),0.0
32.75598,female,0.0,ARF/MOSF w/Sepsis,17.0,under $11k,22857.0,white,no,0.989999771,0.9899998,no dnr,16.0,147.0,11.2988281,78.0,6.0,38.39844,89.0,3.199707,0.69995117,1.19995117,147.0,7.339844,149.0,31.0,2090.0,1.0,1.0,SIP>=30,1.0
80.22498,female,0.0,Lung Cancer,12.0,under $11k,7970.0,white,metastatic,0.799999714,0.3,dnr after sadm,1.0,77.0,6.79980469,80.0,25.0,36.39844,136.65625,4.0996094,0.79992676,1.39990234,141.0,7.319336,104.0,23.0,2720.0,1.0,6.0,<2 mo. follow-up,6.0
79.65796,male,1.0,MOSF w/Malig,12.0,under $11k,9602.0,white,metastatic,0.099999964,0.0,dnr after sadm,1.0,127.0,15.0,110.0,8.0,36.39844,194.0,2.0,0.89990234,6.19921875,137.0,7.419922,73.0,44.0,95.0,0.0,3.0,<2 mo. follow-up,3.0
74.72095,male,0.0,CHF,16.0,>$50k,5136.0,white,no,0.199999928,0.09999996,no dnr,4.0,61.0,9.69921875,108.0,32.0,36.69531,266.625,2.2998047,1.09985352,1.29980469,143.0,7.55957,145.0,21.0,1160.0,0.0,1.0,no(M2 and SIP pres),2.1064453
68.50696,female,0.0,Lung Cancer,12.0,under $11k,12682.0,white,metastatic,0.699999809,0.1999999,no dnr,12.0,67.0,8.8984375,76.0,24.0,36.59375,306.0625,2.8999023,0.89990234,2.29980469,139.0,7.419922,298.0,33.0,928.0,0.0,1.0,<2 mo. follow-up,2.2397461
59.79498,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,33532.0,black,no,0.599999905,0.3999999,dnr after sadm,5.0,48.0,55.59375,70.0,0.0,38.19531,128.0,2.8999023,0.89990234,0.79992676,131.0,7.419922,144.0,9.0,4675.0,0.0,1.0,<2 mo. follow-up,3.2382812
92.32599,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,21252.0,white,no,0.25,0.25,dnr before sadm,0.0,101.0,7.59960938,60.0,28.0,36.09375,163.3125,3.699707,0.59997559,0.89990234,139.0,7.469727,227.0,12.0,1850.0,0.0,1.0,<2 mo. follow-up,6.1230469
73.63696,female,0.0,CHF,12.0,under $11k,8924.0,white,no,0.899999619,0.75,no dnr,9.0,83.0,6.09960938,100.0,25.0,35.59375,271.375,2.8999023,0.89990234,1.19995117,142.0,7.419922,103.0,28.0,800.0,1.0,2.0,SIP>=30,2.0
82.57397,male,0.0,ARF/MOSF w/Sepsis,17.0,$11-$25k,52314.0,white,no,0.699999809,0.5,no dnr,14.0,115.0,12.5996094,156.0,14.0,36.29688,252.375,2.699707,0.89990234,2.39990234,139.0,7.469727,146.0,55.0,1913.0,0.0,1.0,no(M2 and SIP pres),3.1118164
61.728,male,0.0,CHF,13.0,$11-$25k,12263.0,white,yes,0.899999619,0.7999997,no dnr,9.0,135.0,13.8984375,60.0,25.0,37.79688,238.09375,2.8999023,0.59997559,1.29980469,136.0,7.319336,108.0,25.0,2170.0,0.0,0.0,no(M2 and SIP pres),0.0
81.021,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,71731.0,white,yes,0.099999964,0.09999996,no dnr,7.0,33.0,19.3984375,68.0,44.0,40.0,347.0,2.8999023,0.89990234,2.19970703,136.0,7.419922,547.0,39.0,64.0,0.0,0.0,<2 mo. follow-up,0.0
79.68195,female,1.0,MOSF w/Malig,12.0,under $11k,44745.0,white,yes,0.799999714,0.5999999,dnr after sadm,4.0,100.0,12.5,70.0,25.0,36.69531,428.5625,2.3999023,7.29980469,1.39990234,126.0,7.549805,335.0,43.0,2020.0,0.0,1.0,<2 mo. follow-up,2.4433594
75.18695,female,0.0,ARF/MOSF w/Sepsis,13.0,under $11k,7456.0,black,no,1.0,1.0,no dnr,5.0,46.0,15.8984375,109.0,8.0,35.89844,238.09375,3.0996094,0.89990234,1.59985352,135.0,7.419922,204.0,26.0,253.0,0.0,0.0,no(M2 and SIP pres),0.0
62.26099,male,0.0,ARF/MOSF w/Sepsis,14.0,under $11k,39981.0,white,metastatic,0.5,0.09999996,dnr after sadm,2.0,111.0,7.19921875,69.0,36.0,38.29688,196.65625,3.199707,0.89990234,2.79980469,136.0,7.15918,272.0,36.0,2115.0,2.0,0.0,no(M2 and SIP pres),0.0
66.51294,female,0.0,COPD,12.0,under $11k,4732.0,white,yes,0.899999619,0.7999997,no dnr,5.0,63.0,14.0,130.0,35.0,36.59375,150.0,2.2998047,0.19998169,0.79992676,145.0,7.519531,111.0,12.0,1180.0,0.0,1.0,<2 mo. follow-up,3.8969727
70.20099,female,0.0,ARF/MOSF w/Sepsis,14.0,$11-$25k,22622.0,white,no,0.949999809,0.9499998,no dnr,11.0,100.0,8.5,110.0,25.0,36.69531,224.0,3.3999023,0.89990234,1.09985352,137.0,7.419922,209.0,28.0,800.0,0.0,0.0,no(M2 and SIP pres),0.0
75.66296,female,0.0,Lung Cancer,16.0,>$50k,30159.0,white,metastatic,0.899999619,0.5,dnr after sadm,16.0,73.0,6.59960938,120.0,35.0,35.0,457.125,2.8999023,1.0,2.5,142.0,7.529297,227.0,61.0,550.0,1.0,3.0,adl>=4 (>=5 if sur),3.0
73.06,female,0.0,ARF/MOSF w/Sepsis,16.0,$25-$50k,31491.0,white,yes,1.0,1.0,no dnr,10.0,80.0,6.09960938,80.0,25.0,36.69531,276.1875,2.8999023,0.89990234,1.79980469,139.0,7.449219,116.0,41.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
81.73297,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,28287.0,white,yes,0.299999952,0.3,dnr after sadm,3.0,87.0,13.5996094,68.0,20.0,36.5,224.0,4.2998047,0.69995117,0.89990234,139.0,7.419922,124.0,20.0,1750.0,0.0,1.0,<2 mo. follow-up,5.3720703
84.82098,female,1.0,ARF/MOSF w/Sepsis,18.0,>$50k,45150.0,white,no,0.799999714,0.7999997,dnr after sadm,7.0,53.0,14.7988281,106.0,10.0,39.29688,108.32812,2.2998047,0.59997559,8.19921875,147.0,7.429688,109.0,40.0,0.0,0.0,6.0,<2 mo. follow-up,6.0
49.82898,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,32057.0,black,metastatic,0.0,0.0,dnr after sadm,1.0,163.0,5.39941406,150.0,37.0,38.0,72.0,2.5,0.59997559,0.79992676,142.0,7.369141,163.0,31.0,1625.0,0.0,1.0,<2 mo. follow-up,4.8066406
68.31995,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,15734.0,white,no,0.899999619,0.8999996,no dnr,7.0,103.0,9.3984375,60.0,20.0,36.09375,224.0,2.8999023,0.89990234,1.39990234,140.0,7.419922,129.0,44.0,2275.0,0.0,1.0,no(M2 and SIP pres),1.0
47.87399,male,0.0,ARF/MOSF w/Sepsis,16.0,under $11k,124925.0,white,no,0.099999964,0.09999996,no dnr,28.0,56.0,4.39941406,48.0,22.0,36.09375,224.0,3.0996094,0.59997559,1.09985352,143.0,7.419922,106.0,14.0,1370.0,0.0,1.0,no(M2 and SIP pres),1.0
70.35199,female,0.0,ARF/MOSF w/Sepsis,10.0,under $11k,100587.0,hispanic,no,0.699999809,0.6999998,no dnr,17.0,83.0,7.0,80.0,35.0,35.59375,366.625,2.8999023,0.39996338,1.19995117,136.0,7.429688,107.0,14.0,2980.0,1.0,1.0,no(M2 and SIP pres),1.0
85.63196,male,0.0,ARF/MOSF w/Sepsis,14.0,$11-$25k,55663.0,white,yes,0.799999714,0.6999998,no dnr,19.0,69.0,15.0996094,66.0,20.0,36.09375,111.65625,2.0996094,0.89990234,3.29980469,139.0,7.439453,432.0,129.0,2400.0,3.0,1.0,<2 mo. follow-up,2.5107422
64.08197,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,37130.0,black,yes,0.799999714,0.6999998,no dnr,17.0,63.0,7.09960938,120.0,42.0,36.89844,135.0,3.199707,1.19995117,0.79992676,146.0,7.429688,131.0,17.0,1010.0,0.0,0.0,no(M2 and SIP pres),0.0
77.59296,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,37632.0,white,yes,0.25,0.04999998,dnr after sadm,1.0,101.0,4.89941406,55.0,25.0,36.19531,266.625,4.3994141,0.5,0.69995117,144.0,7.439453,117.0,15.0,3200.0,3.0,1.0,<2 mo. follow-up,1.0
76.78595,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,8474.0,white,no,0.989999771,0.8999996,no dnr,5.0,105.0,16.0,80.0,28.0,36.29688,138.3125,2.5996094,0.79992676,0.69995117,142.0,7.40918,136.0,20.0,1550.0,0.0,1.0,no(M2 and SIP pres),1.78125
74.32996,male,1.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,27511.0,white,yes,0.099999964,0.0,dnr after sadm,3.0,100.0,10.5996094,90.0,25.0,36.09375,242.84375,2.8999023,0.29998779,1.09985352,133.0,7.359375,163.0,22.0,1968.0,0.0,1.0,<2 mo. follow-up,5.7832031
58.34598,male,0.0,Colon Cancer,16.0,>$50k,20169.0,white,metastatic,0.899999619,0.6999998,no dnr,13.0,82.0,27.3984375,70.0,24.0,36.09375,197.125,2.699707,0.5,1.09985352,138.0,7.369141,86.0,22.0,1600.0,1.0,0.0,no(M2 and SIP pres),0.0
52.98599,female,1.0,ARF/MOSF w/Sepsis,14.0,>$50k,165799.0,white,no,0.099999964,0.04999998,dnr after sadm,25.0,93.0,6.09960938,60.0,15.0,37.0,224.0,2.7998047,0.89990234,0.69995117,134.0,7.419922,249.0,25.0,1968.0,0.0,4.0,<2 mo. follow-up,4.0
42.17899,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,95443.0,black,no,0.949999809,0.8999996,no dnr,28.0,110.0,4.89941406,110.0,32.0,38.29688,183.3125,2.8999023,0.89990234,0.89990234,143.0,7.489258,121.0,9.0,4685.0,0.0,0.0,SIP>=30,0.0
70.11896,female,0.0,ARF/MOSF w/Sepsis,14.0,under $11k,72087.0,white,no,0.25,0.15,no dnr,35.0,79.0,10.8984375,140.0,38.0,38.09375,269.375,2.7998047,0.59997559,1.19995117,138.0,7.379883,167.0,33.0,600.0,0.0,0.0,<2 mo. follow-up,0.0
72.46497,male,0.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,20845.0,white,yes,0.799999714,0.5999999,no dnr,13.0,48.0,10.3984375,134.0,10.0,38.29688,170.0,2.8999023,0.89990234,1.29980469,143.0,7.359375,121.0,32.0,505.0,0.0,0.0,<2 mo. follow-up,0.0
66.00397,female,0.0,MOSF w/Malig,13.0,$11-$25k,20343.0,hispanic,metastatic,0.099999964,0.0,dnr after sadm,3.0,97.0,24.5,100.0,5.0,37.79688,111.65625,2.8999023,0.89990234,1.09985352,137.0,7.449219,136.0,29.0,1968.0,2.0,3.0,<2 mo. follow-up,3.0
72.38098,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,71071.0,white,no,0.799999714,0.75,no dnr,17.0,129.0,5.0,106.0,34.0,38.19531,360.0,3.199707,1.39990234,1.19995117,142.0,7.449219,95.0,24.0,3710.0,5.0,0.0,no(M2 and SIP pres),0.0
74.875,female,0.0,CHF,12.0,under $11k,7262.0,other,no,0.699999809,0.5,no dnr,7.0,47.0,18.5976562,113.0,34.0,38.79688,53.0,2.2998047,0.89990234,0.89990234,143.0,7.369141,154.0,17.0,1968.0,1.0,1.0,no(M2 and SIP pres),1.0
75.03094,female,0.0,COPD,12.0,under $11k,59400.0,white,no,0.649999619,0.6499996,no dnr,27.0,99.0,24.1992188,70.0,16.0,36.39844,334.25,2.8999023,0.79992676,7.79980469,137.0,7.359375,160.0,47.0,5.0,0.0,1.0,<2 mo. follow-up,2.7119141
30.752,female,0.0,ARF/MOSF w/Sepsis,8.0,under $11k,107237.0,white,no,0.899999619,0.7289996,no dnr,39.0,57.0,6.0,144.0,36.0,40.19531,111.65625,2.8999023,0.89990234,1.29980469,134.0,7.40918,169.0,21.0,3775.0,0.0,1.0,<2 mo. follow-up,2.9794922
93.008,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,30466.0,white,no,0.799999714,0.6999998,dnr after sadm,5.0,56.0,10.2988281,68.0,30.0,36.09375,450.0,3.0996094,0.89990234,1.59985352,143.0,7.339844,112.0,58.0,950.0,0.0,7.0,<2 mo. follow-up,7.0
43.92297,female,0.0,ARF/MOSF w/Sepsis,13.0,$25-$50k,8939.0,white,no,0.699999809,0.5,no dnr,5.0,120.0,14.2988281,74.0,38.0,38.09375,224.0,2.699707,0.29998779,3.79980469,142.0,7.419922,207.0,58.0,3100.0,0.0,1.0,no(M2 and SIP pres),1.7971191
64.52795,female,0.0,ARF/MOSF w/Sepsis,9.0,under $11k,13593.0,white,no,0.899999619,0.8999996,no dnr,7.0,97.0,6.89941406,80.0,20.0,37.79688,261.875,2.8999023,0.89990234,0.89990234,143.0,7.399414,87.0,21.0,250.0,0.0,0.0,no(M2 and SIP pres),0.0
73.89496,female,1.0,MOSF w/Malig,12.0,under $11k,32243.0,white,metastatic,0.699999809,0.5,dnr before sadm,-1.0,76.0,5.39941406,58.0,28.0,36.59375,361.875,2.8999023,0.89990234,1.09985352,135.0,7.439453,133.0,39.0,492.0,0.0,1.0,<2 mo. follow-up,2.4311523
47.16498,male,0.0,Cirrhosis,14.0,>$50k,23887.0,white,no,0.799999714,0.7999997,no dnr,11.0,103.0,4.69921875,60.0,15.0,36.69531,224.0,2.8999023,0.59997559,1.19995117,138.0,7.419922,114.0,20.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
82.409,male,0.0,ARF/MOSF w/Sepsis,16.0,>$50k,133174.0,white,yes,0.989999771,0.9499998,dnr after sadm,22.0,150.0,31.0,102.0,38.0,36.29688,184.0,2.0,1.39990234,1.5,127.0,7.40918,323.0,37.0,1810.0,0.0,0.0,no(M2 and SIP pres),0.0
65.58197,female,0.0,ARF/MOSF w/Sepsis,16.0,>$50k,194085.0,white,no,0.25,0.25,no dnr,73.0,119.0,8.0,119.0,28.0,39.59375,224.0,3.199707,1.59985352,7.09960938,140.0,7.419922,151.0,22.0,0.0,0.0,2.0,adl>=4 (>=5 if sur),2.0
52.89499,female,0.0,ARF/MOSF w/Sepsis,16.0,$25-$50k,64598.0,white,no,0.5,0.3,dnr after sadm,3.0,47.0,3.79980469,108.0,26.0,36.39844,120.0,2.0,0.89990234,3.89990234,136.0,7.419922,179.0,50.0,2030.0,4.0,5.0,adl>=4 (>=5 if sur),5.0
79.85199,female,0.0,MOSF w/Malig,12.0,$11-$25k,38248.0,white,metastatic,0.799999714,0.75,dnr after sadm,4.0,52.0,10.0996094,138.0,24.0,35.0,95.0,3.199707,0.89990234,1.39990234,139.0,7.439453,132.0,38.0,1550.0,0.0,1.0,SIP>=30,1.0
83.20898,female,1.0,ARF/MOSF w/Sepsis,10.0,$25-$50k,23733.0,white,no,0.299999952,0.1999999,dnr after sadm,1.0,113.0,12.0,114.0,28.0,37.59375,75.0,2.8999023,0.89990234,0.69995117,134.0,7.199219,256.0,7.0,2275.0,5.0,0.0,<2 mo. follow-up,0.0
74.45898,female,1.0,Coma,9.0,under $11k,268852.0,white,no,0.699999809,0.5,no dnr,65.0,55.0,6.09960938,49.0,16.0,36.79688,146.9375,3.0996094,0.89990234,2.69970703,139.0,7.419922,103.0,29.0,1365.0,0.0,1.0,<2 mo. follow-up,1.9885254
53.75497,female,0.0,Cirrhosis,4.0,under $11k,20960.0,white,no,0.599999905,0.5,no dnr,14.0,93.0,4.39941406,80.0,20.0,36.69531,246.65625,2.8999023,0.89990234,1.19995117,140.0,7.439453,87.0,30.0,1800.0,5.0,6.0,<2 mo. follow-up,6.0
89.60699,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,11821.0,white,yes,0.5,0.1999999,no dnr,6.0,53.0,8.19921875,68.0,8.0,36.69531,200.0,3.0,1.29980469,0.69995117,142.0,7.389648,111.0,32.0,1050.0,2.0,1.0,adl>=4 (>=5 if sur),1.8388672
76.35297,male,0.0,COPD,12.0,under $11k,78784.0,white,yes,0.899999619,0.6999998,dnr after sadm,1.0,103.0,4.69921875,120.0,28.0,38.79688,343.3125,2.8999023,1.09985352,0.69995117,132.0,7.399414,117.0,6.0,3525.0,0.0,0.0,no(M2 and SIP pres),0.0
68.42999,male,1.0,ARF/MOSF w/Sepsis,8.0,under $11k,229885.0,white,yes,0.599999905,0.5999999,dnr after sadm,14.0,63.0,8.09960938,75.0,10.0,36.19531,230.0,2.7998047,0.69995117,1.09985352,143.0,7.269531,196.0,53.0,850.0,0.0,2.0,<2 mo. follow-up,2.0
78.44995,male,0.0,CHF,12.0,under $11k,25633.0,white,yes,0.299999952,0.04999998,no dnr,9.0,97.0,6.59960938,60.0,20.0,36.09375,224.0,2.8999023,0.89990234,0.69995117,141.0,7.299805,183.0,7.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
73.37994,female,0.0,CHF,9.0,under $11k,4327.0,white,no,0.899999619,0.7999997,no dnr,4.0,80.0,13.5,180.0,20.0,36.09375,260.0,2.8999023,0.89990234,0.69995117,138.0,7.419922,82.0,8.0,850.0,0.0,1.0,no(M2 and SIP pres),0.494751
73.89697,male,0.0,CHF,17.0,$25-$50k,13112.0,white,no,0.949999809,0.8999996,no dnr,9.0,39.0,31.3984375,118.0,28.0,37.29688,70.0,1.5,0.59997559,2.5,136.0,7.109375,230.0,51.0,50.0,0.0,1.0,<2 mo. follow-up,1.0
41.91898,male,0.0,ARF/MOSF w/Sepsis,15.0,$25-$50k,86133.0,white,no,0.699999809,0.6999998,no dnr,21.0,65.0,17.5976562,116.0,16.0,37.89844,224.0,2.0996094,2.09960938,1.09985352,132.0,7.419922,109.0,29.0,450.0,0.0,0.0,no(M2 and SIP pres),0.0
81.16595,male,0.0,Lung Cancer,24.0,$25-$50k,32597.0,white,metastatic,0.799999714,0.3,dnr after sadm,7.0,107.0,7.29980469,72.0,24.0,36.89844,262.9375,2.8999023,0.89990234,2.19970703,139.0,7.40918,129.0,54.0,1450.0,0.0,4.0,<2 mo. follow-up,4.0
22.63399,male,0.0,ARF/MOSF w/Sepsis,12.0,>$50k,489823.0,white,no,0.599999905,0.5,no dnr,154.0,127.0,20.296875,130.0,40.0,38.19531,132.0,2.0996094,0.89990234,0.59997559,146.0,7.439453,111.0,9.0,1016.0,0.0,0.0,Coma or Intub,0.0
84.49298,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,183705.0,white,metastatic,0.799999714,0.5,no dnr,86.0,111.0,17.6992188,105.0,16.0,35.59375,195.21875,3.7998047,0.59997559,4.69921875,132.0,7.489258,119.0,23.0,0.0,0.0,1.0,adl>=4 (>=5 if sur),3.7641602
18.754,female,0.0,ARF/MOSF w/Sepsis,13.0,under $11k,15711.0,other,no,0.979999542,0.9799995,no dnr,8.0,124.0,16.0976562,50.0,24.0,38.5,105.0,2.8999023,0.89990234,1.5,142.0,7.399414,172.0,35.0,1664.0,0.0,1.0,no(M2 and SIP pres),1.0
77.05695,male,0.0,MOSF w/Malig,16.0,under $11k,23606.0,white,yes,0.599999905,0.5,no dnr,11.0,52.0,7.0,120.0,29.0,36.79688,95.90625,2.8999023,0.89990234,0.89990234,131.0,7.489258,95.0,17.0,4300.0,1.0,0.0,no(M2 and SIP pres),0.0
82.86395,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,26475.0,white,no,0.199999928,0.1999999,dnr after sadm,2.0,63.0,16.3984375,60.0,4.0,36.59375,65.0,2.8999023,0.29998779,0.79992676,145.0,7.329102,253.0,15.0,2275.0,0.0,1.0,<2 mo. follow-up,3.0263672
64.81598,female,0.0,ARF/MOSF w/Sepsis,16.0,$11-$25k,227656.0,white,no,0.799999714,0.75,no dnr,79.0,67.0,7.29980469,80.0,20.0,37.0,271.375,2.8999023,6.5,1.5,140.0,7.469727,183.0,21.0,1200.0,0.0,5.0,adl>=4 (>=5 if sur),5.0
91.25,female,0.0,Lung Cancer,12.0,under $11k,6621.0,white,metastatic,0.599999905,0.1999999,dnr after sadm,3.0,59.0,5.0,120.0,24.0,35.79688,261.875,2.8999023,0.89990234,3.79980469,139.0,7.279297,88.0,86.0,490.0,2.0,3.0,<2 mo. follow-up,3.0
73.54999,male,0.0,MOSF w/Malig,12.0,under $11k,37467.0,white,metastatic,0.849999905,0.5999999,dnr after sadm,14.0,77.0,8.69921875,70.0,25.0,36.69531,305.0,2.2998047,1.09985352,1.09985352,140.0,7.479492,106.0,14.0,4745.0,1.0,1.0,<2 mo. follow-up,1.0
84.64899,female,1.0,Coma,12.0,under $11k,10739.0,white,no,0.699999809,0.5,dnr after sadm,3.0,60.0,14.6992188,1.0,40.0,36.89844,100.0,2.0,1.89990234,2.09960938,136.0,7.449219,172.0,26.0,972.0,0.0,1.0,<2 mo. follow-up,3.4047852
34.45898,male,0.0,CHF,12.0,under $11k,3212.0,black,no,0.699999809,0.5,no dnr,3.0,51.0,4.5,79.0,25.0,36.09375,224.0,2.8999023,0.5,1.19995117,138.0,7.419922,101.0,16.0,750.0,0.0,1.0,no(M2 and SIP pres),1.7236328
94.28894,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,4854.0,white,no,0.699999809,0.5999999,no dnr,18.0,120.0,7.69921875,70.0,20.0,35.59375,224.0,2.8999023,0.89990234,1.09985352,137.0,7.419922,250.0,21.0,1000.0,0.0,1.0,adl>=4 (>=5 if sur),1.0
65.65594,female,0.0,ARF/MOSF w/Sepsis,20.0,>$50k,14770.0,white,no,1.0,1.0,no dnr,5.0,105.0,12.0,60.0,24.0,36.59375,224.0,3.7998047,1.79980469,1.89990234,139.0,7.419922,124.0,44.0,1175.0,0.0,1.0,no(M2 and SIP pres),1.9521484
77.14697,male,0.0,ARF/MOSF w/Sepsis,16.0,under $11k,6100.0,white,no,1.0,0.8999996,no dnr,3.0,79.0,12.5996094,106.0,30.0,38.09375,106.65625,2.699707,0.19998169,0.69995117,133.0,7.389648,101.0,13.0,7130.0,1.0,0.0,no(M2 and SIP pres),0.0
63.17899,male,0.0,CHF,22.0,>$50k,4222.0,white,yes,0.849999905,0.5,no dnr,3.0,73.0,8.0,80.0,16.0,36.09375,224.0,3.199707,0.89990234,1.29980469,142.0,7.419922,61.0,27.0,1770.0,0.0,1.0,no(M2 and SIP pres),2.1157227
69.42395,male,0.0,Lung Cancer,10.0,under $11k,7165.0,white,metastatic,0.799999714,0.5,no dnr,6.0,56.0,12.0,130.0,14.0,40.09375,58.0,2.2998047,0.69995117,0.79992676,136.0,7.369141,119.0,8.0,2320.0,2.0,1.0,no(M2 and SIP pres),1.8388672
83.23596,female,0.0,ARF/MOSF w/Sepsis,14.0,>$50k,6498.0,white,no,0.699999809,0.6499996,dnr before sadm,0.0,53.0,8.09960938,60.0,8.0,38.0,278.0,2.5996094,0.89990234,0.69995117,149.0,7.459961,169.0,19.0,349.0,0.0,7.0,adl>=4 (>=5 if sur),7.0
24.474,female,0.0,ARF/MOSF w/Sepsis,10.0,under $11k,84800.0,hispanic,no,0.649999619,0.6499996,no dnr,22.0,67.0,12.7988281,112.0,58.0,38.89844,169.375,2.8999023,0.89990234,0.59997559,141.0,7.439453,121.0,2.0,1375.0,0.0,1.0,SIP>=30,1.0
34.47198,female,0.0,ARF/MOSF w/Sepsis,17.0,$25-$50k,89616.0,white,yes,0.699999809,0.5,no dnr,24.0,80.0,21.0976562,70.0,20.0,36.09375,321.0,3.2998047,0.89990234,6.5,134.0,7.289062,599.0,91.0,1315.0,0.0,0.0,no(M2 and SIP pres),0.0
37.02698,male,0.0,ARF/MOSF w/Sepsis,11.0,$11-$25k,7813.0,white,no,0.949999809,0.7999997,no dnr,6.0,65.0,12.0,131.0,52.0,38.59375,368.0,2.7998047,0.59997559,1.89990234,150.0,7.419922,168.0,78.0,1445.0,0.0,1.0,no(M2 and SIP pres),1.8041992
85.06494,male,0.0,ARF/MOSF w/Sepsis,9.0,$25-$50k,34245.0,white,yes,0.799999714,0.6999998,no dnr,12.0,96.0,9.19921875,68.0,10.0,36.79688,93.75,2.3999023,0.39996338,0.59997559,130.0,7.399414,82.0,17.0,2030.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
89.74097,female,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,17130.0,white,no,0.899999619,0.8999996,dnr after sadm,1.0,60.0,14.7988281,110.0,30.0,36.59375,195.625,2.8999023,0.89990234,0.69995117,144.0,7.449219,83.0,22.0,1968.0,1.0,0.0,no(M2 and SIP pres),0.0
54.09399,female,0.0,Lung Cancer,14.0,$11-$25k,16905.0,white,metastatic,0.199999928,0.04999998,dnr before sadm,-1.0,110.0,15.5,146.0,11.0,36.19531,268.0,4.7998047,0.39996338,2.19970703,142.0,7.329102,111.0,47.0,1275.0,0.0,7.0,adl>=4 (>=5 if sur),7.0
51.38898,male,0.0,Lung Cancer,13.0,$11-$25k,41738.0,white,metastatic,0.699999809,0.5,no dnr,17.0,51.0,4.89941406,60.0,6.0,35.19531,130.59375,2.8999023,0.5,2.29980469,141.0,7.099609,204.0,80.0,1090.0,0.0,0.0,no(M2 and SIP pres),0.0
67.49597,female,0.0,Lung Cancer,12.0,$25-$50k,13784.0,white,metastatic,0.5,0.15,dnr before sadm,-1.0,113.0,4.09960938,60.0,25.0,36.69531,224.0,4.5,0.89990234,1.29980469,143.0,7.419922,60.0,13.0,1968.0,2.0,0.0,no(M2 and SIP pres),0.0
34.793,female,0.0,ARF/MOSF w/Sepsis,10.0,under $11k,10315.0,black,no,0.899999619,0.8999996,no dnr,7.0,122.0,12.2988281,102.0,8.0,37.79688,250.0,3.2998047,0.89990234,0.79992676,134.0,7.449219,155.0,23.0,1035.0,0.0,0.0,no(M2 and SIP pres),0.0
78.086,male,1.0,ARF/MOSF w/Sepsis,11.0,$11-$25k,43260.0,white,no,0.25,0.0,dnr after sadm,9.0,73.0,19.0,68.0,26.0,36.09375,134.6875,2.8999023,0.89990234,0.79992676,135.0,7.40918,106.0,14.0,1970.0,0.0,6.0,<2 mo. follow-up,6.0
54.79797,male,1.0,Lung Cancer,12.0,under $11k,43582.0,white,metastatic,0.5,0.09999996,no dnr,30.0,159.0,9.09960938,128.0,42.0,36.59375,224.0,4.5996094,0.79992676,2.0,141.0,7.419922,91.0,33.0,3748.0,0.0,1.0,<2 mo. follow-up,2.8334961
75.12897,male,0.0,MOSF w/Malig,12.0,under $11k,16763.0,white,metastatic,0.5,0.25,dnr after sadm,1.0,93.0,8.0,110.0,20.0,35.59375,218.3125,4.2998047,0.89990234,1.29980469,142.0,7.459961,76.0,23.0,3800.0,1.0,4.0,<2 mo. follow-up,4.0
71.51794,female,0.0,ARF/MOSF w/Sepsis,10.0,under $11k,41046.0,white,no,0.799999714,0.5999999,no dnr,20.0,73.0,6.09960938,80.0,20.0,37.79688,224.0,2.8999023,0.89990234,0.79992676,138.0,7.419922,71.0,6.0,3000.0,0.0,1.0,no(M2 and SIP pres),1.0
77.88098,female,0.0,Lung Cancer,11.0,under $11k,19490.0,white,metastatic,0.25,0.5,dnr after sadm,3.0,63.0,14.5996094,98.0,30.0,38.19531,242.5,3.199707,0.89990234,1.39990234,144.0,7.419922,174.0,41.0,2280.0,0.0,1.0,<2 mo. follow-up,1.0
76.96594,male,0.0,ARF/MOSF w/Sepsis,3.0,under $11k,22398.0,white,no,0.5,0.5,no dnr,11.0,131.0,25.1992188,103.0,14.0,38.09375,76.25,2.699707,0.5,0.69995117,144.0,7.469727,144.0,11.0,4815.0,0.0,1.0,<2 mo. follow-up,2.5927734
56.06299,male,0.0,Lung Cancer,1.0,$11-$25k,18205.0,white,metastatic,0.75,0.3999999,no dnr,4.0,121.0,25.1992188,71.0,12.0,35.0,111.42188,2.699707,2.69970703,4.29980469,146.0,7.489258,98.0,76.0,2922.0,0.0,1.0,no(M2 and SIP pres),0.494751
43.87698,female,0.0,ARF/MOSF w/Sepsis,14.0,>$50k,19006.0,white,no,0.899999619,0.8999996,no dnr,9.0,108.0,11.5996094,84.0,20.0,36.39844,400.0,4.3994141,0.89990234,0.39996338,138.0,7.539062,122.0,2.0,3900.0,1.0,1.0,<2 mo. follow-up,1.0
73.80396,female,0.0,Colon Cancer,12.0,under $11k,34604.0,white,metastatic,0.099999964,0.09999996,dnr after sadm,20.0,49.0,7.0,63.0,28.0,38.39844,224.0,2.8999023,0.89990234,1.59985352,142.0,7.419922,84.0,21.0,1935.0,0.0,1.0,<2 mo. follow-up,2.5986328
76.20294,male,0.0,Lung Cancer,9.0,$25-$50k,14896.0,white,metastatic,0.199999928,0.0,no dnr,7.0,70.0,6.0,62.0,14.0,36.69531,203.3125,4.0,1.0,1.39990234,142.0,7.189453,106.0,42.0,1710.0,5.0,1.0,<2 mo. follow-up,3.8549805
71.63599,male,0.0,Lung Cancer,10.0,$11-$25k,15393.0,white,metastatic,0.799999714,0.1999999,no dnr,7.0,113.0,7.19921875,100.0,20.0,36.09375,224.0,2.8999023,0.39996338,0.89990234,136.0,7.419922,286.0,14.0,1968.0,0.0,6.0,<2 mo. follow-up,6.0
73.18298,female,0.0,COPD,8.0,under $11k,26832.0,white,no,0.799999714,0.6999998,no dnr,12.0,69.0,11.8984375,108.0,20.0,38.59375,224.0,2.8999023,0.69995117,0.89990234,137.0,7.419922,81.0,7.0,2850.0,0.0,0.0,no(M2 and SIP pres),0.0
70.90997,female,0.0,Coma,6.0,>$50k,48963.0,white,no,0.699999809,0.5,dnr after sadm,5.0,77.0,15.3984375,120.0,25.0,36.09375,224.0,2.8999023,0.89990234,1.0,138.0,7.419922,123.0,20.0,700.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
73.125,female,1.0,ARF/MOSF w/Sepsis,10.0,$11-$25k,282678.0,white,no,0.5,0.3,dnr after sadm,82.0,53.0,10.5996094,59.0,36.0,36.69531,100.0,2.7998047,0.59997559,0.79992676,133.0,7.5,84.0,14.0,500.0,2.0,3.0,SIP>=30,3.0
68.78296,female,0.0,Coma,6.0,under $11k,31924.0,black,no,0.399999857,0.3,no dnr,16.0,61.0,15.7988281,135.0,8.0,37.69531,175.0,2.5,0.39996338,1.0,142.0,7.359375,301.0,19.0,5240.0,0.0,1.0,no(M2 and SIP pres),1.0
71.625,male,0.0,CHF,12.0,under $11k,11909.0,white,yes,1.0,0.75,no dnr,9.0,97.0,6.39941406,120.0,20.0,39.39844,276.1875,2.8999023,0.89990234,0.89990234,139.0,7.479492,124.0,13.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
76.96399,male,1.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,114257.0,white,no,0.5,0.5,dnr after sadm,23.0,78.0,29.296875,68.0,10.0,35.69531,528.5,2.8999023,1.29980469,1.09985352,139.0,7.339844,289.0,33.0,2260.0,0.0,0.0,<2 mo. follow-up,0.0
45.40698,female,0.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,241277.0,white,metastatic,0.009999998,0.0,dnr after sadm,21.0,57.0,7.5,100.0,28.0,36.89844,369.0,3.0996094,0.89990234,0.69995117,139.0,7.5,97.0,5.0,370.0,0.0,0.0,SIP>=30,0.0
89.64496,female,1.0,ARF/MOSF w/Sepsis,18.0,$25-$50k,62130.0,white,no,0.5,0.3999999,dnr after sadm,10.0,77.0,9.09960938,128.0,36.0,36.69531,224.0,2.8999023,0.39996338,0.69995117,143.0,7.419922,104.0,13.0,1050.0,0.0,0.0,<2 mo. follow-up,0.0
86.26697,male,0.0,COPD,9.0,under $11k,9107.0,white,no,0.099999964,0.009999998,dnr before sadm,-1.0,79.0,15.3984375,63.0,32.0,38.69531,316.0,3.3999023,1.59985352,0.79992676,136.0,7.509766,203.0,46.0,1910.0,2.0,3.0,<2 mo. follow-up,3.0
80.30695,female,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,53620.0,white,no,0.199999928,0.0,dnr after sadm,2.0,71.0,9.79882812,88.0,26.0,37.69531,224.0,2.8999023,0.5,1.19995117,134.0,7.419922,169.0,13.0,7650.0,0.0,3.0,no(M2 and SIP pres),3.0
59.06598,female,0.0,ARF/MOSF w/Sepsis,13.0,>$50k,6445.0,white,no,0.75,0.75,no dnr,4.0,57.0,3.89990234,115.0,25.0,38.0,338.0625,3.0,1.09985352,0.5,134.0,7.549805,126.0,3.0,3550.0,1.0,0.0,no(M2 and SIP pres),0.0
78.05597,female,0.0,COPD,12.0,under $11k,45659.0,white,no,0.5,0.6999998,no dnr,23.0,63.0,18.8984375,76.0,26.0,36.19531,224.0,2.0,0.89990234,0.79992676,143.0,7.419922,159.0,15.0,750.0,1.0,1.0,no(M2 and SIP pres),1.1667481
76.04095,male,0.0,COPD,20.0,$11-$25k,10911.0,white,no,0.099999964,0.04999998,dnr after sadm,2.0,77.0,6.19921875,80.0,20.0,36.09375,224.0,3.2998047,0.59997559,1.0,138.0,7.419922,73.0,23.0,1968.0,0.0,1.0,SIP>=30,0.494751
78.06696,female,0.0,CHF,12.0,under $11k,33427.0,white,no,0.899999619,0.75,no dnr,16.0,73.0,5.09960938,100.0,24.0,36.79688,224.0,2.8999023,0.89990234,1.09985352,143.0,7.419922,92.0,19.0,3500.0,0.0,1.0,<2 mo. follow-up,2.6274414
67.17297,male,1.0,ARF/MOSF w/Sepsis,16.0,under $11k,214919.0,white,metastatic,0.5,0.0,dnr after sadm,27.0,58.0,6.29980469,73.0,40.0,38.29688,175.0,2.8999023,0.89990234,1.19995117,134.0,7.429688,171.0,19.0,2094.0,0.0,0.0,<2 mo. follow-up,0.0
61.88599,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,22855.0,white,no,0.699999809,0.5,no dnr,3.0,68.0,12.5996094,66.0,10.0,38.5,158.0,2.7998047,0.59997559,0.5,138.0,7.449219,118.0,21.0,2184.0,0.0,1.0,<2 mo. follow-up,2.1313477
76.07397,male,0.0,COPD,17.0,under $11k,12470.0,white,yes,0.5,0.1999999,dnr after sadm,1.0,58.0,3.69970703,67.0,28.0,38.5,211.65625,1.7998047,0.89990234,5.0,139.0,7.299805,94.0,109.0,215.0,6.0,7.0,<2 mo. follow-up,7.0
69.81195,female,0.0,COPD,12.0,>$50k,8025.0,white,no,0.599999905,0.5999999,dnr after sadm,3.0,62.0,8.3984375,64.0,31.0,37.89844,277.5,2.8999023,1.0,3.19970703,140.0,7.339844,247.0,58.0,1194.0,0.0,0.0,no(M2 and SIP pres),0.0
90.073,male,1.0,Coma,8.0,under $11k,9079.0,white,no,0.329999924,0.3299999,dnr after sadm,7.0,73.0,11.1992188,70.0,15.0,37.79688,290.4375,2.8999023,0.89990234,1.69995117,132.0,7.459961,66.0,15.0,2000.0,0.0,7.0,<2 mo. follow-up,7.0
74.68298,male,1.0,ARF/MOSF w/Sepsis,13.0,under $11k,31918.0,white,yes,0.75,0.6499996,dnr after sadm,5.0,63.0,22.6992188,117.0,10.0,39.39844,91.0,3.0,1.79980469,1.69995117,147.0,7.419922,181.0,52.0,1535.0,0.0,0.0,<2 mo. follow-up,0.0
66.23096,male,0.0,ARF/MOSF w/Sepsis,9.0,under $11k,16752.0,white,no,1.0,1.0,no dnr,6.0,67.0,11.1992188,140.0,16.0,36.5,93.32812,2.7998047,5.09960938,0.69995117,141.0,7.439453,55.0,11.0,1516.0,0.0,1.0,no(M2 and SIP pres),0.494751
72.31995,female,1.0,MOSF w/Malig,10.0,$11-$25k,67687.0,other,yes,0.5,0.25,dnr after sadm,5.0,65.0,11.3984375,70.0,8.0,36.19531,178.0,2.3999023,0.59997559,2.0,135.0,7.479492,69.0,43.0,1745.0,0.0,6.0,<2 mo. follow-up,6.0
49.59299,female,0.0,ARF/MOSF w/Sepsis,14.0,$11-$25k,23496.0,black,no,0.699999809,0.6999998,no dnr,10.0,110.0,9.79882812,100.0,25.0,36.09375,326.625,4.0,0.89990234,7.0,144.0,7.199219,128.0,127.0,650.0,0.0,0.0,no(M2 and SIP pres),0.0
72.49298,female,0.0,MOSF w/Malig,12.0,>$50k,40801.0,white,yes,0.5,0.09999996,dnr before sadm,0.0,63.0,13.3984375,72.0,22.0,36.69531,446.625,2.3999023,1.39990234,3.0,130.0,7.389648,107.0,138.0,2230.0,0.0,6.0,<2 mo. follow-up,6.0
75.35095,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,24854.0,black,no,0.599999905,0.3999999,dnr after sadm,1.0,143.0,8.8984375,80.0,20.0,36.09375,304.75,2.8999023,1.19995117,1.59985352,142.0,7.459961,76.0,19.0,3500.0,0.0,1.0,<2 mo. follow-up,6.2792969
65.69495,female,0.0,Lung Cancer,12.0,$11-$25k,11757.0,white,metastatic,0.75,0.5,no dnr,6.0,59.0,29.1992188,60.0,22.0,35.89844,233.3125,3.199707,0.29998779,2.09960938,128.0,7.379883,154.0,65.0,3000.0,2.0,0.0,<2 mo. follow-up,0.0
53.89499,female,1.0,MOSF w/Malig,12.0,$25-$50k,36722.0,white,metastatic,0.449999809,0.09999996,dnr after sadm,5.0,77.0,8.69921875,62.0,24.0,36.09375,217.375,3.3999023,0.5,1.39990234,131.0,7.359375,176.0,39.0,3175.0,2.0,6.0,<2 mo. follow-up,6.0
71.59998,female,0.0,COPD,18.0,$25-$50k,15622.0,white,no,0.949999809,0.7999997,no dnr,11.0,73.0,5.5,60.0,20.0,36.69531,224.0,2.8999023,0.59997559,1.19995117,137.0,7.419922,102.0,13.0,2600.0,0.0,0.0,no(M2 and SIP pres),0.0
49.495,female,0.0,CHF,11.0,$11-$25k,45617.0,black,no,0.949999809,0.8999996,no dnr,13.0,47.0,13.7988281,176.0,8.0,38.39844,190.0,2.5996094,0.89990234,0.79992676,146.0,7.379883,251.0,16.0,4505.0,1.0,1.0,no(M2 and SIP pres),1.0
90.27795,female,0.0,ARF/MOSF w/Sepsis,10.0,under $11k,29200.0,white,no,0.599999905,0.5,dnr after sadm,1.0,68.0,7.0,80.0,20.0,35.89844,180.0,2.0,6.09960938,0.89990234,132.0,7.299805,117.0,24.0,1425.0,3.0,6.0,<2 mo. follow-up,6.0
77.14697,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,74562.0,white,no,0.599999905,0.216,no dnr,15.0,48.0,17.0,142.0,26.0,39.0,196.65625,3.0,0.89990234,1.5,136.0,7.429688,370.0,35.0,2221.0,0.0,1.0,<2 mo. follow-up,2.800293
71.64996,male,0.0,COPD,12.0,$25-$50k,26614.0,white,yes,1.0,1.0,dnr after sadm,15.0,97.0,11.8984375,80.0,20.0,35.0,233.3125,2.8999023,0.89990234,1.09985352,139.0,7.399414,139.0,39.0,550.0,0.0,3.0,SIP>=30,3.0
70.17395,male,0.0,ARF/MOSF w/Sepsis,8.0,under $11k,30650.0,white,no,0.699999809,0.5,no dnr,13.0,93.0,10.5996094,97.0,24.0,36.79688,304.3125,2.8999023,0.89990234,0.89990234,141.0,7.399414,112.0,29.0,1968.0,0.0,7.0,adl>=4 (>=5 if sur),7.0
44.32898,female,0.0,MOSF w/Malig,18.0,$25-$50k,22641.0,white,metastatic,0.599999905,0.3,no dnr,9.0,53.0,20.5,80.0,30.0,37.79688,224.0,2.8999023,0.89990234,2.5,151.0,7.419922,135.0,64.0,550.0,0.0,1.0,no(M2 and SIP pres),0.494751
89.99896,female,1.0,ARF/MOSF w/Sepsis,12.0,>$50k,165741.0,white,no,0.599999905,0.5999999,dnr after sadm,1.0,42.0,14.5996094,76.0,8.0,36.59375,230.0,2.8999023,0.59997559,1.5,138.0,7.429688,154.0,14.0,3885.0,0.0,5.0,<2 mo. follow-up,5.0
62.42798,male,1.0,ARF/MOSF w/Sepsis,3.0,under $11k,34412.0,black,no,0.5,0.5,dnr after sadm,7.0,70.0,11.1992188,70.0,26.0,37.0,486.625,3.699707,0.39996338,1.0,141.0,7.339844,95.0,11.0,1800.0,0.0,6.0,<2 mo. follow-up,6.0
64.71198,male,0.0,ARF/MOSF w/Sepsis,25.0,>$50k,36616.0,white,no,0.899999619,0.7999997,no dnr,14.0,67.0,1.0,100.0,12.0,35.29688,351.0,1.8999023,4.0,1.79980469,144.0,7.379883,107.0,29.0,845.0,0.0,0.0,no(M2 and SIP pres),0.0
78.75995,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,61702.0,white,no,0.699999809,0.5999999,no dnr,18.0,111.0,12.6992188,128.0,50.0,38.29688,261.875,3.0,0.89990234,7.79980469,140.0,7.369141,126.0,82.0,1600.0,0.0,0.0,no(M2 and SIP pres),0.0
86.70197,male,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,56348.0,white,yes,0.899999619,0.7999997,no dnr,14.0,63.0,0.09999084,109.0,28.0,36.0,144.0,2.199707,0.69995117,0.69995117,146.0,7.439453,118.0,16.0,3950.0,0.0,2.0,adl>=4 (>=5 if sur),2.0
67.33496,female,0.0,MOSF w/Malig,15.0,$25-$50k,37386.0,white,metastatic,0.299999952,0.09999996,dnr after sadm,7.0,50.0,7.79980469,60.0,25.0,39.29688,472.5,2.699707,0.89990234,8.5,144.0,7.349609,76.0,63.0,40.0,0.0,0.0,no(M2 and SIP pres),0.0
85.97095,female,1.0,ARF/MOSF w/Sepsis,14.0,under $11k,40860.0,white,no,0.5,0.5,dnr after sadm,5.0,105.0,10.5996094,70.0,20.0,36.19531,264.0,2.8999023,0.89990234,1.19995117,140.0,7.369141,135.0,23.0,3300.0,0.0,2.0,<2 mo. follow-up,2.0
79.01398,male,1.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,234205.0,white,no,0.5,0.3,dnr after sadm,44.0,93.0,3.79980469,100.0,20.0,36.59375,224.0,2.8999023,0.89990234,1.39990234,140.0,7.419922,118.0,35.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
50.155,male,0.0,ARF/MOSF w/Sepsis,4.0,under $11k,16569.0,black,no,0.799999714,0.6999998,no dnr,8.0,53.0,6.79980469,126.0,38.0,37.59375,93.32812,3.699707,0.89990234,1.39990234,147.0,7.429688,84.0,28.0,2480.0,0.0,3.0,adl>=4 (>=5 if sur),3.0
77.06,male,0.0,COPD,12.0,under $11k,24721.0,white,no,0.799999714,0.5999999,no dnr,10.0,100.0,5.5,80.0,20.0,37.79688,224.0,2.8999023,0.89990234,3.5,138.0,7.419922,179.0,90.0,1968.0,0.0,1.0,<2 mo. follow-up,3.6118164
81.25897,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,17124.0,white,yes,0.099999964,0.04999998,dnr before sadm,0.0,125.0,5.69921875,62.0,30.0,36.5,205.0,2.8999023,0.89990234,1.39990234,142.0,7.489258,98.0,21.0,1350.0,0.0,1.0,<2 mo. follow-up,2.9545898
75.58099,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,16291.0,black,yes,0.899999619,0.7999997,no dnr,12.0,65.0,5.39941406,64.0,16.0,38.09375,285.6875,2.8999023,0.89990234,2.0,140.0,7.379883,103.0,26.0,690.0,0.0,7.0,adl>=4 (>=5 if sur),7.0
48.97998,female,0.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,65038.0,white,no,0.799999714,0.7999997,no dnr,13.0,119.0,14.8984375,62.0,24.0,38.79688,167.34375,2.8999023,0.89990234,2.29980469,140.0,7.369141,125.0,31.0,1965.0,0.0,0.0,no(M2 and SIP pres),0.0
53.75497,male,0.0,Cirrhosis,16.0,$25-$50k,29567.0,white,no,0.799999714,0.5,no dnr,19.0,110.0,6.09960938,80.0,20.0,36.09375,200.0,2.8999023,0.89990234,1.39990234,141.0,7.429688,104.0,25.0,1968.0,1.0,0.0,no(M2 and SIP pres),0.0
85.46497,male,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,76784.0,white,yes,0.899999619,0.8799996,no dnr,27.0,50.0,6.79980469,98.0,26.0,39.29688,235.0,2.8999023,1.19995117,1.09985352,141.0,7.419922,283.0,38.0,2155.0,0.0,1.0,adl>=4 (>=5 if sur),1.0
88.20294,female,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,20010.0,white,no,0.899999619,0.7999997,dnr after sadm,2.0,35.0,11.8984375,182.0,40.0,38.89844,154.28125,2.8999023,0.89990234,4.79980469,135.0,7.289062,319.0,82.0,625.0,0.0,6.0,<2 mo. follow-up,6.0
84.09296,male,0.0,ARF/MOSF w/Sepsis,21.0,$25-$50k,18630.0,white,yes,0.599999905,0.3999999,dnr after sadm,1.0,66.0,4.5,62.0,16.0,36.59375,356.0,3.199707,5.0,0.59997559,141.0,7.369141,130.0,8.0,4530.0,5.0,6.0,SIP>=30,6.0
83.29895,female,0.0,CHF,15.0,under $11k,5048.0,white,no,0.989999771,0.7799997,no dnr,4.0,68.0,27.0976562,83.0,24.0,38.0,348.0,2.8999023,0.89990234,0.89990234,141.0,7.40918,132.0,24.0,3100.0,0.0,1.0,SIP>=30,0.494751
73.04596,female,0.0,ARF/MOSF w/Sepsis,13.0,under $11k,211782.0,white,no,0.25,0.25,no dnr,67.0,106.0,14.5996094,62.0,10.0,37.89844,168.3125,2.0,0.29998779,2.29980469,138.0,7.209961,198.0,42.0,1350.0,0.0,7.0,<2 mo. follow-up,7.0
64.77795,female,0.0,CHF,11.0,under $11k,51994.0,white,no,0.799999714,0.6999998,dnr after sadm,27.0,47.0,16.796875,144.0,28.0,39.19531,168.3125,1.5,0.59997559,2.0,132.0,7.289062,102.0,61.0,4030.0,2.0,3.0,adl>=4 (>=5 if sur),3.0
85.75995,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,17840.0,white,no,0.299999952,0.09999996,dnr after sadm,2.0,72.0,13.7988281,114.0,28.0,35.89844,258.3125,3.0996094,0.89990234,1.5,145.0,7.469727,221.0,29.0,2275.0,0.0,2.0,<2 mo. follow-up,2.0
78.05597,male,1.0,MOSF w/Malig,12.0,under $11k,53410.0,white,metastatic,0.5,0.125,dnr after sadm,2.0,81.0,18.5,82.0,28.0,38.19531,218.34375,3.0,0.59997559,1.0,133.0,7.459961,201.0,41.0,2855.0,0.0,1.0,<2 mo. follow-up,3.237793
75.63599,male,0.0,COPD,12.0,$11-$25k,26626.0,white,no,0.899999619,0.8499999,no dnr,10.0,111.0,7.29980469,80.0,25.0,38.79688,316.0,2.8999023,1.5,1.29980469,145.0,7.429688,121.0,42.0,3815.0,0.0,0.0,no(M2 and SIP pres),0.0
71.78094,male,0.0,COPD,12.0,$25-$50k,46370.0,white,yes,0.299999952,0.09999996,no dnr,25.0,101.0,0.19998169,118.0,22.0,34.79688,224.0,2.199707,2.69970703,0.79992676,141.0,7.419922,87.0,31.0,1550.0,0.0,0.0,<2 mo. follow-up,0.0
21.20699,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,31912.0,white,no,1.0,1.0,no dnr,10.0,124.0,10.0,160.0,37.0,39.09375,356.0,2.699707,4.09960938,1.0,149.0,7.459961,89.0,28.0,1596.0,0.0,0.0,no(M2 and SIP pres),0.0
31.45499,female,0.0,ARF/MOSF w/Sepsis,16.0,under $11k,12363.0,black,no,0.599999905,0.5,no dnr,7.0,131.0,11.0,103.0,10.0,37.69531,96.0,3.0,1.29980469,2.69970703,144.0,7.429688,392.0,53.0,924.0,0.0,1.0,adl>=4 (>=5 if sur),2.0649414
35.60797,female,0.0,ARF/MOSF w/Sepsis,16.0,>$50k,55312.0,white,no,1.0,0.9499998,no dnr,19.0,139.0,10.5996094,106.0,28.0,35.59375,219.03125,3.2998047,0.5,8.3984375,137.0,7.449219,92.0,53.0,325.0,0.0,0.0,no(M2 and SIP pres),0.0
76.18896,female,0.0,COPD,12.0,under $11k,4601.0,white,yes,0.699999809,0.5,dnr before sadm,-1.0,65.0,12.5,60.0,30.0,37.69531,126.51562,3.0996094,0.89990234,1.5,140.0,7.429688,210.0,52.0,800.0,0.0,1.0,<2 mo. follow-up,4.1923828
83.07495,female,0.0,Coma,14.0,$11-$25k,25394.0,white,metastatic,0.5,0.1999999,dnr before sadm,-1.0,38.0,39.3984375,52.0,14.0,38.69531,354.0,2.7998047,0.39996338,7.79980469,130.0,7.329102,63.0,63.0,0.0,0.0,2.0,<2 mo. follow-up,2.0
81.00995,male,0.0,Lung Cancer,16.0,under $11k,12735.0,white,metastatic,0.099999964,0.0,dnr after sadm,2.0,72.0,10.5996094,103.0,12.0,36.39844,241.65625,2.699707,0.39996338,0.69995117,143.0,7.40918,292.0,26.0,1375.0,0.0,3.0,<2 mo. follow-up,3.0
52.11798,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,141717.0,black,no,0.299999952,0.3,no dnr,37.0,53.0,6.5,60.0,24.0,36.59375,161.21875,2.7998047,0.89990234,0.69995117,135.0,7.469727,99.0,7.0,1275.0,0.0,1.0,<2 mo. follow-up,2.0546875
89.547,female,0.0,CHF,12.0,under $11k,16186.0,white,no,0.599999905,0.5,no dnr,12.0,75.0,14.0,74.0,24.0,35.89844,276.1875,2.8999023,0.89990234,1.5,136.0,7.449219,106.0,22.0,3750.0,1.0,3.0,adl>=4 (>=5 if sur),3.0
90.03094,male,0.0,CHF,12.0,>$50k,19286.0,white,no,0.699999809,0.5999999,dnr after sadm,6.0,83.0,11.2988281,100.0,20.0,35.39844,224.0,2.0996094,3.69970703,0.89990234,131.0,7.419922,96.0,11.0,750.0,0.0,0.0,<2 mo. follow-up,0.0
78.00696,female,0.0,Colon Cancer,8.0,$11-$25k,9633.0,white,metastatic,0.899999619,0.8999996,no dnr,9.0,57.0,11.6992188,70.0,10.0,38.19531,176.0,2.2998047,0.5,2.69970703,132.0,7.359375,141.0,63.0,2170.0,1.0,1.0,no(M2 and SIP pres),1.0
74.771,female,1.0,ARF/MOSF w/Sepsis,14.0,$25-$50k,144316.0,hispanic,yes,0.299999952,0.1999999,dnr after sadm,15.0,54.0,117.0,118.0,30.0,38.19531,224.0,2.8999023,0.89990234,0.5,137.0,7.429688,105.0,23.0,930.0,0.0,0.0,<2 mo. follow-up,0.0
79.82794,female,0.0,ARF/MOSF w/Sepsis,14.0,under $11k,16884.0,white,no,0.949999809,0.8999996,no dnr,10.0,57.0,8.79882812,60.0,20.0,38.29688,141.65625,3.0,1.0,1.19995117,137.0,7.379883,129.0,17.0,4600.0,0.0,1.0,no(M2 and SIP pres),0.494751
48.55899,male,0.0,CHF,14.0,$25-$50k,4980.0,white,yes,0.699999809,0.5,no dnr,4.0,100.0,3.69970703,60.0,25.0,36.09375,224.0,2.8999023,0.89990234,2.79980469,143.0,7.419922,89.0,70.0,1600.0,0.0,1.0,no(M2 and SIP pres),2.184082
68.65399,male,0.0,ARF/MOSF w/Sepsis,15.0,under $11k,98707.0,black,no,0.899999619,0.6999998,no dnr,38.0,60.0,10.0,110.0,12.0,38.5,180.0,2.2998047,0.59997559,2.19970703,148.0,7.359375,106.0,46.0,2044.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
20.05199,female,0.0,Cirrhosis,13.0,under $11k,27570.0,asian,no,0.599999905,0.5,no dnr,13.0,82.0,17.0,120.0,30.0,38.09375,135.0,2.8999023,0.89990234,1.0,137.0,7.449219,373.0,30.0,1500.0,0.0,0.0,<2 mo. follow-up,0.0
51.86298,male,0.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,193178.0,white,no,0.199999928,0.09999996,no dnr,49.0,63.0,4.79980469,38.0,26.0,36.19531,224.0,2.8999023,0.69995117,1.89990234,140.0,7.419922,98.0,78.0,1890.0,0.0,0.0,no(M2 and SIP pres),0.0
85.85895,male,0.0,COPD,10.0,under $11k,14731.0,white,no,0.699999809,0.5,dnr after sadm,1.0,73.0,2.59960938,180.0,4.0,36.59375,140.0,2.2998047,4.39941406,2.69970703,136.0,7.359375,97.0,49.0,750.0,0.0,7.0,adl>=4 (>=5 if sur),7.0
72.24597,female,0.0,Lung Cancer,12.0,$11-$25k,10505.0,white,metastatic,0.799999714,0.5999999,no dnr,7.0,77.0,8.19921875,73.0,8.0,37.69531,165.0,2.8999023,0.89990234,1.0,140.0,7.429688,102.0,22.0,4000.0,0.0,0.0,<2 mo. follow-up,0.0
70.26996,female,0.0,CHF,12.0,$25-$50k,15786.0,white,yes,0.599999905,0.5,dnr after sadm,5.0,131.0,13.0996094,120.0,7.0,38.0,240.8125,2.8999023,0.59997559,2.5,143.0,7.269531,114.0,52.0,399.0,2.0,0.0,<2 mo. follow-up,0.0
74.87195,female,0.0,Lung Cancer,12.0,under $11k,4868.0,white,metastatic,0.699999809,0.5,dnr after sadm,1.0,112.0,10.6992188,118.0,40.0,39.19531,266.625,2.3999023,1.79980469,1.69995117,141.0,7.459961,144.0,14.0,3100.0,0.0,1.0,<2 mo. follow-up,2.9086914
59.65198,male,0.0,ARF/MOSF w/Sepsis,10.0,$11-$25k,70523.0,white,no,0.699999809,0.5,no dnr,17.0,123.0,9.09960938,80.0,20.0,37.59375,433.3125,3.2998047,0.89990234,5.19921875,122.0,7.289062,943.0,64.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.5571289
66.34595,female,0.0,COPD,14.0,>$50k,12506.0,white,yes,1.0,1.0,no dnr,11.0,108.0,7.5,114.0,8.0,38.39844,185.0,3.0,0.89990234,0.59997559,139.0,7.40918,75.0,9.0,4895.0,1.0,2.0,no(M2 and SIP pres),2.0
58.60898,female,0.0,COPD,12.0,$11-$25k,76228.0,white,no,0.699999809,0.5999999,no dnr,24.0,83.0,14.5996094,80.0,20.0,36.69531,412.0,3.8999023,0.29998779,0.89990234,146.0,7.329102,124.0,31.0,1968.0,0.0,4.0,no(M2 and SIP pres),4.0
83.13794,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,13636.0,white,no,0.949999809,0.7999997,no dnr,10.0,75.0,10.5996094,67.0,20.0,36.19531,224.0,2.8999023,0.89990234,1.39990234,136.0,7.419922,108.0,17.0,1475.0,0.0,1.0,adl>=4 (>=5 if sur),5.3701172
93.89496,male,0.0,COPD,12.0,under $11k,8276.0,white,yes,0.649999619,0.5,no dnr,7.0,117.0,7.19921875,100.0,20.0,38.69531,420.0,4.1992188,0.5,0.79992676,132.0,7.539062,133.0,11.0,1200.0,0.0,1.0,<2 mo. follow-up,4.4140625
63.55899,male,0.0,COPD,6.0,under $11k,3814.0,white,no,0.949999809,0.8999996,no dnr,4.0,113.0,12.0996094,80.0,20.0,36.69531,224.0,3.5996094,1.19995117,1.59985352,140.0,7.419922,110.0,51.0,1968.0,3.0,1.0,no(M2 and SIP pres),2.5107422
88.10699,male,0.0,CHF,12.0,$11-$25k,11812.0,white,no,0.75,0.5999999,no dnr,11.0,123.0,17.8984375,70.0,12.0,36.79688,160.0,2.199707,0.89990234,1.89990234,148.0,7.389648,362.0,52.0,2360.0,1.0,1.0,no(M2 and SIP pres),1.0
88.65198,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,34155.0,white,no,0.199999928,0.09999996,dnr after sadm,1.0,107.0,12.3984375,80.0,25.0,36.09375,272.0,2.8999023,0.59997559,2.09960938,144.0,7.319336,103.0,50.0,1400.0,0.0,1.0,<2 mo. follow-up,6.1611328
78.18195,female,0.0,Lung Cancer,11.0,under $11k,11763.0,white,metastatic,0.199999928,0.04999998,dnr after sadm,1.0,97.0,7.79980469,80.0,25.0,36.09375,460.0,2.8999023,0.89990234,1.39990234,136.0,7.469727,184.0,39.0,1250.0,0.0,6.0,<2 mo. follow-up,6.0
76.01398,male,0.0,COPD,12.0,$25-$50k,10143.0,white,no,0.699999809,0.5,no dnr,7.0,83.0,24.6992188,80.0,15.0,36.09375,224.0,2.5996094,0.69995117,0.79992676,134.0,7.419922,148.0,11.0,982.0,1.0,1.0,no(M2 and SIP pres),1.1667481
91.71796,female,0.0,ARF/MOSF w/Sepsis,6.0,under $11k,52128.0,white,no,0.699999809,0.5999999,dnr after sadm,11.0,43.0,15.5,113.0,16.0,37.79688,154.0,1.8999023,0.09999084,0.89990234,146.0,7.299805,186.0,14.0,1338.0,0.0,2.0,adl>=4 (>=5 if sur),2.0
60.78,male,0.0,ARF/MOSF w/Sepsis,12.0,>$50k,46709.0,white,yes,0.75,0.75,no dnr,14.0,59.0,10.0996094,78.0,28.0,37.89844,150.0,3.699707,0.69995117,1.0,142.0,7.459961,114.0,26.0,2064.0,0.0,0.0,no(M2 and SIP pres),0.0
48.87299,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,54664.0,white,no,0.979999542,0.9799995,no dnr,9.0,104.0,9.3984375,108.0,22.0,36.59375,224.0,2.8999023,0.89990234,1.29980469,140.0,7.419922,133.0,23.0,2990.0,0.0,0.0,no(M2 and SIP pres),0.0
49.45398,female,0.0,Lung Cancer,12.0,$25-$50k,12241.0,white,metastatic,0.799999714,0.5,no dnr,4.0,49.0,5.69921875,107.0,28.0,38.89844,287.5,2.8999023,0.59997559,1.39990234,142.0,7.429688,110.0,35.0,2710.0,0.0,1.0,no(M2 and SIP pres),0.494751
75.33698,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,30832.0,white,no,0.299999952,0.1999999,dnr after sadm,2.0,72.0,15.0996094,128.0,14.0,36.29688,224.0,2.0,4.09960938,0.59997559,131.0,7.419922,164.0,10.0,1200.0,0.0,6.0,<2 mo. follow-up,6.0
36.44897,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,9396.0,white,no,0.899999619,0.6999998,no dnr,6.0,60.0,29.796875,150.0,12.0,36.09375,66.0,1.6999512,1.09985352,0.79992676,145.0,7.329102,309.0,11.0,965.0,0.0,1.0,<2 mo. follow-up,0.494751
74.48297,male,1.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,53352.0,white,yes,0.699999809,0.0,dnr after sadm,1.0,57.0,5.0,80.0,20.0,36.29688,261.875,2.7998047,0.89990234,1.0,144.0,7.389648,105.0,9.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
90.84998,female,0.0,CHF,16.0,$25-$50k,13773.0,white,yes,0.699999809,0.5,no dnr,8.0,80.0,16.8984375,80.0,20.0,36.09375,300.0,3.2998047,1.09985352,1.09985352,133.0,7.459961,158.0,47.0,500.0,1.0,0.0,no(M2 and SIP pres),0.0
58.70999,male,0.0,Lung Cancer,12.0,under $11k,46753.0,white,metastatic,0.899999619,0.5,no dnr,21.0,103.0,6.69921875,70.0,20.0,35.59375,224.0,2.8999023,0.89990234,2.29980469,138.0,7.419922,151.0,79.0,3050.0,6.0,1.0,<2 mo. follow-up,4.5273438
79.76495,female,0.0,CHF,12.0,under $11k,4730.0,white,no,0.699999809,0.5,no dnr,4.0,77.0,3.5,90.0,20.0,37.79688,290.4375,2.8999023,0.89990234,0.59997559,143.0,7.509766,107.0,11.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.4296875
61.133,male,0.0,CHF,14.0,$11-$25k,4455.0,white,no,0.989999771,0.9899998,no dnr,4.0,60.0,16.8984375,120.0,12.0,38.39844,186.0,2.8999023,0.89990234,1.19995117,138.0,7.429688,196.0,12.0,1138.0,0.0,1.0,no(M2 and SIP pres),0.494751
92.28497,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,32367.0,white,yes,0.5,0.3,dnr before sadm,-1.0,109.0,9.79882812,104.0,12.0,37.59375,168.0,1.8999023,3.79980469,1.09985352,143.0,7.379883,137.0,25.0,3430.0,0.0,1.0,<2 mo. follow-up,1.0
74.32996,male,0.0,ARF/MOSF w/Sepsis,10.0,$11-$25k,78641.0,white,no,0.799999714,0.7999997,no dnr,19.0,103.0,7.5,100.0,25.0,36.09375,304.75,4.2998047,0.89990234,1.0,142.0,7.429688,118.0,21.0,2575.0,0.0,0.0,no(M2 and SIP pres),0.0
89.00195,male,0.0,ARF/MOSF w/Sepsis,16.0,$11-$25k,16165.0,white,no,0.75,0.5999999,no dnr,9.0,75.0,14.2988281,120.0,22.0,36.59375,295.1875,2.8999023,0.59997559,2.39990234,133.0,7.5,114.0,38.0,2200.0,0.0,0.0,no(M2 and SIP pres),0.0
74.71295,female,0.0,COPD,12.0,under $11k,6499.0,white,no,0.699999809,0.5,no dnr,5.0,46.0,13.3984375,128.0,32.0,36.09375,216.0,2.8999023,0.89990234,0.69995117,127.0,7.289062,268.0,19.0,1610.0,0.0,1.0,no(M2 and SIP pres),0.494751
83.68195,female,1.0,ARF/MOSF w/Sepsis,14.0,$11-$25k,16292.0,white,no,0.199999928,0.04999998,dnr after sadm,3.0,53.0,31.5,65.0,22.0,36.09375,98.32812,3.0,0.5,0.89990234,140.0,7.469727,80.0,36.0,725.0,0.0,1.0,<2 mo. follow-up,1.0
84.71698,female,1.0,Cirrhosis,14.0,under $11k,11188.0,white,no,0.199999928,0.09999996,no dnr,10.0,59.0,9.8984375,68.0,25.0,36.09375,262.9375,2.8999023,0.89990234,1.69995117,150.0,7.389648,131.0,69.0,1070.0,0.0,0.0,<2 mo. follow-up,0.0
75.05499,female,0.0,COPD,9.0,under $11k,10896.0,white,no,0.899999619,0.5999999,no dnr,7.0,97.0,3.59960938,56.0,20.0,36.29688,320.0,3.199707,0.89990234,0.89990234,141.0,7.399414,89.0,26.0,725.0,2.0,1.0,<2 mo. follow-up,1.0
75.51294,male,0.0,Colon Cancer,10.0,$11-$25k,10102.0,white,metastatic,0.599999905,0.5,dnr after sadm,3.0,93.0,9.79882812,80.0,20.0,37.0,340.0,2.8999023,0.89990234,0.89990234,146.0,7.389648,110.0,37.0,58.695312,2.0,1.0,<2 mo. follow-up,1.0
69.95197,female,0.0,CHF,12.0,$25-$50k,8304.0,white,no,0.799999714,0.75,no dnr,6.0,70.0,6.19921875,80.0,20.0,36.09375,383.3125,2.5996094,0.69995117,1.29980469,148.0,7.439453,120.0,36.0,1650.0,1.0,1.0,no(M2 and SIP pres),1.0
42.198,male,0.0,ARF/MOSF w/Sepsis,11.0,under $11k,8124.0,other,no,0.699999809,0.6499996,dnr after sadm,2.0,53.0,21.3984375,125.0,34.0,38.29688,125.0,3.0,1.0,2.39990234,152.0,7.439453,420.0,55.0,2661.0,0.0,1.0,<2 mo. follow-up,2.9926758
52.099,male,0.0,Cirrhosis,12.0,under $11k,32432.0,white,no,0.75,0.5999999,dnr after sadm,13.0,100.0,13.5996094,100.0,20.0,36.09375,268.0,2.2998047,0.89990234,0.89990234,141.0,7.459961,137.0,15.0,1968.0,1.0,5.0,no(M2 and SIP pres),5.0
96.55298,female,0.0,CHF,9.0,under $11k,4872.0,white,no,0.699999809,0.5999999,dnr after sadm,1.0,103.0,18.796875,90.0,25.0,36.09375,224.0,2.8999023,0.89990234,1.39990234,138.0,7.419922,188.0,29.0,1968.0,1.0,1.0,no(M2 and SIP pres),1.1667481
60.57999,male,0.0,ARF/MOSF w/Sepsis,7.0,under $11k,17258.0,white,no,0.899999619,0.7999997,no dnr,6.0,123.0,5.79980469,69.0,42.0,39.39844,166.0,2.3999023,0.89990234,1.69995117,149.0,7.459961,245.0,50.0,1415.0,0.0,0.0,SIP>=30,0.0
77.54999,female,1.0,ARF/MOSF w/Sepsis,14.0,$11-$25k,121358.0,white,no,0.5,0.5,dnr after sadm,14.0,121.0,12.7988281,107.0,24.0,38.59375,224.0,3.3999023,0.89990234,8.8984375,133.0,7.419922,116.0,106.0,200.0,0.0,0.0,<2 mo. follow-up,0.0
87.93994,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,10547.0,white,no,0.699999809,0.5,dnr before sadm,-1.0,123.0,10.5996094,121.0,24.0,35.69531,224.0,2.8999023,0.89990234,0.89990234,141.0,7.419922,161.0,18.0,2425.0,0.0,6.0,<2 mo. follow-up,6.0
80.82098,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,66466.0,black,yes,0.5,0.3999999,dnr after sadm,16.0,55.0,7.69921875,72.0,35.0,36.89844,171.65625,2.8999023,0.89990234,0.69995117,140.0,7.419922,112.0,16.0,1470.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
52.405,male,0.0,MOSF w/Malig,14.0,under $11k,73204.0,white,yes,0.099999964,0.0,no dnr,15.0,63.0,6.69921875,64.0,20.0,36.59375,224.0,4.0,0.89990234,1.0,142.0,7.419922,106.0,9.0,3625.0,0.0,0.0,no(M2 and SIP pres),0.0
41.202,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,129721.0,white,no,0.75,0.75,no dnr,32.0,44.0,21.8984375,105.0,10.0,38.5,92.0,2.699707,0.89990234,2.59960938,137.0,7.419922,173.0,55.0,953.0,0.0,1.0,<2 mo. follow-up,2.3608398
66.28595,female,0.0,COPD,12.0,under $11k,16697.0,white,no,0.75,0.5,dnr after sadm,1.0,47.0,6.5,80.0,20.0,36.09375,504.75,3.0,0.29998779,0.79992676,131.0,7.479492,72.0,3.0,1200.0,2.0,1.0,<2 mo. follow-up,1.0
87.06396,female,0.0,COPD,8.0,$11-$25k,5038.0,white,no,0.699999809,0.5,dnr after sadm,3.0,100.0,6.79980469,61.0,24.0,36.09375,159.0625,4.2998047,0.29998779,1.09985352,133.0,7.299805,229.0,15.0,1500.0,0.0,1.0,adl>=4 (>=5 if sur),3.1762695
29.23999,male,0.0,ARF/MOSF w/Sepsis,10.0,under $11k,5007.0,white,no,0.699999809,0.5,no dnr,3.0,120.0,10.5,78.0,4.0,38.69531,151.0,2.8999023,0.89990234,0.89990234,143.0,7.439453,130.0,21.0,1730.0,0.0,1.0,no(M2 and SIP pres),1.826416
62.25299,male,0.0,ARF/MOSF w/Sepsis,19.0,under $11k,47166.0,white,no,0.5,0.5,no dnr,16.0,72.0,6.59960938,80.0,20.0,36.59375,385.6875,2.8999023,0.89990234,1.59985352,131.0,7.429688,118.0,40.0,1730.0,0.0,3.0,SIP>=30,3.0
68.75598,male,0.0,COPD,12.0,under $11k,39370.0,white,no,0.699999809,0.5999999,no dnr,16.0,78.0,5.0,92.0,12.0,35.39844,224.0,3.2998047,0.19998169,0.59997559,140.0,7.419922,131.0,5.0,1968.0,1.0,1.0,no(M2 and SIP pres),1.0
47.379,male,0.0,Colon Cancer,12.0,under $11k,5139.0,white,metastatic,0.949999809,0.5,no dnr,5.0,107.0,12.3984375,60.0,20.0,35.39844,290.4375,2.8999023,0.89990234,1.69995117,142.0,7.369141,53.0,43.0,1300.0,0.0,1.0,<2 mo. follow-up,2.2407227
51.64398,male,0.0,ARF/MOSF w/Sepsis,18.0,>$50k,54163.0,white,yes,0.199999928,0.1999999,no dnr,16.0,83.0,11.2988281,120.0,20.0,38.19531,224.0,3.699707,2.29980469,1.39990234,133.0,7.419922,97.0,20.0,2400.0,0.0,1.0,no(M2 and SIP pres),2.3583984
53.02899,male,0.0,Lung Cancer,12.0,$11-$25k,10443.0,black,metastatic,1.0,0.5,no dnr,6.0,49.0,10.6992188,60.0,10.0,39.0,220.0,2.0996094,0.69995117,4.69921875,160.0,7.349609,150.0,82.0,2000.0,0.0,1.0,<2 mo. follow-up,0.494751
90.42798,female,0.0,CHF,11.0,under $11k,3956.0,white,no,0.949999809,0.8499999,no dnr,4.0,111.0,11.0996094,117.0,26.0,36.19531,127.0,2.8999023,0.89990234,1.89990234,142.0,7.449219,103.0,58.0,1480.0,0.0,1.0,no(M2 and SIP pres),0.494751
76.54797,male,0.0,CHF,12.0,under $11k,7034.0,white,no,0.699999809,0.5,no dnr,7.0,97.0,6.29980469,76.0,24.0,36.59375,115.0,4.1992188,0.89990234,1.5,137.0,7.199219,106.0,26.0,900.0,1.0,0.0,no(M2 and SIP pres),0.0
80.75,female,1.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,45475.0,black,no,0.199999928,0.09999996,dnr after sadm,1.0,73.0,7.5,100.0,25.0,36.09375,217.375,2.8999023,0.89990234,0.89990234,141.0,7.369141,139.0,16.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
49.68698,male,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,48180.0,white,no,0.779999733,0.5999999,no dnr,23.0,125.0,13.3984375,61.0,8.0,38.19531,242.5,3.5996094,0.89990234,0.79992676,140.0,7.589844,112.0,14.0,1560.0,0.0,1.0,no(M2 and SIP pres),0.494751
79.78894,female,0.0,ARF/MOSF w/Sepsis,8.0,under $11k,76279.0,white,no,0.699999809,0.6999998,no dnr,19.0,100.0,9.09960938,60.0,20.0,37.0,224.0,2.3999023,0.89990234,1.29980469,143.0,7.419922,114.0,16.0,280.0,0.0,1.0,no(M2 and SIP pres),1.0
53.58499,male,0.0,Cirrhosis,16.0,>$50k,12397.0,white,no,0.899999619,0.75,no dnr,8.0,80.0,4.29980469,70.0,30.0,36.09375,228.5625,3.8999023,1.09985352,1.19995117,140.0,7.379883,152.0,35.0,1075.0,0.0,0.0,no(M2 and SIP pres),0.0
91.01996,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,11767.0,white,no,0.899999619,0.8999996,dnr before sadm,-1.0,73.0,7.29980469,80.0,20.0,35.59375,224.0,2.3999023,0.89990234,1.69995117,132.0,7.419922,351.0,61.0,1125.0,0.0,1.0,SIP>=30,5.1376953
74.70996,female,1.0,Coma,8.0,$11-$25k,18728.0,white,yes,0.0,0.0,dnr after sadm,4.0,80.0,11.3984375,80.0,25.0,36.69531,276.0,2.8999023,0.89990234,1.0,136.0,7.479492,227.0,20.0,2525.0,0.0,1.0,<2 mo. follow-up,2.4985352
59.82498,female,0.0,Colon Cancer,12.0,under $11k,15538.0,white,metastatic,0.5,0.25,dnr after sadm,1.0,53.0,11.8984375,100.0,15.0,38.29688,224.0,1.7998047,0.59997559,7.29980469,138.0,7.419922,69.0,68.0,0.0,0.0,1.0,<2 mo. follow-up,3.4794922
79.49597,female,0.0,ARF/MOSF w/Sepsis,16.0,under $11k,37583.0,white,no,0.5,0.5,no dnr,15.0,57.0,11.6992188,80.0,20.0,36.09375,224.0,2.3999023,7.39941406,1.5,137.0,7.419922,227.0,51.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.494751
35.17599,male,0.0,MOSF w/Malig,14.0,>$50k,86623.0,white,yes,0.399999857,0.1999999,no dnr,18.0,107.0,3.0,70.0,30.0,36.09375,224.0,2.8999023,0.89990234,0.89990234,140.0,7.419922,98.0,16.0,1800.0,0.0,4.0,no(M2 and SIP pres),4.0
66.58496,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,124293.0,white,no,0.799999714,0.6999998,no dnr,31.0,49.0,9.8984375,70.0,16.0,36.09375,371.375,2.8999023,0.59997559,14.5,135.0,7.339844,88.0,83.0,0.0,0.0,1.0,adl>=4 (>=5 if sur),1.0
86.10797,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,26338.0,white,no,0.949999809,0.8499999,dnr after sadm,1.0,111.0,27.1992188,119.0,10.0,36.0,66.0,2.2998047,0.59997559,7.19921875,135.0,7.489258,184.0,79.0,345.0,0.0,1.0,no(M2 and SIP pres),1.0
75.44696,female,0.0,ARF/MOSF w/Sepsis,11.0,under $11k,87543.0,white,no,0.5,0.5,dnr after sadm,4.0,50.0,6.09960938,60.0,20.0,35.59375,224.0,2.8999023,0.89990234,1.39990234,136.0,7.419922,145.0,42.0,1968.0,0.0,1.0,<2 mo. follow-up,3.8095703
89.09198,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,14379.0,black,yes,0.899999619,0.8999996,no dnr,7.0,109.0,12.3984375,72.0,4.0,38.79688,295.0,2.199707,0.89990234,1.29980469,139.0,7.429688,274.0,19.0,2160.0,0.0,1.0,<2 mo. follow-up,3.8432617
85.70795,male,0.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,55561.0,white,no,0.699999809,0.6999998,no dnr,18.0,113.0,13.1992188,110.0,10.0,36.09375,91.42188,2.0996094,0.89990234,0.59997559,137.0,7.429688,180.0,20.0,8550.0,0.0,5.0,adl>=4 (>=5 if sur),5.0
77.23798,male,1.0,MOSF w/Malig,15.0,$11-$25k,84604.0,hispanic,yes,0.799999714,0.09999996,dnr after sadm,1.0,51.0,2.59960938,155.0,10.0,38.19531,125.0,1.5998535,1.0,0.79992676,143.0,7.259766,73.0,21.0,2640.0,2.0,1.0,<2 mo. follow-up,1.0
49.875,male,0.0,CHF,12.0,under $11k,57210.0,white,no,0.699999809,0.6999998,no dnr,16.0,73.0,9.29882812,70.0,25.0,36.69531,260.0,2.8999023,0.89990234,0.79992676,141.0,7.359375,213.0,27.0,600.0,0.0,0.0,SIP>=30,0.0
88.487,female,0.0,CHF,13.0,under $11k,5350.0,white,no,0.949999809,0.5999999,no dnr,6.0,73.0,11.0996094,70.0,20.0,36.09375,678.25,2.8999023,0.89990234,1.19995117,142.0,7.279297,155.0,38.0,1968.0,2.0,1.0,no(M2 and SIP pres),1.8388672
63.064,male,0.0,COPD,16.0,$25-$50k,44135.0,white,no,0.899999619,0.6999998,dnr after sadm,1.0,57.0,14.5996094,124.0,10.0,39.09375,368.3125,4.3994141,0.5,1.0,136.0,7.5,137.0,11.0,1968.0,0.0,0.0,SIP>=30,0.0
77.84296,male,0.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,16510.0,white,no,0.899999619,0.7999997,no dnr,10.0,67.0,7.5,73.0,12.0,36.29688,152.0,3.0996094,0.39996338,5.59960938,131.0,7.389648,317.0,146.0,2745.0,0.0,0.0,no(M2 and SIP pres),0.0
35.13998,female,1.0,MOSF w/Malig,15.0,>$50k,134773.0,white,yes,0.5,0.3999999,dnr after sadm,7.0,118.0,8.8984375,68.0,24.0,39.0,366.625,2.8999023,0.89990234,1.39990234,140.0,7.459961,96.0,26.0,2100.0,0.0,1.0,<2 mo. follow-up,1.0
77.862,female,0.0,ARF/MOSF w/Sepsis,15.0,$11-$25k,50395.0,white,yes,0.799999714,0.6499996,no dnr,17.0,69.0,6.29980469,72.0,20.0,35.79688,224.0,2.8999023,0.5,1.19995117,142.0,7.419922,106.0,14.0,2875.0,0.0,0.0,no(M2 and SIP pres),0.0
79.59198,female,0.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,81465.0,white,no,0.799999714,0.7999997,no dnr,24.0,111.0,0.39996338,170.0,28.0,36.19531,135.0,2.2998047,2.09960938,7.79980469,135.0,7.349609,90.0,103.0,1660.0,0.0,3.0,no(M2 and SIP pres),3.0
66.10297,female,0.0,COPD,12.0,$11-$25k,7201.0,black,no,0.799999714,0.6999998,no dnr,3.0,87.0,7.09960938,80.0,20.0,36.69531,224.0,2.8999023,0.39996338,3.5,142.0,7.419922,88.0,70.0,1375.0,0.0,1.0,no(M2 and SIP pres),0.494751
53.55499,female,0.0,ARF/MOSF w/Sepsis,14.0,>$50k,65863.0,white,no,0.899999619,0.8999996,no dnr,21.0,97.0,7.79980469,70.0,25.0,36.09375,224.0,2.8999023,0.89990234,0.79992676,139.0,7.419922,162.0,13.0,1600.0,0.0,1.0,SIP>=30,1.0
61.952,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,42843.0,white,no,0.049999982,0.0,dnr after sadm,8.0,70.0,3.79980469,80.0,20.0,35.59375,224.0,3.8999023,0.89990234,1.79980469,137.0,7.419922,112.0,33.0,1968.0,0.0,1.0,<2 mo. follow-up,2.3276367
84.57794,male,0.0,CHF,22.0,under $11k,14980.0,white,no,0.799999714,0.5,no dnr,13.0,63.0,30.0976562,75.0,24.0,36.19531,224.0,2.5,0.89990234,5.09960938,134.0,7.419922,303.0,300.0,2155.0,1.0,4.0,SIP>=30,4.0
81.06494,male,0.0,CHF,12.0,>$50k,5775.0,white,no,0.849999905,0.7999997,no dnr,6.0,111.0,13.0,110.0,34.0,39.59375,162.0,2.8999023,0.89990234,1.5,135.0,7.439453,158.0,37.0,3650.0,0.0,1.0,<2 mo. follow-up,0.494751
58.168,female,0.0,CHF,12.0,under $11k,6601.0,black,yes,0.849999905,0.8499999,no dnr,5.0,110.0,5.69921875,44.0,34.0,36.19531,79.0,2.5996094,0.69995117,1.89990234,138.0,7.359375,132.0,27.0,1675.0,1.0,1.0,no(M2 and SIP pres),1.1667481
71.64398,male,0.0,ARF/MOSF w/Sepsis,12.0,>$50k,49989.0,white,yes,0.899999619,0.6999998,no dnr,17.0,56.0,10.5,70.0,6.0,37.79688,232.5,2.0,0.19998169,1.19995117,143.0,7.479492,152.0,21.0,3200.0,0.0,1.0,<2 mo. follow-up,2.9536133
63.76999,male,0.0,ARF/MOSF w/Sepsis,22.0,>$50k,69599.0,white,no,0.899999619,0.8999996,no dnr,18.0,83.0,6.0,80.0,20.0,38.29688,224.0,3.0,4.5,1.69995117,133.0,7.419922,95.0,39.0,800.0,0.0,0.0,no(M2 and SIP pres),0.0
58.60397,male,0.0,MOSF w/Malig,22.0,$25-$50k,141401.0,white,yes,0.599999905,0.5,no dnr,37.0,112.0,8.3984375,76.0,22.0,36.0,224.0,2.8999023,0.89990234,1.19995117,137.0,7.419922,93.0,25.0,1325.0,0.0,1.0,adl>=4 (>=5 if sur),1.0
44.49597,female,0.0,Lung Cancer,12.0,$25-$50k,5962.0,black,metastatic,0.149999976,0.009999998,dnr after sadm,2.0,116.0,16.796875,118.0,32.0,39.09375,250.0,4.0,0.89990234,0.79992676,145.0,7.40918,315.0,18.0,887.0,0.0,1.0,<2 mo. follow-up,2.5405273
48.37799,male,0.0,MOSF w/Malig,12.0,under $11k,149618.0,white,yes,0.5,0.1999999,no dnr,40.0,45.0,13.5,100.0,20.0,38.29688,224.0,2.3999023,0.19998169,1.0,134.0,7.419922,77.0,17.0,800.0,0.0,0.0,<2 mo. follow-up,0.0
74.73199,male,0.0,COPD,7.0,under $11k,24493.0,white,yes,0.5,0.4499998,no dnr,19.0,119.0,14.0,118.0,11.0,36.79688,238.09375,1.8999023,0.59997559,1.19995117,113.0,7.349609,1092.0,35.0,2370.0,0.0,3.0,<2 mo. follow-up,3.0
77.82599,female,0.0,Coma,12.0,under $11k,31427.0,white,no,0.25,0.09999996,dnr after sadm,1.0,121.0,26.0976562,156.0,40.0,40.19531,224.0,3.2998047,0.39996338,0.79992676,132.0,7.419922,130.0,10.0,4750.0,0.0,6.0,adl>=4 (>=5 if sur),6.0
78.70795,female,0.0,COPD,18.0,$11-$25k,17883.0,white,no,0.899999619,0.7999997,dnr after sadm,7.0,59.0,11.7988281,62.0,28.0,38.5,302.0,3.5996094,0.89990234,2.0,136.0,7.40918,95.0,60.0,2713.0,2.0,1.0,adl>=4 (>=5 if sur),1.8388672
82.80096,male,0.0,ARF/MOSF w/Sepsis,11.0,$11-$25k,8501.0,white,yes,0.5,0.1999999,dnr before sadm,0.0,59.0,6.69921875,66.0,28.0,37.29688,224.0,2.199707,0.59997559,1.79980469,134.0,7.419922,196.0,88.0,2350.0,0.0,5.0,adl>=4 (>=5 if sur),5.0
83.23297,female,0.0,ARF/MOSF w/Sepsis,14.0,under $11k,24143.0,white,no,0.799999714,0.7999997,dnr after sadm,1.0,113.0,14.3984375,152.0,36.0,36.39844,96.65625,3.199707,1.09985352,0.89990234,142.0,7.5,108.0,19.0,5065.0,0.0,6.0,adl>=4 (>=5 if sur),6.0
71.81696,male,0.0,COPD,14.0,$11-$25k,21997.0,white,no,0.699999809,0.6499996,no dnr,9.0,47.0,14.0996094,58.0,10.0,37.79688,87.5,2.7998047,0.79992676,1.0,139.0,7.389648,228.0,21.0,848.0,0.0,0.0,no(M2 and SIP pres),0.0
74.13794,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,27806.0,white,no,0.799999714,0.7999997,dnr after sadm,1.0,107.0,15.2988281,112.0,27.0,36.69531,242.84375,2.8999023,0.89990234,1.19995117,140.0,7.439453,150.0,20.0,1670.0,0.0,6.0,adl>=4 (>=5 if sur),6.0
93.21295,female,0.0,CHF,9.0,under $11k,10108.0,white,no,0.799999714,0.6999998,dnr before sadm,-1.0,113.0,5.79980469,50.0,24.0,37.79688,371.375,2.0996094,4.29980469,1.0,142.0,7.479492,85.0,27.0,1968.0,1.0,1.0,no(M2 and SIP pres),1.0
71.34296,female,0.0,ARF/MOSF w/Sepsis,10.0,under $11k,18782.0,white,no,0.949999809,0.8999996,dnr before sadm,-1.0,60.0,10.8984375,71.0,7.0,37.79688,164.0,3.199707,0.5,1.19995117,145.0,7.489258,103.0,28.0,880.0,0.0,6.0,<2 mo. follow-up,6.0
62.76797,female,0.0,ARF/MOSF w/Sepsis,8.0,under $11k,14804.0,white,no,0.979999542,0.9499998,no dnr,10.0,112.0,3.79980469,80.0,16.0,38.09375,314.25,3.0,0.89990234,1.59985352,142.0,7.229492,145.0,27.0,3050.0,0.0,0.0,no(M2 and SIP pres),0.0
77.38794,male,0.0,ARF/MOSF w/Sepsis,14.0,$25-$50k,276475.0,white,no,0.799999714,0.5,dnr after sadm,56.0,63.0,8.0,109.0,24.0,37.59375,225.0,2.7998047,0.89990234,1.39990234,133.0,7.279297,171.0,27.0,3893.0,4.0,2.0,adl>=4 (>=5 if sur),2.0
44.65698,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,162599.0,white,no,0.599999905,0.5,no dnr,43.0,83.0,7.79980469,62.0,22.0,35.79688,224.0,2.8999023,0.89990234,1.89990234,140.0,7.419922,97.0,51.0,2000.0,0.0,0.0,SIP>=30,0.0
50.73798,male,0.0,ARF/MOSF w/Sepsis,14.0,under $11k,59439.0,white,no,0.299999952,0.1999999,dnr after sadm,6.0,68.0,12.2988281,70.0,8.0,36.0,154.0,2.8999023,0.89990234,0.69995117,147.0,7.349609,149.0,18.0,846.0,0.0,0.0,no(M2 and SIP pres),0.0
73.40497,female,0.0,ARF/MOSF w/Sepsis,14.0,under $11k,25024.0,white,no,0.699999809,0.5499997,no dnr,34.0,113.0,13.1992188,110.0,28.0,36.09375,266.625,3.199707,8.19921875,0.89990234,140.0,7.469727,131.0,13.0,1760.0,0.0,0.0,<2 mo. follow-up,0.0
79.66296,male,1.0,ARF/MOSF w/Sepsis,14.0,under $11k,62999.0,white,yes,0.199999928,0.09999996,dnr after sadm,6.0,53.0,0.09999084,145.0,22.0,38.39844,152.84375,2.0,0.69995117,0.79992676,150.0,7.329102,245.0,35.0,4700.0,0.0,0.0,<2 mo. follow-up,0.0
69.08099,male,1.0,Coma,12.0,under $11k,20163.0,white,no,0.299999952,0.25,dnr after sadm,2.0,49.0,11.7988281,67.0,12.0,36.69531,167.5,2.699707,1.19995117,1.5,136.0,7.359375,184.0,31.0,2311.0,0.0,1.0,<2 mo. follow-up,2.0917969
27.584,male,1.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,19892.0,white,no,0.699999809,0.5,no dnr,4.0,51.0,14.0,120.0,46.0,38.5,235.0,2.3999023,0.69995117,1.79980469,143.0,7.349609,152.0,38.0,2304.0,0.0,1.0,<2 mo. follow-up,2.0629883
86.26996,female,0.0,ARF/MOSF w/Sepsis,8.0,$11-$25k,9650.0,white,no,0.899999619,0.7999997,dnr after sadm,1.0,113.0,7.59960938,70.0,16.0,36.69531,603.25,2.8999023,0.89990234,7.79980469,142.0,7.109375,225.0,33.0,0.0,6.0,1.0,SIP>=30,4.5273438
61.35199,female,0.0,ARF/MOSF w/Sepsis,8.0,under $11k,234324.0,white,no,0.199999928,0.1999999,no dnr,54.0,70.0,17.5,144.0,11.0,39.79688,200.0,2.199707,0.19998169,0.69995117,141.0,7.319336,164.0,12.0,3780.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
77.758,female,1.0,ARF/MOSF w/Sepsis,6.0,under $11k,146557.0,black,no,0.199999928,0.09999996,dnr after sadm,24.0,77.0,15.1992188,124.0,36.0,38.09375,253.03125,2.8999023,1.09985352,1.89990234,134.0,7.319336,224.0,81.0,1225.0,0.0,1.0,<2 mo. follow-up,2.7324219
80.35297,male,0.0,Coma,15.0,$11-$25k,29080.0,white,no,0.949999809,0.75,dnr after sadm,2.0,77.0,5.59960938,60.0,20.0,36.09375,224.0,2.8999023,0.89990234,2.39990234,133.0,7.419922,82.0,61.0,1968.0,0.0,7.0,adl>=4 (>=5 if sur),7.0
84.22699,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,36814.0,white,yes,0.099999964,0.0,dnr after sadm,1.0,102.0,12.5996094,80.0,20.0,36.09375,224.0,2.8999023,0.89990234,1.79980469,136.0,7.419922,163.0,36.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5117188
82.63397,female,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,82585.0,white,yes,0.199999928,0.15,no dnr,22.0,68.0,11.5996094,150.0,24.0,40.0,136.65625,4.5,0.5,3.29980469,138.0,7.519531,146.0,55.0,1040.0,0.0,2.0,<2 mo. follow-up,2.0
59.03098,female,0.0,CHF,12.0,under $11k,3748.0,white,no,0.699999809,0.5,no dnr,4.0,110.0,4.5,80.0,20.0,36.09375,338.0625,2.8999023,0.89990234,9.09960938,141.0,7.289062,78.0,119.0,1950.0,0.0,1.0,<2 mo. follow-up,2.1147461
49.95499,female,0.0,Lung Cancer,14.0,under $11k,12992.0,black,metastatic,0.699999809,0.5,no dnr,4.0,107.0,24.5,80.0,26.0,37.09375,77.0,2.8999023,0.89990234,0.5,134.0,7.439453,144.0,11.0,690.0,0.0,1.0,no(M2 and SIP pres),2.1118164
70.02594,male,0.0,ARF/MOSF w/Sepsis,11.0,under $11k,18838.0,white,no,0.699999809,0.5,no dnr,5.0,67.0,8.29882812,57.0,8.0,38.19531,156.0,4.5996094,0.59997559,1.0,140.0,7.329102,107.0,10.0,1410.0,0.0,1.0,<2 mo. follow-up,3.2270508
50.87198,female,1.0,ARF/MOSF w/Sepsis,18.0,under $11k,60732.0,white,no,0.799999714,0.7999997,dnr after sadm,7.0,47.0,15.1992188,77.0,9.0,36.0,154.53125,2.7998047,0.29998779,2.79980469,134.0,7.349609,113.0,48.0,2015.0,0.0,1.0,<2 mo. follow-up,4.7675781
73.03198,male,0.0,Coma,12.0,under $11k,83542.0,white,no,0.0,0.0,no dnr,29.0,73.0,12.5996094,72.0,4.0,36.29688,224.0,2.5996094,0.29998779,0.89990234,138.0,7.419922,143.0,31.0,260.0,0.0,1.0,<2 mo. follow-up,3.7890625
75.96997,female,0.0,Colon Cancer,13.0,under $11k,9781.0,white,metastatic,0.599999905,0.09999996,dnr after sadm,1.0,133.0,11.7988281,140.0,40.0,37.89844,235.0,2.8999023,0.89990234,0.89990234,141.0,7.279297,138.0,16.0,3239.0,1.0,1.0,SIP>=30,1.1667481
100.849,female,0.0,ARF/MOSF w/Sepsis,8.0,under $11k,10535.0,white,no,0.699999809,0.5,dnr after sadm,3.0,57.0,20.296875,70.0,25.0,36.69531,277.75,2.8999023,0.89990234,2.09960938,132.0,7.399414,407.0,65.0,1350.0,0.0,1.0,<2 mo. follow-up,1.0
89.56097,male,0.0,COPD,12.0,under $11k,10879.0,white,yes,0.5,0.3,dnr before sadm,-1.0,67.0,15.0996094,70.0,20.0,39.39844,233.3125,4.2998047,0.5,2.39990234,144.0,7.219727,176.0,36.0,3600.0,1.0,5.0,<2 mo. follow-up,5.0
76.45197,male,0.0,CHF,16.0,$11-$25k,3710.0,white,yes,0.699999809,0.5,no dnr,3.0,60.0,6.59960938,60.0,25.0,37.79688,232.0,2.8999023,0.89990234,1.19995117,142.0,7.359375,98.0,21.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.494751
86.71295,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,10759.0,black,no,1.0,1.0,no dnr,5.0,100.0,9.79882812,100.0,20.0,35.89844,113.32812,2.8999023,0.89990234,1.59985352,143.0,7.259766,208.0,41.0,900.0,0.0,1.0,no(M2 and SIP pres),0.494751
88.099,female,1.0,COPD,12.0,under $11k,6003.0,white,yes,0.049999982,0.0,dnr before sadm,-1.0,67.0,24.8984375,160.0,30.0,40.0,157.5,2.8999023,0.89990234,1.89990234,140.0,7.489258,166.0,78.0,2510.0,0.0,1.0,<2 mo. follow-up,4.3720703
73.08997,male,0.0,Colon Cancer,15.0,>$50k,3504.0,white,metastatic,0.699999809,0.5,no dnr,3.0,51.0,16.3984375,65.0,24.0,35.59375,224.0,2.699707,0.39996338,0.69995117,147.0,7.419922,88.0,22.0,3020.0,0.0,1.0,no(M2 and SIP pres),1.6003418
41.06,male,1.0,Cirrhosis,12.0,under $11k,34565.0,white,no,0.5,0.3,dnr after sadm,11.0,66.0,10.8984375,66.0,22.0,36.59375,73.0,3.8999023,0.89990234,1.69995117,139.0,7.459961,132.0,31.0,3420.0,0.0,1.0,<2 mo. follow-up,1.0
79.38696,female,0.0,CHF,12.0,under $11k,10367.0,white,no,0.929999828,0.8999996,no dnr,8.0,60.0,16.296875,106.0,24.0,36.89844,250.0,2.699707,0.5,0.69995117,151.0,7.349609,222.0,35.0,1060.0,0.0,1.0,<2 mo. follow-up,3.1455078
88.04095,female,0.0,CHF,12.0,>$50k,14197.0,white,no,0.75,0.6499996,no dnr,12.0,105.0,10.0,85.0,20.0,36.0,224.0,4.0996094,0.29998779,1.29980469,133.0,7.419922,164.0,9.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
72.02496,male,0.0,ARF/MOSF w/Sepsis,11.0,under $11k,26558.0,white,yes,0.949999809,0.8999996,no dnr,14.0,73.0,9.59960938,70.0,20.0,36.69531,224.0,2.8999023,0.89990234,2.59960938,140.0,7.419922,168.0,53.0,275.0,1.0,1.0,SIP>=30,1.0
63.95599,female,0.0,ARF/MOSF w/Sepsis,17.0,$25-$50k,23886.0,black,no,0.75,0.6999998,no dnr,15.0,111.0,11.1992188,70.0,12.0,36.09375,312.0,2.5,0.89990234,0.59997559,137.0,7.5,147.0,23.0,980.0,0.0,0.0,SIP>=30,0.0
59.129,male,0.0,ARF/MOSF w/Sepsis,16.0,under $11k,71912.0,white,no,0.599999905,0.5499997,no dnr,20.0,51.0,12.6992188,76.0,24.0,36.09375,612.0,2.8999023,0.29998779,2.59960938,146.0,7.119141,86.0,41.0,2000.0,0.0,0.0,no(M2 and SIP pres),0.0
44.78,male,0.0,Colon Cancer,17.0,>$50k,9059.0,black,metastatic,0.989999771,0.75,no dnr,7.0,107.0,10.2988281,80.0,26.0,36.29688,176.65625,3.0996094,0.39996338,3.89990234,143.0,7.419922,193.0,90.0,521.0,0.0,0.0,no(M2 and SIP pres),0.0
33.73898,female,1.0,Cirrhosis,16.0,>$50k,156416.0,white,no,0.899999619,0.8999996,dnr after sadm,35.0,49.0,5.19921875,138.0,52.0,38.09375,131.0,1.8999023,0.89990234,2.39990234,138.0,7.259766,160.0,52.0,1937.0,0.0,0.0,<2 mo. follow-up,0.0
63.39798,female,0.0,COPD,12.0,under $11k,10480.0,white,no,0.699999809,0.5,no dnr,8.0,48.0,18.0976562,131.0,14.0,39.19531,140.0,2.699707,0.89990234,1.39990234,148.0,7.349609,164.0,19.0,2095.0,1.0,1.0,no(M2 and SIP pres),1.1667481
74.58997,female,0.0,COPD,12.0,under $11k,30041.0,white,no,0.5,0.3,dnr after sadm,1.0,60.0,14.7988281,80.0,13.0,36.69531,405.0,3.2998047,0.89990234,1.39990234,151.0,7.469727,92.0,67.0,3775.0,0.0,1.0,adl>=4 (>=5 if sur),5.7011719
43.93399,female,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,40720.0,black,no,0.699999809,0.6499996,no dnr,11.0,46.0,8.5,71.0,24.0,36.09375,217.5,3.699707,0.89990234,1.69995117,143.0,7.419922,119.0,19.0,3835.0,0.0,0.0,no(M2 and SIP pres),0.0
74.54095,male,1.0,Colon Cancer,17.0,under $11k,28086.0,white,metastatic,0.5,0.1999999,dnr after sadm,16.0,64.0,6.5,55.0,15.0,36.39844,376.625,2.8999023,0.5,0.89990234,136.0,7.449219,314.0,15.0,380.0,1.0,1.0,<2 mo. follow-up,1.0
61.76297,female,1.0,COPD,12.0,under $11k,9606.0,white,metastatic,0.0,0.0,dnr after sadm,1.0,51.0,9.8984375,126.0,20.0,39.09375,85.70312,2.5,1.59985352,0.69995117,149.0,7.369141,404.0,11.0,6020.0,0.0,1.0,<2 mo. follow-up,3.3886719
31.75899,female,0.0,ARF/MOSF w/Sepsis,14.0,>$50k,13281.0,white,yes,1.0,0.9799995,no dnr,9.0,103.0,6.79980469,80.0,20.0,36.09375,185.0,2.8999023,0.89990234,1.79980469,136.0,7.329102,124.0,42.0,785.0,0.0,0.0,no(M2 and SIP pres),0.0
80.73395,female,0.0,CHF,12.0,under $11k,13755.0,white,yes,0.899999619,0.75,no dnr,13.0,70.0,10.5,100.0,12.0,38.5,150.0,2.199707,0.5,1.0,137.0,7.389648,110.0,13.0,2660.0,2.0,5.0,no(M2 and SIP pres),5.0
57.44299,male,0.0,CHF,12.0,>$50k,16060.0,white,no,0.899999619,0.6499996,no dnr,6.0,63.0,24.296875,80.0,8.0,36.89844,191.65625,1.6999512,0.89990234,1.39990234,132.0,7.489258,279.0,30.0,4375.0,0.0,1.0,no(M2 and SIP pres),0.494751
90.409,female,0.0,CHF,12.0,under $11k,15787.0,white,no,0.599999905,0.5,dnr after sadm,1.0,105.0,7.39941406,71.0,20.0,36.29688,224.0,3.199707,0.69995117,1.69995117,142.0,7.419922,116.0,29.0,1968.0,0.0,1.0,<2 mo. follow-up,4.7402344
64.47595,male,0.0,Coma,12.0,under $11k,69165.0,white,no,0.199999928,0.09999996,no dnr,55.0,46.0,14.5,59.0,12.0,38.59375,423.3125,2.2998047,0.89990234,0.69995117,142.0,7.329102,174.0,19.0,2250.0,0.0,1.0,adl>=4 (>=5 if sur),2.9770508
91.55896,female,1.0,Coma,6.0,under $11k,10485.0,white,no,0.099999964,0.02,dnr before sadm,0.0,115.0,12.2988281,69.0,28.0,35.79688,148.3125,2.8999023,0.89990234,0.89990234,134.0,7.429688,107.0,10.0,1300.0,0.0,7.0,<2 mo. follow-up,7.0
73.69995,male,0.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,25804.0,white,metastatic,0.049999982,0.02,dnr after sadm,5.0,73.0,26.0,110.0,12.0,36.0,70.0,2.2998047,0.5,1.59985352,143.0,7.469727,149.0,20.0,949.0,0.0,1.0,no(M2 and SIP pres),3.7792969
72.41095,male,1.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,67720.0,white,no,0.299999952,0.1999999,dnr after sadm,14.0,103.0,6.29980469,80.0,20.0,36.09375,224.0,4.3994141,0.59997559,5.89941406,135.0,7.419922,91.0,82.0,975.0,1.0,1.0,<2 mo. follow-up,1.1667481
46.06699,male,0.0,ARF/MOSF w/Sepsis,16.0,$25-$50k,25496.0,hispanic,no,1.0,1.0,no dnr,12.0,93.0,6.59960938,96.0,28.0,36.5,224.0,2.8999023,0.89990234,0.59997559,137.0,7.419922,96.0,11.0,2220.0,0.0,0.0,no(M2 and SIP pres),0.0
87.63599,female,0.0,ARF/MOSF w/Sepsis,10.0,under $11k,25788.0,white,no,0.0,0.0,no dnr,15.0,117.0,13.2988281,80.0,25.0,37.79688,224.0,2.0996094,0.39996338,4.29980469,145.0,7.419922,118.0,116.0,2050.0,2.0,1.0,adl>=4 (>=5 if sur),1.0
72.46295,female,0.0,ARF/MOSF w/Sepsis,10.0,under $11k,15090.0,white,yes,0.699999809,0.5999999,no dnr,10.0,79.0,6.59960938,117.0,25.0,38.09375,224.0,2.8999023,0.29998779,0.5,130.0,7.419922,307.0,2.0,2675.0,1.0,2.0,no(M2 and SIP pres),2.0
76.71497,male,0.0,CHF,16.0,>$50k,20323.0,white,no,0.699999809,0.5999999,no dnr,14.0,52.0,7.89941406,106.0,10.0,38.5,224.0,2.8999023,21.0,1.09985352,138.0,7.419922,330.0,23.0,735.0,0.0,6.0,no(M2 and SIP pres),6.0
69.75995,male,0.0,Cirrhosis,12.0,$11-$25k,54999.0,white,no,0.299999952,0.09999996,dnr after sadm,13.0,87.0,15.8984375,80.0,20.0,37.0,224.0,3.3999023,0.5,1.09985352,139.0,7.419922,196.0,17.0,1500.0,1.0,0.0,no(M2 and SIP pres),0.0
90.84198,female,0.0,CHF,12.0,under $11k,8074.0,white,yes,0.899999619,0.5999999,dnr before sadm,0.0,72.0,10.8984375,72.0,24.0,36.19531,225.6875,2.8999023,0.89990234,1.89990234,141.0,7.399414,133.0,58.0,2300.0,0.0,4.0,adl>=4 (>=5 if sur),4.0
57.133,female,0.0,ARF/MOSF w/Sepsis,14.0,$25-$50k,17320.0,white,no,0.799999714,0.6999998,no dnr,7.0,83.0,7.89941406,70.0,30.0,36.09375,190.46875,3.5996094,0.79992676,1.0,142.0,7.459961,117.0,27.0,500.0,0.0,0.0,no(M2 and SIP pres),0.0
79.64697,male,0.0,CHF,14.0,$11-$25k,7423.0,white,metastatic,0.75,0.5,dnr after sadm,2.0,65.0,7.09960938,60.0,18.0,36.19531,224.0,2.8999023,0.89990234,2.29980469,134.0,7.419922,283.0,51.0,1700.0,2.0,1.0,adl>=4 (>=5 if sur),1.0
84.15594,female,0.0,COPD,16.0,under $11k,30009.0,white,no,0.949999809,0.75,dnr after sadm,11.0,109.0,23.5,50.0,10.0,36.39844,224.4375,2.8999023,1.39990234,1.09985352,140.0,7.529297,167.0,18.0,2675.0,1.0,5.0,adl>=4 (>=5 if sur),5.0
74.74896,male,1.0,Coma,16.0,under $11k,22690.0,white,no,0.199999928,0.09999996,dnr after sadm,5.0,69.0,5.29980469,65.0,24.0,36.59375,161.65625,2.8999023,0.89990234,3.0,139.0,7.189453,99.0,42.0,1500.0,0.0,1.0,<2 mo. follow-up,1.0
89.71399,male,0.0,ARF/MOSF w/Sepsis,17.0,under $11k,48745.0,white,yes,0.099999964,0.09999996,no dnr,22.0,113.0,14.0,70.0,20.0,38.29688,247.59375,2.8999023,0.59997559,1.0,130.0,7.519531,171.0,17.0,6625.0,0.0,0.0,no(M2 and SIP pres),0.0
63.51297,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,193988.0,white,no,0.799999714,0.6999998,dnr after sadm,14.0,53.0,8.8984375,120.0,20.0,37.0,196.28125,2.8999023,0.89990234,1.09985352,148.0,7.269531,136.0,43.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),1.0
75.92096,male,0.0,COPD,13.0,$11-$25k,17128.0,white,no,0.849999905,0.75,no dnr,7.0,100.0,14.0,70.0,30.0,36.09375,428.5625,4.1992188,0.69995117,1.19995117,139.0,7.539062,118.0,12.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
67.38696,female,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,50514.0,white,no,0.799999714,0.9499998,dnr after sadm,2.0,87.0,9.5,80.0,20.0,36.09375,224.0,2.5996094,0.89990234,1.09985352,132.0,7.419922,81.0,23.0,1968.0,6.0,6.0,no(M2 and SIP pres),6.0
92.57196,male,0.0,Colon Cancer,7.0,$11-$25k,5912.0,white,metastatic,0.5,0.25,dnr after sadm,1.0,72.0,13.1992188,66.0,22.0,36.69531,224.0,2.8999023,1.0,0.69995117,134.0,7.419922,132.0,8.0,1968.0,0.0,1.0,<2 mo. follow-up,3.6606445
78.97296,male,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,45546.0,white,metastatic,0.5,0.5,no dnr,9.0,77.0,5.0,110.0,20.0,36.09375,392.5625,2.8999023,0.89990234,1.19995117,135.0,7.449219,112.0,21.0,1100.0,0.0,0.0,no(M2 and SIP pres),0.0
65.711,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,20463.0,white,no,0.799999714,0.5999999,no dnr,10.0,87.0,5.19921875,80.0,25.0,36.09375,224.0,2.8999023,1.5,1.69995117,143.0,7.419922,111.0,46.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
71.11597,male,1.0,Lung Cancer,0.0,under $11k,15720.0,white,metastatic,0.649999619,0.3999999,no dnr,12.0,63.0,13.3984375,114.0,20.0,36.09375,177.53125,2.5996094,0.39996338,3.59960938,142.0,7.379883,157.0,79.0,3550.0,0.0,6.0,<2 mo. follow-up,6.0
79.67694,male,0.0,CHF,12.0,$11-$25k,11104.0,white,no,0.399999857,0.09999996,no dnr,11.0,46.0,15.1992188,71.0,16.0,35.39844,168.5625,2.5,2.0,5.59960938,128.0,7.289062,83.0,56.0,0.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
78.34399,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,171445.0,white,no,0.099999964,0.09999996,no dnr,42.0,43.0,10.3984375,107.0,14.0,38.29688,130.0,2.0,0.89990234,1.69995117,136.0,7.40918,284.0,16.0,8404.0,0.0,1.0,no(M2 and SIP pres),2.3637695
77.85895,male,0.0,ARF/MOSF w/Sepsis,16.0,$25-$50k,42725.0,white,yes,0.5,0.1999999,no dnr,15.0,77.0,13.8984375,70.0,20.0,37.89844,224.0,3.2998047,1.29980469,1.29980469,135.0,7.419922,130.0,12.0,1300.0,0.0,1.0,<2 mo. follow-up,3.6811523
75.88196,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,38838.0,white,no,0.799999714,0.7999997,no dnr,14.0,55.0,2.59960938,105.0,20.0,36.79688,420.0,1.5,0.79992676,0.59997559,141.0,7.429688,86.0,13.0,1900.0,0.0,0.0,<2 mo. follow-up,0.0
79.63599,male,0.0,CHF,12.0,under $11k,17408.0,white,no,0.899999619,0.5,no dnr,10.0,57.0,23.3984375,70.0,25.0,36.69531,195.21875,2.8999023,0.89990234,2.0,145.0,7.359375,224.0,50.0,1780.0,1.0,0.0,adl>=4 (>=5 if sur),0.0
53.952,male,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,13302.0,black,no,0.699999809,0.5,no dnr,4.0,117.0,17.8984375,100.0,20.0,38.29688,130.0,2.8999023,0.89990234,0.89990234,151.0,7.149414,121.0,26.0,30.0,0.0,1.0,no(M2 and SIP pres),2.2719727
83.81396,male,1.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,27338.0,white,no,0.699999809,0.6999998,dnr after sadm,1.0,137.0,16.5,66.0,10.0,36.89844,120.0,3.5996094,0.79992676,0.69995117,136.0,7.379883,315.0,15.0,2680.0,0.0,6.0,<2 mo. follow-up,6.0
56.63498,female,0.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,119068.0,white,no,0.799999714,0.8699999,no dnr,26.0,62.0,10.1992188,72.0,12.0,35.69531,224.0,2.8999023,0.89990234,1.19995117,130.0,7.419922,105.0,20.0,850.0,0.0,0.0,<2 mo. follow-up,0.0
72.94196,female,1.0,COPD,12.0,under $11k,16909.0,white,yes,0.099999964,0.04999998,no dnr,5.0,97.0,12.1992188,110.0,25.0,35.79688,420.0,3.199707,0.39996338,0.69995117,144.0,7.449219,158.0,11.0,1968.0,0.0,1.0,<2 mo. follow-up,2.9960938
70.07495,male,0.0,Lung Cancer,19.0,$11-$25k,8271.0,white,metastatic,0.5,0.25,dnr after sadm,4.0,79.0,6.0,70.0,24.0,36.29688,136.71875,3.0,0.39996338,1.0,138.0,7.479492,146.0,17.0,1850.0,0.0,0.0,<2 mo. follow-up,0.0
70.21497,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,55557.0,white,no,0.899999619,0.8999996,dnr after sadm,10.0,107.0,3.79980469,80.0,20.0,36.69531,224.0,2.8999023,0.89990234,4.59960938,135.0,7.419922,105.0,53.0,825.0,0.0,1.0,<2 mo. follow-up,1.0
44.65997,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,94668.0,black,no,0.599999905,0.5999999,no dnr,25.0,117.0,6.5,82.0,20.0,35.89844,309.5,2.8999023,0.89990234,3.5,142.0,7.389648,226.0,55.0,5860.0,0.0,0.0,no(M2 and SIP pres),0.0
70.44995,female,0.0,COPD,12.0,under $11k,6921.0,white,yes,0.899999619,0.8999996,no dnr,7.0,67.0,6.79980469,64.0,12.0,36.39844,155.09375,2.8999023,0.39996338,2.39990234,141.0,7.329102,90.0,64.0,2360.0,0.0,1.0,<2 mo. follow-up,2.3833008
64.89294,male,1.0,MOSF w/Malig,12.0,$25-$50k,37234.0,white,metastatic,0.699999809,0.5,dnr after sadm,3.0,64.0,6.5,63.0,30.0,38.19531,126.65625,3.5996094,1.09985352,1.39990234,143.0,7.399414,86.0,30.0,1885.0,0.0,1.0,<2 mo. follow-up,2.4599609
66.37598,female,0.0,CHF,10.0,under $11k,8253.0,black,no,0.599999905,0.3,no dnr,7.0,60.0,17.5,40.0,20.0,35.79688,224.0,2.8999023,0.89990234,2.29980469,150.0,7.419922,98.0,93.0,925.0,0.0,6.0,<2 mo. follow-up,6.0
71.80798,male,1.0,Cirrhosis,16.0,$11-$25k,11112.0,white,metastatic,0.5,0.09999996,dnr after sadm,1.0,107.0,11.5996094,116.0,28.0,35.29688,286.625,2.3999023,0.89990234,0.69995117,130.0,7.419922,260.0,21.0,1968.0,0.0,5.0,<2 mo. follow-up,5.0
77.32794,male,1.0,MOSF w/Malig,16.0,$25-$50k,38514.0,white,yes,0.299999952,0.04999998,dnr after sadm,12.0,75.0,19.6992188,108.0,32.0,35.0,240.0,1.7998047,2.39990234,4.39941406,131.0,7.30957,214.0,67.0,285.0,0.0,0.0,<2 mo. follow-up,0.0
64.63196,female,0.0,Lung Cancer,13.0,$25-$50k,13459.0,white,metastatic,0.5,0.04999998,no dnr,11.0,60.0,6.19921875,75.0,22.0,36.59375,714.25,3.199707,0.5,0.59997559,137.0,7.069336,400.0,10.0,9000.0,1.0,1.0,no(M2 and SIP pres),1.0
29.29799,male,0.0,ARF/MOSF w/Sepsis,10.0,$25-$50k,25024.0,white,no,0.799999714,0.7999997,no dnr,9.0,116.0,10.6992188,74.0,20.0,38.19531,272.0,3.699707,1.09985352,0.89990234,150.0,7.449219,209.0,30.0,690.0,0.0,0.0,no(M2 and SIP pres),0.0
74.06195,male,1.0,ARF/MOSF w/Sepsis,14.0,$25-$50k,87620.0,white,no,0.099999964,0.04999998,dnr after sadm,22.0,64.0,19.6992188,60.0,24.0,37.39844,76.65625,2.8999023,0.89990234,1.89990234,135.0,7.269531,331.0,40.0,3310.0,0.0,1.0,<2 mo. follow-up,1.0
63.22198,male,0.0,Cirrhosis,13.0,under $11k,11623.0,white,no,0.75,0.5,no dnr,8.0,43.0,11.6992188,70.0,20.0,35.59375,135.0,2.8999023,0.89990234,2.0,139.0,7.439453,93.0,54.0,1075.0,3.0,3.0,no(M2 and SIP pres),3.0
83.65198,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,21889.0,white,no,1.0,1.0,no dnr,9.0,76.0,17.5,114.0,28.0,36.39844,322.1875,2.0,2.39990234,0.79992676,141.0,7.439453,101.0,21.0,910.0,0.0,1.0,no(M2 and SIP pres),3.1210938
70.08899,female,0.0,CHF,12.0,$11-$25k,8502.0,white,no,0.599999905,0.3999999,no dnr,8.0,107.0,10.3984375,90.0,20.0,37.0,220.0,2.8999023,0.89990234,1.5,140.0,7.449219,179.0,23.0,800.0,0.0,0.0,no(M2 and SIP pres),0.0
82.57098,female,0.0,CHF,8.0,under $11k,5274.0,white,no,0.799999714,0.6499996,no dnr,5.0,117.0,18.0976562,140.0,30.0,40.19531,162.5,4.0,0.59997559,1.09985352,141.0,7.459961,151.0,19.0,1625.0,2.0,2.0,no(M2 and SIP pres),2.0
74.21796,male,0.0,CHF,12.0,$25-$50k,10267.0,white,no,0.909999847,0.8999996,no dnr,7.0,55.0,14.5996094,80.0,8.0,37.69531,374.25,2.199707,0.69995117,1.59985352,136.0,7.319336,261.0,44.0,1970.0,1.0,1.0,SIP>=30,1.0
56.698,female,0.0,COPD,13.0,$25-$50k,11830.0,white,no,0.699999809,0.5,no dnr,6.0,100.0,8.5,70.0,20.0,36.09375,224.0,3.0996094,0.59997559,1.79980469,135.0,7.419922,276.0,30.0,1350.0,0.0,0.0,no(M2 and SIP pres),0.0
55.34,male,0.0,CHF,11.0,under $11k,30451.0,white,no,0.899999619,0.7999997,no dnr,16.0,62.0,6.79980469,119.0,30.0,36.69531,240.0,2.8999023,0.89990234,0.79992676,138.0,7.429688,312.0,25.0,1775.0,0.0,0.0,<2 mo. follow-up,0.0
63.71799,female,0.0,COPD,8.0,under $11k,6560.0,white,no,0.699999809,0.5,dnr after sadm,1.0,111.0,12.0,73.0,30.0,39.89844,166.0,3.5996094,0.79992676,2.09960938,148.0,7.439453,141.0,56.0,1660.0,0.0,1.0,no(M2 and SIP pres),2.0039062
70.54895,female,0.0,CHF,12.0,under $11k,14419.0,white,no,0.799999714,0.6999998,no dnr,9.0,48.0,16.8984375,105.0,12.0,38.09375,59.0,3.7998047,1.29980469,2.19970703,138.0,7.359375,183.0,71.0,5380.0,0.0,1.0,no(M2 and SIP pres),1.0
64.82996,male,0.0,CHF,12.0,under $11k,16287.0,white,no,0.899999619,0.8499999,no dnr,8.0,63.0,3.5,110.0,16.0,38.59375,238.0,2.0,0.89990234,3.59960938,133.0,7.389648,115.0,61.0,0.0,0.0,1.0,<2 mo. follow-up,2.6801758
67.797,male,1.0,MOSF w/Malig,12.0,$25-$50k,99187.0,white,yes,0.199999928,0.1999999,no dnr,10.0,76.0,14.7988281,72.0,25.0,36.19531,356.0,3.7998047,0.69995117,2.0,137.0,7.089844,123.0,25.0,1320.0,0.0,0.0,<2 mo. follow-up,0.0
78.836,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,140610.0,white,no,0.699999809,0.5,dnr after sadm,14.0,61.0,15.6992188,79.0,30.0,38.19531,224.0,2.8999023,0.89990234,0.59997559,136.0,7.419922,132.0,6.0,1550.0,0.0,0.0,<2 mo. follow-up,0.0
76.49597,male,0.0,COPD,10.0,under $11k,3392.0,white,yes,0.699999809,0.5,no dnr,3.0,72.0,11.6992188,64.0,20.0,36.29688,224.0,3.5996094,1.09985352,0.89990234,136.0,7.419922,96.0,21.0,600.0,0.0,1.0,no(M2 and SIP pres),0.494751
61.40198,male,1.0,MOSF w/Malig,12.0,>$50k,54985.0,white,metastatic,0.699999809,0.5,dnr after sadm,2.0,104.0,10.0,60.0,12.0,36.29688,108.32812,2.8999023,0.89990234,1.29980469,137.0,7.399414,97.0,40.0,1400.0,0.0,1.0,<2 mo. follow-up,2.2880859
64.51996,male,0.0,ARF/MOSF w/Sepsis,10.0,$11-$25k,11983.0,white,no,0.989999771,0.9499998,no dnr,6.0,55.0,11.0,71.0,14.0,36.09375,600.0,3.699707,0.69995117,6.79980469,138.0,7.389648,197.0,55.0,390.0,0.0,0.0,no(M2 and SIP pres),0.0
62.155,male,1.0,ARF/MOSF w/Sepsis,10.0,under $11k,32587.0,white,no,0.699999809,0.5,dnr after sadm,5.0,77.0,12.0996094,130.0,30.0,39.0,357.125,2.7998047,0.59997559,0.89990234,136.0,7.469727,140.0,9.0,1750.0,0.0,1.0,<2 mo. follow-up,1.0
65.98499,male,0.0,Lung Cancer,8.0,under $11k,16239.0,white,metastatic,0.5,0.09999996,dnr after sadm,1.0,70.0,10.5996094,80.0,20.0,34.39844,224.0,2.8999023,0.89990234,1.39990234,126.0,7.419922,115.0,38.0,350.0,0.0,3.0,<2 mo. follow-up,3.0
64.95599,male,0.0,Lung Cancer,10.0,$11-$25k,6889.0,white,metastatic,0.649999619,0.25,no dnr,6.0,54.0,18.296875,121.0,10.0,38.79688,165.0,2.699707,0.89990234,1.39990234,146.0,7.489258,264.0,23.0,3751.0,0.0,2.0,no(M2 and SIP pres),2.0
73.77997,female,0.0,Colon Cancer,12.0,under $11k,7095.0,white,metastatic,0.799999714,0.6999998,no dnr,5.0,57.0,16.0,138.0,40.0,38.09375,182.0,2.5996094,1.29980469,0.89990234,139.0,7.449219,250.0,24.0,1515.0,0.0,1.0,<2 mo. follow-up,2.0170898
48.83197,female,0.0,Lung Cancer,12.0,>$50k,19926.0,white,metastatic,0.5,0.3,no dnr,12.0,55.0,10.0996094,49.0,10.0,38.79688,84.4375,2.8999023,1.0,6.69921875,139.0,7.359375,114.0,112.0,2395.0,0.0,1.0,<2 mo. follow-up,1.0
99.198,female,0.0,CHF,12.0,under $11k,9626.0,white,yes,0.799999714,0.6999998,dnr after sadm,2.0,75.0,37.6953125,66.0,22.0,36.39844,187.5,3.199707,0.39996338,1.59985352,140.0,7.369141,181.0,29.0,4525.0,1.0,2.0,no(M2 and SIP pres),2.0
41.46198,male,1.0,MOSF w/Malig,12.0,$25-$50k,17453.0,white,yes,0.049999982,0.04999998,dnr after sadm,3.0,72.0,10.0996094,65.0,20.0,35.79688,148.3125,3.3999023,0.39996338,1.89990234,135.0,7.239258,191.0,49.0,1560.0,0.0,1.0,<2 mo. follow-up,2.0996094
68.90594,female,0.0,Lung Cancer,12.0,$11-$25k,26221.0,white,metastatic,0.5,0.09999996,dnr after sadm,2.0,140.0,7.59960938,114.0,24.0,36.59375,355.0,2.8999023,0.69995117,21.5,136.0,7.219727,187.0,174.0,625.0,0.0,0.0,<2 mo. follow-up,0.0
68.06799,female,0.0,CHF,12.0,under $11k,6274.0,white,no,0.799999714,0.5999999,no dnr,4.0,42.0,15.8984375,70.0,37.0,39.39844,102.84375,2.2998047,1.09985352,1.39990234,148.0,7.449219,78.0,51.0,4460.0,0.0,1.0,<2 mo. follow-up,3.6503906
72.00494,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,66389.0,white,no,0.899999619,0.8999996,no dnr,26.0,107.0,14.1992188,100.0,12.0,38.29688,241.0,3.0,5.79980469,4.5,144.0,7.429688,163.0,39.0,859.0,2.0,2.0,no(M2 and SIP pres),2.0
69.21796,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,75486.0,white,no,0.5,0.5,no dnr,19.0,51.0,5.89941406,116.0,10.0,38.79688,55.0,2.8999023,0.89990234,2.29980469,131.0,7.25,253.0,29.0,765.0,0.0,0.0,no(M2 and SIP pres),0.0
59.63599,male,0.0,Cirrhosis,16.0,$25-$50k,5450.0,black,no,0.799999714,0.6999998,no dnr,4.0,60.0,7.89941406,80.0,20.0,36.09375,224.0,4.0,0.59997559,0.79992676,130.0,7.419922,412.0,15.0,1968.0,0.0,1.0,<2 mo. follow-up,0.494751
86.13794,female,0.0,Colon Cancer,12.0,under $11k,15685.0,black,metastatic,0.199999928,0.009999998,dnr after sadm,2.0,195.0,18.296875,180.0,33.0,38.09375,102.84375,2.8999023,0.89990234,1.39990234,137.0,7.30957,150.0,16.0,3275.0,0.0,1.0,<2 mo. follow-up,0.494751
85.00195,male,0.0,ARF/MOSF w/Sepsis,16.0,>$50k,43153.0,white,no,0.5,0.5,no dnr,21.0,55.0,14.3984375,80.0,42.0,38.39844,153.3125,2.8999023,0.89990234,0.79992676,141.0,7.399414,115.0,14.0,1081.0,0.0,1.0,no(M2 and SIP pres),1.0
52.25198,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,37267.0,white,yes,1.0,0.5,dnr after sadm,9.0,127.0,6.69921875,114.0,16.0,38.59375,91.25,2.0996094,0.19998169,0.79992676,141.0,7.439453,112.0,11.0,2780.0,0.0,1.0,no(M2 and SIP pres),0.494751
74.81494,female,1.0,Coma,12.0,under $11k,41314.0,white,no,0.199999928,0.1999999,dnr after sadm,4.0,117.0,7.69921875,80.0,20.0,36.09375,366.625,3.2998047,0.89990234,0.79992676,139.0,7.40918,92.0,14.0,750.0,0.0,1.0,<2 mo. follow-up,4.53125
80.99896,male,1.0,Lung Cancer,14.0,$25-$50k,10073.0,white,metastatic,0.899999619,0.5,dnr after sadm,1.0,60.0,13.6992188,130.0,12.0,39.39844,58.0,2.8999023,0.69995117,2.89990234,141.0,7.25,128.0,30.0,2226.0,0.0,1.0,<2 mo. follow-up,2.6552734
69.19397,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,52004.0,white,yes,0.799999714,0.5,dnr after sadm,1.0,57.0,6.59960938,100.0,25.0,36.19531,304.0,3.2998047,1.79980469,1.09985352,142.0,7.479492,109.0,14.0,1968.0,3.0,1.0,adl>=4 (>=5 if sur),2.5107422
73.69495,female,1.0,Lung Cancer,12.0,under $11k,25491.0,white,metastatic,0.199999928,0.09999996,dnr after sadm,3.0,70.0,11.3984375,90.0,20.0,36.09375,224.0,2.199707,1.89990234,0.89990234,132.0,7.419922,158.0,25.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
75.27399,male,1.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,25024.0,white,no,0.25,0.25,no dnr,9.0,63.0,1.59985352,45.0,32.0,36.09375,412.0,2.3999023,1.29980469,1.79980469,135.0,7.40918,216.0,41.0,685.0,0.0,0.0,<2 mo. follow-up,0.0
42.60898,female,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,460909.0,white,no,0.599999905,0.5999999,dnr after sadm,93.0,97.0,11.6992188,80.0,25.0,36.69531,224.0,2.3999023,0.29998779,0.79992676,132.0,7.419922,528.0,13.0,2900.0,0.0,1.0,adl>=4 (>=5 if sur),1.0
67.37897,male,0.0,COPD,11.0,under $11k,14515.0,white,no,0.899999619,0.5999999,no dnr,9.0,77.0,14.2988281,130.0,12.0,38.89844,354.0,2.0,0.89990234,0.79992676,140.0,7.479492,154.0,22.0,3680.0,1.0,0.0,no(M2 and SIP pres),0.0
82.034,female,0.0,Colon Cancer,12.0,under $11k,3777.0,white,metastatic,0.699999809,0.5,no dnr,4.0,110.0,8.79882812,110.0,14.0,37.89844,192.5,1.8999023,0.59997559,6.89941406,136.0,7.429688,164.0,87.0,1490.0,0.0,1.0,<2 mo. follow-up,2.8754883
75.87396,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,269854.0,white,yes,0.25,0.1999999,no dnr,109.0,81.0,6.69921875,80.0,20.0,36.89844,224.0,3.3999023,4.69921875,0.79992676,136.0,7.419922,93.0,17.0,1968.0,0.0,1.0,SIP>=30,2.4067383
75.69598,male,0.0,ARF/MOSF w/Sepsis,8.0,under $11k,50793.0,white,no,0.899999619,0.8999996,no dnr,26.0,103.0,17.0976562,64.0,22.0,38.0,434.5625,3.3999023,3.5,4.09960938,153.0,7.469727,75.0,137.0,3040.0,1.0,0.0,no(M2 and SIP pres),0.0
89.72998,female,0.0,COPD,14.0,under $11k,5463.0,white,no,0.199999928,0.0,dnr after sadm,1.0,70.0,12.0996094,60.0,20.0,36.5,224.0,3.199707,0.89990234,2.19970703,131.0,7.419922,99.0,54.0,1675.0,1.0,1.0,adl>=4 (>=5 if sur),1.1667481
70.073,female,0.0,Colon Cancer,15.0,$11-$25k,17889.0,white,metastatic,0.5,0.1999999,dnr after sadm,2.0,73.0,3.69970703,60.0,20.0,35.59375,224.0,3.2998047,0.89990234,1.5,140.0,7.419922,203.0,32.0,1350.0,1.0,0.0,no(M2 and SIP pres),0.0
66.32196,female,1.0,Cirrhosis,12.0,under $11k,40175.0,white,metastatic,0.75,0.09999996,dnr after sadm,2.0,73.0,6.5,80.0,25.0,36.09375,242.84375,3.5996094,0.5,2.39990234,143.0,7.539062,50.0,68.0,2100.0,0.0,1.0,<2 mo. follow-up,4.5820312
90.75995,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,18985.0,white,no,0.699999809,0.5,dnr before sadm,-1.0,123.0,10.5996094,104.0,28.0,36.19531,200.0,2.3999023,0.59997559,4.09960938,137.0,7.449219,166.0,76.0,1800.0,0.0,1.0,<2 mo. follow-up,4.5380859
71.13495,female,0.0,ARF/MOSF w/Sepsis,8.0,under $11k,15780.0,white,no,0.399999857,0.3,no dnr,4.0,77.0,13.5,60.0,24.0,36.09375,145.0,2.8999023,0.59997559,0.69995117,141.0,7.359375,144.0,14.0,1700.0,0.0,6.0,adl>=4 (>=5 if sur),6.0
57.92499,female,0.0,CHF,12.0,under $11k,8734.0,hispanic,no,0.989999771,0.9899998,no dnr,9.0,65.0,11.5,106.0,28.0,37.79688,224.0,2.8999023,0.89990234,1.0,136.0,7.419922,130.0,14.0,1150.0,2.0,3.0,SIP>=30,3.0
89.47296,male,0.0,ARF/MOSF w/Sepsis,12.0,>$50k,44299.0,white,yes,0.799999714,0.6999998,no dnr,13.0,83.0,16.0,80.0,20.0,36.09375,214.8125,3.8999023,0.89990234,0.69995117,142.0,7.389648,102.0,20.0,1968.0,0.0,7.0,<2 mo. follow-up,7.0
68.17499,male,1.0,ARF/MOSF w/Sepsis,9.0,under $11k,24260.0,white,yes,0.5,0.1999999,no dnr,11.0,77.0,6.5,80.0,25.0,36.29688,288.0,2.8999023,0.89990234,1.0,136.0,7.469727,208.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
79.80597,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,34574.0,white,no,1.0,0.8999996,dnr after sadm,2.0,107.0,6.89941406,100.0,26.0,35.39844,224.0,4.0,0.89990234,1.09985352,139.0,7.419922,106.0,19.0,3250.0,0.0,1.0,no(M2 and SIP pres),1.0
63.198,male,1.0,MOSF w/Malig,12.0,under $11k,34958.0,white,yes,0.299999952,0.5,dnr after sadm,6.0,119.0,0.19998169,124.0,38.0,38.59375,121.65625,2.2998047,1.19995117,1.39990234,151.0,7.419922,145.0,27.0,3455.0,2.0,2.0,<2 mo. follow-up,2.0
81.21796,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,30348.0,white,no,0.599999905,0.5,dnr before sadm,-1.0,62.0,14.3984375,180.0,12.0,38.0,197.5,2.8999023,0.89990234,4.79980469,140.0,7.449219,179.0,45.0,540.0,0.0,4.0,SIP>=30,4.0
56.556,female,0.0,COPD,8.0,under $11k,11227.0,white,no,0.899999619,0.75,no dnr,7.0,53.0,20.8984375,120.0,8.0,32.59375,48.0,1.0,0.89990234,1.19995117,130.0,7.379883,147.0,13.0,419.0,0.0,0.0,<2 mo. follow-up,0.0
91.01996,female,0.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,18010.0,white,no,0.849999905,0.6141248,dnr after sadm,1.0,127.0,11.1992188,80.0,20.0,36.09375,224.0,3.5996094,0.89990234,3.89990234,142.0,7.419922,124.0,56.0,1968.0,0.0,2.0,adl>=4 (>=5 if sur),2.0
40.67599,female,0.0,ARF/MOSF w/Sepsis,13.0,>$50k,89921.0,white,no,0.649999619,0.6499996,no dnr,28.0,38.0,1.0,140.0,32.0,36.29688,193.3125,2.8999023,0.89990234,2.59960938,146.0,7.389648,146.0,82.0,0.0,0.0,0.0,no(M2 and SIP pres),0.0
81.00195,male,0.0,ARF/MOSF w/Sepsis,10.0,under $11k,79981.0,white,no,0.599999905,0.5499997,dnr after sadm,33.0,71.0,11.2988281,110.0,22.0,35.59375,200.0,3.0,0.79992676,1.79980469,136.0,7.469727,102.0,45.0,3925.0,0.0,1.0,no(M2 and SIP pres),1.0
85.80194,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,20685.0,white,no,0.799999714,0.6999998,dnr before sadm,-1.0,47.0,12.0996094,144.0,16.0,38.09375,100.0,1.7998047,0.39996338,1.09985352,137.0,7.359375,91.0,20.0,2760.0,0.0,6.0,<2 mo. follow-up,6.0
73.24298,female,0.0,COPD,12.0,under $11k,14628.0,white,no,0.799999714,0.5999999,dnr before sadm,-1.0,57.0,10.5996094,120.0,20.0,36.19531,224.0,2.8999023,0.89990234,1.19995117,140.0,7.419922,135.0,23.0,1968.0,3.0,2.0,SIP>=30,2.0
83.20099,male,0.0,Lung Cancer,12.0,under $11k,8584.0,white,metastatic,0.599999905,0.3999999,no dnr,8.0,67.0,9.29882812,87.0,16.0,36.09375,224.0,2.8999023,0.89990234,0.69995117,132.0,7.419922,147.0,14.0,1968.0,0.0,7.0,<2 mo. follow-up,7.0
65.34399,male,1.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,65291.0,white,yes,0.5,0.0,dnr after sadm,24.0,90.0,12.8984375,100.0,20.0,37.19531,290.4375,2.8999023,0.89990234,0.79992676,139.0,7.449219,126.0,17.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
70.47998,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,124697.0,white,yes,0.199999928,0.04999998,no dnr,33.0,107.0,4.39941406,70.0,20.0,36.69531,304.75,2.5996094,0.29998779,1.0,143.0,7.449219,122.0,14.0,445.0,0.0,1.0,Coma or Intub,2.5854492
31.17899,male,1.0,MOSF w/Malig,14.0,$25-$50k,120808.0,white,yes,0.5,0.5,dnr after sadm,12.0,85.0,9.59960938,60.0,18.0,36.5,224.0,2.3999023,0.59997559,0.69995117,141.0,7.419922,208.0,14.0,3600.0,0.0,0.0,<2 mo. follow-up,0.0
46.55399,male,0.0,ARF/MOSF w/Sepsis,13.0,$11-$25k,41692.0,white,yes,0.989999771,0.9899998,no dnr,11.0,73.0,6.69921875,80.0,20.0,36.69531,483.3125,2.8999023,0.89990234,1.19995117,139.0,7.349609,97.0,30.0,625.0,0.0,0.0,no(M2 and SIP pres),0.0
78.45898,male,0.0,ARF/MOSF w/Sepsis,3.0,$11-$25k,13683.0,white,yes,0.799999714,0.75,no dnr,7.0,111.0,0.09999084,130.0,16.0,35.59375,145.0,2.0,2.69970703,3.0,130.0,7.259766,116.0,67.0,243.0,0.0,0.0,no(M2 and SIP pres),0.0
83.59198,female,0.0,ARF/MOSF w/Sepsis,8.0,under $11k,16860.0,white,no,0.899999619,0.7999997,no dnr,10.0,71.0,15.5996094,64.0,8.0,36.69531,160.0,2.699707,0.39996338,1.19995117,141.0,7.459961,156.0,22.0,1020.0,1.0,1.0,no(M2 and SIP pres),1.1667481
79.75598,male,0.0,MOSF w/Malig,12.0,$25-$50k,17840.0,white,yes,0.5,0.3,dnr after sadm,1.0,38.0,6.5,120.0,15.0,36.69531,419.0,3.0996094,0.89990234,1.0,132.0,7.449219,92.0,9.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),1.0
78.76794,male,0.0,ARF/MOSF w/Sepsis,13.0,under $11k,18086.0,white,no,0.799999714,0.6999998,no dnr,8.0,97.0,10.6992188,70.0,25.0,36.79688,224.0,2.8999023,0.89990234,2.79980469,141.0,7.419922,154.0,46.0,1750.0,0.0,2.0,adl>=4 (>=5 if sur),2.0
28.44099,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,11832.0,white,no,1.0,1.0,no dnr,5.0,49.0,8.3984375,53.0,36.0,35.79688,169.375,2.8999023,0.89990234,1.69995117,134.0,7.439453,57.0,26.0,3025.0,0.0,1.0,<2 mo. follow-up,2.2167969
41.69199,male,0.0,Lung Cancer,15.0,$11-$25k,16184.0,white,metastatic,1.0,0.7999997,no dnr,4.0,102.0,10.5996094,70.0,30.0,36.89844,121.65625,2.8999023,7.29980469,1.0,142.0,7.459961,91.0,16.0,3955.0,0.0,1.0,no(M2 and SIP pres),1.597168
69.76294,female,0.0,COPD,10.0,under $11k,8789.0,white,no,0.699999809,0.6999998,no dnr,7.0,80.0,4.19921875,70.0,20.0,36.09375,224.0,1.6999512,3.29980469,1.19995117,132.0,7.419922,88.0,32.0,1968.0,1.0,1.0,no(M2 and SIP pres),1.0
82.14099,female,0.0,MOSF w/Malig,12.0,under $11k,12928.0,white,yes,0.699999809,0.5,dnr after sadm,1.0,100.0,13.3984375,112.0,20.0,36.09375,224.0,2.199707,0.89990234,0.69995117,141.0,7.419922,78.0,8.0,1968.0,0.0,1.0,<2 mo. follow-up,5.5888672
73.28998,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,22415.0,white,no,0.75,0.6499996,no dnr,9.0,80.0,12.7988281,60.0,28.0,36.69531,78.32812,2.0,0.89990234,0.79992676,148.0,7.439453,120.0,30.0,2125.0,0.0,0.0,no(M2 and SIP pres),0.0
70.70197,female,0.0,Lung Cancer,18.0,>$50k,8339.0,white,metastatic,0.599999905,0.1999999,no dnr,6.0,103.0,15.3984375,121.0,6.0,37.79688,520.0,2.5,0.79992676,10.0996094,147.0,7.339844,185.0,67.0,2870.0,0.0,0.0,no(M2 and SIP pres),0.0
50.52399,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,176139.0,white,no,0.849999905,0.75,no dnr,47.0,130.0,19.8984375,79.0,44.0,37.69531,97.95312,2.5,0.5,3.29980469,148.0,7.449219,185.0,56.0,1160.0,0.0,1.0,<2 mo. follow-up,2.6069336
91.68799,male,0.0,COPD,12.0,under $11k,9399.0,black,yes,0.699999809,0.1999999,no dnr,7.0,77.0,61.296875,80.0,30.0,37.0,224.0,2.8999023,0.89990234,1.0,143.0,7.419922,435.0,18.0,1968.0,0.0,1.0,<2 mo. follow-up,7.0732422
54.95398,female,0.0,Lung Cancer,9.0,under $11k,15766.0,hispanic,metastatic,0.599999905,0.3999999,dnr after sadm,1.0,67.0,4.29980469,112.0,10.0,36.19531,330.0,2.5996094,2.79980469,1.59985352,148.0,7.339844,100.0,22.0,1155.0,0.0,2.0,<2 mo. follow-up,2.0
80.41095,female,0.0,CHF,12.0,under $11k,10985.0,white,no,0.699999809,0.6999998,dnr after sadm,1.0,121.0,11.1992188,81.0,22.0,36.5,244.0,3.2998047,0.29998779,3.5,135.0,7.449219,125.0,37.0,2775.0,0.0,1.0,<2 mo. follow-up,3.7236328
82.90198,female,1.0,Coma,12.0,under $11k,12558.0,white,yes,0.699999809,0.5,dnr after sadm,1.0,123.0,10.5996094,104.0,24.0,38.59375,357.125,2.8999023,0.89990234,1.09985352,134.0,7.459961,79.0,16.0,1121.0,0.0,1.0,<2 mo. follow-up,2.8261719
78.80096,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,23985.0,white,yes,0.949999809,0.8999996,dnr before sadm,-1.0,60.0,23.8984375,100.0,16.0,37.89844,160.0,4.0996094,2.5,4.59960938,137.0,7.389648,227.0,62.0,202.0,0.0,7.0,adl>=4 (>=5 if sur),7.0
94.60095,female,0.0,CHF,17.0,>$50k,8027.0,white,no,0.899999619,0.5999999,dnr after sadm,1.0,66.0,8.69921875,116.0,16.0,37.89844,224.0,4.0996094,1.0,2.79980469,133.0,7.419922,291.0,39.0,4525.0,0.0,1.0,<2 mo. follow-up,6.5625
47.56998,female,1.0,MOSF w/Malig,17.0,$25-$50k,141244.0,white,yes,0.5,0.3,no dnr,28.0,60.0,21.6992188,130.0,14.0,38.69531,97.0,1.5,1.19995117,0.59997559,137.0,7.379883,313.0,10.0,1764.0,0.0,7.0,<2 mo. follow-up,7.0
55.68799,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,73326.0,white,no,0.899999619,0.8999996,no dnr,19.0,70.0,6.29980469,73.0,30.0,35.89844,228.0,2.8999023,0.59997559,2.29980469,136.0,7.299805,265.0,116.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
76.66296,female,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,90617.0,white,yes,0.5,0.3999999,no dnr,18.0,117.0,8.3984375,90.0,20.0,36.09375,224.0,3.7998047,11.0,0.79992676,136.0,7.419922,89.0,8.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
77.87799,male,0.0,MOSF w/Malig,20.0,under $11k,20672.0,white,metastatic,0.25,0.04999998,dnr after sadm,2.0,57.0,7.89941406,100.0,30.0,39.29688,121.65625,1.8999023,0.89990234,1.79980469,140.0,7.449219,295.0,43.0,5690.0,0.0,0.0,<2 mo. follow-up,0.0
68.98297,female,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,73746.0,white,no,0.5,0.5,no dnr,33.0,123.0,10.5996094,102.0,28.0,36.19531,224.0,3.0996094,0.89990234,5.19921875,148.0,7.419922,155.0,40.0,1255.0,0.0,0.0,no(M2 and SIP pres),0.0
59.66098,male,0.0,CHF,22.0,>$50k,4702.0,white,yes,0.949999809,0.8999996,no dnr,4.0,123.0,9.8984375,70.0,20.0,36.09375,368.3125,2.8999023,0.89990234,0.79992676,135.0,7.209961,181.0,30.0,1550.0,0.0,0.0,no(M2 and SIP pres),0.0
93.09796,female,0.0,ARF/MOSF w/Sepsis,9.0,under $11k,23038.0,white,no,0.5,0.3999999,no dnr,9.0,48.0,10.0996094,105.0,24.0,37.79688,80.0,3.0996094,0.79992676,1.19995117,132.0,7.469727,153.0,20.0,1850.0,0.0,7.0,<2 mo. follow-up,7.0
84.79395,female,0.0,CHF,12.0,under $11k,5262.0,white,no,1.0,0.8999996,no dnr,5.0,75.0,5.69921875,96.0,24.0,36.29688,244.0,3.5996094,0.69995117,0.79992676,129.0,7.389648,139.0,31.0,3125.0,0.0,1.0,<2 mo. follow-up,2.4179688
49.10599,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,58753.0,white,yes,0.649999619,0.3,dnr after sadm,7.0,97.0,7.0,78.0,24.0,36.09375,224.0,2.2998047,2.39990234,0.69995117,135.0,7.419922,82.0,15.0,960.0,0.0,1.0,<2 mo. follow-up,2.7182617
50.92099,female,0.0,ARF/MOSF w/Sepsis,11.0,under $11k,20417.0,white,no,0.699999809,0.5,no dnr,6.0,73.0,12.2988281,143.0,30.0,38.29688,528.25,2.5996094,1.19995117,0.79992676,132.0,7.349609,211.0,24.0,627.0,0.0,2.0,SIP>=30,2.0
88.82996,female,0.0,ARF/MOSF w/Sepsis,8.0,under $11k,14288.0,white,no,0.649999619,0.5,dnr after sadm,1.0,107.0,8.29882812,124.0,24.0,36.29688,330.0,1.5,0.89990234,0.79992676,147.0,7.429688,104.0,12.0,4650.0,0.0,4.0,<2 mo. follow-up,4.0
63.37598,female,0.0,COPD,10.0,under $11k,27526.0,other,no,0.899999619,0.6999998,no dnr,17.0,55.0,19.1992188,70.0,28.0,35.59375,370.3125,3.0996094,1.19995117,2.5,146.0,7.519531,251.0,67.0,1560.0,0.0,1.0,no(M2 and SIP pres),1.0
47.20099,male,0.0,MOSF w/Malig,18.0,>$50k,19269.0,white,yes,0.989999771,0.9899998,no dnr,8.0,57.0,6.09960938,70.0,25.0,36.09375,533.25,2.8999023,0.89990234,0.69995117,141.0,7.40918,108.0,5.0,2780.0,0.0,0.0,no(M2 and SIP pres),0.0
31.72899,female,0.0,ARF/MOSF w/Sepsis,16.0,>$50k,46277.0,black,no,0.949999809,0.8499999,no dnr,17.0,130.0,6.89941406,80.0,20.0,37.0,224.0,2.8999023,0.89990234,2.69970703,144.0,7.419922,79.0,36.0,1400.0,0.0,1.0,no(M2 and SIP pres),1.7744141
51.31299,female,0.0,Cirrhosis,12.0,under $11k,18757.0,white,no,0.799999714,0.6999998,no dnr,11.0,77.0,11.7988281,80.0,20.0,35.89844,224.0,2.8999023,0.89990234,1.69995117,145.0,7.419922,94.0,16.0,800.0,0.0,1.0,<2 mo. follow-up,2.9536133
77.69995,male,0.0,CHF,13.0,$11-$25k,13155.0,white,yes,0.699999809,0.5,no dnr,10.0,53.0,4.79980469,77.0,40.0,35.79688,120.0,1.7998047,0.5,1.0,135.0,7.279297,115.0,24.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
86.07794,female,0.0,COPD,8.0,under $11k,19059.0,white,no,0.75,0.6999998,no dnr,8.0,79.0,13.0,58.0,44.0,38.09375,285.6875,2.2998047,0.5,1.19995117,145.0,7.399414,176.0,48.0,1540.0,0.0,0.0,no(M2 and SIP pres),0.0
82.96198,female,0.0,CHF,9.0,under $11k,5468.0,white,no,0.949999809,0.8999996,no dnr,5.0,74.0,8.29882812,72.0,40.0,34.79688,224.0,1.8999023,3.5,0.89990234,138.0,7.419922,299.0,35.0,1505.0,0.0,1.0,no(M2 and SIP pres),0.494751
85.90295,female,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,8641.0,white,no,0.799999714,0.5999999,no dnr,6.0,103.0,15.6992188,58.0,16.0,38.19531,436.0,2.699707,0.5,0.89990234,144.0,7.459961,185.0,20.0,1510.0,0.0,7.0,no(M2 and SIP pres),7.0
60.85999,male,0.0,CHF,12.0,under $11k,8193.0,white,yes,0.799999714,0.3999999,no dnr,7.0,120.0,5.19921875,90.0,25.0,36.09375,208.0,2.8999023,0.89990234,1.09985352,132.0,7.339844,537.0,31.0,1968.0,1.0,1.0,no(M2 and SIP pres),1.1667481
46.71899,male,0.0,MOSF w/Malig,14.0,$25-$50k,31701.0,white,yes,0.899999619,0.8499999,no dnr,12.0,67.0,15.1992188,61.0,12.0,38.0,543.25,3.0996094,0.69995117,1.09985352,138.0,7.259766,111.0,13.0,750.0,0.0,0.0,no(M2 and SIP pres),0.0
68.01398,male,0.0,Lung Cancer,9.0,under $11k,5924.0,black,metastatic,0.75,0.1999999,dnr after sadm,4.0,49.0,12.5,110.0,14.0,39.29688,85.0,2.8999023,4.29980469,0.79992676,142.0,7.349609,86.0,12.0,4865.0,2.0,1.0,<2 mo. follow-up,1.8388672
80.05499,male,1.0,ARF/MOSF w/Sepsis,8.0,$25-$50k,75188.0,white,no,0.5,0.3,no dnr,10.0,101.0,14.5996094,110.0,23.0,38.89844,230.0,2.5,1.89990234,1.09985352,131.0,7.519531,123.0,29.0,1450.0,0.0,0.0,<2 mo. follow-up,0.0
75.33496,male,0.0,Colon Cancer,20.0,$25-$50k,5624.0,white,metastatic,0.799999714,0.5,no dnr,4.0,63.0,7.89941406,100.0,25.0,38.69531,143.3125,2.8999023,0.79992676,1.39990234,143.0,7.419922,161.0,33.0,920.0,0.0,1.0,no(M2 and SIP pres),0.494751
74.15698,male,0.0,Lung Cancer,12.0,$25-$50k,11663.0,white,metastatic,0.989999771,0.8999996,no dnr,8.0,100.0,13.2988281,120.0,25.0,36.5,400.0,3.7998047,0.89990234,1.29980469,142.0,7.419922,184.0,20.0,800.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
65.52795,male,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,30687.0,white,no,0.5,0.3999999,dnr after sadm,1.0,83.0,10.5996094,80.0,20.0,37.09375,253.3125,2.8999023,0.89990234,1.0,147.0,7.379883,99.0,25.0,1968.0,2.0,1.0,no(M2 and SIP pres),1.0
76.67096,male,0.0,CHF,16.0,>$50k,30798.0,white,no,0.199999928,0.09999996,no dnr,13.0,62.0,11.0996094,110.0,42.0,39.29688,187.5,3.0,0.39996338,2.89990234,130.0,7.379883,234.0,64.0,1190.0,0.0,0.0,no(M2 and SIP pres),0.0
77.31396,male,0.0,MOSF w/Malig,10.0,under $11k,58339.0,white,metastatic,0.299999952,0.09999996,no dnr,16.0,131.0,11.8984375,160.0,27.0,39.0,222.0,2.8999023,0.5,1.19995117,147.0,7.469727,127.0,26.0,1239.0,5.0,6.0,no(M2 and SIP pres),6.0
47.41098,male,0.0,MOSF w/Malig,16.0,>$50k,19594.0,white,yes,0.299999952,0.15,no dnr,4.0,55.0,3.5,150.0,22.0,39.39844,135.6875,2.3999023,2.79980469,1.19995117,139.0,7.389648,106.0,17.0,4420.0,0.0,1.0,<2 mo. follow-up,1.923584
44.25998,male,0.0,ARF/MOSF w/Sepsis,14.0,under $11k,183799.0,white,no,0.949999809,0.9499998,no dnr,44.0,73.0,14.3984375,70.0,6.0,38.59375,334.0,2.8999023,0.89990234,1.0,144.0,7.459961,126.0,16.0,1715.0,0.0,1.0,no(M2 and SIP pres),2.3081055
29.517,male,1.0,ARF/MOSF w/Sepsis,19.0,under $11k,72789.0,white,no,0.299999952,0.1999999,dnr after sadm,5.0,97.0,5.69921875,100.0,20.0,38.89844,195.21875,2.8999023,0.89990234,1.59985352,138.0,7.5,137.0,22.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
41.90799,male,1.0,Cirrhosis,12.0,$25-$50k,23213.0,white,no,0.799999714,0.5999999,no dnr,5.0,80.0,10.2988281,70.0,25.0,36.69531,96.65625,4.6992188,0.39996338,1.79980469,139.0,7.399414,145.0,31.0,2620.0,0.0,0.0,<2 mo. follow-up,0.0
72.56897,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,12717.0,white,no,0.5,0.3,dnr after sadm,1.0,72.0,7.29980469,50.0,28.0,35.29688,508.0,3.3999023,1.59985352,0.89990234,141.0,7.459961,160.0,28.0,1420.0,0.0,1.0,adl>=4 (>=5 if sur),4.9863281
48.01898,male,0.0,Lung Cancer,12.0,$25-$50k,23905.0,white,metastatic,0.699999809,0.5,no dnr,5.0,69.0,12.7988281,80.0,24.0,39.09375,506.625,3.199707,0.79992676,2.0,144.0,7.509766,245.0,47.0,3110.0,0.0,0.0,no(M2 and SIP pres),0.0
55.633,male,0.0,Lung Cancer,12.0,$25-$50k,19481.0,white,metastatic,0.699999809,0.5,no dnr,4.0,116.0,6.19921875,69.0,22.0,38.19531,376.625,5.5,0.89990234,1.09985352,141.0,6.90918,106.0,6.0,8175.0,0.0,1.0,no(M2 and SIP pres),0.494751
43.20297,male,0.0,ARF/MOSF w/Sepsis,9.0,$11-$25k,12806.0,white,no,0.949999809,0.8999996,no dnr,4.0,73.0,5.0,80.0,16.0,36.79688,224.0,4.5996094,0.89990234,0.89990234,140.0,7.419922,111.0,14.0,1100.0,0.0,1.0,<2 mo. follow-up,0.494751
78.00098,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,56931.0,white,no,0.5,0.25,dnr after sadm,7.0,103.0,7.0,80.0,30.0,38.89844,128.3125,3.699707,0.89990234,0.79992676,137.0,7.319336,98.0,9.0,2400.0,0.0,0.0,<2 mo. follow-up,0.0
77.61298,male,0.0,COPD,8.0,under $11k,26894.0,black,yes,0.899999619,0.7999997,no dnr,11.0,51.0,39.3984375,80.0,20.0,37.0,121.65625,2.8999023,0.89990234,1.69995117,144.0,7.479492,96.0,50.0,700.0,0.0,0.0,no(M2 and SIP pres),0.0
69.24799,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,19191.0,white,no,0.009999998,0.009999998,dnr after sadm,5.0,70.0,12.8984375,114.0,28.0,38.09375,304.75,3.0996094,0.89990234,0.69995117,131.0,7.349609,189.0,13.0,1968.0,0.0,1.0,<2 mo. follow-up,2.1279297
59.44699,male,0.0,Cirrhosis,12.0,$25-$50k,4928.0,white,no,0.899999619,0.75,no dnr,5.0,100.0,10.5996094,70.0,20.0,36.69531,224.0,2.8999023,0.89990234,0.69995117,139.0,7.419922,144.0,7.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
86.13599,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,59443.0,white,no,0.399999857,0.3,no dnr,26.0,60.0,7.89941406,130.0,26.0,38.0,353.3125,2.8999023,0.89990234,6.19921875,134.0,7.389648,80.0,43.0,0.0,0.0,0.0,<2 mo. follow-up,0.0
71.56195,female,1.0,COPD,12.0,under $11k,31438.0,white,no,0.5,0.6999998,dnr after sadm,5.0,107.0,9.69921875,70.0,20.0,36.09375,238.09375,2.8999023,0.89990234,6.09960938,142.0,7.349609,124.0,68.0,1968.0,0.0,6.0,<2 mo. follow-up,6.0
81.91895,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,12394.0,white,yes,0.099999964,0.009999998,dnr before sadm,-1.0,70.0,10.8984375,92.0,50.0,37.09375,224.0,2.8999023,0.89990234,0.59997559,136.0,7.419922,81.0,6.0,700.0,0.0,1.0,<2 mo. follow-up,3.2094727
86.80896,female,1.0,ARF/MOSF w/Sepsis,8.0,$11-$25k,222569.0,white,no,0.799999714,0.5999999,dnr after sadm,39.0,80.0,4.59960938,80.0,20.0,36.09375,224.0,3.7998047,0.59997559,1.5,138.0,7.419922,83.0,20.0,1.0,0.0,0.0,<2 mo. follow-up,0.0
52.76398,male,1.0,MOSF w/Malig,10.0,under $11k,38836.0,white,yes,0.049999982,0.009999998,dnr after sadm,4.0,106.0,10.0996094,62.0,54.0,38.19531,217.5,1.0,0.89990234,1.69995117,139.0,7.389648,95.0,38.0,500.0,0.0,0.0,<2 mo. follow-up,0.0
77.42896,male,0.0,CHF,9.0,under $11k,9491.0,white,no,0.899999619,0.7999997,no dnr,8.0,67.0,21.3984375,60.0,20.0,36.09375,319.0,2.8999023,0.19998169,0.69995117,142.0,7.479492,498.0,32.0,2100.0,1.0,0.0,no(M2 and SIP pres),0.0
74.72998,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,24127.0,white,no,0.0,0.0,dnr after sadm,2.0,53.0,5.69921875,60.0,20.0,35.59375,266.625,3.699707,1.69995117,1.79980469,144.0,7.449219,166.0,92.0,1968.0,0.0,1.0,<2 mo. follow-up,3.7675781
84.745,male,0.0,ARF/MOSF w/Sepsis,10.0,under $11k,32357.0,white,no,0.599999905,0.5,no dnr,18.0,122.0,13.2988281,157.0,38.0,36.09375,285.0,2.8999023,0.69995117,0.79992676,137.0,7.299805,209.0,23.0,750.0,0.0,1.0,no(M2 and SIP pres),1.0
88.19397,female,0.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,19104.0,white,no,0.799999714,0.6999998,dnr after sadm,3.0,107.0,8.5,68.0,24.0,38.5,275.0,3.5996094,0.69995117,1.0,137.0,7.359375,284.0,16.0,1285.0,0.0,3.0,no(M2 and SIP pres),3.0
67.02295,female,0.0,MOSF w/Malig,13.0,under $11k,159022.0,white,yes,0.699999809,0.3,dnr after sadm,20.0,60.0,14.5996094,61.0,8.0,38.29688,80.0,2.8999023,0.89990234,1.79980469,146.0,7.349609,121.0,26.0,3765.0,2.0,1.0,SIP>=30,1.0
47.45798,male,0.0,CHF,10.0,under $11k,17973.0,white,no,1.0,1.0,no dnr,7.0,79.0,24.5976562,71.0,18.0,35.59375,362.0,2.0996094,6.59960938,1.5,152.0,7.419922,561.0,45.0,3585.0,0.0,0.0,no(M2 and SIP pres),0.0
76.87097,male,0.0,CHF,18.0,$11-$25k,5444.0,white,no,0.899999619,0.7999997,no dnr,6.0,113.0,30.6992188,80.0,16.0,36.19531,170.0,2.8999023,29.0976562,7.19921875,136.0,7.339844,85.0,118.0,185.0,1.0,1.0,no(M2 and SIP pres),1.1667481
73.92694,female,0.0,ARF/MOSF w/Sepsis,14.0,$11-$25k,21820.0,hispanic,no,0.989999771,0.9899998,no dnr,8.0,103.0,9.29882812,60.0,20.0,37.79688,224.0,2.8999023,0.89990234,1.69995117,141.0,7.419922,104.0,23.0,5200.0,0.0,3.0,no(M2 and SIP pres),3.0
62.89099,female,0.0,COPD,12.0,under $11k,4700.0,white,yes,0.899999619,0.5,dnr before sadm,-1.0,43.0,4.89941406,64.0,26.0,37.69531,176.65625,2.8999023,0.89990234,1.79980469,135.0,7.439453,76.0,33.0,525.0,6.0,1.0,SIP>=30,4.5273438
83.72296,male,0.0,CHF,12.0,under $11k,11448.0,white,yes,0.949999809,0.5,no dnr,8.0,80.0,9.3984375,50.0,20.0,36.09375,224.0,2.8999023,0.89990234,1.5,142.0,7.419922,76.0,31.0,1450.0,0.0,0.0,<2 mo. follow-up,0.0
73.15796,male,1.0,Lung Cancer,8.0,$11-$25k,30549.0,white,metastatic,0.5,0.3,dnr after sadm,14.0,100.0,17.1992188,130.0,40.0,35.89844,131.65625,2.0996094,0.89990234,0.79992676,137.0,7.5,178.0,22.0,700.0,2.0,1.0,<2 mo. follow-up,1.0
97.59595,male,0.0,CHF,20.0,>$50k,6900.0,white,yes,0.5,0.3,dnr after sadm,1.0,130.0,4.39941406,80.0,20.0,37.79688,224.0,2.8999023,0.89990234,5.19921875,143.0,7.419922,118.0,50.0,950.0,0.0,1.0,adl>=4 (>=5 if sur),4.0439453
84.67596,female,0.0,ARF/MOSF w/Sepsis,16.0,$11-$25k,123202.0,white,no,0.699999809,0.6999998,no dnr,29.0,113.0,14.8984375,80.0,25.0,36.09375,138.3125,2.8999023,0.89990234,3.79980469,145.0,7.439453,117.0,72.0,950.0,2.0,0.0,no(M2 and SIP pres),0.0
81.06995,female,1.0,ARF/MOSF w/Sepsis,16.0,$25-$50k,29290.906,white,yes,0.049999982,0.0001249999,dnr before sadm,0.0,115.0,24.0,142.0,36.0,37.69531,143.3125,2.5,0.79992676,1.5,155.0,7.389648,135.0,23.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
78.10797,male,1.0,ARF/MOSF w/Sepsis,10.0,under $11k,59070.875,black,yes,0.5,0.25,dnr after sadm,14.0,107.0,6.39941406,118.0,26.0,38.5,260.0,1.8999023,4.69921875,2.0,139.0,7.429688,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
66.16595,female,1.0,ARF/MOSF w/Sepsis,20.0,$11-$25k,204219.875,black,no,0.5,0.5,dnr after sadm,34.0,117.0,10.0,110.0,8.0,39.0,290.0,2.8999023,0.89990234,3.5,134.0,7.429688,135.0,23.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
27.76199,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,70693.625,black,no,0.299999952,0.1999999,dnr after sadm,16.0,60.0,13.6992188,152.0,12.0,35.69531,76.65625,1.5998535,13.0996094,3.59960938,132.0,7.40918,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
71.29095,male,0.0,CHF,9.0,under $11k,15564.695,white,no,0.899999619,0.5,no dnr,12.0,80.0,8.19921875,80.0,22.0,36.5,226.65625,2.8999023,0.89990234,1.59985352,137.0,7.459961,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
63.67099,male,0.0,Lung Cancer,9.0,under $11k,5074.648,white,metastatic,0.799999714,0.5,no dnr,6.0,87.0,26.0,108.0,36.0,37.69531,314.25,2.3999023,0.39996338,0.79992676,139.0,7.479492,135.0,23.0,1968.0,2.0,4.0,<2 mo. follow-up,4.0
42.09698,male,1.0,MOSF w/Malig,12.0,under $11k,65025.031,white,metastatic,0.099999964,0.0009999992,no dnr,9.0,63.0,0.19998169,145.0,28.0,37.89844,242.84375,2.0,5.19921875,4.09960938,161.0,7.519531,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.9853516
66.30499,female,1.0,ARF/MOSF w/Sepsis,11.0,$11-$25k,182129.875,white,no,0.699999809,0.75,dnr after sadm,31.0,93.0,18.796875,100.0,10.0,38.5,203.3125,2.0,1.0,3.09960938,138.0,7.369141,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
29.33299,female,0.0,ARF/MOSF w/Sepsis,10.0,under $11k,48388.219,white,no,0.5,0.5,no dnr,20.0,62.0,27.796875,62.0,16.0,38.79688,118.45312,1.8999023,3.0,0.89990234,140.0,7.449219,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
48.87097,male,0.0,Colon Cancer,17.0,>$50k,13197.648,white,metastatic,0.799999714,0.1999999,no dnr,14.0,101.0,5.19921875,95.0,18.0,38.5,224.0,2.3999023,0.19998169,0.89990234,137.0,7.419922,135.0,23.0,1968.0,1.0,0.0,no(M2 and SIP pres),0.0
71.81696,female,0.0,CHF,10.0,under $11k,11220.297,black,no,1.0,0.7999997,dnr after sadm,2.0,130.0,5.79980469,60.0,26.0,35.5,509.5,2.7998047,0.5,1.5,139.0,7.379883,135.0,23.0,1968.0,0.0,7.0,<2 mo. follow-up,7.0
63.48297,male,0.0,Colon Cancer,18.0,>$50k,3371.1,white,metastatic,0.899999619,0.6999998,no dnr,6.0,83.0,4.69921875,72.0,24.0,36.69531,224.0,3.0,0.5,0.89990234,139.0,7.419922,135.0,23.0,1968.0,1.0,1.0,no(M2 and SIP pres),1.1668997
60.939,male,0.0,CHF,7.0,$11-$25k,4007.6,black,no,0.799999714,0.5,no dnr,4.0,97.0,5.59960938,80.0,20.0,36.59375,224.0,2.8999023,0.89990234,1.0,139.0,7.419922,135.0,23.0,1968.0,1.0,3.0,no(M2 and SIP pres),3.0
74.52399,female,0.0,CHF,12.0,under $11k,5275.547,white,no,0.899999619,0.7999997,no dnr,12.0,87.0,3.89990234,65.0,20.0,35.89844,224.0,4.0996094,0.89990234,1.19995117,144.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
50.42599,male,0.0,Cirrhosis,12.0,$25-$50k,2317.148,white,no,0.979999542,0.7999997,no dnr,5.0,96.0,5.29980469,82.0,20.0,37.09375,224.0,2.5996094,5.39941406,0.89990234,133.0,7.419922,135.0,23.0,1968.0,1.0,0.0,no(M2 and SIP pres),0.0
45.91098,female,0.0,Cirrhosis,8.0,under $11k,3229.148,white,yes,0.979999542,0.8999996,no dnr,7.0,69.0,4.09960938,60.0,16.0,37.39844,224.0,2.2998047,2.09960938,1.39990234,135.0,7.419922,135.0,23.0,1968.0,0.0,5.0,no(M2 and SIP pres),5.0
33.73297,female,0.0,CHF,10.0,under $11k,65649.062,white,no,0.899999619,0.7999997,no dnr,32.0,77.0,20.3984375,110.0,16.0,37.09375,328.0,2.8999023,0.39996338,0.69995117,138.0,7.429688,135.0,23.0,1968.0,0.0,3.0,no(M2 and SIP pres),3.0
46.77899,female,1.0,ARF/MOSF w/Sepsis,8.0,$11-$25k,18037.5,white,no,0.699999809,0.5,dnr after sadm,3.0,85.0,22.3984375,130.0,14.0,39.09375,432.5,3.7998047,0.69995117,0.89990234,137.0,7.449219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
49.85098,male,1.0,MOSF w/Malig,11.0,under $11k,70955.75,white,yes,0.099999964,0.0009999992,dnr after sadm,8.0,67.0,1.39990234,112.0,25.0,37.39844,300.0,2.0996094,1.39990234,0.69995117,142.0,7.469727,135.0,23.0,1968.0,0.0,6.0,<2 mo. follow-up,6.0
50.82797,female,0.0,Cirrhosis,12.0,under $11k,12101.797,white,no,0.699999809,0.5,no dnr,6.0,91.0,10.0996094,125.0,22.0,36.89844,224.0,2.8999023,2.89990234,1.89990234,136.0,7.419922,135.0,23.0,1968.0,0.0,0.0,SIP>=30,0.0
68.01398,female,1.0,ARF/MOSF w/Sepsis,1.0,under $11k,68718.562,other,no,0.5,0.3999999,no dnr,17.0,90.0,18.296875,100.0,10.0,37.29688,147.5,2.699707,0.5,3.19970703,137.0,7.429688,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
62.67999,male,0.0,CHF,12.0,under $11k,5012.098,white,no,0.75,0.5,no dnr,10.0,63.0,7.0,100.0,24.0,36.19531,319.0,3.7998047,0.69995117,1.59985352,137.0,7.479492,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
54.543,male,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,119274.125,white,no,0.199999928,0.09999996,no dnr,35.0,109.0,16.5,118.0,40.0,38.79688,176.34375,1.3999023,0.19998169,0.79992676,136.0,7.389648,135.0,23.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
82.62,female,1.0,ARF/MOSF w/Sepsis,11.0,under $11k,123505.188,white,no,0.699999809,0.5,dnr after sadm,6.0,73.0,30.0,110.0,11.0,35.89844,116.65625,2.7998047,0.79992676,3.39990234,151.0,7.319336,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
54.55399,male,0.0,CHF,14.0,$11-$25k,14758.742,black,no,0.699999809,0.5,no dnr,10.0,90.0,7.79980469,104.0,32.0,36.59375,224.0,2.8999023,0.89990234,1.09985352,137.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
48.827,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,24232.469,white,no,0.599999905,0.5999999,no dnr,14.0,60.0,16.3984375,108.0,24.0,37.5,368.0,1.6999512,1.79980469,2.79980469,140.0,7.389648,135.0,23.0,1968.0,1.0,1.0,SIP>=30,1.0
42.41498,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,26228.594,white,no,0.699999809,0.5,dnr after sadm,4.0,47.0,16.5,200.0,34.0,39.0,74.0,2.5996094,30.5,6.19921875,141.0,7.229492,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.8813477
70.01196,male,0.0,COPD,12.0,under $11k,2736.148,black,no,1.0,0.7999997,no dnr,5.0,113.0,13.0996094,70.0,20.0,36.19531,252.375,2.8999023,0.89990234,1.09985352,138.0,7.479492,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.1855469
60.34497,female,0.0,COPD,10.0,under $11k,5197.066,white,no,0.949999809,0.7999997,no dnr,7.0,99.0,7.39941406,90.0,28.0,37.09375,194.375,4.0996094,0.5,0.79992676,144.0,7.369141,135.0,23.0,1968.0,2.0,3.0,no(M2 and SIP pres),3.0
55.98898,female,0.0,CHF,8.0,$11-$25k,6171.199,white,no,1.0,0.9899998,no dnr,6.0,108.0,10.6992188,126.0,18.0,37.29688,224.0,2.8999023,0.89990234,1.0,144.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
42.89099,male,0.0,CHF,12.0,$11-$25k,4847.797,white,no,0.799999714,0.5999999,no dnr,4.0,77.0,8.59960938,94.0,16.0,36.5,224.0,2.8999023,0.89990234,1.69995117,139.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
26.407,female,1.0,Cirrhosis,10.0,under $11k,25024.0,black,no,0.099999964,0.0009999992,dnr after sadm,15.0,52.0,52.0,82.0,25.0,36.89844,285.6875,2.2998047,44.09375,5.0,139.0,7.389648,135.0,23.0,1968.0,6.0,1.0,<2 mo. follow-up,4.5273972
55.13797,male,0.0,Lung Cancer,14.0,$25-$50k,4260.598,white,metastatic,0.899999619,0.5,no dnr,5.0,73.0,9.79882812,84.0,12.0,38.5,224.0,2.699707,0.19998169,0.59997559,139.0,7.419922,135.0,23.0,1968.0,0.0,4.0,<2 mo. follow-up,4.0
37.65399,female,0.0,Colon Cancer,17.0,$25-$50k,25829.297,other,metastatic,1.0,1.0,no dnr,7.0,91.0,4.39941406,86.0,20.0,37.59375,224.0,2.8999023,0.29998779,0.69995117,144.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
64.323,female,0.0,CHF,12.0,under $11k,3637.6,black,no,0.75,0.5999999,no dnr,8.0,110.0,23.1992188,100.0,16.0,36.59375,270.0,2.8999023,0.19998169,5.19921875,144.0,7.339844,135.0,23.0,1968.0,1.0,1.0,<2 mo. follow-up,1.1668997
58.21198,female,1.0,Cirrhosis,12.0,under $11k,14696.945,white,no,0.699999809,0.5,dnr after sadm,2.0,37.0,34.296875,35.0,12.0,35.79688,261.0,2.3999023,8.79882812,3.0,122.0,7.269531,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.3979492
71.31799,male,1.0,COPD,12.0,under $11k,25847.641,black,no,1.0,0.7999997,no dnr,14.0,102.0,11.2988281,88.0,28.0,36.5,229.15625,2.8999023,0.89990234,0.79992676,146.0,7.339844,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.1699219
69.79095,male,0.0,CHF,12.0,under $11k,50310.688,white,no,0.699999809,0.5,no dnr,35.0,63.0,10.5996094,70.0,20.0,35.09375,566.625,2.8999023,0.89990234,1.29980469,137.0,7.399414,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.3188477
69.92694,female,1.0,ARF/MOSF w/Sepsis,9.0,under $11k,82018.938,white,no,0.099999964,0.0009999992,no dnr,21.0,113.0,19.5976562,65.0,27.0,35.0,147.5,1.6999512,0.19998169,2.89990234,135.0,7.40918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
44.35599,female,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,336191.75,white,no,0.699999809,0.6999998,no dnr,136.0,130.0,20.3984375,100.0,10.0,36.89844,170.0,3.8999023,12.5996094,1.29980469,138.0,7.479492,135.0,23.0,1968.0,2.0,0.0,SIP>=30,0.0
46.83899,male,0.0,CHF,11.0,$11-$25k,4346.148,white,no,0.699999809,0.5,no dnr,6.0,71.0,6.0,68.0,24.0,36.59375,357.125,2.8999023,1.09985352,1.79980469,141.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
65.28998,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,115224.25,black,no,0.699999809,0.5,no dnr,29.0,83.0,22.6992188,110.0,26.0,38.0,463.3125,3.3999023,0.89990234,0.59997559,152.0,7.479492,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.0893555
69.05396,male,0.0,CHF,11.0,$11-$25k,25024.0,white,no,0.699999809,0.5,no dnr,5.0,73.0,7.0,68.0,20.0,35.39844,224.0,2.8999023,0.89990234,1.5,143.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
18.946,male,1.0,MOSF w/Malig,9.0,under $11k,61863.156,black,yes,0.399999857,0.3999999,dnr after sadm,9.0,110.0,0.09999084,110.0,29.0,37.79688,137.125,1.5998535,1.39990234,0.5,146.0,7.40918,135.0,23.0,1968.0,0.0,3.0,<2 mo. follow-up,3.0
23.573,female,1.0,ARF/MOSF w/Sepsis,14.0,under $11k,63657.625,white,no,0.0,0.0,no dnr,7.0,110.0,0.19998169,184.0,26.0,39.29688,128.875,2.8999023,0.19998169,0.79992676,134.0,7.389648,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
71.07996,male,0.0,CHF,16.0,under $11k,10907.797,hispanic,no,0.5,0.25,dnr after sadm,3.0,63.0,5.09960938,89.0,16.0,37.29688,223.78125,2.8999023,1.19995117,1.09985352,128.0,7.509766,135.0,23.0,1968.0,6.0,4.0,SIP>=30,4.0
73.40198,male,1.0,MOSF w/Malig,11.0,$11-$25k,80833.062,white,yes,0.049999982,0.0001249999,dnr after sadm,10.0,137.0,1.79980469,140.0,30.0,39.19531,146.65625,1.2998047,13.1992188,2.29980469,139.0,7.399414,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
61.599,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,20699.797,white,no,0.299999952,0.3,dnr after sadm,3.0,48.0,11.0996094,118.0,12.0,36.69531,227.5,2.2998047,5.79980469,4.09960938,138.0,7.359375,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.0581055
39.31,male,1.0,ARF/MOSF w/Sepsis,13.0,under $11k,32710.188,black,no,0.199999928,0.09999996,dnr after sadm,1.0,94.0,21.6992188,120.0,24.0,37.29688,363.3125,2.8999023,8.79882812,1.89990234,132.0,7.359375,135.0,23.0,1968.0,2.0,3.0,<2 mo. follow-up,3.0
62.26398,male,0.0,Lung Cancer,13.0,$25-$50k,4991.348,white,metastatic,1.0,0.5999999,no dnr,5.0,127.0,5.39941406,115.0,20.0,36.0,224.0,2.8999023,0.89990234,0.79992676,135.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
78.93799,female,0.0,Lung Cancer,12.0,under $11k,11457.445,white,metastatic,0.75,0.5,no dnr,12.0,87.0,7.19921875,68.0,32.0,39.0,224.0,2.8999023,0.89990234,1.09985352,133.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.3818359
67.745,female,0.0,Colon Cancer,12.0,under $11k,7447.699,white,metastatic,0.799999714,0.09999996,no dnr,7.0,110.0,6.5,72.0,16.0,36.79688,224.0,1.8999023,0.89990234,1.69995117,137.0,7.419922,135.0,23.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
59.45499,male,0.0,CHF,10.0,under $11k,14134.297,white,no,0.799999714,0.5999999,no dnr,11.0,58.0,12.6992188,120.0,28.0,37.29688,224.0,2.8999023,0.89990234,2.19970703,124.0,7.419922,135.0,23.0,1968.0,1.0,2.0,<2 mo. follow-up,2.0
72.91998,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,25024.0,white,no,0.199999928,0.1999999,dnr after sadm,3.0,132.0,16.5976562,116.0,25.0,38.5,98.875,2.8999023,0.5,1.79980469,150.0,7.509766,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
78.35699,male,1.0,Coma,12.0,under $11k,29703.188,white,no,0.099999964,0.0009999992,no dnr,4.0,63.0,32.59375,110.0,14.0,39.09375,110.0,2.0,10.0,5.19921875,127.0,7.349609,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
59.13797,female,1.0,Coma,11.0,under $11k,10753.492,black,no,0.009999998,9.999994e-07,dnr after sadm,2.0,110.0,18.6992188,72.0,32.0,38.19531,225.0,2.8999023,0.89990234,1.5,163.0,7.469727,135.0,23.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
64.98596,male,0.0,CHF,12.0,$11-$25k,32710.891,white,no,0.899999619,0.6999998,no dnr,11.0,53.0,6.59960938,50.0,22.0,36.39844,224.0,2.8999023,0.89990234,1.39990234,135.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
90.75397,female,0.0,CHF,7.0,under $11k,2153.648,black,no,0.699999809,0.5,no dnr,5.0,115.0,1.69995117,76.0,18.0,34.89844,224.0,2.699707,0.29998779,0.79992676,146.0,7.419922,135.0,23.0,1968.0,4.0,2.0,no(M2 and SIP pres),2.0
69.48895,female,0.0,ARF/MOSF w/Sepsis,5.0,$11-$25k,114818.812,white,no,0.899999619,0.7999997,no dnr,70.0,117.0,10.2988281,135.0,40.0,38.59375,118.32812,2.8999023,0.89990234,0.59997559,132.0,7.459961,135.0,23.0,1968.0,0.0,4.0,adl>=4 (>=5 if sur),4.0
71.29095,female,0.0,ARF/MOSF w/Sepsis,9.0,under $11k,117566.938,black,yes,0.5,0.5,no dnr,90.0,55.0,42.8984375,59.0,8.0,36.0,276.625,2.2998047,6.5,5.69921875,134.0,7.379883,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),1.0
69.30597,female,0.0,CHF,12.0,$11-$25k,12514.547,white,no,0.899999619,0.5999999,no dnr,10.0,84.0,7.19921875,96.0,30.0,37.0,385.6875,2.8999023,0.89990234,1.5,139.0,7.479492,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
44.31998,female,0.0,ARF/MOSF w/Sepsis,11.0,under $11k,34999.438,black,no,0.799999714,0.7999997,no dnr,14.0,87.0,12.1992188,120.0,25.0,38.59375,125.45312,2.3999023,1.69995117,0.79992676,140.0,7.489258,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.1767578
33.85098,male,0.0,MOSF w/Malig,12.0,under $11k,36510.125,white,yes,0.899999619,0.6999998,no dnr,22.0,79.0,7.69921875,60.0,10.0,36.29688,284.4375,2.8999023,0.59997559,1.0,151.0,7.459961,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.6982422
51.67697,male,0.0,Colon Cancer,16.0,>$50k,5212.348,white,metastatic,0.75,0.25,no dnr,4.0,63.0,4.0,68.0,18.0,37.39844,224.0,3.0,0.89990234,0.59997559,144.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
82.086,female,1.0,Coma,10.0,under $11k,13969.148,black,no,0.0,0.0,dnr after sadm,1.0,103.0,7.09960938,80.0,16.0,36.79688,263.25,2.8999023,0.89990234,1.29980469,144.0,7.379883,135.0,23.0,1968.0,0.0,5.0,<2 mo. follow-up,5.0
40.05197,female,0.0,CHF,17.0,under $11k,10388.547,other,no,0.899999619,0.6999998,no dnr,4.0,80.0,11.5996094,88.0,16.0,37.0,224.0,2.8999023,0.89990234,1.79980469,130.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
43.129,female,0.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,32229.891,white,no,0.949999809,0.9499998,no dnr,15.0,80.0,12.8984375,110.0,8.0,36.89844,340.0,2.8999023,0.69995117,1.19995117,142.0,7.479492,135.0,23.0,1968.0,0.0,3.0,no(M2 and SIP pres),3.0
69.35498,female,0.0,CHF,9.0,$11-$25k,34208.688,white,no,0.979999542,0.8999996,no dnr,12.0,97.0,6.5,60.0,28.0,36.79688,224.0,3.7998047,0.59997559,1.09985352,136.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
66.53796,male,0.0,CHF,12.0,under $11k,15308.594,white,no,0.949999809,0.5,no dnr,33.0,59.0,8.5,54.0,20.0,35.29688,224.0,2.8999023,0.89990234,2.89990234,131.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.0239258
52.392,male,0.0,CHF,11.0,under $11k,2009.25,black,no,0.699999809,0.5,no dnr,4.0,110.0,6.29980469,70.0,18.0,36.0,404.75,2.8999023,1.09985352,4.69921875,140.0,7.479492,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
70.14899,male,0.0,MOSF w/Malig,8.0,under $11k,85999.312,white,metastatic,0.5,0.3,dnr after sadm,1.0,94.0,6.29980469,112.0,16.0,37.09375,226.90625,2.5,1.5,0.89990234,139.0,7.40918,135.0,23.0,1968.0,0.0,4.0,SIP>=30,4.0
61.64297,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,69951.25,white,no,0.199999928,0.09999996,dnr after sadm,11.0,111.0,1.19995117,82.0,11.0,37.69531,226.65625,2.8999023,1.29980469,0.79992676,131.0,7.429688,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.2856445
65.396,male,1.0,Coma,12.0,under $11k,26288.375,black,no,0.0,0.0,dnr after sadm,4.0,80.0,30.296875,130.0,32.0,37.89844,240.0,2.7998047,0.89990234,2.19970703,133.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.6391602
64.17499,female,0.0,Lung Cancer,8.0,under $11k,2555.35,black,metastatic,0.5,0.1999999,no dnr,3.0,79.0,10.1992188,100.0,20.0,36.79688,224.0,2.8999023,0.19998169,0.79992676,137.0,7.419922,135.0,23.0,1968.0,1.0,3.0,adl>=4 (>=5 if sur),3.0
77.77399,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,25024.0,white,no,0.699999809,0.5,no dnr,25.0,106.0,11.2988281,68.0,11.0,38.59375,350.0,2.8999023,1.39990234,1.0,138.0,7.5,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.8273926
64.70398,female,1.0,ARF/MOSF w/Sepsis,8.0,under $11k,146233.75,white,no,0.199999928,0.1999999,dnr after sadm,34.0,87.0,15.8984375,94.0,14.0,37.5,165.0,2.8999023,0.89990234,0.59997559,129.0,7.459961,135.0,23.0,1968.0,0.0,5.0,<2 mo. follow-up,5.0
51.362,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,18635.0,black,no,0.099999964,0.0009999992,no dnr,5.0,117.0,8.59960938,110.0,11.0,38.69531,400.0,2.8999023,0.89990234,0.69995117,140.0,7.509766,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.0844727
78.66699,female,0.0,Lung Cancer,8.0,under $11k,10843.562,white,metastatic,0.699999809,0.5,no dnr,12.0,93.0,4.69921875,112.0,20.0,37.0,233.3125,2.8999023,0.89990234,0.59997559,141.0,7.429688,135.0,23.0,1968.0,3.0,7.0,adl>=4 (>=5 if sur),7.0
65.53595,male,0.0,Lung Cancer,12.0,under $11k,5538.25,white,metastatic,0.5,0.1999999,no dnr,7.0,93.0,9.79882812,86.0,20.0,38.69531,342.8125,2.7998047,0.29998779,0.79992676,138.0,7.489258,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.8876953
62.37399,female,0.0,Colon Cancer,12.0,under $11k,23129.641,white,metastatic,0.899999619,0.5,no dnr,17.0,70.0,8.0,68.0,20.0,37.19531,224.0,3.199707,1.0,0.79992676,140.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.2993164
54.168,male,0.0,ARF/MOSF w/Sepsis,8.0,under $11k,9294.195,white,no,0.699999809,0.5,no dnr,5.0,87.0,15.5996094,90.0,26.0,35.0,336.625,2.8999023,0.89990234,9.09960938,135.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
74.84198,female,1.0,ARF/MOSF w/Sepsis,8.0,under $11k,72912.25,white,no,0.699999809,0.5,dnr after sadm,11.0,85.0,14.1992188,60.0,26.0,36.59375,157.5,1.6999512,0.89990234,2.89990234,138.0,7.439453,135.0,23.0,1968.0,0.0,7.0,<2 mo. follow-up,7.0
52.047,male,1.0,CHF,12.0,under $11k,4845.676,white,no,0.25,0.0,no dnr,6.0,88.0,10.5996094,100.0,32.0,35.29688,197.5,3.699707,1.69995117,1.0,133.0,7.449219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.2431641
57.34198,male,0.0,Colon Cancer,12.0,$25-$50k,5654.199,white,metastatic,0.899999619,0.7999997,no dnr,6.0,129.0,2.89990234,95.0,20.0,36.5,224.0,3.699707,0.39996338,1.09985352,139.0,7.419922,135.0,23.0,1968.0,1.0,0.0,no(M2 and SIP pres),0.0
67.92096,male,0.0,CHF,11.0,$11-$25k,23931.641,white,no,0.75,0.5,no dnr,20.0,83.0,10.5996094,72.0,22.0,37.0,224.0,2.8999023,0.89990234,1.29980469,139.0,7.419922,135.0,23.0,1968.0,2.0,7.0,no(M2 and SIP pres),7.0
60.17499,female,0.0,ARF/MOSF w/Sepsis,14.0,$11-$25k,26265.516,white,no,0.699999809,0.5,no dnr,10.0,100.0,7.29980469,82.0,24.0,37.09375,190.0,2.8999023,0.89990234,1.09985352,133.0,7.479492,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
75.06097,male,0.0,CHF,12.0,under $11k,36334.688,black,no,0.799999714,0.75,no dnr,15.0,84.0,8.69921875,100.0,32.0,36.5,264.0,2.8999023,0.89990234,1.19995117,140.0,7.469727,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
66.04797,male,0.0,Lung Cancer,6.0,under $11k,31104.797,black,metastatic,0.5,0.09999996,no dnr,37.0,107.0,7.0,100.0,0.0,37.0,276.1875,2.8999023,0.89990234,0.89990234,138.0,7.569336,135.0,23.0,1968.0,1.0,2.0,<2 mo. follow-up,2.0
29.37399,male,0.0,ARF/MOSF w/Sepsis,13.0,$11-$25k,83731.188,white,no,0.399999857,0.3999999,no dnr,38.0,127.0,26.6992188,115.0,30.0,37.5,122.0,1.7998047,0.5,7.39941406,139.0,7.449219,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
76.31195,male,1.0,ARF/MOSF w/Sepsis,12.0,>$50k,167402.25,white,no,0.699999809,0.5999999,dnr after sadm,48.0,65.0,23.0,80.0,8.0,35.69531,192.5,2.8999023,0.19998169,11.0,135.0,7.339844,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
64.92798,female,0.0,COPD,13.0,under $11k,28759.891,white,no,0.5,0.3999999,dnr after sadm,5.0,85.0,7.69921875,192.0,20.0,36.69531,247.8125,2.8999023,0.89990234,0.5,137.0,7.329102,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
40.24597,male,0.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,46602.594,white,no,0.799999714,0.7999997,no dnr,14.0,117.0,11.6992188,92.0,26.0,37.79688,352.0,2.8999023,0.89990234,0.59997559,135.0,7.459961,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
37.21597,female,0.0,CHF,10.0,under $11k,3067.549,black,no,0.899999619,0.75,no dnr,6.0,79.0,9.3984375,68.0,28.0,36.29688,552.375,3.199707,1.09985352,1.79980469,137.0,7.419922,135.0,23.0,1968.0,2.0,1.0,<2 mo. follow-up,1.8389997
36.91199,male,0.0,CHF,9.0,under $11k,7022.199,black,no,0.799999714,0.5999999,no dnr,4.0,84.0,5.29980469,54.0,22.0,35.79688,224.0,2.8999023,0.89990234,1.0,138.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
64.87598,female,0.0,MOSF w/Malig,16.0,$11-$25k,38151.344,white,metastatic,0.699999809,0.5,no dnr,10.0,131.0,16.0,68.0,26.0,35.0,155.0,2.8999023,0.89990234,1.19995117,136.0,7.229492,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
61.68698,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,68088.938,black,no,0.699999809,0.6999998,dnr after sadm,2.0,67.0,11.2988281,110.0,40.0,36.69531,160.0,2.8999023,19.0976562,1.5,148.0,7.509766,135.0,23.0,1968.0,0.0,7.0,<2 mo. follow-up,7.0
60.91397,male,1.0,Coma,12.0,under $11k,20829.844,white,metastatic,0.099999964,0.0009999992,dnr after sadm,2.0,73.0,21.6992188,98.0,18.0,38.89844,383.0,2.8999023,0.69995117,2.19970703,136.0,7.269531,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.9545898
72.09296,male,0.0,Lung Cancer,12.0,under $11k,2642.119,white,metastatic,0.699999809,0.5,no dnr,3.0,93.0,11.2988281,96.0,20.0,37.09375,224.0,2.8999023,0.29998779,1.0,136.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.2226562
51.28,male,0.0,Cirrhosis,12.0,under $11k,5919.547,white,no,0.399999857,0.09999996,dnr after sadm,2.0,67.0,6.79980469,118.0,36.0,36.59375,309.5,2.5,0.89990234,5.59960938,127.0,7.449219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.2866211
49.87799,female,0.0,ARF/MOSF w/Sepsis,15.0,under $11k,9162.547,black,no,0.799999714,0.75,no dnr,6.0,90.0,6.69921875,68.0,10.0,36.19531,271.375,2.8999023,1.09985352,1.0,142.0,7.269531,135.0,23.0,1968.0,7.0,7.0,adl>=4 (>=5 if sur),7.0
76.71198,male,0.0,ARF/MOSF w/Sepsis,9.0,>$50k,41699.688,white,no,0.699999809,0.5999999,no dnr,46.0,109.0,5.0,115.0,29.0,35.59375,228.0,2.699707,0.79992676,1.0,142.0,7.479492,135.0,23.0,1968.0,0.0,7.0,adl>=4 (>=5 if sur),7.0
63.392,male,1.0,ARF/MOSF w/Sepsis,18.0,$25-$50k,39656.938,white,no,0.399999857,0.3,dnr after sadm,9.0,67.0,14.1992188,130.0,20.0,37.09375,180.0,2.2998047,0.29998779,5.29980469,130.0,7.369141,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
68.99396,female,1.0,Coma,12.0,under $11k,17598.688,white,no,0.049999982,0.0001249999,dnr after sadm,2.0,53.0,12.7988281,114.0,10.0,39.29688,323.3125,2.8999023,0.09999084,4.09960938,151.0,7.55957,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.3818359
61.84497,female,0.0,CHF,12.0,$11-$25k,11096.047,white,no,0.699999809,0.5,no dnr,13.0,83.0,9.5,88.0,20.0,36.0,224.0,2.8999023,0.5,1.0,126.0,7.419922,135.0,23.0,1968.0,3.0,6.0,<2 mo. follow-up,6.0
76.90094,female,1.0,ARF/MOSF w/Sepsis,14.0,under $11k,25024.0,white,no,0.399999857,0.25,dnr after sadm,5.0,130.0,11.0996094,85.0,26.0,37.89844,130.0,1.6999512,2.19970703,0.79992676,129.0,7.419922,135.0,23.0,1968.0,0.0,7.0,<2 mo. follow-up,7.0
51.63898,male,0.0,COPD,12.0,$11-$25k,77591.312,white,no,0.5,0.3,no dnr,25.0,132.0,10.8984375,138.0,11.0,37.79688,202.5,2.8999023,0.89990234,2.19970703,151.0,7.40918,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
53.85898,male,0.0,CHF,8.0,$11-$25k,7230.598,white,no,0.799999714,0.6999998,no dnr,9.0,90.0,12.0996094,76.0,20.0,36.0,224.0,2.8999023,0.79992676,1.29980469,138.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
48.08798,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,97578.812,white,no,0.699999809,0.5,no dnr,19.0,83.0,11.1992188,110.0,26.0,39.09375,328.5625,2.8999023,0.89990234,0.79992676,145.0,7.389648,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.7900391
63.07498,male,0.0,CHF,12.0,under $11k,15978.344,white,no,0.699999809,0.5999999,no dnr,9.0,73.0,8.0,112.0,20.0,36.79688,224.0,2.8999023,0.89990234,1.59985352,135.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.3588867
31.16499,female,1.0,ARF/MOSF w/Sepsis,14.0,$25-$50k,94713.188,white,yes,0.149999976,0.15,dnr after sadm,9.0,95.0,4.89941406,84.0,14.0,36.69531,164.0,2.8999023,0.89990234,1.59985352,141.0,7.529297,135.0,23.0,1968.0,0.0,7.0,<2 mo. follow-up,7.0
46.22598,male,0.0,ARF/MOSF w/Sepsis,9.0,under $11k,379459.75,black,no,0.099999964,0.0009999992,no dnr,223.0,73.0,22.796875,70.0,18.0,38.89844,134.0,2.8999023,0.89990234,0.79992676,147.0,7.419922,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),1.0
50.754,male,0.0,Cirrhosis,15.0,$25-$50k,25024.0,white,no,0.5,0.3,no dnr,38.0,107.0,9.69921875,95.0,12.0,38.89844,200.0,1.1999512,4.19921875,1.09985352,140.0,7.479492,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
68.0,female,0.0,CHF,8.0,under $11k,28079.641,white,no,0.699999809,0.3999999,no dnr,16.0,93.0,3.69970703,105.0,24.0,37.19531,280.0,2.8999023,0.59997559,4.69921875,130.0,7.439453,135.0,23.0,1968.0,2.0,5.0,no(M2 and SIP pres),5.0
75.40594,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,113901.062,black,yes,0.5,0.5,no dnr,39.0,110.0,25.0,114.0,35.0,37.29688,202.5,2.0,5.39941406,1.59985352,150.0,7.429688,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.0527344
54.15997,female,0.0,Lung Cancer,12.0,>$50k,3714.449,white,metastatic,0.899999619,0.5,no dnr,4.0,87.0,4.59960938,64.0,24.0,37.0,224.0,2.8999023,0.19998169,0.69995117,139.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
55.36499,male,0.0,Lung Cancer,12.0,$11-$25k,3038.5,white,metastatic,0.699999809,0.5999999,no dnr,4.0,73.0,7.89941406,86.0,20.0,37.09375,476.1875,2.8999023,0.89990234,1.19995117,141.0,7.459961,135.0,23.0,1968.0,0.0,2.0,no(M2 and SIP pres),2.0
43.20599,male,1.0,ARF/MOSF w/Sepsis,6.0,under $11k,49218.781,black,no,0.149999976,0.5,dnr after sadm,8.0,60.0,9.5,130.0,34.0,37.29688,120.0,2.0,16.796875,1.79980469,143.0,7.419922,135.0,23.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
31.088,male,0.0,ARF/MOSF w/Sepsis,6.0,$25-$50k,68183.562,black,no,0.699999809,0.5,no dnr,42.0,89.0,12.6992188,84.0,15.0,35.19531,383.3125,2.8999023,0.89990234,0.79992676,139.0,7.369141,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),2.6416016
59.28,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,17659.438,black,no,0.099999964,0.0009999992,dnr after sadm,1.0,79.0,21.5,130.0,22.0,37.19531,100.0,2.8999023,0.59997559,1.5,130.0,7.389648,135.0,23.0,1968.0,0.0,6.0,<2 mo. follow-up,6.0
60.67398,male,1.0,MOSF w/Malig,12.0,under $11k,25024.0,white,yes,0.199999928,0.3,dnr after sadm,15.0,96.0,5.59960938,125.0,24.0,35.09375,89.40625,2.8999023,0.29998779,1.0,138.0,7.509766,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5361328
39.633,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,140303.625,white,no,0.75,0.75,no dnr,37.0,105.0,27.6992188,114.0,37.0,38.5,296.625,1.7998047,2.59960938,0.59997559,132.0,7.449219,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
59.87399,female,0.0,ARF/MOSF w/Sepsis,16.0,$11-$25k,149420.5,white,no,0.699999809,0.5,no dnr,60.0,67.0,9.69921875,118.0,36.0,39.5,106.65625,2.5,0.89990234,0.59997559,135.0,7.479492,135.0,23.0,1968.0,0.0,0.0,SIP>=30,0.0
47.97498,male,0.0,CHF,12.0,$25-$50k,34673.594,black,no,0.699999809,0.5,no dnr,15.0,89.0,6.39941406,62.0,16.0,36.39844,224.0,2.8999023,0.29998779,1.5,135.0,7.419922,135.0,23.0,1968.0,1.0,0.0,no(M2 and SIP pres),0.0
60.03598,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,47314.344,white,no,0.199999928,0.09999996,dnr after sadm,5.0,67.0,3.09960938,75.0,26.0,38.0,353.3125,2.8999023,1.19995117,2.0,136.0,7.449219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
73.57697,female,1.0,ARF/MOSF w/Sepsis,6.0,under $11k,89045.438,black,no,0.099999964,0.0009999992,dnr after sadm,12.0,111.0,15.8984375,116.0,41.0,38.5,350.0,2.7998047,1.09985352,1.59985352,141.0,7.459961,135.0,23.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
86.41199,male,1.0,CHF,12.0,under $11k,18622.797,white,no,0.699999809,0.5,dnr after sadm,2.0,43.0,12.5,40.0,40.0,37.09375,104.07812,2.8999023,0.89990234,3.29980469,143.0,7.40918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.7089844
32.97498,male,1.0,Coma,14.0,$11-$25k,74168.5,white,no,0.299999952,0.3,no dnr,20.0,120.0,25.0,95.0,37.0,38.69531,192.5,2.8999023,0.89990234,1.0,141.0,7.429688,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
68.50696,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,195778.25,white,no,0.699999809,0.5,dnr after sadm,31.0,107.0,28.296875,100.0,36.0,36.09375,250.0,3.199707,1.29980469,0.69995117,131.0,7.439453,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.2753906
36.16199,female,0.0,Coma,12.0,under $11k,120483.062,white,no,0.5,0.5,no dnr,47.0,77.0,18.796875,110.0,25.0,36.19531,277.125,3.5996094,1.29980469,0.89990234,137.0,7.489258,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
49.12299,male,0.0,CHF,12.0,$25-$50k,32006.594,white,no,0.699999809,0.5,no dnr,23.0,63.0,6.69921875,74.0,24.0,36.79688,224.0,2.8999023,2.5,1.29980469,118.0,7.419922,135.0,23.0,1968.0,1.0,0.0,<2 mo. follow-up,0.0
24.049,male,0.0,CHF,14.0,under $11k,25024.0,black,no,0.699999809,0.5,no dnr,22.0,88.0,30.0,112.0,36.0,38.0,322.8125,2.8999023,9.79882812,1.19995117,136.0,7.449219,135.0,23.0,1968.0,0.0,6.0,<2 mo. follow-up,6.0
30.76799,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,20983.391,black,no,0.799999714,0.75,no dnr,17.0,67.0,12.1992188,80.0,30.0,39.29688,276.1875,2.3999023,7.09960938,0.59997559,131.0,7.489258,135.0,23.0,1968.0,1.0,0.0,no(M2 and SIP pres),0.0
76.40497,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,130559.938,white,yes,0.699999809,0.5,dnr after sadm,12.0,58.0,13.2988281,68.0,25.0,39.29688,316.625,2.0996094,0.89990234,0.89990234,135.0,7.449219,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
46.53,male,1.0,ARF/MOSF w/Sepsis,11.0,under $11k,21262.891,white,no,0.699999809,0.5,dnr after sadm,6.0,61.0,15.0,122.0,8.0,37.29688,196.0,3.0,3.89990234,2.39990234,135.0,7.269531,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
44.60498,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,148688.0,black,no,0.899999619,0.7999997,no dnr,31.0,133.0,9.59960938,90.0,22.0,37.5,440.0,2.5996094,23.6992188,2.79980469,136.0,7.329102,135.0,23.0,1968.0,0.0,7.0,no(M2 and SIP pres),7.0
71.69098,male,1.0,Coma,12.0,under $11k,12116.844,white,no,0.0,0.0,dnr after sadm,2.0,55.0,10.5,152.0,50.0,38.0,282.8125,2.8999023,0.5,7.5,138.0,7.219727,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.9052734
64.94995,female,0.0,MOSF w/Malig,12.0,under $11k,62986.688,black,metastatic,0.699999809,0.5,no dnr,36.0,52.0,24.6992188,180.0,7.0,38.0,260.0,2.5,2.39990234,1.69995117,141.0,7.529297,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.8496094
46.85797,male,1.0,ARF/MOSF w/Sepsis,6.0,under $11k,73627.125,white,no,0.299999952,0.1999999,dnr after sadm,9.0,68.0,28.6992188,100.0,29.0,38.09375,186.0,2.8999023,24.5,6.29980469,144.0,7.399414,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
67.70197,male,0.0,Lung Cancer,12.0,under $11k,7427.547,white,metastatic,0.099999964,0.0009999992,dnr after sadm,2.0,83.0,12.5996094,100.0,36.0,36.19531,308.0,2.8999023,0.29998779,1.09985352,143.0,7.459961,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.8491211
38.883,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,25195.344,black,no,0.849999905,0.75,dnr after sadm,10.0,70.0,11.0,98.0,9.0,34.59375,384.0,2.8999023,3.59960938,0.39996338,142.0,7.489258,135.0,23.0,1968.0,0.0,3.0,<2 mo. follow-up,3.0
76.06799,male,0.0,Lung Cancer,12.0,under $11k,3971.6,white,metastatic,0.699999809,0.5,no dnr,5.0,74.0,7.59960938,88.0,24.0,36.59375,480.9375,2.8999023,0.89990234,1.09985352,142.0,7.5,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.0610352
65.52197,male,0.0,Cirrhosis,16.0,$25-$50k,5249.898,black,metastatic,0.699999809,0.5,no dnr,7.0,87.0,3.09960938,84.0,20.0,36.5,224.0,2.3999023,2.59960938,0.79992676,137.0,7.419922,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),1.0
62.366,female,0.0,Colon Cancer,16.0,$25-$50k,2857.299,white,metastatic,0.099999964,0.0009999992,no dnr,4.0,78.0,13.0,110.0,36.0,36.0,224.0,2.2998047,4.0,1.0,131.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
57.64798,female,0.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,45167.531,white,yes,0.699999809,0.5,no dnr,21.0,78.0,11.0,112.0,40.0,38.5,290.0,2.8999023,0.89990234,1.09985352,138.0,7.519531,135.0,23.0,1968.0,3.0,0.0,<2 mo. follow-up,0.0
56.60498,female,0.0,CHF,12.0,under $11k,4187.199,white,no,0.699999809,0.5,no dnr,3.0,67.0,6.89941406,68.0,20.0,36.0,224.0,2.8999023,0.59997559,1.19995117,139.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.9326172
63.04199,male,0.0,ARF/MOSF w/Sepsis,16.0,$25-$50k,504659.5,white,no,0.75,0.6999998,dnr after sadm,148.0,72.0,18.1992188,120.0,10.0,37.79688,267.5,1.7998047,0.39996338,1.39990234,137.0,7.389648,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
21.13599,male,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,163675.25,white,no,0.699999809,0.5,no dnr,32.0,143.0,16.296875,68.0,8.0,35.09375,260.0,2.5,9.79882812,0.89990234,147.0,7.509766,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
58.32199,female,0.0,COPD,12.0,under $11k,15772.445,white,no,0.699999809,0.5,no dnr,7.0,90.0,13.5996094,110.0,20.0,37.19531,148.0,2.8999023,0.89990234,0.59997559,138.0,7.459961,135.0,23.0,1968.0,4.0,0.0,no(M2 and SIP pres),0.0
44.97998,female,0.0,Colon Cancer,12.0,under $11k,14023.094,white,metastatic,0.899999619,0.75,no dnr,15.0,97.0,7.19921875,72.0,16.0,36.79688,224.0,4.0996094,5.29980469,0.69995117,139.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.0927734
53.43997,male,0.0,ARF/MOSF w/Sepsis,14.0,$25-$50k,88128.812,white,no,0.699999809,0.5,no dnr,53.0,65.0,16.6992188,125.0,31.0,38.19531,152.0,3.3999023,2.69970703,7.39941406,133.0,7.369141,135.0,23.0,1968.0,0.0,6.0,no(M2 and SIP pres),6.0
65.17999,male,0.0,ARF/MOSF w/Sepsis,5.0,under $11k,96142.25,white,no,0.949999809,0.9399996,no dnr,52.0,112.0,15.3984375,85.0,15.0,37.19531,266.625,1.6999512,0.59997559,0.89990234,131.0,7.469727,135.0,23.0,1968.0,4.0,1.0,<2 mo. follow-up,3.1831989
70.69397,male,0.0,ARF/MOSF w/Sepsis,11.0,under $11k,22192.984,white,no,0.699999809,0.5,no dnr,18.0,74.0,12.0,90.0,19.0,35.5,316.0,2.5996094,5.79980469,0.89990234,133.0,7.349609,135.0,23.0,1968.0,1.0,0.0,no(M2 and SIP pres),0.0
62.806,male,0.0,Lung Cancer,10.0,$25-$50k,6054.199,white,metastatic,0.899999619,0.5,no dnr,5.0,135.0,15.0996094,92.0,20.0,36.79688,224.0,4.0996094,0.5,1.5,135.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
45.38498,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,49908.031,black,metastatic,0.099999964,0.0009999992,dnr after sadm,8.0,80.0,5.89941406,115.0,26.0,36.09375,282.8125,2.8999023,0.89990234,0.69995117,130.0,7.339844,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.7504883
44.13998,male,0.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,148803.75,black,no,0.949999809,0.9499998,no dnr,84.0,123.0,11.2988281,115.0,38.0,37.59375,175.5,2.7998047,0.89990234,1.0,142.0,7.399414,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
76.33099,female,1.0,Coma,12.0,under $11k,25024.0,black,no,0.009999998,9.999994e-07,dnr after sadm,5.0,125.0,15.0,85.0,22.0,37.29688,243.3125,2.8999023,0.89990234,1.09985352,141.0,7.439453,135.0,23.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
77.11694,male,1.0,ARF/MOSF w/Sepsis,11.0,under $11k,25024.0,white,yes,0.399999857,0.09999996,no dnr,21.0,55.0,17.8984375,110.0,14.0,36.0,140.0,1.5998535,0.39996338,1.09985352,151.0,7.389648,135.0,23.0,1968.0,0.0,7.0,<2 mo. follow-up,7.0
53.11697,male,1.0,ARF/MOSF w/Sepsis,6.0,under $11k,36496.094,black,no,0.699999809,0.5,dnr after sadm,13.0,72.0,24.296875,98.0,24.0,35.39844,344.4375,2.5,50.1953125,2.09960938,134.0,7.40918,135.0,23.0,1968.0,0.0,4.0,<2 mo. follow-up,4.0
50.64999,male,0.0,ARF/MOSF w/Sepsis,14.0,$25-$50k,25024.0,white,no,0.899999619,0.8499999,no dnr,38.0,82.0,8.3984375,70.0,16.0,37.29688,466.625,2.8999023,0.39996338,1.09985352,141.0,7.379883,135.0,23.0,1968.0,1.0,0.0,no(M2 and SIP pres),0.0
72.47894,male,1.0,Lung Cancer,12.0,under $11k,25024.0,white,metastatic,0.699999809,0.5,no dnr,4.0,43.0,12.2988281,0.0,0.0,36.59375,108.32812,2.8999023,0.79992676,0.89990234,133.0,7.179688,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.7460938
66.90997,female,1.0,ARF/MOSF w/Sepsis,10.0,$11-$25k,25024.0,other,no,0.799999714,0.5119996,dnr after sadm,17.0,72.0,11.5,120.0,40.0,38.09375,271.375,2.8999023,0.89990234,1.09985352,138.0,7.449219,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
58.42798,female,1.0,MOSF w/Malig,12.0,under $11k,81086.875,white,metastatic,0.75,0.3,dnr before sadm,-8.0,67.0,18.0,135.0,10.0,38.0,276.625,2.699707,1.0,2.89990234,145.0,7.40918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.3833008
53.09497,male,0.0,ARF/MOSF w/Sepsis,14.0,under $11k,57829.438,white,no,0.699999809,0.5,no dnr,32.0,100.0,15.1992188,70.0,28.0,37.59375,212.0,2.8999023,0.69995117,0.69995117,136.0,7.40918,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
42.95697,male,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,45774.219,white,no,0.799999714,0.8999996,no dnr,22.0,67.0,28.5,125.0,24.0,38.69531,59.0,1.2998047,1.59985352,4.5,149.0,7.429688,135.0,23.0,1968.0,0.0,2.0,adl>=4 (>=5 if sur),2.0
61.38797,female,0.0,Lung Cancer,16.0,>$50k,7101.348,white,metastatic,0.299999952,0.04999998,no dnr,7.0,94.0,7.0,86.0,18.0,36.19531,224.0,2.8999023,0.89990234,0.89990234,135.0,7.419922,135.0,23.0,1968.0,1.0,6.0,adl>=4 (>=5 if sur),6.0
30.63699,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,24373.297,black,no,0.699999809,0.5,no dnr,5.0,131.0,16.0976562,220.0,36.0,35.5,465.0,2.8999023,32.59375,1.69995117,151.0,7.509766,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.9372559
51.77298,male,0.0,MOSF w/Malig,12.0,$25-$50k,71611.188,white,yes,0.5,0.5,no dnr,23.0,54.0,0.09999084,90.0,36.0,39.09375,115.0,2.8999023,1.09985352,2.5,136.0,7.389648,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
80.41595,female,0.0,ARF/MOSF w/Sepsis,13.0,under $11k,19865.688,white,yes,0.599999905,0.5,no dnr,14.0,112.0,18.296875,140.0,37.0,35.19531,142.84375,2.199707,0.39996338,1.29980469,136.0,7.489258,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
67.01398,female,0.0,Lung Cancer,10.0,under $11k,25024.0,white,metastatic,0.899999619,0.6999998,no dnr,32.0,96.0,9.29882812,52.0,20.0,37.0,224.0,2.8999023,0.39996338,0.79992676,138.0,7.419922,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
80.44098,male,1.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,221947.625,white,no,0.699999809,0.6499996,dnr after sadm,69.0,58.0,14.5996094,154.0,10.0,38.59375,135.0,2.0,3.29980469,1.0,132.0,7.399414,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),1.0
46.45898,male,0.0,ARF/MOSF w/Sepsis,10.0,$25-$50k,87008.125,white,no,0.699999809,0.5,no dnr,33.0,45.0,25.1992188,124.0,28.0,39.0,206.65625,3.7998047,2.19970703,1.39990234,140.0,7.5,135.0,23.0,1968.0,0.0,0.0,SIP>=30,0.0
64.04095,female,0.0,MOSF w/Malig,16.0,$11-$25k,12177.0,white,metastatic,0.299999952,0.3,no dnr,13.0,107.0,0.69995117,100.0,29.0,37.09375,371.375,2.8999023,0.5,0.59997559,132.0,7.469727,135.0,23.0,1968.0,5.0,5.0,adl>=4 (>=5 if sur),5.0
63.211,male,0.0,CHF,12.0,under $11k,8286.344,white,no,0.799999714,0.5999999,no dnr,10.0,70.0,8.0,80.0,20.0,36.39844,428.5625,2.8999023,1.5,1.09985352,142.0,7.459961,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.3369141
44.909,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,45405.188,black,no,0.25,0.25,no dnr,5.0,112.0,21.796875,146.0,55.0,39.0,94.0,2.0996094,0.19998169,0.79992676,142.0,7.349609,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
38.784,male,0.0,Lung Cancer,12.0,under $11k,8524.148,white,metastatic,0.799999714,0.5,no dnr,6.0,103.0,23.0976562,90.0,20.0,36.5,224.0,3.0,0.29998779,0.89990234,139.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.1420898
45.00497,male,0.0,Coma,12.0,$25-$50k,177418.375,white,no,0.099999964,0.0009999992,dnr after sadm,4.0,130.0,19.5976562,130.0,10.0,38.69531,246.65625,2.8999023,0.89990234,1.0,140.0,7.539062,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
65.91595,male,0.0,Lung Cancer,1.0,under $11k,25024.0,black,metastatic,0.699999809,0.5,no dnr,8.0,73.0,6.19921875,90.0,18.0,36.5,224.0,2.8999023,0.89990234,0.79992676,135.0,7.419922,135.0,23.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
49.89697,male,1.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,36192.281,white,no,0.399999857,0.3999999,no dnr,7.0,73.0,0.29998779,116.0,33.0,37.79688,225.0,2.8999023,0.39996338,1.19995117,135.0,7.40918,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
55.28799,female,1.0,Cirrhosis,7.0,$11-$25k,25024.0,white,no,0.5,0.5,no dnr,25.0,84.0,6.09960938,110.0,24.0,36.89844,224.0,3.199707,6.69921875,1.39990234,140.0,7.469727,135.0,23.0,1968.0,0.0,5.0,<2 mo. follow-up,5.0
33.254,male,1.0,MOSF w/Malig,12.0,under $11k,123138.188,black,yes,0.199999928,0.1999999,dnr after sadm,61.0,69.0,0.39996338,145.0,52.0,39.39844,373.3125,2.0,16.296875,1.69995117,148.0,7.509766,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
45.97098,male,0.0,CHF,14.0,$11-$25k,34001.469,white,no,0.5,0.3,no dnr,16.0,80.0,14.3984375,114.0,26.0,36.79688,283.3125,2.7998047,1.39990234,1.0,125.0,7.369141,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
79.81897,male,1.0,MOSF w/Malig,12.0,under $11k,89738.938,white,yes,0.199999928,0.09999996,dnr after sadm,7.0,63.0,0.39996338,112.0,10.0,37.19531,131.65625,2.8999023,0.59997559,9.19921875,134.0,7.469727,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.0644531
75.30194,male,1.0,MOSF w/Malig,12.0,under $11k,23312.641,white,yes,0.399999857,0.3999999,dnr after sadm,3.0,0.0,58.59375,0.0,0.0,39.59375,137.75,2.5,0.89990234,1.69995117,149.0,7.439453,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.5441894
60.30399,male,0.0,Colon Cancer,12.0,$11-$25k,25024.0,black,metastatic,0.099999964,0.0009999992,no dnr,9.0,93.0,4.89941406,112.0,28.0,39.79688,224.0,2.8999023,0.69995117,0.69995117,133.0,7.419922,135.0,23.0,1968.0,2.0,0.0,<2 mo. follow-up,0.0
59.62198,male,0.0,CHF,12.0,under $11k,14459.148,white,no,0.949999809,0.8499999,no dnr,5.0,97.0,10.2988281,110.0,24.0,36.39844,210.0,2.8999023,0.89990234,1.0,137.0,7.449219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.1704102
43.159,male,0.0,CHF,12.0,under $11k,13811.0,black,no,0.699999809,0.5,no dnr,4.0,77.0,4.29980469,90.0,18.0,36.89844,224.0,2.8999023,0.79992676,0.79992676,138.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.215332
68.19196,male,1.0,COPD,9.0,under $11k,69824.688,white,no,0.399999857,0.3999999,dnr after sadm,7.0,83.0,13.3984375,98.0,8.0,35.89844,156.0,2.8999023,0.89990234,1.29980469,152.0,7.469727,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
77.98798,female,0.0,COPD,12.0,under $11k,25024.0,white,no,0.799999714,0.6999998,no dnr,23.0,113.0,15.1992188,82.0,25.0,37.59375,303.3125,3.5996094,0.29998779,0.39996338,137.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
68.99396,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,53060.125,black,no,0.899999619,0.8999996,no dnr,23.0,118.0,7.19921875,150.0,20.0,38.59375,206.65625,2.8999023,0.89990234,0.79992676,138.0,7.519531,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.861084
50.40097,male,0.0,Lung Cancer,14.0,$11-$25k,4376.5,other,metastatic,0.799999714,0.1999999,no dnr,7.0,83.0,2.69970703,52.0,24.0,37.5,224.0,2.8999023,0.69995117,1.5,133.0,7.419922,135.0,23.0,1968.0,0.0,5.0,<2 mo. follow-up,5.0
77.10596,male,1.0,MOSF w/Malig,12.0,under $11k,28218.141,white,yes,0.75,0.5,dnr after sadm,5.0,103.0,10.7988281,112.0,9.0,37.59375,213.3125,2.3999023,0.39996338,0.79992676,143.0,7.449219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.9489746
80.13397,male,1.0,ARF/MOSF w/Sepsis,3.0,$25-$50k,67287.125,white,no,0.199999928,0.1999999,dnr after sadm,2.0,59.0,10.5,94.0,12.0,38.0,85.0,2.8999023,1.0,2.39990234,130.0,7.359375,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
71.05298,female,0.0,COPD,12.0,under $11k,73721.125,white,no,0.989999771,0.8999996,no dnr,71.0,103.0,26.0,98.0,18.0,36.09375,385.6875,4.0,0.59997559,0.89990234,142.0,7.489258,135.0,23.0,1968.0,1.0,1.0,no(M2 and SIP pres),1.0
65.073,male,0.0,COPD,9.0,$11-$25k,8162.348,white,yes,0.899999619,0.75,no dnr,10.0,90.0,20.1992188,75.0,26.0,35.79688,214.28125,2.8999023,0.69995117,1.0,137.0,7.399414,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
39.43597,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,111050.375,white,no,0.699999809,0.5,dnr after sadm,21.0,59.0,16.8984375,115.0,60.0,38.29688,226.65625,2.8999023,0.59997559,1.09985352,133.0,7.379883,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.862793
77.02698,male,1.0,CHF,15.0,$25-$50k,86263.0,white,yes,0.599999905,0.5999999,dnr after sadm,6.0,67.0,20.6992188,135.0,31.0,38.39844,211.40625,2.8999023,0.29998779,1.5,140.0,7.40918,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
37.41498,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,140070.375,black,no,0.979999542,0.9799995,no dnr,14.0,111.0,19.0976562,98.0,16.0,35.5,268.0,2.7998047,0.29998779,5.0,138.0,7.40918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.78125
48.84299,female,0.0,ARF/MOSF w/Sepsis,9.0,$25-$50k,55942.812,black,no,0.919999599,0.8999996,no dnr,21.0,77.0,20.296875,142.0,10.0,39.09375,168.0,2.699707,0.89990234,0.79992676,135.0,7.379883,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
65.04596,female,1.0,MOSF w/Malig,12.0,under $11k,87928.938,black,yes,0.099999964,0.0009999992,dnr after sadm,19.0,93.0,11.3984375,106.0,11.0,38.5,406.625,2.5996094,0.5,1.0,133.0,7.459961,135.0,23.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
72.29297,male,1.0,Lung Cancer,12.0,under $11k,1849.149,white,metastatic,0.699999809,0.5,dnr after sadm,1.0,70.0,5.5,64.0,36.0,36.39844,335.0,2.8999023,0.89990234,3.09960938,142.0,7.369141,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.9194336
50.30298,female,0.0,COPD,9.0,$25-$50k,25024.0,white,no,0.899999619,0.8999996,dnr after sadm,1.0,108.0,9.5,115.0,24.0,35.39844,285.6875,2.8999023,0.29998779,0.79992676,142.0,7.339844,135.0,23.0,1968.0,5.0,5.0,SIP>=30,5.0
27.55899,male,0.0,ARF/MOSF w/Sepsis,9.0,under $11k,54286.625,white,no,0.699999809,0.6999998,no dnr,24.0,70.0,9.5,110.0,23.0,36.5,280.0,2.0996094,0.59997559,7.69921875,146.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
66.31598,male,0.0,CHF,7.0,$11-$25k,27578.297,white,no,0.949999809,0.9299998,no dnr,18.0,80.0,12.1992188,100.0,24.0,37.29688,224.0,3.3999023,0.89990234,1.59985352,136.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
38.74298,female,1.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,121979.062,white,no,0.0,0.0,no dnr,7.0,93.0,12.2988281,112.0,12.0,35.59375,144.875,4.0996094,29.1992188,3.69970703,142.0,7.399414,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
82.89697,male,1.0,COPD,3.0,under $11k,37978.875,black,no,0.099999964,0.0009999992,dnr after sadm,4.0,63.0,18.0,150.0,26.0,37.5,135.0,1.5998535,0.19998169,1.09985352,136.0,7.319336,135.0,23.0,1968.0,0.0,7.0,<2 mo. follow-up,7.0
60.84299,male,0.0,ARF/MOSF w/Sepsis,6.0,$11-$25k,31849.109,white,no,0.799999714,0.7999997,no dnr,15.0,108.0,20.0976562,110.0,34.0,38.39844,168.5625,2.8999023,0.59997559,1.0,146.0,7.429688,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.9399414
59.48297,male,0.0,Lung Cancer,12.0,$25-$50k,10657.312,white,metastatic,0.899999619,0.5999999,no dnr,14.0,80.0,11.8984375,100.0,20.0,38.59375,304.75,2.8999023,0.89990234,0.69995117,135.0,7.5,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
66.00397,male,0.0,Colon Cancer,21.0,>$50k,25024.0,white,metastatic,0.699999809,0.3999999,no dnr,6.0,93.0,6.89941406,70.0,16.0,36.19531,224.0,2.7998047,0.39996338,1.5,135.0,7.419922,135.0,23.0,1968.0,4.0,4.0,<2 mo. follow-up,4.0
55.90698,male,0.0,Lung Cancer,12.0,under $11k,2410.699,white,metastatic,0.949999809,0.5999999,no dnr,3.0,113.0,7.19921875,80.0,22.0,35.89844,224.0,2.8999023,0.89990234,1.59985352,137.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.2163086
83.92596,male,0.0,CHF,7.0,under $11k,22317.844,white,yes,0.699999809,0.5,no dnr,6.0,99.0,11.0,68.0,20.0,36.79688,342.8125,2.8999023,0.89990234,2.29980469,139.0,7.449219,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
78.11395,male,1.0,ARF/MOSF w/Sepsis,13.0,$11-$25k,67608.5,white,yes,0.0,0.0,dnr after sadm,5.0,43.0,8.8984375,124.0,25.0,39.0,122.84375,2.0,0.89990234,1.09985352,147.0,7.489258,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
58.09698,male,1.0,Lung Cancer,12.0,under $11k,9295.594,white,metastatic,0.899999619,0.6999998,dnr after sadm,10.0,90.0,7.89941406,120.0,24.0,36.79688,224.0,2.5996094,1.29980469,0.79992676,139.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.2607422
73.04596,female,1.0,ARF/MOSF w/Sepsis,16.0,$11-$25k,99060.062,black,no,0.5,0.5,no dnr,18.0,67.0,6.39941406,68.0,10.0,38.29688,533.25,1.1999512,0.29998779,2.09960938,141.0,7.419922,135.0,23.0,1968.0,0.0,6.0,<2 mo. follow-up,6.0
69.15295,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,272269.5,white,no,0.699999809,0.5,no dnr,28.0,87.0,9.29882812,100.0,50.0,38.5,165.0,4.6992188,3.09960938,2.0,140.0,7.5,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,4.0703125
65.52496,female,1.0,Coma,16.0,$25-$50k,16579.594,black,no,0.699999809,0.5,dnr after sadm,5.0,62.0,14.5996094,64.0,28.0,35.29688,476.625,2.8999023,1.0,1.5,136.0,7.429688,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.3056641
76.77997,male,1.0,ARF/MOSF w/Sepsis,3.0,under $11k,419652.25,white,no,0.699999809,0.5,no dnr,110.0,59.0,7.0,142.0,8.0,35.69531,226.65625,2.7998047,0.89990234,1.89990234,134.0,7.379883,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
37.74698,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,75506.125,black,no,0.699999809,0.5,dnr after sadm,55.0,63.0,4.29980469,130.0,10.0,39.29688,544.0,2.699707,0.09999084,0.69995117,135.0,7.389648,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.4042969
57.57397,male,1.0,CHF,12.0,under $11k,13889.844,white,no,0.099999964,0.0009999992,no dnr,5.0,74.0,6.19921875,108.0,14.0,35.0,264.0,2.8999023,0.69995117,1.59985352,135.0,7.469727,135.0,23.0,1968.0,2.0,0.0,<2 mo. follow-up,0.0
53.07898,female,0.0,ARF/MOSF w/Sepsis,7.0,$11-$25k,59744.844,white,metastatic,0.899999619,0.8499999,no dnr,38.0,83.0,9.19921875,135.0,8.0,37.29688,323.3125,2.3999023,0.89990234,1.0,132.0,7.40918,135.0,23.0,1968.0,0.0,4.0,no(M2 and SIP pres),4.0
62.03998,male,0.0,Lung Cancer,9.0,$25-$50k,28018.188,white,metastatic,0.5,0.0,no dnr,15.0,112.0,29.5976562,130.0,36.0,35.79688,152.5,2.3999023,0.29998779,0.59997559,140.0,7.389648,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
66.46698,female,1.0,ARF/MOSF w/Sepsis,10.0,under $11k,35396.781,black,no,0.699999809,0.5,dnr after sadm,2.0,45.0,10.5996094,140.0,36.0,38.59375,172.5,2.8999023,0.89990234,1.5,143.0,7.319336,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
55.85498,male,1.0,Cirrhosis,12.0,under $11k,19714.938,white,no,0.5,0.3,dnr after sadm,14.0,90.0,11.1992188,94.0,18.0,34.39844,224.0,2.7998047,33.0,1.39990234,126.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.3227539
65.81195,male,0.0,CHF,9.0,under $11k,47714.625,white,no,0.199999928,0.007999994,no dnr,26.0,75.0,8.5,110.0,26.0,37.19531,312.0,2.8999023,0.79992676,1.69995117,135.0,7.429688,135.0,23.0,1968.0,0.0,7.0,<2 mo. follow-up,7.0
26.834,female,0.0,ARF/MOSF w/Sepsis,14.0,$11-$25k,16465.844,black,no,0.799999714,0.7999997,no dnr,11.0,136.0,16.8984375,0.0,0.0,35.89844,336.0,2.8999023,1.29980469,5.89941406,139.0,7.329102,135.0,23.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
69.11395,male,1.0,Coma,12.0,under $11k,45662.281,black,no,0.699999809,0.5,dnr after sadm,12.0,123.0,12.0996094,94.0,35.0,38.09375,456.625,2.8999023,0.89990234,1.69995117,139.0,7.649414,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
49.71698,male,1.0,ARF/MOSF w/Sepsis,16.0,>$50k,345511.75,white,no,0.049999982,0.0001249999,dnr after sadm,18.0,83.0,11.5996094,140.0,36.0,39.0,73.32812,2.0,0.19998169,0.59997559,147.0,7.479492,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
43.03897,male,0.0,Lung Cancer,14.0,$25-$50k,25087.047,white,metastatic,0.899999619,0.5999999,no dnr,18.0,100.0,9.59960938,140.0,18.0,37.29688,224.0,3.5996094,0.29998779,1.09985352,142.0,7.419922,135.0,23.0,1968.0,1.0,1.0,adl>=4 (>=5 if sur),1.0
67.85498,male,1.0,CHF,12.0,under $11k,29172.891,white,no,0.699999809,0.5,dnr after sadm,4.0,46.0,14.0996094,62.0,24.0,36.69531,160.0,2.8999023,0.89990234,4.0,124.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
76.59698,male,1.0,ARF/MOSF w/Sepsis,7.0,under $11k,68324.75,white,no,0.299999952,0.1999999,no dnr,9.0,65.0,8.0,58.0,9.0,37.29688,242.84375,2.8999023,0.89990234,2.0,142.0,7.439453,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
54.409,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,28525.047,white,no,0.699999809,0.5,dnr after sadm,3.0,103.0,29.0976562,140.0,24.0,37.59375,160.0,2.8999023,1.39990234,2.79980469,133.0,7.489258,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.597168
71.82996,male,0.0,CHF,6.0,under $11k,110116.562,black,no,0.699999809,0.5,no dnr,44.0,86.0,15.2988281,72.0,18.0,37.0,224.0,2.8999023,0.89990234,1.79980469,132.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
71.91797,male,0.0,ARF/MOSF w/Sepsis,9.0,under $11k,84830.938,white,no,0.699999809,0.5,dnr after sadm,16.0,57.0,5.69921875,110.0,8.0,38.59375,500.0,2.8999023,0.89990234,0.89990234,134.0,7.389648,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
85.57996,male,1.0,ARF/MOSF w/Sepsis,16.0,under $11k,25024.0,white,no,0.099999964,0.0009999992,dnr after sadm,3.0,60.0,23.5,62.0,18.0,37.09375,149.0,2.2998047,0.69995117,1.19995117,135.0,7.389648,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
61.92697,male,0.0,COPD,12.0,under $11k,17596.484,black,no,0.699999809,0.5999999,no dnr,9.0,83.0,2.0,80.0,33.0,36.69531,216.65625,2.8999023,0.5,1.69995117,141.0,7.449219,135.0,23.0,1968.0,1.0,1.0,<2 mo. follow-up,1.0
21.405,female,0.0,CHF,12.0,$11-$25k,25024.0,white,no,0.899999619,0.6999998,no dnr,12.0,65.0,10.8984375,118.0,20.0,36.5,224.0,2.8999023,0.89990234,1.09985352,138.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
62.83899,female,0.0,COPD,3.0,under $11k,15547.047,black,no,0.699999809,0.5,no dnr,9.0,100.0,10.5996094,92.0,16.0,36.59375,252.0,3.2998047,0.09999084,7.09960938,136.0,7.219727,135.0,23.0,1968.0,0.0,0.0,SIP>=30,0.0
62.004,female,0.0,ARF/MOSF w/Sepsis,8.0,under $11k,18162.547,black,no,0.899999619,0.8999996,no dnr,14.0,77.0,14.8984375,90.0,24.0,36.29688,321.6875,2.8999023,0.29998779,0.89990234,140.0,7.359375,135.0,23.0,1968.0,0.0,5.0,no(M2 and SIP pres),5.0
59.29599,female,0.0,Colon Cancer,12.0,under $11k,25024.0,white,metastatic,0.899999619,0.6999998,no dnr,5.0,100.0,7.59960938,96.0,20.0,36.79688,224.0,3.5996094,0.69995117,0.59997559,137.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.7023926
78.84698,male,1.0,CHF,12.0,under $11k,4319.68,black,no,0.699999809,0.5,no dnr,5.0,62.0,4.5,78.0,20.0,35.59375,338.0625,2.8999023,0.89990234,1.79980469,141.0,7.479492,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.1801758
65.83997,female,1.0,ARF/MOSF w/Sepsis,11.0,under $11k,96527.75,white,yes,0.199999928,0.1799999,dnr after sadm,16.0,48.0,6.79980469,110.0,29.0,38.5,138.0,2.5996094,5.09960938,2.69970703,137.0,7.359375,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
66.38995,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,14528.797,black,no,0.799999714,0.6999998,no dnr,8.0,99.0,8.79882812,62.0,15.0,36.89844,319.0,2.8999023,0.89990234,0.59997559,140.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.3774414
79.34296,male,0.0,CHF,14.0,under $11k,33593.688,white,no,0.699999809,0.5,no dnr,14.0,66.0,6.39941406,120.0,8.0,35.79688,392.5,2.8999023,0.89990234,2.09960938,134.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
67.95898,male,0.0,CHF,4.0,under $11k,2900.449,black,no,0.699999809,0.5,no dnr,5.0,82.0,7.59960938,80.0,16.0,36.29688,290.4375,2.8999023,0.89990234,1.19995117,139.0,7.5,135.0,23.0,1968.0,0.0,2.0,no(M2 and SIP pres),2.0
66.20697,female,1.0,Colon Cancer,4.0,under $11k,4139.977,black,metastatic,0.099999964,0.0009999992,dnr after sadm,4.0,93.0,35.0,96.0,28.0,35.79688,224.0,2.8999023,6.59960938,2.19970703,128.0,7.419922,135.0,23.0,1968.0,0.0,3.0,<2 mo. follow-up,3.0
63.168,male,0.0,COPD,11.0,under $11k,24771.141,hispanic,yes,0.699999809,0.5,no dnr,19.0,97.0,11.5996094,106.0,26.0,37.69531,240.0,3.199707,0.79992676,0.89990234,133.0,7.399414,135.0,23.0,1968.0,3.0,5.0,SIP>=30,5.0
71.48798,female,0.0,CHF,8.0,$11-$25k,5364.898,white,no,0.699999809,0.5,no dnr,8.0,83.0,7.09960938,54.0,16.0,36.59375,224.0,4.0,0.69995117,1.0,139.0,7.419922,135.0,23.0,1968.0,2.0,5.0,SIP>=30,5.0
59.58398,female,0.0,Colon Cancer,12.0,under $11k,6601.348,white,metastatic,0.699999809,0.5,no dnr,7.0,87.0,8.59960938,80.0,20.0,37.69531,224.0,2.8999023,0.89990234,0.69995117,142.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.6523438
68.39197,male,0.0,ARF/MOSF w/Sepsis,14.0,$11-$25k,38632.281,white,no,0.699999809,0.5,no dnr,12.0,112.0,12.3984375,98.0,16.0,37.39844,334.75,2.8999023,1.29980469,1.09985352,138.0,7.429688,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
31.83299,male,0.0,ARF/MOSF w/Sepsis,10.0,under $11k,24312.484,black,no,0.699999809,0.5999999,no dnr,11.0,75.0,10.5,78.0,25.0,38.59375,272.0,2.5,5.69921875,0.89990234,140.0,7.389648,135.0,23.0,1968.0,1.0,0.0,SIP>=30,0.0
50.23398,female,0.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,58971.531,white,no,0.099999964,0.0009999992,no dnr,12.0,68.0,9.79882812,120.0,12.0,39.09375,254.28125,2.8999023,0.89990234,1.79980469,134.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
70.29199,male,1.0,ARF/MOSF w/Sepsis,9.0,under $11k,73765.25,black,no,0.199999928,0.15,dnr after sadm,22.0,69.0,5.59960938,114.0,16.0,38.5,148.0,2.8999023,0.89990234,13.7988281,139.0,7.389648,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
55.62799,male,0.0,ARF/MOSF w/Sepsis,13.0,$11-$25k,71645.5,white,no,0.0,0.0,no dnr,23.0,63.0,11.5996094,110.0,12.0,38.5,145.0,2.699707,0.89990234,1.19995117,128.0,7.439453,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
52.293,male,0.0,CHF,12.0,$11-$25k,8464.25,black,no,0.799999714,0.5999999,no dnr,8.0,90.0,6.59960938,88.0,20.0,35.79688,224.0,3.5996094,1.29980469,1.0,142.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
54.78998,female,0.0,CHF,12.0,under $11k,5985.949,black,no,0.699999809,0.5,no dnr,3.0,90.0,3.79980469,94.0,20.0,36.29688,320.0,2.8999023,0.79992676,1.0,136.0,7.449219,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
60.69498,female,0.0,ARF/MOSF w/Sepsis,5.0,under $11k,32884.094,black,metastatic,0.699999809,0.5,no dnr,13.0,91.0,15.1992188,114.0,8.0,36.39844,305.6875,2.8999023,1.69995117,2.09960938,136.0,7.529297,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
80.52594,female,0.0,CHF,12.0,under $11k,6475.199,black,no,0.699999809,0.5,no dnr,4.0,79.0,7.89941406,76.0,25.0,36.29688,85.0,2.8999023,0.5,1.89990234,135.0,7.319336,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5893555
71.15094,male,1.0,ARF/MOSF w/Sepsis,7.0,under $11k,137788.75,black,no,0.899999619,0.8999996,dnr after sadm,42.0,93.0,7.19921875,78.0,8.0,35.69531,265.6875,2.7998047,0.29998779,9.69921875,146.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.1655273
39.84097,male,1.0,Cirrhosis,10.0,$11-$25k,31942.234,black,no,0.099999964,0.0009999992,dnr after sadm,8.0,92.0,4.29980469,110.0,14.0,36.69531,207.5,1.7998047,4.79980469,1.79980469,134.0,7.399414,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
51.61099,female,1.0,ARF/MOSF w/Sepsis,7.0,under $11k,136609.375,white,no,0.399999857,0.1999999,dnr after sadm,30.0,86.0,22.8984375,112.0,30.0,36.59375,160.0,2.8999023,1.29980469,6.09960938,141.0,7.299805,135.0,23.0,1968.0,0.0,5.0,<2 mo. follow-up,5.0
63.431,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,150283.625,white,no,0.949999809,0.9199996,no dnr,60.0,67.0,13.5,188.0,25.0,39.09375,76.0,2.8999023,0.79992676,1.29980469,143.0,7.449219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.3330078
68.64899,female,0.0,CHF,8.0,under $11k,21254.391,white,no,0.599999905,0.4499998,no dnr,13.0,70.0,8.69921875,110.0,10.0,35.5,430.0,2.8999023,0.89990234,1.29980469,131.0,7.5,135.0,23.0,1968.0,0.0,5.0,adl>=4 (>=5 if sur),5.0
38.18198,female,0.0,Colon Cancer,12.0,>$50k,3886.5,white,metastatic,0.699999809,0.5,no dnr,5.0,91.0,9.59960938,126.0,16.0,38.59375,224.0,2.8999023,0.69995117,0.5,137.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
73.41296,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,57947.938,black,no,0.099999964,0.0009999992,dnr after sadm,8.0,111.0,9.5,102.0,13.0,35.79688,153.3125,2.699707,12.5996094,4.19921875,126.0,7.40918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.4824219
56.45999,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,253438.625,white,no,0.75,0.5999999,no dnr,117.0,67.0,16.0976562,110.0,36.0,38.59375,230.0,2.5996094,2.59960938,8.5,134.0,7.319336,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5493164
62.75998,female,0.0,Colon Cancer,16.0,under $11k,6991.598,white,metastatic,1.0,0.5,no dnr,8.0,90.0,11.5996094,78.0,18.0,35.59375,224.0,2.8999023,0.89990234,0.79992676,140.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
71.62195,male,0.0,CHF,12.0,under $11k,10631.492,black,no,0.699999809,0.5,dnr after sadm,2.0,110.0,3.79980469,76.0,20.0,35.5,224.0,2.8999023,0.79992676,3.39990234,139.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.9091797
83.61096,male,0.0,CHF,12.0,under $11k,4798.297,black,no,0.699999809,0.5,no dnr,8.0,67.0,7.5,64.0,28.0,37.29688,224.0,2.8999023,1.09985352,2.89990234,132.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.8242188
83.32397,male,0.0,ARF/MOSF w/Sepsis,23.0,$11-$25k,22936.141,white,yes,0.699999809,0.5,dnr after sadm,3.0,90.0,15.5,118.0,24.0,35.59375,282.5625,2.5,3.59960938,0.69995117,131.0,7.449219,135.0,23.0,1968.0,2.0,1.0,SIP>=30,1.0
57.65399,male,0.0,CHF,12.0,under $11k,2742.049,black,no,0.699999809,0.5,no dnr,3.0,63.0,6.69921875,60.0,22.0,37.19531,224.0,2.8999023,1.0,1.39990234,140.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.9379883
45.18799,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,121575.062,white,no,0.099999964,0.0009999992,dnr after sadm,13.0,74.0,14.0,142.0,36.0,39.59375,87.14062,2.8999023,2.0,2.0,134.0,7.40918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
53.25098,male,1.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,83062.625,white,no,0.849999905,0.6999998,dnr after sadm,10.0,87.0,10.8984375,92.0,8.0,37.19531,116.35938,2.8999023,0.89990234,1.5,145.0,7.419922,135.0,23.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
47.86298,female,1.0,Cirrhosis,12.0,under $11k,23279.203,black,no,0.099999964,0.0009999992,no dnr,8.0,89.0,11.5996094,110.0,11.0,35.89844,157.5,2.8999023,39.0,3.0,152.0,7.419922,135.0,23.0,1968.0,0.0,4.0,<2 mo. follow-up,4.0
64.61896,male,0.0,Colon Cancer,26.0,$11-$25k,21980.688,white,metastatic,1.0,1.0,no dnr,10.0,102.0,7.69921875,78.0,32.0,38.59375,390.0,2.8999023,0.5,0.79992676,134.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
25.47299,male,0.0,ARF/MOSF w/Sepsis,9.0,under $11k,51170.219,white,no,0.699999809,0.5,dnr after sadm,4.0,113.0,22.796875,134.0,52.0,39.0,423.3125,2.8999023,0.89990234,3.59960938,137.0,7.329102,135.0,23.0,1968.0,0.0,3.0,<2 mo. follow-up,3.0
68.84595,male,0.0,COPD,13.0,>$50k,11347.469,white,no,0.989999771,0.9499998,no dnr,13.0,117.0,9.59960938,112.0,18.0,36.0,266.625,2.8999023,0.39996338,1.0,142.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
66.86694,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,148144.625,black,no,0.699999809,0.5,no dnr,18.0,58.0,24.296875,114.0,27.0,37.0,166.0,2.8999023,30.0,5.69921875,155.0,7.40918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.3989258
39.93198,male,1.0,MOSF w/Malig,12.0,under $11k,202703.625,white,metastatic,0.099999964,0.0009999992,dnr after sadm,31.0,90.0,1.0,114.0,16.0,38.0,148.875,2.5,3.79980469,1.5,142.0,7.479492,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
66.97894,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,306380.25,white,no,0.699999809,0.5,no dnr,92.0,117.0,17.8984375,80.0,28.0,38.0,233.3125,2.8999023,0.89990234,1.59985352,133.0,7.449219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.2045898
75.59497,female,1.0,Lung Cancer,10.0,under $11k,13365.695,white,metastatic,0.5,0.1999999,dnr after sadm,3.0,91.0,7.5,96.0,20.0,35.0,371.375,2.3999023,0.39996338,0.79992676,140.0,7.339844,135.0,23.0,1968.0,3.0,3.0,<2 mo. follow-up,3.0
61.00497,male,0.0,COPD,6.0,under $11k,3199.719,white,no,0.989999771,0.8499999,no dnr,5.0,128.0,6.69921875,100.0,20.0,36.5,257.125,2.8999023,0.19998169,1.09985352,132.0,7.40918,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.3891602
75.65796,male,0.0,ARF/MOSF w/Sepsis,14.0,$11-$25k,88611.688,white,no,0.699999809,0.5,dnr after sadm,1.0,107.0,5.5,48.0,10.0,37.39844,323.3125,2.5996094,0.89990234,0.89990234,136.0,7.5,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
61.86697,male,1.0,MOSF w/Malig,16.0,>$50k,74204.75,white,yes,0.0,0.0,dnr after sadm,8.0,63.0,0.29998779,146.0,17.0,36.69531,89.32812,2.8999023,0.89990234,2.79980469,127.0,7.389648,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
80.80194,male,1.0,ARF/MOSF w/Sepsis,20.0,$25-$50k,133353.125,white,no,0.099999964,0.0009999992,dnr after sadm,3.0,99.0,21.3984375,110.0,10.0,36.59375,122.4375,2.3999023,1.29980469,5.89941406,151.0,7.449219,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
72.65198,male,1.0,Coma,12.0,under $11k,20842.734,white,no,0.699999809,0.5,dnr before sadm,-1.0,0.0,6.19921875,0.0,0.0,38.0,312.5,2.8999023,0.89990234,2.59960938,142.0,7.469727,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.8364258
47.39999,female,0.0,Colon Cancer,15.0,>$50k,9032.297,white,metastatic,0.699999809,0.5,no dnr,7.0,93.0,5.19921875,68.0,24.0,37.39844,224.0,2.8999023,0.39996338,0.5,140.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
76.11499,female,0.0,CHF,10.0,under $11k,6222.898,black,no,0.899999619,0.8499999,no dnr,6.0,102.0,6.69921875,68.0,20.0,36.59375,508.0,2.8999023,0.89990234,3.19970703,137.0,7.379883,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
43.67999,male,0.0,Colon Cancer,12.0,under $11k,3973.898,white,metastatic,0.989999771,0.5,no dnr,5.0,95.0,7.09960938,74.0,19.0,37.19531,224.0,2.8999023,0.89990234,1.0,138.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.6225586
50.15997,female,1.0,CHF,16.0,$25-$50k,144129.25,black,no,0.799999714,0.5999999,dnr after sadm,88.0,79.0,10.0996094,118.0,36.0,37.5,428.5625,3.199707,3.19970703,1.19995117,138.0,7.5,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),0.4947999
63.80798,male,0.0,CHF,12.0,under $11k,3234.049,white,no,0.699999809,0.5,no dnr,6.0,84.0,6.19921875,90.0,20.0,36.79688,224.0,2.8999023,0.89990234,0.89990234,141.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
41.79599,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,41557.875,black,no,0.299999952,0.25,no dnr,3.0,0.0,20.6992188,0.0,0.0,39.69531,531.0,2.8999023,0.39996338,7.09960938,168.0,7.469727,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
49.94098,female,0.0,Colon Cancer,14.0,>$50k,27833.797,white,metastatic,1.0,1.0,no dnr,12.0,103.0,7.39941406,118.0,8.0,36.5,370.0,3.5996094,0.19998169,0.89990234,142.0,7.349609,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
66.05096,female,0.0,Lung Cancer,12.0,$25-$50k,4287.848,hispanic,metastatic,1.0,0.7999997,no dnr,5.0,87.0,7.89941406,60.0,20.0,36.39844,224.0,2.8999023,0.19998169,0.79992676,143.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
63.82199,male,1.0,MOSF w/Malig,11.0,$11-$25k,30126.047,white,metastatic,0.5,0.3,dnr after sadm,13.0,109.0,44.09375,110.0,34.0,35.89844,255.8125,3.199707,0.19998169,0.79992676,143.0,7.439453,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
60.01599,male,1.0,MOSF w/Malig,12.0,under $11k,29811.031,white,yes,0.009999998,9.999994e-07,dnr after sadm,4.0,44.0,0.09999084,180.0,12.0,37.29688,252.5,1.8999023,4.69921875,3.79980469,153.0,7.289062,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.4750977
71.75598,male,0.0,ARF/MOSF w/Sepsis,8.0,under $11k,59008.219,black,no,0.849999905,0.8199997,no dnr,16.0,63.0,24.796875,110.0,18.0,36.39844,170.0,2.5996094,0.89990234,2.09960938,140.0,7.5,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
39.34598,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,25024.0,black,no,0.75,0.6999998,no dnr,13.0,114.0,20.0,118.0,40.0,37.0,442.8125,2.8999023,2.29980469,1.19995117,146.0,7.429688,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
66.22595,male,0.0,ARF/MOSF w/Sepsis,17.0,under $11k,34187.938,white,no,0.5,0.3999999,no dnr,17.0,108.0,8.79882812,70.0,26.0,35.59375,142.84375,2.8999023,0.89990234,0.5,138.0,7.30957,135.0,23.0,1968.0,0.0,6.0,adl>=4 (>=5 if sur),6.0
29.55499,female,1.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,51709.438,black,no,0.049999982,0.0001249999,dnr after sadm,5.0,47.0,18.3984375,112.0,30.0,35.89844,90.0,2.8999023,3.59960938,5.79980469,142.0,7.529297,135.0,23.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
69.90594,male,0.0,Cirrhosis,9.0,$25-$50k,4728.047,white,no,0.849999905,0.5,no dnr,5.0,81.0,9.19921875,80.0,18.0,37.29688,224.0,3.199707,6.09960938,1.0,140.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
56.97998,male,0.0,MOSF w/Malig,12.0,$11-$25k,29052.234,white,yes,0.799999714,0.5,no dnr,18.0,89.0,100.0,90.0,36.0,38.79688,133.3125,2.8999023,0.89990234,1.59985352,137.0,7.459961,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
57.81497,male,1.0,Lung Cancer,10.0,$25-$50k,23437.938,white,metastatic,0.099999964,0.0009999992,dnr after sadm,11.0,88.0,19.0976562,100.0,18.0,36.0,224.0,2.8999023,0.19998169,0.89990234,136.0,7.419922,135.0,23.0,1968.0,1.0,0.0,<2 mo. follow-up,0.0
61.32498,male,0.0,MOSF w/Malig,12.0,under $11k,33008.531,white,metastatic,0.0,0.0,dnr after sadm,3.0,131.0,15.5996094,48.0,8.0,37.29688,302.8125,2.699707,0.29998779,1.29980469,146.0,7.5,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.8583984
76.11798,male,0.0,CHF,12.0,$11-$25k,5847.648,white,no,0.699999809,0.5,no dnr,11.0,97.0,4.19921875,74.0,20.0,35.79688,224.0,4.0,2.09960938,1.79980469,140.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
72.94995,female,1.0,ARF/MOSF w/Sepsis,3.0,under $11k,73442.438,black,no,0.699999809,0.5,dnr after sadm,10.0,65.0,7.89941406,110.0,8.0,37.89844,356.625,2.5,0.39996338,1.79980469,132.0,7.40918,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
26.92699,male,1.0,ARF/MOSF w/Sepsis,10.0,under $11k,141803.25,other,no,0.099999964,0.0009999992,dnr after sadm,34.0,67.0,16.796875,140.0,36.0,37.5,130.0,2.7998047,5.5,5.39941406,134.0,7.289062,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
77.05396,female,1.0,Coma,12.0,under $11k,9438.594,black,no,0.699999809,0.5,dnr after sadm,4.0,131.0,12.7988281,112.0,10.0,39.09375,366.625,2.8999023,0.29998779,0.79992676,142.0,7.459961,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,4.4248047
71.52594,male,1.0,ARF/MOSF w/Sepsis,7.0,$11-$25k,238583.125,white,no,1.0,1.0,dnr after sadm,48.0,80.0,6.29980469,110.0,39.0,36.09375,287.5,2.5,0.39996338,2.0,152.0,7.399414,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
43.31799,male,0.0,Cirrhosis,16.0,$25-$50k,3554.6,white,no,0.949999809,0.5999999,no dnr,6.0,103.0,8.5,76.0,20.0,36.69531,438.0625,3.0,6.09960938,1.69995117,126.0,7.40918,135.0,23.0,1968.0,1.0,1.0,<2 mo. follow-up,1.0
63.12399,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,80263.875,white,no,0.699999809,0.5,dnr after sadm,14.0,87.0,0.79992676,76.0,10.0,36.59375,293.3125,2.5,0.89990234,7.39941406,136.0,7.439453,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
72.03595,female,0.0,ARF/MOSF w/Sepsis,16.0,$25-$50k,25024.0,white,no,0.75,0.6999998,no dnr,23.0,123.0,11.6992188,78.0,25.0,35.89844,310.0,2.8999023,0.89990234,2.09960938,136.0,7.399414,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
71.79199,female,1.0,MOSF w/Malig,12.0,$11-$25k,48463.688,white,metastatic,0.699999809,0.5,dnr after sadm,6.0,63.0,7.09960938,110.0,25.0,36.0,220.0,2.7998047,15.2988281,3.59960938,130.0,7.449219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
65.97894,male,0.0,Lung Cancer,7.0,under $11k,13066.297,white,metastatic,0.899999619,0.5,no dnr,12.0,105.0,7.79980469,74.0,18.0,36.59375,224.0,2.8999023,0.29998779,0.69995117,141.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
66.15698,male,0.0,Lung Cancer,12.0,under $11k,3142.35,white,metastatic,0.699999809,0.5,no dnr,3.0,99.0,3.89990234,88.0,20.0,36.0,224.0,2.8999023,0.19998169,0.79992676,135.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.9938965
67.74298,male,0.0,CHF,18.0,$11-$25k,3384.398,white,no,0.899999619,0.7999997,no dnr,8.0,93.0,6.39941406,54.0,20.0,36.09375,224.0,2.8999023,0.79992676,1.29980469,140.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
58.48599,female,0.0,Lung Cancer,12.0,under $11k,3006.998,white,metastatic,0.0,0.0,dnr after sadm,2.0,81.0,7.79980469,100.0,16.0,38.09375,238.09375,2.8999023,0.5,0.59997559,135.0,7.299805,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.7084961
59.75098,male,0.0,ARF/MOSF w/Sepsis,2.0,under $11k,405592.0,white,no,0.699999809,0.5,no dnr,245.0,98.0,9.29882812,104.0,8.0,40.0,292.5,3.2998047,0.89990234,1.39990234,142.0,7.5,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.0610352
87.52899,male,1.0,Coma,12.0,under $11k,9511.203,black,no,0.049999982,0.0001249999,no dnr,3.0,0.0,9.29882812,0.0,0.0,36.59375,260.0,4.1992188,0.39996338,2.29980469,141.0,7.379883,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.1782227
43.09097,male,0.0,CHF,12.0,$11-$25k,9515.945,white,no,0.699999809,0.5,no dnr,11.0,101.0,9.19921875,86.0,20.0,35.79688,819.0,2.8999023,1.39990234,1.09985352,135.0,7.489258,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
76.06598,male,0.0,CHF,12.0,under $11k,2045.55,white,no,0.699999809,0.5,no dnr,4.0,79.0,8.8984375,64.0,16.0,35.59375,285.6875,2.8999023,0.89990234,2.59960938,138.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.8129883
67.64398,male,0.0,Lung Cancer,16.0,$25-$50k,6064.5,white,metastatic,1.0,0.8999996,no dnr,6.0,93.0,9.69921875,68.0,18.0,36.79688,224.0,2.8999023,0.29998779,1.0,139.0,7.419922,135.0,23.0,1968.0,1.0,1.0,no(M2 and SIP pres),1.0
56.06299,female,1.0,Cirrhosis,18.0,>$50k,141836.875,asian,no,0.599999905,0.3999999,dnr after sadm,19.0,81.0,7.0,84.0,20.0,36.5,224.0,2.5996094,21.5,1.29980469,135.0,7.419922,135.0,23.0,1968.0,0.0,6.0,<2 mo. follow-up,6.0
77.01599,female,0.0,MOSF w/Malig,12.0,under $11k,25024.0,white,metastatic,0.699999809,0.5,no dnr,9.0,113.0,34.796875,110.0,10.0,36.79688,400.0,1.3999023,0.89990234,1.0,131.0,7.429688,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.4233398
45.67297,male,0.0,Cirrhosis,12.0,under $11k,10358.094,white,no,0.699999809,0.5,no dnr,14.0,85.0,4.39941406,86.0,24.0,36.69531,374.9375,2.7998047,0.79992676,0.69995117,141.0,7.389648,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.809082
74.29395,female,0.0,ARF/MOSF w/Sepsis,7.0,under $11k,19400.234,white,no,0.949999809,0.8999996,no dnr,9.0,67.0,25.0976562,66.0,16.0,36.69531,194.28125,2.8999023,0.59997559,1.59985352,141.0,7.449219,135.0,23.0,1968.0,0.0,5.0,no(M2 and SIP pres),5.0
59.91498,male,0.0,MOSF w/Malig,9.0,under $11k,51688.625,black,metastatic,0.25,0.15,dnr after sadm,4.0,60.0,0.89990234,200.0,35.0,39.0,277.0,2.2998047,1.79980469,3.69970703,140.0,7.179688,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
73.57697,male,0.0,Colon Cancer,24.0,>$50k,13001.945,white,metastatic,0.699999809,0.5,no dnr,9.0,97.0,13.1992188,66.0,12.0,36.69531,436.0,2.8999023,0.69995117,0.79992676,133.0,7.399414,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.4335938
56.09598,female,0.0,CHF,9.0,under $11k,182209.5,other,no,0.699999809,0.5,no dnr,66.0,67.0,8.0,120.0,16.0,37.09375,356.625,2.8999023,1.5,0.89990234,127.0,7.5,135.0,23.0,1968.0,5.0,5.0,SIP>=30,5.0
49.43997,female,0.0,Colon Cancer,16.0,>$50k,5030.449,hispanic,metastatic,0.799999714,0.5,no dnr,6.0,83.0,8.29882812,72.0,18.0,36.39844,224.0,2.8999023,1.0,0.89990234,135.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
40.81598,male,0.0,CHF,16.0,$25-$50k,548741.5,white,no,0.149999976,0.09999996,no dnr,207.0,63.0,7.89941406,114.0,16.0,36.79688,224.0,2.8999023,1.19995117,1.0,135.0,7.419922,135.0,23.0,1968.0,0.0,0.0,SIP>=30,0.0
38.19299,male,0.0,Cirrhosis,14.0,$11-$25k,16639.641,white,no,0.5,0.3,no dnr,24.0,89.0,4.89941406,80.0,12.0,36.5,240.0,2.7998047,5.59960938,1.89990234,123.0,7.5,135.0,23.0,1968.0,2.0,0.0,SIP>=30,0.0
62.46997,male,1.0,CHF,10.0,$25-$50k,26328.797,white,no,0.699999809,0.5,dnr after sadm,10.0,69.0,11.6992188,80.0,20.0,36.79688,180.0,2.8999023,1.89990234,1.09985352,133.0,7.489258,135.0,23.0,1968.0,0.0,3.0,<2 mo. follow-up,3.0
41.09799,male,0.0,Lung Cancer,12.0,under $11k,5966.547,white,metastatic,0.899999619,0.5999999,no dnr,8.0,86.0,8.19921875,116.0,24.0,38.09375,366.625,2.7998047,0.59997559,0.69995117,138.0,7.459961,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.0063477
73.81,male,0.0,COPD,12.0,under $11k,17738.891,black,no,0.5,0.3,no dnr,14.0,113.0,6.69921875,114.0,12.0,36.29688,228.5625,2.8999023,0.89990234,0.89990234,139.0,7.349609,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,5.5947266
38.36298,male,0.0,ARF/MOSF w/Sepsis,14.0,$25-$50k,15814.742,white,no,0.899999619,0.8499999,no dnr,9.0,116.0,15.7988281,82.0,26.0,36.5,176.65625,1.7998047,0.29998779,2.69970703,137.0,7.5,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
59.20099,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,121286.188,white,no,0.049999982,0.0001249999,dnr after sadm,1.0,63.0,12.0996094,122.0,36.0,35.79688,195.90625,2.8999023,0.89990234,2.5,124.0,7.489258,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.0175781
62.64999,male,1.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,25024.0,white,no,0.599999905,0.5,dnr after sadm,16.0,121.0,13.0996094,110.0,20.0,38.59375,215.53125,2.8999023,0.39996338,1.5,141.0,7.439453,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
70.46997,female,0.0,COPD,6.0,under $11k,5841.199,black,no,0.899999619,0.6999998,no dnr,7.0,83.0,11.3984375,80.0,18.0,37.0,273.3125,2.8999023,0.89990234,1.0,141.0,7.139648,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
64.01099,female,0.0,COPD,12.0,under $11k,2651.699,white,no,0.699999809,0.5,no dnr,4.0,63.0,4.5,80.0,22.0,36.19531,328.5625,3.3999023,0.79992676,0.89990234,145.0,7.359375,135.0,23.0,1968.0,4.0,6.0,no(M2 and SIP pres),6.0
23.07999,male,0.0,ARF/MOSF w/Sepsis,10.0,under $11k,12763.844,black,no,0.699999809,0.5,no dnr,6.0,106.0,7.0,72.0,32.0,39.0,205.6875,2.8999023,0.29998779,1.0,134.0,7.399414,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.5126953
75.58398,male,1.0,MOSF w/Malig,12.0,under $11k,91257.875,white,yes,0.699999809,0.5,dnr after sadm,17.0,123.0,0.09999084,124.0,37.0,38.5,410.0,2.8999023,5.0,4.79980469,145.0,7.479492,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
63.28,male,0.0,Lung Cancer,12.0,$11-$25k,3109.75,white,metastatic,0.699999809,0.5,no dnr,4.0,103.0,4.79980469,100.0,20.0,36.29688,224.0,2.8999023,0.29998779,1.0,139.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
50.47198,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,59530.938,white,no,0.799999714,0.7999997,no dnr,31.0,120.0,14.7988281,124.0,32.0,39.09375,226.65625,2.8999023,0.89990234,0.69995117,142.0,7.479492,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.425293
26.53499,female,1.0,MOSF w/Malig,17.0,under $11k,43313.031,white,yes,0.699999809,0.5,dnr after sadm,1.0,0.0,50.09375,0.0,0.0,38.89844,252.5,2.0996094,1.79980469,0.89990234,146.0,7.449219,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
67.88794,male,0.0,COPD,8.0,under $11k,34118.438,white,yes,0.199999928,0.1999999,no dnr,12.0,121.0,14.7988281,146.0,9.0,39.39844,150.0,2.5996094,0.39996338,0.59997559,134.0,7.299805,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
76.24896,male,1.0,COPD,12.0,under $11k,99316.812,black,no,0.799999714,0.7999997,no dnr,29.0,143.0,6.19921875,180.0,12.0,36.59375,285.6875,2.2998047,0.19998169,1.0,138.0,7.389648,135.0,23.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
60.28699,male,0.0,Lung Cancer,6.0,>$50k,6261.598,white,metastatic,0.799999714,0.5,no dnr,7.0,104.0,9.8984375,72.0,26.0,38.29688,224.0,3.0,0.29998779,1.39990234,135.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
49.26199,female,1.0,MOSF w/Malig,16.0,>$50k,178246.625,white,yes,0.699999809,0.5,dnr after sadm,23.0,131.0,1.09985352,138.0,29.0,39.89844,230.0,2.5996094,6.79980469,0.69995117,134.0,7.429688,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
62.26999,female,1.0,ARF/MOSF w/Sepsis,18.0,$11-$25k,89426.625,black,no,0.199999928,0.15,no dnr,30.0,59.0,11.2988281,124.0,45.0,39.09375,128.3125,2.699707,0.89990234,2.09960938,158.0,7.459961,135.0,23.0,1968.0,0.0,5.0,<2 mo. follow-up,5.0
62.004,female,0.0,Cirrhosis,12.0,under $11k,14802.898,white,no,0.699999809,0.5,no dnr,10.0,47.0,12.7988281,64.0,16.0,34.69531,110.20312,2.0996094,0.39996338,0.69995117,141.0,7.439453,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.0693359
48.32898,male,0.0,COPD,12.0,under $11k,3862.049,black,no,0.699999809,0.5,no dnr,3.0,81.0,4.69921875,80.0,28.0,36.79688,190.46875,3.199707,0.5,0.89990234,142.0,7.279297,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.4345703
70.23096,female,0.0,ARF/MOSF w/Sepsis,14.0,under $11k,61871.781,white,no,0.849999905,0.8499999,no dnr,27.0,63.0,14.1992188,72.0,24.0,36.69531,211.40625,2.8999023,0.89990234,1.5,136.0,7.419922,135.0,23.0,1968.0,1.0,1.0,<2 mo. follow-up,1.0
66.297,female,0.0,Colon Cancer,12.0,$11-$25k,5967.0,white,metastatic,0.799999714,0.5999999,no dnr,6.0,97.0,7.29980469,100.0,16.0,37.59375,224.0,4.0,0.29998779,0.69995117,141.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
69.62396,male,0.0,ARF/MOSF w/Sepsis,16.0,>$50k,38503.188,white,no,0.5,0.25,no dnr,15.0,67.0,12.5,110.0,14.0,38.59375,120.40625,2.8999023,0.89990234,2.19970703,144.0,7.509766,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
54.409,male,0.0,CHF,14.0,>$50k,4717.898,white,no,0.699999809,0.5,no dnr,3.0,78.0,6.5,84.0,18.0,36.79688,224.0,4.2998047,4.0,0.69995117,146.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
52.03598,female,0.0,Colon Cancer,21.0,under $11k,4229.547,white,metastatic,0.899999619,0.5,no dnr,5.0,105.0,5.09960938,120.0,20.0,39.0,224.0,2.8999023,0.5,0.59997559,142.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
63.33499,male,0.0,Colon Cancer,8.0,$25-$50k,5371.25,white,metastatic,0.899999619,0.5999999,no dnr,6.0,47.0,5.09960938,60.0,12.0,35.09375,224.0,2.8999023,0.5,0.89990234,140.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
20.605,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,152497.25,black,no,0.949999809,0.9499998,no dnr,90.0,77.0,6.19921875,40.0,8.0,36.19531,187.5,2.8999023,3.09960938,2.09960938,147.0,7.509766,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
62.52698,male,0.0,CHF,22.0,$25-$50k,2618.5,white,no,0.899999619,0.7999997,no dnr,7.0,79.0,4.69921875,70.0,18.0,36.0,224.0,2.8999023,0.89990234,1.29980469,141.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
53.81,male,0.0,CHF,7.0,under $11k,4520.699,black,no,0.699999809,0.5,no dnr,6.0,85.0,6.0,78.0,22.0,36.09375,368.0,2.8999023,1.5,1.0,133.0,7.459961,135.0,23.0,1968.0,4.0,1.0,<2 mo. follow-up,3.1831989
42.24799,male,0.0,CHF,13.0,$11-$25k,18666.984,black,no,0.799999714,0.5999999,no dnr,11.0,47.0,4.59960938,112.0,28.0,35.39844,224.0,2.8999023,1.5,1.0,134.0,7.489258,135.0,23.0,1968.0,5.0,0.0,<2 mo. follow-up,0.0
52.13998,female,0.0,ARF/MOSF w/Sepsis,14.0,under $11k,25024.0,white,yes,0.899999619,0.8499999,no dnr,19.0,163.0,5.5,118.0,38.0,37.79688,245.6875,2.8999023,0.19998169,5.29980469,140.0,7.479492,135.0,23.0,1968.0,0.0,6.0,no(M2 and SIP pres),6.0
69.08398,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,95429.812,black,no,0.5,0.5,no dnr,7.0,76.0,27.1992188,118.0,10.0,36.09375,363.3125,2.8999023,2.19970703,2.39990234,152.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5175781
63.35699,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,15985.195,black,no,0.699999809,0.5,no dnr,8.0,57.0,4.0,148.0,24.0,35.89844,352.375,2.8999023,1.89990234,2.69970703,132.0,7.439453,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.8442383
83.24194,female,0.0,CHF,12.0,under $11k,16066.695,black,no,0.699999809,0.5,no dnr,15.0,83.0,5.79980469,60.0,16.0,36.0,163.25,2.8999023,2.69970703,1.5,140.0,7.359375,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
57.28699,female,0.0,Lung Cancer,10.0,$11-$25k,23456.391,white,metastatic,0.799999714,0.5,no dnr,22.0,76.0,9.19921875,108.0,28.0,36.29688,319.0,2.8999023,0.69995117,0.69995117,143.0,7.399414,135.0,23.0,1968.0,6.0,1.0,<2 mo. follow-up,4.5273972
46.65799,female,0.0,ARF/MOSF w/Sepsis,9.0,under $11k,39171.875,black,no,0.899999619,0.8999996,no dnr,19.0,145.0,17.6992188,110.0,32.0,38.59375,376.1875,2.8999023,1.09985352,8.19921875,132.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
42.935,male,1.0,Coma,12.0,under $11k,21663.938,black,no,0.699999809,0.5,no dnr,7.0,78.0,17.0,54.0,12.0,38.0,323.3125,2.8999023,0.89990234,0.79992676,142.0,7.5,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.0869141
65.24597,male,0.0,MOSF w/Malig,12.0,under $11k,18175.234,white,metastatic,0.25,0.09999996,no dnr,9.0,103.0,14.8984375,64.0,12.0,36.5,116.0,2.8999023,0.59997559,0.69995117,136.0,7.489258,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.3769531
79.07495,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,25024.0,black,no,0.699999809,0.5,no dnr,9.0,97.0,21.6992188,75.0,28.0,37.19531,240.8125,3.2998047,0.59997559,9.0,140.0,7.399414,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.7412109
72.70398,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,108508.375,white,no,0.699999809,0.5,no dnr,77.0,81.0,14.7988281,110.0,32.0,38.0,140.0,1.8999023,0.29998779,2.89990234,128.0,7.25,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
44.90598,male,0.0,ARF/MOSF w/Sepsis,10.0,under $11k,38080.625,black,no,0.899999619,0.7799997,no dnr,17.0,121.0,14.7988281,116.0,35.0,36.79688,155.0,2.8999023,1.0,2.79980469,139.0,7.489258,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
50.75198,male,0.0,CHF,12.0,under $11k,61610.688,black,no,0.699999809,0.5,no dnr,40.0,55.0,8.3984375,138.0,40.0,39.0,330.0,2.7998047,1.5,1.5,129.0,7.489258,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
83.33997,male,0.0,CHF,16.0,under $11k,1314.449,black,yes,0.949999809,0.75,no dnr,3.0,93.0,5.79980469,80.0,20.0,36.39844,224.0,2.8999023,0.89990234,1.19995117,141.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
56.27399,female,1.0,COPD,12.0,under $11k,72193.188,black,no,0.199999928,0.15,dnr after sadm,19.0,110.0,10.0,148.0,8.0,36.29688,300.0,2.8999023,3.79980469,1.79980469,130.0,7.379883,135.0,23.0,1968.0,0.0,6.0,<2 mo. follow-up,6.0
72.56097,male,0.0,CHF,8.0,under $11k,8884.898,black,no,0.699999809,0.5,no dnr,11.0,103.0,4.69921875,82.0,24.0,37.0,223.3125,3.199707,0.89990234,2.0,136.0,7.389648,135.0,23.0,1968.0,0.0,0.0,SIP>=30,0.0
45.14398,male,0.0,ARF/MOSF w/Sepsis,7.0,under $11k,116927.5,black,no,0.849999905,0.7999997,no dnr,113.0,135.0,24.6992188,114.0,30.0,38.09375,188.5625,2.8999023,0.89990234,0.89990234,147.0,7.479492,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
65.65399,female,0.0,CHF,10.0,under $11k,25024.0,white,no,0.75,0.421875,no dnr,5.0,69.0,5.29980469,72.0,20.0,36.29688,328.5625,3.5996094,0.59997559,1.09985352,141.0,7.369141,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
28.66299,female,1.0,MOSF w/Malig,12.0,under $11k,44095.188,black,yes,0.0,0.0,dnr after sadm,7.0,67.0,0.39996338,144.0,32.0,38.89844,226.0,2.199707,2.39990234,1.69995117,143.0,7.399414,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.28125
69.85596,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,111948.75,black,no,0.25,0.15,no dnr,62.0,61.0,1.39990234,130.0,26.0,37.79688,144.28125,2.8999023,0.39996338,1.59985352,129.0,7.449219,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
64.56897,female,1.0,MOSF w/Malig,11.0,under $11k,65322.344,white,yes,0.149999976,0.09999996,dnr after sadm,6.0,129.0,11.2988281,118.0,37.0,37.79688,380.0,2.8999023,0.79992676,3.79980469,153.0,7.329102,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
69.39398,female,1.0,ARF/MOSF w/Sepsis,8.0,under $11k,25024.0,white,no,0.699999809,0.5,dnr after sadm,3.0,125.0,17.1992188,180.0,36.0,38.89844,420.0,2.8999023,0.89990234,0.5,133.0,7.519531,135.0,23.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
51.61398,female,0.0,Cirrhosis,12.0,under $11k,6321.5,white,no,0.899999619,0.5,no dnr,8.0,80.0,5.09960938,100.0,24.0,36.79688,523.75,2.8999023,20.0976562,0.79992676,133.0,7.619141,135.0,23.0,1968.0,5.0,5.0,adl>=4 (>=5 if sur),5.0
69.02899,male,0.0,MOSF w/Malig,10.0,under $11k,50995.469,white,yes,0.699999809,0.3999999,no dnr,18.0,70.0,0.19998169,104.0,42.0,36.09375,142.5,1.8999023,0.89990234,1.19995117,132.0,7.55957,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
77.99298,female,1.0,ARF/MOSF w/Sepsis,7.0,under $11k,97410.875,white,no,0.699999809,0.5,dnr after sadm,16.0,59.0,24.0976562,130.0,12.0,38.09375,70.0,2.5,0.89990234,3.29980469,132.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
28.465,female,0.0,ARF/MOSF w/Sepsis,16.0,$25-$50k,175319.625,white,no,0.199999928,0.1999999,no dnr,59.0,111.0,30.1992188,150.0,24.0,37.79688,112.71875,2.8999023,0.29998779,5.89941406,142.0,7.40918,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
54.409,female,0.0,Lung Cancer,12.0,under $11k,5722.949,black,metastatic,0.699999809,0.5,no dnr,6.0,117.0,8.09960938,62.0,18.0,36.89844,224.0,2.8999023,0.5,1.5,136.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.0019531
72.85095,female,0.0,COPD,12.0,under $11k,8237.742,white,no,0.989999771,0.9499998,no dnr,10.0,100.0,6.69921875,100.0,22.0,36.59375,285.6875,3.3999023,0.39996338,0.69995117,144.0,7.449219,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
62.439,female,0.0,Lung Cancer,12.0,under $11k,8158.945,black,metastatic,0.799999714,0.1999999,no dnr,7.0,76.0,8.0,100.0,24.0,36.29688,271.375,2.8999023,0.79992676,1.09985352,140.0,7.459961,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.6962891
50.41498,male,1.0,Lung Cancer,13.0,$25-$50k,7345.949,white,metastatic,0.199999928,0.009999998,dnr after sadm,7.0,77.0,6.5,120.0,24.0,36.0,224.0,3.0996094,0.59997559,1.0,138.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
42.56497,female,1.0,MOSF w/Malig,10.0,under $11k,20683.688,white,metastatic,0.149999976,0.15,dnr after sadm,2.0,120.0,29.0976562,160.0,31.0,38.69531,113.32812,3.699707,0.89990234,1.09985352,137.0,7.399414,135.0,23.0,1968.0,0.0,5.0,<2 mo. follow-up,5.0
69.93799,male,1.0,Coma,8.0,under $11k,26657.688,black,no,0.699999809,0.5,no dnr,10.0,69.0,19.5976562,130.0,22.0,40.0,147.5,2.8999023,0.5,3.69970703,146.0,7.449219,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
56.452,male,0.0,CHF,12.0,under $11k,5301.496,black,no,0.699999809,0.5,no dnr,9.0,75.0,9.3984375,72.0,20.0,36.29688,271.375,3.7998047,0.59997559,5.39941406,133.0,7.379883,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.793457
65.08997,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,361896.0,white,no,0.75,0.421875,dnr after sadm,3.0,120.0,29.1992188,118.0,36.0,35.79688,156.65625,2.8999023,4.5,5.39941406,134.0,7.359375,135.0,23.0,1968.0,0.0,6.0,no(M2 and SIP pres),6.0
42.02899,male,0.0,Lung Cancer,14.0,$11-$25k,5846.648,white,metastatic,0.849999905,0.5,no dnr,6.0,80.0,6.69921875,78.0,16.0,36.0,224.0,2.8999023,0.19998169,0.79992676,139.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
21.13599,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,31238.188,white,yes,0.199999928,0.1999999,no dnr,14.0,135.0,2.89990234,62.0,32.0,37.79688,384.0,2.8999023,2.59960938,0.59997559,136.0,7.479492,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
70.88599,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,68258.0,white,no,0.699999809,0.6999998,no dnr,35.0,55.0,11.3984375,56.0,10.0,35.5,134.0,1.1999512,0.5,1.29980469,142.0,7.449219,135.0,23.0,1968.0,0.0,5.0,SIP>=30,5.0
63.28799,female,1.0,ARF/MOSF w/Sepsis,10.0,under $11k,88884.0,white,no,0.099999964,0.0009999992,dnr after sadm,17.0,57.0,19.0,134.0,30.0,38.19531,88.0,2.8999023,0.89990234,4.5,133.0,7.389648,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
70.81494,female,1.0,Coma,2.0,under $11k,42977.75,black,no,0.199999928,0.09999996,dnr after sadm,15.0,55.0,19.0976562,64.0,8.0,36.59375,383.3125,2.8999023,0.89990234,2.39990234,150.0,7.429688,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
67.66895,male,1.0,Coma,4.0,under $11k,39055.375,white,no,0.099999964,0.0009999992,dnr after sadm,3.0,40.0,27.5976562,150.0,30.0,40.19531,228.0,2.8999023,3.09960938,9.79882812,131.0,7.30957,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
47.03897,male,0.0,Cirrhosis,7.0,under $11k,3280.449,white,no,0.899999619,0.7999997,no dnr,5.0,92.0,8.0,100.0,24.0,36.5,224.0,1.7998047,2.59960938,0.69995117,130.0,7.419922,135.0,23.0,1968.0,1.0,1.0,<2 mo. follow-up,1.1668997
77.18799,male,0.0,COPD,2.0,under $11k,25724.891,other,no,0.699999809,0.5,no dnr,15.0,70.0,7.69921875,142.0,8.0,38.09375,194.28125,3.2998047,1.09985352,1.19995117,144.0,7.399414,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.9472656
49.23798,female,0.0,Cirrhosis,8.0,$11-$25k,5958.297,white,no,0.899999619,0.7999997,no dnr,5.0,60.0,4.0,72.0,20.0,35.5,500.0,2.7998047,8.0,0.89990234,133.0,7.449219,135.0,23.0,1968.0,4.0,0.0,no(M2 and SIP pres),0.0
62.68597,male,0.0,Colon Cancer,16.0,$25-$50k,5468.949,white,metastatic,0.899999619,0.5,no dnr,6.0,107.0,5.59960938,120.0,24.0,35.59375,224.0,2.8999023,0.59997559,1.09985352,141.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
68.03296,male,0.0,COPD,12.0,under $11k,11001.445,black,no,0.799999714,0.7999997,no dnr,7.0,127.0,16.8984375,68.0,26.0,35.79688,284.0,2.8999023,0.39996338,1.19995117,141.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.2504883
89.76294,male,1.0,ARF/MOSF w/Sepsis,0.0,under $11k,63745.625,black,no,0.399999857,0.3999999,dnr after sadm,19.0,62.0,7.69921875,58.0,4.0,35.29688,438.0625,2.3999023,0.89990234,4.09960938,136.0,7.369141,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
54.30798,female,1.0,ARF/MOSF w/Sepsis,13.0,$25-$50k,22134.484,white,no,0.049999982,0.0001249999,dnr after sadm,3.0,68.0,18.5,122.0,8.0,38.09375,188.0,2.0996094,2.19970703,0.79992676,160.0,7.509766,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
48.586,male,0.0,ARF/MOSF w/Sepsis,6.0,$11-$25k,132172.5,white,no,0.399999857,0.3,no dnr,45.0,103.0,23.0976562,132.0,28.0,39.39844,192.5,2.8999023,2.69970703,1.19995117,149.0,7.439453,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
64.28198,male,0.0,CHF,8.0,$25-$50k,6832.246,white,no,0.899999619,0.7999997,no dnr,11.0,97.0,6.0,76.0,28.0,36.29688,495.1875,4.3994141,0.69995117,2.0,139.0,7.429688,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
65.40997,male,0.0,Lung Cancer,6.0,under $11k,5862.547,white,metastatic,0.899999619,0.7999997,no dnr,5.0,119.0,5.09960938,72.0,20.0,36.89844,224.0,3.3999023,0.59997559,0.89990234,141.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
68.159,male,1.0,CHF,12.0,under $11k,4788.25,white,no,0.699999809,0.5,no dnr,8.0,72.0,7.09960938,84.0,24.0,35.89844,224.0,2.8999023,0.89990234,1.79980469,133.0,7.419922,135.0,23.0,1968.0,2.0,1.0,<2 mo. follow-up,1.0
76.28198,male,0.0,Lung Cancer,12.0,under $11k,3523.699,black,metastatic,0.5,0.09999996,no dnr,8.0,107.0,7.59960938,68.0,16.0,35.19531,224.0,2.8999023,0.89990234,1.0,137.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.0517578
24.54999,male,1.0,MOSF w/Malig,12.0,under $11k,39816.438,white,yes,0.0,0.0,no dnr,6.0,130.0,0.09999084,150.0,55.0,37.89844,381.0,2.699707,0.5,1.09985352,137.0,7.369141,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.190918
68.40198,female,0.0,CHF,12.0,under $11k,85186.938,white,no,0.699999809,0.5,no dnr,36.0,93.0,6.59960938,80.0,20.0,36.39844,224.0,2.8999023,0.59997559,1.09985352,134.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
65.45898,male,0.0,Cirrhosis,12.0,under $11k,8641.648,white,no,0.199999928,0.09999996,no dnr,8.0,73.0,8.09960938,100.0,24.0,38.5,224.0,2.199707,10.2988281,3.19970703,126.0,7.419922,135.0,23.0,1968.0,4.0,1.0,<2 mo. follow-up,3.1831989
67.10699,female,0.0,Lung Cancer,9.0,under $11k,16886.344,white,metastatic,0.699999809,0.1999999,dnr after sadm,5.0,103.0,6.5,92.0,24.0,38.09375,137.5,2.8999023,0.89990234,0.59997559,129.0,7.539062,135.0,23.0,1968.0,5.0,1.0,adl>=4 (>=5 if sur),1.0
56.08798,male,0.0,Cirrhosis,9.0,$25-$50k,3525.949,white,no,0.699999809,0.5,no dnr,7.0,83.0,3.19970703,80.0,20.0,36.5,224.0,3.0,3.5,0.89990234,134.0,7.419922,135.0,23.0,1968.0,1.0,0.0,no(M2 and SIP pres),0.0
32.73898,male,0.0,ARF/MOSF w/Sepsis,16.0,>$50k,164466.375,white,no,0.25,0.25,no dnr,45.0,49.0,15.7988281,148.0,15.0,39.29688,113.32812,2.8999023,3.79980469,1.19995117,132.0,7.459961,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
69.09796,male,1.0,COPD,11.0,$11-$25k,109626.688,white,no,0.099999964,0.0009999992,no dnr,16.0,43.0,25.5,175.0,23.0,38.39844,160.84375,2.8999023,0.89990234,1.19995117,141.0,7.399414,135.0,23.0,1968.0,0.0,6.0,<2 mo. follow-up,6.0
65.27594,female,0.0,Colon Cancer,14.0,$25-$50k,6469.598,white,metastatic,1.0,1.0,no dnr,7.0,100.0,6.09960938,76.0,16.0,36.0,224.0,3.2998047,0.39996338,0.69995117,142.0,7.419922,135.0,23.0,1968.0,1.0,1.0,no(M2 and SIP pres),1.1668997
67.77295,male,0.0,COPD,12.0,$11-$25k,3056.35,white,no,0.799999714,0.7999997,no dnr,5.0,73.0,18.5,100.0,16.0,35.69531,340.0,2.8999023,0.89990234,1.09985352,139.0,7.329102,135.0,23.0,1968.0,3.0,0.0,no(M2 and SIP pres),0.0
77.80194,male,0.0,Lung Cancer,9.0,under $11k,2793.549,white,metastatic,0.25,0.04999998,dnr after sadm,1.0,110.0,10.5996094,84.0,20.0,36.09375,224.0,1.0,0.89990234,1.19995117,140.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
35.84399,female,0.0,Coma,17.0,>$50k,82952.688,white,no,0.599999905,0.5999999,no dnr,48.0,75.0,18.3984375,130.0,7.0,38.0,396.0,2.8999023,0.5,0.89990234,137.0,7.479492,135.0,23.0,1968.0,0.0,0.0,SIP>=30,0.0
77.93799,male,1.0,CHF,11.0,$25-$50k,6770.699,white,no,0.199999928,0.1999999,dnr after sadm,6.0,73.0,4.79980469,156.0,28.0,35.89844,224.0,3.2998047,1.59985352,1.79980469,145.0,7.419922,135.0,23.0,1968.0,0.0,7.0,<2 mo. follow-up,7.0
56.51199,male,0.0,Colon Cancer,12.0,$25-$50k,11222.547,white,metastatic,0.899999619,0.5,no dnr,13.0,89.0,8.79882812,98.0,20.0,35.19531,224.0,3.199707,0.59997559,3.19970703,138.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
66.91595,male,0.0,Lung Cancer,16.0,$25-$50k,5290.047,white,metastatic,0.899999619,0.6999998,no dnr,5.0,80.0,7.79980469,76.0,20.0,36.69531,224.0,3.7998047,0.29998779,1.19995117,143.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
58.94299,female,0.0,CHF,10.0,under $11k,6483.449,white,no,0.799999714,0.5999999,no dnr,6.0,65.0,9.8984375,80.0,20.0,36.29688,323.75,2.8999023,0.89990234,1.19995117,140.0,7.439453,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
68.16394,male,1.0,Lung Cancer,12.0,under $11k,6288.598,black,metastatic,0.299999952,0.09999996,no dnr,3.0,157.0,4.29980469,20.0,48.0,35.79688,308.5625,2.8999023,0.29998779,0.79992676,137.0,7.469727,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.4746094
63.41998,female,0.0,CHF,10.0,under $11k,17999.094,black,no,0.699999809,0.5,no dnr,11.0,70.0,4.09960938,44.0,22.0,36.09375,264.0,2.8999023,0.5,1.89990234,137.0,7.549805,135.0,23.0,1968.0,3.0,4.0,no(M2 and SIP pres),4.0
81.31696,male,0.0,CHF,8.0,under $11k,4875.238,black,no,0.75,0.5,no dnr,8.0,63.0,3.39990234,66.0,16.0,36.09375,224.0,3.2998047,0.19998169,4.79980469,147.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
69.17694,male,1.0,COPD,15.0,>$50k,398248.0,white,no,0.799999714,0.75,dnr after sadm,126.0,63.0,13.6992188,110.0,32.0,36.59375,97.0,2.8999023,0.69995117,1.29980469,129.0,7.25,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
64.99695,male,0.0,CHF,10.0,$11-$25k,7358.797,white,no,0.699999809,0.5,no dnr,7.0,100.0,6.09960938,78.0,20.0,36.39844,224.0,2.8999023,0.89990234,1.5,144.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
25.62099,female,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,434315.75,black,no,0.099999964,0.0009999992,no dnr,30.0,139.0,16.0,138.0,28.0,36.29688,91.65625,2.699707,7.79980469,1.0,150.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
42.20398,male,0.0,Cirrhosis,16.0,>$50k,8795.25,white,no,0.799999714,0.5999999,no dnr,10.0,97.0,5.39941406,72.0,28.0,38.59375,224.0,2.2998047,5.89941406,0.79992676,120.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
52.375,female,0.0,ARF/MOSF w/Sepsis,13.0,under $11k,20454.188,black,no,0.799999714,0.7999997,no dnr,15.0,101.0,16.796875,80.0,24.0,38.09375,270.0,1.8999023,2.69970703,0.69995117,138.0,7.40918,135.0,23.0,1968.0,4.0,4.0,no(M2 and SIP pres),4.0
57.86398,male,0.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,96380.75,white,no,0.5,0.3999999,no dnr,38.0,75.0,14.1992188,62.0,42.0,36.39844,96.65625,1.1999512,0.19998169,0.79992676,146.0,7.459961,135.0,23.0,1968.0,0.0,1.0,SIP>=30,1.0
55.086,male,0.0,Lung Cancer,16.0,>$50k,5840.5,white,metastatic,0.899999619,0.5999999,no dnr,8.0,80.0,2.29980469,78.0,20.0,37.69531,224.0,3.199707,1.0,0.89990234,140.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
68.22699,female,0.0,ARF/MOSF w/Sepsis,11.0,under $11k,112743.062,white,no,0.799999714,0.7999997,no dnr,32.0,134.0,10.1992188,110.0,40.0,38.09375,183.3125,4.0996094,0.79992676,0.69995117,145.0,7.479492,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
71.61694,male,0.0,ARF/MOSF w/Sepsis,16.0,under $11k,153677.0,white,no,0.899999619,0.5999999,no dnr,52.0,110.0,35.3984375,130.0,7.0,36.39844,306.625,2.8999023,0.89990234,1.89990234,139.0,7.349609,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),2.6728516
54.44199,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,19789.594,white,metastatic,0.5,0.15,dnr after sadm,4.0,126.0,26.6992188,176.0,44.0,38.09375,124.0,2.8999023,5.39941406,0.69995117,126.0,7.519531,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.6069336
68.59399,female,1.0,CHF,6.0,under $11k,58190.719,black,no,0.5,0.25,dnr after sadm,17.0,61.0,19.796875,108.0,27.0,35.59375,404.0,2.8999023,0.89990234,1.89990234,124.0,7.5,135.0,23.0,1968.0,1.0,0.0,<2 mo. follow-up,0.0
69.72998,female,0.0,CHF,6.0,under $11k,3366.648,white,no,0.899999619,0.7999997,no dnr,5.0,69.0,5.69921875,66.0,16.0,36.89844,224.0,2.699707,3.39990234,0.79992676,127.0,7.419922,135.0,23.0,1968.0,1.0,0.0,SIP>=30,0.0
41.40698,male,0.0,Coma,16.0,$25-$50k,154288.875,black,no,0.5,0.5,no dnr,44.0,65.0,15.8984375,180.0,20.0,38.29688,133.3125,2.5996094,5.59960938,4.5,151.0,7.439453,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
63.87097,female,0.0,ARF/MOSF w/Sepsis,16.0,$11-$25k,48938.531,white,no,0.699999809,0.5,no dnr,23.0,107.0,9.09960938,162.0,28.0,35.0,309.5,2.8999023,13.1992188,5.19921875,138.0,7.40918,135.0,23.0,1968.0,0.0,4.0,no(M2 and SIP pres),4.0
46.72998,male,0.0,Colon Cancer,12.0,$25-$50k,6932.848,white,metastatic,0.899999619,0.3,no dnr,6.0,107.0,7.5,96.0,20.0,37.29688,224.0,2.8999023,0.89990234,1.09985352,134.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
45.36899,female,0.0,Lung Cancer,12.0,$25-$50k,6296.898,white,metastatic,0.699999809,0.5,no dnr,9.0,70.0,10.5996094,110.0,24.0,38.09375,224.0,2.199707,0.39996338,1.0,136.0,7.419922,135.0,23.0,1968.0,3.0,1.0,<2 mo. follow-up,2.5110989
61.42398,male,1.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,85084.125,white,no,0.199999928,0.09999996,dnr after sadm,6.0,61.0,10.0,126.0,32.0,38.79688,127.14062,2.8999023,1.59985352,1.19995117,131.0,7.359375,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
51.56699,male,1.0,Coma,12.0,under $11k,22312.328,white,yes,0.699999809,0.5,dnr after sadm,3.0,119.0,18.1992188,132.0,12.0,39.29688,228.0,3.0,0.5,0.89990234,138.0,7.40918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.3178711
43.625,female,0.0,ARF/MOSF w/Sepsis,13.0,$25-$50k,401867.0,white,no,0.899999619,0.8999996,no dnr,134.0,135.0,21.3984375,130.0,26.0,37.59375,250.0,2.8999023,0.79992676,9.0,143.0,7.449219,135.0,23.0,1968.0,7.0,6.0,adl>=4 (>=5 if sur),6.0
38.67999,male,1.0,Coma,12.0,under $11k,71634.188,white,no,0.099999964,0.0009999992,dnr after sadm,8.0,136.0,25.0,108.0,8.0,36.0,330.0,1.8999023,0.89990234,8.0,145.0,7.449219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.7885742
66.84497,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,77906.438,white,yes,0.099999964,0.0009999992,dnr after sadm,5.0,105.0,24.6992188,118.0,25.0,36.5,370.0,3.0,8.19921875,2.79980469,129.0,7.479492,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.1875
58.56497,male,0.0,ARF/MOSF w/Sepsis,9.0,under $11k,18640.047,black,no,0.799999714,0.5999999,no dnr,14.0,78.0,24.8984375,62.0,10.0,35.09375,217.125,2.8999023,1.39990234,2.29980469,134.0,7.389648,135.0,23.0,1968.0,2.0,1.0,<2 mo. follow-up,1.8389997
59.42798,female,0.0,ARF/MOSF w/Sepsis,9.0,$11-$25k,284272.0,white,no,0.599999905,0.5,no dnr,88.0,59.0,24.1992188,122.0,40.0,38.59375,263.3125,2.8999023,1.39990234,1.19995117,145.0,7.349609,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),1.0
35.62198,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,200353.75,white,no,0.099999964,0.0009999992,no dnr,67.0,131.0,14.5996094,108.0,12.0,39.19531,240.0,2.8999023,12.0996094,0.89990234,156.0,7.5,135.0,23.0,1968.0,0.0,4.0,adl>=4 (>=5 if sur),4.0
66.94299,male,0.0,Lung Cancer,12.0,under $11k,25465.234,white,metastatic,0.799999714,0.5,no dnr,24.0,85.0,6.19921875,116.0,24.0,35.69531,224.0,2.8999023,0.59997559,1.19995117,141.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
54.995,male,0.0,CHF,13.0,$25-$50k,22609.641,white,no,0.699999809,0.1999999,no dnr,19.0,57.0,8.3984375,65.0,16.0,35.29688,224.0,2.8999023,0.89990234,2.0,136.0,7.419922,135.0,23.0,1968.0,1.0,1.0,<2 mo. follow-up,1.0
60.51199,female,0.0,Lung Cancer,12.0,$11-$25k,5159.949,white,metastatic,1.0,0.7999997,no dnr,5.0,73.0,6.69921875,110.0,16.0,36.89844,224.0,2.8999023,0.39996338,0.59997559,137.0,7.419922,135.0,23.0,1968.0,1.0,4.0,no(M2 and SIP pres),4.0
57.84299,female,0.0,Cirrhosis,12.0,$25-$50k,23635.938,white,no,0.699999809,0.5,no dnr,23.0,77.0,12.5,80.0,18.0,36.19531,442.8125,2.5996094,4.79980469,4.09960938,138.0,7.379883,135.0,23.0,1968.0,2.0,0.0,<2 mo. follow-up,0.0
41.42899,male,0.0,ARF/MOSF w/Sepsis,11.0,$11-$25k,12460.844,black,no,0.899999619,0.8999996,no dnr,6.0,107.0,5.69921875,108.0,22.0,37.69531,390.4375,3.3999023,0.89990234,12.3984375,144.0,7.319336,135.0,23.0,1968.0,2.0,0.0,no(M2 and SIP pres),0.0
60.06,male,1.0,ARF/MOSF w/Sepsis,9.0,$25-$50k,29518.891,white,no,0.049999982,0.0001249999,dnr after sadm,4.0,61.0,31.5,126.0,30.0,38.0,137.75,2.8999023,19.5,4.59960938,145.0,7.539062,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
73.19397,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,60910.531,white,no,0.399999857,0.5999999,no dnr,25.0,80.0,13.6992188,114.0,24.0,36.0,200.0,2.8999023,0.89990234,1.29980469,136.0,7.459961,135.0,23.0,1968.0,0.0,0.0,SIP>=30,0.0
53.63998,male,1.0,Lung Cancer,14.0,$25-$50k,6536.648,black,metastatic,0.5,0.3,dnr after sadm,8.0,83.0,10.7988281,120.0,28.0,36.29688,280.9375,2.7998047,0.69995117,1.0,132.0,7.389648,135.0,23.0,1968.0,3.0,1.0,<2 mo. follow-up,2.5110989
74.68298,female,1.0,Coma,6.0,under $11k,11897.195,black,metastatic,0.699999809,0.5,dnr after sadm,2.0,131.0,18.1992188,116.0,36.0,36.0,304.0,2.8999023,23.5976562,2.09960938,125.0,7.40918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
73.862,female,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,37997.719,white,no,0.799999714,0.5999999,no dnr,14.0,123.0,9.79882812,82.0,20.0,36.09375,176.65625,2.8999023,0.89990234,1.0,136.0,7.479492,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
72.12299,male,1.0,Coma,12.0,under $11k,70576.5,black,no,0.099999964,0.0009999992,dnr after sadm,11.0,109.0,15.3984375,82.0,75.0,39.09375,185.0,2.199707,0.69995117,1.79980469,145.0,7.449219,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
58.52197,male,0.0,CHF,12.0,$25-$50k,21888.344,white,no,0.699999809,0.5,no dnr,12.0,67.0,8.29882812,118.0,26.0,36.19531,224.0,2.8999023,0.69995117,1.39990234,135.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
60.84598,male,0.0,Cirrhosis,16.0,>$50k,14564.594,white,no,0.989999771,0.9702988,no dnr,18.0,80.0,6.89941406,106.0,24.0,39.09375,347.5625,1.8999023,3.89990234,0.79992676,127.0,7.479492,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
59.85498,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,53360.844,black,no,1.0,0.9499998,no dnr,36.0,101.0,20.296875,110.0,12.0,36.19531,322.1875,2.5,0.89990234,1.69995117,146.0,7.429688,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),3.0253906
67.047,female,0.0,ARF/MOSF w/Sepsis,13.0,$11-$25k,21429.297,white,no,0.799999714,0.6999998,no dnr,17.0,118.0,11.6992188,84.0,24.0,36.19531,215.0,2.8999023,0.89990234,0.5,127.0,7.459961,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
45.21799,male,0.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,97645.375,white,no,0.75,0.5999999,no dnr,35.0,65.0,12.7988281,108.0,10.0,39.19531,224.0,2.8999023,0.89990234,0.89990234,133.0,7.369141,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
69.75494,male,1.0,COPD,12.0,$11-$25k,28524.625,white,no,0.699999809,0.5,dnr after sadm,9.0,103.0,20.6992188,156.0,26.0,35.0,128.5625,2.8999023,0.89990234,1.29980469,137.0,7.539062,135.0,23.0,1968.0,0.0,3.0,<2 mo. follow-up,3.0
58.08398,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,26848.094,white,no,0.699999809,0.5,no dnr,5.0,99.0,8.19921875,130.0,40.0,37.59375,142.84375,2.8999023,26.8984375,1.59985352,134.0,7.299805,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.3183594
68.30896,male,0.0,Lung Cancer,11.0,$11-$25k,19022.094,black,metastatic,0.799999714,0.5,no dnr,15.0,81.0,4.39941406,80.0,24.0,36.5,224.0,3.2998047,0.5,1.09985352,140.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
49.56299,male,0.0,Lung Cancer,12.0,$11-$25k,20963.141,white,metastatic,0.599999905,0.5,no dnr,26.0,75.0,10.1992188,100.0,24.0,35.29688,224.0,2.8999023,0.89990234,0.89990234,129.0,7.419922,135.0,23.0,1968.0,2.0,0.0,adl>=4 (>=5 if sur),0.0
45.89499,female,1.0,ARF/MOSF w/Sepsis,8.0,$11-$25k,105779.312,white,no,0.699999809,0.5,no dnr,14.0,153.0,6.59960938,102.0,14.0,40.0,297.125,2.8999023,0.89990234,0.69995117,142.0,7.399414,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
57.51099,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,74188.188,black,no,0.049999982,0.0001249999,dnr after sadm,15.0,63.0,21.1992188,80.0,11.0,36.69531,216.0,2.8999023,15.8984375,2.19970703,122.0,7.40918,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
76.03595,male,0.0,ARF/MOSF w/Sepsis,16.0,$11-$25k,194034.0,white,yes,0.899999619,0.8999996,no dnr,68.0,55.0,10.3984375,126.0,28.0,38.5,272.0,3.0,1.19995117,3.0,149.0,7.469727,135.0,23.0,1968.0,0.0,6.0,adl>=4 (>=5 if sur),6.0
72.86798,female,0.0,COPD,10.0,under $11k,70304.062,white,yes,0.899999619,0.8999996,no dnr,31.0,131.0,14.7988281,144.0,28.0,38.5,270.0,2.5,0.89990234,0.69995117,132.0,7.439453,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
46.15198,female,1.0,ARF/MOSF w/Sepsis,15.0,>$50k,68531.375,white,no,0.199999928,0.04999998,dnr after sadm,21.0,117.0,15.5996094,74.0,22.0,36.09375,386.625,2.8999023,0.89990234,7.89941406,132.0,7.369141,135.0,23.0,1968.0,0.0,6.0,<2 mo. follow-up,6.0
72.94196,male,1.0,COPD,12.0,$25-$50k,224667.25,white,yes,0.599999905,0.5999999,dnr after sadm,60.0,127.0,19.5976562,130.0,34.0,37.69531,260.0,2.5,0.89990234,0.79992676,148.0,7.429688,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
56.01398,male,0.0,CHF,8.0,$11-$25k,4446.297,white,no,0.699999809,0.5,no dnr,4.0,60.0,5.69921875,124.0,24.0,36.09375,224.0,2.8999023,0.5,1.19995117,142.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
47.36798,male,1.0,Cirrhosis,10.0,under $11k,32115.641,white,no,0.199999928,0.09999996,dnr after sadm,12.0,109.0,10.7988281,114.0,12.0,37.79688,433.3125,2.0,31.0976562,1.59985352,131.0,7.5,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
60.39697,male,0.0,CHF,8.0,under $11k,27399.438,black,no,0.599999905,0.3999999,dnr after sadm,17.0,61.0,5.0,118.0,25.0,35.59375,224.0,2.8999023,0.89990234,4.09960938,130.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.0913086
66.35199,female,0.0,COPD,12.0,under $11k,26706.297,white,no,0.899999619,0.6999998,no dnr,16.0,115.0,27.3984375,114.0,26.0,38.0,210.0,2.8999023,0.39996338,0.79992676,140.0,7.399414,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
46.133,male,0.0,CHF,12.0,$11-$25k,135704.5,white,no,0.899999619,0.5999999,no dnr,65.0,63.0,10.2988281,106.0,24.0,36.59375,252.0,2.8999023,0.69995117,1.29980469,149.0,7.449219,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
61.33298,male,0.0,CHF,12.0,$25-$50k,22090.984,white,yes,0.5,0.3,no dnr,15.0,53.0,6.59960938,112.0,36.0,35.29688,210.0,2.8999023,0.89990234,2.09960938,125.0,7.489258,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
67.50195,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,25024.0,white,no,0.5,0.3999999,no dnr,95.0,44.0,14.2988281,168.0,27.0,39.0,116.25,2.8999023,0.89990234,2.09960938,142.0,7.319336,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.9936523
60.03799,male,0.0,ARF/MOSF w/Sepsis,6.0,$11-$25k,62400.594,white,no,0.899999619,0.8499999,no dnr,21.0,50.0,5.89941406,140.0,31.0,40.29688,116.3125,2.8999023,0.89990234,1.39990234,128.0,7.419922,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
30.92999,female,0.0,ARF/MOSF w/Sepsis,18.0,$11-$25k,17066.641,black,no,0.799999714,0.6999998,no dnr,9.0,117.0,17.5,100.0,20.0,37.39844,495.1875,2.8999023,0.89990234,7.19921875,136.0,7.419922,135.0,23.0,1968.0,4.0,0.0,no(M2 and SIP pres),0.0
68.53699,male,0.0,CHF,6.0,under $11k,11333.148,white,no,0.699999809,0.5,no dnr,9.0,65.0,10.2988281,70.0,28.0,38.39844,224.0,2.8999023,0.89990234,1.19995117,135.0,7.419922,135.0,23.0,1968.0,1.0,0.0,<2 mo. follow-up,0.0
62.853,male,0.0,Coma,16.0,>$50k,67972.5,white,no,0.099999964,0.0009999992,dnr after sadm,16.0,130.0,14.5,116.0,8.0,37.79688,356.625,2.5,0.5,4.29980469,137.0,7.369141,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),2.3671875
84.79895,male,1.0,Coma,16.0,under $11k,14790.844,black,no,0.199999928,0.09999996,no dnr,6.0,140.0,13.2988281,124.0,9.0,36.0,280.9375,2.699707,1.0,1.19995117,141.0,7.359375,135.0,23.0,1968.0,0.0,7.0,<2 mo. follow-up,7.0
75.71295,male,0.0,Colon Cancer,12.0,>$50k,21044.891,black,metastatic,0.799999714,0.7999997,no dnr,14.0,127.0,7.59960938,116.0,8.0,34.0,393.3125,2.2998047,3.39990234,2.59960938,136.0,7.319336,135.0,23.0,1968.0,1.0,2.0,no(M2 and SIP pres),2.0
60.55298,male,0.0,ARF/MOSF w/Sepsis,7.0,$11-$25k,139645.375,white,no,0.699999809,0.5,no dnr,38.0,56.0,21.8984375,150.0,38.0,40.19531,240.0,2.0,0.89990234,2.69970703,151.0,7.40918,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
62.87198,female,0.0,Colon Cancer,13.0,$11-$25k,5380.949,white,metastatic,0.799999714,0.09999996,no dnr,5.0,100.0,13.0996094,84.0,20.0,36.89844,224.0,2.7998047,0.39996338,0.89990234,135.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
43.73199,female,0.0,Cirrhosis,13.0,under $11k,23367.25,white,no,0.599999905,0.5,no dnr,10.0,121.0,5.69921875,76.0,26.0,36.39844,376.625,2.0,2.39990234,0.79992676,140.0,7.439453,135.0,23.0,1968.0,0.0,1.0,SIP>=30,1.0
72.64899,female,1.0,Coma,7.0,under $11k,18816.297,black,no,0.009999998,9.999994e-07,dnr after sadm,4.0,80.0,22.1992188,126.0,32.0,38.09375,285.0,2.3999023,0.39996338,1.59985352,134.0,7.40918,135.0,23.0,1968.0,0.0,6.0,<2 mo. follow-up,6.0
44.50897,male,0.0,Colon Cancer,13.0,$11-$25k,7222.297,black,metastatic,0.899999619,0.6999998,no dnr,7.0,103.0,6.29980469,64.0,16.0,37.29688,224.0,2.8999023,0.39996338,1.09985352,135.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
49.11398,female,1.0,Coma,16.0,under $11k,13132.547,white,no,0.0,0.0,dnr after sadm,3.0,193.0,16.6992188,68.0,16.0,38.5,296.625,2.8999023,0.39996338,3.39990234,148.0,7.639648,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
61.33099,male,0.0,Lung Cancer,10.0,$11-$25k,14604.5,white,metastatic,0.799999714,0.5999999,no dnr,18.0,93.0,9.5,124.0,28.0,36.79688,224.0,3.3999023,0.29998779,0.69995117,140.0,7.419922,135.0,23.0,1968.0,2.0,2.0,adl>=4 (>=5 if sur),2.0
75.33698,male,1.0,ARF/MOSF w/Sepsis,6.0,$11-$25k,25024.0,white,yes,0.299999952,0.1999999,dnr after sadm,8.0,57.0,10.0,118.0,14.0,35.79688,140.0,2.8999023,0.19998169,2.29980469,139.0,7.469727,135.0,23.0,1968.0,0.0,7.0,<2 mo. follow-up,7.0
63.87097,male,0.0,Colon Cancer,12.0,under $11k,5620.898,black,metastatic,0.099999964,0.0009999992,no dnr,6.0,82.0,15.6992188,60.0,20.0,35.79688,224.0,2.8999023,0.39996338,1.0,143.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.7595215
46.146,female,0.0,Coma,12.0,under $11k,110333.188,other,no,0.5,0.3999999,dnr after sadm,12.0,114.0,22.6992188,130.0,33.0,37.79688,226.65625,2.699707,1.59985352,1.29980469,143.0,7.479492,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
62.642,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,134189.125,white,no,0.5,0.5,dnr after sadm,16.0,73.0,7.0,72.0,32.0,35.69531,266.625,2.8999023,0.89990234,2.19970703,126.0,7.539062,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.3432617
60.71198,male,0.0,COPD,11.0,under $11k,18054.734,white,no,0.5,0.3999999,dnr after sadm,2.0,59.0,17.0976562,128.0,29.0,35.59375,186.65625,2.8999023,0.89990234,0.79992676,136.0,7.379883,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
48.41599,male,0.0,Lung Cancer,12.0,$11-$25k,6101.648,white,metastatic,0.799999714,0.1999999,no dnr,5.0,113.0,14.2988281,116.0,24.0,36.59375,224.0,3.8999023,0.29998779,0.89990234,141.0,7.419922,135.0,23.0,1968.0,1.0,1.0,no(M2 and SIP pres),1.0
79.33997,female,1.0,Coma,14.0,$11-$25k,16749.594,white,no,0.199999928,0.15,dnr after sadm,5.0,110.0,15.6992188,122.0,8.0,38.09375,340.0,2.8999023,0.89990234,1.19995117,140.0,7.479492,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
80.10095,male,1.0,Coma,7.0,under $11k,29686.375,white,no,0.099999964,0.0009999992,dnr after sadm,2.0,103.0,16.796875,60.0,32.0,36.39844,283.3125,2.8999023,0.89990234,2.19970703,138.0,7.429688,135.0,23.0,1968.0,0.0,7.0,<2 mo. follow-up,7.0
83.02496,female,1.0,ARF/MOSF w/Sepsis,7.0,under $11k,22340.797,black,no,0.25,0.1999999,dnr after sadm,14.0,83.0,13.6992188,76.0,22.0,36.29688,300.0,2.8999023,1.09985352,1.69995117,148.0,7.369141,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
51.89899,male,0.0,ARF/MOSF w/Sepsis,12.0,>$50k,20532.094,white,no,0.989999771,0.9799995,no dnr,10.0,99.0,15.6992188,112.0,28.0,38.19531,180.0,2.8999023,0.89990234,1.39990234,130.0,7.489258,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
33.54999,female,0.0,Colon Cancer,14.0,$25-$50k,7093.848,white,metastatic,0.899999619,0.6999998,no dnr,6.0,73.0,15.1992188,140.0,22.0,39.59375,224.0,2.8999023,0.89990234,0.59997559,135.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
21.043,female,1.0,Coma,15.0,$25-$50k,15271.648,white,no,0.849999905,0.8399997,no dnr,4.0,46.0,12.2988281,134.0,10.0,32.5,112.5,3.5996094,0.79992676,0.79992676,175.0,7.599609,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
46.09998,male,0.0,CHF,11.0,under $11k,2824.148,black,no,0.949999809,0.5999999,no dnr,4.0,97.0,6.39941406,72.0,24.0,36.5,224.0,2.8999023,1.39990234,1.09985352,141.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
50.09998,male,0.0,Cirrhosis,4.0,$25-$50k,2701.25,white,no,0.699999809,0.5,no dnr,3.0,81.0,5.0,86.0,18.0,36.59375,224.0,3.5996094,3.19970703,1.29980469,130.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
66.87695,male,0.0,CHF,5.0,$11-$25k,24346.391,black,no,0.849999905,0.7999997,no dnr,16.0,70.0,13.0996094,120.0,22.0,36.5,224.0,2.8999023,0.89990234,1.59985352,135.0,7.419922,135.0,23.0,1968.0,0.0,0.0,SIP>=30,0.0
58.55399,male,1.0,Lung Cancer,11.0,$25-$50k,4597.379,white,metastatic,0.5,0.3,dnr after sadm,2.0,73.0,0.39996338,114.0,40.0,38.39844,252.375,2.199707,2.19970703,0.89990234,160.0,7.489258,135.0,23.0,1968.0,0.0,7.0,<2 mo. follow-up,7.0
32.77499,female,0.0,ARF/MOSF w/Sepsis,16.0,under $11k,72100.438,black,no,0.25,0.15,no dnr,41.0,147.0,22.3984375,108.0,8.0,38.5,388.0,2.8999023,2.09960938,1.69995117,148.0,7.369141,135.0,23.0,1968.0,0.0,5.0,SIP>=30,5.0
79.82196,male,0.0,CHF,5.0,under $11k,26503.984,black,no,0.699999809,0.3999999,dnr after sadm,10.0,71.0,18.0,108.0,24.0,36.39844,280.9375,2.8999023,1.09985352,1.39990234,129.0,7.529297,135.0,23.0,1968.0,3.0,1.0,no(M2 and SIP pres),2.5110989
66.97595,male,0.0,ARF/MOSF w/Sepsis,11.0,$11-$25k,17114.547,white,no,0.699999809,0.5,no dnr,7.0,129.0,11.0996094,100.0,20.0,37.69531,120.40625,2.8999023,0.89990234,5.19921875,128.0,7.459961,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
78.69397,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,17514.391,black,yes,0.0,0.0,no dnr,3.0,27.0,9.69921875,26.0,24.0,35.5,41.0,1.5998535,1.09985352,4.79980469,164.0,7.149414,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.6669922
61.58499,female,0.0,Cirrhosis,12.0,$25-$50k,21559.438,white,no,0.5,0.5,no dnr,12.0,109.0,9.3984375,68.0,25.0,38.29688,336.625,3.3999023,13.7988281,0.79992676,142.0,7.429688,135.0,23.0,1968.0,1.0,0.0,no(M2 and SIP pres),0.0
41.336,female,0.0,ARF/MOSF w/Sepsis,16.0,$25-$50k,14625.898,white,no,0.899999619,0.8999996,no dnr,11.0,77.0,11.5,110.0,31.0,36.19531,216.65625,2.0,0.5,0.69995117,139.0,7.439453,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
80.69299,female,1.0,Coma,8.0,under $11k,19765.344,black,no,0.099999964,0.0009999992,dnr after sadm,2.0,117.0,16.0,120.0,30.0,38.79688,342.8125,2.8999023,0.89990234,0.59997559,131.0,7.509766,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
55.66299,male,0.0,CHF,0.0,under $11k,4980.25,black,no,0.899999619,0.75,no dnr,4.0,90.0,10.5996094,68.0,22.0,36.89844,224.0,3.3999023,0.79992676,1.5,139.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
34.53,female,0.0,CHF,14.0,under $11k,6055.898,black,yes,1.0,0.5,no dnr,4.0,71.0,12.5,96.0,20.0,36.29688,224.0,2.8999023,1.39990234,0.79992676,141.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
62.30499,male,1.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,49924.438,white,yes,0.5,0.3999999,dnr after sadm,11.0,113.0,12.2988281,106.0,28.0,38.5,117.5,2.8999023,1.39990234,0.89990234,130.0,7.449219,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
78.58496,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,14208.648,white,yes,0.699999809,0.5,dnr after sadm,2.0,0.0,80.09375,0.0,0.0,38.19531,53.32812,1.6999512,2.5,7.39941406,142.0,7.15918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.5786133
73.56299,male,0.0,MOSF w/Malig,12.0,under $11k,54476.031,white,yes,0.199999928,0.04999998,dnr after sadm,16.0,47.0,0.09999084,190.0,32.0,36.09375,304.0,2.2998047,0.29998779,3.09960938,143.0,7.40918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.237793
57.793,female,1.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,25024.0,white,no,0.099999964,0.0009999992,no dnr,3.0,23.0,6.69921875,0.0,24.0,36.0,65.0,2.7998047,5.5,6.0,164.0,7.129883,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
41.16098,female,0.0,Colon Cancer,12.0,under $11k,4960.0,white,metastatic,0.799999714,0.5,no dnr,5.0,85.0,7.5,78.0,16.0,36.39844,224.0,2.8999023,0.29998779,0.79992676,140.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.6408691
62.81198,female,0.0,ARF/MOSF w/Sepsis,8.0,under $11k,84675.625,white,no,0.989999771,0.9899998,no dnr,11.0,61.0,14.7988281,118.0,30.0,36.29688,190.0,2.5,0.89990234,0.5,134.0,7.439453,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
62.70798,male,1.0,Lung Cancer,14.0,$25-$50k,3095.148,white,metastatic,0.0,0.0,dnr after sadm,1.0,80.0,9.8984375,70.0,22.0,36.0,224.0,2.8999023,0.89990234,1.0,135.0,7.419922,135.0,23.0,1968.0,0.0,7.0,<2 mo. follow-up,7.0
50.29199,male,0.0,MOSF w/Malig,16.0,>$50k,31121.438,white,metastatic,1.0,0.5,no dnr,8.0,59.0,31.0,102.0,22.0,36.79688,396.0,1.5998535,0.89990234,7.19921875,131.0,7.389648,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
79.81696,male,0.0,COPD,20.0,$25-$50k,8032.547,white,no,0.899999619,0.5999999,no dnr,10.0,97.0,11.5996094,102.0,24.0,37.29688,247.59375,2.8999023,0.89990234,1.39990234,138.0,7.329102,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
63.64398,male,0.0,Colon Cancer,16.0,$11-$25k,7005.727,white,metastatic,0.099999964,0.0009999992,no dnr,7.0,113.0,11.0996094,94.0,16.0,36.29688,224.0,2.5996094,2.0,1.59985352,131.0,7.419922,135.0,23.0,1968.0,0.0,4.0,<2 mo. follow-up,4.0
57.67297,male,0.0,COPD,16.0,$25-$50k,12842.945,white,yes,0.599999905,0.5,no dnr,9.0,111.0,7.39941406,110.0,21.0,36.69531,268.0,2.5996094,0.89990234,2.79980469,155.0,7.30957,135.0,23.0,1968.0,0.0,4.0,no(M2 and SIP pres),4.0
58.97598,male,0.0,ARF/MOSF w/Sepsis,16.0,under $11k,209815.5,white,no,0.5,0.4499998,no dnr,26.0,73.0,18.296875,74.0,8.0,35.5,250.0,2.7998047,0.89990234,8.09960938,128.0,7.419922,135.0,23.0,1968.0,0.0,0.0,SIP>=30,0.0
63.89899,female,1.0,ARF/MOSF w/Sepsis,4.0,under $11k,68388.125,black,no,0.599999905,0.5,no dnr,17.0,71.0,18.3984375,110.0,40.0,35.79688,109.07812,2.8999023,0.89990234,2.29980469,129.0,7.469727,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
49.37198,male,0.0,Colon Cancer,12.0,>$50k,7472.5,white,metastatic,0.799999714,0.5,no dnr,7.0,87.0,12.1992188,56.0,16.0,36.59375,224.0,2.8999023,0.89990234,0.79992676,142.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
68.20496,female,0.0,CHF,20.0,$25-$50k,6022.0,other,no,0.699999809,0.5,no dnr,5.0,77.0,9.8984375,102.0,20.0,36.19531,328.5625,3.5996094,0.39996338,2.39990234,137.0,7.439453,135.0,23.0,1968.0,1.0,2.0,no(M2 and SIP pres),2.0
57.91397,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,38281.625,hispanic,no,0.799999714,0.7999997,no dnr,24.0,119.0,14.1992188,116.0,40.0,38.29688,213.3125,2.8999023,0.29998779,0.79992676,134.0,7.40918,135.0,23.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
68.37195,female,1.0,Coma,12.0,under $11k,27641.391,white,no,0.699999809,0.5,dnr after sadm,4.0,110.0,9.69921875,42.0,11.0,36.89844,250.0,2.8999023,0.89990234,0.59997559,148.0,7.479492,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
69.19897,male,0.0,Cirrhosis,12.0,under $11k,91875.625,white,no,0.599999905,0.5999999,no dnr,37.0,101.0,14.1992188,108.0,22.0,36.79688,285.6875,2.3999023,4.39941406,1.0,148.0,7.55957,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
33.07898,male,1.0,ARF/MOSF w/Sepsis,16.0,$11-$25k,164121.625,black,no,0.699999809,0.6999998,dnr after sadm,27.0,73.0,16.0976562,72.0,10.0,36.0,228.5625,2.8999023,1.0,11.3984375,133.0,7.319336,135.0,23.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
72.64899,male,1.0,Coma,12.0,under $11k,12858.797,white,no,0.019999996,7.999995e-06,dnr after sadm,4.0,120.0,13.1992188,58.0,8.0,38.19531,197.125,2.8999023,0.89990234,1.29980469,139.0,7.40918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.059082
69.01794,female,1.0,ARF/MOSF w/Sepsis,10.0,$11-$25k,57983.438,white,no,0.799999714,0.6499996,no dnr,18.0,80.0,10.0,90.0,12.0,38.5,242.84375,2.8999023,0.89990234,2.09960938,131.0,7.479492,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
46.13797,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,165522.0,white,no,0.599999905,0.5999999,no dnr,81.0,151.0,22.5976562,136.0,25.0,38.89844,116.0,3.2998047,1.79980469,0.89990234,132.0,7.449219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.2304688
63.422,male,0.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,56185.094,white,no,0.099999964,0.0009999992,no dnr,34.0,126.0,8.79882812,104.0,8.0,35.29688,142.84375,2.699707,4.39941406,7.0,128.0,7.459961,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.65625
65.89496,female,0.0,Coma,9.0,$11-$25k,97451.25,white,no,0.699999809,0.5,no dnr,29.0,125.0,10.5996094,70.0,9.0,37.69531,331.375,2.8999023,0.89990234,0.69995117,134.0,7.469727,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
64.10394,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,65610.625,white,no,0.599999905,0.5,dnr after sadm,13.0,65.0,15.2988281,118.0,10.0,36.59375,167.5,3.199707,1.0,1.0,136.0,7.509766,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
68.20496,female,0.0,COPD,16.0,under $11k,89705.938,white,no,0.799999714,0.5999999,no dnr,15.0,136.0,10.0996094,54.0,26.0,36.19531,145.6875,3.199707,0.89990234,1.39990234,133.0,7.359375,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
42.88797,male,0.0,ARF/MOSF w/Sepsis,9.0,under $11k,107267.375,black,no,0.699999809,0.5,no dnr,49.0,127.0,28.0976562,154.0,36.0,36.09375,226.65625,4.2998047,4.69921875,0.69995117,138.0,7.439453,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.8745117
70.51599,female,0.0,Lung Cancer,8.0,$11-$25k,7154.898,white,metastatic,0.899999619,0.5,no dnr,8.0,97.0,8.29882812,68.0,16.0,35.29688,224.0,2.8999023,0.29998779,0.5,136.0,7.419922,135.0,23.0,1968.0,4.0,5.0,<2 mo. follow-up,5.0
74.09998,female,0.0,Lung Cancer,12.0,under $11k,11191.844,black,metastatic,0.5,0.1999999,dnr after sadm,2.0,137.0,13.6992188,112.0,24.0,36.39844,224.0,2.8999023,0.29998779,1.0,137.0,7.419922,135.0,23.0,1968.0,0.0,3.0,adl>=4 (>=5 if sur),3.0
69.10895,male,0.0,ARF/MOSF w/Sepsis,13.0,$25-$50k,53654.719,white,yes,0.199999928,0.04999998,dnr after sadm,9.0,119.0,6.59960938,110.0,50.0,38.0,296.0,2.8999023,0.89990234,0.59997559,134.0,7.489258,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
72.73895,male,0.0,ARF/MOSF w/Sepsis,11.0,$25-$50k,30448.625,white,no,0.699999809,0.5,no dnr,7.0,72.0,12.0996094,64.0,30.0,36.79688,196.65625,3.0,0.89990234,1.39990234,136.0,7.479492,135.0,23.0,1968.0,1.0,0.0,no(M2 and SIP pres),0.0
68.62994,male,1.0,ARF/MOSF w/Sepsis,14.0,$25-$50k,128551.688,white,no,0.299999952,0.3,dnr after sadm,27.0,68.0,29.5976562,144.0,40.0,40.59375,71.0,2.8999023,0.39996338,1.59985352,136.0,7.40918,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
56.30899,female,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,16926.094,white,metastatic,0.0,0.0,no dnr,12.0,81.0,11.2988281,118.0,32.0,37.09375,144.875,2.8999023,0.69995117,1.09985352,136.0,7.449219,135.0,23.0,1968.0,1.0,2.0,adl>=4 (>=5 if sur),2.0
75.12695,male,0.0,COPD,12.0,under $11k,6113.828,black,yes,0.699999809,0.5,no dnr,6.0,100.0,15.0,76.0,40.0,36.0,252.375,2.8999023,0.19998169,0.79992676,138.0,7.419922,135.0,23.0,1968.0,0.0,6.0,adl>=4 (>=5 if sur),6.0
65.80194,male,1.0,COPD,8.0,$11-$25k,5412.527,white,yes,0.199999928,0.04999998,dnr after sadm,1.0,120.0,11.7988281,124.0,24.0,35.09375,364.0,2.8999023,0.89990234,0.89990234,135.0,7.25,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
42.67798,male,0.0,CHF,10.0,under $11k,3498.949,black,no,0.699999809,0.5,no dnr,6.0,97.0,7.59960938,70.0,21.0,36.39844,357.125,2.8999023,1.19995117,3.09960938,134.0,7.389648,135.0,23.0,1968.0,0.0,5.0,adl>=4 (>=5 if sur),5.0
47.51797,female,0.0,Lung Cancer,12.0,$25-$50k,10569.695,white,metastatic,0.899999619,0.8999996,no dnr,8.0,99.0,20.1992188,74.0,10.0,36.69531,366.625,3.199707,0.5,0.69995117,143.0,7.459961,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
28.211,male,1.0,Coma,12.0,under $11k,75495.125,black,no,0.699999809,0.5,dnr after sadm,14.0,133.0,30.0976562,126.0,12.0,38.69531,172.5,2.8999023,0.79992676,1.89990234,143.0,7.5,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
77.89496,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,33176.25,black,no,0.599999905,0.5999999,no dnr,40.0,60.0,27.5976562,104.0,10.0,36.39844,263.3125,2.8999023,0.29998779,5.79980469,131.0,7.379883,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),3.1694336
56.12299,female,0.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,59076.75,white,no,0.5,0.3999999,no dnr,23.0,61.0,10.1992188,74.0,12.0,35.09375,83.0625,2.8999023,0.09999084,4.89941406,138.0,7.519531,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
72.81897,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,51952.594,white,no,0.5,0.3999999,no dnr,20.0,59.0,15.7988281,48.0,22.0,37.5,176.65625,2.8999023,0.89990234,2.89990234,128.0,7.5,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
74.80396,male,0.0,ARF/MOSF w/Sepsis,4.0,$11-$25k,24017.844,white,no,0.75,0.421875,no dnr,12.0,64.0,7.59960938,104.0,26.0,38.29688,220.0,2.8999023,0.5,1.39990234,135.0,7.459961,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
65.39099,male,1.0,MOSF w/Malig,16.0,>$50k,65632.688,white,yes,0.5,0.3,dnr after sadm,6.0,45.0,0.09999084,140.0,30.0,38.69531,230.0,1.1999512,4.89941406,2.59960938,149.0,7.449219,135.0,23.0,1968.0,0.0,6.0,<2 mo. follow-up,6.0
65.01794,male,1.0,Coma,14.0,>$50k,10533.594,white,yes,0.699999809,0.5,dnr after sadm,2.0,73.0,14.3984375,0.0,0.0,35.89844,270.0,3.699707,2.19970703,1.59985352,149.0,7.459961,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
37.70798,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,28257.281,black,no,0.5,0.5,dnr after sadm,7.0,123.0,2.39990234,120.0,22.0,39.19531,485.6875,1.3999023,3.79980469,0.89990234,145.0,7.489258,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
51.80798,male,0.0,ARF/MOSF w/Sepsis,16.0,$11-$25k,85036.875,white,no,0.699999809,0.5,dnr after sadm,23.0,69.0,18.8984375,110.0,10.0,36.29688,90.0,2.2998047,7.29980469,1.29980469,150.0,7.5,135.0,23.0,1968.0,0.0,3.0,no(M2 and SIP pres),3.0
34.905,female,0.0,Lung Cancer,15.0,$11-$25k,30184.844,black,metastatic,0.699999809,0.1999999,no dnr,32.0,83.0,1.09985352,80.0,16.0,36.79688,224.0,2.8999023,0.39996338,1.09985352,142.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
67.16797,male,0.0,Colon Cancer,19.0,$25-$50k,2869.35,white,metastatic,0.899999619,0.7999997,no dnr,5.0,105.0,5.39941406,72.0,20.0,36.59375,224.0,2.8999023,0.29998779,1.0,142.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
75.53198,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,65764.688,black,no,0.199999928,0.1999999,dnr after sadm,13.0,43.0,9.59960938,0.0,25.0,35.59375,294.0,2.8999023,1.29980469,3.39990234,149.0,7.359375,135.0,23.0,1968.0,0.0,7.0,<2 mo. follow-up,7.0
59.53699,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,36440.969,white,no,0.699999809,0.5,dnr after sadm,3.0,0.0,26.296875,0.0,25.0,36.79688,151.0,3.199707,0.39996338,10.0996094,131.0,7.239258,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.0654297
52.49799,female,1.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,64625.125,white,no,0.0,0.0,no dnr,3.0,32.0,60.09375,0.0,12.0,38.09375,58.0,2.8999023,17.1992188,4.69921875,128.0,7.179688,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
33.49799,male,0.0,ARF/MOSF w/Sepsis,10.0,under $11k,38352.75,black,no,0.899999619,0.8999996,no dnr,17.0,46.0,10.1992188,114.0,34.0,34.89844,138.3125,3.2998047,0.79992676,0.5,138.0,7.339844,135.0,23.0,1968.0,0.0,5.0,adl>=4 (>=5 if sur),5.0
63.31299,male,0.0,Colon Cancer,12.0,under $11k,6546.547,white,metastatic,1.0,0.8999996,no dnr,7.0,125.0,7.69921875,100.0,20.0,36.19531,224.0,2.8999023,0.29998779,0.79992676,139.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.2763672
71.09698,male,0.0,Colon Cancer,5.0,$11-$25k,6796.148,white,metastatic,0.799999714,0.5,no dnr,8.0,90.0,13.2988281,100.0,20.0,38.0,224.0,1.7998047,2.39990234,1.0,135.0,7.419922,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),1.0
33.336,female,0.0,ARF/MOSF w/Sepsis,9.0,$11-$25k,38332.438,white,no,0.699999809,0.5,no dnr,16.0,145.0,21.1992188,124.0,25.0,35.89844,300.0,1.0,0.19998169,0.89990234,135.0,7.509766,135.0,23.0,1968.0,1.0,0.0,no(M2 and SIP pres),0.0
68.323,male,1.0,Coma,11.0,$25-$50k,40760.781,white,yes,0.699999809,0.5,dnr after sadm,6.0,115.0,3.89990234,110.0,40.0,38.29688,276.625,2.5,2.0,1.39990234,139.0,7.519531,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
70.06195,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,60256.219,black,no,0.0,0.0,no dnr,10.0,105.0,7.29980469,126.0,32.0,36.09375,223.3125,2.8999023,1.09985352,1.19995117,142.0,7.399414,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.1630859
30.56499,male,1.0,ARF/MOSF w/Sepsis,7.0,under $11k,111994.75,black,no,0.299999952,0.3,dnr after sadm,14.0,101.0,17.1992188,114.0,9.0,35.29688,253.3125,1.0998535,5.29980469,4.19921875,137.0,7.439453,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
55.047,male,0.0,ARF/MOSF w/Sepsis,9.0,$25-$50k,57010.281,white,no,0.5,0.3999999,no dnr,17.0,62.0,10.5,136.0,22.0,37.89844,140.8125,2.8999023,0.89990234,2.0,142.0,7.479492,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
64.51495,male,0.0,ARF/MOSF w/Sepsis,9.0,under $11k,134926.125,white,no,0.799999714,0.6999998,no dnr,43.0,62.0,11.1992188,108.0,30.0,38.89844,196.65625,2.8999023,0.89990234,1.0,137.0,7.479492,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
72.55896,male,1.0,MOSF w/Malig,14.0,$25-$50k,117551.375,white,metastatic,0.299999952,0.09999996,dnr after sadm,5.0,43.0,1.39990234,46.0,30.0,38.5,132.625,2.7998047,1.59985352,3.39990234,145.0,7.399414,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
53.771,male,1.0,ARF/MOSF w/Sepsis,7.0,under $11k,144017.875,black,no,0.199999928,0.09999996,dnr after sadm,28.0,65.0,21.5976562,136.0,40.0,39.69531,127.5,1.0998535,0.89990234,0.5,135.0,7.489258,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
36.78,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,69588.438,white,no,0.899999619,0.8999996,no dnr,34.0,110.0,27.0976562,64.0,29.0,36.79688,196.65625,2.5,2.19970703,1.59985352,143.0,7.449219,135.0,23.0,1968.0,6.0,6.0,adl>=4 (>=5 if sur),6.0
57.37198,female,0.0,CHF,12.0,under $11k,6919.348,black,no,0.699999809,0.5,no dnr,5.0,57.0,11.2988281,74.0,12.0,36.0,224.0,2.8999023,0.89990234,1.79980469,131.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
66.06696,male,0.0,COPD,11.0,under $11k,8746.344,white,no,0.699999809,0.5,no dnr,11.0,101.0,12.5,120.0,24.0,36.19531,314.8125,2.8999023,0.89990234,1.39990234,138.0,7.379883,135.0,23.0,1968.0,5.0,6.0,adl>=4 (>=5 if sur),6.0
44.71198,female,1.0,MOSF w/Malig,10.0,under $11k,34335.719,black,metastatic,0.049999982,0.0001249999,dnr after sadm,8.0,82.0,30.3984375,136.0,37.0,38.09375,193.3125,1.7998047,0.39996338,0.89990234,148.0,7.509766,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
66.53296,male,0.0,ARF/MOSF w/Sepsis,9.0,under $11k,84241.938,black,no,0.699999809,0.5999999,no dnr,53.0,113.0,7.39941406,64.0,22.0,35.29688,390.4375,2.8999023,0.89990234,1.0,139.0,7.389648,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
64.47095,female,1.0,ARF/MOSF w/Sepsis,14.0,$11-$25k,239038.625,white,no,0.699999809,0.5,dnr after sadm,19.0,79.0,25.6992188,150.0,14.0,38.5,274.25,3.699707,46.0,2.29980469,156.0,7.509766,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
86.771,male,0.0,COPD,6.0,$25-$50k,9572.992,white,no,0.699999809,0.5,dnr after sadm,1.0,77.0,5.39941406,96.0,24.0,36.29688,254.15625,2.8999023,0.69995117,0.89990234,144.0,7.319336,135.0,23.0,1968.0,1.0,1.0,no(M2 and SIP pres),1.0
65.84497,male,0.0,CHF,8.0,$11-$25k,36142.5,white,no,0.099999964,0.0009999992,no dnr,11.0,56.0,7.5,96.0,26.0,34.89844,173.3125,2.8999023,0.89990234,0.69995117,130.0,7.509766,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
36.46298,female,1.0,ARF/MOSF w/Sepsis,9.0,under $11k,43674.094,black,no,0.699999809,0.5,dnr after sadm,7.0,49.0,6.69921875,130.0,10.0,36.89844,380.0,2.8999023,3.79980469,3.29980469,143.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
66.01196,female,0.0,CHF,10.0,under $11k,4544.449,white,no,1.0,1.0,no dnr,6.0,73.0,7.59960938,80.0,20.0,36.0,232.0,2.8999023,0.89990234,1.59985352,142.0,7.40918,135.0,23.0,1968.0,1.0,0.0,no(M2 and SIP pres),0.0
57.34399,male,0.0,CHF,8.0,$11-$25k,16616.234,white,no,0.799999714,0.5999999,no dnr,14.0,73.0,8.0,114.0,16.0,35.29688,361.875,4.0,0.5,1.29980469,142.0,7.469727,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
64.30096,male,0.0,Colon Cancer,8.0,$25-$50k,2797.75,white,metastatic,0.75,0.25,no dnr,4.0,103.0,10.0,100.0,20.0,36.59375,224.0,2.8999023,1.09985352,0.59997559,135.0,7.419922,135.0,23.0,1968.0,0.0,0.0,SIP>=30,0.0
74.836,male,1.0,ARF/MOSF w/Sepsis,10.0,under $11k,100695.688,white,no,0.699999809,0.5,no dnr,20.0,114.0,11.5996094,154.0,51.0,38.0,176.65625,3.0,0.09999084,5.09960938,148.0,7.429688,135.0,23.0,1968.0,0.0,3.0,<2 mo. follow-up,3.0
44.45697,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,64678.375,white,no,0.799999714,0.7999997,no dnr,23.0,71.0,13.1992188,120.0,40.0,39.0,169.375,2.8999023,0.5,1.19995117,152.0,7.369141,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
65.17694,male,1.0,MOSF w/Malig,12.0,under $11k,75953.688,white,yes,0.199999928,0.09999996,dnr after sadm,2.0,52.0,0.09999084,146.0,23.0,39.0,126.65625,2.3999023,1.09985352,0.79992676,139.0,7.389648,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.1538086
40.961,female,1.0,ARF/MOSF w/Sepsis,14.0,under $11k,26437.453,white,no,0.0,0.0,dnr after sadm,4.0,60.0,6.5,134.0,42.0,38.5,200.0,2.8999023,0.29998779,1.79980469,143.0,7.389648,135.0,23.0,1968.0,0.0,7.0,<2 mo. follow-up,7.0
46.20099,male,0.0,ARF/MOSF w/Sepsis,16.0,under $11k,48938.625,white,no,0.899999619,0.7999997,no dnr,16.0,47.0,7.69921875,114.0,8.0,38.09375,205.0,2.699707,1.59985352,0.79992676,142.0,7.339844,135.0,23.0,1968.0,0.0,5.0,adl>=4 (>=5 if sur),5.0
46.80099,female,0.0,MOSF w/Malig,12.0,$25-$50k,100731.312,white,yes,0.199999928,0.09999996,no dnr,24.0,70.0,0.29998779,80.0,24.0,36.09375,215.0,2.2998047,1.39990234,0.79992676,138.0,7.429688,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
71.78894,male,0.0,CHF,12.0,under $11k,14408.992,white,no,0.799999714,0.75,no dnr,13.0,82.0,5.79980469,76.0,20.0,35.79688,304.75,2.8999023,0.39996338,1.79980469,144.0,7.389648,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
33.98798,male,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,32652.094,white,no,0.979999542,0.9699998,no dnr,11.0,107.0,8.79882812,78.0,24.0,36.69531,348.9375,2.8999023,0.89990234,1.19995117,137.0,7.40918,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
34.44498,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,90605.125,black,no,0.099999964,0.0009999992,no dnr,55.0,59.0,28.5,70.0,19.0,35.29688,323.75,1.7998047,8.59960938,2.39990234,153.0,7.469727,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
62.37598,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,26869.891,black,no,0.049999982,0.0001249999,no dnr,7.0,42.0,13.5,116.0,14.0,35.5,173.46875,2.2998047,0.89990234,2.59960938,129.0,7.329102,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.3037109
72.73895,male,0.0,COPD,6.0,$11-$25k,237319.75,white,no,0.799999714,0.7999997,no dnr,14.0,57.0,7.39941406,116.0,24.0,36.19531,259.25,2.8999023,0.89990234,0.89990234,135.0,7.349609,135.0,23.0,1968.0,0.0,0.0,SIP>=30,0.0
62.60397,male,0.0,Colon Cancer,16.0,$11-$25k,6939.148,white,metastatic,0.899999619,0.7999997,no dnr,8.0,113.0,4.29980469,66.0,16.0,37.69531,224.0,3.5996094,0.59997559,1.09985352,139.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
73.05695,male,0.0,MOSF w/Malig,8.0,$11-$25k,26677.734,white,metastatic,0.699999809,0.5,no dnr,13.0,69.0,20.296875,134.0,36.0,38.0,128.5625,2.8999023,0.89990234,1.29980469,142.0,7.5,135.0,23.0,1968.0,0.0,3.0,no(M2 and SIP pres),3.0
33.30899,male,0.0,CHF,9.0,under $11k,1949.499,white,no,0.949999809,0.9499998,no dnr,3.0,93.0,14.2988281,102.0,18.0,36.5,319.0,2.8999023,0.89990234,5.5,135.0,7.359375,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.1293945
39.392,female,1.0,ARF/MOSF w/Sepsis,7.0,under $11k,25431.641,black,no,0.25,0.1999999,dnr after sadm,12.0,59.0,35.296875,100.0,32.0,36.39844,428.0,2.0,2.0,1.09985352,133.0,7.439453,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
50.297,male,0.0,CHF,17.0,$25-$50k,37236.906,white,no,0.75,0.5999999,dnr after sadm,16.0,79.0,6.0,76.0,28.0,36.29688,342.8125,2.8999023,1.19995117,1.09985352,138.0,7.459961,135.0,23.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
62.64798,female,1.0,MOSF w/Malig,12.0,under $11k,114017.812,white,yes,0.099999964,0.0009999992,dnr after sadm,15.0,113.0,13.7988281,136.0,33.0,36.19531,55.0,2.8999023,0.89990234,0.69995117,130.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
46.431,male,0.0,Cirrhosis,18.0,>$50k,13625.547,white,no,0.899999619,0.7999997,no dnr,6.0,109.0,7.59960938,92.0,20.0,38.19531,154.0,2.199707,5.19921875,0.79992676,141.0,7.469727,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
44.48199,male,1.0,MOSF w/Malig,15.0,$25-$50k,14491.094,white,yes,0.0,0.0,dnr after sadm,3.0,46.0,1.09985352,130.0,12.0,36.29688,165.28125,1.6999512,0.89990234,1.5,125.0,7.369141,135.0,23.0,1968.0,0.0,4.0,<2 mo. follow-up,4.0
38.22598,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,113644.312,black,no,0.0,0.0,dnr after sadm,6.0,53.0,9.5,166.0,20.0,38.59375,222.84375,2.8999023,0.79992676,1.19995117,147.0,7.399414,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.0595703
43.46899,male,0.0,CHF,16.0,>$50k,9109.25,white,no,0.899999619,0.5,no dnr,6.0,79.0,7.0,60.0,16.0,36.0,224.0,2.8999023,1.59985352,1.19995117,142.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
53.448,male,0.0,CHF,10.0,$25-$50k,8706.695,white,no,0.699999809,0.5,no dnr,5.0,81.0,10.5,76.0,20.0,36.19531,224.0,2.8999023,0.59997559,1.79980469,140.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.7338867
53.86697,male,0.0,Lung Cancer,3.0,under $11k,4178.297,black,metastatic,0.75,0.3999999,no dnr,6.0,70.0,42.3984375,106.0,20.0,36.29688,224.0,3.7998047,0.69995117,1.39990234,141.0,7.419922,135.0,23.0,1968.0,0.0,7.0,SIP>=30,7.0
63.51797,female,0.0,CHF,7.0,$25-$50k,12290.547,black,no,0.899999619,0.8499999,no dnr,7.0,122.0,11.2988281,70.0,15.0,36.59375,156.65625,2.8999023,0.89990234,3.09960938,136.0,7.369141,135.0,23.0,1968.0,1.0,0.0,no(M2 and SIP pres),0.0
43.50699,male,0.0,COPD,9.0,$11-$25k,35417.5,white,no,0.849999905,0.7999997,no dnr,23.0,71.0,13.2988281,66.0,14.0,35.39844,160.0,2.8999023,0.89990234,0.89990234,134.0,7.439453,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
49.79898,male,1.0,MOSF w/Malig,12.0,$25-$50k,44865.125,hispanic,yes,0.5,0.1999999,dnr after sadm,6.0,66.0,0.09999084,120.0,12.0,36.0,177.5,1.3999023,1.19995117,0.79992676,136.0,7.319336,135.0,23.0,1968.0,0.0,6.0,<2 mo. follow-up,6.0
64.12897,female,0.0,Colon Cancer,13.0,under $11k,4552.0,white,metastatic,1.0,1.0,no dnr,6.0,80.0,8.59960938,60.0,16.0,37.5,224.0,2.8999023,0.89990234,1.09985352,141.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
40.88397,female,0.0,Cirrhosis,16.0,>$50k,164417.875,white,no,0.699999809,0.5,no dnr,35.0,59.0,12.0,118.0,41.0,38.69531,165.0,0.3999634,14.3984375,1.0,147.0,7.519531,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
65.92999,female,0.0,COPD,12.0,under $11k,31304.594,white,no,0.799999714,0.6999998,no dnr,14.0,105.0,9.09960938,60.0,8.0,37.59375,216.65625,2.8999023,2.69970703,0.69995117,141.0,7.429688,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
63.88498,male,1.0,MOSF w/Malig,12.0,under $11k,70330.438,white,yes,0.5,0.3999999,dnr after sadm,3.0,42.0,0.29998779,210.0,40.0,40.09375,57.0,3.199707,3.59960938,1.69995117,154.0,7.389648,135.0,23.0,1968.0,0.0,3.0,<2 mo. follow-up,3.0
70.51599,male,1.0,MOSF w/Malig,12.0,under $11k,72465.938,white,metastatic,0.699999809,0.5,no dnr,8.0,61.0,18.3984375,166.0,16.0,39.0,70.0,2.8999023,5.69921875,1.39990234,136.0,7.339844,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5200195
59.69299,male,0.0,CHF,7.0,under $11k,6527.398,white,no,0.699999809,0.5,no dnr,8.0,65.0,12.5996094,94.0,20.0,35.09375,348.0,2.8999023,1.69995117,1.69995117,141.0,7.449219,135.0,23.0,1968.0,3.0,3.0,<2 mo. follow-up,3.0
51.01398,female,0.0,MOSF w/Malig,14.0,under $11k,26606.234,white,yes,0.699999809,0.5,no dnr,18.0,64.0,9.8984375,110.0,16.0,35.89844,236.0,2.8999023,0.89990234,1.0,126.0,7.55957,135.0,23.0,1968.0,2.0,0.0,no(M2 and SIP pres),0.0
39.98898,male,0.0,Coma,11.0,$11-$25k,96140.5,black,no,0.699999809,0.5,no dnr,47.0,150.0,21.5,54.0,16.0,36.5,314.25,2.8999023,0.79992676,2.0,142.0,7.549805,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
77.36896,male,1.0,MOSF w/Malig,16.0,$11-$25k,82882.0,white,metastatic,0.0,0.0,no dnr,6.0,56.0,27.796875,144.0,15.0,36.39844,95.0,3.0,0.59997559,1.89990234,137.0,7.329102,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
49.28699,female,0.0,Lung Cancer,18.0,>$50k,6130.148,white,metastatic,0.799999714,0.5999999,no dnr,3.0,93.0,50.0,92.0,18.0,36.89844,224.0,2.5996094,0.29998779,0.89990234,137.0,7.419922,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
42.38199,male,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,17956.734,white,no,0.699999809,0.5,no dnr,13.0,100.0,10.3984375,104.0,22.0,39.09375,165.28125,2.8999023,0.89990234,0.59997559,145.0,7.40918,135.0,23.0,1968.0,0.0,7.0,<2 mo. follow-up,7.0
72.82996,male,1.0,ARF/MOSF w/Sepsis,26.0,$25-$50k,64584.969,white,yes,0.699999809,0.5,no dnr,28.0,123.0,25.5976562,100.0,26.0,38.09375,220.0,2.8999023,0.89990234,0.79992676,136.0,7.479492,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
38.63397,male,0.0,ARF/MOSF w/Sepsis,11.0,$11-$25k,64797.125,white,no,0.699999809,0.5999999,no dnr,40.0,148.0,10.2988281,64.0,35.0,36.0,280.9375,2.699707,0.19998169,8.19921875,129.0,7.379883,135.0,23.0,1968.0,5.0,6.0,SIP>=30,6.0
57.33099,female,0.0,Cirrhosis,14.0,$25-$50k,7634.297,white,no,0.699999809,0.5999999,no dnr,9.0,77.0,5.5,80.0,22.0,36.5,224.0,3.2998047,4.0,1.19995117,128.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
71.51495,male,1.0,Coma,12.0,under $11k,79534.062,black,no,0.049999982,0.0001249999,dnr after sadm,3.0,60.0,12.6992188,114.0,12.0,39.5,208.5625,2.8999023,0.89990234,9.79882812,140.0,7.449219,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
70.30798,male,1.0,MOSF w/Malig,17.0,>$50k,65747.0,white,yes,0.699999809,0.5,no dnr,16.0,56.0,9.69921875,130.0,29.0,37.89844,226.65625,2.5996094,1.29980469,3.69970703,137.0,7.489258,135.0,23.0,1968.0,0.0,3.0,<2 mo. follow-up,3.0
51.258,female,0.0,Colon Cancer,11.0,>$50k,6629.898,white,metastatic,0.799999714,0.5,no dnr,6.0,150.0,6.39941406,68.0,20.0,36.5,224.0,2.8999023,0.59997559,0.69995117,137.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
40.75,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,56770.312,white,no,0.949999809,0.9399996,no dnr,29.0,77.0,13.7988281,124.0,38.0,38.19531,233.3125,2.0996094,0.5,0.59997559,137.0,7.479492,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
71.03595,female,1.0,COPD,12.0,under $11k,101556.688,white,no,0.75,0.5999999,dnr after sadm,46.0,73.0,9.09960938,70.0,28.0,36.19531,736.625,2.8999023,0.89990234,0.69995117,137.0,7.40918,135.0,23.0,1968.0,2.0,0.0,<2 mo. follow-up,0.0
68.01898,male,0.0,Colon Cancer,7.0,under $11k,3755.648,white,metastatic,1.0,0.7999997,no dnr,5.0,107.0,7.0,76.0,24.0,36.19531,224.0,2.8999023,0.39996338,1.69995117,137.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
67.11298,male,0.0,ARF/MOSF w/Sepsis,11.0,under $11k,73551.25,black,no,0.5,0.3999999,no dnr,33.0,67.0,19.6992188,114.0,8.0,39.09375,195.0,2.8999023,1.5,2.09960938,132.0,7.509766,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),1.0
53.04898,female,1.0,Coma,12.0,under $11k,33600.531,other,yes,0.099999964,0.0009999992,dnr after sadm,5.0,62.0,2.29980469,136.0,27.0,37.89844,273.3125,2.8999023,0.89990234,1.39990234,150.0,7.5,135.0,23.0,1968.0,0.0,7.0,<2 mo. follow-up,7.0
61.06198,male,0.0,Coma,12.0,>$50k,25385.047,white,no,0.199999928,0.09999996,no dnr,14.0,105.0,18.8984375,74.0,8.0,36.5,310.0,2.8999023,0.89990234,1.09985352,135.0,7.479492,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
24.01399,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,98734.0,white,no,0.5,0.3,dnr after sadm,17.0,112.0,16.8984375,144.0,30.0,40.0,110.0,2.8999023,0.89990234,0.69995117,147.0,7.489258,135.0,23.0,1968.0,0.0,5.0,<2 mo. follow-up,5.0
54.02899,male,0.0,CHF,9.0,$11-$25k,9305.555,white,no,0.699999809,0.5,no dnr,5.0,53.0,6.89941406,54.0,11.0,36.09375,316.0,2.8999023,0.89990234,1.19995117,138.0,7.389648,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
45.81497,male,1.0,Cirrhosis,12.0,under $11k,20466.234,white,no,0.049999982,0.0001249999,dnr after sadm,3.0,0.0,7.19921875,0.0,22.0,36.39844,155.6875,1.8999023,0.89990234,4.19921875,152.0,7.25,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.1298828
62.65298,female,0.0,CHF,8.0,under $11k,9345.742,white,no,0.599999905,0.5,no dnr,10.0,87.0,10.7988281,74.0,26.0,36.19531,436.0,2.8999023,0.89990234,1.09985352,147.0,7.419922,135.0,23.0,1968.0,2.0,3.0,no(M2 and SIP pres),3.0
48.95599,male,1.0,MOSF w/Malig,18.0,$25-$50k,158581.125,white,yes,0.199999928,0.09999996,dnr after sadm,62.0,111.0,6.69921875,114.0,11.0,36.29688,202.84375,2.8999023,0.89990234,6.89941406,141.0,7.40918,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
68.60199,female,0.0,MOSF w/Malig,13.0,$11-$25k,32563.297,white,yes,0.5,0.3,no dnr,26.0,63.0,25.1992188,126.0,42.0,38.29688,194.28125,2.5996094,0.89990234,1.09985352,145.0,7.549805,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
80.93097,male,1.0,ARF/MOSF w/Sepsis,21.0,$11-$25k,57927.031,white,yes,0.5,0.3999999,dnr after sadm,16.0,134.0,1.0,126.0,36.0,36.0,160.0,2.3999023,1.89990234,3.5,142.0,7.489258,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
50.95999,female,0.0,ARF/MOSF w/Sepsis,16.0,under $11k,20149.438,white,no,0.699999809,0.6999998,no dnr,11.0,59.0,10.1992188,120.0,6.0,38.09375,347.5625,2.5996094,0.19998169,0.69995117,143.0,7.449219,135.0,23.0,1968.0,0.0,4.0,no(M2 and SIP pres),4.0
50.64999,male,0.0,Colon Cancer,12.0,$25-$50k,7671.547,white,metastatic,0.899999619,0.5999999,no dnr,5.0,117.0,12.6992188,50.0,20.0,36.39844,224.0,4.1992188,0.59997559,1.09985352,141.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
37.396,male,0.0,ARF/MOSF w/Sepsis,7.0,under $11k,27632.438,black,no,0.299999952,0.28,no dnr,9.0,61.0,6.89941406,126.0,10.0,38.39844,223.3125,2.7998047,0.59997559,1.09985352,153.0,7.479492,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
68.02496,male,0.0,ARF/MOSF w/Sepsis,15.0,>$50k,27549.688,white,no,0.699999809,0.5999999,no dnr,16.0,110.0,18.8984375,104.0,40.0,36.59375,146.40625,2.8999023,0.89990234,0.89990234,139.0,7.369141,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
59.86899,male,0.0,ARF/MOSF w/Sepsis,15.0,>$50k,212689.5,white,no,0.799999714,0.7999997,no dnr,73.0,117.0,14.8984375,116.0,27.0,39.09375,216.65625,2.7998047,6.39941406,1.29980469,131.0,7.479492,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
74.59796,male,0.0,CHF,12.0,under $11k,3740.498,black,no,0.699999809,0.5,no dnr,6.0,101.0,8.0,100.0,24.0,35.5,356.0,2.8999023,6.79980469,1.69995117,146.0,7.459961,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.637207
69.00494,female,0.0,CHF,5.0,$11-$25k,20171.688,white,no,0.949999809,0.8999996,no dnr,9.0,124.0,6.69921875,176.0,8.0,36.19531,233.3125,2.8999023,0.89990234,1.39990234,137.0,7.389648,135.0,23.0,1968.0,1.0,0.0,no(M2 and SIP pres),0.0
70.89398,female,1.0,Coma,11.0,$25-$50k,20252.891,white,no,0.699999809,0.5,dnr after sadm,5.0,119.0,11.8984375,100.0,8.0,36.79688,386.625,2.8999023,0.89990234,9.8984375,133.0,7.399414,135.0,23.0,1968.0,0.0,5.0,<2 mo. follow-up,5.0
64.91998,male,0.0,MOSF w/Malig,14.0,$25-$50k,107884.5,white,yes,0.699999809,0.5,no dnr,32.0,55.0,49.3984375,210.0,5.0,39.29688,253.3125,3.0,0.89990234,2.0,131.0,7.319336,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
67.88495,female,0.0,Colon Cancer,14.0,$25-$50k,7538.297,white,metastatic,0.299999952,0.0,dnr after sadm,1.0,77.0,4.29980469,98.0,20.0,37.19531,224.0,2.8999023,19.0976562,1.09985352,135.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
52.99899,male,1.0,Colon Cancer,10.0,>$50k,24066.344,black,metastatic,0.699999809,0.5,no dnr,17.0,126.0,4.59960938,64.0,28.0,38.09375,224.0,2.8999023,13.0,1.09985352,139.0,7.419922,135.0,23.0,1968.0,3.0,1.0,<2 mo. follow-up,2.5110989
64.909,male,0.0,Colon Cancer,12.0,$25-$50k,3950.5,white,metastatic,0.5,0.1999999,no dnr,7.0,67.0,5.39941406,52.0,16.0,37.69531,224.0,2.8999023,0.19998169,1.39990234,135.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
30.795,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,59516.188,white,no,0.5,0.5,dnr after sadm,13.0,55.0,13.3984375,116.0,11.0,38.69531,148.0,2.5,0.5,0.89990234,140.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.7836914
38.133,female,0.0,ARF/MOSF w/Sepsis,14.0,$11-$25k,202750.625,white,no,0.149999976,0.09999996,no dnr,91.0,113.0,27.796875,140.0,33.0,38.59375,368.0,2.5,4.89941406,1.69995117,148.0,7.469727,135.0,23.0,1968.0,0.0,2.0,SIP>=30,2.0
69.00195,female,1.0,ARF/MOSF w/Sepsis,11.0,under $11k,160610.125,white,no,0.5,0.1999999,dnr after sadm,19.0,96.0,19.6992188,110.0,10.0,36.59375,290.0,2.699707,7.69921875,2.0,151.0,7.459961,135.0,23.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
74.31299,female,0.0,COPD,6.0,under $11k,27789.391,white,no,0.699999809,0.5,no dnr,15.0,72.0,5.79980469,124.0,31.0,35.5,176.0,2.8999023,0.89990234,0.39996338,138.0,7.459961,135.0,23.0,1968.0,0.0,7.0,<2 mo. follow-up,7.0
66.18994,male,0.0,Colon Cancer,10.0,under $11k,6248.0,black,metastatic,0.5,0.09999996,no dnr,7.0,101.0,11.7988281,64.0,16.0,37.39844,224.0,2.5,0.89990234,0.89990234,136.0,7.419922,135.0,23.0,1968.0,1.0,1.0,<2 mo. follow-up,1.0
58.89697,female,0.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,91730.875,white,no,0.5,0.25,no dnr,25.0,72.0,11.1992188,74.0,8.0,39.0,266.625,2.8999023,0.89990234,0.5,135.0,7.459961,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
65.83398,male,1.0,Coma,11.0,$11-$25k,24014.984,black,no,0.25,0.1999999,dnr after sadm,5.0,75.0,6.79980469,11.0,10.0,39.29688,386.625,3.0996094,0.59997559,1.5,142.0,7.429688,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
57.487,male,1.0,MOSF w/Malig,11.0,under $11k,122004.25,white,yes,0.799999714,0.5,dnr after sadm,24.0,70.0,10.0,100.0,9.0,36.19531,226.65625,2.8999023,0.89990234,0.89990234,139.0,7.419922,135.0,23.0,1968.0,0.0,7.0,<2 mo. follow-up,7.0
70.65295,male,0.0,COPD,5.0,under $11k,19755.547,black,no,0.199999928,0.09999996,no dnr,18.0,77.0,9.79882812,72.0,26.0,36.79688,225.0,2.3999023,0.89990234,1.0,134.0,7.429688,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),3.6118164
53.185,male,0.0,MOSF w/Malig,12.0,under $11k,33711.281,black,yes,0.699999809,0.5,no dnr,8.0,48.0,13.0,52.0,30.0,35.19531,104.0,2.0996094,0.69995117,2.39990234,136.0,7.339844,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.6381836
77.63696,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,9904.242,white,no,0.149999976,0.09999996,dnr after sadm,1.0,37.0,26.0,96.0,38.0,35.79688,108.32812,2.8999023,0.89990234,1.69995117,141.0,7.129883,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,4.7861328
31.59799,male,0.0,ARF/MOSF w/Sepsis,16.0,under $11k,156964.25,white,no,0.949999809,0.9499998,no dnr,11.0,145.0,4.69921875,64.0,28.0,36.39844,132.5,2.0996094,0.39996338,5.19921875,142.0,7.439453,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
59.13998,male,0.0,Lung Cancer,17.0,>$50k,6011.648,white,metastatic,0.399999857,0.0,dnr after sadm,1.0,87.0,11.0,120.0,24.0,36.29688,224.0,2.8999023,0.19998169,0.59997559,135.0,7.419922,135.0,23.0,1968.0,0.0,5.0,no(M2 and SIP pres),5.0
47.99698,male,0.0,CHF,12.0,under $11k,337299.25,white,no,0.699999809,0.5,no dnr,117.0,62.0,14.1992188,126.0,27.0,38.29688,384.0,3.0,1.09985352,0.79992676,128.0,7.449219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.0444336
61.15298,male,0.0,CHF,4.0,under $11k,6116.449,white,no,0.5,0.3,no dnr,6.0,60.0,7.19921875,62.0,36.0,35.89844,224.0,2.8999023,0.89990234,1.09985352,139.0,7.399414,135.0,23.0,1968.0,2.0,1.0,no(M2 and SIP pres),1.8389997
64.07397,male,1.0,Lung Cancer,8.0,under $11k,55642.438,black,metastatic,0.199999928,0.09999996,dnr after sadm,12.0,73.0,28.6992188,114.0,27.0,36.0,123.32812,3.0996094,2.5,6.19921875,135.0,7.379883,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
60.73398,male,0.0,ARF/MOSF w/Sepsis,6.0,$11-$25k,98783.438,white,no,0.699999809,0.5,no dnr,24.0,71.0,19.1992188,114.0,8.0,38.09375,155.0,2.8999023,3.0,1.09985352,132.0,7.369141,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
38.27499,female,0.0,ARF/MOSF w/Sepsis,10.0,under $11k,218732.875,black,no,1.0,1.0,no dnr,145.0,147.0,17.5976562,134.0,12.0,38.5,160.0,2.2998047,1.29980469,0.59997559,130.0,7.359375,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),2.2563477
43.53998,male,0.0,Lung Cancer,12.0,under $11k,25725.641,black,metastatic,0.799999714,0.5,no dnr,21.0,77.0,6.39941406,124.0,38.0,39.89844,376.1875,2.8999023,2.39990234,0.5,141.0,7.459961,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
35.66898,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,158145.75,white,no,0.75,0.75,no dnr,39.0,49.0,19.6992188,144.0,48.0,39.59375,55.0,2.7998047,0.5,0.79992676,135.0,7.40918,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
56.81598,female,1.0,CHF,9.0,under $11k,12576.898,white,no,0.899999619,0.75,no dnr,5.0,115.0,7.79980469,72.0,24.0,36.19531,300.0,2.8999023,0.89990234,1.59985352,133.0,7.449219,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
42.14099,male,0.0,CHF,12.0,under $11k,88426.188,white,no,0.799999714,0.6999998,no dnr,27.0,59.0,7.39941406,74.0,24.0,37.79688,376.625,2.8999023,1.0,1.09985352,132.0,7.469727,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
47.62198,male,0.0,Colon Cancer,16.0,>$50k,3364.6,white,metastatic,0.899999619,0.6999998,no dnr,5.0,78.0,3.59960938,64.0,16.0,36.19531,224.0,3.699707,1.69995117,0.79992676,136.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.6801758
65.20697,female,0.0,CHF,8.0,under $11k,4139.348,black,no,0.5,0.3,no dnr,7.0,100.0,5.19921875,80.0,32.0,36.39844,161.875,3.3999023,2.19970703,1.09985352,136.0,7.399414,135.0,23.0,1968.0,4.0,4.0,no(M2 and SIP pres),4.0
75.07495,male,1.0,ARF/MOSF w/Sepsis,11.0,$25-$50k,75079.25,white,no,0.099999964,0.0009999992,no dnr,18.0,71.0,15.5996094,74.0,11.0,37.79688,146.65625,2.3999023,3.19970703,4.09960938,138.0,7.469727,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
58.29199,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,20454.547,white,no,0.0,0.0,dnr before sadm,-5.0,70.0,15.5996094,0.0,0.0,35.5,228.0,2.8999023,0.39996338,3.5,124.0,7.15918,135.0,23.0,1968.0,0.0,3.0,<2 mo. follow-up,3.0
65.86395,male,0.0,Lung Cancer,12.0,under $11k,15353.195,black,metastatic,0.599999905,0.09999996,dnr after sadm,2.0,75.0,11.0,88.0,28.0,37.19531,228.5625,4.0,0.5,0.79992676,130.0,7.489258,135.0,23.0,1968.0,0.0,2.0,no(M2 and SIP pres),2.0
59.064,male,0.0,Colon Cancer,9.0,$25-$50k,6036.098,white,metastatic,0.899999619,0.6999998,no dnr,5.0,109.0,5.89941406,80.0,24.0,38.19531,224.0,3.199707,0.89990234,0.89990234,139.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
35.57797,male,0.0,COPD,12.0,under $11k,16707.297,black,no,0.699999809,0.5,no dnr,13.0,70.0,9.79882812,120.0,30.0,36.0,295.625,2.699707,0.89990234,0.89990234,133.0,7.349609,135.0,23.0,1968.0,0.0,5.0,no(M2 and SIP pres),5.0
25.56899,male,0.0,ARF/MOSF w/Sepsis,15.0,under $11k,36389.594,white,no,0.699999809,0.5,no dnr,22.0,119.0,1.29980469,114.0,12.0,35.79688,456.625,2.199707,0.89990234,5.29980469,144.0,7.439453,135.0,23.0,1968.0,2.0,1.0,<2 mo. follow-up,1.8389997
60.05197,male,0.0,Cirrhosis,16.0,under $11k,4399.648,white,no,0.699999809,0.5,no dnr,4.0,71.0,6.29980469,72.0,16.0,36.69531,224.0,2.8999023,7.29980469,1.0,136.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.8688965
88.19196,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,29291.234,black,no,0.799999714,0.5999999,dnr after sadm,2.0,52.0,7.29980469,144.0,11.0,36.69531,240.0,2.0996094,0.39996338,2.29980469,139.0,7.269531,135.0,23.0,1968.0,0.0,7.0,adl>=4 (>=5 if sur),7.0
48.42999,male,1.0,Cirrhosis,10.0,$11-$25k,22941.047,white,no,0.099999964,0.0009999992,dnr after sadm,3.0,75.0,12.8984375,138.0,10.0,34.79688,98.32812,2.199707,2.39990234,1.89990234,138.0,7.449219,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
72.78894,male,0.0,Lung Cancer,14.0,>$50k,3910.1,white,metastatic,0.799999714,0.5,no dnr,4.0,120.0,11.3984375,120.0,28.0,36.09375,224.0,2.8999023,0.59997559,1.79980469,136.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
25.618,female,1.0,Cirrhosis,13.0,under $11k,47193.688,black,no,0.5,0.5,dnr after sadm,10.0,59.0,15.6992188,100.0,33.0,35.59375,213.3125,2.2998047,20.296875,3.29980469,130.0,7.439453,135.0,23.0,1968.0,0.0,3.0,<2 mo. follow-up,3.0
50.11398,male,0.0,CHF,12.0,under $11k,8178.348,black,no,0.699999809,0.5,no dnr,6.0,115.0,5.79980469,100.0,28.0,36.69531,304.75,2.8999023,0.89990234,0.89990234,141.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
59.28497,male,1.0,Lung Cancer,12.0,$25-$50k,42512.125,white,metastatic,0.099999964,0.0009999992,dnr after sadm,8.0,103.0,20.1992188,100.0,20.0,37.0,290.4375,2.0996094,0.19998169,0.5,138.0,7.5,135.0,23.0,1968.0,4.0,6.0,<2 mo. follow-up,6.0
50.396,female,1.0,MOSF w/Malig,10.0,$11-$25k,134989.125,white,yes,0.699999809,0.3999999,dnr after sadm,14.0,109.0,39.1953125,106.0,28.0,36.59375,160.0,2.699707,0.89990234,1.09985352,137.0,7.479492,135.0,23.0,1968.0,0.0,5.0,<2 mo. follow-up,5.0
69.72498,female,1.0,COPD,11.0,under $11k,303683.5,white,no,0.0,0.0,dnr after sadm,46.0,113.0,12.5996094,120.0,36.0,38.0,193.3125,2.5996094,1.5,0.79992676,148.0,7.349609,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
47.10999,female,0.0,Cirrhosis,10.0,under $11k,6076.496,black,no,0.699999809,0.5,no dnr,7.0,80.0,10.3984375,100.0,20.0,38.0,224.0,1.5998535,5.79980469,0.89990234,136.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
77.96899,female,1.0,COPD,12.0,under $11k,63867.688,white,no,0.049999982,0.0001249999,dnr after sadm,16.0,103.0,12.1992188,96.0,36.0,36.09375,260.0,2.5,5.29980469,0.69995117,129.0,7.429688,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
43.99698,male,1.0,Cirrhosis,14.0,under $11k,42310.281,hispanic,no,0.699999809,0.5,no dnr,19.0,97.0,8.19921875,130.0,12.0,38.79688,496.625,2.8999023,1.79980469,0.79992676,142.0,7.5,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
19.85199,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,95530.875,white,no,0.009999998,9.999994e-07,no dnr,8.0,63.0,20.0976562,124.0,20.0,38.39844,98.32812,3.199707,21.1992188,3.69970703,137.0,7.429688,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.8825684
79.69098,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,172505.125,white,no,0.699999809,0.5,dnr after sadm,17.0,56.0,9.59960938,114.0,34.0,38.5,293.3125,4.0996094,9.5,0.79992676,136.0,7.449219,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
40.34998,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,34898.594,black,no,0.699999809,0.5,no dnr,19.0,87.0,13.6992188,80.0,20.0,35.59375,125.0,2.7998047,0.29998779,8.3984375,127.0,7.40918,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
36.90298,male,0.0,ARF/MOSF w/Sepsis,14.0,>$50k,25755.594,hispanic,no,0.699999809,0.5,no dnr,16.0,73.0,12.2988281,130.0,9.0,34.89844,347.5625,2.3999023,5.5,2.59960938,131.0,7.40918,135.0,23.0,1968.0,5.0,6.0,<2 mo. follow-up,6.0
76.51196,female,0.0,Lung Cancer,8.0,under $11k,6821.75,white,metastatic,0.799999714,0.5,no dnr,9.0,109.0,1.29980469,92.0,20.0,36.79688,224.0,2.8999023,0.89990234,1.09985352,139.0,7.419922,135.0,23.0,1968.0,1.0,1.0,no(M2 and SIP pres),1.1668997
41.629,male,0.0,Coma,8.0,$11-$25k,64012.688,white,no,0.799999714,0.75,no dnr,38.0,114.0,13.7988281,114.0,60.0,40.0,227.5,2.8999023,1.19995117,1.39990234,144.0,7.439453,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
40.452,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,31204.594,black,no,0.799999714,0.6999998,no dnr,12.0,117.0,16.0976562,98.0,26.0,36.09375,260.0,2.8999023,0.89990234,0.79992676,135.0,7.339844,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
71.96698,female,1.0,Coma,12.0,$25-$50k,50624.125,white,no,0.199999928,0.09999996,dnr after sadm,10.0,137.0,15.5,116.0,35.0,38.5,372.0,2.7998047,0.89990234,2.09960938,134.0,7.389648,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
43.37299,male,1.0,MOSF w/Malig,15.0,$25-$50k,21115.188,black,metastatic,0.099999964,0.0009999992,dnr after sadm,3.0,0.0,16.8984375,0.0,14.0,35.79688,273.3125,2.5996094,12.5996094,4.29980469,149.0,7.319336,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
56.556,female,0.0,Colon Cancer,12.0,$25-$50k,6480.297,white,metastatic,0.899999619,0.5999999,no dnr,6.0,103.0,6.0,100.0,28.0,38.5,224.0,2.8999023,1.19995117,0.59997559,140.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
82.58197,female,1.0,ARF/MOSF w/Sepsis,10.0,under $11k,63105.875,white,no,0.0,0.0,dnr after sadm,7.0,47.0,17.0,106.0,10.0,36.09375,260.0,2.8999023,10.0,6.09960938,123.0,7.319336,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
36.74197,male,1.0,MOSF w/Malig,12.0,under $11k,36980.094,black,yes,0.5,0.09999996,dnr after sadm,8.0,63.0,14.5,140.0,32.0,35.69531,146.65625,2.8999023,0.89990234,1.09985352,143.0,7.469727,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
48.30698,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,33070.469,white,no,1.0,1.0,no dnr,17.0,110.0,28.1992188,50.0,16.0,37.0,443.4375,2.7998047,0.89990234,5.0,131.0,7.40918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.6401367
65.13599,male,0.0,ARF/MOSF w/Sepsis,11.0,$25-$50k,57069.969,white,yes,0.899999619,0.8999996,no dnr,15.0,53.0,20.0,116.0,28.0,39.0,194.0,3.2998047,4.79980469,2.19970703,130.0,7.439453,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
48.931,male,0.0,ARF/MOSF w/Sepsis,18.0,>$50k,79986.812,black,no,0.699999809,0.5999999,no dnr,37.0,111.0,13.7988281,74.0,8.0,38.89844,304.0,3.199707,0.29998779,1.0,138.0,7.369141,135.0,23.0,1968.0,0.0,2.0,no(M2 and SIP pres),2.0
73.54999,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,154653.25,white,no,0.049999982,0.0001249999,no dnr,40.0,136.0,14.5996094,158.0,29.0,35.59375,200.0,1.5998535,3.29980469,5.5,138.0,7.519531,135.0,23.0,1968.0,0.0,7.0,<2 mo. follow-up,7.0
77.86694,male,0.0,ARF/MOSF w/Sepsis,16.0,$11-$25k,492828.0,white,no,0.599999905,0.5999999,dnr after sadm,82.0,75.0,21.5976562,140.0,9.0,38.29688,187.5,2.8999023,0.89990234,2.19970703,151.0,7.389648,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),2.6162109
67.54297,female,1.0,COPD,13.0,under $11k,7606.227,white,no,0.299999952,0.15,dnr after sadm,1.0,80.0,3.69970703,106.0,24.0,37.39844,164.0,2.8999023,0.29998779,0.39996338,136.0,7.25,135.0,23.0,1968.0,5.0,5.0,<2 mo. follow-up,5.0
76.61597,male,1.0,ARF/MOSF w/Sepsis,7.0,under $11k,54942.594,white,no,0.699999809,0.5,dnr after sadm,1.0,81.0,13.8984375,64.0,40.0,39.79688,410.0,3.0996094,0.89990234,0.79992676,146.0,7.469727,135.0,23.0,1968.0,0.0,5.0,<2 mo. follow-up,5.0
56.91998,male,1.0,Coma,16.0,>$50k,39522.688,white,metastatic,0.599999905,0.3,dnr after sadm,2.0,111.0,12.1992188,116.0,22.0,36.59375,316.625,1.7998047,0.69995117,0.5,135.0,7.429688,135.0,23.0,1968.0,0.0,5.0,<2 mo. follow-up,5.0
42.46997,male,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,22030.047,white,no,0.899999619,0.8999996,no dnr,11.0,101.0,5.79980469,70.0,12.0,38.09375,304.75,2.8999023,0.19998169,0.69995117,136.0,7.439453,135.0,23.0,1968.0,0.0,2.0,no(M2 and SIP pres),2.0
34.56299,male,0.0,Lung Cancer,12.0,under $11k,6135.598,white,metastatic,0.699999809,0.5,no dnr,5.0,87.0,11.8984375,84.0,20.0,36.09375,266.625,3.699707,0.5,0.69995117,140.0,7.469727,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.9155273
79.19196,male,0.0,ARF/MOSF w/Sepsis,10.0,>$50k,99666.938,white,no,0.75,0.75,no dnr,44.0,52.0,16.296875,74.0,26.0,37.59375,179.5625,2.5,0.89990234,4.29980469,130.0,7.359375,135.0,23.0,1968.0,0.0,0.0,SIP>=30,0.0
80.60498,male,0.0,COPD,24.0,$25-$50k,36915.625,white,yes,0.699999809,0.5,no dnr,36.0,87.0,15.5996094,64.0,28.0,36.59375,145.6875,2.8999023,0.29998779,1.0,134.0,7.439453,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
44.39398,male,1.0,Coma,12.0,under $11k,11347.344,black,no,0.0,0.0,dnr after sadm,3.0,0.0,20.796875,0.0,0.0,35.0,544.0,2.8999023,0.89990234,2.5,154.0,7.479492,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.3742676
51.504,male,0.0,Coma,12.0,under $11k,156180.375,black,no,0.399999857,0.09999996,dnr after sadm,36.0,81.0,7.5,66.0,26.0,38.29688,303.3125,2.8999023,0.89990234,1.19995117,145.0,7.439453,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.0087891
75.35699,male,1.0,ARF/MOSF w/Sepsis,9.0,under $11k,169118.25,black,no,0.699999809,0.5,dnr after sadm,59.0,65.0,0.19998169,110.0,8.0,36.79688,233.3125,2.3999023,0.89990234,0.59997559,134.0,7.5,135.0,23.0,1968.0,0.0,7.0,<2 mo. follow-up,7.0
67.52399,male,0.0,Coma,8.0,under $11k,141597.75,black,no,0.949999809,0.8999996,no dnr,44.0,75.0,8.3984375,156.0,37.0,38.5,305.6875,2.3999023,0.39996338,1.5,138.0,7.40918,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
48.728,male,0.0,CHF,12.0,under $11k,10446.398,black,no,0.799999714,0.5999999,no dnr,10.0,106.0,5.69921875,84.0,20.0,35.79688,224.0,3.0996094,2.19970703,1.69995117,134.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
66.80597,male,0.0,Lung Cancer,12.0,$11-$25k,7554.199,white,metastatic,0.599999905,0.3999999,no dnr,8.0,100.0,14.7988281,100.0,24.0,36.59375,420.0,2.2998047,1.29980469,1.0,144.0,7.389648,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
68.70898,male,1.0,ARF/MOSF w/Sepsis,11.0,$11-$25k,94199.812,white,no,0.599999905,0.5,dnr after sadm,19.0,115.0,12.7988281,124.0,33.0,37.19531,108.32812,2.8999023,0.79992676,0.89990234,140.0,7.439453,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
40.99899,male,0.0,CHF,11.0,under $11k,13750.117,black,no,0.699999809,0.5,no dnr,14.0,120.0,5.29980469,85.0,22.0,36.0,300.0,2.0996094,0.39996338,3.29980469,142.0,7.449219,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
52.97198,male,1.0,Coma,11.0,under $11k,18601.594,black,no,0.019999996,7.999995e-06,no dnr,8.0,96.0,17.1992188,52.0,12.0,36.69531,290.0,2.8999023,0.29998779,1.09985352,136.0,7.5,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
66.64496,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,269475.5,black,no,0.799999714,0.7999997,no dnr,78.0,51.0,20.0,104.0,38.0,38.79688,208.0,3.7998047,12.0996094,2.09960938,131.0,7.399414,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.4394531
62.69998,male,0.0,ARF/MOSF w/Sepsis,13.0,$11-$25k,55241.594,white,no,0.799999714,0.7999997,no dnr,14.0,100.0,16.296875,124.0,14.0,36.0,255.53125,2.8999023,0.89990234,0.69995117,147.0,7.479492,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
49.45099,female,0.0,ARF/MOSF w/Sepsis,8.0,under $11k,92412.438,white,no,0.799999714,0.6999998,no dnr,23.0,133.0,8.0,64.0,12.0,37.39844,292.0,2.8999023,0.89990234,0.39996338,132.0,7.469727,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
61.99298,female,1.0,MOSF w/Malig,7.0,under $11k,58915.594,white,yes,0.699999809,0.5,dnr after sadm,13.0,50.0,25.296875,110.0,20.0,36.59375,54.0,2.3999023,0.09999084,1.09985352,139.0,7.349609,135.0,23.0,1968.0,0.0,5.0,<2 mo. follow-up,5.0
39.82999,female,0.0,ARF/MOSF w/Sepsis,13.0,under $11k,28210.188,black,no,0.699999809,0.5,no dnr,9.0,142.0,6.39941406,114.0,28.0,38.29688,160.0,2.5996094,0.5,1.19995117,137.0,7.479492,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
41.91898,male,0.0,Colon Cancer,12.0,under $11k,4684.547,black,metastatic,0.699999809,0.5,no dnr,5.0,73.0,5.69921875,104.0,24.0,38.29688,224.0,2.8999023,0.19998169,1.19995117,139.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.8041992
70.52197,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,93077.688,white,no,0.299999952,0.15,dnr after sadm,19.0,65.0,14.5996094,118.0,23.0,36.79688,157.5,2.8999023,2.59960938,1.09985352,152.0,7.509766,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.0449219
59.95099,male,0.0,ARF/MOSF w/Sepsis,6.0,under $11k,37907.438,white,no,0.599999905,0.5,no dnr,9.0,109.0,9.29882812,126.0,32.0,35.39844,168.5625,2.8999023,0.89990234,1.59985352,138.0,7.469727,135.0,23.0,1968.0,5.0,7.0,SIP>=30,7.0
63.064,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,70353.0,white,no,0.799999714,0.75,no dnr,23.0,67.0,11.3984375,120.0,17.0,37.79688,141.65625,2.5,0.59997559,1.19995117,156.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
52.70898,female,0.0,Lung Cancer,10.0,under $11k,13646.242,white,metastatic,0.799999714,0.5999999,no dnr,9.0,77.0,7.19921875,124.0,24.0,38.59375,292.0,2.3999023,0.39996338,0.69995117,140.0,7.389648,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
31.28299,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,52990.125,white,no,0.599999905,0.5,dnr after sadm,6.0,105.0,19.3984375,124.0,30.0,38.19531,303.3125,2.5996094,20.0,2.5,145.0,7.489258,135.0,23.0,1968.0,0.0,3.0,<2 mo. follow-up,3.0
57.21597,female,0.0,ARF/MOSF w/Sepsis,14.0,under $11k,173402.5,white,no,0.899999619,0.7999997,no dnr,53.0,129.0,8.19921875,124.0,10.0,38.39844,146.0,2.5996094,0.79992676,5.0,131.0,7.359375,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
53.33298,male,1.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,57244.219,white,no,0.299999952,0.1999999,no dnr,10.0,70.0,6.0,130.0,18.0,38.29688,93.32812,2.8999023,0.89990234,0.79992676,135.0,7.389648,135.0,23.0,1968.0,0.0,7.0,<2 mo. follow-up,7.0
56.04898,male,0.0,MOSF w/Malig,12.0,under $11k,67626.438,white,yes,0.699999809,0.5,no dnr,38.0,95.0,0.79992676,136.0,9.0,38.29688,185.0,2.8999023,0.89990234,2.59960938,144.0,7.299805,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
54.92099,male,0.0,ARF/MOSF w/Sepsis,7.0,under $11k,244624.625,white,no,0.699999809,0.5,no dnr,148.0,77.0,11.0,70.0,38.0,36.09375,312.0,1.7998047,9.59960938,9.19921875,132.0,7.399414,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
59.29898,male,0.0,Lung Cancer,14.0,$25-$50k,16175.344,white,metastatic,1.0,0.7999997,no dnr,14.0,95.0,10.7988281,76.0,16.0,36.89844,224.0,2.8999023,0.5,0.79992676,138.0,7.419922,135.0,23.0,1968.0,0.0,3.0,adl>=4 (>=5 if sur),3.0
53.03198,male,0.0,CHF,10.0,$11-$25k,25024.0,white,no,0.699999809,0.5,no dnr,261.0,67.0,7.89941406,112.0,15.0,35.59375,428.5625,2.8999023,0.79992676,1.09985352,134.0,7.509766,135.0,23.0,1968.0,3.0,3.0,no(M2 and SIP pres),3.0
61.55499,male,0.0,ARF/MOSF w/Sepsis,18.0,$25-$50k,35619.375,white,no,0.699999809,0.5,no dnr,15.0,172.0,6.5,136.0,47.0,35.59375,233.3125,1.8999023,0.39996338,1.39990234,141.0,7.339844,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
77.659,male,1.0,CHF,8.0,$11-$25k,37074.156,white,no,0.699999809,0.5,dnr after sadm,2.0,63.0,7.19921875,106.0,15.0,35.69531,167.5,2.8999023,0.89990234,2.69970703,128.0,7.439453,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
68.18597,male,0.0,Lung Cancer,13.0,$25-$50k,32881.094,white,metastatic,0.5,0.3,no dnr,29.0,83.0,13.0996094,80.0,20.0,37.5,224.0,2.8999023,0.19998169,0.69995117,134.0,7.419922,135.0,23.0,1968.0,3.0,2.0,adl>=4 (>=5 if sur),2.0
63.83298,male,0.0,Colon Cancer,16.0,>$50k,5728.848,white,metastatic,0.899999619,0.6999998,no dnr,6.0,99.0,4.5,76.0,22.0,36.69531,224.0,3.0996094,0.89990234,1.0,142.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
43.58698,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,116817.688,white,metastatic,0.849999905,0.7999997,no dnr,35.0,114.0,15.8984375,134.0,10.0,38.5,140.0,2.7998047,5.5,0.79992676,142.0,7.459961,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
89.23199,male,0.0,COPD,4.0,under $11k,33702.719,black,no,0.049999982,0.0001249999,no dnr,18.0,63.0,5.69921875,130.0,6.0,37.0,117.76562,2.8999023,0.89990234,1.79980469,146.0,7.489258,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
69.98499,female,0.0,Colon Cancer,16.0,>$50k,7079.297,white,metastatic,0.399999857,0.1999999,no dnr,8.0,122.0,31.0976562,76.0,28.0,35.79688,224.0,2.699707,0.09999084,0.59997559,137.0,7.479492,135.0,23.0,1968.0,2.0,0.0,adl>=4 (>=5 if sur),0.0
65.62396,male,0.0,ARF/MOSF w/Sepsis,3.0,under $11k,43053.844,black,metastatic,0.799999714,0.7999997,dnr after sadm,8.0,75.0,10.0,130.0,24.0,36.5,224.0,2.8999023,0.89990234,0.79992676,139.0,7.419922,135.0,23.0,1968.0,0.0,3.0,<2 mo. follow-up,3.0
23.19199,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,24461.188,black,no,0.989999771,0.9799995,no dnr,11.0,122.0,15.1992188,114.0,41.0,37.69531,220.0,2.8999023,0.89990234,0.19998169,136.0,7.589844,135.0,23.0,1968.0,0.0,5.0,adl>=4 (>=5 if sur),5.0
60.646,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,79154.938,white,no,0.699999809,0.5,dnr after sadm,4.0,61.0,16.5976562,124.0,8.0,36.0,160.0,2.5,3.09960938,5.39941406,131.0,7.369141,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.0366211
44.05197,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,121420.875,white,no,0.699999809,0.5,no dnr,5.0,51.0,9.8984375,60.0,31.0,40.09375,283.3125,3.2998047,12.0,3.0,133.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
70.14899,female,1.0,Coma,7.0,under $11k,83997.625,white,no,0.699999809,0.5,dnr after sadm,2.0,70.0,16.5976562,64.0,28.0,38.5,220.0,2.5,1.09985352,2.69970703,135.0,7.579102,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.46875
69.66498,female,0.0,COPD,11.0,under $11k,4562.496,white,no,0.75,0.6499996,no dnr,9.0,107.0,9.59960938,84.0,22.0,36.39844,214.28125,3.3999023,0.29998779,1.59985352,136.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
65.47296,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,87248.375,white,no,0.699999809,0.5,dnr after sadm,2.0,0.0,11.8984375,0.0,0.0,38.09375,248.0,4.0996094,4.5,2.59960938,135.0,7.459961,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.7382812
68.18097,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,40095.0,white,yes,0.25,0.15,dnr after sadm,7.0,69.0,29.5976562,122.0,34.0,36.79688,72.0,1.3999023,0.89990234,0.69995117,139.0,7.539062,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.1450195
75.15399,male,0.0,COPD,12.0,under $11k,6329.598,white,no,0.899999619,0.5999999,no dnr,9.0,107.0,5.5,108.0,24.0,36.0,364.0,4.2998047,0.39996338,0.89990234,144.0,7.359375,135.0,23.0,1968.0,1.0,0.0,no(M2 and SIP pres),0.0
65.42395,female,0.0,Cirrhosis,14.0,$11-$25k,9626.047,white,no,0.699999809,0.5,no dnr,13.0,77.0,3.59960938,80.0,20.0,37.0,224.0,2.8999023,3.5,0.69995117,124.0,7.419922,135.0,23.0,1968.0,1.0,0.0,no(M2 and SIP pres),0.0
72.79095,male,1.0,ARF/MOSF w/Sepsis,9.0,under $11k,26893.812,white,no,0.699999809,0.5,dnr after sadm,4.0,68.0,22.296875,112.0,8.0,38.79688,151.65625,2.8999023,0.09999084,7.29980469,128.0,7.40918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.4125977
66.146,male,1.0,MOSF w/Malig,7.0,under $11k,71331.938,black,yes,0.699999809,0.5,dnr after sadm,5.0,53.0,1.0,160.0,40.0,36.5,313.3125,3.0,1.09985352,5.29980469,134.0,7.349609,135.0,23.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
74.89697,male,0.0,CHF,18.0,$11-$25k,23341.547,white,no,0.979999542,0.9499998,no dnr,10.0,75.0,14.3984375,96.0,12.0,36.59375,288.0,2.8999023,1.19995117,1.59985352,131.0,7.429688,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
60.241,female,0.0,MOSF w/Malig,12.0,under $11k,59781.688,white,yes,0.799999714,0.6999998,no dnr,9.0,108.0,7.0,46.0,16.0,36.19531,396.0,1.2998047,0.29998779,0.59997559,129.0,7.449219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
51.85498,female,0.0,ARF/MOSF w/Sepsis,14.0,$25-$50k,24805.141,white,no,0.699999809,0.5,no dnr,14.0,76.0,8.5,114.0,24.0,36.19531,328.0,2.8999023,0.89990234,0.5,137.0,7.399414,135.0,23.0,1968.0,1.0,0.0,no(M2 and SIP pres),0.0
43.63898,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,45775.469,white,no,0.699999809,0.5,no dnr,18.0,78.0,7.0,56.0,24.0,36.0,352.375,2.8999023,2.09960938,0.79992676,139.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.1977539
40.41898,female,1.0,ARF/MOSF w/Sepsis,15.0,$25-$50k,363470.25,white,no,0.199999928,0.1999999,no dnr,99.0,69.0,14.0,114.0,26.0,37.79688,126.65625,2.8999023,1.19995117,3.39990234,149.0,7.469727,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
33.66998,male,0.0,Colon Cancer,14.0,under $11k,9953.547,black,metastatic,0.199999928,0.09999996,no dnr,10.0,107.0,17.1992188,84.0,24.0,36.29688,224.0,2.699707,0.79992676,0.79992676,137.0,7.419922,135.0,23.0,1968.0,1.0,6.0,<2 mo. follow-up,6.0
75.66595,female,1.0,ARF/MOSF w/Sepsis,11.0,$25-$50k,60396.969,white,no,0.699999809,0.5,dnr after sadm,13.0,71.0,8.5,64.0,40.0,38.59375,194.28125,2.199707,0.89990234,0.59997559,138.0,7.369141,135.0,23.0,1968.0,0.0,4.0,<2 mo. follow-up,4.0
44.85999,male,0.0,ARF/MOSF w/Sepsis,13.0,under $11k,27579.141,black,no,0.699999809,0.5,no dnr,9.0,141.0,11.5996094,116.0,60.0,35.39844,447.5625,2.8999023,0.89990234,0.39996338,130.0,7.429688,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
51.90097,male,0.0,CHF,9.0,under $11k,12283.992,black,no,0.699999809,0.5999999,no dnr,6.0,65.0,7.19921875,64.0,26.0,36.29688,385.6875,3.199707,1.69995117,1.0,126.0,7.5,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
69.06799,male,1.0,ARF/MOSF w/Sepsis,16.0,$25-$50k,238776.0,white,no,0.25,0.1999999,no dnr,36.0,120.0,19.296875,110.0,25.0,38.29688,303.3125,2.7998047,5.59960938,7.0,138.0,7.429688,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
30.70499,female,1.0,ARF/MOSF w/Sepsis,10.0,under $11k,71635.188,other,no,0.099999964,0.0009999992,dnr after sadm,15.0,70.0,13.6992188,156.0,36.0,41.0,125.0,2.8999023,1.29980469,1.59985352,145.0,7.429688,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
52.57498,male,0.0,Lung Cancer,12.0,under $11k,3042.049,white,metastatic,0.799999714,0.5,no dnr,4.0,115.0,12.1992188,84.0,20.0,36.89844,224.0,2.8999023,0.79992676,1.09985352,139.0,7.419922,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),1.9589844
59.69598,male,0.0,CHF,8.0,under $11k,2390.049,black,no,0.699999809,0.5,no dnr,4.0,87.0,5.5,110.0,20.0,35.69531,433.3125,2.8999023,4.19921875,1.39990234,129.0,7.519531,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
65.62598,male,0.0,COPD,12.0,under $11k,53957.688,black,no,0.699999809,0.5,no dnr,18.0,109.0,11.7988281,60.0,10.0,36.79688,142.0,2.8999023,0.89990234,1.29980469,128.0,7.469727,135.0,23.0,1968.0,0.0,2.0,no(M2 and SIP pres),2.0
62.30298,male,0.0,COPD,11.0,under $11k,24865.984,white,no,0.599999905,0.5,no dnr,11.0,67.0,10.5996094,108.0,16.0,37.0,312.0,2.8999023,0.5,2.19970703,136.0,7.40918,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
48.72299,female,0.0,ARF/MOSF w/Sepsis,11.0,under $11k,115659.5,black,no,0.25,0.1999999,no dnr,32.0,55.0,4.09960938,130.0,14.0,39.79688,288.0,2.7998047,0.19998169,10.0,145.0,7.439453,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
79.80798,male,1.0,ARF/MOSF w/Sepsis,13.0,>$50k,30417.844,white,yes,0.5,0.25,dnr after sadm,3.0,64.0,13.3984375,50.0,6.0,37.5,310.0,2.5,0.89990234,5.09960938,133.0,7.359375,135.0,23.0,1968.0,0.0,7.0,<2 mo. follow-up,7.0
55.64999,female,0.0,ARF/MOSF w/Sepsis,13.0,under $11k,92960.125,white,no,0.799999714,0.7799997,no dnr,37.0,63.0,17.296875,110.0,24.0,38.0,253.3125,2.8999023,0.39996338,4.59960938,143.0,7.429688,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
45.57397,female,0.0,ARF/MOSF w/Sepsis,13.0,$25-$50k,34929.969,black,no,0.989999771,0.9899998,no dnr,15.0,80.0,12.6992188,104.0,40.0,38.59375,316.625,2.8999023,0.89990234,0.59997559,128.0,7.429688,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
52.16199,male,0.0,Lung Cancer,12.0,$25-$50k,4945.75,white,metastatic,0.699999809,0.5,no dnr,5.0,107.0,10.0,75.0,16.0,35.79688,224.0,2.8999023,0.39996338,0.89990234,142.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
73.52795,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,44709.406,white,no,0.199999928,0.09999996,dnr after sadm,3.0,51.0,9.5,114.0,30.0,39.09375,162.5,2.8999023,0.89990234,1.19995117,154.0,7.339844,135.0,23.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
61.37399,male,0.0,Colon Cancer,12.0,$25-$50k,3351.299,white,metastatic,0.399999857,0.3,no dnr,4.0,83.0,14.0996094,75.0,16.0,35.69531,342.8125,2.8999023,1.69995117,0.59997559,140.0,7.489258,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
66.52698,female,1.0,ARF/MOSF w/Sepsis,16.0,under $11k,82417.812,white,yes,0.5,0.3,dnr after sadm,8.0,50.0,8.69921875,110.0,25.0,35.69531,111.65625,2.699707,0.29998779,1.09985352,141.0,7.339844,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
59.60599,male,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,142387.875,white,no,0.899999619,0.8999996,no dnr,75.0,110.0,13.7988281,96.0,8.0,38.19531,316.625,2.7998047,4.29980469,1.29980469,142.0,7.439453,135.0,23.0,1968.0,0.0,7.0,SIP>=30,7.0
54.92999,female,0.0,Lung Cancer,12.0,$11-$25k,7007.297,white,metastatic,0.899999619,0.7999997,no dnr,6.0,87.0,5.79980469,80.0,20.0,36.5,224.0,3.2998047,0.09999084,0.5,143.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
30.07799,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,209604.625,white,no,0.0,0.0,no dnr,6.0,129.0,6.89941406,70.0,45.0,35.39844,283.3125,4.8994141,44.09375,4.79980469,151.0,7.469727,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.2128906
71.83795,male,0.0,Lung Cancer,11.0,$11-$25k,4572.348,white,metastatic,0.899999619,0.5,no dnr,6.0,99.0,5.59960938,96.0,24.0,36.79688,224.0,3.3999023,8.79882812,0.79992676,139.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
83.21997,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,118611.438,white,no,0.699999809,0.5,dnr after sadm,2.0,28.0,11.3984375,70.0,24.0,38.5,184.0,2.8999023,27.0,5.39941406,152.0,7.379883,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.2944336
69.60999,male,0.0,CHF,3.0,under $11k,10542.648,other,no,0.699999809,0.5,no dnr,10.0,80.0,6.89941406,60.0,24.0,36.59375,224.0,2.8999023,0.89990234,2.0,143.0,7.419922,135.0,23.0,1968.0,0.0,6.0,adl>=4 (>=5 if sur),6.0
65.65399,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,76424.625,white,no,0.5,0.4499998,no dnr,17.0,133.0,10.1992188,11.398438,36.0,38.79688,137.5,2.8999023,0.89990234,0.79992676,136.0,7.509766,135.0,23.0,1968.0,0.0,2.0,no(M2 and SIP pres),2.0
72.797,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,168419.875,white,no,0.5,0.5,dnr after sadm,7.0,66.0,4.69921875,130.0,10.0,35.89844,260.0,1.8999023,12.8984375,1.39990234,149.0,7.449219,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),2.0439453
77.46198,male,0.0,ARF/MOSF w/Sepsis,16.0,$11-$25k,237865.75,white,no,0.299999952,0.1999999,dnr after sadm,38.0,117.0,22.1992188,118.0,10.0,35.39844,230.0,1.5998535,0.5,3.59960938,149.0,7.489258,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
71.06097,female,0.0,COPD,15.0,under $11k,10342.977,white,no,0.699999809,0.5999999,no dnr,10.0,90.0,10.6992188,126.0,28.0,38.0,200.0,2.8999023,0.89990234,0.89990234,134.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
68.73395,female,0.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,16283.492,white,no,0.699999809,0.5,no dnr,8.0,97.0,3.79980469,110.0,25.0,38.29688,126.51562,2.8999023,0.89990234,0.89990234,139.0,7.439453,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
40.92499,female,0.0,MOSF w/Malig,12.0,>$50k,53731.688,white,yes,0.699999809,0.5,no dnr,19.0,63.0,11.6992188,120.0,14.0,36.09375,74.28125,2.8999023,0.69995117,0.59997559,143.0,7.509766,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
61.74399,male,1.0,ARF/MOSF w/Sepsis,6.0,under $11k,26100.234,white,no,0.699999809,0.5,dnr after sadm,6.0,137.0,12.5996094,60.0,10.0,35.0,230.0,2.0996094,0.09999084,0.79992676,147.0,7.5,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
61.405,female,0.0,Lung Cancer,16.0,$25-$50k,5310.949,white,metastatic,0.699999809,0.5,no dnr,5.0,120.0,20.5976562,86.0,20.0,36.19531,224.0,2.8999023,0.29998779,1.09985352,141.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
25.00999,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,25024.0,black,no,0.699999809,0.5,no dnr,116.0,69.0,12.2988281,104.0,11.0,36.19531,352.0,2.3999023,4.0,1.19995117,137.0,7.359375,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
46.702,female,0.0,ARF/MOSF w/Sepsis,15.0,>$50k,61325.469,white,no,0.799999714,0.75,no dnr,16.0,73.0,11.1992188,74.0,24.0,38.29688,177.5,2.3999023,0.89990234,1.29980469,136.0,7.449219,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
78.98999,female,0.0,COPD,11.0,under $11k,40662.344,white,yes,0.799999714,0.3,no dnr,24.0,65.0,10.5996094,96.0,8.0,36.29688,326.625,2.8999023,0.89990234,1.59985352,139.0,7.369141,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
80.45197,female,1.0,Colon Cancer,16.0,under $11k,9865.195,white,metastatic,0.099999964,0.0009999992,dnr after sadm,6.0,89.0,13.8984375,86.0,20.0,36.39844,224.0,2.5,11.1992188,1.19995117,140.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.1020508
50.88599,male,1.0,MOSF w/Malig,12.0,under $11k,45795.031,white,yes,0.199999928,0.1999999,no dnr,10.0,67.0,6.5,134.0,30.0,38.5,98.65625,2.199707,0.39996338,0.79992676,141.0,7.389648,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.1328125
68.39996,male,0.0,MOSF w/Malig,7.0,under $11k,76318.688,black,yes,0.5,0.5,no dnr,28.0,121.0,3.39990234,140.0,8.0,39.79688,167.5,1.5,0.5,2.19970703,148.0,7.529297,135.0,23.0,1968.0,0.0,5.0,no(M2 and SIP pres),5.0
59.35898,male,0.0,COPD,12.0,under $11k,19767.641,white,no,0.699999809,0.6999998,no dnr,11.0,113.0,13.5,110.0,24.0,36.5,220.0,3.199707,0.09999084,0.69995117,147.0,7.399414,135.0,23.0,1968.0,0.0,4.0,no(M2 and SIP pres),4.0
30.33299,female,1.0,ARF/MOSF w/Sepsis,11.0,under $11k,191009.625,white,no,0.299999952,0.3,dnr after sadm,42.0,113.0,11.5996094,130.0,28.0,39.0,132.71875,2.0,0.19998169,0.59997559,143.0,7.429688,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
64.82996,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,213969.625,white,no,0.699999809,0.5,no dnr,62.0,145.0,5.59960938,186.0,8.0,38.0,91.0,2.8999023,0.89990234,0.69995117,142.0,7.369141,135.0,23.0,1968.0,0.0,3.0,adl>=4 (>=5 if sur),3.0
68.75,female,1.0,Coma,8.0,>$50k,36883.469,black,no,0.099999964,0.0009999992,dnr after sadm,9.0,70.0,14.5,108.0,8.0,36.19531,423.3125,1.1999512,0.29998779,3.0,134.0,7.449219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
83.79999,male,0.0,Lung Cancer,16.0,under $11k,6363.598,white,metastatic,0.75,0.5,no dnr,12.0,99.0,5.89941406,80.0,16.0,36.19531,224.0,3.199707,0.5,1.19995117,145.0,7.439453,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
64.698,male,0.0,Colon Cancer,12.0,$11-$25k,8570.148,white,metastatic,0.799999714,0.5,no dnr,7.0,119.0,8.8984375,60.0,24.0,36.29688,224.0,3.8999023,0.59997559,0.89990234,136.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
29.30299,female,0.0,MOSF w/Malig,12.0,under $11k,78111.062,white,yes,0.199999928,0.1999999,no dnr,48.0,56.0,1.09985352,134.0,38.0,39.29688,414.25,2.2998047,5.89941406,0.89990234,135.0,7.419922,135.0,23.0,1968.0,0.0,3.0,SIP>=30,3.0
74.89697,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,202651.25,white,no,0.849999905,0.8199997,no dnr,100.0,103.0,14.5,55.0,32.0,38.5,108.15625,2.8999023,0.89990234,2.89990234,134.0,7.459961,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.3496094
60.44098,male,0.0,Cirrhosis,18.0,>$50k,16636.344,white,no,0.5,0.3,dnr after sadm,14.0,63.0,7.0,74.0,22.0,36.19531,542.75,2.8999023,1.29980469,3.79980469,132.0,7.269531,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
37.06198,female,0.0,MOSF w/Malig,12.0,under $11k,217273.625,white,yes,0.399999857,0.3999999,dnr after sadm,14.0,73.0,0.29998779,144.0,32.0,39.29688,206.65625,1.6999512,0.39996338,1.0,154.0,7.379883,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),1.0
85.40997,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,19168.188,black,no,0.199999928,0.1999999,dnr after sadm,4.0,70.0,42.6953125,120.0,48.0,33.89844,112.23438,2.8999023,1.69995117,0.79992676,139.0,7.529297,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
35.71799,female,1.0,MOSF w/Malig,12.0,$25-$50k,239604.75,white,metastatic,0.599999905,0.5,dnr after sadm,5.0,59.0,14.2988281,144.0,9.0,36.79688,286.625,2.2998047,0.89990234,5.5,134.0,7.289062,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
57.65097,male,0.0,Lung Cancer,8.0,under $11k,6005.699,white,metastatic,0.799999714,0.1999999,no dnr,5.0,83.0,15.5996094,108.0,16.0,36.19531,224.0,3.0,0.29998779,0.89990234,135.0,7.419922,135.0,23.0,1968.0,3.0,1.0,no(M2 and SIP pres),1.0
57.34399,female,0.0,Cirrhosis,12.0,$11-$25k,4947.398,white,no,0.699999809,0.5,no dnr,5.0,70.0,3.89990234,74.0,20.0,36.79688,224.0,2.5,2.5,0.89990234,138.0,7.419922,135.0,23.0,1968.0,1.0,0.0,no(M2 and SIP pres),0.0
79.05499,female,0.0,ARF/MOSF w/Sepsis,6.0,under $11k,60292.469,black,no,0.799999714,0.5999999,no dnr,47.0,87.0,9.5,114.0,28.0,37.79688,452.375,2.199707,1.09985352,2.0,141.0,7.439453,135.0,23.0,1968.0,0.0,3.0,adl>=4 (>=5 if sur),3.0
52.38599,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,64889.688,black,no,0.699999809,0.5,no dnr,12.0,65.0,11.7988281,106.0,8.0,37.39844,110.0,2.8999023,0.89990234,2.89990234,136.0,7.389648,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.3422852
19.92599,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,17898.344,white,no,0.5,0.5,dnr after sadm,2.0,125.0,9.19921875,136.0,44.0,38.69531,376.1875,2.8999023,0.89990234,0.69995117,144.0,7.469727,135.0,23.0,1968.0,0.0,7.0,<2 mo. follow-up,7.0
57.72998,male,1.0,Coma,3.0,under $11k,125777.25,black,no,0.699999809,0.5,dnr after sadm,12.0,107.0,7.09960938,136.0,8.0,35.89844,266.625,3.0996094,7.0,4.69921875,135.0,7.469727,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.9760742
73.13898,female,0.0,ARF/MOSF w/Sepsis,13.0,under $11k,140687.375,white,no,0.799999714,0.7999997,no dnr,52.0,107.0,12.5996094,116.0,10.0,38.69531,260.0,2.3999023,0.69995117,1.79980469,146.0,7.40918,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
43.90399,male,0.0,ARF/MOSF w/Sepsis,14.0,>$50k,63622.125,white,no,0.699999809,0.5,no dnr,14.0,111.0,13.1992188,68.0,10.0,38.29688,172.5,2.8999023,4.39941406,1.0,134.0,7.399414,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.9741211
25.67,male,0.0,Colon Cancer,16.0,under $11k,3895.0,white,metastatic,0.5,0.3,no dnr,5.0,81.0,3.69970703,20.0,20.0,36.5,224.0,2.2998047,0.29998779,0.89990234,139.0,7.419922,135.0,23.0,1968.0,1.0,1.0,<2 mo. follow-up,1.1668997
80.13696,female,0.0,ARF/MOSF w/Sepsis,8.0,$25-$50k,54550.188,white,no,0.699999809,0.5,no dnr,30.0,111.0,6.19921875,56.0,26.0,36.0,157.5,2.8999023,0.89990234,0.79992676,140.0,7.479492,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
70.57898,male,0.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,176328.0,white,no,0.799999714,0.6999998,no dnr,81.0,129.0,4.79980469,68.0,9.0,36.69531,142.0,2.0,1.59985352,0.89990234,132.0,7.519531,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
86.35999,female,0.0,CHF,12.0,under $11k,7843.297,white,no,0.699999809,0.5,dnr after sadm,3.0,61.0,6.39941406,56.0,16.0,35.69531,442.8125,2.8999023,0.89990234,1.09985352,134.0,7.469727,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.5561523
40.74698,male,0.0,Cirrhosis,7.0,$11-$25k,10535.398,white,no,0.75,0.75,no dnr,9.0,103.0,4.39941406,100.0,20.0,36.79688,224.0,2.5,1.5,1.5,127.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
54.86398,male,0.0,Cirrhosis,12.0,under $11k,16353.844,white,no,0.699999809,0.5,dnr after sadm,9.0,83.0,8.19921875,106.0,24.0,36.19531,347.5625,2.0,11.1992188,0.89990234,130.0,7.529297,135.0,23.0,1968.0,1.0,2.0,<2 mo. follow-up,2.0
60.46799,male,1.0,COPD,12.0,under $11k,15643.797,white,no,0.0,0.0,dnr after sadm,4.0,115.0,13.0,139.0,32.0,37.69531,256.625,1.2998047,0.29998779,1.39990234,138.0,7.349609,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.4399414
57.49799,female,0.0,Colon Cancer,9.0,under $11k,7245.699,white,metastatic,0.699999809,0.5,dnr after sadm,4.0,83.0,5.29980469,94.0,20.0,36.19531,224.0,2.0996094,0.19998169,0.39996338,136.0,7.419922,135.0,23.0,1968.0,3.0,3.0,adl>=4 (>=5 if sur),3.0
68.45197,female,0.0,Colon Cancer,12.0,under $11k,18796.734,white,metastatic,0.699999809,0.5,dnr after sadm,2.0,75.0,2.79980469,60.0,10.0,38.29688,358.3125,3.3999023,0.89990234,0.69995117,134.0,7.5,135.0,23.0,1968.0,1.0,0.0,no(M2 and SIP pres),0.0
39.67697,male,0.0,Cirrhosis,12.0,$11-$25k,14717.844,black,no,0.699999809,0.5,dnr after sadm,5.0,88.0,6.19921875,106.0,28.0,37.69531,285.6875,1.5998535,5.39941406,1.0,133.0,7.449219,135.0,23.0,1968.0,0.0,7.0,SIP>=30,7.0
60.81897,male,0.0,CHF,5.0,under $11k,25250.438,other,no,0.5,0.1999999,no dnr,12.0,113.0,9.3984375,64.0,22.0,36.79688,300.0,1.7998047,0.69995117,1.69995117,130.0,7.439453,135.0,23.0,1968.0,6.0,6.0,SIP>=30,6.0
66.70795,male,1.0,ARF/MOSF w/Sepsis,14.0,under $11k,125133.938,white,yes,0.699999809,0.5,dnr after sadm,22.0,56.0,15.1992188,124.0,46.0,38.29688,116.0,2.699707,0.29998779,9.59960938,138.0,7.5,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
76.43298,female,0.0,ARF/MOSF w/Sepsis,8.0,$11-$25k,38696.375,white,no,0.699999809,0.5,no dnr,28.0,115.0,10.2988281,66.0,6.0,38.39844,428.5625,2.8999023,0.89990234,6.89941406,136.0,7.379883,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
47.21997,male,1.0,Coma,12.0,under $11k,30785.938,black,no,0.009999998,9.999994e-07,dnr after sadm,7.0,150.0,7.09960938,70.0,10.0,38.69531,388.0,1.7998047,0.79992676,5.29980469,145.0,7.459961,135.0,23.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
43.05798,female,0.0,ARF/MOSF w/Sepsis,14.0,$25-$50k,56844.312,hispanic,no,0.75,0.75,no dnr,15.0,118.0,20.796875,104.0,52.0,37.79688,200.0,2.2998047,7.45996094,1.19995117,137.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
88.94495,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,54263.375,white,no,0.799999714,0.5999999,dnr after sadm,12.0,107.0,6.79980469,124.0,28.0,38.5,290.0,2.7998047,0.89990234,0.89990234,142.0,7.40918,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
62.31598,female,0.0,ARF/MOSF w/Sepsis,11.0,under $11k,18113.938,black,no,0.599999905,0.7999997,no dnr,12.0,117.0,24.0,104.0,32.0,36.39844,300.0,2.2998047,0.39996338,1.39990234,141.0,7.439453,135.0,23.0,1968.0,2.0,0.0,no(M2 and SIP pres),0.0
90.95996,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,18570.594,white,no,0.299999952,0.3,dnr after sadm,1.0,107.0,8.3984375,154.0,54.0,36.19531,105.70312,2.8999023,0.89990234,0.69995117,151.0,7.419922,135.0,23.0,1968.0,0.0,6.0,<2 mo. follow-up,6.0
84.17798,male,0.0,COPD,12.0,under $11k,3358.498,white,no,0.699999809,0.5,no dnr,4.0,93.0,29.0,120.0,28.0,36.19531,204.75,2.8999023,0.39996338,1.79980469,143.0,7.339844,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),4.3662109
66.00696,male,0.0,Cirrhosis,5.0,under $11k,3166.85,black,no,0.699999809,0.5,no dnr,4.0,100.0,7.59960938,60.0,28.0,35.69531,224.0,2.199707,3.39990234,0.79992676,136.0,7.419922,135.0,23.0,1968.0,1.0,1.0,no(M2 and SIP pres),1.1668997
78.05896,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,171969.5,black,yes,0.25,0.15,dnr after sadm,20.0,50.0,23.0,100.0,32.0,38.0,131.09375,3.2998047,2.89990234,6.19921875,136.0,7.5,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.1533203
85.06195,female,0.0,CHF,12.0,under $11k,4003.299,white,no,0.5,0.4499998,dnr after sadm,3.0,107.0,8.0,52.0,36.0,35.39844,224.0,3.0996094,0.79992676,1.0,139.0,7.419922,135.0,23.0,1968.0,1.0,0.0,<2 mo. follow-up,0.0
45.89499,male,0.0,CHF,9.0,under $11k,18237.391,white,no,0.699999809,0.5,no dnr,8.0,75.0,7.89941406,76.0,16.0,35.79688,272.0,2.8999023,0.89990234,0.69995117,134.0,7.479492,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
